Citrus Sinensis ID: 040501

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------23
Protein Sequence
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHcccccccccccEEEEccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccHHHccccccccccccccHHHHHHHHHHHccccccHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccHHHHHEcccccccHHcHccHHEEccccccccEEEEEccccccHHHHHccccccccHHHHHHEEEEEEHcccccccHHHHHHHHcccccHHHHccHHHcccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcc
Coil and Loop (DISEMBL)
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLEngslsvilnndtsaeelgwSRRINVIKGIAHALSylhhdcippivhrdissknvlldleyeahvsdfgiakfiqpdssnwtefagtygyvapelAYTMKVTAKCDVYSFGVLALEVikgkhprdflsnvsssnpnilvnemldprlpplsvdirgKVISIMEVAFLCldnnpesrpnMQTICQLLCK
Flexible Loop (DISEMBL)
DKKEFLREItvlteirhrnivKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCldnnpesrpnMQTICQLLCK
Low Complexity Region (SEG)
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK
Disordered region (IsUnstruct)
****FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV*****NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN**********IC*****
Disordered Region (DISOPRED)
*KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP*ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK
Disordered Region (DISEMBL)
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK
Disordered Region (DISPRO)
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN*QTICQLLC*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	228	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.969	0.211	0.614	1e-79
Q9LP24	1120	Probable leucine-rich rep	no	no	0.973	0.198	0.605	4e-77
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.982	0.203	0.450	8e-51
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.973	0.201	0.446	7e-50
O49318	1124	Probable leucine-rich rep	no	no	0.978	0.198	0.440	1e-48
O49545	1003	Leucine-rich repeat recep	no	no	0.960	0.218	0.415	2e-46
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.973	0.177	0.392	8e-46
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.960	0.218	0.419	8e-46
C0LGV1	1135	LRR receptor-like serine/	no	no	0.969	0.194	0.393	1e-45
Q9LHP4	1141	Receptor-like protein kin	no	no	0.964	0.192	0.389	7e-45

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  295 bits (756), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 137/223 (61%), Positives = 176/223 (78%), Gaps = 2/223 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            K+EFL EI  LTEIRHRN+VK +GFC+H R++FLVYEY+E GSL  +L ND  A++L W 
Sbjct: 818  KQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWG 877

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +RINV+KG+AHALSY+HHD  P IVHRDISS N+LL  +YEA +SDFG AK ++PDSSNW
Sbjct: 878  KRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNW 937

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN--ILV 179
            +  AGTYGYVAPELAY MKVT KCDVYSFGVL LEVIKG+HP D +S +SSS P+  + +
Sbjct: 938  SAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSL 997

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              + D RLP  + +I+ +V+ I++VA LCL ++P++RP M +I
Sbjct: 998  KSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  287 bits (735), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 135/223 (60%), Positives = 170/223 (76%), Gaps = 1/223 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            K+EFL E+  LTEIRHRN+VK +GFC+H RH+FL+YEY+E GSL+ +L ND  A+ L W+
Sbjct: 894  KQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWT 953

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +RINV+KG+AHALSY+HHD I PIVHRDISS N+LLD +Y A +SDFG AK ++ DSSNW
Sbjct: 954  KRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNW 1013

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL-VN 180
            +  AGTYGYVAPE AYTMKVT KCDVYSFGVL LE+I GKHP D +S++SSS    L + 
Sbjct: 1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLR 1073

Query: 181  EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
             + D R+       R K++ ++E+A LCL  NPESRP M +I 
Sbjct: 1074 SISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  200 bits (508), Expect = 8e-51,   Method: Compositional matrix adjust.
 Identities = 105/233 (45%), Positives = 139/233 (59%), Gaps = 9/233 (3%)

Query: 5    FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
            F  EI+ L +IRHRNIVK YGFC H   + L+YEY+  GSL   L        L W+ R 
Sbjct: 842  FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901

Query: 65   NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSNWTE 123
             +  G A  L YLHHDC P IVHRDI S N+LLD  ++AHV DFG+AK I    S + + 
Sbjct: 902  RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA 961

Query: 124  FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSSNPN 176
             AG+YGY+APE AYTMKVT KCD+YSFGV+ LE+I GK P        D ++ V  S  N
Sbjct: 962  VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRN 1021

Query: 177  ILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            ++   EM D RL         ++  ++++A  C  N+P SRP M+ +  ++ +
Sbjct: 1022 MIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  197 bits (500), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 104/233 (44%), Positives = 146/233 (62%), Gaps = 11/233 (4%)

Query: 5    FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
            F  EI  L  IRHRNIVK +GFC H   + L+YEY+  GSL  IL++ +    L WS+R 
Sbjct: 850  FRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRF 907

Query: 65   NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI-QPDSSNWTE 123
             +  G A  L+YLHHDC P I HRDI S N+LLD ++EAHV DFG+AK I  P S + + 
Sbjct: 908  KIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA 967

Query: 124  FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSS-NP 175
             AG+YGY+APE AYTMKVT K D+YS+GV+ LE++ GK P        D ++ V S    
Sbjct: 968  IAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRR 1027

Query: 176  NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            + L + +LD RL      I   +++++++A LC   +P +RP+M+ +  +L +
Sbjct: 1028 DALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  192 bits (489), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 104/236 (44%), Positives = 146/236 (61%), Gaps = 13/236 (5%)

Query: 5    FLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
            F  EI  L +IRHRNIV+ Y FC H  +  + L+YEY+  GSL  +L+   S   + W  
Sbjct: 867  FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-HSMDWPT 925

Query: 63   RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI-QPDSSNW 121
            R  +  G A  L+YLHHDC P I+HRDI S N+L+D  +EAHV DFG+AK I  P S + 
Sbjct: 926  RFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSV 985

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFL---SNVSSSNPN-- 176
            +  AG+YGY+APE AYTMKVT KCD+YSFGV+ LE++ GK P   L    ++++   N  
Sbjct: 986  SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHI 1045

Query: 177  ---ILVNEMLDPRLPPLSVD-IRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                L +E+LDP L  +  D I   +I++ ++A LC  ++P  RP M+ +  +L +
Sbjct: 1046 RDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  185 bits (469), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 98/236 (41%), Positives = 142/236 (60%), Gaps = 17/236 (7%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F  EI  L  IRHR+IV+  GFC++   + LVYEY+ NGSL  +L+       L W  R 
Sbjct: 737 FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRY 795

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WT 122
            +    A  L YLHHDC P IVHRD+ S N+LLD  +EAHV+DFG+AKF+Q   ++   +
Sbjct: 796 KIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 855

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP----------RDFLSNVSS 172
             AG+YGY+APE AYT+KV  K DVYSFGV+ LE++ G+ P            ++  ++ 
Sbjct: 856 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTD 915

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           SN + ++ ++LDPRL  + +    +V  +  VA LC++     RP M+ + Q+L +
Sbjct: 916 SNKDSVL-KVLDPRLSSIPIH---EVTHVFYVAMLCVEEQAVERPTMREVVQILTE 967

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  183 bits (465), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 97/247 (39%), Positives = 141/247 (57%), Gaps = 25/247 (10%)

Query: 3    KEFLREITVLTEIRHRNIVKFYGFCTHARH--SFLVYEYLENGSLSVILNNDTSAEE--- 57
            K F RE+  L  IRHR++VK  G+C+      + L+YEY++NGS+   L+ D    E   
Sbjct: 991  KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050

Query: 58   --LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI- 114
              L W  R+ +  G+A  + YLHHDC+PPIVHRDI S NVLLD   EAH+ DFG+AK + 
Sbjct: 1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110

Query: 115  -----QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDF--- 166
                   DS+ W  FA +YGY+APE AY++K T K DVYS G++ +E++ GK P D    
Sbjct: 1111 ENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFG 1168

Query: 167  --LSNVSSSNPNILV-----NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
              +  V     ++ V     ++++DP+L PL          ++E+A  C   +P+ RP+ 
Sbjct: 1169 AEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSS 1228

Query: 220  QTICQLL 226
            +  C  L
Sbjct: 1229 RQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  183 bits (465), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/236 (41%), Positives = 143/236 (60%), Gaps = 17/236 (7%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F  EI  L  IRHR+IV+  GFC++   + LVYEY+ NGSL  +L+       L W+ R 
Sbjct: 733 FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHWNTRY 791

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WT 122
            +    A  L YLHHDC P IVHRD+ S N+LLD  +EAHV+DFG+AKF+Q   ++   +
Sbjct: 792 KIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 851

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP----------RDFLSNVSS 172
             AG+YGY+APE AYT+KV  K DVYSFGV+ LE+I GK P            ++ +++ 
Sbjct: 852 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTD 911

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           SN + ++ +++D RL  + V    +V  +  VA LC++     RP M+ + Q+L +
Sbjct: 912 SNKDCVL-KVIDLRLSSVPVH---EVTHVFYVALLCVEEQAVERPTMREVVQILTE 963

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  183 bits (464), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 140/239 (58%), Gaps = 18/239 (7%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +  F  E+  L  IRH+NIV+F G C +     L+Y+Y+ NGSL  +L+  +    LGW 
Sbjct: 833  RDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWE 892

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---- 117
             R  +I G A  L+YLHHDC+PPIVHRDI + N+L+  ++E ++ DFG+AK +       
Sbjct: 893  VRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFAR 952

Query: 118  SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD--------FLSN 169
            SSN    AG+YGY+APE  Y+MK+T K DVYS+GV+ LEV+ GK P D         +  
Sbjct: 953  SSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDW 1010

Query: 170  VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V       ++++ L  R P   V+   +++  + VA LC++  PE RP M+ +  +L +
Sbjct: 1011 VKKIRDIQVIDQGLQAR-PESEVE---EMMQTLGVALLCINPIPEDRPTMKDVAAMLSE 1065

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  180 bits (456), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 92/236 (38%), Positives = 140/236 (59%), Gaps = 16/236 (6%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +  F  E+  L  IRH+NIV+F G C +     L+Y+Y+ NGSL  +L+ +     L W 
Sbjct: 833  RDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWD 891

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--- 118
             R  ++ G A  L+YLHHDC+PPIVHRDI + N+L+ L++E +++DFG+AK +       
Sbjct: 892  LRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGR 951

Query: 119  -SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD-------FLSNV 170
             SN    AG+YGY+APE  Y+MK+T K DVYS+GV+ LEV+ GK P D        L + 
Sbjct: 952  CSN--TVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDW 1009

Query: 171  SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               N   L  E+LD  L   +     +++ ++  A LC++++P+ RP M+ +  +L
Sbjct: 1010 VRQNRGSL--EVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	228
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.995	0.219	0.637	9e-88
359491509	1032	PREDICTED: probable LRR receptor-like se	0.995	0.219	0.633	2e-86
297734327	622	unnamed protein product [Vitis vinifera]	0.995	0.364	0.626	9e-82
225456159	1038	PREDICTED: probable LRR receptor-like se	0.995	0.218	0.626	3e-81
147772402	996	hypothetical protein VITISV_022117 [Viti	0.995	0.227	0.630	4e-81
359491512	1078	PREDICTED: probable LRR receptor-like se	0.995	0.210	0.626	3e-80
225456161	1037	PREDICTED: probable LRR receptor-like se	0.995	0.218	0.593	4e-78
186511602	1045	Leucine-rich repeat-containing protein [	0.969	0.211	0.614	7e-78
7267528	1027	receptor protein kinase-like protein [Ar	0.969	0.215	0.614	7e-78
297734328	2131	unnamed protein product [Vitis vinifera]	0.986	0.105	0.594	1e-77

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  328 bits (841), Expect = 9e-88,   Method: Compositional matrix adjust.
 Identities = 146/229 (63%), Positives = 190/229 (82%), Gaps = 2/229 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +K+F+ EI  LTEI+HRNIVK  GFC+H+RHSFLVYEYLE GSL  IL+ +  A+E+GW 
Sbjct: 802  QKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             R+N+IKG+AHALSYLHHDC+PPIVHRDISS NVLLD +YEAHVSDFG AKF++ DSSNW
Sbjct: 862  TRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS--NPNILV 179
            +  AGTYGYVAPELAYTMKVT KCDVYSFGVLALEV++G+HP D +S++S+S    N+++
Sbjct: 922  STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVL 981

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
             ++LDPRLPP ++    +V+S++++A  CL+ +P+SRP MQ + Q+L +
Sbjct: 982  KDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQMLSQ 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  324 bits (830), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 145/229 (63%), Positives = 187/229 (81%), Gaps = 2/229 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +K+F+ EI  LTEI+HRNIVK  GFC+H+RHSFLVYEYLE GSL  IL+ +  A+E+GW 
Sbjct: 802  QKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             R+N+IKG++HALSYLHHDC+PPIVHRDISS NVLLD +YEAHVSDFG AKF++ DSSNW
Sbjct: 862  TRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS--NPNILV 179
            +  AGTYGYVAPELAYTMKVT KCDVYSFGVLALEV++G+HP D +S++S S    N+++
Sbjct: 922  STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVL 981

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
             ++LDPRLPP +     +V S++++A  CL+ +P+SRP MQ + Q+L +
Sbjct: 982  KDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQMLSQ 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734327|emb|CBI15574.3| unnamed protein product [Vitis vinifera]

 Score =  308 bits (790), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 144/230 (62%), Positives = 184/230 (80%), Gaps = 3/230 (1%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++K+FL EI  LTEI+HRNIVK  GFC+H RH FLVYEYLE GSL+ IL+ +  A++LGW
Sbjct: 392 NQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGW 450

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           + R+N+IKG+AHAL+Y+HHDC PPIVHRD+SS N+LLD +YEAH+SDFG AK ++ DSSN
Sbjct: 451 ATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSN 510

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD-FLS-NVSSSNPNIL 178
            +  AGT+GY+APELAYTMKVT K DV+SFGV+ALEVIKG+HP D  LS +VS    NI 
Sbjct: 511 QSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIA 570

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           + +MLDPRLPPL+    G+VI+I++ A  CL  NP+SRP MQT+ Q+L +
Sbjct: 571 LEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQMLSQ 620

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  306 bits (785), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 144/230 (62%), Positives = 184/230 (80%), Gaps = 3/230 (1%)

Query: 1    DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++K+FL EI  LTEI+HRNIVK  GFC+H RH FLVYEYLE GSL+ IL+ +  A++LGW
Sbjct: 808  NQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGW 866

Query: 61   SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + R+N+IKG+AHAL+Y+HHDC PPIVHRD+SS N+LLD +YEAH+SDFG AK ++ DSSN
Sbjct: 867  ATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSN 926

Query: 121  WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD-FLS-NVSSSNPNIL 178
             +  AGT+GY+APELAYTMKVT K DV+SFGV+ALEVIKG+HP D  LS +VS    NI 
Sbjct: 927  QSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIA 986

Query: 179  VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            + +MLDPRLPPL+    G+VI+I++ A  CL  NP+SRP MQT+ Q+L +
Sbjct: 987  LEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQMLSQ 1036

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  306 bits (784), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 145/230 (63%), Positives = 184/230 (80%), Gaps = 3/230 (1%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++K+FL EI  LTEI+HRNIVK  GFC+H RH FLVYEYLE GSL+ IL+ +  A++LGW
Sbjct: 766 NQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGW 824

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           + R+N+IKG+AHAL+Y+HHDC PPIVHRDISS N+LLD +YEAH+SDFG AK ++ DSSN
Sbjct: 825 ATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSN 884

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD-FLS-NVSSSNPNIL 178
            +  AGT+GY+APELAYTMKVT K DV+SFGV+ALEVIKG+HP D  LS +VS    NI 
Sbjct: 885 QSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIA 944

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           + +MLDPRLPPL+    G+VI+I++ A  CL  NP+SRP MQT+ Q+L +
Sbjct: 945 LEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQMLSQ 994

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  303 bits (777), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 144/230 (62%), Positives = 181/230 (78%), Gaps = 3/230 (1%)

Query: 1    DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++++F  E+  LTEI+HRNIVK  GFC+H RHSFLVYEYLE GSL+ +L+ +  A++LGW
Sbjct: 815  NQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSRE-EAKKLGW 873

Query: 61   SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + RIN+IKG+AHALSY+HHDC PPIVHRDISS N+LLD +YE H+SDFG AK ++ DSSN
Sbjct: 874  ATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSN 933

Query: 121  WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD-FLS-NVSSSNPNIL 178
             +  AGT+GYVAPE AYTMKVT K DVYSFGV+ LEVIKG+HP D  LS +VS    NI+
Sbjct: 934  QSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIV 993

Query: 179  VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            + +MLDPRLPPL+    G+VISI+ +A  CL  NPESRP M+ I Q+L +
Sbjct: 994  LEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQMLSQ 1043

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  296 bits (759), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 136/229 (59%), Positives = 184/229 (80%), Gaps = 2/229 (0%)

Query: 1    DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++K+FL ++  +TEI+HRNIV+  GFC++ RHSFLVYEYLE GSL+ IL+ +  A++LGW
Sbjct: 808  NQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSRE-EAKKLGW 866

Query: 61   SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + R+ +IKG+AHALSY+HHDC PPIVHRDISS N+LLD +YEAH+S+ G AK ++ DSSN
Sbjct: 867  ATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSN 926

Query: 121  WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS-SSNPNILV 179
             ++ AGT GYVAPE AYTMKVT K DVYSFGV+ALEVIKG+HP D + ++S S   NI++
Sbjct: 927  QSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSPEKNIVL 986

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
             +MLDPRLPPL+    G+V++I+++A  CL+ NP+SRP M+ I Q+L +
Sbjct: 987  KDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQMLSQ 1035

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana]

 Score =  295 bits (756), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 137/223 (61%), Positives = 176/223 (78%), Gaps = 2/223 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            K+EFL EI  LTEIRHRN+VK +GFC+H R++FLVYEY+E GSL  +L ND  A++L W 
Sbjct: 818  KQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWG 877

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +RINV+KG+AHALSY+HHD  P IVHRDISS N+LL  +YEA +SDFG AK ++PDSSNW
Sbjct: 878  KRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNW 937

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN--ILV 179
            +  AGTYGYVAPELAY MKVT KCDVYSFGVL LEVIKG+HP D +S +SSS P+  + +
Sbjct: 938  SAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSL 997

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              + D RLP  + +I+ +V+ I++VA LCL ++P++RP M +I
Sbjct: 998  KSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7267528|emb|CAB78010.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|7321074|emb|CAB82121.1| receptor protein kinase-like protein [Arabidopsis thaliana]

 Score =  295 bits (756), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 137/223 (61%), Positives = 176/223 (78%), Gaps = 2/223 (0%)

Query: 2    KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            K+EFL EI  LTEIRHRN+VK +GFC+H R++FLVYEY+E GSL  +L ND  A++L W 
Sbjct: 800  KQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWG 859

Query: 62   RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +RINV+KG+AHALSY+HHD  P IVHRDISS N+LL  +YEA +SDFG AK ++PDSSNW
Sbjct: 860  KRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNW 919

Query: 122  TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN--ILV 179
            +  AGTYGYVAPELAY MKVT KCDVYSFGVL LEVIKG+HP D +S +SSS P+  + +
Sbjct: 920  SAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSL 979

Query: 180  NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              + D RLP  + +I+ +V+ I++VA LCL ++P++RP M +I
Sbjct: 980  KSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1022

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734328|emb|CBI15575.3| unnamed protein product [Vitis vinifera]

 Score =  295 bits (754), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 135/227 (59%), Positives = 182/227 (80%), Gaps = 2/227 (0%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++K+FL ++  +TEI+HRNIV+  GFC++ RHSFLVYEYLE GSL+ IL+ +  A++LGW
Sbjct: 549 NQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSRE-EAKKLGW 607

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           + R+ +IKG+AHALSY+HHDC PPIVHRDISS N+LLD +YEAH+S+ G AK ++ DSSN
Sbjct: 608 ATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSN 667

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS-SSNPNILV 179
            ++ AGT GYVAPE AYTMKVT K DVYSFGV+ALEVIKG+HP D + ++S S   NI++
Sbjct: 668 QSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSPEKNIVL 727

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            +MLDPRLPPL+    G+V++I+++A  CL+ NP+SRP M+ I Q+ 
Sbjct: 728 KDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQMF 774

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	228
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.969	0.211	0.614	3.5e-73
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.964	0.196	0.614	2.1e-70
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.973	0.201	0.454	5.9e-47
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.964	0.199	0.458	2.6e-46
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.969	0.196	0.444	4.5e-46
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.951	0.216	0.431	1.6e-43
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.951	0.216	0.431	5.6e-43
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.960	0.371	0.421	1.5e-42
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.951	0.366	0.420	2.5e-42
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.973	0.177	0.396	3.2e-42

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 3.5e-73, P = 3.5e-73
 Identities = 137/223 (61%), Positives = 176/223 (78%)

Query:     2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
             K+EFL EI  LTEIRHRN+VK +GFC+H R++FLVYEY+E GSL  +L ND  A++L W 
Sbjct:   818 KQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWG 877

Query:    62 RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +RINV+KG+AHALSY+HHD  P IVHRDISS N+LL  +YEA +SDFG AK ++PDSSNW
Sbjct:   878 KRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNW 937

Query:   122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN--ILV 179
             +  AGTYGYVAPELAY MKVT KCDVYSFGVL LEVIKG+HP D +S +SSS P+  + +
Sbjct:   938 SAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSL 997

Query:   180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
               + D RLP  + +I+ +V+ I++VA LCL ++P++RP M +I
Sbjct:   998 KSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSI 1040

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 2.1e-70, P = 2.1e-70
 Identities = 137/223 (61%), Positives = 172/223 (77%)

Query:     2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
             K+EFL E+  LTEIRHRN+VK +GFC+H RH+FL+YEY+E GSL+ +L ND  A+ L W+
Sbjct:   894 KQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWT 953

Query:    62 RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +RINV+KG+AHALSY+HHD I PIVHRDISS N+LLD +Y A +SDFG AK ++ DSSNW
Sbjct:   954 KRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNW 1013

Query:   122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL-VN 180
             +  AGTYGYVAPE AYTMKVT KCDVYSFGVL LE+I GKHP D +S++SSS    L + 
Sbjct:  1014 SAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLR 1073

Query:   181 EMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              + D R L P   + R K++ ++E+A LCL  NPESRP M +I
Sbjct:  1074 SISDERVLEPRGQN-REKLLKMVEMALLCLQANPESRPTMLSI 1115

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 502 (181.8 bits), Expect = 5.9e-47, P = 5.9e-47
 Identities = 105/231 (45%), Positives = 138/231 (59%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F  EI+ L +IRHRNIVK YGFC H   + L+YEY+  GSL   L        L W+ R 
Sbjct:   842 FRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARY 901

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSNWTE 123
              +  G A  L YLHHDC P IVHRDI S N+LLD  ++AHV DFG+AK I    S + + 
Sbjct:   902 RIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA 961

Query:   124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSSNPN 176
              AG+YGY+APE AYTMKVT KCD+YSFGV+ LE+I GK P        D ++ V  S  N
Sbjct:   962 VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRN 1021

Query:   177 ILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             ++   EM D RL         ++  ++++A  C  N+P SRP M+ +  ++
Sbjct:  1022 MIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 496 (179.7 bits), Expect = 2.6e-46, P = 2.6e-46
 Identities = 106/231 (45%), Positives = 145/231 (62%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F  EI  L  IRHRNIVK +GFC H   + L+YEY+  GSL  IL+ D S   L WS+R 
Sbjct:   850 FRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH-DPSCN-LDWSKRF 907

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSSNWTE 123
              +  G A  L+YLHHDC P I HRDI S N+LLD ++EAHV DFG+AK I  P S + + 
Sbjct:   908 KIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA 967

Query:   124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSS-NP 175
              AG+YGY+APE AYTMKVT K D+YS+GV+ LE++ GK P        D ++ V S    
Sbjct:   968 IAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRR 1027

Query:   176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             + L + +LD RL      I   +++++++A LC   +P +RP+M+ +  +L
Sbjct:  1028 DALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 494 (179.0 bits), Expect = 4.5e-46, P = 4.5e-46
 Identities = 104/234 (44%), Positives = 145/234 (61%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
             F  EI  L +IRHRNIV+ Y FC H  +  + L+YEY+  GSL  +L+   S   + W  
Sbjct:   867 FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-HSMDWPT 925

Query:    63 RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSSNW 121
             R  +  G A  L+YLHHDC P I+HRDI S N+L+D  +EAHV DFG+AK I  P S + 
Sbjct:   926 RFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSV 985

Query:   122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS---NVSSSNPN-- 176
             +  AG+YGY+APE AYTMKVT KCD+YSFGV+ LE++ GK P   L    ++++   N  
Sbjct:   986 SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHI 1045

Query:   177 ---ILVNEMLDPRLPPLSVD-IRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 L +E+LDP L  +  D I   +I++ ++A LC  ++P  RP M+ +  +L
Sbjct:  1046 RDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 469 (170.2 bits), Expect = 1.6e-43, P = 1.6e-43
 Identities = 101/234 (43%), Positives = 143/234 (61%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F  EI  L  IRHR+IV+  GFC++   + LVYEY+ NGSL  +L+       L W  R 
Sbjct:   737 FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRY 795

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WT 122
              +    A  L YLHHDC P IVHRD+ S N+LLD  +EAHV+DFG+AKF+Q   ++   +
Sbjct:   796 KIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 855

Query:   123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-RDF---------LSNVSS 172
               AG+YGY+APE AYT+KV  K DVYSFGV+ LE++ G+ P  +F         +  ++ 
Sbjct:   856 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTD 915

Query:   173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             SN + ++ ++LDPRL   S+ I  +V  +  VA LC++     RP M+ + Q+L
Sbjct:   916 SNKDSVL-KVLDPRLS--SIPIH-EVTHVFYVAMLCVEEQAVERPTMREVVQIL 965

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 5.6e-43, P = 5.6e-43
 Identities = 101/234 (43%), Positives = 144/234 (61%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F  EI  L  IRHR+IV+  GFC++   + LVYEY+ NGSL  +L+       L W+ R 
Sbjct:   733 FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHWNTRY 791

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WT 122
              +    A  L YLHHDC P IVHRD+ S N+LLD  +EAHV+DFG+AKF+Q   ++   +
Sbjct:   792 KIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 851

Query:   123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-RDF---------LSNVSS 172
               AG+YGY+APE AYT+KV  K DVYSFGV+ LE+I GK P  +F         + +++ 
Sbjct:   852 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTD 911

Query:   173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             SN + ++ +++D RL   SV +  +V  +  VA LC++     RP M+ + Q+L
Sbjct:   912 SNKDCVL-KVIDLRLS--SVPVH-EVTHVFYVALLCVEEQAVERPTMREVVQIL 961

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 450 (163.5 bits), Expect = 1.5e-42, P = 1.5e-42
 Identities = 97/230 (42%), Positives = 137/230 (59%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F RE+ +L  I+HR +V   G+C       L+Y+YL  GSL   L+     E+L W  R+
Sbjct:   345 FERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHK--RGEQLDWDSRV 402

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             N+I G A  L+YLHHDC P I+HRDI S N+LLD   EA VSDFG+AK ++ + S+ T  
Sbjct:   403 NIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 462

Query:   125 -AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD--FLS---NVSSSNPNIL 178
              AGT+GY+APE   + + T K DVYSFGVL LEV+ GK P D  F+    N+     N L
Sbjct:   463 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWL-NFL 521

Query:   179 VNEMLDPRLPPLSVD--IRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             ++E     +  LS +   R  + +++ +A  C+ ++P+ RP M  + QLL
Sbjct:   522 ISENRAKEIVDLSCEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLL 571

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
 Identities = 98/233 (42%), Positives = 138/233 (59%)

Query:     5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             F RE+ +L  I+HR +V   G+C       L+Y+YL  GSL   L+ +   E+L W  R+
Sbjct:   347 FERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVERG-EQLDWDSRV 405

Query:    65 NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             N+I G A  LSYLHHDC P I+HRDI S N+LLD   EA VSDFG+AK ++ + S+ T  
Sbjct:   406 NIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 465

Query:   125 -AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD--FLS---NVSSSNPNIL 178
              AGT+GY+APE   + + T K DVYSFGVL LEV+ GK P D  F+    NV       L
Sbjct:   466 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWL-KFL 524

Query:   179 VNE-----MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             ++E     ++DP    + ++    + +++ +A  C+  +PE RP M  + QLL
Sbjct:   525 ISEKRPRDIVDPNCEGMQME---SLDALLSIATQCVSPSPEERPTMHRVVQLL 574

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 459 (166.6 bits), Expect = 3.2e-42, P = 3.2e-42
 Identities = 98/247 (39%), Positives = 142/247 (57%)

Query:     3 KEFLREITVLTEIRHRNIVKFYGFCTHARH--SFLVYEYLENGSLSVILNNDTSAEE--- 57
             K F RE+  L  IRHR++VK  G+C+      + L+YEY++NGS+   L+ D    E   
Sbjct:   991 KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050

Query:    58 --LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI- 114
               L W  R+ +  G+A  + YLHHDC+PPIVHRDI S NVLLD   EAH+ DFG+AK + 
Sbjct:  1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110

Query:   115 -----QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD--F- 166
                    DS+ W  FA +YGY+APE AY++K T K DVYS G++ +E++ GK P D  F 
Sbjct:  1111 ENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFG 1168

Query:   167 --LSNVSSSNPNILV-----NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
               +  V     ++ V     ++++DP+L PL          ++E+A  C   +P+ RP+ 
Sbjct:  1169 AEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSS 1228

Query:   220 QTICQLL 226
             +  C  L
Sbjct:  1229 RQACDSL 1235

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017829001 SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (399 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	228
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  144 bits (365), Expect = 2e-42
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 16/227 (7%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +   REI +L  + H NIV+         H +LV EY E G L   L+       L   
Sbjct: 42  DQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSED 98

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
               +   I   L YLH +    I+HRD+  +N+LLD      ++DFG+AK +   SS+ 
Sbjct: 99  EAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL 155

Query: 122 TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
           T F GT  Y+APE L        K DV+S GV+  E++ GK P    S  +  +   L+ 
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP---FSGENILDQLQLIR 212

Query: 181 EMLDPRLP---PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            +L P L    P       +   +++    CL+ +P  RP  + I Q
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKK---CLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (350), Expect = 8e-41
 Identities = 56/157 (35%), Positives = 83/157 (52%), Gaps = 7/157 (4%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            +E LREI +L ++ H NIVK YG      H +LV EY E GSL  +L  +    +L   
Sbjct: 35  LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSED 92

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSN 120
             + ++  I   L YLH +    I+HRD+  +N+LLD    +  ++DFG++K +  D S 
Sbjct: 93  EILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL 149

Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALE 156
                GT  Y+APE L      + K D++S GV+  E
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (347), Expect = 6e-40
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 17/226 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D++  LREI +L +++H NIV+ Y         +LV EY E G L  +L       E   
Sbjct: 40  DRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--- 96

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 ++ I  AL YLH      IVHRD+  +N+LLD +    ++DFG+A+ + P    
Sbjct: 97  DEARFYLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL 153

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
            T F GT  Y+APE+          D++S GV+  E++ GK P              L  
Sbjct: 154 TT-FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFK 207

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQ 224
           ++  P+ P          IS      +   L  +PE R   +   Q
Sbjct: 208 KIGKPKPPF---PPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  135 bits (343), Expect = 3e-39
 Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 39/244 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDTS 54
           ++K+FL+E  V+ ++ H N+V+  G CT     +LV EY+E G L      S  +     
Sbjct: 39  ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPE 98

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
              L     ++    IA  + YL        VHRD++++N L+  +    +SDFG+++ +
Sbjct: 99  KSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155

Query: 115 QPDSSN-----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKH 162
             D              W          APE       T+K DV+SFGVL  E+   G  
Sbjct: 156 YDDDYYRKKTGGKLPIRWM---------APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           P      +S+     ++  +      P       ++  +M     C   +PE RP    +
Sbjct: 207 P---YPGLSNEE---VLEYLRKGYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSEL 257

Query: 223 CQLL 226
            + L
Sbjct: 258 VERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (340), Expect = 7e-39
 Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 48/244 (19%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             +EFLRE  ++ ++ H N+VK  G CT     ++V EY+E G L S +  N     +L 
Sbjct: 44  QIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR---PKLS 100

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            S  ++    IA  + YL        +HRD++++N L+       +SDFG+++ +  D  
Sbjct: 101 LSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 157

Query: 120 N----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-------KGKH 162
                      W          APE     K T+K DV+SFGVL  E+         G  
Sbjct: 158 YRKRGGKLPIRWM---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + L  + +             RLP    +   ++  +M     C   +PE RP    +
Sbjct: 209 NEEVLEYLKNGY-----------RLPQPP-NCPPELYDLML---QCWAEDPEDRPTFSEL 253

Query: 223 CQLL 226
            ++L
Sbjct: 254 VEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (339), Expect = 9e-39
 Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 33/237 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +EFLRE  ++ ++ H NIVK  G CT      +V EY+  G L   L      +EL  
Sbjct: 44  QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSL 102

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S  ++    IA  + YL        +HRD++++N L+       +SDFG+++ +  D   
Sbjct: 103 SDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159

Query: 121 ----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSN 169
                     W          APE     K T+K DV+SFGVL  E+   G+ P   +SN
Sbjct: 160 KVKGGKLPIRWM---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210

Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  +     L    PP       ++  +M     C   +PE RP    + ++L
Sbjct: 211 AEVLE-YLKKGYRLPK--PPNCPP---ELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  134 bits (339), Expect = 1e-38
 Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 49/245 (20%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +++EFL E +++ ++ H NIV+  G CT     ++V EY+  G L   L      E+L  
Sbjct: 44  EREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTL 101

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              + +   IA  + YL   + +    HRD++++N L+       +SDFG+++ I  D  
Sbjct: 102 KDLLQMALQIAKGMEYLESKNFV----HRDLAARNCLVTENLVVKISDFGLSRDIYEDDY 157

Query: 120 -----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-------KGK 161
                       W          APE     K T+K DV+SFGVL  E+         G 
Sbjct: 158 YRKRGGGKLPIKWM---------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208

Query: 162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT 221
              + L  +           +  P   P       ++  +M     C   +PE RP    
Sbjct: 209 SNEEVLELLEDGYR------LPRPENCPD------ELYELML---QCWAYDPEDRPTFSE 253

Query: 222 ICQLL 226
           + + L
Sbjct: 254 LVEDL 258

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (304), Expect = 1e-33
 Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 36/236 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K++ + EI +L + +H NIVK+YG        ++V E+   GSL  +L +         
Sbjct: 40  KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------T 91

Query: 61  SRRIN------VIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           ++ +       V K +   L YLH        I+HRDI + N+LL  + E  + DFG++ 
Sbjct: 92  NQTLTESQIAYVCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSA 146

Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
            +  D+       GT  ++APE+        K D++S G+ A+E+ +GK P         
Sbjct: 147 QLS-DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY-------- 197

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
           S    +          P       +  S     FL  CL  NPE RP   T  QLL
Sbjct: 198 SELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLL 249

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  114 bits (289), Expect = 3e-31
 Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 44/240 (18%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFC-THARHSFLVY-EYLENGSLSVILNNDTSAEELGW 60
           +   REI +L+ ++H NIV++YG      +++  ++ EY+  GSLS +L       E   
Sbjct: 44  EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE--- 100

Query: 61  SRRINVIKG----IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
                VI+     I   L+YLH +     IVHRDI   N+L+D +    ++DFG AK + 
Sbjct: 101 ----PVIRKYTRQILEGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRL- 151

Query: 116 PDSSNWTEF----AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
                  E      GT  ++APE+    +     D++S G   +E+  GK P    S + 
Sbjct: 152 -GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELG 207

Query: 172 SSNPNIL--VNEMLDPRLPP-LSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
           +    +    +    P +P  LS + +          FL  CL  +P+ RP   T  +LL
Sbjct: 208 NPMAALYKIGSSGEPPEIPEHLSEEAK---------DFLRKCLRRDPKKRP---TADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (279), Expect = 3e-28
 Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 19/227 (8%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI  + +++H NIVK  G C   + ++L++EY+E  +LS +L N      L W RR  + 
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIA 786

Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
            GIA AL +LH  C P +V  ++S + +++D + E H+    +   +  D+  +   A  
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA-- 843

Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS--------NPNILV 179
             YVAPE   T  +T K D+Y FG++ +E++ GK P D    V  S          +  +
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  +DP +       + +++ +M +A  C   +P +RP    + + L
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 3e-27
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 22/228 (9%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+ E  V+ ++ H N+V+ YG CT  R  F+V EY+ NG L   L          W   
Sbjct: 45  DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--L 102

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---SSN 120
           +++   +  A+ YL  +     +HRD++++N L+  +    VSDFG+A+++  D   SS 
Sbjct: 103 LDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNILV 179
            T+F     +  PE+    + ++K DV+SFGVL  EV  +GK P +  SN S    ++  
Sbjct: 160 GTKFP--VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSA 216

Query: 180 NEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              L  P+L P  V           + + C    PE RP  + +   L
Sbjct: 217 GYRLYRPKLAPTEV---------YTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (263), Expect = 6e-27
 Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 17/231 (7%)

Query: 3   KEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           + FLREI +L  + H  NIVK Y F       +LV EY++ GSL  +L        L  S
Sbjct: 42  ERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSES 101

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI------ 114
             + ++  I  AL YLH      I+HRDI  +N+LLD +     + DFG+AK +      
Sbjct: 102 EALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158

Query: 115 QPDSSNWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
               +  +   GT GY+APE+   +     ++  D++S G+   E++ G  P +   N S
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218

Query: 172 SSNPNI-LVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNM 219
           +++  + ++ E+  P L         ++IS      L   L  +P++R + 
Sbjct: 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 1e-26
 Identities = 57/163 (34%), Positives = 92/163 (56%), Gaps = 12/163 (7%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI +L E++H NIV++ G    A H  +  EY+  GS++ +LNN  + EE   +   N 
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNF 111

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT---- 122
           ++ I   L+YLH+     I+HRDI   N+L+D +    +SDFGI+K ++ +S +      
Sbjct: 112 VRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168

Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                G+  ++APE+      T K D++S G L +E++ GKHP
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  100 bits (252), Expect = 6e-26
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 33/236 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA----- 55
           ++++ L E+ +L ++ H NI+K+Y          +V EY + G LS  +           
Sbjct: 42  EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP 101

Query: 56  EELGWSRRINVIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
           EE      +     +  AL YLH        I+HRDI  +N+ L       + DFGI+K 
Sbjct: 102 EEQILDWFVQ----LCLALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152

Query: 114 IQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
           +           GT  Y++PEL        K D++S G +  E+   KHP  F       
Sbjct: 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F----EGE 206

Query: 174 NPNILVNEMLDPRLPPL----SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           N   L  ++L  + PP+    S ++R  ++S +      L  +PE RP++  I Q 
Sbjct: 207 NLLELALKILKGQYPPIPSQYSSELR-NLVSSL------LQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 31/230 (13%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           K  ++EI +L  ++H NIVK+ G    +   +++ EY ENGSL  I+       E   S 
Sbjct: 44  KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SL 100

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
               +  +   L+YLH      ++HRDI + N+L   +    ++DFG+A  +   S +  
Sbjct: 101 VAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP-----NI 177
              GT  ++APE+      +   D++S G   +E++ G  P   L      NP      I
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL------NPMAALFRI 211

Query: 178 LVNEMLDPRLPP-LSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQ 224
           + ++   P LP  +S +++          FL  C   +P  RP  + + +
Sbjct: 212 VQDDH--PPLPEGISPELKD---------FLMQCFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.5 bits (248), Expect = 2e-25
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 19/228 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---AEE 57
           +++E + E  VL ++    I+++Y          +V EY ENG L  +L         E+
Sbjct: 42  EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED 101

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
             W   I ++ G    L++LH      I+HRDI S N+ LD      + D G+AK +  +
Sbjct: 102 QVWRFFIQILLG----LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
           ++      GT  Y++PEL        K DV++ GV+  E   GKHP D      ++N   
Sbjct: 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD------ANNQGA 208

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           L+ +++    PP+S     ++  +++    CL  +   RP+   + + 
Sbjct: 209 LILKIIRGVFPPVSQMYSQQLAQLID---QCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 97.3 bits (243), Expect = 1e-24
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 25/231 (10%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +K+ LRE+  L       +VK YG         +V EY++ GSL+ +L      +     
Sbjct: 43  RKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIP 97

Query: 62  RRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   + + I   L YLH      I+HRDI   N+L++ + E  ++DFGI+K ++    
Sbjct: 98  EPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL- 178
               F GT  Y++PE       +   D++S G+  LE   GK P  FL     S   ++ 
Sbjct: 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQ 213

Query: 179 -VNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
            + +   P LP        +  S     F+  CL  +P+ RP   +  +LL
Sbjct: 214 AICDGPPPSLPA-------EEFSPEFRDFISACLQKDPKKRP---SAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 5e-24
 Identities = 55/174 (31%), Positives = 97/174 (55%), Gaps = 12/174 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-NNDTSAEELG 59
            + +FL E +++ +  H NI++  G  T +R   ++ EY+ENGSL   L  ND    +  
Sbjct: 48  QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFT 104

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++   +
Sbjct: 105 VGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161

Query: 120 NWTEFAGTYG--YVAPE-LAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSN 169
            +T   G     + APE +AY  K T+  DV+SFG++  EV+  G+ P   +SN
Sbjct: 162 TYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 1e-23
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)

Query: 1   DKKEFLREITVLTEIRH---RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE 57
           D  +  RE+ +L+++R     NI K+YG        +++ EY E GS+  ++     AE 
Sbjct: 42  DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE- 100

Query: 58  LGWSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
               + I+VI + +  AL Y+H      ++HRDI + N+L+       + DFG+A  +  
Sbjct: 101 ----KYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
           +SS  + F GT  ++APE+    K    K D++S G+   E+  G  P    S+V +   
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP---YSDVDAFRA 210

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
            +L+ +   PRL        G    + E    CLD  P+ R
Sbjct: 211 MMLIPKSKPPRLED-----NGYSKLLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.1 bits (234), Expect = 2e-23
 Identities = 61/229 (26%), Positives = 110/229 (48%), Gaps = 20/229 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++F+ E  V+ ++ H  +V+ YG CT  +  ++V E++ENG L   L       +L   
Sbjct: 43  EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKD 100

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---S 118
             +++ + +   + YL  +     +HRD++++N L+       VSDFG+ +++  D   S
Sbjct: 101 MLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNI 177
           S+  +F     +  PE+    K ++K DV+SFGVL  EV  +GK P +  SN        
Sbjct: 158 SSGAKFP--VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +  P+L  ++V          EV + C    PE RP    + + +
Sbjct: 216 RGFRLYRPKLASMTV---------YEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.8 bits (233), Expect = 3e-23
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 20/223 (8%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+ ++ H  +V+ YG CT  R  ++V EY+ NG L   L      +    S+ 
Sbjct: 45  EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQL 102

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---SSN 120
           + + K +   ++YL        +HRD++++N L+D +    VSDFG+++++  D   SS 
Sbjct: 103 LEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
            ++F   +    PE+    K ++K DV++FGVL  EV   GK P +  +N   S     V
Sbjct: 160 GSKFPVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKV 214

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           ++ L    P L+ +   KV +IM   + C     E RP  Q +
Sbjct: 215 SQGLRLYRPHLASE---KVYAIM---YSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 5e-23
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 26/223 (11%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG CT      LV+E++E+G LS  L       S E L
Sbjct: 43  EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL 102

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL       ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 103 -----LGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154

Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    K ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 155 YTSSTGTKFP--VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212

Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                  +  PRL   SV          E+   C    PE RP
Sbjct: 213 TINAGFRLYKPRLASQSV---------YELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 1e-22
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 35/234 (14%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + FL+E  ++ ++RH  +V+ Y  C+     ++V EY+  GSL   L +    ++L  
Sbjct: 44  SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRL 102

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +++   IA  ++YL        +HRD++++N+L+       ++DFG+A+ I+ D   
Sbjct: 103 PQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159

Query: 121 ----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSN 169
                     WT         APE A   + T K DV+SFG+L  E++  G+ P      
Sbjct: 160 AREGAKFPIKWT---------APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP---- 206

Query: 170 VSSSNPNILVNEMLDPRLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              +N  +L       R+P P           + ++   C D +PE RP  + +
Sbjct: 207 -GMTNREVLEQVERGYRMPRP-----PNCPEELYDLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 92.6 bits (230), Expect = 1e-22
 Identities = 59/195 (30%), Positives = 107/195 (54%), Gaps = 18/195 (9%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGW 60
           +++FL E +++ +  H NI+   G  T +R   ++ E++ENG+L S +  ND     +  
Sbjct: 49  RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-- 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++F++ D+S+
Sbjct: 107 -QLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162

Query: 121 WTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSN 174
            T  +   G     + APE     K T+  DV+S+G++  EV+  G+ P   +SN    N
Sbjct: 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222

Query: 175 PNILVNEMLDPRLPP 189
               + +  D RLPP
Sbjct: 223 A---IEQ--DYRLPP 232

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.7 bits (231), Expect = 1e-22
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 17/170 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLS-VILNNDTSAEELG 59
           +K+  + EI ++ + +H NIV +Y         ++V EY++ GSL+ +I  N     E  
Sbjct: 58  NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-- 115

Query: 60  WSRRIN-VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
              +I  V + +   L YLH      ++HRDI S N+LL  +    ++DFG A  +  + 
Sbjct: 116 --PQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Query: 119 SNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPR 164
           S      GT  ++APE+     Y  KV    D++S G++ +E+ +G+ P 
Sbjct: 171 SKRNSVVGTPYWMAPEVIKRKDYGPKV----DIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 92.9 bits (230), Expect = 2e-22
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 22/223 (9%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E+++ NIV F          F+V EYL  GSL+ ++  +T  +E   
Sbjct: 59  KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDE--- 114

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           ++   V +    AL +LH +    ++HRDI S NVLL ++    ++DFG    I P+ S 
Sbjct: 115 AQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSS 173
            +   GT  ++APE+        K D++S G++A+E+++G+ P       R      ++ 
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231

Query: 174 NPNILVNEMLDP-------RLPPLSVDIRGKVISIMEVAFLCL 209
            P +   E L P       R   + V+ RG    +++  FL L
Sbjct: 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 2e-22
 Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 36/221 (16%)

Query: 6   LREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  +L+ I H  IVK  Y F T     +LV EY   G L   L+ +    E   +R  
Sbjct: 41  LTERNILSRINHPFIVKLHYAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY 98

Query: 65  NVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWT 122
                I  AL YLH       I++RD+  +N+LLD +    ++DFG+AK      S   T
Sbjct: 99  --AAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152

Query: 123 EFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
            F GT  Y+APE+     Y   V    D +S GVL  E++ GK P        + +   +
Sbjct: 153 -FCGTPEYLAPEVLLGKGYGKAV----DWWSLGVLLYEMLTGKPP------FYAEDRKEI 201

Query: 179 VNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
             ++L    R P  LS + R     ++      L  +P  R
Sbjct: 202 YEKILKDPLRFPEFLSPEAR----DLISG---LLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.1 bits (229), Expect = 2e-22
 Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 40/243 (16%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +F REI +L  + H NIVK+ G C     R   L+ EYL +GSL   L      +++   
Sbjct: 52  DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLK 109

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           R +     I   + YL        +HRD++++N+L++ E    +SDFG+AK +  D    
Sbjct: 110 RLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD-- 164

Query: 122 TEFAGTYGYV-----------APELAYTMKVTAKCDVYSFGVLALEVI----KGKHP-RD 165
                 Y YV           APE   T K ++  DV+SFGV   E+       + P  +
Sbjct: 165 ------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218

Query: 166 FLSNVSSSNPNILVNEMLD-----PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
           FL  +  +   ++V  +L+      RLP        +V  +M+   LC +  P+ RP+  
Sbjct: 219 FLRMIGIAQGQMIVTRLLELLKEGERLPR-PPSCPDEVYDLMK---LCWEAEPQDRPSFA 274

Query: 221 TIC 223
            + 
Sbjct: 275 DLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 90.6 bits (225), Expect = 4e-22
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 26/226 (11%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F +E+  L  +RH++++  +  C+     +++ E +E GSL   L +    + L  +  
Sbjct: 48  DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASL 106

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           I++   +A  ++YL        +HRD++++N+L+  +    V+DFG+A+ I+ D    ++
Sbjct: 107 IDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNILVNEM 182
               Y + APE A     + K DV+SFG+L  E+   G+ P           P +  +E+
Sbjct: 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY----------PGMNNHEV 213

Query: 183 LDP-----RLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            D      R+P P       ++  IM     C    PE RP+ + +
Sbjct: 214 YDQITAGYRMPCPAKCP--QEIYKIM---LECWAAEPEDRPSFKAL 254

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.1 bits (224), Expect = 8e-22
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 44/242 (18%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE   E+ VL  ++H N+VK+YG   H    ++  EY   G+L  +L       E G   
Sbjct: 44  KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRIL 96

Query: 63  RINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
             +VI+         L+YLH      IVHRDI   N+ LD      + DFG A  ++ ++
Sbjct: 97  DEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153

Query: 119 SNWTE----FAGTYGYVAPELAYTMKVTAK---CDVYSFGVLALEVIKGKHPRDFLSN-- 169
           +   E     AGT  Y+APE+    K        D++S G + LE+  GK P   L N  
Sbjct: 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213

Query: 170 -----VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                V + +   +          P S+ +  +    ++    CL+++P+ RP   T  +
Sbjct: 214 QIMFHVGAGHKPPI----------PDSLQLSPEGKDFLD---RCLESDPKKRP---TASE 257

Query: 225 LL 226
           LL
Sbjct: 258 LL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.6 bits (222), Expect = 1e-21
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 18/231 (7%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T  + + ++ EY+ENG+L   L +     E    
Sbjct: 50  RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSY 107

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++   E  VSDFG+++ ++ D    
Sbjct: 108 QLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164

Query: 121 WTEFAGTYG--YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + APE     K T+  DV+SFG++  EV+  G+ P   +SN        
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA-- 222

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            +N+    RLP   +D    V  +M     C   +   RP    I  LL K
Sbjct: 223 -INDGF--RLPA-PMDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.4 bits (222), Expect = 2e-21
 Identities = 68/234 (29%), Positives = 100/234 (42%), Gaps = 30/234 (12%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFL--VYEYLENGSLSVIL------NNDT 53
           +K+ LRE+ +    +   IVK+YG       S +    EY E GSL  I           
Sbjct: 43  QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI 102

Query: 54  SAEELGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
             + LG   +I  +V+KG    LSYLH      I+HRDI   N+LL  + +  + DFG++
Sbjct: 103 GEKVLG---KIAESVLKG----LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152

Query: 112 -KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV 170
            + +   +S    F GT  Y+APE       +   DV+S G+  LEV + + P  F    
Sbjct: 153 GELV---NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP--FPPEG 207

Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEV--AFL--CLDNNPESRPNMQ 220
                 I +   +     P   D  G  I   E    F+  CL+ +P  RP   
Sbjct: 208 EPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW 261

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 2e-21
 Identities = 50/159 (31%), Positives = 89/159 (55%), Gaps = 11/159 (6%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 47  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 105

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 106 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 160

Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEV 157
             AG      + APE LAY  K + K DV++FGVL  E+
Sbjct: 161 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.8 bits (221), Expect = 2e-21
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 30/238 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYG--FCTHARHSFLVYEYLENGSLSVIL-----NNDT 53
           +K++ + E+ +L E++H NIV++Y        +  ++V EY E G L+ ++         
Sbjct: 42  EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY 101

Query: 54  SAEELGWSRRINVIKGIAHALSYLHH--DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
             EE  W     ++  +  AL   H+  D    ++HRD+   N+ LD      + DFG+A
Sbjct: 102 IEEEFIWR----ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157

Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP---RDFLS 168
           K +  DSS    + GT  Y++PE    M    K D++S G L  E+     P   R+ L 
Sbjct: 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217

Query: 169 NVSSSNPNILVNEMLDPRLPPL-SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
             S       + E    R+P   S ++  +VI         L+ +P+ RP+ + + QL
Sbjct: 218 LAS------KIKEGKFRRIPYRYSSELN-EVIK------SMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 3e-21
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 55/245 (22%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILNND 52
            + FL E +V+T +RH N+V+  G        ++V EY+  GSL         +VI    
Sbjct: 44  AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---- 99

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           T A++LG++        +   + YL        VHRD++++NVL+  +  A VSDFG+AK
Sbjct: 100 TLAQQLGFALD------VCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Query: 113 FIQP--DSS----NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI---KGKHP 163
                 DS      WT         APE     K + K DV+SFG+L  E+    +  +P
Sbjct: 151 EASQGQDSGKLPVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201

Query: 164 RDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT 221
           R  L +V    P++     ++     PP           + +V   C + +P  RP  + 
Sbjct: 202 RIPLKDVV---PHVEKGYRMEAPEGCPP----------EVYKVMKDCWELDPAKRPTFKQ 248

Query: 222 ICQLL 226
           + + L
Sbjct: 249 LREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.2 bits (221), Expect = 3e-21
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E +H NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 59  KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 114

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 115 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+++G+ P
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.5 bits (220), Expect = 3e-21
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 25/230 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA---EELG 59
           K+ LRE+ +L +     IV FYG   +     +  EY++ GSL  IL           LG
Sbjct: 44  KQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG 103

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
                 +   +   L+YLH      I+HRD+   N+L++   +  + DFG++  +    +
Sbjct: 104 -----KIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
               F GT  Y+APE       + K D++S G+  +E+  G+ P     N        L+
Sbjct: 157 K--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-ENDPPDGIFELL 213

Query: 180 NEMLD---PRLPPLSVDIRGKVISIMEVAF--LCLDNNPESRPNMQTICQ 224
             +++   PRLP           S     F  LCL  +P  RP+ + + +
Sbjct: 214 QYIVNEPPPRLP-------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 88.7 bits (220), Expect = 3e-21
 Identities = 69/246 (28%), Positives = 114/246 (46%), Gaps = 40/246 (16%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-----------N 50
           +K+F RE  +LT  +H NIVKFYG CT      +V+EY+E+G L+  L           +
Sbjct: 52  RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111

Query: 51  NDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDF 108
            D+   EL  S+ + +   IA  + YL   H      VHRD++++N L+  +    + DF
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDF 166

Query: 109 GIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           G+++ +   ++++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 167 GMSRDVY--TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Query: 164 RDFLSNVSSSNPNILVNEMLDPRL---PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
              LSN         V E +        P     R     + ++   C   +P+ R N++
Sbjct: 225 WYGLSNEE-------VIECITQGRLLQRP-----RTCPSEVYDIMLGCWKRDPQQRINIK 272

Query: 221 TICQLL 226
            I + L
Sbjct: 273 DIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.0 bits (218), Expect = 5e-21
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 26/225 (11%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +   +EI ++  + H +I++  G      H  L  E++  GS+S +L+   + +E   + 
Sbjct: 48  EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AV 104

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNW 121
            IN  + +   LSYLH +    I+HRD+   N+L+D       ++DFG A  +    +  
Sbjct: 105 IINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161

Query: 122 TEFA----GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            EF     GT  ++APE+    +    CDV+S G + +E+   K P    +    SN   
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLA 218

Query: 178 LVNEMLDPRLPP-----LSVDIRGKVISIMEVAFLCLDNNPESRP 217
           L+ ++      P     LS  +R       +V   CL+  PE RP
Sbjct: 219 LIFKIASATTAPSIPEHLSPGLR-------DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 5e-21
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 21/227 (9%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D K+FL E  ++ ++RH  +++ Y  CT     ++V E ++ GSL   L        L  
Sbjct: 44  DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKL 102

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + I++   +A  ++YL   + I    HRD++++NVL+       V+DFG+A+ I+ D  
Sbjct: 103 PQLIDMAAQVASGMAYLEAQNYI----HRDLAARNVLVGENNICKVADFGLARVIKEDIY 158

Query: 120 NWTEFAG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
              E A     + APE A   + + K DV+SFG+L  E++  G+ P   ++N        
Sbjct: 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------ 212

Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            V + +D   R+P       G    + ++   C   +P+ RP  +T+
Sbjct: 213 -VLQQVDQGYRMPCPP----GCPKELYDIMLDCWKEDPDDRPTFETL 254

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 5e-21
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 33/237 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K++FL+E  +L +  H NIVK  G C   +  ++V E +  GSL   L        L  
Sbjct: 35  LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTV 92

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + + +    A  + YL   +CI    HRD++++N L+       +SDFG+++  + +  
Sbjct: 93  KKLLQMSLDAAAGMEYLESKNCI----HRDLAARNCLVGENNVLKISDFGMSR--EEEGG 146

Query: 120 NWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
            +T   G       + APE     + T++ DV+S+G+L  E    G  P   +SN  +  
Sbjct: 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-- 204

Query: 175 PNILVNEMLDP--RLPP---LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 E ++   R+P       +I      +M     C   +PE+RP+   I   L
Sbjct: 205 -----RERIESGYRMPAPQLCPEEIY----RLML---QCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.0 bits (215), Expect = 2e-20
 Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 34/244 (13%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND--------- 52
           +K+F RE  +LT ++H +IVKFYG C       +V+EY+++G L+  L            
Sbjct: 51  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 110

Query: 53  ----TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDF 108
                +  ELG S+ +++   IA  + YL        VHRD++++N L+       + DF
Sbjct: 111 GQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDF 167

Query: 109 GIAKFIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           G+++ +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 168 GMSRDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Query: 164 RDFLSNVSSSNPNILVNEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              LSN +     I    +L+ PR+ P  V          ++   C    P+ R N++ I
Sbjct: 226 WFQLSN-TEVIECITQGRVLERPRVCPKEV---------YDIMLGCWQREPQQRLNIKEI 275

Query: 223 CQLL 226
            ++L
Sbjct: 276 YKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.6 bits (214), Expect = 2e-20
 Identities = 66/241 (27%), Positives = 113/241 (46%), Gaps = 37/241 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------------ 49
           +++F RE  +LT ++H++IV+FYG CT  R   +V+EY+ +G L+  L            
Sbjct: 51  RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG 110

Query: 50  NNDTSAEELGWSRRINVIKGIAHALSY---LHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
             D +  +L   + + +   IA  + Y   LH       VHRD++++N L+       + 
Sbjct: 111 GEDVAPGQLTLGQMLAIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIG 164

Query: 107 DFGIAKFIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK 161
           DFG+++ I   S+++    G       ++ PE     K T + D++SFGV+  E+   GK
Sbjct: 165 DFGMSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Query: 162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT 221
            P   LSN  +        E+  PR  P       +V +IM+    C    P+ R  ++ 
Sbjct: 223 QPWYQLSNTEAIECITQGRELERPRTCP------PEVYAIMQG---CWQREPQQRMVIKD 273

Query: 222 I 222
           I
Sbjct: 274 I 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 3e-20
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 25/232 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--NDTSAEEL 58
           D +E ++EI++L +     IVK+YG        ++V EY   GS+S I+   N T  EE 
Sbjct: 41  DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE- 99

Query: 59  GWSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
                I  I       L YLH +     +HRDI + N+LL+ E +A ++DFG++  +   
Sbjct: 100 ----EIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            +      GT  ++APE+   +    K D++S G+ A+E+ +GK P    S++       
Sbjct: 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHPMRAIF 209

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLLC 227
           ++     P  PP ++    K  S     F+  CL  +PE RP+     QLL 
Sbjct: 210 MI-----PNKPPPTLSDPEKW-SPEFNDFVKKCLVKDPEERPSAI---QLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 5e-20
 Identities = 53/170 (31%), Positives = 77/170 (45%), Gaps = 11/170 (6%)

Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRR 63
           L E  +L E+ H  +V   Y F     + +LV + L  G L   +      +EE     +
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVK 103

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             + + I  AL YLH      I+HRDI   N+LLD +   H++DF IA       +  T 
Sbjct: 104 FWICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTS 158

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
            +GT GY+APE+      +   D +S GV A E ++GK P    S     
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 6e-20
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 41/227 (18%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLS-----VILNNDTSAEEL 58
           +  +EI  L++ R   I K+YG        +++ EY   GS         L+    A   
Sbjct: 45  DIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-- 102

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                  +++ +   L YLH +     +HRDI + N+LL  E +  ++DFG++  +    
Sbjct: 103 -------ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSS 172
           S    F GT  ++APE+        K D++S G+ A+E+ KG+      HP   L  +  
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212

Query: 173 SNPNILVNEMLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRP 217
           +NP         P L     S   +  V        LCL+ +P+ RP
Sbjct: 213 NNP---------PSLEGNKFSKPFKDFVS-------LCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.5 bits (211), Expect = 7e-20
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 115

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-19
 Identities = 68/238 (28%), Positives = 102/238 (42%), Gaps = 36/238 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--NDTSAEELG 59
           +K+ LRE+ ++ E R   IV FYG   +  +  +  E+++ GSL  I         E LG
Sbjct: 47  RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG 106

Query: 60  WSRRINVIKGIAHALSYL---HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQ 115
                 +   +   L+YL   H      I+HRDI   N+L++   +  + DFG++ + I 
Sbjct: 107 -----KIAVAVVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI- 155

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDF---LSNVSS 172
             +S    F GT  Y++PE     K T K DV+S G+  +E+  GK P  F     +   
Sbjct: 156 --NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213

Query: 173 SNPNIL------VNEMLDPRLPPLSVDIRGKVISIME-VAFLCLDNNPESRPNMQTIC 223
               IL      V E   PRLP             +      CL  +P  RP  Q +C
Sbjct: 214 DPMGILDLLQQIVQEP-PPRLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 2e-19
 Identities = 51/172 (29%), Positives = 93/172 (54%), Gaps = 9/172 (5%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI+   G  T ++   +V EY+ENGSL   L       +    
Sbjct: 49  RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVI 106

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 107 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163

Query: 121 WTEFAGTYG--YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSN 169
           +T   G     + APE     K T+  DV+S+G++  EV+  G+ P   +SN
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.0 bits (207), Expect = 2e-19
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 29/240 (12%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL----------SVILNN 51
           +K+F RE  +LT ++H +IVKFYG C       +V+EY+++G L          +V++  
Sbjct: 51  RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110

Query: 52  DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
                EL  S+ +++ + IA  + YL        VHRD++++N L+       + DFG++
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS 167

Query: 112 KFIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDF 166
           + +   S+++    G       ++ PE     K T + DV+S GV+  E+   GK P   
Sbjct: 168 RDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LSN            +  PR  P  V          ++   C    P  R N++ I  LL
Sbjct: 226 LSNNEVIECITQGRVLQRPRTCPKEV---------YDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.2 bits (205), Expect = 5e-19
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 22/223 (9%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 59  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 114

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 115 GQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDFLSNVSSS 173
            +   GT  ++APE+        K D++S G++A+E+++G+ P       R      ++ 
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231

Query: 174 NPNILVNEMLDP-------RLPPLSVDIRGKVISIMEVAFLCL 209
            P +   E L         R   + VD RG    +++  FL L
Sbjct: 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.4 bits (203), Expect = 9e-19
 Identities = 45/163 (27%), Positives = 85/163 (52%), Gaps = 8/163 (4%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++E L  E+ ++ + +H+N+V+ Y         +++ E+L+ G+L+ I++     EE   
Sbjct: 61  RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE--- 117

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V + +  AL YLH      ++HRDI S ++LL L+    +SDFG    I  D   
Sbjct: 118 -QIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT  ++APE+        + D++S G++ +E++ G+ P
Sbjct: 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 1e-18
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 20/217 (9%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-LGWSRRINV 66
           EI  L ++ H NIV++ GF T   +  +  EY+  GS+   L      EE L       V
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP--DSSNWTEF 124
           ++G    L+YLH      I+HRD+ + N+L+D +    +SDFGI+K      D+      
Sbjct: 118 LEG----LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 125 AGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM 182
            G+  ++APE+  +Y+   +AK D++S G + LE+  G+ P      +++     L N+ 
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKR 228

Query: 183 LDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRP 217
             P +PP   D+    +S + + FL  C   NP++RP
Sbjct: 229 SAPPIPP---DVSMN-LSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.6 bits (201), Expect = 1e-18
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L     A      +   +
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATM 106

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           +K I   L YLH +     +HRDI + NVLL  + +  ++DFG+A  +         F G
Sbjct: 107 LKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ KG+      HP   L  +  +NP  L  
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTG 223

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           E                     E    CL+ +P  RP  + +
Sbjct: 224 EFSK---------------PFKEFIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-18
 Identities = 67/238 (28%), Positives = 100/238 (42%), Gaps = 36/238 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL--NNDTSAEEL 58
            KKEFLRE +V+ ++ H  IV+  G C       LV E    G L   L    +    +L
Sbjct: 39  GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL 97

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                  +   +A  ++YL        VHRD++++NVLL   ++A +SDFG+++ +   S
Sbjct: 98  -----KELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149

Query: 119 SNWTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSS 172
             +   A T G     + APE     K ++K DV+S+GV   E    G  P   +     
Sbjct: 150 DYYR--ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE- 206

Query: 173 SNPNILVNEMLDP--RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 V  ML+   RL  P        ++ SIM     C    PE RP    +    
Sbjct: 207 ------VIAMLESGERLPRPEECPQ---EIYSIML---SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.1 bits (198), Expect = 5e-18
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 22/226 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
            E  +E+  +++  H N+VK+Y         +LV  YL  GSL  I+ +      L  + 
Sbjct: 44  DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI 103

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW- 121
              V+K +   L YLH +     +HRDI + N+LL  +    ++DFG++  +        
Sbjct: 104 IATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160

Query: 122 ---TEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
                F GT  ++APE+   +     K D++SFG+ A+E+  G  P        S  P +
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP-------YSKYPPM 213

Query: 178 LVNEML---DPRLPPLSVDIRGKVIS--IMEVAFLCLDNNPESRPN 218
            V  +    DP  P L      K  S    ++  LCL  +P  RP 
Sbjct: 214 KVLMLTLQNDP--PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.1 bits (197), Expect = 6e-18
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E    ++   +
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATI 106

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +         F G
Sbjct: 107 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ KG+      HP   L  +  +NP  L  
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG 223

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
               P               + E    CL+  P  RP  + +
Sbjct: 224 NYSKP---------------LKEFVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 9e-18
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 21/172 (12%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----SAEEL 58
           KE L E  V+  + H ++V+  G C  ++   L+ + +  G L   + N      S   L
Sbjct: 54  KEILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLL 112

Query: 59  GWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            W  +I      A  +SYL         +VHRD++++NVL+       ++DFG+AK +  
Sbjct: 113 NWCVQI------AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161

Query: 117 DSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRD 165
           D   +    G     ++A E       T K DV+S+GV   E++  G  P +
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 1e-17
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 28/177 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFL--VYEYLENGSLSVILN-NDTSAEE 57
           D +   +EI++L E RH NIV ++G  ++ R   L  V EY   GSL  I         E
Sbjct: 43  DFEIIQQEISMLKECRHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE 100

Query: 58  LGWSRRINVIKGIAH-------ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
           L           IA+        L+YLH       +HRDI   N+LL  + +  ++DFG+
Sbjct: 101 LQ----------IAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGV 147

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPELA---YTMKVTAKCDVYSFGVLALEVIKGKHPR 164
           +  +    +    F GT  ++APE+A          KCD+++ G+ A+E+ + + P 
Sbjct: 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.5 bits (193), Expect = 2e-17
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 38/237 (16%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + FL E  ++ ++RH  +V+ Y   +     ++V EY+  GSL   L  D     L    
Sbjct: 46  ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK-DGEGRALKLPN 103

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +++   +A  ++Y+        +HRD+ S N+L+       ++DFG+A+ I+ +     
Sbjct: 104 LVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN----- 155

Query: 123 EFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNP 175
           E+    G      + APE A   + T K DV+SFG+L  E++ KG+ P   ++N      
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------ 209

Query: 176 NILVNEMLDP-----RLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                E+L+      R+P P     +   IS+ E+   C   +PE RP  + +   L
Sbjct: 210 ----REVLEQVERGYRMPCP-----QDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 77.8 bits (192), Expect = 3e-17
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 27/229 (11%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           K+  +EI +L++++H NIV++ G      + ++  E +  GSL+ +L    S  E     
Sbjct: 47  KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PV 103

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
                + I   L YLH       VHRDI   N+L+D      ++DFG+AK +  + S   
Sbjct: 104 IRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAK 159

Query: 123 EFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
            F G+  ++APE +A         D++S G   LE+  GK P   L  V++     +   
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKI 214

Query: 182 MLDPRLPP----LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                LPP    LS + +       +    CL  +P  RP   T  +LL
Sbjct: 215 GRSKELPPIPDHLSDEAK-------DFILKCLQRDPSLRP---TAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 18/166 (10%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           KK  LRE+ VL ++RH NIV            +LV+EY+E   L ++  +          
Sbjct: 44  KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-V 102

Query: 62  RRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSS 119
           R    I  +  A++Y H H+    I+HRDI  +N+L+       + DFG A+ ++   +S
Sbjct: 103 RSY--IWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156

Query: 120 NWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKG 160
             T++  T  Y APEL      Y   V    DV++ G +  E++ G
Sbjct: 157 PLTDYVATRWYRAPELLVGDTNYGKPV----DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 4e-17
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 21/230 (9%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K +FL+E  +L +  H NIV+  G CT  +  ++V E ++ G     L  +     L   
Sbjct: 37  KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GPRLKVK 94

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I +++  A  + YL        +HRD++++N L+  +    +SDFG+++  + +   +
Sbjct: 95  ELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVY 149

Query: 122 TEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
               G       + APE     + +++ DV+SFG+L  E    G  P   LSN  +    
Sbjct: 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                +  P L P        V  +ME    C + +P  RP+  T+ Q L
Sbjct: 210 EQGVRLPCPELCP------DAVYRLME---RCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.5 bits (192), Expect = 4e-17
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI++L E++H NIVK        R  +LV+EY +   L   L+              N
Sbjct: 46  LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP------N 98

Query: 66  VIKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +IK I       L+Y H      I+HRD+  +N+L++ +    ++DFG+A+        +
Sbjct: 99  LIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           T    T  Y APE+      Y+  V    D++S G +  E+I GK
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.8 bits (191), Expect = 5e-17
 Identities = 51/189 (26%), Positives = 94/189 (49%), Gaps = 15/189 (7%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE   
Sbjct: 60  RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 119

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +  + V+K    ALS LH      ++HRDI S ++LL  +    +SDFG    +  +   
Sbjct: 120 AVCLAVLK----ALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 172

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +   
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKAM 225

Query: 181 EMLDPRLPP 189
           +M+   LPP
Sbjct: 226 KMIRDNLPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.0 bits (189), Expect = 5e-17
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 15/224 (6%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++  ++H  +V+ Y   T     +++ EY+  GSL   L +D   + L   + I
Sbjct: 48  FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLI 106

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           +    IA  ++Y+        +HRD+ + NVL+       ++DFG+A+ I+ +     E 
Sbjct: 107 DFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163

Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE       T K DV+SFG+L  E++  GK P         SN +++    
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP-----GMSNSDVMSALQ 218

Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              R+P +  +   ++  IM+    C     E RP    +  +L
Sbjct: 219 RGYRMPRME-NCPDELYDIMK---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.4 bits (190), Expect = 6e-17
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++E L  E+ ++ +  H N+V  Y         ++V E+LE G+L+ I+ +    EE   
Sbjct: 62  RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA 121

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +  ++V++    ALSYLH+     ++HRDI S ++LL  +    +SDFG    +  +   
Sbjct: 122 TVCLSVLR----ALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  ++APE+   +    + D++S G++ +E+I G+ P         + P +   
Sbjct: 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP-------YFNEPPLQAM 227

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAF--LCLDNNPESRPNMQTICQ 224
             +   LPP   D   KV S++   F  L L   P  R   Q + Q
Sbjct: 228 RRIRDNLPPRVKDSH-KVSSVLR-GFLDLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.6 bits (188), Expect = 8e-17
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 48  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLV 105

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     E+
Sbjct: 106 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 157

Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----------PGM 207

Query: 178 LVNEMLDP-----RLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
           +  E+LD      R+P P          S+ ++   C    PE RP  +
Sbjct: 208 VNREVLDQVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.3 bits (188), Expect = 1e-16
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 38/242 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------------ 49
           ++EF +E  ++++++H NIV   G CT  + + +++EYL +G L   L            
Sbjct: 52  QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 50  -NNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
             ++T    L  S  +++   IA  + YL  HH      VHRD++++N L+       +S
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKIS 166

Query: 107 DFGIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK 161
           DFG+++ I   S+++            ++ PE     K T + D++SFGV+  E+   G 
Sbjct: 167 DFGLSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224

Query: 162 HPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
            P    SN         V EM+  R L P   D   +V ++M     C +  P  RP  +
Sbjct: 225 QPYYGFSNQE-------VIEMIRSRQLLPCPEDCPARVYALMIE---CWNEIPARRPRFK 274

Query: 221 TI 222
            I
Sbjct: 275 DI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.7 bits (186), Expect = 1e-16
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 26/229 (11%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H  +V+ Y   T     +++ EY+ENGSL   L       +L  ++ I
Sbjct: 48  FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-EGIKLTINKLI 105

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 106 DMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162

Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-----TNPEVIQNLE 217

Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M  P   P           + E+  LC    PE RP  + +  +L
Sbjct: 218 RGYRMPRPDNCPE---------ELYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 63/244 (25%), Positives = 97/244 (39%), Gaps = 47/244 (19%)

Query: 2   KKEFLREITVLTEI-RHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
           ++E   E  +L +   H NI  FYG              +LV E    GS++ ++     
Sbjct: 46  EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--- 102

Query: 55  AEELGWSRRINVI----KGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             + G   +   I    +     L+YLH +  I    HRDI  +N+LL    E  + DFG
Sbjct: 103 LRKKGKRLKEEWIAYILRETLRGLAYLHENKVI----HRDIKGQNILLTKNAEVKLVDFG 158

Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-----VTAKCDVYSFGVLALEVIKGK--- 161
           ++  +         F GT  ++APE+    +       A+ DV+S G+ A+E+  GK   
Sbjct: 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Query: 162 ---HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESR 216
              HP   L                 PR PP ++    +  S     F+  CL  N E R
Sbjct: 219 CDMHPMRAL--------------FKIPRNPPPTLK-SPENWSKKFNDFISECLIKNYEQR 263

Query: 217 PNMQ 220
           P M+
Sbjct: 264 PFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 2e-16
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 48/246 (19%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TS 54
           +++  + E+ +++ +  H NIV   G CT      ++ EY   G L   L        T 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
            + L +S +  V KG+A   S    +CI    HRD++++NVLL       + DFG+A+ I
Sbjct: 141 EDLLSFSYQ--VAKGMAFLAS---KNCI----HRDLAARNVLLTHGKIVKICDFGLARDI 191

Query: 115 QPDSSNWTEFAGTY---GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
             D SN+           ++APE  +    T + DV+S+G+L  E+          S  S
Sbjct: 192 MND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI---------FSLGS 241

Query: 172 SSNPNILVNE-----------MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
           +  P + V+            M  P   P       ++  IM+    C D +P  RP  +
Sbjct: 242 NPYPGMPVDSKFYKLIKEGYRMAQPEHAP------AEIYDIMKT---CWDADPLKRPTFK 292

Query: 221 TICQLL 226
            I QL+
Sbjct: 293 QIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 23/229 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA----- 55
           ++++ + EI +L  + H NI+ +           +V EY   G LS  ++          
Sbjct: 42  EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIP 101

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           E+  W   I +++G    L  LH      I+HRD+ S N+LL       + D GI+K ++
Sbjct: 102 EQEIWRIFIQLLRG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK 154

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
            + +  T+  GT  Y+APE+      + K D++S G L  E+     P       S  + 
Sbjct: 155 KNMAK-TQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDL 209

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              V     P +PP+        I  M      L   P+ RPN   I  
Sbjct: 210 RYKVQRGKYPPIPPIYSQDLQNFIRSM------LQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 3e-16
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+ EI +L+E +H NIV  Y    +    +++ E+ + G+L  I+       EL     
Sbjct: 48  DFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM------LELERGLT 101

Query: 64  INVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI-AKFIQPDS 118
              I+ +      AL++LH      ++HRD+ + N+LL L+ +  ++DFG+ AK      
Sbjct: 102 EPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158

Query: 119 SNWTEFAGTYGYVAPELAY--TMKVTA---KCDVYSFGVLALEVIKGK------HPRDFL 167
              T F GT  ++APE+    T K      K D++S G+  +E+ + +      +P   L
Sbjct: 159 KRDT-FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217

Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
             +  S P  L      P     S      + S       CL  +P+ RP
Sbjct: 218 LKILKSEPPTLDQ----PSK--WSSSFNDFLKS-------CLVKDPDDRP 254

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.0 bits (184), Expect = 3e-16
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +   +  LG    
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCL 104

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +     +  A+ YL  +     VHRD++++NVL+  +  A VSDFG+ K     SS    
Sbjct: 105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDT 158

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
                 + APE     K + K DV+SFG+L  E+
Sbjct: 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 75.3 bits (186), Expect = 3e-16
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 29/180 (16%)

Query: 6   LREITVLTEI-RHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRR 63
             E  VLT +  H  I+K Y +      + + V EY  NG L   +    S +E   +R 
Sbjct: 49  KIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-CTR- 105

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
                 I  AL YLH      I+HRD+  +N+LLD +    ++DFG AK + P+SS  + 
Sbjct: 106 -FYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 124 --------------------FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                               F GT  YV+PEL          D+++ G +  +++ GK P
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 75.2 bits (185), Expect = 3e-16
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 25/231 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  LV EYL  GSL   L      E L  
Sbjct: 50  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDH 107

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        VHRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 108 RKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164

Query: 121 WTEF----AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKHP-RDFLSNVS 171
           +       +  + Y APE     K +   DV+SFGV+  E+     K   P  +F+  + 
Sbjct: 165 YKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG 223

Query: 172 SSNPNI-----LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           +          L+  + +    P       ++ +IM+    C +N+P  RP
Sbjct: 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMK---ECWNNDPSQRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 3e-16
 Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 9/163 (5%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             K  LREI +L E+ H NI+K      H    +LV+E+++     +I         L  
Sbjct: 41  IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPE 97

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           S   + +  +   L++ H H  +    HRD+  +N+L++ E    ++DFG+A+       
Sbjct: 98  SLIKSYLYQLLQGLAFCHSHGIL----HRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153

Query: 120 NWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK 161
            +T +  T  Y APEL    K  +   D++S G +  E++  +
Sbjct: 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.1 bits (184), Expect = 4e-16
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 28/222 (12%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     I ++YG        +++ EYL  GS   +L      E    +    +
Sbjct: 51  QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATI 106

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL  + +  ++DFG+A  +         F G
Sbjct: 107 LREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+        K D++S G+ A+E+ KG+      HP   L  +  ++P  L  
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           +   P                 E    CL+ +P  RP  + +
Sbjct: 224 QYSKP---------------FKEFVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 74.6 bits (184), Expect = 4e-16
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 14/170 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
             + L E  +L++ +   +VK Y      ++ +LV EYL  G L+ +L N  S +E   +
Sbjct: 37  VDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVA 95

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF-------- 113
           R    I  I  AL YLH +    I+HRD+   N+L+D      ++DFG++K         
Sbjct: 96  R--IYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150

Query: 114 IQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +  D        GT  Y+APE+      +   D +S G +  E + G  P
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 17/163 (10%)

Query: 6   LREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           LREIT+L  +RH NIV+        H    FLV EY E    S++ N  T   E      
Sbjct: 54  LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE------ 107

Query: 64  INVIKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + +K +       L YLH + I   +HRD+   N+LL  +    ++DFG+A+     + 
Sbjct: 108 -SQVKCLMLQLLRGLQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163

Query: 120 NWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK 161
             T    T  Y APEL       T   D+++ G +  E++  K
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.4 bits (183), Expect = 6e-16
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 8/163 (4%)

Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++E L  E+ ++ + +H NIV+ Y         ++V E+LE G+L+ I+ +    EE   
Sbjct: 59  RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--- 115

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V   +  ALS+LH      ++HRDI S ++LL  +    +SDFG    +  +   
Sbjct: 116 -QIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT  ++APE+   +    + D++S G++ +E++ G+ P
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 7e-16
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 38/235 (16%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  ++ ++RH  +V  Y   +     ++V E++  GSL   L  +   + L   + +
Sbjct: 48  FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLV 105

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        +HRD+ + N+L+       ++DFG+A+ I+ +     E+
Sbjct: 106 DMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-----EY 157

Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E++ KG+ P           P +
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY----------PGM 207

Query: 178 LVNEMLDP-----RLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+L+      R+P P     +G   S+ E+  LC   +P+ RP  + I   L
Sbjct: 208 VNREVLEQVERGYRMPCP-----QGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.9 bits (182), Expect = 9e-16
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 57/257 (22%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLS------VILNNDTSA 55
           +++FL+E+ +L+ +   NI +  G CT      ++ EY+ENG L+      V   +  + 
Sbjct: 63  REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 56  EELGWSRR--INVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
                S    + +   IA  + YL   +     VHRD++++N L+   Y   ++DFG+  
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFGM-- 176

Query: 113 FIQPDSSNWTEFAGTYGYV-----------APELAYTMKVTAKCDVYSFGVLALEVIK-- 159
                S N   ++  Y  V           A E     K T K DV++FGV   E++   
Sbjct: 177 -----SRNL--YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229

Query: 160 GKHPRDFLSNVSSSNPNILVN----------EMLDPRLPPLSVDIRGKVISIMEVAFLCL 209
            + P + L     ++  ++ N          ++  PR PP           I E+   C 
Sbjct: 230 REQPYEHL-----TDQQVIENAGHFFRDDGRQIYLPR-PPNCPK------DIYELMLECW 277

Query: 210 DNNPESRPNMQTICQLL 226
             + E RP  + I   L
Sbjct: 278 RRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 9e-16
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 25/220 (11%)

Query: 8   EITVLTE-IRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-----DTSAEELGWS 61
           E+T++ E +RH NIV++Y         ++V + +E   L    N+         EE  W 
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW- 116

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
              N+   +  AL YLH +    IVHRD++  N++L  + +  ++DFG+AK  QP+S   
Sbjct: 117 ---NIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-L 170

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           T   GT  Y  PE+        K DV++FG +  ++   + P  F S    S    +V  
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIVEA 228

Query: 182 MLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
           + +P LP    S D+   + S       CL  + E+RP++
Sbjct: 229 VYEP-LPEGMYSEDVTDVITS-------CLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.1 bits (179), Expect = 1e-15
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 14/160 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E LRE  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +    E    
Sbjct: 40  KDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---K 95

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
               ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K +  D + +
Sbjct: 96  NITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152

Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALE 156
              A T+G     + APE     K ++K DV+SFGVL  E
Sbjct: 153 K--AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.2 bits (180), Expect = 1e-15
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 21/216 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----SAEELGWS 61
           L EI +L+ ++H NI+ +Y          +  EY   G+L   +          E + W 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW- 105

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                +  I  A+SY+H      I+HRDI + N+ L       + DFGI+K +  + S  
Sbjct: 106 ----YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  Y++PEL   +K   K D+++ G +  E++  K  R F     ++NP  LV +
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK--RTF----DATNPLNLVVK 212

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           ++     P+      ++IS++      L  +PE RP
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHS---LLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 1e-15
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 32/171 (18%)

Query: 6   LREITVLTEIRHRNIVKFYGFCT-HARHS-FLVYEYLENGSLSVILNND---TSAEELGW 60
           +REI +L ++RH NIV+     T   + S ++V+EY+++    ++ + +   T ++    
Sbjct: 46  IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ---- 101

Query: 61  SRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
                 IK         L YLH +    I+HRDI   N+L++ +    ++DFG+A+    
Sbjct: 102 ------IKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152

Query: 117 DSS-NWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
            +S ++T    T  Y  PEL      Y  +V    D++S G +  E+  GK
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 25/174 (14%)

Query: 3   KEFLREITVLTEIRHRNIVKFY--GFCTHARHSFLVYEYLENGSLSVILNND--TSAEEL 58
             F RE  +   + H NIV     G        F V+EY+   +L  +L  D    A E 
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAGET 81

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQ 115
           G    + V+  +A A     H+    IVHRD+  +N+++    +   A V DFGI   + 
Sbjct: 82  G-RLMLQVLDALACA-----HN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL- 132

Query: 116 PDSSNW--------TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
           P   +         TE  GT  Y APE      VT   D+Y++G++ LE + G+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.3 bits (180), Expect = 2e-15
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 27/221 (12%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++ ++E+  L ++RH N +++ G C    H+ +LV EY   GS S IL  +   + L   
Sbjct: 60  QDIIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEV 115

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
               +  G    L+YLH       +HRDI + N+LL       ++DFG A  + P +S  
Sbjct: 116 EIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-- 170

Query: 122 TEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I 
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIA 227

Query: 179 VNEMLDPRLPPL--SVDIRGKVISIMEVAFLCLDNNPESRP 217
            N+   P L     S   R  V S       CL   P+ RP
Sbjct: 228 QND--SPTLSSNDWSDYFRNFVDS-------CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.9 bits (176), Expect = 4e-15
 Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 52/242 (21%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TSAEELG 59
           FL E  V+T++ H+N+V+  G   H    ++V E +  G+L   L        +  + L 
Sbjct: 46  FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP--- 116
           +S  ++V +G+ +  S         +VHRD++++N+L+  +  A VSDFG+A+ +     
Sbjct: 105 FS--LDVAEGMEYLES-------KKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGV 154

Query: 117 DSS----NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVS 171
           D+S     WT         APE     K ++K DV+S+GVL  EV   G+ P        
Sbjct: 155 DNSKLPVKWT---------APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY------- 198

Query: 172 SSNPNILVNEMLDP-----RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              P + + E+ +      R+ P        V  +M     C +  P+ RP+   + + L
Sbjct: 199 ---PKMSLKEVKECVEKGYRMEPPE-GCPADVYVLMTS---CWETEPKKRPSFHKLREKL 251

Query: 227 CK 228
            K
Sbjct: 252 EK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 4e-15
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 41/225 (18%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-----NDTSAEELGWSR 62
           EI +L  ++H  IV++YG         +  EY+  GS+   L       +T   +  ++R
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK--YTR 111

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           +I         + YLH +    IVHRDI   N+L D      + DFG +K +Q   S+ T
Sbjct: 112 QI------LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162

Query: 123 ---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-RDF-----LSNVSSS 173
                 GT  +++PE+        K DV+S G   +E++  K P  +F     +  +++ 
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222

Query: 174 NPNILVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRP 217
             N        P+LP  +S D R                N + RP
Sbjct: 223 PTN--------PQLPSHVSPDAR-------NFLRRTFVENAKKRP 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 5e-15
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ ++E+  L +++H N +++ G       ++LV EY   GS S +L  +   + L    
Sbjct: 66  QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVE 122

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
              +  G    L+YLH   +   +HRDI + N+LL    +  ++DFG A    P +S   
Sbjct: 123 IAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS--- 176

Query: 123 EFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
            F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I  
Sbjct: 177 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQ 234

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           N+    +    +   RG V         CL   P+ RP
Sbjct: 235 NDSPTLQSNEWTDSFRGFVD-------YCLQKIPQERP 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.9 bits (176), Expect = 5e-15
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 10/157 (6%)

Query: 7   REITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H NIVK+ G CT        L+ E+L +GSL   L  + +   L   +++
Sbjct: 55  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQL 112

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT-- 122
                I   + YL        VHRD++++NVL++ E++  + DFG+ K I+ D   +T  
Sbjct: 113 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Query: 123 -EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
            +      + APE     K     DV+SFGV   E++
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 5e-15
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 28/230 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--------FLVYEYLENGSLSVILNND 52
           ++K   +E  +L++++H NIV +       R S        ++V  + E G L   L  +
Sbjct: 42  ERKAAEQEAQLLSQLKHPNIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLK-E 93

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
              + L  ++ +     IA AL YLH      I+HRD+ ++NV L       V D GIA+
Sbjct: 94  QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150

Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
            ++      +   GT  Y++PEL        K DV++ G    E+   KH        ++
Sbjct: 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA------FNA 204

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            + N LV  +++ +LPP+  D   ++  ++      L   PE RP++++I
Sbjct: 205 KDMNSLVYRIIEGKLPPMPKDYSPELGELIATM---LSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 7e-15
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 16/164 (9%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI + + ++HRNIV++ G  +      +  E +  GSLS +L +     +      I   
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA--HVSDFGIAKFIQPDSSNWTEFA 125
           K I   L YLH +    IVHRDI   NVL++  Y     +SDFG +K +   +     F 
Sbjct: 115 KQILEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT 170

Query: 126 GTYGYVAPEL------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT  Y+APE+       Y     A  D++S G   +E+  GK P
Sbjct: 171 GTLQYMAPEVIDKGPRGY----GAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 1e-14
 Identities = 64/232 (27%), Positives = 109/232 (46%), Gaps = 32/232 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TSA 55
           +K+   +E+ +L +++H NIV F+         F+V EY + G L   +N       +  
Sbjct: 42  EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED 101

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFI 114
           + L W  +I++  G+ H      HD    I+HRDI S+N+ L      A + DFGIA+ +
Sbjct: 102 QILSWFVQISL--GLKHI-----HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Query: 115 QPDSSNWTEFA----GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV 170
               ++  E A    GT  Y++PE+        K D++S G +  E+   KHP  F  N 
Sbjct: 153 ----NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP--FEGN- 205

Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              N + LV ++      P+S +    + S++   F     +P  RP++ +I
Sbjct: 206 ---NLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV---SPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 1e-14
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 39/241 (16%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE------ 57
           EF RE+ +  ++ H+N+V+  G C  A   +++ EY + G L   L    S +E      
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 58  LGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           L   +++ +   IA  + +L          VHRD++++N L+  + E  VS   ++K   
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK--D 166

Query: 116 PDSSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVS 171
             +S + +         ++APE       + K DV+SFGVL  EV  +G+ P   LS+  
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-- 224

Query: 172 SSNPNILVNEML------DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                    E+L         LP       G    + ++   C   NP+ RP+   +   
Sbjct: 225 --------EEVLNRLQAGKLELPVPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272

Query: 226 L 226
           L
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 2e-14
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TSA 55
           +++E  +E+ VL+ ++H NIV++        + ++V +Y E G L   +N          
Sbjct: 42  EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED 101

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           + L W  +I +      AL ++H      I+HRDI S+N+ L  +    + DFGIA+ + 
Sbjct: 102 QILDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL- 151

Query: 116 PDSSNWTEFA----GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
              ++  E A    GT  Y++PE+        K D+++ G +  E+   KH         
Sbjct: 152 ---NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA------FE 202

Query: 172 SSNPNILVNEMLDPRLPPLSV----DIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           + N   LV +++    PP+S     D+R  V  + +        NP  RP++ +I
Sbjct: 203 AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK-------RNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 38/185 (20%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ L E  +L ++ H +++K YG C+      L+ EY + GSL   L           SR
Sbjct: 48  RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE---------SR 98

Query: 63  RIN---VIKGIAHALSYLHHDCIPPI------------------------VHRDISSKNV 95
           ++    +        SYL +     +                        VHRD++++NV
Sbjct: 99  KVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158

Query: 96  LLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVL 153
           L+    +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL
Sbjct: 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 218

Query: 154 ALEVI 158
             E++
Sbjct: 219 LWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 3e-14
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 19/217 (8%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E+ +L  ++H NIV++ G C       +  E++  GS+S ILN      E  + +     
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YT 108

Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE---- 123
           K I   ++YLH++C   +VHRDI   NV+L       + DFG A+ +     + T     
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 124 --FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  ++APE+        K D++S G    E+  GK P   L+++        +  
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGA 222

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
                +P L        I  +     CL  +   RP+
Sbjct: 223 HRGL-MPRLPDSFSAAAIDFVT---SCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 44/241 (18%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++++ EI +L    H  IVK  G        +++ E+   G++ +++L  D    E    
Sbjct: 54  EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---- 109

Query: 62  RRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQP 116
            +I VI + +  AL YLH      I+HRD+ + NVLL L+ +  ++DFG++    K +Q 
Sbjct: 110 PQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166

Query: 117 DSSNWTEFAGTYGYVAPELAY--TMKVTA---KCDVYSFGVLALEV--IKGKH----PRD 165
             S    F GT  ++APE+    TMK T    K D++S G+  +E+  I+  H    P  
Sbjct: 167 RDS----FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222

Query: 166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
            L  ++ S P  L            S++ R      ++ A   LD +PE+RP   +  QL
Sbjct: 223 VLLKIAKSEPPTLSQP------SKWSMEFR----DFLKTA---LDKHPETRP---SAAQL 266

Query: 226 L 226
           L
Sbjct: 267 L 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.3 bits (169), Expect = 6e-14
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 21/218 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ ++E+  L  I+H N +++ G       ++LV EY   GS S +L  +   + L    
Sbjct: 70  QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVE 126

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
              +  G    L+YLH      ++HRDI + N+LL    +  ++DFG A    P +S   
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS--- 180

Query: 123 EFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
            F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I  
Sbjct: 181 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQ 238

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           NE    +    S   R  V S       CL   P+ RP
Sbjct: 239 NESPTLQSNEWSDYFRNFVDS-------CLQKIPQDRP 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 44/246 (17%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           KK  +REI +L ++RH N+V         +  +LV+E++++  L  +       +E    
Sbjct: 44  KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR 103

Query: 62  RRI-NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           + +  +++GI     + H      I+HRDI  +N+L+       + DFG A+ +      
Sbjct: 104 KYLFQILRGIE----FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156

Query: 121 WTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKG------------------- 160
           +T++  T  Y APEL     K     D+++ G L  E++ G                   
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216

Query: 161 ------KHPRDFLSN---VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN 211
                 +H   F  N        P +   E L+ R P LS    G V+ + +    CL  
Sbjct: 217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS----GLVLDLAK---QCLRI 269

Query: 212 NPESRP 217
           +P+ RP
Sbjct: 270 DPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 52/168 (30%), Positives = 76/168 (45%), Gaps = 27/168 (16%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------NNDTSAEELG 59
             E  +L E  H  IVK Y      ++ +++ EY   G L  IL      +  T+     
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA----- 95

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             R    I  +  A  YLH+     I++RD+  +N+LLD      + DFG AK ++    
Sbjct: 96  --RFY--IACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148

Query: 120 NWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            WT F GT  YVAPE+     Y   V    D +S G+L  E++ G+ P
Sbjct: 149 TWT-FCGTPEYVAPEIILNKGYDFSV----DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.2 bits (166), Expect = 1e-13
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 23/219 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ ++E+  L ++RH N +++ G       ++LV EY   GS S +L  +   + L    
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVE 116

Query: 63  RINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
              V  G    L+YLH H+    ++HRD+ + N+LL       + DFG A  + P +   
Sbjct: 117 IAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-- 170

Query: 122 TEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I 
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIA 227

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
            NE    +    S   R  V S       CL   P+ RP
Sbjct: 228 QNESPALQSGHWSEYFRNFVDS-------CLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.4 bits (164), Expect = 3e-13
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 9/163 (5%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       EE+  
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I V++G+A+ L   H      I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 107 KVSIAVLRGLAY-LREKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 161 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 16/224 (7%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  V+  ++H  +VK +   T     +++ E++  GSL   L +D    +    + I
Sbjct: 48  FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLI 105

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           +    IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 106 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162

Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE       T K DV+SFG+L +E++  G+ P   +     SNP ++    
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALE 217

Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              R+P            +  +   C  N PE RP  + I  +L
Sbjct: 218 RGYRMPRPENCPE----ELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 3e-13
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 14/169 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + E +RE  ++ ++ +  IV+  G C  A    LV E    G L+  L+     +E+  
Sbjct: 38  VRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITV 94

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S  + ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K +  D S 
Sbjct: 95  SNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151

Query: 121 WTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           +   A + G     + APE     K +++ DV+S+G+   E    G+ P
Sbjct: 152 YK--ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.6 bits (163), Expect = 4e-13
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 9/161 (5%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           KK  LREI +L +++H N+V         R   LV+EY ++  L+ +  N     E    
Sbjct: 44  KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH--- 100

Query: 62  RRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
               +I     A+++ H H+CI    HRD+  +N+L+  + +  + DFG A+ +     +
Sbjct: 101 LIKKIIWQTLQAVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156

Query: 121 WTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKG 160
           +T++  T  Y APEL     +     DV++ G +  E++ G
Sbjct: 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 46/140 (32%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 26  FCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP 83
           FCT     H F V EYL  G L   + +    +E   +R       I   L +LH     
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICGLQFLHKK--- 115

Query: 84  PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
            I++RD+   NVLLD +    ++DFG+ K         + F GT  Y+APE+    K   
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 144 KCDVYSFGVLALEVIKGKHP 163
             D +SFGVL  E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.5 bits (162), Expect = 5e-13
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 8/140 (5%)

Query: 26  FCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP 83
           +CT     + F V EYL  G L   + +  S  +    R       I   L +LH     
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK--- 115

Query: 84  PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
            IV+RD+   N+LLD +    ++DFG+ K      +    F GT  Y+APE+    K   
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 144 KCDVYSFGVLALEVIKGKHP 163
             D +SFGVL  E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.4 bits (163), Expect = 5e-13
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAEELGWS 61
           LREI +L E++H NI+       H  +  LV+E++E   L  ++ +     T A+     
Sbjct: 50  LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPAD----- 103

Query: 62  RRINVIKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
                IK         L YLH + I   +HRD+   N+L+  +    ++DFG+A+     
Sbjct: 104 -----IKSYMLMTLRGLEYLHSNWI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155

Query: 118 SSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +   T    T  Y APEL +         D++S G +  E++   
Sbjct: 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.4 bits (162), Expect = 6e-13
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 15/167 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  REI +L ++ H N+VK +    H     ++ E+++ GS    L     A+E   +
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLA 171

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
              +V + I   ++YLH      IVHRDI   N+L++      ++DFG+++ +       
Sbjct: 172 ---DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225

Query: 122 TEFAGTYGYVAPE-----LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               GT  Y++PE     L +        D++S GV  LE   G+ P
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.9 bits (161), Expect = 7e-13
 Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 38/244 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL----NNDTSAE 56
           D+ +FL E  ++++  H+NIV+  G        F++ E +  G L   L           
Sbjct: 52  DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS 111

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     +   + +A    YL  +     +HRDI+++N LL  +     A ++DFG+A+ 
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168

Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-------GKH 162
           I    +++    G       ++ PE       T+K DV+SFGVL  E+         G+ 
Sbjct: 169 IY--RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            ++ +  V+           LDP  P       G V  IM     C  + PE RPN  TI
Sbjct: 227 NQEVMEFVTGGG-------RLDP--PK---GCPGPVYRIMTD---CWQHTPEDRPNFATI 271

Query: 223 CQLL 226
            + +
Sbjct: 272 LERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 7e-13
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 24/227 (10%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K +FL E  +L +  H NIVK  G CT  +  ++V E +  G     L      +EL   
Sbjct: 36  KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTK 93

Query: 62  RRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           + +      A  ++YL   +CI    HRD++++N L+       +SDFG+++  Q D   
Sbjct: 94  QLVKFALDAAAGMAYLESKNCI----HRDLAARNCLVGENNVLKISDFGMSR--QEDDGI 147

Query: 121 WTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNP 175
           ++  +G       + APE     + +++ DV+S+G+L  E    G  P   ++N  +   
Sbjct: 148 YSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                 M  P+  P        V  +M+    C D  PE+RP    +
Sbjct: 207 VEKGYRMSCPQKCP------DDVYKVMQ---RCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 9e-13
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 38/241 (15%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H NIVK+ G C+    +   L+ EY+  GSL   L       +L  ++ +
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLL 110

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
              + I   ++YLH       +HRD++++NVLLD +    + DFG+AK + P+   +   
Sbjct: 111 LFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 166

Query: 125 A----GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-----KGKHPRDFLSNVSSSNP 175
                    + A E     K +   DV+SFGV   E++     K   P+ F   +     
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226

Query: 176 NILVNEMLD-----PRLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
            + V  +++      RLP     P  V I      +M+    C +   + RP  +++  +
Sbjct: 227 QMTVVRLIELLERGMRLPCPKNCPQEVYI------LMKN---CWETEAKFRPTFRSLIPI 277

Query: 226 L 226
           L
Sbjct: 278 L 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (160), Expect = 9e-13
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 18/169 (10%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           + +FL+EI +++ +++ NI++  G C       ++ EY+ENG L+  L+          +
Sbjct: 61  RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 62  RRINVIK---------GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
             I  +           IA  + YL        VHRD++++N L+   Y   ++DFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 113 FIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
            +   S ++    G       ++A E     K T   DV++FGV   E+
Sbjct: 178 NLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 65.6 bits (161), Expect = 9e-13
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 29/168 (17%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR-- 63
           L E  +L  IRH  +V  YG      + +LV EY+  G L   L           S R  
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---------SGRFP 99

Query: 64  INVIK----GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             V +     +  AL YLH      IV+RD+  +N+LLD +    ++DFG AK ++  + 
Sbjct: 100 EPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT- 155

Query: 120 NWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +T   GT  Y+APE+     Y   V    D ++ G+L  E++ G  P
Sbjct: 156 -YT-LCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 23/221 (10%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TSAEELGWS 61
           +E  +L +++H NIV F        H ++V EY + G L   +             L W 
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            ++ +  G+ H      H+    ++HRDI SKN+ L    +  + DFG A+ +    +  
Sbjct: 107 VQMCL--GVQHI-----HE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
             + GT  YV PE+   M    K D++S G +  E+   KHP  F +N S  N   L+ +
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP--FQAN-SWKN---LILK 211

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           +      PL      ++ S+++  F     NP SRP+  TI
Sbjct: 212 VCQGSYKPLPSHYSYELRSLIKQMF---KRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-12
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E  VL E+ H  I++ +      R  +++ EY+  G L   L N         S R +  
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNS 101

Query: 68  KG------IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            G      I  AL YLH      IV+RD+  +N+LLD E    ++DFG AK ++     W
Sbjct: 102 TGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTW 156

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T   GT  Y+APE+  +       D ++ G+L  E++ G  P
Sbjct: 157 T-LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 107 KVSIAVIKG----LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 161 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 8/221 (3%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           + + ++EI +L ++ H N++K+Y          +V E  + G LS ++ +    + L   
Sbjct: 46  RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE 105

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +   V K      S L H     ++HRDI   NV +       + D G+ +F    ++  
Sbjct: 106 K--TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  Y++PE  +      K D++S G L  E+   + P  F  +    N   L  +
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGD--KMNLYSLCKK 219

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           +     PPL  D   +   + ++  +C++ +PE RP++  +
Sbjct: 220 IEQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCT------HARHSFLVYEYLENGSLS-VILNND 52
           +++E   EI +L +   HRNI  +YG         H    +LV E+   GS++ ++ N  
Sbjct: 55  EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK 114

Query: 53  TSAEELGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
            +A +  W   I   +++G+AH   + H      ++HRDI  +NVLL    E  + DFG+
Sbjct: 115 GNALKEDWIAYICREILRGLAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGV 167

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  +         F GT  ++APE+             + D++S G+ A+E+ +G  P  
Sbjct: 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP-- 225

Query: 166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIR---GKVISIMEVAFLCLDNNPESRPNMQTI 222
            L ++       L+     PR PP  +  +    K I  +E    CL  N  SRP+ + +
Sbjct: 226 -LCDMHPMRALFLI-----PRNPPPKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 11/161 (6%)

Query: 8   EITVLTEIRHRNIVKFYG-FCTHARHSFLVY-EYLENGSLSVILNNDTSAEELGWSRRIN 65
           EI +L  ++H  IV++YG     A  +  ++ EY+  GS+   L    +  E   S    
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRK 110

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT--- 122
             + I   +SYLH + I   VHRDI   N+L D      + DFG +K +Q    + T   
Sbjct: 111 YTRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              GT  +++PE+        K DV+S G   +E++  K P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 64/262 (24%), Positives = 108/262 (41%), Gaps = 57/262 (21%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE--LG 59
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E  LG
Sbjct: 43  RNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG 102

Query: 60  WSRRINVIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
               I V++G    L+YL   H     I+HRD+   N+L++   E  + DFG++  +   
Sbjct: 103 -KISIAVLRG----LTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-------------- 163
            +N   F GT  Y++PE       T + D++S G+  +E+  G++P              
Sbjct: 154 MAN--SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211

Query: 164 ------------RDFLSNVSSSNPNILVNEMLD-------PRLPPLSVDIRGKVISIMEV 204
                       R    +   S   + + E+LD       P+LP           S    
Sbjct: 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP-------SGAFSDEFQ 264

Query: 205 AFL--CLDNNPESRPNMQTICQ 224
            F+  CL  NP+ R +++ + +
Sbjct: 265 DFVDKCLKKNPKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)

Query: 17  HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY 76
           H  IV+  G C  A    LV +    GSL   +     +  L   R +N    IA  + Y
Sbjct: 68  HAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYY 124

Query: 77  LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPE 134
           L    +   VHR+++++N+LL  +    ++DFG+A  + PD     ++E      ++A E
Sbjct: 125 LEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 135 LAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
                + T + DV+S+GV   E++  G  P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 26/225 (11%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI ++ E +H NIV ++G        ++  EY   GSL  I +      EL  +    V
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---V 111

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            +     L+YLH       +HRDI   N+LL    +  ++DFG+A  I    +    F G
Sbjct: 112 CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168

Query: 127 TYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNI 177
           T  ++APE+A   K       CD+++ G+ A+E+ + +      HP   L  +S SN   
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ- 227

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                     PP   D      +      + L  NP+ RP  + +
Sbjct: 228 ----------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 3e-12
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)

Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRI 64
           E  +L E+ H  IVK  Y F T  +  +L+ ++L  G L   L+ +   + E++ +    
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF---- 102

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +A AL +LH      I++RD+  +N+LLD E    ++DFG++K           F
Sbjct: 103 -YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+      T   D +SFGVL  E++ G  P
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.0 bits (155), Expect = 3e-12
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 24/234 (10%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDT 53
           +++E  +EI +L +   HRNI  +YG              +LV E+   GS++ ++ N T
Sbjct: 45  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-T 103

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
               L       + + I   LS+LH      ++HRDI  +NVLL    E  + DFG++  
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160

Query: 114 IQPDSSNWTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEVIKGKHPRDFLS 168
           +         F GT  ++APE+             K D++S G+ A+E+ +G  P   L 
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LC 217

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           ++       L+     PRL   S     K  S +E    CL  N   RP  + +
Sbjct: 218 DMHPMRALFLIPRNPAPRLK--SKKWSKKFQSFIES---CLVKNHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.3 bits (154), Expect = 5e-12
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 24/238 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE--- 57
           +KKEFL+E  +++   H NIVK  G C      +++ E +E G L   L +         
Sbjct: 42  EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPP 101

Query: 58  -LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-----DLEYEAHVSDFGIA 111
            L     +++   +A    YL        +HRD++++N L+     D +    + DFG+A
Sbjct: 102 LLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Query: 112 KFIQPDSSNWTEFAGTYG--YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           + I        E  G     ++APE     K T + DV+SFGVL  E++  G+ P   L+
Sbjct: 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N            +  P   P       K+  +M     C   +P  RP    I ++L
Sbjct: 219 NQEVLQHVTAGGRLQKPENCP------DKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.7 bits (155), Expect = 6e-12
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 40/175 (22%)

Query: 70  IAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT- 127
           +A  + +L   +CI    HRD++++NVLL     A + DFG+A+ I  D SN+       
Sbjct: 221 VAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 128 --YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN---- 180
               ++APE  +    T + DV+S+G+L  E+   GK P           P ILVN    
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----------PGILVNSKFY 325

Query: 181 -------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +M  P   P       ++ SIM+   +C +  P  RP    I QL+ +
Sbjct: 326 KMVKRGYQMSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.4 bits (152), Expect = 8e-12
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 18/162 (11%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +FL+E  ++  + H N+++ YG   TH     +V E    GSL   L  D     L  S 
Sbjct: 42  DFLKEAAIMHSLDHENLIRLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFL-IST 98

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
             +    IA+ + YL        +HRD++++N+LL  + +  + DFG+ + +  +  ++ 
Sbjct: 99  LCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155

Query: 123 -------EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
                   FA    + APE   T   +   DV+ FGV   E+
Sbjct: 156 MEEHLKVPFA----WCAPESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 30/229 (13%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN---NDTSAEELGWSRRI 64
           E  VL  + H NI+++Y      +   +V EY   G+L+  +    N    E+       
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED------- 101

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-AHVSDFGIAKFIQPDSSNWTE 123
            ++      L  LHH     I+HRD+ ++N+LLD       + DFGI+K +   S  +T 
Sbjct: 102 TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT- 160

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y++PEL        K D+++ G +  E+   K  R F     ++N   LV +++
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK--RAF----EAANLPALVLKIM 214

Query: 184 DPRLPPL----SVDIRGKVISIMEVAFLCLDNNPESRPNM-QTICQLLC 227
                P+    S D+R  ++S+       L+ +P  RP + Q + Q +C
Sbjct: 215 SGTFAPISDRYSPDLRQLILSM-------LNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 14/160 (8%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND---TSAEELGWSR 62
           LREI  L   +H  +VK      H     LV EY+ +    V+ + +     A+   + R
Sbjct: 47  LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMR 106

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNW 121
            +  +KG+A    Y+H +    I+HRD+   N+L+  +    ++DFG+A+ F + +   +
Sbjct: 107 ML--LKGVA----YMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157

Query: 122 TEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKG 160
           +    T  Y APEL Y   K     D+++ G +  E++ G
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 23/184 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE--- 57
           ++ EFL E +V+ E    ++V+  G  +  + + +V E +  G L   L +     E   
Sbjct: 52  ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP 111

Query: 58  ----LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                   + I +   IA  ++YL        VHRD++++N ++  +    + DFG+ + 
Sbjct: 112 GLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRD 168

Query: 114 IQPDSSNWTEFAGTYG-------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRD 165
           I       T++    G       ++APE       T K DV+SFGV+  E+    + P  
Sbjct: 169 I-----YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223

Query: 166 FLSN 169
            LSN
Sbjct: 224 GLSN 227

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 6/132 (4%)

Query: 32  HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDIS 91
           H F V E+L  G L   +  D    +L   R       I   L +LH      I++RD+ 
Sbjct: 70  HLFFVMEFLNGGDLMFHIQ-DKGRFDL--YRATFYAAEIVCGLQFLHSK---GIIYRDLK 123

Query: 92  SKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFG 151
             NV+LD +    ++DFG+ K      +  + F GT  Y+APE+   +K T   D +SFG
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFG 183

Query: 152 VLALEVIKGKHP 163
           VL  E++ G+ P
Sbjct: 184 VLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 29/178 (16%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 63  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122

Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 178

Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 179 ADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 53/222 (23%), Positives = 102/222 (45%), Gaps = 18/222 (8%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  ++  + H ++V+  G C       LV + + +G L   ++     + +G    
Sbjct: 55  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLL 111

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +N    IA  + YL       +VHRD++++NVL+       ++DFG+A+ ++ D   +  
Sbjct: 112 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168

Query: 124 FAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN 180
             G     ++A E  +  K T + DV+S+GV   E++  G  P D +   +   P++L  
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEK 226

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
               P+ P  ++D       +  V   C   + +SRP  + +
Sbjct: 227 GERLPQPPICTID-------VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 19/172 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSF----LVYEYLENGSLSVI-LNNDTS 54
           D    LREI +L  +RH +IV+  +     +R  F    +V+E +E+    VI  N+D +
Sbjct: 42  DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLT 101

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
            E   +      +  +  AL Y+H      + HRD+  KN+L + + +  + DFG+A+  
Sbjct: 102 PEHHQF-----FLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA 153

Query: 115 QPDSSN---WTEFAGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGK 161
             D+     WT++  T  Y APEL  ++  K T   D++S G +  EV+ GK
Sbjct: 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 15/162 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E++H NIV+        +  +LV+EYL+   L +  + D+S +   +++   
Sbjct: 49  IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPD---FAKNPR 102

Query: 66  VIKG----IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKFIQPDSSN 120
           +IK     I   ++Y H      ++HRD+  +N+L+D    A  ++DFG+A+        
Sbjct: 103 LIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159

Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +T    T  Y APE L  +   +   D++S G +  E++  K
Sbjct: 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 26/227 (11%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI ++ + +H NIV ++G        ++  E+   GSL  I +      E   +    V
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---V 111

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            +     L YLH       +HRDI   N+LL       ++DFG++  I    +    F G
Sbjct: 112 SRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG 168

Query: 127 TYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNI 177
           T  ++APE+A   +       CD+++ G+ A+E+ + +      HP   L  ++ SN   
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ- 227

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                     PP   D      S      + L  NP+ RP  + + Q
Sbjct: 228 ----------PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 30/178 (16%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNND- 52
           D ++F  E+ VL ++  H NI+   G C H  + +L  EY  +G+L      S +L  D 
Sbjct: 50  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 109

Query: 53  ------TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                 ++A  L   + ++    +A  + YL        +HRD++++N+L+   Y A ++
Sbjct: 110 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166

Query: 107 DFGIAKFIQPDSSNWTEFAGTYG-----YVAPE-LAYTMKVTAKCDVYSFGVLALEVI 158
           DFG+++              T G     ++A E L Y++  T   DV+S+GVL  E++
Sbjct: 167 DFGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)

Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 98

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 99  FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 39/133 (29%), Positives = 57/133 (42%), Gaps = 8/133 (6%)

Query: 32  HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDI 90
             F V EY+  G L   +      +E    R       I   L +LH       I++RD+
Sbjct: 70  RLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHERG----IIYRDL 122

Query: 91  SSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
              NVLLD E    ++DFG+ K         + F GT  Y+APE+          D ++ 
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL 182

Query: 151 GVLALEVIKGKHP 163
           GVL  E++ G+ P
Sbjct: 183 GVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 10/220 (4%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI- 64
           L+EI +L ++ H N++K+           +V E  + G LS ++ +    + L   R I 
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                +  AL ++H      I+HRDI   NV +       + D G+ +F    ++     
Sbjct: 110 KYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD 184
            GT  Y++PE  +      K D++S G L  E+   + P  F       N   L  ++  
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYG--DKMNLYSLCKKIEK 222

Query: 185 PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              PPL  D   +   + ++   C++ +PE RP++  + Q
Sbjct: 223 CDYPPLPADHYSE--ELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.1 bits (149), Expect = 4e-11
 Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 6   LREITVLTEIRHRNIV--KFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           LREI +L +++H NIV  K     ++    ++V EY+E+   S++   +T  +    S  
Sbjct: 52  LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM---ETMKQPFLQSEV 108

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             ++  +   +++LH +    I+HRD+ + N+LL+      + DFG+A+        +T+
Sbjct: 109 KCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ 165

Query: 124 FAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
              T  Y APEL     + +   D++S G +  E++  K
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 17/155 (10%)

Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELG---WSRRINVIKGIAHALSYLHHDCI 82
           F T +R  F V EY+  G L   +       E     +S  I++      AL+YLH    
Sbjct: 65  FQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER-- 115

Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTYGYVAPELAYTMKV 141
             I++RD+   NVLLD E    ++D+G+ K  ++P  +  + F GT  Y+APE+      
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDY 173

Query: 142 TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
               D ++ GVL  E++ G+ P D +   SS NP+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVG--SSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 5e-11
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 17  HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGI 70
           H N+VKFYG    A        +LV E    GS++ ++       + L  +    ++ G 
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 71  AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGY 130
              L +LH++    I+HRD+   N+LL  E    + DFG++  +           GT  +
Sbjct: 138 LLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 131 VAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +APE+      Y     A+CDV+S G+ A+E+  G  P
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.5 bits (146), Expect = 7e-11
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 8/159 (5%)

Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F T  R  F V EY+  G L   L+ +    E    R  
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCF-VMEYVNGGELFFHLSRERVFSE---DRTR 98

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH      IV+RD+  +N++LD +    ++DFG+ K    D++    F
Sbjct: 99  FYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 8e-11
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 8/224 (3%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++ ++EI +L ++ H N++K+           +V E  + G LS ++      + L   
Sbjct: 46  RQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPE 105

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           R   V K      S + H     ++HRDI   NV +       + D G+ +F    ++  
Sbjct: 106 R--TVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  Y++PE  +      K D++S G L  E+   + P  F  +    N   L  +
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGD--KMNLFSLCQK 219

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           +     PPL  +   +   + E+  +C+  +P+ RP++  + Q+
Sbjct: 220 IEQCDYPPLPTEHYSE--KLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (144), Expect = 9e-11
 Identities = 52/163 (31%), Positives = 76/163 (46%), Gaps = 15/163 (9%)

Query: 8   EITVLTEIRHRNIVKFYGFC----THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EI +L  +RH  IV++YG C       + S  V EY+  GS+   L    +  E   +RR
Sbjct: 54  EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTE-NVTRR 110

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
               + I   +SYLH + I   VHRDI   N+L D      + DFG +K IQ    + T 
Sbjct: 111 YT--RQILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165

Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT  +++PE+        K DV+S     +E++  K P
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 35/239 (14%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF +E +++ E+ H NIV   G  T  +   +++EYL  G L   L   +   ++G S  
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 64  --------------INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
                         +++   IA  + YL        VH+D++++N+L+  +    +SD G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLG 169

Query: 110 IAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPR 164
           +++ I   S+++            ++ PE     K ++  D++SFGV+  E+   G  P 
Sbjct: 170 LSREIY--SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Query: 165 DFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              SN         V EM+  R L P S D   ++ S+M     C    P  RP  + I
Sbjct: 228 YGFSNQE-------VIEMVRKRQLLPCSEDCPPRMYSLMTE---CWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 8/131 (6%)

Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISS 92
           F V EY+  G L   +      +E    R       +  AL +LH H     +++RD+  
Sbjct: 72  FFVMEYVNGGDLMFQIQRSRKFDE---PRSRFYAAEVTLALMFLHRHG----VIYRDLKL 124

Query: 93  KNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
            N+LLD E    ++DFG+ K    +    T F GT  Y+APE+   ++     D ++ GV
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGV 184

Query: 153 LALEVIKGKHP 163
           L  E++ G+ P
Sbjct: 185 LMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 49/156 (31%), Positives = 72/156 (46%), Gaps = 16/156 (10%)

Query: 77  LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPE 134
           +HH     ++HRDI S N+LL       + DFG +K      S+     F GT  YVAPE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 135 LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDI 194
           +      + K D++S GVL  E++  K P D        N   ++++ L  R  PL   I
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD------GENMEEVMHKTLAGRYDPLPPSI 269

Query: 195 RGKVISIMEVAFLCLDNNPESRPNMQT-----ICQL 225
             ++  I+  A L  D  P+ RP+        IC+L
Sbjct: 270 SPEMQEIVT-ALLSSD--PKRRPSSSKLLNMPICKL 302

Length = 496

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 1e-10
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 28/170 (16%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F    ++++++ H+++V  YG C     S +V EY++ GSL   L  + +   + W  ++
Sbjct: 46  FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--------VSDFGIAKFIQP 116
            V K +A AL +L    +    H ++ +KNVLL  E +          +SD GI+  + P
Sbjct: 104 EVAKQLAWALHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160

Query: 117 -----DSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG 160
                +   W         V PE +     ++   D +SFG    E+  G
Sbjct: 161 KEILLERIPW---------VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 8/159 (5%)

Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           + E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERAR 98

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F
Sbjct: 99  FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 47/164 (28%), Positives = 68/164 (41%), Gaps = 35/164 (21%)

Query: 70  IAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           I  AL YL   H     ++HRD+   N+LLD      + DFGI+  +  DS   T  AG 
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGC 177

Query: 128 YGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP-----RDF--LSNVSSSNPN 176
             Y+APE         K   + DV+S G+  +E+  G+ P      +F  L+ +    P 
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP- 236

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPN 218
                   P LPP       +  S    +F+  CL  +   RP 
Sbjct: 237 --------PSLPP------NEGFSPDFCSFVDLCLTKDHRKRPK 266

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 13/159 (8%)

Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI 85
           F T +R  FLV EY+  G L   +       E     R    + I  AL++LH      I
Sbjct: 65  FQTTSR-LFLVIEYVNGGDLMFHMQRQRKLPE--EHARFYAAE-ICIALNFLHER---GI 117

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAK 144
           ++RD+   NVLLD +    ++D+G+ K  + P  +  T F GT  Y+APE+    +    
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFS 176

Query: 145 CDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
            D ++ GVL  E++ G+ P D +++    NP++   + L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITD----NPDMNTEDYL 211

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 21/220 (9%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYG-FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +K+ + E+ +L +     I+ FYG F    R S +  E+++ GSL V        E +  
Sbjct: 43  QKQIMSELEILYKCDSPYIIGFYGAFFVENRIS-ICTEFMDGGSLDVY---RKIPEHVLG 98

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              + V+KG+ +  S         I+HRD+   N+L++   +  + DFG++   Q  +S 
Sbjct: 99  RIAVAVVKGLTYLWSL-------KILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSI 149

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPR-DFLSNVSSSNPNILV 179
              + GT  Y+APE     +     DV+S G+  +E+  G+ P      N  S  P  L+
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRP 217
             ++D   P L V    +      V F+  C+   P+ RP
Sbjct: 210 QCIVDEDPPVLPVGQFSEKF----VHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 36/233 (15%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLV-YEYLENGSLSVIL----NNDTSAEEL 58
           +FL+E  ++ +  H N++   G C  +  S LV   Y+++G L   +    +N T  + +
Sbjct: 42  QFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI 101

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD  +   V+DFG+A+ I  D 
Sbjct: 102 GFG--LQVAKGMEYLAS-------KKFVHRDLAARNCMLDESFTVKVADFGLARDIY-DK 151

Query: 119 SNWTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSS 172
             ++    T       ++A E   T K T K DV+SFGVL  E++ +G  P         
Sbjct: 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------YPD 205

Query: 173 SNPNILVNEMLDPR---LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            +   +   +L  R    P    D       + EV   C    PE RP    +
Sbjct: 206 VDSFDITVYLLQGRRLLQPEYCPD------PLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 39/184 (21%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN---DTSAEE- 57
           + +FL+E+ +L+ ++  NI++  G C       ++ EY+ENG L+  L++   D   E  
Sbjct: 63  RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122

Query: 58  ------------LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                       + +S  ++V   IA  + YL        VHRD++++N L+       +
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKI 179

Query: 106 SDFGIAKFIQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYSFGVLA 154
           +DFG+++ +         +AG Y            ++A E     K T   DV++FGV  
Sbjct: 180 ADFGMSRNL---------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230

Query: 155 LEVI 158
            E++
Sbjct: 231 WEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.3 bits (142), Expect = 3e-10
 Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 38/182 (20%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTH-ARHSF----LVYEYLENGSLSVILNNDTSA 55
           D K  LREI +L  +RH NI+         +   F    +V E +E     VI +     
Sbjct: 42  DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101

Query: 56  EELGWSRRI-----NVIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDF 108
           ++      I      +++G    L YLH  +     ++HRD+   N+L++   +  + DF
Sbjct: 102 DD-----HIQYFLYQILRG----LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDF 147

Query: 109 GIAKFIQPDSS---NWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKG 160
           G+A+ + PD       TE+  T  Y APEL      YT  +    D++S G +  E++  
Sbjct: 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTR 203

Query: 161 KH 162
           K 
Sbjct: 204 KP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 41/169 (24%), Positives = 81/169 (47%), Gaps = 17/169 (10%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN--------DT 53
           + +FL+EI +++ ++  NI++    C  +    ++ EY+ENG L+  L+           
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
               + +S  I +   IA  + YL        VHRD++++N L+   Y   ++DFG+++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +   S ++    G       +++ E     K T   DV++FGV   E++
Sbjct: 180 LY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 58.3 bits (141), Expect = 4e-10
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTY 128
           IA  L +LH      I++RD+   NV+LD E    ++DFG+ K  I    +  T F GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 129 GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
            Y+APE+          D ++FGVL  E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 4e-10
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 8/155 (5%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E+ H NIVK           +LV+E+L +  L   ++  +    +      +
Sbjct: 47  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDA-SPLSGIPLPLIKS 104

Query: 66  VIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            +  +   L++ H H     ++HRD+  +N+L++ E    ++DFG+A+        +T  
Sbjct: 105 YLFQLLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 125 AGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVI 158
             T  Y APE+    K  +   D++S G +  E++
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.9 bits (140), Expect = 4e-10
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 22/221 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           + E+ +L +     IV FYG        ++  EY++ GSL  +     + E +       
Sbjct: 47  IMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR 106

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           +   +   L +L  +    I+HRD+   NVL++   +  + DFG++      +S      
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI 162

Query: 126 GTYGYVAPE------LAYTMKVTAKCDVYSFGVLALEVIKGKHPR--DFLSNVSSSNPNI 177
           G   Y+APE             T + DV+S G+  LE+  G++P   +  +N+ +    I
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222

Query: 178 LVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRP 217
           +  +   P LP   S D +  V         CL+  P  RP
Sbjct: 223 V--DGDPPTLPSGYSDDAQDFVAK-------CLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 13/187 (6%)

Query: 8   EITVLTEIRHRNIVKFYGFC--THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           EI +L  + H  IV++YG       R   +  E++  GS+   L +  +  E   +R+  
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT 112

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP---DSSNWT 122
             + I   +SYLH + I   VHRDI   N+L D      + DFG +K +Q      +   
Sbjct: 113 --RQILEGVSYLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM 182
              GT  +++PE+        K D++S G   +E++  K P      +++     +  + 
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IATQP 225

Query: 183 LDPRLPP 189
            +P LPP
Sbjct: 226 TNPVLPP 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 5e-10
 Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 24/152 (15%)

Query: 19  NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG-----WSRRINVIKGIAHA 73
            + K Y       + +LV EYL  G  + ++      + LG     W++    I  +   
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLG 109

Query: 74  LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK--FIQPDSSNWTEFAGTYGYV 131
           +  LH      I+HRDI  +N+L+D      ++DFG+++             F GT  Y+
Sbjct: 110 VEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYL 160

Query: 132 APELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           APE    +      D +S G +  E + G  P
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.1 bits (140), Expect = 5e-10
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 60  DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119

Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV 105
                    E+L +   ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKI 175

Query: 106 SDFGIAKFI-QPDSSNWTEFAGT-YGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ +   D    T        ++APE  +    T + DV+SFG+L  E+
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 26/234 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG- 59
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L +     E   
Sbjct: 52  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 111

Query: 60  ------WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                   + I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 112 VQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168

Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   +S
Sbjct: 169 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 227 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 60/238 (25%), Positives = 110/238 (46%), Gaps = 34/238 (14%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++++ EI +L    H NIVK      +  + +++ E+   G++ +V+L  +    E    
Sbjct: 47  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE---- 102

Query: 62  RRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +I V+ K    AL+YLH +    I+HRD+ + N+L  L+ +  ++DFG++         
Sbjct: 103 PQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159

Query: 121 WTEFAGTYGYVAPELAYTMKVTA-------KCDVYSFGVLALEV--IKGKH----PRDFL 167
              F GT  ++APE+   M  T+       K DV+S G+  +E+  I+  H    P   L
Sbjct: 160 RDSFIGTPYWMAPEV--VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217

Query: 168 SNVSSSNPNILV---------NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             ++ S P  L           + L   L   +VD R     +++  F+ +++N   R
Sbjct: 218 LKIAKSEPPTLAQPSRWSSEFKDFLKKCLEK-NVDARWTTTQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 44/179 (24%), Positives = 79/179 (44%), Gaps = 29/179 (16%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           D  + + E+ ++  I +H+NI+   G CT     ++V EY  +G+L   L       E  
Sbjct: 58  DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 60  WSRRINVIKG-------------IAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                   +              +A  + +L    CI    HRD++++NVL+  ++   +
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKI 173

Query: 106 SDFGIAKFIQPDSSNWTEFAGT------YGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D  +   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 174 ADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 7e-10
 Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 6/158 (3%)

Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRIN 65
           E  +L ++  R IV   Y F T      LV   +  G L   I N D         R   
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLC-LVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
               I   L +LH      I++RD+  +NVLLD +    +SD G+A  ++   S    +A
Sbjct: 102 YTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158

Query: 126 GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT G++APEL    +     D ++ GV   E+I  + P
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 29/178 (16%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-------- 51
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 60  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119

Query: 52  --DTSA---EELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
             DT     E+L +   ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKI 175

Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+    D  N   +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 176 ADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 7e-10
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 7/161 (4%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K+  LRE+ +L  ++  NIV+           +LV+EY+E   L ++             
Sbjct: 44  KETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---E 100

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-SN 120
           +  + I  +  A+ + H +    IVHRDI  +N+L+       + DFG A+ +   S +N
Sbjct: 101 KVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +TE+  T  Y +PEL          D++S G +  E+  G+
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 8e-10
 Identities = 63/239 (26%), Positives = 90/239 (37%), Gaps = 44/239 (18%)

Query: 1   DKKEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEY----LENGSLSVILNNDTSA 55
           ++K  L ++ V+        IVKFYG        ++  E     L+     V     +  
Sbjct: 45  EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI 104

Query: 56  EELGWSRRINVIKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
            E        ++  IA     AL+YL  +    I+HRD+   N+LLD      + DFGI+
Sbjct: 105 PE-------EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHPR---- 164
             +  DS   T  AG   Y+APE            + DV+S G+   EV  GK P     
Sbjct: 156 GQLV-DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Query: 165 ---DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAF--LCLDNNPESRPN 218
              D L+ V   +P         P L         +  S   V F  LCL  +   RP 
Sbjct: 215 SVFDQLTQVVKGDP---------PILSNSE----EREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.9 bits (137), Expect = 9e-10
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 10/173 (5%)

Query: 2   KKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELG 59
           +K  L E  +L ++    IV   Y F +   H  LV   +  G L   I N      E+ 
Sbjct: 37  EKMALLEKEILEKVNSPFIVNLAYAFESKT-HLCLVMSLMNGGDLKYHIYNVGERGLEM- 94

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             R I+    I   + +LH      IV+RD+  +NVLLD +    +SD G+A  +  D  
Sbjct: 95  -ERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGK 149

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP-RDFLSNVS 171
             T+ AGT GY+APE+      +   D ++ G    E++ G+ P +D    V+
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 30/234 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL+E  ++ +  H +IVK  G  T     ++V E    G L   L    +   L  
Sbjct: 50  VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDL 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +  I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ D S 
Sbjct: 107 ASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESY 162

Query: 121 WTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +    G     ++APE     + T+  DV+ FGV   E++  G  P   + N    N  I
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVI 218

Query: 178 LVNEM-----LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI-CQL 225
              E      + P  PP        + S+M     C   +P  RP    +  QL
Sbjct: 219 GRIENGERLPMPPNCPP-------TLYSLMT---KCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 22/171 (12%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LRE+ ++ EI+H NI+             LV + +    L  +++      E   S+   
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKC 123

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQPDSS----- 119
           ++  I + L+ LH       +HRD+S  N+ ++ +    ++DFG+A ++  P  S     
Sbjct: 124 ILLQILNGLNVLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 120 --------NWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
                     T    T  Y APEL     K     D++S G +  E++ GK
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 56/178 (31%), Positives = 78/178 (43%), Gaps = 25/178 (14%)

Query: 2   KKEFLREITVLTEIRHRNIV--------------KFYGFCTHARHSFLVYEYLENGSLSV 47
           KKE + +  V   I  RNI+              KF  F T     +LV +Y+  G L  
Sbjct: 28  KKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKF-SFQT-DSDLYLVTDYMSGGELFW 85

Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVS 106
            L  +    E    R    I  +  AL +LH +D    IV+RD+  +N+LLD      + 
Sbjct: 86  HLQKEGRFSE---DRAKFYIAELVLALEHLHKYD----IVYRDLKPENILLDATGHIALC 138

Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHP 163
           DFG++K    D+     F GT  Y+APE+    K  T   D +S GVL  E+  G  P
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 49/242 (20%), Positives = 93/242 (38%), Gaps = 36/242 (14%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E+    E+ H N+++  G C  +    LV E+   G L   L ++         + +
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101

Query: 65  ------NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA------K 112
                  V  G+      LH       +H D++ +N  L  +    + D+G+A       
Sbjct: 102 LQRMACEVASGLLW----LHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154

Query: 113 FIQPDSSNWTEFAGTYGYVAPELA-------YTMKVTAKCDVYSFGVLALEVIK-GKHPR 164
           +      +         ++APEL             T K +++S GV   E+      P 
Sbjct: 155 YYITKDCHAVPLR----WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210

Query: 165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             LS+       +   ++  P+ P L +    +   +M+  +L    +PE+RP  + + +
Sbjct: 211 PDLSDEQVLKQVVREQDIKLPK-PQLDLKYSDRWYEVMQFCWL----DPETRPTAEEVHE 265

Query: 225 LL 226
           LL
Sbjct: 266 LL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 5/108 (4%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTY 128
           I+ AL++LH      I++RD+   NVLLD E    ++D+G+ K  I+P  +  T F GT 
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160

Query: 129 GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            Y+APE+          D ++ GVL  E++ G+ P D +    + + N
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++ FL E   L +  H NIV+  G  T      +V EY+ NG+L   L       +L   
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAG 107

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN- 120
           + + ++ G+A  + YL        VH+ +++  VL++ +    +S F     +Q D S  
Sbjct: 108 QLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEA 161

Query: 121 -WTEFAGTYG--YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
            +T  +G     + APE       ++  DV+SFG++  EV+  G+ P
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 4/94 (4%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I   L +LH      IV+RD+  +NVLLD      +SD G+A  +          AGT G
Sbjct: 104 IICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPG 159

Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           Y+APE+          D ++ G    E+I G+ P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 42/247 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
           D +EFLRE   + E  H N++K  G    +R         ++  ++++G L   L     
Sbjct: 44  DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103

Query: 55  AEE---LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
            EE   L     +  +  IA  + YL        +HRD++++N +L+      V+DFG++
Sbjct: 104 GEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLS 160

Query: 112 KFIQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYSFGVLALEVI-K 159
           K I         ++G Y            ++A E       T   DV++FGV   E++ +
Sbjct: 161 KKI---------YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Query: 160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
           G+ P   + N    N  I  N +   + PP  ++       + E+   C    P+ RP+ 
Sbjct: 212 GQTPYAGVENSEIYNYLIKGNRL---KQPPDCLE------DVYELMCQCWSPEPKCRPSF 262

Query: 220 QTICQLL 226
           Q +   L
Sbjct: 263 QHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 57/248 (22%), Positives = 101/248 (40%), Gaps = 56/248 (22%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFC--THARHSF----LVYEYLENGSLSVILNNDTSAE 56
           ++FL E   + E  H N+++  G C  T     +    ++  ++++G L   L      +
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 57  E---LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
               L     +  +  IA  + YL        +HRD++++N +L+      V+DFG++K 
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 114 IQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGK 161
           I         + G Y            ++A E       T K DV+SFGV   E+  +G+
Sbjct: 162 I---------YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Query: 162 HPRDFLSNVSSSNPNILVNEMLD-----PRL--PPLSVDIRGKVISIMEVAFLCLDNNPE 214
            P           P +  +E+ D      RL  PP  +D       +  +   C   NP+
Sbjct: 213 TPY----------PGVENSEIYDYLRQGNRLKQPPDCLD------GLYSLMSSCWLLNPK 256

Query: 215 SRPNMQTI 222
            RP+ +T+
Sbjct: 257 DRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 28/179 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-----SAE 56
           + +F RE  ++ E  H NIVK  G C   +   L++EY+  G L+  L + +     S  
Sbjct: 52  QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111

Query: 57  ELGWSRR--------------INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE 102
               S R              + + K +A  ++YL        VHRD++++N L+     
Sbjct: 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 168

Query: 103 AHVSDFGIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
             ++DFG+++ I   S+++ + +        ++ PE  +  + T + DV+++GV+  E+
Sbjct: 169 VKIADFGLSRNIY--SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 25/179 (13%)

Query: 6   LREITVLTEIRHRNIVKFY------GFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           LREI +L   +H NI+          F +     ++V E +E     +I     S + + 
Sbjct: 51  LREIKILRRFKHENIIGILDIIRPPSFESF-NDVYIVQELMETDLYKLIKTQHLSNDHIQ 109

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           +      +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   P+  
Sbjct: 110 Y-----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 120 N---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLS 168
           +    TE+  T  Y APE+    K  T   D++S G +  E++       GK     L+
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 25/205 (12%)

Query: 8   EITVLTEIRHRN--IVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           E  VL  +R     +   Y F T A+ H  L+ +Y+  G +   L    +  E      +
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLH--LILDYVSGGEMFTHLYQRDNFSE----DEV 107

Query: 65  NVIKG-IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWT 122
               G I  AL +LH      IV+RDI  +N+LLD E    ++DFG++K F+  +     
Sbjct: 108 RFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164

Query: 123 EFAGTYGYVAPELAYTMKVTAKC-DVYSFGVLALEVIKGKHP------RDFLSNVSSSNP 175
            F GT  Y+APE+        K  D +S G+L  E++ G  P      R+  S VS    
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--- 221

Query: 176 NIL-VNEMLDPRLPPLSVDIRGKVI 199
            IL  +      + P + D+  K++
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.3 bits (133), Expect = 3e-09
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 30/210 (14%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI--- 64
           E  +L+++ H  IVKF+          ++ EY E   L      D   EEL  + +    
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSE 105

Query: 65  -NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             V +     L  +H+     I+HRD+ +KN+ L       + DFG+++ +       T 
Sbjct: 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP---RDFLSNV---------- 170
           F GT  Y++PE        +K D++S G +  E+    H    ++FLS V          
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224

Query: 171 ----SSSNPNILVNEML--DPRLPPLSVDI 194
                S   N ++  ML  DP L P + +I
Sbjct: 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 18/223 (8%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 54  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQY 110

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  D   + 
Sbjct: 111 LLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 225

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM     C   + +SRP  + +
Sbjct: 226 KGERLPQPPICTID----VYMIM---VKCWMIDADSRPKFREL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 3e-09
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 41/237 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D   F    ++++++ H+++VK YG C    +  +V EY++ G L V L+ + +   L W
Sbjct: 44  DSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW 102

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYE----AHVSDFGIAKF 113
             +++V K +A AL YL       +VH ++  KN+L+    L         +SD GI   
Sbjct: 103 --KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157

Query: 114 IQPDSSNWTEFAGTYGYVAPELAY--TMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNV 170
           +        E      ++APE        +T   D +SFG   LE+   G+ P   LS +
Sbjct: 158 VLSRE----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTL 210

Query: 171 SSSNPNILVNEMLD-----PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           SSS       E         RLP         +I+       C   +P  RP+ + I
Sbjct: 211 SSS-------EKERFYQDQHRLPMPDCAELANLIN------QCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I   L  LH +    IV+RD+  +N+LLD      +SD G+A  + P+        GT G
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVG 166

Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           Y+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I+  L +LH      I++RD+   NV+LD E    ++DFG+ K    D      F GT  
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           Y+APE+          D +++GVL  E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 55.3 bits (133), Expect = 4e-09
 Identities = 43/141 (30%), Positives = 64/141 (45%), Gaps = 7/141 (4%)

Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
           +  F T  R  F V E++  G L   +      +E   +R       I  AL +LH    
Sbjct: 62  YCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEITSALMFLHDK-- 115

Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT 142
             I++RD+   NVLLD E    ++DFG+ K    +    + F GT  Y+APE+   M   
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 143 AKCDVYSFGVLALEVIKGKHP 163
              D ++ GVL  E++ G  P
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 25/151 (16%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL       + DFG+A+ I   PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL--------PPLSVDIR 195
           + DV+SFGVL  E+          S  +S  P + ++E    RL        P  +    
Sbjct: 255 QSDVWSFGVLLWEI---------FSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP-- 303

Query: 196 GKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            ++ SIM     C  NNPE RP    + ++L
Sbjct: 304 -EIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 4e-09
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           IA  L +LH      I++RD+   NV+LD E    ++DFG+ K    D      F GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           Y+APE+          D ++FGVL  E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL---------- 49
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 66  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125

Query: 50  --NNDTSAEE-LGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
             N     EE L +   ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 181

Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 46/143 (32%), Positives = 66/143 (46%), Gaps = 20/143 (13%)

Query: 32  HSFLVYEYLENGSLSVILN--NDTSAEELGWSRRINVIKGI--AHALSYLHHDCIPPIVH 87
           + +LV EY   G L  +LN   D   E++       ++  I   H + Y         VH
Sbjct: 75  NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---------VH 125

Query: 88  RDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAK-- 144
           RDI  +NVL+D      ++DFG A  +  +   N     GT  Y+APE+  TM    K  
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 145 ----CDVYSFGVLALEVIKGKHP 163
               CD +S GV+A E+I G+ P
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 27/177 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           KK FLRE  +  ++ H  IV  Y  C+     +    Y+E  +L  +L +    E L  S
Sbjct: 46  KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--S 103

Query: 62  RRINVIKGIAHALSYLHHDCIP-------PIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
           + +     +   LS  H  C          ++HRD+   N+LL L  E  + D+G A F 
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163

Query: 115 QPD---------------SSNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           + +                S+ T   +  GT  Y+APE    +  +   D+Y+ GV+
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 5e-09
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 7/93 (7%)

Query: 73  ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS--DFGIAKFIQPDSSNWTEFAGTYGY 130
           AL  LH      +++RD+  +N+LLD  Y+ H++  DFG+ K    D      F GT  Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 131 VAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +APEL      T   D ++ GVL  E++ G  P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.8 bits (132), Expect = 6e-09
 Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 8/159 (5%)

Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 43  LTESRVLQNTRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 98

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH      +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 99  FYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 6e-09
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 22/164 (13%)

Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV------ILNNDTSAEELGW 60
           E  +L  ++H  IV   Y F T  +  +L+ EYL  G L +      I   DT+   L  
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS- 107

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSS 119
                    I+ AL +LH      I++RD+  +N+LLD +    ++DFG+ K  I   + 
Sbjct: 108 --------EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             T F GT  Y+APE+          D +S G L  +++ G  P
Sbjct: 157 THT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 6e-09
 Identities = 45/144 (31%), Positives = 65/144 (45%), Gaps = 10/144 (6%)

Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
            Y F T  +   L+ +Y+  G L   L       E   S     I  I  AL +LH    
Sbjct: 71  HYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLALDHLHQ--- 123

Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTYGYVAPELAYTMKV 141
             I++RDI  +N+LLD E    ++DFG++K F+  +      F GT  Y+APE+      
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 142 --TAKCDVYSFGVLALEVIKGKHP 163
                 D +S GVL  E++ G  P
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 26/238 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L        N+ 
Sbjct: 52  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                     I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       ++APE       T   D++SFGV+  E+    + P   LS
Sbjct: 169 IY--ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N        ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 227 NEQ------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 7e-09
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F    ++++++ H ++   +G C     + +V E++E+G L V L  +     + W  +I
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-DLEYEAHVSDFGIAKFIQPDSS---- 119
            V + +A ALSYL       +VH ++ +KN+LL  L      S F   K   P  S    
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF--IKLSDPGVSFTAL 175

Query: 120 NWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
           +  E      ++APE +     ++   D +SFG   LE+   G+ P   L   + S    
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP---LKERTPSEKER 232

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              +    RLP  S      +IS       CL   P  RP+ +TI
Sbjct: 233 FYEKKH--RLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 55.1 bits (132), Expect = 7e-09
 Identities = 61/246 (24%), Positives = 112/246 (45%), Gaps = 40/246 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYG-FCTHARHS-FLVYEYLENGSLSVILNNDTSAEEL 58
           +K + + E+ V+ E++H+NIV++   F   A    +++ E+ + G LS   N     +  
Sbjct: 55  EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS--RNIQKCYKMF 112

Query: 59  GWSRR---INVIKGIAHALSYLHHDCIPP----IVHRDISSKNVLLDLEYE--------- 102
           G       +++ + + HAL+Y H+    P    ++HRD+  +N+ L              
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 103 --------AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY--TMKVTAKCDVYSFGV 152
                   A + DFG++K I  +S   +   GT  Y +PEL    T     K D+++ G 
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGC 231

Query: 153 LALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN 212
           +  E+  GK P    +N S      L++E+   R P L +  + K ++I+    L L  +
Sbjct: 232 IIYELCSGKTPFHKANNFSQ-----LISEL--KRGPDLPIKGKSKELNILIKNLLNL--S 282

Query: 213 PESRPN 218
            + RP+
Sbjct: 283 AKERPS 288

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 15/140 (10%)

Query: 32  HSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRD 89
           + +LV +Y   G L  +L+   D   E++       ++  I H++  LH+      VHRD
Sbjct: 75  YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY------VHRD 127

Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   NVLLD+     ++DFG    +  D +  +  A GT  Y++PE+   M     K   
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 187

Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.2 bits (130), Expect = 7e-09
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 24/175 (13%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDT 53
           D ++F  E+ VL ++  H NI+   G C +  + ++  EY   G+L      S +L  D 
Sbjct: 45  DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDP 104

Query: 54  S-AEELGWSRRIN---VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
           + A+E G +  +    +++  +   + + +      +HRD++++NVL+     + ++DFG
Sbjct: 105 AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 110 IAKFIQPDSSNWTEFAGTYG-----YVAPE-LAYTMKVTAKCDVYSFGVLALEVI 158
           +++              T G     ++A E L Y++  T K DV+SFGVL  E++
Sbjct: 165 LSR------GEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 8e-09
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 14/182 (7%)

Query: 1   DKKEFLREITVLTE-IRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           ++K  + E  VL + ++H  +V   + F T  +  F V +Y+  G L   L  +    E 
Sbjct: 38  EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF-VLDYINGGELFYHLQRERCFLE- 95

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPD 117
              R       IA AL YLH      IV+RD+  +N+LLD +    ++DFG+ K  I+ +
Sbjct: 96  --PRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS-NVSSSNPN 176
            +  T F GT  Y+APE+ +        D +  G +  E++ G  P  F S N +    N
Sbjct: 151 GTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDN 207

Query: 177 IL 178
           IL
Sbjct: 208 IL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.2 bits (130), Expect = 9e-09
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 37/227 (16%)

Query: 17  HRNIVKFYGF-----CTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN--VIKG 69
           H N+VKFYG        +    +LV E    GS++     D     L    R+   +I  
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAY 128

Query: 70  IAH-ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTY 128
           I H AL  L H  +   +HRD+   N+LL  E    + DFG++  +           GT 
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188

Query: 129 GYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNI 177
            ++APE+            A+CDV+S G+ A+E+  G       HP   L  +  + P  
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L         P L  +     I        CL  + E RP +  + Q
Sbjct: 249 L-------HQPELWSNEFNDFIR------KCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 49/167 (29%), Positives = 70/167 (41%), Gaps = 40/167 (23%)

Query: 69  GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTY 128
            I  AL YLH      ++HRD+   NVL++   +  + DFGI+ ++  DS   T  AG  
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCK 167

Query: 129 GYVAPEL--------AYTMKVTAKCDVYSFGVLALEVIKGKHPRD-----F--LSNVSSS 173
            Y+APE          Y +    K DV+S G+  +E+  G+ P D     F  L  V   
Sbjct: 168 PYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223

Query: 174 NPNILVNEMLDPRLP--PLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
                      P+LP    S + +  V         CL  N + RPN
Sbjct: 224 PS---------PQLPAEKFSPEFQDFVNK-------CLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 18/142 (12%)

Query: 6   LREITVLTEIRHRNIVKFYGFC-------THARHSF-LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C          + SF LV+E+ E+  L+ +L+N      
Sbjct: 59  LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT 117

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQP 116
           L   ++  V+K + + L Y+H +    I+HRD+ + N+L+  +    ++DFG+A+ F   
Sbjct: 118 LSEIKK--VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 117 DSSNWTEFAG---TYGYVAPEL 135
            +S    +     T  Y  PEL
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 18/172 (10%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDT 53
           D ++F  E+ VL ++  H NI+   G C H  + +L  EY  +G+L      S +L  D 
Sbjct: 38  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 97

Query: 54  -------SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                  +A  L   + ++    +A  + YL        +HRD++++N+L+   Y A ++
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 154

Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           DFG+++  +                   L Y++  T   DV+S+GVL  E++
Sbjct: 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 10/184 (5%)

Query: 1   DKKEFLREITVLTE-IRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           ++K  + E  VL + ++H  +V   Y F T  +  F V +++  G L   L  + S  E 
Sbjct: 38  EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYF-VLDFVNGGELFFHLQRERSFPE- 95

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
              R       IA AL YLH      IV+RD+  +N+LLD +    ++DFG+ K     S
Sbjct: 96  --PRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              T F GT  Y+APE+          D +  G +  E++ G  P  +  +V+    NIL
Sbjct: 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNIL 209

Query: 179 VNEM 182
              +
Sbjct: 210 HKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 8/157 (5%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYE-YLENGSLSVILNNDTSAEELGWSRRIN 65
           RE+ +L  ++H N++      T A       E YL    +   LNN    ++L       
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           +I  +   L Y+H      I+HRD+   NV ++ + E  + DFG+A+  Q D    T + 
Sbjct: 123 LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE-MTGYV 176

Query: 126 GTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+    M      D++S G +  E++KGK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAK 144
           IV+RD+  +N+LLD      +SD G+A  I P+        GT GY+APE+    + T  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 145 CDVYSFGVLALEVIKGKHP 163
            D +  G L  E+I+GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 120 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 173

Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 4/94 (4%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I   L  LH +     V+RD+  +N+LLD      +SD G+A  I P+  +     GT G
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVG 166

Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           Y+APE+    + T   D +  G L  E+I+G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAK 144
           IV+RD+  +N+LLD      +SD G+A  I P+        GT GY+APE+    K T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 145 CDVYSFGVLALEVIKGKHP 163
            D +  G L  E+I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 18/166 (10%)

Query: 3   KEFLREITVLTEIRHRNIVK----FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           K  LRE+ +L   +H NI+             +  ++V + +E+    +I ++    EE 
Sbjct: 49  KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108

Query: 59  GWSRRINVIKG-IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI--- 114
                I      +   L Y+H   +   +HRD+   N+L++ + E  + DFG+A+ +   
Sbjct: 109 -----IRYFLYQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 115 QPDSSNW-TEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVI 158
             +   + TE+  T  Y APEL  ++ + T   D++S G +  E++
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 19/202 (9%)

Query: 16  RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS 75
           RH  +V  +       H   V EY   G L + ++ D  +E     R +     +   L 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE----PRAVFYAACVVLGLQ 115

Query: 76  YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL 135
           YLH +    IV+RD+   N+LLD E    ++DFG+ K         + F GT  ++APE+
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 136 AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPP-LSVDI 194
                 T   D +  GVL  E++ G+ P  F  +      + +VN+  + R P  LS + 
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDSIVND--EVRYPRFLSRE- 227

Query: 195 RGKVISIMEVAFLCLDNNPESR 216
               ISIM      L  NPE R
Sbjct: 228 ---AISIMRR---LLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 13/161 (8%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI+++ E++H NIV+ +          LV+EY++      +   DT           N
Sbjct: 46  IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYM---DTHGVRGALD--PN 100

Query: 66  VIKGIAHAL----SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +K   + L    ++ H +    ++HRD+  +N+L++   E  ++DFG+A+      + +
Sbjct: 101 TVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157

Query: 122 TEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK 161
           +    T  Y AP++    +  +   D++S G +  E+I G+
Sbjct: 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 52.2 bits (126), Expect = 4e-08
 Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 16/162 (9%)

Query: 6   LREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           LRE+  L ++  H NIVK           + V+EY+E     ++ +           R  
Sbjct: 45  LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR-- 102

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++I  I   L+++H        HRD+  +N+L+       ++DFG+A+ I+     +T++
Sbjct: 103 SIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDY 158

Query: 125 AGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
             T  Y APE+     +Y+  V    D+++ G +  E+   +
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 17/161 (10%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F    +++ ++ H++IV  YG C     + +V E++E G L + ++  +      W  + 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-----DLEYEAHV--SDFGIAKFIQPD 117
            V K +A ALSYL       +VH ++ +KN+LL     D E    +  SD GI   +   
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 118 SSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEV 157
                E      ++APE     K  +   D +SFG    E+
Sbjct: 166 Q----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCT-HARHSF----LVYEYLENGSLSVILNNDTSA 55
           D K  LREI +L  + H N++          R +F    +VYE ++     +I ++ T +
Sbjct: 47  DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS 106

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           ++        +++G    L Y+H      ++HRD+   N+LL+   +  + DFG+A+   
Sbjct: 107 DDHCQYFLYQLLRG----LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159

Query: 116 PDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK 161
                 TE+  T  Y APEL     + T   DV+S G +  E++  K
Sbjct: 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 13/171 (7%)

Query: 11  VLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKG 69
           +L  ++H  +V   Y F T A   + V +Y+  G L   L  +    E    R       
Sbjct: 49  LLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAE 104

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTY 128
           +A A+ YLH      I++RD+  +N+LLD +    ++DFG+ K  ++P+ +  T F GT 
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160

Query: 129 GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS-NVSSSNPNIL 178
            Y+APE+          D +  G +  E++ G  P  F S +VS    NIL
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP--FYSRDVSQMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 7/157 (4%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L  ++H NIV  +      R   LV+EYL++  L   L+N  +   +  + +I 
Sbjct: 51  IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH-NVKIF 108

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           + + +   LSY H      I+HRD+  +N+L++ + E  ++DFG+A+     +  ++   
Sbjct: 109 MFQ-LLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164

Query: 126 GTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
            T  Y  P+ L  + + +   D++  G +  E+  G+
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 5e-08
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 24/166 (14%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E+ H NIV+           +LV+E+L +  L   ++   S+   G    + 
Sbjct: 46  IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMD---SSPLTGLDPPL- 100

Query: 66  VIKG----IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            IK     +   ++Y H H     ++HRD+  +N+L+D E    ++DFG+A+        
Sbjct: 101 -IKSYLYQLLQGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155

Query: 121 WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           +T    T  Y APE+      Y+  V    D++S G +  E++  +
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 5e-08
 Identities = 34/155 (21%), Positives = 69/155 (44%), Gaps = 11/155 (7%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           L E  +L  + H ++++          + +V  +  +   + +         L   + + 
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR---PLPIDQALI 161

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF--IQPDSSNWTE 123
           + K I   L YLH      I+HRD+ ++N+ ++   +  + D G A+F  + P    +  
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
            AGT    APE+    K  +K D++S G++  E++
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 3   KEFLREITVLTEIRHRNIVKFYG-FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K   RE+ +L  +RH NI+     F +     + V E L    L  +L +    ++    
Sbjct: 54  KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQY 112

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
               +++G    L Y+H      +VHRD+   N+L++   +  + DFG+A+         
Sbjct: 113 FLYQILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQM 162

Query: 122 TEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
           T +  T  Y APE+  T  K   + D++S G +  E+++GK
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.4 bits (124), Expect = 7e-08
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 43/177 (24%)

Query: 7   REITVLTEIR-HRNIVKFYGF--CTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           REI  L E+  H NIVK        + +  +LV+EY+E    +VI              R
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--------------R 100

Query: 64  INVIKGIAH---------ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
            N+++ +           AL Y+H      ++HRD+   N+LL+ +    ++DFG+A+ +
Sbjct: 101 ANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157

Query: 115 QPDSSNW-----TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
                N      T++  T  Y APE+      YT  V    D++S G +  E++ GK
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 30/178 (16%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRR 63
            REI +L E++H N+V     F  HA  S +L+++Y E+  L  I+     A+ +     
Sbjct: 50  CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPS 108

Query: 64  I--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFIQPD 117
           +  +++  I + + YLH +    ++HRD+   N+L+  E        + D G+A+     
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 118 SSNWTEFAG---TYGYVAPELA-----YTMKVTAKCDVYSFG-----VLALEVI-KGK 161
                +      T  Y APEL      YT  +    D+++ G     +L LE I KG+
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 50/188 (26%)

Query: 6   LREITVLTEIRHRNIVK----FY---GFCTHARHSF-LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L +++H N+V                R S  +V  Y+++  LS +L N      
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP----- 108

Query: 58  LGWSRRINV----IKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
                 + +    IK         ++YLH +    I+HRDI + N+L+D +    ++DFG
Sbjct: 109 -----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160

Query: 110 IAKFIQPDSSNWTEFAG-----------TYGYVAPELA-----YTMKVTAKCDVYSFGVL 153
           +A+       N     G           T  Y  PEL      YT  V    D++  G +
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCV 216

Query: 154 ALEVIKGK 161
             E+   +
Sbjct: 217 FAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 27/178 (15%)

Query: 3   KEFLREITVLTEIRHRNIVKFY--------------GFCTHARHSFLVYEYLENGSLSVI 48
           K  LREI ++  + H NIVK Y              G  T     ++V EY+E   L+ +
Sbjct: 47  KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANV 105

Query: 49  LNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSD 107
           L     +EE        +++G    L Y+H      ++HRD+   NV ++ E     + D
Sbjct: 106 LEQGPLSEEHARLFMYQLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158

Query: 108 FGIAKFIQPDSSN---WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
           FG+A+ + P  S+    +E   T  Y +P L  +    T   D+++ G +  E++ GK
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 14/162 (8%)

Query: 8   EITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           E  VL  IR     +   Y F T  +   L+ +Y+  G L   L+     +E    + + 
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFKE----QEVQ 108

Query: 66  VIKG-IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTE 123
           +  G I  AL +LH      I++RDI  +N+LLD      ++DFG++K F + +      
Sbjct: 109 IYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 124 FAGTYGYVAPELAYTMKV--TAKCDVYSFGVLALEVIKGKHP 163
           F GT  Y+AP++            D +S GVL  E++ G  P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 55/182 (30%), Positives = 79/182 (43%), Gaps = 40/182 (21%)

Query: 2   KKEFLR---------EITVLTEIRHRNIVKFY-GFCTHARHSFLVYEYLENGSLSVILN- 50
           K+E L+         E ++L E+ H  IV     F    R  FL+ E++  G L   L  
Sbjct: 53  KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRK 111

Query: 51  -----NDT----SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY 101
                ND      AE             +  A  YLH      I++RD+  +N+LLD + 
Sbjct: 112 AGRFPNDVAKFYHAE-------------LVLAFEYLHSK---DIIYRDLKPENLLLDNKG 155

Query: 102 EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
              V+DFG AK + PD + +T   GT  Y+APE+  +       D ++ GVL  E I G 
Sbjct: 156 HVKVTDFGFAKKV-PDRT-FT-LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212

Query: 162 HP 163
            P
Sbjct: 213 PP 214

Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 15/140 (10%)

Query: 32  HSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRD 89
           + +LV +Y   G L  +L+   D   E++       ++  I  ++  L +      VHRD
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI-DSVHQLGY------VHRD 127

Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   NVLLD      ++DFG    +  D +  +  A GT  Y++PE+   M     +   
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGP 187

Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 56/242 (23%), Positives = 106/242 (43%), Gaps = 38/242 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------------ 49
           ++EF  E  + + ++H NIV   G  T  +   +++ Y  +  L   L            
Sbjct: 52  REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST 111

Query: 50  -NNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
            ++ T    L  +  ++++  IA  + +L  HH     +VH+D++++NVL+  +    +S
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKIS 166

Query: 107 DFGIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK 161
           D G+  F +  ++++ +  G       +++PE     K +   D++S+GV+  EV   G 
Sbjct: 167 DLGL--FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Query: 162 HPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
            P    SN         V EM+  R + P   D    V ++M     C +  P  RP  +
Sbjct: 225 QPYCGYSNQD-------VIEMIRNRQVLPCPDDCPAWVYTLM---LECWNEFPSRRPRFK 274

Query: 221 TI 222
            I
Sbjct: 275 DI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           LREI +L ++    H NIV+    C   R        LV+E+++   L+  L+      +
Sbjct: 46  LREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK---CPK 101

Query: 58  LGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
            G       ++++ +   + +LH   I   VHRD+  +N+L+  + +  ++DFG+A+ I 
Sbjct: 102 PGLPPETIKDLMRQLLRGVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLAR-IY 157

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFG 151
                 T    T  Y APE+          D++S G
Sbjct: 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 16/165 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNNDTSAEE 57
           K   RE+ +L  ++H N++      T        H F    YL    +   L      E+
Sbjct: 59  KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF----YLVMPFMGTDLGKLMKHEK 114

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L   R   ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+  Q D
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTD 169

Query: 118 SSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
           S   T +  T  Y APE+    M  T   D++S G +  E++ GK
Sbjct: 170 SE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 27/152 (17%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL       + DFG+A+ I   PD            ++APE  +    T 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL--------PPL-SVDI 194
           + DV+SFGVL  E+          S  +S  P + +NE    RL        P   + +I
Sbjct: 256 QSDVWSFGVLLWEI---------FSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEI 306

Query: 195 RGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +++       C   +P+ RP    + ++L
Sbjct: 307 YRIMLA-------CWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 30/243 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ +FL E      ++H N+++  G CT      LV E+   G L   L +   AE +  
Sbjct: 38  EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP 97

Query: 61  SRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK------ 112
                  +   IA  L +LH +     +H D++ +N LL  +    + D+G++       
Sbjct: 98  DPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154

Query: 113 -FIQPDSSNWTEFAGTYGYVAPELA-------YTMKVTAKCDVYSFGVLALEVIK-GKHP 163
            ++ PD   W        ++APEL          +  T + +V+S GV   E+ + G  P
Sbjct: 155 YYVTPDQL-WVPLR----WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Query: 164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
              LS+       +   ++  P+ P L + +  +   +M+  +L     PE RP+ + + 
Sbjct: 210 YRHLSDEQVLTYTVREQQLKLPK-PRLKLPLSDRWYEVMQFCWL----QPEQRPSAEEVH 264

Query: 224 QLL 226
            LL
Sbjct: 265 LLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 25/173 (14%)

Query: 3   KEFLREITVLTEIR-HRNIVKFYG----FCTHARHSFLVYEYLENGSLSVILNNDTSAEE 57
           K  LRE+ +L   R H+NI   Y     F  +    +L YE L    L  I+    S + 
Sbjct: 46  KRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIR---SGQP 101

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L  +   + I  I   L Y+H      ++HRD+   N+L++ + E  + DFG+A+    +
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158

Query: 118 ----SSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
               +   TE+  T  Y APE+     +YT  +    DV+S G +  E++  K
Sbjct: 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 33/149 (22%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHS----------FLVYEY--------LENGSLSV 47
           +REI +L ++ HRNIV      T  + +          +LV+EY        LE+G +  
Sbjct: 54  IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF 113

Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSD 107
             ++  S            +K +   L+Y H       +HRDI   N+LL+ + +  ++D
Sbjct: 114 SEDHIKS-----------FMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159

Query: 108 FGIAKFIQPDSSN-WTEFAGTYGYVAPEL 135
           FG+A+    + S  +T    T  Y  PEL
Sbjct: 160 FGLARLYNSEESRPYTNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEELGW 60
           KE L E  V+  +    + +  G C  +    LV + +  G L   V  N D     +G 
Sbjct: 54  KEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKD----RIGS 108

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              +N    IA  +SYL       +VHRD++++NVL+       ++DFG+A+ +  D + 
Sbjct: 109 QDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Query: 121 WTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +    G     ++A E     + T + DV+S+GV   E++  G  P D +   +   P++
Sbjct: 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDL 223

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           L      P+ P  ++D    V  IM     C   + E RP  + +
Sbjct: 224 LEKGERLPQPPICTID----VYMIM---VKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 20/166 (12%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ +L  + H+NI+      T  +        +LV E L + +L  +++ +   E
Sbjct: 65  KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDHE 123

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 124 RMSY-LLYQMLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 172

Query: 117 DSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
             +N+  T +  T  Y APE+   M      D++S G +  E++KG
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 55/195 (28%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHAR--------------------HSFLVYEYL 40
           + +EFL E   + +  H N++K  G C  A                     HSFL+Y  L
Sbjct: 44  EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL 103

Query: 41  ENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
                 + L              +  +  IA  + YL +      +HRD++++N +L  +
Sbjct: 104 GGLPEKLPLQ-----------TLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRED 149

Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYS 149
               V+DFG++K I         ++G Y            ++A E       T+K DV++
Sbjct: 150 MTVCVADFGLSKKI---------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 200

Query: 150 FGVLALEVI-KGKHP 163
           FGV   E+  +G+ P
Sbjct: 201 FGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 44/205 (21%)

Query: 39  YLENGSLSVILNNDTSA---EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV 95
           Y++    S IL  D  A   E+L  S    V KG++   S    +CI    HRD++++N+
Sbjct: 194 YIDQDVTSEILEEDELALDTEDL-LSFSYQVAKGMSFLAS---KNCI----HRDLAARNI 245

Query: 96  LLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT---YGYVAPELAYTMKVTAKCDVYSFGV 152
           LL       + DFG+A+ I+ D SN+           ++APE  +    T + DV+S+G+
Sbjct: 246 LLTHGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 304

Query: 153 LALEVIKGKHPRDFLSNVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISI 201
           L  E+          S  SS  P + V+            ML P   P       ++  I
Sbjct: 305 LLWEI---------FSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS------EMYDI 349

Query: 202 MEVAFLCLDNNPESRPNMQTICQLL 226
           M+    C D +P  RP  + I QL+
Sbjct: 350 MKS---CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 19/173 (10%)

Query: 6   LREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  +LT  +   +VK  Y F     + +L  EY+  G    +LNN     E     R 
Sbjct: 49  LTERDILTTTKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARF 105

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTE 123
            + +    A+  LH       +HRD+  +N L+D      ++DFG++K  +   +S    
Sbjct: 106 YMAEMFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS---- 157

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
             G+  Y+APE+          D +S G +  E + G  P       S S PN
Sbjct: 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP------FSGSTPN 204

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 27/156 (17%)

Query: 17  HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY 76
           + N +K Y   T  +   L+ +Y+++G L  +L  +    E   +    +I+ +  AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE---AEVKKIIRQLVEALND 124

Query: 77  LH-HDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPE 134
           LH H+    I+H DI  +NVL D  +   ++ D+G+ K I   S     + GT  Y +PE
Sbjct: 125 LHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE 176

Query: 135 LAYTMKVTAKCDVY--SF-----GVLALEVIKGKHP 163
                K+  K   Y  SF     GVL  E++ GKHP
Sbjct: 177 -----KI--KGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 19/140 (13%)

Query: 34  FLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGI--AHALSYLHHDCIPPIVHRD 89
           +LV +Y   G L  +L+   D   E++       ++  I   H L Y         VHRD
Sbjct: 77  YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---------VHRD 127

Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   N+L+D+     ++DFG    +  D +  +  A GT  Y++PE+   M     K   
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187

Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 14/182 (7%)

Query: 1   DKKEFLREITVLTE-IRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           ++K  + E  VL + ++H  +V   Y F T  +  F V +Y+  G L   L  + S  E 
Sbjct: 38  EQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYF-VLDYVNGGELFFHLQRERSFPE- 95

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPD 117
              R       IA AL YLH      I++RD+  +N+LLD +    ++DFG+ K  I+  
Sbjct: 96  --PRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS-NVSSSNPN 176
            +  T F GT  Y+APE+          D +  G +  E++ G  P  F S + +    N
Sbjct: 151 KTTST-FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRDTAEMYDN 207

Query: 177 IL 178
           IL
Sbjct: 208 IL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 15/159 (9%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-NDTSAEELG--WSRRI 64
           E  +L  I H   V  YG      + +LV E++  G     L  N     ++G  ++ +I
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            +I     +L+         IV+RD+  +N+LLD +    ++DFG AK +  D+  +T  
Sbjct: 141 VLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-L 188

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+   +      D ++ G+   E++ G  P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.0 bits (117), Expect = 5e-07
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 13/162 (8%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--NDTSAEELGWSRR 63
           LREI +L E++H+NIV+ Y      +   LV+EY +   L    +  N     E+  S  
Sbjct: 47  LREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFM 105

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWT 122
             ++KG+A   S  H+     ++HRD+  +N+L++   E  ++DFG+A+ F  P      
Sbjct: 106 FQLLKGLAFCHS--HN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158

Query: 123 EFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHP 163
           E   T  Y  P++ +  K+ +   D++S G +  E+     P
Sbjct: 159 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.8 bits (116), Expect = 6e-07
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 24/163 (14%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLV--------YEYLENGSLSVILNNDTSAEELG 59
           E  +L  I H +I++  G  T+ + + L+        Y YL             +   + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL------------AAKRNIA 180

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF-IQPDS 118
               + + + +  A+ YLH +    I+HRDI ++N+ ++   +  + DFG A F +  ++
Sbjct: 181 ICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
           + +  +AGT    APEL          D++S G++  E+    
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 14/164 (8%)

Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H NIV+    C  +R        LV+E+++   L   L+       
Sbjct: 47  VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPG 104

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L      ++++     L +LH +CI   VHRD+  +N+L+    +  ++DFG+A+ I   
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGQVKLADFGLAR-IYSC 160

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
               T    T  Y APE+          D++S G +  E+ + K
Sbjct: 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E++H NIV            +L++E+L    L   L++    + +      +
Sbjct: 47  IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKS 105

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +  I   + + H      ++HRD+  +N+L+D +    ++DFG+A+        +T   
Sbjct: 106 YLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162

Query: 126 GTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+      Y+  V    D++S G +  E+   K
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPV----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 8e-07
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 23/189 (12%)

Query: 37  YEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNV 95
           Y+   +  +  +L++D S E L     ++    +A  + +L   +C    VHRD++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268

Query: 96  LLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTY---GYVAPELAYTMKVTAKCDVYSFGV 152
           LL       + DFG+A+ I  D SN+     T+    ++APE  +    T   DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 153 LALEVIK-GKHPRDFLSNVSSSNPNILVN--EMLDPRLPPLSVDIRGKVISIMEVAFLCL 209
           L  E+   G  P   +  V S+  N + +   M  P      V          ++   C 
Sbjct: 328 LLWEIFSLGGTPYPGMI-VDSTFYNKIKSGYRMAKPDHATQEV---------YDIMVKCW 377

Query: 210 DNNPESRPN 218
           ++ PE RP+
Sbjct: 378 NSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 8e-07
 Identities = 41/166 (24%), Positives = 76/166 (45%), Gaps = 19/166 (11%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCT-----HARHSF-LVYEYLENGSLSVILNNDTSAE 56
           K   RE+T+L  ++H N++      T          F LV  Y++   L  I+ +  S +
Sbjct: 59  KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSED 117

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           ++ +     ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    
Sbjct: 118 KVQY-----LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA-- 167

Query: 117 DSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
             +  T +  T  Y APE+    M      D++S G +  E++ GK
Sbjct: 168 -DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 36/161 (22%), Positives = 78/161 (48%), Gaps = 15/161 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L +++H NIV  +      +   LV+EYL+        +     ++ G    ++
Sbjct: 52  IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-------DLKQYMDDCGNIMSMH 104

Query: 66  VIK----GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +K     I   L+Y H      ++HRD+  +N+L++   E  ++DFG+A+     +  +
Sbjct: 105 NVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161

Query: 122 TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +    T  Y  P+ L  + + + + D++  G +  E+  G+
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 38/161 (23%), Positives = 79/161 (49%), Gaps = 15/161 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L +++H NIV  +      +   LV+EYL+   L   L      ++ G S  ++
Sbjct: 52  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL------DDCGNSINMH 104

Query: 66  VIK----GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +K     +   L+Y H      ++HRD+  +N+L++   E  ++DFG+A+     +  +
Sbjct: 105 NVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161

Query: 122 TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +    T  Y  P+ L  +   + + D++  G +  E+  G+
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 13/146 (8%)

Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
           FY F    R+ ++V EY+  G L  +++N    E+  W+R       +  AL  +H    
Sbjct: 109 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHS--- 160

Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTMKV 141
              +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 142 TA----KCDVYSFGVLALEVIKGKHP 163
                 +CD +S GV   E++ G  P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 9/83 (10%)

Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L   + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172

Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 25/161 (15%)

Query: 7   REITVLTEIRHRNIVKFYG-------FCTHARH-SFLVYEYLENGSLSVILNNDTSAEEL 58
           REI +L  I HR I+            C         ++ Y++  S  + L         
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD-RSGPLPLEQ------- 186

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI--QP 116
                I + + +  AL+YLH      I+HRD+ ++N+ LD    A + DFG A  +   P
Sbjct: 187 ----AITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           D+     ++GT    +PEL       AK D++S G++  E+
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 35/160 (21%), Positives = 70/160 (43%), Gaps = 19/160 (11%)

Query: 8   EITVLTEIRHRNIVKF--------YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           EI  L  + H NI+K           +    ++ F +Y ++ + +       D     L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPLL 266

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQPDS 118
              R  ++K +  A+ Y+H      ++HRDI  +N+ L+ + +  + DFG A  F +   
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +    + GT    +PE+          D++S G++ L+++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 28/164 (17%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAG 126
           I  AL  +H   +   +HRD+ S N+ L       + DFG +K    DS +    + F G
Sbjct: 178 IVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCG 233

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVI------KGKHPRDFLSNVSSSNPNILVN 180
           T  Y+APEL    + + K D++S GV+  E++      KG   R+ +  V          
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK------ 287

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              DP   P+S  ++    ++++     L  NP  RP  Q +  
Sbjct: 288 --YDPFPCPVSSGMK----ALLDP---LLSKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 14/145 (9%)

Query: 26  FCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP 83
           FC     ++ ++V EY+  G L  +++N    E+  W++       +  AL  +H     
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYTA--EVVLALDAIHS---M 161

Query: 84  PIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQPDSSNWTEFAGTYGYVAPELAYTMKVT 142
            ++HRD+   N+LLD      ++DFG   K  +          GT  Y++PE+  +    
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 143 A----KCDVYSFGVLALEVIKGKHP 163
                +CD +S GV   E++ G  P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 55/198 (27%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEE---LGWSR 62
           E  +L E     +VK FY F    R+ +L+ E+L  G + ++++  DT +EE      + 
Sbjct: 51  ERDILVEADGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE 109

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +  I  I H L +         +HRDI   N+LLD +    +SDFG+   ++   ++ T
Sbjct: 110 TVLAIDAI-HQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRT 157

Query: 123 EF-------------------------------------AGTYGYVAPELAYTMKVTAKC 145
           EF                                      GT  Y+APE+         C
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 146 DVYSFGVLALEVIKGKHP 163
           D +S GV+  E++ G  P
Sbjct: 218 DWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 2/74 (2%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL       + DFG+A+ I   PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 144 KCDVYSFGVLALEV 157
           + DV+SFGVL  E+
Sbjct: 261 QSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 20/171 (11%)

Query: 19  NIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEEL--GWSRRINVIKGIAHALS 75
           N+V  + +       FLV ++ E G L S I       EE    W+  + V      AL 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99

Query: 76  YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL 135
            LH +    IV RD++  N+LLD      ++ F     ++         A    Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG---EAVENMYCAPEV 153

Query: 136 AYTMKVTAKCDVYSFGVLALEVIKGK-----HPRDFLSNVSSSNPNILVNE 181
               + T  CD +S G +  E++ GK     HP    ++ + + P  +  E
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEE 204

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.9 bits (109), Expect = 6e-06
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
            Y F    ++ ++V EY+  G L  +++N    E+  W+R       +  AL  +H    
Sbjct: 109 HYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARF--YTAEVVLALDAIHS--- 160

Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTMKV 141
              +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 142 TA----KCDVYSFGVLALEVIKGKHP 163
                 +CD +S GV   E++ G  P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 27/75 (36%), Positives = 43/75 (57%), Gaps = 4/75 (5%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTY---GYVAPELAYTMKVT 142
           VHRD++++NVL+       + DFG+A+ I  DS N+     T+    ++APE  +    T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYT 319

Query: 143 AKCDVYSFGVLALEV 157
              DV+SFG+L  E+
Sbjct: 320 TLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 9/83 (10%)

Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L     
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172

Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 45.1 bits (106), Expect = 1e-05
 Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 7/156 (4%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE ++L  ++H NIV  +          LV+EY+       +   D     L       
Sbjct: 51  IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKL 107

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +  +   LSY+H   I   +HRD+  +N+L+    E  ++DFG+A+     S  ++   
Sbjct: 108 FLFQLLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEV 164

Query: 126 GTYGYVAPELAYTMKVTAKC-DVYSFGVLALEVIKG 160
            T  Y  P++       + C D++  G + +E+I+G
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 15/161 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF-LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +RE ++L  ++H NIV  +    H + +   V+EY+       +       +  G     
Sbjct: 51  IREASLLKGLKHANIVLLHDI-IHTKETLTFVFEYMHTDLAQYM------IQHPGGLHPY 103

Query: 65  NV---IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           NV   +  +   L+Y+H      I+HRD+  +N+L+    E  ++DFG+A+     S  +
Sbjct: 104 NVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160

Query: 122 TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +    T  Y  P+ L      ++  D++  G + +E+++G+
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 13/98 (13%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTY 128
           I   L YLH      I+HRDI   N+L++      + DFG+A+  +PD S + T+   T 
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 129 GYVAPELA-----YTMKVTAKCDVYSFGVLALEVIKGK 161
            Y APE+      YT  V    D++S G +  E++  +
Sbjct: 169 YYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 45/188 (23%), Positives = 90/188 (47%), Gaps = 25/188 (13%)

Query: 7   REITVLTEIRHRNIVKFYG-FCTHA-RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           REI +L E++H N++     F +HA R  +L+++Y E+    +I  +  S       + +
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPV 103

Query: 65  NVIKGIAHALSY-----LHHDCIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKF-- 113
            + +G+  +L Y     +H+     ++HRD+   N+L+  E        ++D G A+   
Sbjct: 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 114 --IQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK---HPRDFL 167
             ++P  ++      T+ Y APEL    +  T   D+++ G +  E++  +   H R   
Sbjct: 164 SPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ-- 220

Query: 168 SNVSSSNP 175
            ++ +SNP
Sbjct: 221 EDIKTSNP 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 29/169 (17%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGW--- 60
            L+E  +L  + H+NI+     C       F++Y Y+  G+L + L      E       
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 61  SRRINVIKG--IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP-- 116
           S +  V     IA  +SYLH      ++H+DI+++N ++D E +  ++D  +++ + P  
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 117 -----DSSN----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE 156
                D+ N    W         +A E     + ++  DV+SFGVL  E
Sbjct: 172 YHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 18/166 (10%)

Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ VL  +    H N+V+ +  CT +R        LV+E+++   L+  L+      E
Sbjct: 49  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPE 104

Query: 58  LGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
            G       +++  +   L +LH      +VHRD+  +N+L+    +  ++DFG+A+ I 
Sbjct: 105 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IY 160

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                 T    T  Y APE+          D++S G +  E+ + K
Sbjct: 161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 48/224 (21%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E  +L  + H  +   Y       +  LV +Y   G L  +L       + G      V 
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-----RQPGKCLSEEVA 105

Query: 68  KGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK--------- 112
           +  A     AL YLH   +  IV+RD+  +N+LL      H+  SDF ++K         
Sbjct: 106 RFYAAEVLLALEYLH---LLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPV 160

Query: 113 --------------------FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
                               F +  S     F GT  Y+APE+       +  D ++ G+
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220

Query: 153 LALEVIKGKHPRDFL-SNVSSSNPNILVNEMLDPRLPPLSVDIR 195
           L  E++ G  P  F  SN   +  NIL  E+  P  PP+S   R
Sbjct: 221 LLYEMLYGTTP--FKGSNRDETFSNILKKEVTFPGSPPVSSSAR 262

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QM 114

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 170

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 47/187 (25%), Positives = 89/187 (47%), Gaps = 23/187 (12%)

Query: 7   REITVLTEIRHRNIVKFYG-FCTHA-RHSFLVYEYLENGSLSVILNNDTSAE-----ELG 59
           REI +L E++H N++     F +H+ R  +L+++Y E+    +I  +  S       +L 
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAK-FI 114
            S   +++  I   + YLH +    ++HRD+   N+L+  E        ++D G A+ F 
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 115 QPDS--SNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK---HPRDFLS 168
            P    ++      T+ Y APEL    +  T   D+++ G +  E++  +   H R    
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ--E 221

Query: 169 NVSSSNP 175
           ++ +SNP
Sbjct: 222 DIKTSNP 228

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 16/165 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 121

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+IKG 
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 8/157 (5%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYE-YLENGSLSVILNNDTSAEELGWSRRIN 65
           RE+ +L  + H N++      T A       + YL    +   LNN    ++L       
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           ++  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+         T + 
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV 176

Query: 126 GTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+    M      D++S G +  E++ GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.2 bits (99), Expect = 8e-05
 Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 18/169 (10%)

Query: 15  IRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI--NVIKGIAH 72
           I H  I K+YG C   +   + Y ++    L V    +        ++++  N++K +  
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLT 137

Query: 73  ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FI--------QPDSSNWTE 123
            L Y+H   I    H DI  +N+++D     ++ D+GIA  FI          +  +   
Sbjct: 138 TLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHR 194

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
             GT  Y   +      VT + D+ S G   L+    K P     +  +
Sbjct: 195 --GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241

Length = 294

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.3 bits (100), Expect = 8e-05
 Identities = 34/177 (19%), Positives = 68/177 (38%), Gaps = 20/177 (11%)

Query: 1   DKKEFLR---EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE 57
            K++      EI    +++H NI+ +          ++V   +  GS   +L      E 
Sbjct: 39  SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEG 97

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQP 116
           L       ++K + +AL Y+H       +HR + + ++LL  + +  +S    +   I+ 
Sbjct: 98  LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK- 153

Query: 117 DSSNWTEFAGTYG--------YVAPELAYT--MKVTAKCDVYSFGVLALEVIKGKHP 163
                      +         +++PE+          K D+YS G+ A E+  G  P
Sbjct: 154 -HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 50/224 (22%), Positives = 99/224 (44%), Gaps = 22/224 (9%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTSAEELGW 60
              EI  L  I   NI+K YGF            L+ EY   G L  +L+ +   ++L +
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSF 121

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
             ++++       L  L+     P  +++++S + L+   Y+  +   G+ K +      
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK 179

Query: 121 WTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              F     Y + ++   +  + T K D+YS GV+  E+  GK P + L+  +    +++
Sbjct: 180 NVNFMV---YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLI 234

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           +N+    +LP   +D   ++  I+E    C  ++   RPN++ I
Sbjct: 235 INKNNSLKLP---LDCPLEIKCIVEA---CTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 5/86 (5%)

Query: 73  ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF--AGTYGY 130
           A+ Y+H +    I+HRDI ++NVL++   +  + DFG A F +   S    +  AGT   
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 131 VAPELAYTMKVTAKCDVYSFGVLALE 156
            APE+      T   D++S G++  E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 32/167 (19%)

Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-NDTSAEELGWSRR 63
           LREI  L  +  H NI++            L     + G L+++    D +  EL   R+
Sbjct: 45  LREIQALRRLSPHPNILRL--------IEVLFDR--KTGRLALVFELMDMNLYELIKGRK 94

Query: 64  --------INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI- 114
                    + +  +  +L ++H +    I HRDI  +N+L+  +    ++DFG  + I 
Sbjct: 95  RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIY 150

Query: 115 --QPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVI 158
              P    +TE+  T  Y APE   T      K D+++ G +  E++
Sbjct: 151 SKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 33/177 (18%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN------DTSAEELGWS 61
           E  +LT   +  +V  +      RH  +V EY+E G  + +L N      D +       
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA------- 103

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK--------- 112
            R+   + +  AL YLH+     IVHRD+   N+L+       ++DFG++K         
Sbjct: 104 -RMYFAETVL-ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158

Query: 113 ----FIQPDSSNWT--EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                I+ D+  +   +  GT  Y+APE+          D ++ G++  E + G  P
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 1e-04
 Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 55/198 (27%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEE---LGWSR 62
           E  +L E     +VK FY F     + +L+ E+L  G + ++++  DT  EE      + 
Sbjct: 51  ERDILVEADSLWVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +  I  I H L +         +HRDI   N+LLD +    +SDFG+   ++   ++ T
Sbjct: 110 TVLAIDSI-HQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRT 157

Query: 123 EF-------------------------------------AGTYGYVAPELAYTMKVTAKC 145
           EF                                      GT  Y+APE+         C
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 146 DVYSFGVLALEVIKGKHP 163
           D +S GV+  E++ G  P
Sbjct: 218 DWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 16/165 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E L + +L  ++  D   E
Sbjct: 60  KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMDLDHE 118

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 119 RMSY-LLYQMLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 169

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+I+G 
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 58/205 (28%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGW---SRR 63
           E  +L E  +  +VK Y       + +L+ EYL  G + ++++  DT  EE      +  
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           I  I  I H L Y         +HRDI   N+LLD +    +SDFG+   ++   S+ TE
Sbjct: 111 ILAIDSI-HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTE 158

Query: 124 FA----------------------------------------GTYGYVAPELAYTMKVTA 143
           F                                         GT  Y+APE+        
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218

Query: 144 KCDVYSFGVLALEVIKGKHPRDFLS 168
           +CD +S GV+  E++ G  P  F S
Sbjct: 219 ECDWWSLGVIMYEMLVGYPP--FCS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 30/115 (26%), Positives = 58/115 (50%), Gaps = 22/115 (19%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF-LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +RE ++L +++H NIV  +    H + +  LV+EYL+   L   +++      +      
Sbjct: 51  IREASLLKDLKHANIVTLHDI-IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH----- 103

Query: 65  NV-------IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           NV       ++G    L+Y H      ++HRD+  +N+L+    E  ++DFG+A+
Sbjct: 104 NVRLFLFQLLRG----LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 63/245 (25%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRINV 66
           E  +L E  +  +VK Y       + + V +Y+  G + S+++  +   E L    R  +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYI 107

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI---------AKF---- 113
            + +  A+  +H       +HRDI   N+L+DL+    ++DFG+         +K+    
Sbjct: 108 AE-LTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163

Query: 114 --IQPDSSNWTEF--------------------------------AGTYGYVAPELAYTM 139
             I+ DS   ++                                  GT  Y+APE+    
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223

Query: 140 KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN---EMLDP---RLPPLSVD 193
             T  CD +S GV+  E++ G+ P  FL+   +     ++N    +  P   +L P +VD
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPP--FLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD 281

Query: 194 IRGKV 198
           +  K+
Sbjct: 282 LITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 36/191 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL++      ++H NI++  G C  A    LV+EY E G L   L+ +       W
Sbjct: 38  EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ------W 91

Query: 61  SRRINVIK-------GIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA- 111
            RR + +         IA  ++++H H+     +H D++ +N  L  +    V D+GI  
Sbjct: 92  HRRNSQLLLLQRMACEIAAGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGP 147

Query: 112 -----KFIQPDSSNWTEFAGTYGYVAPELA-------YTMKVTAKCDVYSFGVLALEVIK 159
                 +I+ +            ++APEL         T + T   +V++ GV   E+ +
Sbjct: 148 SRYKEDYIETEDDKCVPLR----WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203

Query: 160 -GKHPRDFLSN 169
               P   LS+
Sbjct: 204 NAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 13/94 (13%)

Query: 26  FCTHARHS-------FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH 78
           F  H  +S       +LV EYL  G +  +L+     +E      +  I  +A AL YLH
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE---EMAVKYISEVALALDYLH 121

Query: 79  HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
                 I+HRD+   N+L+  E    ++DFG++K
Sbjct: 122 RH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.001
 Identities = 50/193 (25%), Positives = 73/193 (37%), Gaps = 45/193 (23%)

Query: 5   FLREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNN-DTSAEELGWSR 62
              E  +L +     IVK +Y F     H +LV EY+  G L  +L   D   EE   +R
Sbjct: 48  VRAERDILADADSPWIVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TAR 104

Query: 63  RINVIKGIAHALSYLHH-DCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSS 119
               I  +  AL  +H    I    HRDI   N+L+D   + H+  +DFG+ K +     
Sbjct: 105 FY--IAELVLALDSVHKLGFI----HRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKD 156

Query: 120 NWTEF-----------------------------AGTYGYVAPELAYTMKVTAKCDVYSF 150
                                              GT  Y+APE+        +CD +S 
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216

Query: 151 GVLALEVIKGKHP 163
           GV+  E++ G  P
Sbjct: 217 GVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 45/127 (35%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGI---------AKFIQP------DS-SNWTEFA---- 125
           +HRDI   N+L+D +    ++DFG+         +K+ Q       DS     E++    
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 126 -----------------------GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
                                  GT  Y+APE+      T  CD +S GV+  E++ G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 163 PRDFLSN 169
           P  FL++
Sbjct: 243 P--FLAD 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 47/125 (37%)

Query: 86  VHRDISSKNVLLDLEYEAHVSDFGI---------AKFIQPD----------SSNWTE--- 123
           +HRDI   N+L+D +    ++DFG+         +K+ Q            S+ W +   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 124 -------------------------FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
                                      GT  Y+APE+      T  CD +S GV+  E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 159 KGKHP 163
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 37.4 bits (86), Expect = 0.004
 Identities = 27/76 (35%), Positives = 36/76 (47%), Gaps = 11/76 (14%)

Query: 62  RRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           R INVIKG+       L  LH      IVHRDI  +N+L+ ++ +  + DFG A     D
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAV----D 358

Query: 118 SSNWTEFAGTYGYVAP 133
                 F   YG + P
Sbjct: 359 MCTGINFNPLYGMLDP 374

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	228
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
PRK10345	210	hypothetical protein; Provisional	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG1243	690	consensus Protein kinase [General function predict	99.7
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
smart00090	237	RIO RIO-like kinase.	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
COG4248	637	Uncharacterized protein with protein kinase and he	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.19
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.09
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
PRK09902	216	hypothetical protein; Provisional	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.92
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.5
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.31
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.28
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.94
PF01636	239	APH: Phosphotransferase enzyme family This family	97.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.74
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.7
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.59
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.45
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.35
PRK10593	297	hypothetical protein; Provisional	97.31
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.21
PLN02236	344	choline kinase	97.07
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.87
PTZ00384	383	choline kinase; Provisional	96.72
KOG2270	520	consensus Serine/threonine protein kinase involved	96.64
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.45
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.28
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.27
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.2
PRK05231	319	homoserine kinase; Provisional	96.09
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	96.01
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.0
PRK10271	188	thiK thiamine kinase; Provisional	95.82
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	95.79
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.7
COG2334	331	Putative homoserine kinase type II (protein kinase	95.31
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.15
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.14
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.99
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	94.79
PLN02756	418	S-methyl-5-thioribose kinase	94.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.18
PRK06148	1013	hypothetical protein; Provisional	93.78
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	93.62

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=306.67  Aligned_cols=212  Identities=27%  Similarity=0.431  Sum_probs=187.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCe-EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARH-SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-   79 (228)
                      ++++.+|+++++.++||+||++++.|+.+.. .+|+||||++|+|++++...+   .+++.....++.++++||.|||. 
T Consensus       121 ~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~  197 (364)
T KOG0581|consen  121 QKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE  197 (364)
T ss_pred             HHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc
Confidence            6789999999999999999999999999884 999999999999999997653   38999999999999999999996 


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      .   +|+||||||+|+|++..|.+||+|||.+......  ...++.||..|||||-+.+..|+.++||||||+.++|+.+
T Consensus       198 ~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~  272 (364)
T KOG0581|consen  198 R---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI  272 (364)
T ss_pred             c---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence            7   9999999999999999999999999999876544  4466899999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+.||... ........+....+.....|..+..  .+++++..+|..||++||.+|||++++++
T Consensus       273 GrfP~~~~-~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  273 GRFPYPPP-NPPYLDIFELLCAIVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCCCCc-CCCCCCHHHHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            99998754 2223456667777777666665544  58889999999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-52  Score=310.70  Aligned_cols=209  Identities=27%  Similarity=0.404  Sum_probs=184.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++|++|+|||||+++++|+.....|+||||+.||.|.+.+-.+..   +.+..-..+++|++.|+.|||++   
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---  295 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---  295 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---
Confidence            357999999999999999999999999999999999999999999876654   66777788999999999999999   


Q ss_pred             CeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCc---ccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV---TAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~~  157 (228)
                      ||+||||||+|||++.+   -.+||+|||+++..+ ......+.+|||.|.|||++.+...   ..+.|+|||||++|-+
T Consensus       296 GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc  374 (475)
T KOG0615|consen  296 GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC  374 (475)
T ss_pred             CcccccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence            99999999999999877   678999999999877 4455677899999999999987754   3478999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|.+||...     ........++..++....+..+...+++..+||.+||..||++|||++|+++
T Consensus       375 LsG~pPFS~~-----~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  375 LSGYPPFSEE-----YTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             eccCCCcccc-----cCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            9999997522     1222367788889998888889999999999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-50  Score=290.50  Aligned_cols=215  Identities=23%  Similarity=0.372  Sum_probs=182.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeee-eeeec-CeEEEEEEeecCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYG-FCTHA-RHSFLVYEYLENGSLSVILNN-DTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~-~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      |++...|+.+|++|+|||||++++ .|.++ ..++||||+|++|+|...++. ....+.+++..+|+++.|++.||.+||
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH  141 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH  141 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh
Confidence            677889999999999999999998 45444 458999999999999999976 233445999999999999999999999


Q ss_pred             hCCCC-CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           79 HDCIP-PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        79 ~~~~~-~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                      +..+. -+.||||||.|||++.+|.+||+|||+++..........+..|||.||+||.+.+.+|+.+|||||+||++|||
T Consensus       142 ~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM  221 (375)
T KOG0591|consen  142 SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM  221 (375)
T ss_pred             ccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence            93221 38999999999999999999999999999887666666778999999999999999999999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +..++||...      +....-..+.....++.+..  -++..+.++|..|+..||..||+.-.++.
T Consensus       222 caL~~PF~g~------n~~~L~~KI~qgd~~~~p~~--~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  222 CALQSPFYGD------NLLSLCKKIEQGDYPPLPDE--HYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             HhcCCCcccc------cHHHHHHHHHcCCCCCCcHH--HhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence            9999998643      45556667777766655543  57778999999999999999998544433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-49  Score=308.04  Aligned_cols=207  Identities=24%  Similarity=0.421  Sum_probs=181.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      |+.+.+||++-++|+|||||+++++|++.+.+|||.|.|..++|..++++.   +.+++..+..+++||+.|+.|||+. 
T Consensus        62 reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~-  137 (592)
T KOG0575|consen   62 REKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL-  137 (592)
T ss_pred             HHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc-
Confidence            577899999999999999999999999999999999999999999998743   4499999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        +|+|||||..|+|++++.++||+|||+|..+..+.....+.+|||-|.|||++.....+..+||||+||+||.++.|+
T Consensus       138 --~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~  215 (592)
T KOG0575|consen  138 --GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGR  215 (592)
T ss_pred             --CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCC
Confidence              999999999999999999999999999999988877788899999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +||+...      ..+....+........    ...+.+..+||.++|++||.+|||+++|+.
T Consensus       216 PPFetk~------vkety~~Ik~~~Y~~P----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  216 PPFETKT------VKETYNKIKLNEYSMP----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             CCcccch------HHHHHHHHHhcCcccc----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            9986432      2233333322222111    134456789999999999999999999984

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-48  Score=297.89  Aligned_cols=213  Identities=33%  Similarity=0.568  Sum_probs=180.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +++|.+|+.+|.+++|||||++++.+.... ..++||||+++|+|.+++... ....++...++.++.|++.|+.|||+.
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~  161 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE  161 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            458999999999999999999999999887 799999999999999999874 334599999999999999999999999


Q ss_pred             CCCC-eeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCcccc--cCCcccchhhhhHHHHHHH
Q 040501           81 CIPP-IVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY--TMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~-i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~  156 (228)
                         + |+||||||+|||++.++ ++||+|||+++.........+...||+.|||||++.  ...++.++||||+|+++||
T Consensus       162 ---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWE  238 (362)
T KOG0192|consen  162 ---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWE  238 (362)
T ss_pred             ---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHH
Confidence               8 99999999999999997 999999999987664433444468999999999999  5689999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|..||.....      ......+. ....+..+.   .++..+..++..||..||..||++.+++..|+
T Consensus       239 l~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  239 LLTGEIPFEDLAP------VQVASAVVVGGLRPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             HHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            9999999875433      22233332 222222222   26678999999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=301.29  Aligned_cols=212  Identities=30%  Similarity=0.510  Sum_probs=179.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ++|.+|+++|++|+|++||+++++|+.+..+||||||++.|+|.++++... ...++..+.+.++.|||+|++||+++  
T Consensus       246 ~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~--  322 (468)
T KOG0197|consen  246 EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK--  322 (468)
T ss_pred             hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC--
Confidence            578999999999999999999999999889999999999999999998732 34489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       ++|||||..+|||++.++.+||+|||+++...++... ......+..|.|||.+....++.+|||||||++|||++| |
T Consensus       323 -~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G  401 (468)
T KOG0197|consen  323 -NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG  401 (468)
T ss_pred             -CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence             9999999999999999999999999999965544332 222344678999999999999999999999999999998 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +.||+.+...      +.+..+.++...+.+   ..++.++.+++..||+.+|++|||++.+...|+
T Consensus       402 ~~py~~msn~------ev~~~le~GyRlp~P---~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  402 RVPYPGMSNE------EVLELLERGYRLPRP---EGCPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CCCCCCCCHH------HHHHHHhccCcCCCC---CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            9997765443      344444333332222   357788999999999999999999999988875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=279.85  Aligned_cols=201  Identities=27%  Similarity=0.380  Sum_probs=176.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+...+|..+|.+++||+||+++..|++...+|+|+||+.||.|...+++.+.   +++..+..++.+|+.||.|||+. 
T Consensus        69 ~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~-  144 (357)
T KOG0598|consen   69 VRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK-  144 (357)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC-
Confidence            45678899999999999999999999999999999999999999999987654   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+|||+||+|||++.+|.++|+|||+++..........+.+||+.|+|||++.+..++.++|.||||+++|+|++|.
T Consensus       145 --gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~  222 (357)
T KOG0598|consen  145 --GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK  222 (357)
T ss_pred             --CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence              999999999999999999999999999997666656666789999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      +||.      ..+.......+...+.+..+.   -.+.+..++++++|..||++|.
T Consensus       223 pPF~------~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  223 PPFY------AEDVKKMYDKILKGKLPLPPG---YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCCc------CccHHHHHHHHhcCcCCCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence            9975      344455666666666333221   2445678999999999999996

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-47  Score=294.16  Aligned_cols=209  Identities=27%  Similarity=0.447  Sum_probs=186.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++-+..|+.+|+..+|+|||.+++.|-..+.+|+||||++||+|.|.+....    +++.++..+++++++||+|||.+ 
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~-  388 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR-  388 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc-
Confidence            4557899999999999999999999988899999999999999999987554    88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+|||||.+||+++.+|.+||+|||.|..+........+..|||.|||||+.....|+.+.||||||+++.||+.|.
T Consensus       389 --gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE  466 (550)
T KOG0578|consen  389 --GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE  466 (550)
T ss_pred             --ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence              999999999999999999999999999999888777778889999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +||-.      .++....+.+.....+... .....+..+.+++.+||..|+.+|+|+.|+|+
T Consensus       467 PPYln------E~PlrAlyLIa~ng~P~lk-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  467 PPYLN------ENPLRALYLIATNGTPKLK-NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccC------CChHHHHHHHhhcCCCCcC-CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            99643      4455566666554444433 33567788999999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=276.84  Aligned_cols=207  Identities=29%  Similarity=0.455  Sum_probs=165.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+..|+.+|+.++|||||.+++++..++.+|+|||||+||+|.+++++.+.   +++.++..++.|++.|+++||++ 
T Consensus        53 ~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~-  128 (429)
T KOG0595|consen   53 VELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHEN-  128 (429)
T ss_pred             HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC-
Confidence            45678999999999999999999999999999999999999999999987653   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC------CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLE------YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                        +|+||||||+||+++..      -.+||.|||+++..... ....+.+|++.|||||++...+|+.|+|+||+|+++|
T Consensus       129 --~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ily  205 (429)
T KOG0595|consen  129 --NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILY  205 (429)
T ss_pred             --CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHH
Confidence              99999999999999875      35799999999987733 3345679999999999999999999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      ++++|+.||...      ...+....+....- .........+....+++...+..+|.+|.+..+.
T Consensus       206 q~l~g~~Pf~a~------t~~eL~~~~~k~~~-~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  206 QCLTGKPPFDAE------TPKELLLYIKKGNE-IVPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             HHHhCCCCcccc------CHHHHHHHHhcccc-ccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            999999998632      22223222211111 1111112233345567777777777777665543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=283.30  Aligned_cols=207  Identities=26%  Similarity=0.366  Sum_probs=175.3

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.++++++ ||||+++++++.....+|+||||+.||.|.+++...+.   +.+..+..+++|+++|++|||+. 
T Consensus        64 ~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~-  139 (370)
T KOG0583|consen   64 ELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSR-  139 (370)
T ss_pred             hhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhC-
Confidence            34568999999998 99999999999999999999999999999999987433   77899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCC-cc-cchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VT-AKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~~~  158 (228)
                        ||+||||||+|++++.+ +.+||+|||++.............+|++.|+|||++.+.. |+ .++||||+|+++|.|+
T Consensus       140 --gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml  217 (370)
T KOG0583|consen  140 --GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL  217 (370)
T ss_pred             --CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence              99999999999999999 9999999999998743344566789999999999999987 86 6899999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||..      .+.......+......-.... .  +.+...++.+||..||.+|+|+.++++
T Consensus       218 ~G~~PF~d------~~~~~l~~ki~~~~~~~p~~~-~--S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  218 CGRLPFDD------SNVPNLYRKIRKGEFKIPSYL-L--SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             hCCCCCCC------ccHHHHHHHHhcCCccCCCCc-C--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            99999864      233334444444443221111 1  667899999999999999999999973

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-45  Score=275.47  Aligned_cols=213  Identities=24%  Similarity=0.395  Sum_probs=179.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++.++.++||||++++..|..+..+|+||++|++|++.+++...-... +++..+..+++++++||.|||++ 
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~-  145 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN-  145 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc-
Confidence            3678999999999999999999999999999999999999999999998765443 89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC--CcccchhhhhHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~  155 (228)
                        |.+|||||+.||+++.+|.++|+|||.+..+-.....    .....|+++|+|||++...  .|+.|+||||||++..
T Consensus       146 --G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~  223 (516)
T KOG0582|consen  146 --GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC  223 (516)
T ss_pred             --CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence              9999999999999999999999999977655433332    2456899999999996543  5899999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCC-----C-CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLP-----P-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+.+|+.||.....      ...+-..++..++     . .......+..++.++|..||++||++|||++++++
T Consensus       224 ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  224 ELAHGHAPFSKYPP------MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHhcCCCCcccCCh------HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            99999999865543      3344444444443     1 12224566778999999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=276.01  Aligned_cols=210  Identities=27%  Similarity=0.433  Sum_probs=169.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC--eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR--HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|+++|++++|||||++++......  .++++|||+++|+|.+++.+.+.  .+++..+..+.+|+++||+|||++
T Consensus        59 ~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~  136 (313)
T KOG0198|consen   59 ESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK  136 (313)
T ss_pred             HHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45899999999999999999999854444  68999999999999999987664  499999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCC---CceecccccceeCCcccccC-CcccchhhhhHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~  155 (228)
                         |++|+||||+||+++. ++.+||.|||++........   ......||+.|+|||++... ....++|||||||++.
T Consensus       137 ---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVv  213 (313)
T KOG0198|consen  137 ---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVV  213 (313)
T ss_pred             ---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEE
Confidence               9999999999999999 79999999999887653111   13347899999999999853 3345999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ||+||..||...     .........+. ....|..+   ...+.+..+++.+|+..||.+|||+.++++-
T Consensus       214 EM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip---~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  214 EMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP---DSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             eccCCCCcchhh-----cchHHHHHHHhccCCCCCCC---cccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            999999998642     11112222222 22222222   2366678999999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=282.12  Aligned_cols=206  Identities=27%  Similarity=0.400  Sum_probs=177.9

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|-.+|.+| .||+|++++..|.+...+|+|+||+++|.|.+++...++   +++..+..++.+|+.||.|||+. 
T Consensus       118 kYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~-  193 (604)
T KOG0592|consen  118 KYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN-  193 (604)
T ss_pred             chhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc-
Confidence            4456788899999 899999999999999999999999999999999987755   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-----------c--eecccccceeCCcccccCCcccchhhh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-----------W--TEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----------~--~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                        ||+||||||+|||++.+|+++|+|||.+..+......           .  ..+.||..|.+||++.....+..+|+|
T Consensus       194 --GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiW  271 (604)
T KOG0592|consen  194 --GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLW  271 (604)
T ss_pred             --CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchH
Confidence              9999999999999999999999999999877542211           2  458899999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|||++|.|+.|.+||...++      ...+.+++.......    .+.++.+.+||++.|..||.+|+|+.+|-+
T Consensus       272 AlGCilyQmlaG~PPFra~Ne------yliFqkI~~l~y~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  272 ALGCILYQMLAGQPPFRAANE------YLIFQKIQALDYEFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHHHHhcCCCCCccccH------HHHHHHHHHhcccCC----CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            999999999999999865443      345555555444322    245567899999999999999999988864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-45  Score=266.50  Aligned_cols=216  Identities=23%  Similarity=0.386  Sum_probs=173.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +-.++|+++|++++|+|+|.++++|.....+++|+|||+..-|.+ +.+...+  ++...+..+++|++.|+.|+|+.  
T Consensus        46 KIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~e-Le~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~--  120 (396)
T KOG0593|consen   46 KIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHE-LERYPNG--VPSELVKKYLYQLLKAIHFCHKN--  120 (396)
T ss_pred             HHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHH-HHhccCC--CCHHHHHHHHHHHHHHhhhhhhc--
Confidence            446899999999999999999999999999999999998755544 4444333  88899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       +++||||||+||+++.+|.+||+|||.++....+....+....|..|+|||.+.+ .+|....||||+||++.||++|.
T Consensus       121 -n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~  199 (396)
T KOG0593|consen  121 -NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE  199 (396)
T ss_pred             -CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence             9999999999999999999999999999988866667777889999999999887 67999999999999999999999


Q ss_pred             CCccccccccCCC--------------------chhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          162 HPRDFLSNVSSSN--------------------PNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       162 ~p~~~~~~~~~~~--------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      +.|+.....+...                    +....-.+..+.- .+.....++.+.-+.+++++||..||.+|++.+
T Consensus       200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~  279 (396)
T KOG0593|consen  200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE  279 (396)
T ss_pred             cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence            9997654432210                    0000111111110 111222344555689999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       280 qll~  283 (396)
T KOG0593|consen  280 QLLH  283 (396)
T ss_pred             HHhc
Confidence            9874

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-45  Score=279.98  Aligned_cols=211  Identities=25%  Similarity=0.404  Sum_probs=188.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCe-EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARH-SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      |.....|+.++++++|||||.+.++|.+++. .+|+|+||+||++.+.+.+.. ...++++++..|+.|++.|+.|||+.
T Consensus        47 r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~  125 (426)
T KOG0589|consen   47 RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN  125 (426)
T ss_pred             hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh
Confidence            4577899999999999999999999998888 999999999999999998755 45589999999999999999999998


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         +|+|||||+.|||++.++.++|+|||+++..+.......+..||+.|++||.+.+..|..++|||||||++|||++-
T Consensus       126 ---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~l  202 (426)
T KOG0589|consen  126 ---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTL  202 (426)
T ss_pred             ---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhc
Confidence               99999999999999999999999999999988766556678999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +.+|.      ..+......++......+.+   ..++.++..+|+.||..+|..||++.+++..
T Consensus       203 k~aF~------a~~m~~Li~ki~~~~~~Plp---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  203 KPAFK------ASNMSELILKINRGLYSPLP---SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccccC------ccchHHHHHHHhhccCCCCC---ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            99965      44555677777766654443   4677889999999999999999999999863

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=274.40  Aligned_cols=224  Identities=41%  Similarity=0.715  Sum_probs=182.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++|..|++++.+++|||++++++||.+.+ ..++|+||+++|+|.+.+...... .++|.++++|+.++|.||+|||..+
T Consensus       116 ~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  116 REFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCC
Confidence            45999999999999999999999999888 599999999999999999875543 5899999999999999999999998


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceec-ccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF-AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                      +..|+|||||++|||+|.+...||+|||++............. .|+..|++||+......+.++||||+|+++.|+++|
T Consensus       195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg  274 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG  274 (361)
T ss_pred             CCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence            7779999999999999999999999999996544312222222 789999999999888899999999999999999999


Q ss_pred             CCCccccccccCCCchh---------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNI---------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +.+.+............         ...+++++.+.............+..+..+|++.+|.+||++.++++.|+
T Consensus       275 r~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  275 RKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             CcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            98865433111111111         34556666654222211145556889999999999999999999998884

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-42  Score=264.63  Aligned_cols=208  Identities=22%  Similarity=0.329  Sum_probs=169.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.+.+|+.++++++||||+++++++.+    ....+++|||+++++|.+++....   .+++...+.++.+++.|+.+||
T Consensus        63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH  139 (283)
T PHA02988         63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLY  139 (283)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHH
Confidence            467799999999999999999999876    357899999999999999997643   3788999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc--CCcccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~  156 (228)
                      +..  +++||||||+||+++.++.+||+|||++.......   ....++..|+|||.+.+  ..++.++||||||+++|+
T Consensus       140 ~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~e  214 (283)
T PHA02988        140 KYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE  214 (283)
T ss_pred             hcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHH
Confidence            731  88999999999999999999999999987654322   22457789999999876  578999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||....      .......+..... ...+   ..++..+.+++.+||+.||.+|||++++++.|+
T Consensus       215 l~~g~~Pf~~~~------~~~~~~~i~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        215 IFTGKIPFENLT------TKEIYDLIINKNNSLKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             HHHCCCCCCCCC------HHHHHHHHHhcCCCCCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            999999986432      2222222221111 1111   245668999999999999999999999999886

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-43  Score=284.93  Aligned_cols=214  Identities=27%  Similarity=0.466  Sum_probs=184.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-----------AEELGWSRRINVIKGI   70 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~l   70 (228)
                      |++|.+|++++..|+|||||++++.|.+++..++|+||+..|+|..+++.+..           ..+++..+.+.++.||
T Consensus       533 ~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QI  612 (774)
T KOG1026|consen  533 RQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQI  612 (774)
T ss_pred             HHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHH
Confidence            67899999999999999999999999999999999999999999999874221           2337889999999999


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhh
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      |.|+.||-++   .+|||||..+|++++++..|||+|||+++.+.......  ....-+.+|||||.+...+++++||||
T Consensus       613 AaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVW  689 (774)
T KOG1026|consen  613 AAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVW  689 (774)
T ss_pred             HHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhh
Confidence            9999999999   99999999999999999999999999999775443331  123457899999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+|+++||+++ |..||...      ...+.++.+-.++..+.   ..+++.++++|+..||+.+|++||+++||-..|+
T Consensus       690 s~GVvLWEIFsyG~QPy~gl------Sn~EVIe~i~~g~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  690 SFGVVLWEIFSYGKQPYYGL------SNQEVIECIRAGQLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             hhhhhhhhhhccccCccccc------chHHHHHHHHcCCcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            99999999997 88886533      34456666666666332   2578889999999999999999999999999886

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-43  Score=254.56  Aligned_cols=209  Identities=22%  Similarity=0.389  Sum_probs=185.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++-.+|+.+|+++ .||+|+++.++++.+..+++|+|.++.|.|+|++...-   .+++.....+++|+.+++.|||.+ 
T Consensus        67 EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~-  142 (411)
T KOG0599|consen   67 EATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR-  142 (411)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh-
Confidence            4556899999999 69999999999999999999999999999999997644   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc------CCcccchhhhhHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT------MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~  155 (228)
                        +|+||||||+||+++++.+++|+|||.+..... .......+|||.|+|||.+..      ..|+...|+|+.|+++|
T Consensus       143 --~IVHRDLKpENILlddn~~i~isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImy  219 (411)
T KOG0599|consen  143 --NIVHRDLKPENILLDDNMNIKISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMY  219 (411)
T ss_pred             --hhhhcccChhheeeccccceEEeccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHH
Confidence              999999999999999999999999999988764 344566899999999998753      35788899999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .++.|-+||--      ..+..+...+..++....+..+.+.+....+||++||+.||.+|.|++|++.
T Consensus       220 TLLaGcpPFwH------RkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  220 TLLAGCPPFWH------RKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHcCCCchhH------HHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            99999999743      2234467778888888888889999999999999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=269.79  Aligned_cols=213  Identities=20%  Similarity=0.328  Sum_probs=175.7

Q ss_pred             HHHHHHHhccC-CCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            6 LREITVLTEIR-HRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         6 ~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .||++.|++++ ||||+++.+++.++. .+|+|||||+. +|+.++++.  ...+++..+..|+.||++||+|+|..   
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---  129 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---  129 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---
Confidence            58999999997 999999999998877 99999999965 899998876  34599999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |+.|||+||+|||+.....+||.|||+++.+. .....+....|..|+|||++... .|+.+.|+|++||+++|+.+.++
T Consensus       130 GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP  208 (538)
T KOG0661|consen  130 GFFHRDLKPENILISGNDVIKIADFGLAREVR-SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP  208 (538)
T ss_pred             CcccccCChhheEecccceeEecccccccccc-cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence            99999999999999988899999999999775 34556777889999999987654 58999999999999999999999


Q ss_pred             CccccccccC---------------CCchhhhhhhcCCCCCCC-----chhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          163 PRDFLSNVSS---------------SNPNILVNEMLDPRLPPL-----SVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       163 p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .|++.++.+.               ......+.+.+.-.++..     .......+.+..++|.+|+..||.+|||+.++
T Consensus       209 LFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a  288 (538)
T KOG0661|consen  209 LFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA  288 (538)
T ss_pred             cCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH
Confidence            9876544321               111123333333333322     22344577788999999999999999999999


Q ss_pred             HHH
Q 040501          223 CQL  225 (228)
Q Consensus       223 l~~  225 (228)
                      ++.
T Consensus       289 l~~  291 (538)
T KOG0661|consen  289 LQH  291 (538)
T ss_pred             hcC
Confidence            863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=251.46  Aligned_cols=194  Identities=26%  Similarity=0.336  Sum_probs=171.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      ...+|..+|+.+.||+++++++.|.+...+|+||||++||.|+++++..+.   +++..+..++.|++.||+|||+.   
T Consensus        90 H~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---  163 (355)
T KOG0616|consen   90 HTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---  163 (355)
T ss_pred             HHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---
Confidence            456799999999999999999999999999999999999999999987654   89999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      +|++||+||+|||++++|.+||+|||.++.....   .-+.+|||.|+|||++....+..++|.||||+++|||+.|.+|
T Consensus       164 ~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pP  240 (355)
T KOG0616|consen  164 DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPP  240 (355)
T ss_pred             CeeeccCChHHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999999987643   3457999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      |...      ++....+.++..+....    .-.+.++.+|+++.|+.|-.+|
T Consensus       241 F~~~------~~~~iY~KI~~~~v~fP----~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  241 FYDD------NPIQIYEKILEGKVKFP----SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CcCC------ChHHHHHHHHhCcccCC----cccCHHHHHHHHHHHhhhhHhh
Confidence            7533      34566677777665432    2345578899999999999888

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-42  Score=269.83  Aligned_cols=215  Identities=24%  Similarity=0.417  Sum_probs=169.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeec-CeEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHA-RHSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      +.+.+|+.++..+ +||||+++++++... ..++++|||+++|+|.+++.....                          
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD  134 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence            4688999999999 899999999988654 468999999999999999875321                          


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCC
Q 040501           55 ---------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY  101 (228)
Q Consensus        55 ---------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~  101 (228)
                                                       ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~  211 (338)
T cd05102         135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENN  211 (338)
T ss_pred             cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCC
Confidence                                             12367788899999999999999999   999999999999999999


Q ss_pred             ceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhh
Q 040501          102 EAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNIL  178 (228)
Q Consensus       102 ~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~  178 (228)
                      .++|+|||++.........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....     ....
T Consensus       212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-----~~~~  286 (338)
T cd05102         212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----NEEF  286 (338)
T ss_pred             cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-----cHHH
Confidence            9999999998765332211  122345678999999988889999999999999999997 9999864321     1111


Q ss_pred             hhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ............   ....+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       287 ~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         287 CQRLKDGTRMRA---PENATPEIYRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHhcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            122222211111   12445678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-42  Score=269.85  Aligned_cols=206  Identities=24%  Similarity=0.291  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.++++++||||+++++.+..+...|+||||+.+++|.+++....   .+++.++..++.|++.||+|||+.  
T Consensus        40 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~--  114 (323)
T cd05571          40 AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC--  114 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            356789999999999999999999999999999999999999999887543   378999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       115 -~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~  193 (323)
T cd05571         115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL  193 (323)
T ss_pred             -CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence             9999999999999999999999999998754333333444678999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+.......    ....+.++.++|.+||+.||++||     ++.++++
T Consensus       194 Pf~~~~------~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         194 PFYNQD------HEKLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCC------HHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            985322      122222222222111    123556789999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=267.51  Aligned_cols=204  Identities=25%  Similarity=0.319  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++.+......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        38 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  112 (312)
T cd05585          38 THTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKF--  112 (312)
T ss_pred             HHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            456789999999999999999999999999999999999999999987543   388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       113 -~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~  191 (312)
T cd05585         113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP  191 (312)
T ss_pred             -CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence             9999999999999999999999999998754333333344568999999999999889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      ||....      .......+.......    ....+..+.+++.+||..||.+||++..+
T Consensus       192 pf~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         192 PFYDEN------VNEMYRKILQEPLRF----PDGFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             CcCCCC------HHHHHHHHHcCCCCC----CCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence            986321      222333333322211    12355678899999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=246.32  Aligned_cols=210  Identities=24%  Similarity=0.355  Sum_probs=183.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      -+.+.+|+.+-+.|+||||+++.+...+....|+|+|++.|+.|..-|-..   ..+++..+...++|++++|.|+|.. 
T Consensus        54 ~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n-  129 (355)
T KOG0033|consen   54 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN-  129 (355)
T ss_pred             HHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc-
Confidence            357889999999999999999999999999999999999999885544322   3378888899999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        ||+|||+||+|+++..   ..-+||+|||++...+ ....+....|+|.|+|||++....++..+|||+-|+++|-++
T Consensus       130 --~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL  206 (355)
T KOG0033|consen  130 --GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL  206 (355)
T ss_pred             --CceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence              9999999999999943   3558999999999887 556678889999999999999999999999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .|.+||.      ..+.....+++..+.....+..+...+++..+|+++||..||.+|+|+.|.++
T Consensus       207 ~G~~PF~------~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  207 VGYPPFW------DEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             hCCCCCC------CccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            9999964      33455677777777776666677888889999999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-42  Score=265.32  Aligned_cols=221  Identities=22%  Similarity=0.392  Sum_probs=169.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC----------------CCCCCHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS----------------AEELGWSRRIN   65 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~   65 (228)
                      ++.|.+|++++.+++||||+++++++......+++|||+.+++|.+++.....                ...+++..++.
T Consensus        63 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (304)
T cd05096          63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH  142 (304)
T ss_pred             HHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence            35688999999999999999999999999999999999999999998864321                12367788999


Q ss_pred             HHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCccc
Q 040501           66 VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        66 ~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  143 (228)
                      ++.|++.||.|||+.   |++|+||||+||+++.++.+||+|||++.........  .....++..|+|||++.+..++.
T Consensus       143 i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  219 (304)
T cd05096         143 VALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT  219 (304)
T ss_pred             HHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc
Confidence            999999999999999   9999999999999999999999999998765432211  11234467899999998888999


Q ss_pred             chhhhhHHHHHHHHHh--CCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          144 KCDVYSFGVLALEVIK--GKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      ++||||||+++|+|++  +..||.......   ............ ..........++..+.+++.+||..||.+|||+.
T Consensus       220 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             hhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            9999999999999986  556665332111   011111111100 0000011124456789999999999999999999


Q ss_pred             HHHHHhhC
Q 040501          221 TICQLLCK  228 (228)
Q Consensus       221 ~il~~l~~  228 (228)
                      ++.+.|++
T Consensus       297 ~i~~~l~~  304 (304)
T cd05096         297 DIHAFLTE  304 (304)
T ss_pred             HHHHHHhC
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-44  Score=269.39  Aligned_cols=207  Identities=27%  Similarity=0.453  Sum_probs=180.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ++++.|+.+|..++++||.++++.+..+..+|++|||+.||++.+.+..+..   +.+..+..++++++.|+.|||++  
T Consensus        56 ediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~--  130 (467)
T KOG0201|consen   56 EDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE--  130 (467)
T ss_pred             HHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc--
Confidence            5678899999999999999999999999999999999999999999976543   46777778999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +.+|||||+.||+++.+|.+|+.|||.+...........++.||+.|||||++.+..|+.++||||||++.+||.+|.+
T Consensus       131 -~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP  209 (467)
T KOG0201|consen  131 -KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP  209 (467)
T ss_pred             -ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence             9999999999999999999999999999888766666678899999999999998899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+....+      .....-+....+|....   .++..+.++|..||++||+.||||+++++
T Consensus       210 P~s~~hP------mrvlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  210 PHSKLHP------MRVLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCcccCc------ceEEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            9765443      33444444444443332   67778999999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-42  Score=272.81  Aligned_cols=204  Identities=26%  Similarity=0.418  Sum_probs=180.5

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+-+|+.+.|||++.+++.++.+.++|+|.||+.||-|++++-+++.   +++..+.++++|++.|+.|||..   
T Consensus        58 ~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---  131 (786)
T KOG0588|consen   58 GIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---  131 (786)
T ss_pred             chhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---
Confidence            478999999999999999999999999999999999999999999987665   88899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~~~~g~~  162 (228)
                      +|+|||+||+|++++..+.+||.|||++..... .....+-+|+|.|.+||++.|.+|. .++||||-|+++|.+++|+.
T Consensus       132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L  210 (786)
T KOG0588|consen  132 NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL  210 (786)
T ss_pred             cceeccCCchhhhhhcccCEeeeccceeecccC-CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC
Confidence            999999999999999999999999999987543 3345567999999999999999985 58999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||+      ..+....+..+.++.+.-.    ...+.+..+|+.+||..||..|.|.++|++
T Consensus       211 PFd------DdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  211 PFD------DDNIRVLLLKVQRGVFEMP----SNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             CCC------CccHHHHHHHHHcCcccCC----CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            975      4556666666666655322    366778899999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=245.30  Aligned_cols=217  Identities=22%  Similarity=0.304  Sum_probs=172.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTS-AEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+..++|++..++++|||+++++++...+     ...|++++|...|+|.+.+.+... ...+++.+++.++.++++||+
T Consensus        62 ~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~  141 (302)
T KOG2345|consen   62 IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLE  141 (302)
T ss_pred             HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHH
Confidence            56788999999999999999999987433     359999999999999999886433 335899999999999999999


Q ss_pred             HhhhCCCCC--eeecCCCCCceEEcCCCceEEeecccccccCCCCCC---------ceecccccceeCCcccccC---Cc
Q 040501           76 YLHHDCIPP--IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---------WTEFAGTYGYVAPELAYTM---KV  141 (228)
Q Consensus        76 ~lh~~~~~~--i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~---~~  141 (228)
                      +||..   .  +.||||||.||++++++.+++.|||.++...-....         +.....+..|+|||.+.-.   ..
T Consensus       142 ~lH~~---~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti  218 (302)
T KOG2345|consen  142 ALHEK---EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI  218 (302)
T ss_pred             HHhcc---CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc
Confidence            99999   6  999999999999999999999999988765322111         3345678899999988644   46


Q ss_pred             ccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          142 TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       142 ~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ++++|||||||++|.|+.|..||+...+....    ....+..+......  ...+++.+.++|++||+.||.+||++.+
T Consensus       219 ~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS----laLAv~n~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~  292 (302)
T KOG2345|consen  219 TERTDIWSLGCTLYAMMFGESPFERIYQQGGS----LALAVQNAQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTIPE  292 (302)
T ss_pred             ccccchhhhhHHHHHHHHcCCcchHHhhcCCe----EEEeeeccccccCC--CCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence            78999999999999999999999765442211    11112222221111  1237788999999999999999999999


Q ss_pred             HHHHhh
Q 040501          222 ICQLLC  227 (228)
Q Consensus       222 il~~l~  227 (228)
                      ++..+.
T Consensus       293 ll~~~d  298 (302)
T KOG2345|consen  293 LLSKLD  298 (302)
T ss_pred             HHHHHH
Confidence            998775

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.4e-41  Score=258.31  Aligned_cols=214  Identities=25%  Similarity=0.448  Sum_probs=174.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIKG   69 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~~   69 (228)
                      ++|.+|++++++++||||+++++++......|+++||+.+++|.+++.....             ...++...++.++.|
T Consensus        53 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  132 (283)
T cd05048          53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ  132 (283)
T ss_pred             HHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHH
Confidence            4688999999999999999999999988899999999999999999875322             134788899999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhh
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      ++.||+|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++|+
T Consensus       133 l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv  209 (283)
T cd05048         133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDI  209 (283)
T ss_pred             HHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhH
Confidence            99999999999   9999999999999999999999999998765332211  122345678999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||||+++|+|++ |..||....      .......+........   ...++.++.+++.+||+.||.+|||+.++++.|
T Consensus       210 ~slG~il~el~~~g~~p~~~~~------~~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         210 WSFGVVLWEIFSYGLQPYYGFS------NQEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999999998 999975322      1222233322222221   235677899999999999999999999999998


Q ss_pred             hC
Q 040501          227 CK  228 (228)
Q Consensus       227 ~~  228 (228)
                      ++
T Consensus       281 ~~  282 (283)
T cd05048         281 RS  282 (283)
T ss_pred             hc
Confidence            74

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-42  Score=264.46  Aligned_cols=214  Identities=26%  Similarity=0.384  Sum_probs=169.8

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+||.+|++|.||||+++.+...+.  ..+|+|+|||+. +|.-++....-  .+++.++..++.||+.||.|||++  
T Consensus       163 ~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~--  237 (560)
T KOG0600|consen  163 AIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSR--  237 (560)
T ss_pred             HHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhc--
Confidence            46999999999999999999999876  689999999976 67777655432  399999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g  160 (228)
                       |+.|||||.+|||++.+|.+||.|||++++....... .+....|..|+|||.+.|. .|+.+.|+||.||++.||+.|
T Consensus       238 -gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g  316 (560)
T KOG0600|consen  238 -GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG  316 (560)
T ss_pred             -CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence             9999999999999999999999999999977655433 6667789999999998876 599999999999999999999


Q ss_pred             CCCccccccccCCCch--------hhhhh--------hcCCCCC---CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSSSNPN--------ILVNE--------MLDPRLP---PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~--------~~~~~--------~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ++.|+...++...+..        +....        ...+..+   .........+....+|+..+|..||.+|.|+.+
T Consensus       317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~  396 (560)
T KOG0600|consen  317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS  396 (560)
T ss_pred             CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence            9998765444321110        00011        0001000   011113344556789999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       397 aL~  399 (560)
T KOG0600|consen  397 ALQ  399 (560)
T ss_pred             Hhc
Confidence            875

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.5e-42  Score=265.23  Aligned_cols=206  Identities=24%  Similarity=0.290  Sum_probs=168.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+++++.++||||+++++.|......|+||||+.+++|..++....   .+++..+..++.|++.||.|||+.  
T Consensus        40 ~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  114 (323)
T cd05595          40 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR--  114 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346789999999999999999999999999999999999999988886543   378999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus       115 -~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~  193 (323)
T cd05595         115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL  193 (323)
T ss_pred             -CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence             9999999999999999999999999988754333333334568899999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+.......    ....+.++.++|.+||+.||.+||     ++.++++
T Consensus       194 Pf~~~~------~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         194 PFYNQD------HERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCC------HHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            985322      122222222222111    123456789999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-41  Score=264.32  Aligned_cols=206  Identities=23%  Similarity=0.319  Sum_probs=169.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.+++.++||||+++++.|..+...|+||||+.+++|.+++....   .+....+..++.|++.||.|||+.  
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  119 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ--  119 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346789999999999999999999999999999999999999999987543   277888889999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       120 -~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  198 (323)
T cd05584         120 -GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP  198 (323)
T ss_pred             -CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence             9999999999999999999999999998754333333334568899999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+.......    ....+..+.++|.+||+.+|.+||     ++.++++
T Consensus       199 pf~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         199 PFTAEN------RKKTIDKILKGKLNL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCC------HHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            986432      222333333333211    123455788999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=270.28  Aligned_cols=205  Identities=27%  Similarity=0.396  Sum_probs=178.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+.++++|+...++|+|.||+.| +|+.++.....   ++++++..++.+++.||.|||+.  
T Consensus        46 ~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~--  119 (808)
T KOG0597|consen   46 KNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN--  119 (808)
T ss_pred             HHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc--
Confidence            4578999999999999999999999999999999999977 99999876543   89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +|.|||+||.||+++.+|.+|++|||+++.++......+...|||.|||||...+..|+..+|+|||||++||+++|++
T Consensus       120 -rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P  198 (808)
T KOG0597|consen  120 -RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP  198 (808)
T ss_pred             -CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence             9999999999999999999999999999998877777778899999999999999999999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||-.      .........+........    ...+..+..++...|.+||.+|.|..+++.
T Consensus       199 PF~a------~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  199 PFYA------RSITQLVKSILKDPVKPP----STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CchH------HHHHHHHHHHhcCCCCCc----ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            9742      122334444444333222    255567889999999999999999988764

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-41  Score=264.66  Aligned_cols=206  Identities=25%  Similarity=0.303  Sum_probs=169.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+++++.++||||+++.+.+......|+||||+.+++|.+++....   .+++.++..++.|++.||.|||+.  
T Consensus        40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~--  114 (328)
T cd05593          40 AHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG--  114 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            457789999999999999999999999999999999999999998886543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.+||+|||++..............|++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus       115 -~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~  193 (328)
T cd05593         115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL  193 (328)
T ss_pred             -CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCC
Confidence             9999999999999999999999999998754333333334568999999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||.....      ......+.......    ....+.++.++|.+||+.||.+|+     ++.++++
T Consensus       194 Pf~~~~~------~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         194 PFYNQDH------EKLFELILMEDIKF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCCH------HHHHHHhccCCccC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            9853221      12222222221111    123456788999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-42  Score=259.05  Aligned_cols=203  Identities=24%  Similarity=0.405  Sum_probs=175.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++++.|+||||+.++++|+..+.+.|||||..+|.|+|++.+.+.   +++..+..+++||.+|+.|+|..   
T Consensus        99 hIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---  172 (668)
T KOG0611|consen   99 HIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---  172 (668)
T ss_pred             HHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---
Confidence            467899999999999999999999999999999999999999999998765   89999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~~~~g~~  162 (228)
                      +++|||||.+||+++.++++||.|||++...... ....+++|++-|.+||++.+..|. ...|.||||+++|.++.|..
T Consensus       173 rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM  251 (668)
T KOG0611|consen  173 RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM  251 (668)
T ss_pred             cceecccchhheeecCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence            9999999999999999999999999999876643 334668999999999999999885 57999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||+.      .+-.....++..+.....     ..+....-||++||..||.+|.|+.+|..
T Consensus       252 PFDG------~Dhk~lvrQIs~GaYrEP-----~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  252 PFDG------RDHKRLVRQISRGAYREP-----ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ccCC------chHHHHHHHhhcccccCC-----CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            9763      334445555555544321     22234568999999999999999998864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-41  Score=262.39  Aligned_cols=213  Identities=23%  Similarity=0.361  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++..+...++||||+++++|.+++....   .++...+..++.|++.||.|||+.+ 
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~-  123 (331)
T cd06649          48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH-  123 (331)
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC-
Confidence            568899999999999999999999999999999999999999999987543   3788999999999999999999862 


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||||+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus       124 -~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~  200 (331)
T cd06649         124 -QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY  200 (331)
T ss_pred             -CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence             69999999999999999999999999987653222  233468899999999998889999999999999999999999


Q ss_pred             CccccccccCCC-----------c-----------------------------hhhhhhhcCCCCCCCchhhhhhHHHHH
Q 040501          163 PRDFLSNVSSSN-----------P-----------------------------NILVNEMLDPRLPPLSVDIRGKVISIM  202 (228)
Q Consensus       163 p~~~~~~~~~~~-----------~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (228)
                      ||..........           .                             ......+.....+..  ....++.++.
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  278 (331)
T cd06649         201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQ  278 (331)
T ss_pred             CCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHH
Confidence            985322110000           0                             000000000000000  0123566799


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 040501          203 EVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       203 ~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|.+||+.||++|||+.++++
T Consensus       279 ~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         279 EFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             HHHHHHccCCcccCCCHHHHhc
Confidence            9999999999999999999986

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.5e-41  Score=254.61  Aligned_cols=212  Identities=24%  Similarity=0.372  Sum_probs=171.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+++++.++||||+++++++..+...++||||+++++|.+++....  ..+++.+++.++.|++.||+|||+.  
T Consensus        51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~--  126 (266)
T cd05064          51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM--  126 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            468899999999999999999999999999999999999999999987643  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||||+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++||||||+++|++++ |
T Consensus       127 -~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g  205 (266)
T cd05064         127 -GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG  205 (266)
T ss_pred             -CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCC
Confidence             9999999999999999999999999977654322111 111234568999999988889999999999999999775 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||.....      ......+.+....+.   ...++..+.+++.+||+.+|.+|||+.++++.|.+
T Consensus       206 ~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         206 ERPYWDMSG------QDVIKAVEDGFRLPA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCcCcCCH------HHHHHHHHCCCCCCC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            999864322      122222222221111   12456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-41  Score=274.67  Aligned_cols=210  Identities=24%  Similarity=0.290  Sum_probs=172.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|+.+++.++||||++++++|..+...|+||||+.+++|.+++... .....++...+..++.|++.||.|||+. 
T Consensus       110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-  188 (478)
T PTZ00267        110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-  188 (478)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35678999999999999999999999999999999999999999887542 2233478899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.++.++|+|||++........  ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus       189 --~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t  266 (478)
T PTZ00267        189 --KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT  266 (478)
T ss_pred             --CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh
Confidence              999999999999999999999999999986543322  1234568999999999998889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+......+..   ...+..+.++|.+||..||.+|||+.++++
T Consensus       267 g~~Pf~~~~------~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        267 LHRPFKGPS------QREIMQQVLYGKYDPFP---CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCCCCC------HHHHHHHHHhCCCCCCC---ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            999985322      22333333333322211   234567899999999999999999999874

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.5e-41  Score=255.89  Aligned_cols=215  Identities=30%  Similarity=0.514  Sum_probs=175.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-----------AEELGWSRRINVIKGI   70 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~l   70 (228)
                      ++.+.+|+++++.++|+||+++++++......+++|||+.+++|.+++.....           ...+++.++..++.|+
T Consensus        52 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  131 (280)
T cd05049          52 RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI  131 (280)
T ss_pred             HHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHH
Confidence            35788999999999999999999999999999999999999999999875421           2347888999999999


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhh
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      +.++.+||+.   |++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+..++.++|||
T Consensus       132 ~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  208 (280)
T cd05049         132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW  208 (280)
T ss_pred             HHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHH
Confidence            9999999999   999999999999999999999999999875432221  11223446789999999988899999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||+++|+|++ |..||....      .......+.........   ...+..+.+++.+||..||.+|||+.++++.|+
T Consensus       209 slG~il~e~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         209 SFGVVLWEIFTYGKQPWYGLS------NEEVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            99999999998 999975332      12223333333322211   245667899999999999999999999999987


Q ss_pred             C
Q 040501          228 K  228 (228)
Q Consensus       228 ~  228 (228)
                      +
T Consensus       280 ~  280 (280)
T cd05049         280 K  280 (280)
T ss_pred             C
Confidence            5

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.2e-41  Score=257.92  Aligned_cols=214  Identities=29%  Similarity=0.521  Sum_probs=174.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      ++.+.+|++++++++|+||+++++++......++||||+++++|.+++..+..             ...+++.+++.++.
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (291)
T cd05094          51 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS  130 (291)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence            35688999999999999999999999999999999999999999999875431             23478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.|++|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|
T Consensus       131 ~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  207 (291)
T cd05094         131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  207 (291)
T ss_pred             HHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhh
Confidence            999999999999   9999999999999999999999999998765432211  12234567899999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|+|++ |..||.....      ................   ...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       208 i~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         208 VWSFGVILWEIFTYGKQPWFQLSN------TEVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999999999998 9999754322      1222223222222211   2345678999999999999999999999999


Q ss_pred             hh
Q 040501          226 LC  227 (228)
Q Consensus       226 l~  227 (228)
                      |+
T Consensus       279 l~  280 (291)
T cd05094         279 LH  280 (291)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-41  Score=264.32  Aligned_cols=203  Identities=23%  Similarity=0.291  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......|++|||+.+++|.+++....   .++...+..++.|++.||+|||+.  
T Consensus        63 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  137 (329)
T PTZ00263         63 QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK--  137 (329)
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457899999999999999999999999999999999999999999987543   378888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++.......   ....|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       138 -~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  213 (329)
T PTZ00263        138 -DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP  213 (329)
T ss_pred             -CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence             99999999999999999999999999987654322   23568899999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      ||....      .......+....... +   ...+..+.++|.+||+.||.+||+     ++++++
T Consensus       214 pf~~~~------~~~~~~~i~~~~~~~-p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        214 PFFDDT------PFRIYEKILAGRLKF-P---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCCC------HHHHHHHHhcCCcCC-C---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            985322      222333333333221 1   124456889999999999999997     566653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-41  Score=258.96  Aligned_cols=210  Identities=23%  Similarity=0.262  Sum_probs=168.0

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++++.++|++|+++++.+.++...++++||+.+++|.+.+..... ..+++..+..++.|++.||.|||+.   
T Consensus        46 ~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---  121 (285)
T cd05631          46 MALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---  121 (285)
T ss_pred             HHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            567899999999999999999999999999999999999999888754322 2488999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       122 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987653222 22345688999999999988999999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      |........  ............. .   .....+..+.+++.+||+.||.+||+     ++++++
T Consensus       201 f~~~~~~~~--~~~~~~~~~~~~~-~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         201 FRKRKERVK--REEVDRRVKEDQE-E---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCCCCcchh--HHHHHHHhhcccc-c---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            864322110  1111111111111 1   11245667899999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-41  Score=254.88  Aligned_cols=217  Identities=21%  Similarity=0.340  Sum_probs=175.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|+++++.++||||+++++++......++++||+.+++|.+++.... ....++...++.++.|++.|+.|||+. 
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-  125 (267)
T cd08228          47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-  125 (267)
T ss_pred             HHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-
Confidence            467889999999999999999999999999999999999999998886422 223478899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       126 --~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  203 (267)
T cd08228         126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  203 (267)
T ss_pred             --CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCC
Confidence              999999999999999999999999999887654333333456788999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      .||....    .........+.....++..  ....+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       204 ~p~~~~~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         204 SPFYGDK----MNLFSLCQKIEQCDYPPLP--TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             CCCcccc----ccHHHHHHHHhcCCCCCCC--hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            9975321    1112222222222222221  12455678999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-42  Score=266.53  Aligned_cols=203  Identities=25%  Similarity=0.304  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+..|++++++++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~--  117 (318)
T cd05582          43 VRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL--  117 (318)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            456789999999999999999999999999999999999999999886543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       118 -~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~  196 (318)
T cd05582         118 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL  196 (318)
T ss_pred             -CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCC
Confidence             9999999999999999999999999998765443333344678899999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ||....      .......+.......    ....+..+.+++.+||+.||.+|||+.+
T Consensus       197 p~~~~~------~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         197 PFQGKD------RKETMTMILKAKLGM----PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCC------HHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            985322      222333333322211    1234567889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=261.17  Aligned_cols=203  Identities=26%  Similarity=0.335  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++.+....|+||||+.+++|.+++....   .++...+..++.|++.||+|||+.  
T Consensus        46 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  120 (291)
T cd05612          46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK--  120 (291)
T ss_pred             HHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++......   .....|++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       121 -~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~  196 (291)
T cd05612         121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP  196 (291)
T ss_pred             -CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765432   223468899999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      ||....      .......+........    ...+..+.++|++||+.||.+||+     ++++++
T Consensus       197 pf~~~~------~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         197 PFFDDN------PFGIYEKILAGKLEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCCCCC------HHHHHHHHHhCCcCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            986432      2223333333322111    123557889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=261.91  Aligned_cols=209  Identities=26%  Similarity=0.345  Sum_probs=187.1

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +..+.+|+++|+++. ||||+.+.+.|+.....++|||++.||.|.+.+...    .+++..+..++.|++.+++|||+.
T Consensus        79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~  154 (382)
T KOG0032|consen   79 REDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL  154 (382)
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC
Confidence            468899999999997 999999999999999999999999999999999876    289999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCC----CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                         |++|||+||+|+++...    +.++++|||++..... ........|++.|+|||++....++..+|+||+|+++|.
T Consensus       155 ---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi  230 (382)
T KOG0032|consen  155 ---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI  230 (382)
T ss_pred             ---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence               99999999999999543    4799999999998876 555677899999999999999999999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|.+||....      .......+...........+..++....++|+.||..||..|+|+.++++
T Consensus       231 LL~G~~PF~~~~------~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  231 LLSGVPPFWGET------EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HhhCCCCCcCCC------hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            999999975432      33344477777777777778888999999999999999999999999986

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-41  Score=254.47  Aligned_cols=217  Identities=21%  Similarity=0.362  Sum_probs=176.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.+++.++|+||+++++++..+...++++|++.+++|.+++... .....+++.+++.++.|++.|+.|||+. 
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-  125 (267)
T cd08229          47 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-  125 (267)
T ss_pred             HHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            56789999999999999999999999999999999999999999988642 2234488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       126 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~  203 (267)
T cd08229         126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ  203 (267)
T ss_pred             --CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999998876544333333456788999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      .||.....    ..............++..  ....+..+.+++.+||..||.+|||+.+|++.+++
T Consensus       204 ~p~~~~~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         204 SPFYGDKM----NLYSLCKKIEQCDYPPLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCcccccc----hHHHHhhhhhcCCCCCCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            99853221    111222222222222111  12456689999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-41  Score=258.42  Aligned_cols=216  Identities=21%  Similarity=0.288  Sum_probs=165.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|++++++++|+||+++++++......++|||++.+ +|.+++.....  .++...+..++.|++.||+|||+.  
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--  122 (288)
T cd07871          48 CTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR--  122 (288)
T ss_pred             hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            3567899999999999999999999998999999999975 88888765432  378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++..............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus       123 -~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~  201 (288)
T cd07871         123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR  201 (288)
T ss_pred             -CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999998765433333344567889999998865 45788999999999999999999


Q ss_pred             CCccccccccCC---------Cchh---------hhhhhcCCCC--CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSS---------NPNI---------LVNEMLDPRL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~---------~~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      .||.........         ....         .......+..  .+........+.+..+++++||..||.+|||+++
T Consensus       202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~  281 (288)
T cd07871         202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA  281 (288)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence            998643211000         0000         0000000000  0000111234567889999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       282 ~l~  284 (288)
T cd07871         282 ALR  284 (288)
T ss_pred             Hhc
Confidence            985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.1e-41  Score=256.32  Aligned_cols=214  Identities=29%  Similarity=0.490  Sum_probs=173.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----------SAEELGWSRRINVIKGIAH   72 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~~l~~   72 (228)
                      +.+.+|++++++++|+||+++++++......++++||+.+++|.+++....          ....+++.+++.++.|++.
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~  131 (288)
T cd05093          52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA  131 (288)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHH
Confidence            468899999999999999999999999999999999999999999986432          1234889999999999999


Q ss_pred             HHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhH
Q 040501           73 ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSF  150 (228)
Q Consensus        73 ~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  150 (228)
                      ||+|||+.   |++||||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|+|||
T Consensus       132 aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl  208 (288)
T cd05093         132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL  208 (288)
T ss_pred             HHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHH
Confidence            99999999   9999999999999999999999999998765432211  122334678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          151 GVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       151 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |+++|+|++ |..||....      .......+.........   ...+.++.+++.+||+.||.+|||+.++++.|++
T Consensus       209 G~il~~l~t~g~~p~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         209 GVVLWEIFTYGKQPWYQLS------NNEVIECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            999999998 899975332      12222333332222211   2345679999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-41  Score=259.02  Aligned_cols=216  Identities=24%  Similarity=0.339  Sum_probs=166.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++..+...|+||||+.++++..+....   ..+++..+..++.|++.||.|||+.  
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~--  119 (287)
T cd07848          45 ETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN--  119 (287)
T ss_pred             hhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            56789999999999999999999999999999999999987776654332   2388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||||+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.++|+||+|+++|+|++|+
T Consensus       120 -~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             -CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence             999999999999999999999999999887543222 223356788999999998888999999999999999999999


Q ss_pred             CCccccccccCCC---------chhhhhhh-cCC-----CCCCC-------chhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSN---------PNILVNEM-LDP-----RLPPL-------SVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~---------~~~~~~~~-~~~-----~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      +||+.........         +....... ..+     ..+..       .......+.++.+++++||+.||++|||+
T Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~  278 (287)
T cd07848         199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT  278 (287)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence            9986432211000         00000000 000     00000       00011245679999999999999999999


Q ss_pred             HHHHH
Q 040501          220 QTICQ  224 (228)
Q Consensus       220 ~~il~  224 (228)
                      +++++
T Consensus       279 ~~~l~  283 (287)
T cd07848         279 EQCLN  283 (287)
T ss_pred             HHHhc
Confidence            99885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-40  Score=250.19  Aligned_cols=212  Identities=25%  Similarity=0.389  Sum_probs=169.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|++++++++|+||+++++++......++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+.  
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~--  113 (252)
T cd05084          38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK--  113 (252)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            468899999999999999999999999999999999999999999987543  2378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+..........  .....+..|+|||.+.+..++.++|+||||+++|++++ 
T Consensus       114 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~  192 (252)
T cd05084         114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL  192 (252)
T ss_pred             -CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence             99999999999999999999999999987544221111  11123457999999988889999999999999999997 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ...............   ...++..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       193 ~~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         193 GAVPYANLSN------QQTREAIEQGVRLPC---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCCCccccCH------HHHHHHHHcCCCCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            8888753321      111111111111111   12345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.8e-41  Score=252.13  Aligned_cols=210  Identities=27%  Similarity=0.425  Sum_probs=175.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++|+||+++++++......|+++||+++++|.+++.... ...++..+++.++.+++.||.|||+. 
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~-  120 (256)
T cd08529          43 REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK-  120 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678899999999999999999999999999999999999999999987642 23488899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||+..+..++.++|+||||+++|+|++|.
T Consensus       121 --~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  198 (256)
T cd08529         121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK  198 (256)
T ss_pred             --CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence              999999999999999999999999999887654443344456788999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||....      .............+....   .++.++.+++.+||+.+|++||++.++++
T Consensus       199 ~p~~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         199 HPFDANN------QGALILKIIRGVFPPVSQ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCCC------HHHHHHHHHcCCCCCCcc---ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            9986433      222333333333332221   45567899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-40  Score=252.11  Aligned_cols=213  Identities=26%  Similarity=0.417  Sum_probs=171.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++..+...+++|||+++++|.+++..... ..++...++.++.|++.+|++||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~--  123 (263)
T cd05052          47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK--  123 (263)
T ss_pred             HHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5688999999999999999999999999999999999999999999865432 3478899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||||+||+++.++.++|+|||.+.......... .....+..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       124 -~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g  202 (263)
T cd05052         124 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG  202 (263)
T ss_pred             -CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence             99999999999999999999999999987654322211 11223567999999988889999999999999999998 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||+...      ...............   .....+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       203 ~~p~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         203 MSPYPGID------LSQVYELLEKGYRME---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCC------HHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            99975322      112222221111111   112456689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-41  Score=256.56  Aligned_cols=213  Identities=23%  Similarity=0.273  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|+++++.++|+||+++.+.+......|+||||+++++|.+.+... .....+++..+..++.|++.||.|||+. 
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-  116 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-  116 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35678999999999999999999999999999999999999998877542 2234588999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       117 --~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  194 (280)
T cd05608         117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR  194 (280)
T ss_pred             --CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999876554433334456888999999999988999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||.......  ...............    .....+..+.+++.+||+.||.+||     |++++++
T Consensus       195 ~pf~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         195 GPFRARGEKV--ENKELKQRILNDSVT----YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCCCCCcch--hHHHHHHhhcccCCC----CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            9986432111  111112222221111    1124566789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-40  Score=250.72  Aligned_cols=212  Identities=26%  Similarity=0.484  Sum_probs=171.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......+++|||+.+++|.+++.....  .+++..++.++.|++.||.|||+. 
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  119 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN-  119 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35788999999999999999999999999999999999999999999875432  378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|++++ 
T Consensus       120 --~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~  197 (256)
T cd05114         120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE  197 (256)
T ss_pred             --CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence              9999999999999999999999999988765322211 112234567999999988889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+.||....      .......+........+   ...+..+.+++.+||+.+|.+|||++++++.|.
T Consensus       198 g~~p~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         198 GKMPFEKKS------NYEVVEMISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCCC------HHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            899975432      22222233222211111   123456899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.5e-41  Score=240.52  Aligned_cols=216  Identities=22%  Similarity=0.303  Sum_probs=172.9

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      ...+|++.|+.++|+||+.+++.|...+.+.+|+||++ .+|...++.....  ++...+..++.+++.|++|||+.   
T Consensus        47 talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~--l~pa~iK~y~~m~LkGl~y~H~~---  120 (318)
T KOG0659|consen   47 TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNII--LSPADIKSYMLMTLKGLAYCHSK---  120 (318)
T ss_pred             HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccc--cCHHHHHHHHHHHHHHHHHHHhh---
Confidence            46899999999999999999999999999999999996 4899999865543  88899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      .|.||||||.|++++.+|.+||.|||+++..+...........|..|+|||.+.|. .|+...|+||.||++.|++-|.+
T Consensus       121 ~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P  200 (318)
T KOG0659|consen  121 WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP  200 (318)
T ss_pred             hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence            99999999999999999999999999999988777766666788999999988876 58999999999999999998888


Q ss_pred             CccccccccCCCch------------------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPN------------------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      -|+..+..+.....                  .....+..-..+.........+.+..+++.+||..||.+|+|+.++++
T Consensus       201 ~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  201 FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             CCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            77543322110000                  000000000011111122344556789999999999999999999986


Q ss_pred             H
Q 040501          225 L  225 (228)
Q Consensus       225 ~  225 (228)
                      .
T Consensus       281 ~  281 (318)
T KOG0659|consen  281 H  281 (318)
T ss_pred             c
Confidence            3

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.9e-41  Score=262.15  Aligned_cols=207  Identities=24%  Similarity=0.362  Sum_probs=165.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|..+++.+ +||||++++++|......|+||||+++++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~-  115 (329)
T cd05588          40 DWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER-  115 (329)
T ss_pred             HHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3467899999998 79999999999999999999999999999998886543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|++++|.
T Consensus       116 --~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~  193 (329)
T cd05588         116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  193 (329)
T ss_pred             --CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence              999999999999999999999999999875332233334457899999999999988999999999999999999999


Q ss_pred             CCccccccccC--CCc-hhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSS--SNP-NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||........  ... ......+...... .+   ...+..+.+++++||+.||.+|+|+
T Consensus       194 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p---~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         194 SPFDIVGMSDNPDQNTEDYLFQVILEKQIR-IP---RSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCcccccccccccccchHHHHHHHHcCCCC-CC---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            99864322211  111 1112222222211 11   2345578899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-40  Score=251.58  Aligned_cols=218  Identities=22%  Similarity=0.354  Sum_probs=177.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|++++++++|++++++++.+......+++|||+++++|.+++.... ....++..+++.++.+++.|+.+||+.
T Consensus        46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  125 (267)
T cd08224          46 RQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK  125 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678899999999999999999999999999999999999999999886532 233478999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       126 ---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g  202 (267)
T cd08224         126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  202 (267)
T ss_pred             ---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHC
Confidence               99999999999999999999999999987654433333345678889999999888899999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....    ...............++..  ....+..+.++|.+||..+|.+|||+.++++.|++
T Consensus       203 ~~p~~~~~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         203 QSPFYGDK----MNLYSLCKKIEKCDYPPLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             CCCcccCC----ccHHHHHhhhhcCCCCCCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            99975322    1111222222222222221  12456678999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-41  Score=262.87  Aligned_cols=203  Identities=22%  Similarity=0.302  Sum_probs=169.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        76 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  150 (340)
T PTZ00426         76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL--  150 (340)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999987653   388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++......   .....|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       151 -~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~  226 (340)
T PTZ00426        151 -NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP  226 (340)
T ss_pred             -CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence             9999999999999999999999999998765422   234578899999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+....... +   ...+..+.++|++||+.||.+|+     |++++++
T Consensus       227 Pf~~~~------~~~~~~~i~~~~~~~-p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        227 PFYANE------PLLIYQKILEGIIYF-P---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCCC------HHHHHHHHhcCCCCC-C---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            986432      222333333332211 1   12345678999999999999995     7888765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=264.21  Aligned_cols=216  Identities=20%  Similarity=0.323  Sum_probs=165.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||++++++|......++++|++. ++|..++....   .+++..++.++.|++.||.|||+. 
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~-  201 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN-  201 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3567899999999999999999999999999999999985 57777775443   378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCC-CCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       202 --~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  279 (391)
T PHA03212        202 --RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC  279 (391)
T ss_pred             --CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence              99999999999999999999999999986533221 223345789999999999988899999999999999999999


Q ss_pred             CCCccccccccCC-Cchhhhhhh--------------------------c---C--CCCCCCchhhhhhHHHHHHHHHHh
Q 040501          161 KHPRDFLSNVSSS-NPNILVNEM--------------------------L---D--PRLPPLSVDIRGKVISIMEVAFLC  208 (228)
Q Consensus       161 ~~p~~~~~~~~~~-~~~~~~~~~--------------------------~---~--~~~~~~~~~~~~~~~~~~~li~~~  208 (228)
                      ..||......... ........+                          .   .  +...+........+.++.++|.+|
T Consensus       280 ~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~m  359 (391)
T PHA03212        280 HDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKM  359 (391)
T ss_pred             CCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHH
Confidence            9876422111100 000000000                          0   0  000001111224566789999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |+.||.+|||++++++
T Consensus       360 L~~dP~~Rpta~elL~  375 (391)
T PHA03212        360 LAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhCCCHHHHhc
Confidence            9999999999999985

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-40  Score=251.33  Aligned_cols=214  Identities=24%  Similarity=0.477  Sum_probs=175.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ...+.+|+.+++.++|+||+++++++......+++|||+++++|.+++.... ...+++.+++.++.|++.|+.|||+. 
T Consensus        46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~-  123 (261)
T cd05148          46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ-  123 (261)
T ss_pred             HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999999999999999999999999999997643 23478999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       124 --~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g  201 (261)
T cd05148         124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG  201 (261)
T ss_pred             --CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence              9999999999999999999999999998765433222223345678999999988889999999999999999998 8


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....      ..............+.   ....+.++.+++.+||+.||.+|||++++++.|+.
T Consensus       202 ~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         202 QVPYPGMN------NHEVYDQITAGYRMPC---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCcCC------HHHHHHHHHhCCcCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            99985432      1222222222211111   13455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.8e-41  Score=255.42  Aligned_cols=212  Identities=24%  Similarity=0.279  Sum_probs=169.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+..|++++++++||||+++++.+..+...|+||||+.+++|.+++..... ..+++..+..++.|++.|++|||+.   
T Consensus        39 ~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---  114 (277)
T cd05607          39 MALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---  114 (277)
T ss_pred             HHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            456799999999999999999999999999999999999999988765432 3378899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++|+||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||+|+++|+|++|..|
T Consensus       115 ~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p  193 (277)
T cd05607         115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987654322 22335678899999999888899999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |......  .................   ....++.++.+++.+||+.||.+||+++++++.
T Consensus       194 ~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         194 FKDHKEK--VAKEELKRRTLEDEVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CCCCcch--hhHHHHHHHhhcccccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            8642211  11122222222222211   122456678999999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-41  Score=264.24  Aligned_cols=215  Identities=25%  Similarity=0.406  Sum_probs=163.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .++.+|+++++.++||||+++++++...     ...|+||||+. ++|.+++....   .+++..+..++.|++.||.||
T Consensus        44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~L  119 (338)
T cd07859          44 TRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYI  119 (338)
T ss_pred             HHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999988533     35899999995 58888876543   388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---CceecccccceeCCccccc--CCcccchhhhhHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGV  152 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~  152 (228)
                      |+.   |++||||||+||+++.++.+||+|||++........   ......+++.|+|||++.+  ..++.++|||||||
T Consensus       120 H~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGv  196 (338)
T cd07859         120 HTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC  196 (338)
T ss_pred             HHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHH
Confidence            999   999999999999999999999999999875432221   1234568899999998865  56888999999999


Q ss_pred             HHHHHHhCCCCccccccccC---------CCch------------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhcc
Q 040501          153 LALEVIKGKHPRDFLSNVSS---------SNPN------------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN  211 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~---------~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  211 (228)
                      ++|+|++|+.||........         ....            ...................+.+..+.+++.+||+.
T Consensus       197 vl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  276 (338)
T cd07859         197 IFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF  276 (338)
T ss_pred             HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence            99999999999864321110         0000            00111111111111122234556788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 040501          212 NPESRPNMQTICQ  224 (228)
Q Consensus       212 ~p~~Rpt~~~il~  224 (228)
                      ||.+|||++++++
T Consensus       277 ~P~~Rpt~~e~l~  289 (338)
T cd07859         277 DPKDRPTAEEALA  289 (338)
T ss_pred             CcccCCCHHHHhc
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=262.69  Aligned_cols=207  Identities=20%  Similarity=0.240  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~--  120 (333)
T cd05600          46 RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL--  120 (333)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999997543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++.....   ......|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       121 -~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~  196 (333)
T cd05600         121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP  196 (333)
T ss_pred             -CccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence             999999999999999999999999999876543   2234568899999999998899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcC----CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLD----PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.....      ......+..    ...+.........+.++.+++.+||..+|.+|||+.++++
T Consensus       197 pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         197 PFSGSTP------NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             CCCCCCH------HHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            9864322      111111111    0111111111245667899999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-41  Score=263.36  Aligned_cols=206  Identities=25%  Similarity=0.292  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~   81 (228)
                      ..+.+|+++++.++||||+++.+.+......|+||||+.+++|..++....   .+++..+..++.|++.||.|||+ . 
T Consensus        40 ~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~-  115 (325)
T cd05594          40 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK-  115 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence            356789999999999999999999999999999999999999998886543   38899999999999999999997 7 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       116 --~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~  193 (325)
T cd05594         116 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  193 (325)
T ss_pred             --CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCC
Confidence              999999999999999999999999999875433333334456899999999998888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||....      .......+.......    ....+.++.+++.+||+.||++|+     ++.++++
T Consensus       194 ~Pf~~~~------~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         194 LPFYNQD------HEKLFELILMEEIRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCC------HHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            9985322      112222222221111    123456789999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.9e-41  Score=264.79  Aligned_cols=216  Identities=25%  Similarity=0.410  Sum_probs=170.1

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      ++.+.+|+++++.+ +||||++++++|......++||||+++|+|.+++.....                          
T Consensus        82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (375)
T cd05104          82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMS  161 (375)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhccc
Confidence            35688999999999 899999999999999999999999999999998864221                          


Q ss_pred             ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeec
Q 040501           55 ----------------------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHR   88 (228)
Q Consensus        55 ----------------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~   88 (228)
                                                                    ...+++..++.++.|++.||+|||+.   |++||
T Consensus       162 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~  238 (375)
T cd05104         162 CDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHR  238 (375)
T ss_pred             chhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence                                                          12367888899999999999999999   99999


Q ss_pred             CCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCcc
Q 040501           89 DISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRD  165 (228)
Q Consensus        89 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~  165 (228)
                      ||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       239 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         239 DLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             CCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999999998765433221  112234567999999998889999999999999999997 888875


Q ss_pred             ccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      .....      ...............  ....+.++.+++.+||+.||.+|||+.++++.|++
T Consensus       319 ~~~~~------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         319 GMPVD------SKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCch------HHHHHHHHhCccCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            43211      111111111111100  01234578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.5e-41  Score=264.21  Aligned_cols=207  Identities=24%  Similarity=0.371  Sum_probs=162.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++|+||+++++++......|+||||+.+++|.+..       ......+..++.|++.||.|||+. 
T Consensus       116 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~-  187 (353)
T PLN00034        116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR-  187 (353)
T ss_pred             HHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            356889999999999999999999999999999999999999886532       245677888999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-----CcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-----KVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~  156 (228)
                        |++||||||+||+++.++.+||+|||++..............|+..|+|||.+...     ..+.++|||||||++|+
T Consensus       188 --~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e  265 (353)
T PLN00034        188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE  265 (353)
T ss_pred             --CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence              99999999999999999999999999988765433333445788999999987432     23568999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||.....   .........+.....+.   .....+.++.++|.+||..||.+|||+.++++
T Consensus       266 l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        266 FYLGRFPFGVGRQ---GDWASLMCAICMSQPPE---APATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHhCCCCCCCCCC---ccHHHHHHHHhccCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999862211   11111111111111111   11245567899999999999999999999986

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-41  Score=265.47  Aligned_cols=215  Identities=26%  Similarity=0.419  Sum_probs=169.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------------------------
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------   54 (228)
                      +.+.+|+++++.+ +|+||+++++.|......++||||+.+++|.+++.....                           
T Consensus        86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (374)
T cd05106          86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK  165 (374)
T ss_pred             HHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcc
Confidence            4678999999999 899999999999999999999999999999998854210                           


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 040501           55 ----------------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKN   94 (228)
Q Consensus        55 ----------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~n   94 (228)
                                                              ...+++..++.++.|++.||.|||+.   |++||||||+|
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~N  242 (374)
T cd05106         166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARN  242 (374)
T ss_pred             cccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchhe
Confidence                                                    12367888999999999999999999   99999999999


Q ss_pred             eEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCcccccccc
Q 040501           95 VLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVS  171 (228)
Q Consensus        95 il~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~  171 (228)
                      |+++.++.++|+|||++.........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       243 il~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-  321 (374)
T cd05106         243 VLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-  321 (374)
T ss_pred             EEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-
Confidence            99999999999999998765432211  112234567999999988889999999999999999997 99998643211 


Q ss_pred             CCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          172 SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                           ...............  ....+.++.+++.+||+.||.+|||+.++++.|++
T Consensus       322 -----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         322 -----SKFYKMVKRGYQMSR--PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             -----HHHHHHHHcccCccC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 111111111111100  01235678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-40  Score=250.23  Aligned_cols=212  Identities=26%  Similarity=0.476  Sum_probs=171.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++||||+++++++......+++|||+.+++|.+++.....  .+++.+++.++.|++.||.|||+. 
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  119 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK-  119 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35688999999999999999999999988899999999999999999875433  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       120 --~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~  197 (256)
T cd05113         120 --QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL  197 (256)
T ss_pred             --CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcC
Confidence              9999999999999999999999999988765433221 112234567999999988888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+.........   ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       198 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         198 GKMPYERFNN------SETVEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCcCcCCH------HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            9999754322      1222223222222111   123567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=265.09  Aligned_cols=207  Identities=28%  Similarity=0.456  Sum_probs=174.1

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      ..+|+-|++|+|+||+++.++|.....+|||||||+.|-|...++....   +.......|..+|+.|+.|||..   .|
T Consensus       160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KI  233 (904)
T KOG4721|consen  160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KI  233 (904)
T ss_pred             hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hH
Confidence            3588999999999999999999999999999999999999999976543   78888999999999999999999   99


Q ss_pred             eecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           86 VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      +|||||.-|||++.+..+||+|||-++....- .....+.||..|||||++.....+.|+||||||++||||+||..||.
T Consensus       234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  234 IHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            99999999999999999999999988876543 33456889999999999999999999999999999999999999986


Q ss_pred             ccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      .....-  ..--+....+...+|      ..++.-+.-|+++||+-.|..||++.+++.-|.
T Consensus       313 dVdssA--IIwGVGsNsL~LpvP------stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  313 DVDSSA--IIWGVGSNSLHLPVP------STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             ccchhe--eEEeccCCcccccCc------ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            432211  011122233333333      255667889999999999999999999987653

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-40  Score=253.05  Aligned_cols=214  Identities=21%  Similarity=0.378  Sum_probs=171.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------AEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      +.+.+|+.+++.++|+||+++++++..+...++||||+.+++|.+++.....       ....++.++..++.|++.||.
T Consensus        54 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  133 (277)
T cd05062          54 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999999999999865321       123567888999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      |||+.   |++|+||||+||+++.++.++++|||.+.........  .....++..|+|||.+.+..++.++|+||||++
T Consensus       134 ~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  210 (277)
T cd05062         134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV  210 (277)
T ss_pred             HHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence            99999   9999999999999999999999999998755432221  112234678999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +|++++ |..||....      .................   ...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       211 l~el~~~~~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         211 LWEIATLAEQPYQGMS------NEQVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCCCCCCCCC------HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            999998 788875332      12222222222222111   2345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=251.42  Aligned_cols=216  Identities=23%  Similarity=0.361  Sum_probs=171.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .++..+|+++|+.++|+||+.+.+++..     -+.+|+|+|++ +.+|...++.+..   ++...+..+++|++.||+|
T Consensus        65 akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKy  140 (359)
T KOG0660|consen   65 AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKY  140 (359)
T ss_pred             HHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcch
Confidence            4667899999999999999999999965     35799999999 5688888876543   7888899999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCC--CCCceecccccceeCCcccc-cCCcccchhhhhHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD--SSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVL  153 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~  153 (228)
                      +|+.   |++|||+||+|++++.+..+||+|||+++.....  ....+....|..|+|||.+. ...|+.+.||||+||+
T Consensus       141 iHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI  217 (359)
T KOG0660|consen  141 IHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCI  217 (359)
T ss_pred             hhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHH
Confidence            9999   9999999999999999999999999999987543  22346677899999999765 4569999999999999


Q ss_pred             HHHHHhCCCCccccccccC---------CCchhhhh------------hhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSS---------SNPNILVN------------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~---------~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +.||++|++.|++.+....         ....+...            ........+.....++..+...+|+.+||..|
T Consensus       218 ~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fd  297 (359)
T KOG0660|consen  218 LAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFD  297 (359)
T ss_pred             HHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccC
Confidence            9999999999976544321         11111111            11111112223334566677899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|+|++|+++
T Consensus       298 P~kRita~eAL~  309 (359)
T KOG0660|consen  298 PKKRITAEEALA  309 (359)
T ss_pred             ccccCCHHHHhc
Confidence            999999999875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.2e-40  Score=250.17  Aligned_cols=214  Identities=24%  Similarity=0.428  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++|+||+++++.+......++++|++.+++|.+++.... ...+++.+++.++.|++.||+|||+. 
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~-  122 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK-  122 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3578899999999999999999999999999999999999999999987543 23478889999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       123 --~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~  200 (261)
T cd05072         123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY  200 (261)
T ss_pred             --CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence              9999999999999999999999999999865432211 122334667999999988888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||....      .......+......+.   ....+.++.+++.+||..+|++|||++++.+.|++
T Consensus       201 g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         201 GKIPYPGMS------NSDVMSALQRGYRMPR---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            999985322      1122222222211111   12355678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-40  Score=252.42  Aligned_cols=214  Identities=27%  Similarity=0.452  Sum_probs=172.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC------------CCCCCHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS------------AEELGWSRRINVIKGI   70 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~l   70 (228)
                      +.+.+|++++++++|+||+++++++......++++||+.+++|.+++.....            ...+++.+++.++.|+
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  131 (280)
T cd05092          52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI  131 (280)
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHH
Confidence            5688999999999999999999999999999999999999999999875432            1237889999999999


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhh
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      +.|++|||+.   |++|+||||+||++++++.++|+|||++.........  .....+++.|+|||.+.+..++.++|+|
T Consensus       132 ~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  208 (280)
T cd05092         132 ASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW  208 (280)
T ss_pred             HHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHH
Confidence            9999999999   9999999999999999999999999998755322211  1122346789999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||+++|+|++ |.+||.....      ...............   ...++..+.+++.+||..||.+||++.++++.|+
T Consensus       209 slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         209 SFGVVLWEIFTYGKQPWYQLSN------TEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHHHHHcCCCCCCccCCH------HHHHHHHHcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            99999999998 8999753221      122222222221111   1245567899999999999999999999999987


Q ss_pred             C
Q 040501          228 K  228 (228)
Q Consensus       228 ~  228 (228)
                      +
T Consensus       280 ~  280 (280)
T cd05092         280 A  280 (280)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7e-41  Score=259.79  Aligned_cols=201  Identities=24%  Similarity=0.344  Sum_probs=165.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|..+++.+ +||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        40 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~-  115 (320)
T cd05590          40 ECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK-  115 (320)
T ss_pred             HHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3456788888877 69999999999999999999999999999998887543   388899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       116 --~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (320)
T cd05590         116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH  193 (320)
T ss_pred             --CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCC
Confidence              999999999999999999999999999875433333334457899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||....      .......+........    ...+.++.+++++||+.||.+||++
T Consensus       194 ~Pf~~~~------~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         194 APFEAEN------EDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCC------HHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            9986432      2223333333222111    1345578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-40  Score=256.94  Aligned_cols=210  Identities=21%  Similarity=0.299  Sum_probs=162.3

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++++.++||||+++++++......|+||||+. ++|.+++....  ..++...+..++.|++.||.|||+.   
T Consensus        49 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---  122 (303)
T cd07869          49 TAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---  122 (303)
T ss_pred             hHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            56789999999999999999999999999999999996 46766665432  2378889999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |++|+||||+||+++.++.+||+|||++..............+++.|+|||++.+. .++.++||||+||++|+|++|..
T Consensus       123 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  202 (303)
T cd07869         123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA  202 (303)
T ss_pred             CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987654333333445678899999988654 57889999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhc---------------------CCCCCC-Cch------hhhhhHHHHHHHHHHhhccCCC
Q 040501          163 PRDFLSNVSSSNPNILVNEML---------------------DPRLPP-LSV------DIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~-~~~------~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ||.......     .....+.                     ...... ...      .....+..+.+++.+||+.||+
T Consensus       203 pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~  277 (303)
T cd07869         203 AFPGMKDIQ-----DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK  277 (303)
T ss_pred             CCCCCccHH-----HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch
Confidence            986432110     0000000                     000000 000      0011235678999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       278 ~R~s~~~~l~  287 (303)
T cd07869         278 NRLSAQAALS  287 (303)
T ss_pred             hccCHHHHhc
Confidence            9999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=257.54  Aligned_cols=208  Identities=24%  Similarity=0.347  Sum_probs=165.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +...+||.+|++++|+|||+++++..+  .+.+|+|+|||..|.+...   ......+++.+++++++++..||.|||.+
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q  229 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ  229 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence            467899999999999999999999864  5689999999998876532   12222389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-----ceecccccceeCCcccccCC----cccchhhhhHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-----WTEFAGTYGYVAPELAYTMK----VTAKCDVYSFG  151 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG  151 (228)
                         ||+||||||+|+|++.+|.+||+|||.+.........     .....|||.|+|||...+..    .+.+.||||+|
T Consensus       230 ---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG  306 (576)
T KOG0585|consen  230 ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG  306 (576)
T ss_pred             ---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence               9999999999999999999999999988865322111     23368999999999887632    25678999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +++|.++.|+.||...      ........+....+.....  ......+.+||++||.+||..|.+..+|..
T Consensus       307 VTLYCllfG~~PF~~~------~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  307 VTLYCLLFGQLPFFDD------FELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hhHHHhhhccCCcccc------hHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            9999999999997532      2334455555444432221  245567899999999999999999988753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=265.68  Aligned_cols=212  Identities=29%  Similarity=0.428  Sum_probs=178.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|++|+++++.++||||++++|++.....+|+|||+|.||+|.++++....  .++..+.+.++.+.+.||+|||+. 
T Consensus       205 ~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k-  281 (474)
T KOG0194|consen  205 IKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK-  281 (474)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC-
Confidence            46789999999999999999999999999999999999999999999987654  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                        +++||||-.+|+|++.++.+||+|||++..............-+..|+|||.+....++.++||||+|+++||+++ |
T Consensus       282 --~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g  359 (474)
T KOG0194|consen  282 --NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG  359 (474)
T ss_pred             --CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccC
Confidence              9999999999999999999999999998765422222222345789999999999999999999999999999998 8


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||.....      ......+..... .+.+   ...+.++..++.+||..+|++|||+.++.+.|+
T Consensus       360 ~~Py~g~~~------~~v~~kI~~~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  360 AEPYPGMKN------YEVKAKIVKNGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             CCCCCCCCH------HHHHHHHHhcCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            889765433      234444422222 2211   155667889999999999999999999998875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-40  Score=257.77  Aligned_cols=213  Identities=23%  Similarity=0.363  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||++++++|..+...++||||+.+++|.+++....   .++...+..++.|++.|+.|||+.+ 
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~-  123 (333)
T cd06650          48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH-  123 (333)
T ss_pred             HHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence            468899999999999999999999999999999999999999999987543   3788899999999999999999742 


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||||+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+|||||++|++++|..
T Consensus       124 -~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~  200 (333)
T cd06650         124 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY  200 (333)
T ss_pred             -CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence             7999999999999999999999999998754322  1223467889999999988889999999999999999999999


Q ss_pred             CccccccccCC----------Cch----------------------------hhhhhhcCCCCCCCchhhhhhHHHHHHH
Q 040501          163 PRDFLSNVSSS----------NPN----------------------------ILVNEMLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       163 p~~~~~~~~~~----------~~~----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                      ||.........          ...                            .....+.....+...  ....+.++.++
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  278 (333)
T cd06650         201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDF  278 (333)
T ss_pred             CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHH
Confidence            98643210000          000                            000000000000000  01245678999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.+||+.||++|||+.++++
T Consensus       279 i~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         279 VNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             HHHhccCCcccCcCHHHHhh
Confidence            99999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.1e-40  Score=248.20  Aligned_cols=210  Identities=27%  Similarity=0.420  Sum_probs=169.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.+.|+||+++++++. ....+++||++.+++|.+++....   .+++..+..++.|++.|+.+||+.  
T Consensus        41 ~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~--  114 (257)
T cd05116          41 DELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET--  114 (257)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            56889999999999999999999875 456789999999999999986543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||||.||+++.++.++|+|||.+..........   ....++..|+|||.+....++.++|+||||+++|+|++
T Consensus       115 -~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             -CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence             99999999999999999999999999987665433221   11223568999999888888999999999999999997


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||.....      ......+.....+..+   ...+.++.++|.+||+.||.+|||+.+|.+.|++
T Consensus       194 ~g~~p~~~~~~------~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         194 YGQKPYKGMKG------NEVTQMIESGERMECP---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCCH------HHHHHHHHCCCCCCCC---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             9999864321      1222222222221111   2456678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.1e-40  Score=248.19  Aligned_cols=211  Identities=23%  Similarity=0.384  Sum_probs=168.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++++.. ...++||||+++++|.+++....  ..+++.+++.++.|++.|++|||+.  
T Consensus        40 ~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--  114 (257)
T cd05115          40 DEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK--  114 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc--
Confidence            568899999999999999999998754 57899999999999999986533  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||||+||+++.++.++|+|||++..........   ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       115 -~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             -CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence             99999999999999999999999999987654332211   11223568999999888888999999999999999996


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||.....      ......+........   ...++.++.+++.+||..+|++||++.++.+.|++
T Consensus       194 ~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         194 YGQKPYKKMKG------PEVMSFIEQGKRLDC---PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCcCcCCH------HHHHHHHHCCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence             9999864322      112222222221111   12456688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4e-40  Score=249.40  Aligned_cols=213  Identities=27%  Similarity=0.483  Sum_probs=173.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|+.++++++|+||+++++++......+++||++.+++|.+++.....  .++..+++.++.|++.|+.|||+. 
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~-  125 (266)
T cd05033          49 RLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM-  125 (266)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35688899999999999999999999999999999999999999999876433  488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce--ecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT--EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++|+||+|+||+++.++.++++|||++...........  ...++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       126 --~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~  203 (266)
T cd05033         126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             --CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence              999999999999999999999999999987652222111  2234567999999988889999999999999999997


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||....      .......+......+..   ...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       204 ~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         204 YGERPYWDMS------NQDVIKAVEDGYRLPPP---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             cCCCCCCCCC------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             999975322      11222222222111111   2456678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-41  Score=254.82  Aligned_cols=212  Identities=36%  Similarity=0.587  Sum_probs=166.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++.+++++||||+++++++......++|+||+.+++|.+++.... ...++..+++.++.|++.|+.|||+. 
T Consensus        45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~-  122 (259)
T PF07714_consen   45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN-  122 (259)
T ss_dssp             HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             ceeeeecccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccc-
Confidence            4688999999999999999999999998888999999999999999998762 23389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        +++|++|+++||+++.++.+||+|||++.........  .........|+|||.+.+..++.++||||||+++|++++
T Consensus       123 --~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~  200 (259)
T PF07714_consen  123 --NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT  200 (259)
T ss_dssp             --TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence              9999999999999999999999999998876322111  122345678999999988889999999999999999999


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                       |..||...      ........+.+.......   ..++..+.+++.+||..+|.+|||+.++++.|
T Consensus       201 ~~~~p~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  201 LGKFPFSDY------DNEEIIEKLKQGQRLPIP---DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSSGTTTTS------CHHHHHHHHHTTEETTSB---TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccccccc------ccccccccccccccceec---cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             67886432      222333333333322221   24566789999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-40  Score=258.89  Aligned_cols=206  Identities=23%  Similarity=0.325  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|.+++..+ +||||+++++++......|+||||+.+++|...+....   .+++..+..++.|++.||.|||+. 
T Consensus        40 ~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  115 (321)
T cd05591          40 DCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH-  115 (321)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567888888876 79999999999999999999999999999998886543   378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       116 --~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~  193 (321)
T cd05591         116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ  193 (321)
T ss_pred             --CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCC
Confidence              999999999999999999999999999875433333334456889999999998888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-------CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-------NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------t~~~il~  224 (228)
                      .||....      .......+........    ...+.++.+++.+||+.||.+||       ++.++++
T Consensus       194 ~Pf~~~~------~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         194 PPFEADN------EDDLFESILHDDVLYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCC------HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            9986432      2233333333222111    12455788999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-40  Score=247.31  Aligned_cols=214  Identities=26%  Similarity=0.473  Sum_probs=173.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++|+||+++++++......|+++|++.+++|.+++.... ...+++..+..++.|++.|+.+||+. 
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-  122 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ-  122 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999987644 23488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++|+|||++......... ......+..|+|||.+.+..++.++|+||||+++|++++ 
T Consensus       123 --~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~  200 (261)
T cd05068         123 --NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY  200 (261)
T ss_pred             --CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence              9999999999999999999999999998876532211 111223457999999988889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |+.||....      .......+........   ....+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       201 g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         201 GRMPYPGMT------NAEVLQQVDQGYRMPC---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCC---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            999985432      2222222222211111   12345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=248.15  Aligned_cols=211  Identities=28%  Similarity=0.516  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++......|+++|++++++|.+++.....  .+++..++.++.|++.|+++||+.  
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--  119 (256)
T cd05059          44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN--  119 (256)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4688999999999999999999999999999999999999999999875443  488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       120 -~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g  198 (256)
T cd05059         120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG  198 (256)
T ss_pred             -CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccC
Confidence             99999999999999999999999999887654322111 11223457999999988889999999999999999998 8


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||.....      ...............   ....+.++.+++.+||..+|++|||+.++++.|.
T Consensus       199 ~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         199 KMPYERFSN------SEVVESVSAGYRLYR---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCCH------HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            999754321      112222221111111   1235668999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-40  Score=259.09  Aligned_cols=208  Identities=23%  Similarity=0.324  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.++.++ +|++|+++++++......|+||||+.+++|..++....   .+++..+..++.|++.||+|||+. 
T Consensus        40 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~-  115 (327)
T cd05617          40 DWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER-  115 (327)
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3467899999888 69999999999999999999999999999998886543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       116 --~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~  193 (327)
T cd05617         116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  193 (327)
T ss_pred             --CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence              999999999999999999999999999875433333334467899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||..........................+   ...+..+.+++.+||+.||.+|+++
T Consensus       194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         194 SPFDIITDNPDMNTEDYLFQVILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCccCCCcccccHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            998643222111121222222111111111   1344568899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-40  Score=257.79  Aligned_cols=205  Identities=24%  Similarity=0.348  Sum_probs=164.1

Q ss_pred             HHHHHHHHHH---hccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVL---TEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +.+.+|+.++   +.++||||+++++++......|+||||+.+++|...+...    .+++..+..++.|++.||.|||+
T Consensus        44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~  119 (324)
T cd05589          44 ESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE  119 (324)
T ss_pred             HHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh
Confidence            3456666555   4567999999999999999999999999999998887542    38999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      .   |++||||||+||+++.++.+||+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus       120 ~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  196 (324)
T cd05589         120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV  196 (324)
T ss_pred             C---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh
Confidence            9   9999999999999999999999999988754333333344678899999999998889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      |..||....      .......+.......    ....+..+.++|.+||+.||.+||     ++.++++
T Consensus       197 G~~pf~~~~------~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         197 GESPFPGDD------EEEVFDSIVNDEVRY----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCCC------HHHHHHHHHhCCCCC----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            999986432      122222232222111    123456788999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-40  Score=258.79  Aligned_cols=207  Identities=25%  Similarity=0.384  Sum_probs=164.7

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|+.++.++ +||||+++++++......|+||||+.+++|..++....   .+++..+..++.|++.||.|||+. 
T Consensus        40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~-  115 (329)
T cd05618          40 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER-  115 (329)
T ss_pred             HHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3467888888877 79999999999999999999999999999988886543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       116 --~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  193 (329)
T cd05618         116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  193 (329)
T ss_pred             --CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence              999999999999999999999999999875432333334457899999999999988999999999999999999999


Q ss_pred             CCccccccccCC--Cc-hhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSS--NP-NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||.........  .. ......+...... .+   ...+..+.+++.+||+.||.+|||+
T Consensus       194 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~p---~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         194 SPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IP---RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCccCCCcCCcccccHHHHHHHHhcCCCC-CC---CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            998643221111  11 1111222222211 11   2345578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-40  Score=251.75  Aligned_cols=218  Identities=23%  Similarity=0.369  Sum_probs=168.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ++.+.+|+++++.++||||+++++++...  ...+++||++.+++|.+++...    .+++.+++.++.|++.|+.|||+
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~  125 (283)
T cd05080          50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS  125 (283)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999988653  4689999999999999998653    28999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+
T Consensus       126 ~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~e  202 (283)
T cd05080         126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE  202 (283)
T ss_pred             C---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHH
Confidence            9   9999999999999999999999999998765432221   112234567999999988888999999999999999


Q ss_pred             HHhCCCCccccccccC--------CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIKGKHPRDFLSNVSS--------SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++|..||........        .................  .....++.++.+++.+||+.+|++|||++++++.|++
T Consensus       203 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         203 LLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             HHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            9999999754321100        00000000011111000  0112456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-40  Score=248.52  Aligned_cols=209  Identities=22%  Similarity=0.274  Sum_probs=174.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+.|-+||+.+.||.++.++..|+.+...|++||||+||+|..+.+++.. +.++++.+..++.+++-||+|||-.  
T Consensus       122 ~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml--  198 (459)
T KOG0610|consen  122 KRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML--  198 (459)
T ss_pred             HHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh--
Confidence            3567799999999999999999999999999999999999999999886654 4599999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCC----------------------------------C----------
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD----------------------------------S----------  118 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~----------------------------------~----------  118 (228)
                       ||++|||||+|||+.++|++.|+||.++......                                  .          
T Consensus       199 -GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~  277 (459)
T KOG0610|consen  199 -GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS  277 (459)
T ss_pred             -ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence             9999999999999999999999999987655210                                  0          


Q ss_pred             ------------CCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCC
Q 040501          119 ------------SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR  186 (228)
Q Consensus       119 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  186 (228)
                                  .....+.||-+|+|||++.|...+.++|.|+||+++|||+.|..||..      .+..+.+..++...
T Consensus       278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG------~~~~~Tl~NIv~~~  351 (459)
T KOG0610|consen  278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG------SNNKETLRNIVGQP  351 (459)
T ss_pred             ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC------CCchhhHHHHhcCC
Confidence                        001235678899999999999999999999999999999999999754      33445555555544


Q ss_pred             CCCCchhhhhhHHHHHHHHHHhhccCCCCCCC----HHHHH
Q 040501          187 LPPLSVDIRGKVISIMEVAFLCLDNNPESRPN----MQTIC  223 (228)
Q Consensus       187 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il  223 (228)
                      +.....  ...+....+||++.|.+||++|.-    ++||.
T Consensus       352 l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  352 LKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CcCCCC--CcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            432222  256667899999999999999987    66654

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-40  Score=248.05  Aligned_cols=214  Identities=29%  Similarity=0.454  Sum_probs=176.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS------AEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++.....      ...+++..++.++.|++.||+
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~  119 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME  119 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            46788999999999999999999999999999999999999999999986521      244899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      +||+.   |++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||||++
T Consensus       120 ~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  196 (262)
T cd00192         120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL  196 (262)
T ss_pred             HHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHH
Confidence            99999   99999999999999999999999999998765432  11233456788999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|+|++ |..||....      ................   ....+.++.+++.+||..+|.+|||+.++++.|+
T Consensus       197 l~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         197 LWEIFTLGATPYPGLS------NEEVLEYLRKGYRLPK---PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHhcCCCCCCCCC------HHHHHHHHHcCCCCCC---CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            999998 699976432      2223333332222111   1234668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-40  Score=257.68  Aligned_cols=206  Identities=25%  Similarity=0.323  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|.++++.+ +||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||+|||+. 
T Consensus        40 ~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~-  115 (318)
T cd05570          40 ECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER-  115 (318)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3567888899888 69999999999999999999999999999998887553   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||||+||+++.++.++|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       116 --~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~  193 (318)
T cd05570         116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ  193 (318)
T ss_pred             --CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCC
Confidence              999999999999999999999999998865332333333456889999999999989999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-----QTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~  224 (228)
                      .||....      .......+.......    ....+..+.++|.+||+.||.+|||+     .++++
T Consensus       194 ~pf~~~~------~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         194 SPFEGDD------EDELFQSILEDEVRY----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCCCC------HHHHHHHHHcCCCCC----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            9986332      222222232222211    12345678999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.6e-40  Score=250.38  Aligned_cols=214  Identities=23%  Similarity=0.402  Sum_probs=171.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|++++++++|+||+++++++......|++|||+++++|.+++.....              ...+++.+++.++.
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  131 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI  131 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence            4688999999999999999999999999999999999999999999853221              22377888999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.|++|||+.   |++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|
T Consensus       132 ~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  208 (283)
T cd05090         132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD  208 (283)
T ss_pred             HHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhh
Confidence            999999999999   9999999999999999999999999999765432211  22234466799999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +||||+++|+|++ |..||....      .......+........   ...++..+.+++.+||+.||.+||++.++++.
T Consensus       209 v~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         209 IWSFGVVLWEIFSFGLQPYYGFS------NQEVIEMVRKRQLLPC---SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             hHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999999999998 998975321      1122222222222211   12455678999999999999999999999998


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |..
T Consensus       280 l~~  282 (283)
T cd05090         280 LRS  282 (283)
T ss_pred             hhc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2e-40  Score=261.68  Aligned_cols=209  Identities=20%  Similarity=0.259  Sum_probs=168.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++...    .+++..+..++.|++.||+|||+.  
T Consensus        88 ~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~--  161 (370)
T cd05596          88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM--  161 (370)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            34678999999999999999999999999999999999999999998653    278888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccC----CcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM----KVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~~  157 (228)
                       |++||||||+||+++.++.++|+|||.+........ ......|++.|+|||.+.+.    .++.++|+|||||++|+|
T Consensus       162 -~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel  240 (370)
T cd05596         162 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM  240 (370)
T ss_pred             -CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence             999999999999999999999999999876543222 22345689999999988654    378899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+.++.++|.+||..+|.+  |+|++++++
T Consensus       241 ltG~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         241 LVGDTPFYADS------LVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HhCCCCcCCCC------HHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            99999986432      22223333322211111112245678899999999999987  999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.2e-40  Score=247.01  Aligned_cols=211  Identities=25%  Similarity=0.402  Sum_probs=176.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|++++++++|+||+++++++.+....++++||+++++|.+++.... ...++..++..++.|++.++.+||+.  
T Consensus        44 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~--  120 (256)
T cd08221          44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA--  120 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            568899999999999999999999999999999999999999999987643 23478999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|.|||.+.+..++.++|+||||+++|+|++|..
T Consensus       121 -~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~  199 (256)
T cd08221         121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR  199 (256)
T ss_pred             -CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCC
Confidence             9999999999999999999999999998766544333344567889999999988888899999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||...      ........+.........   ...+.++.+++.+||..+|.+|||+.++++.+
T Consensus       200 ~~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         200 TFDAT------NPLNLVVKIVQGNYTPVV---SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCC------CHHHHHHHHHcCCCCCCc---cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            97532      223333344444333222   34566789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-40  Score=259.44  Aligned_cols=210  Identities=22%  Similarity=0.281  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|+++++.+ +|++|+++++++......++||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~-  124 (332)
T cd05614          49 EHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL-  124 (332)
T ss_pred             HHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567899999999 59999999999999999999999999999999886543   388899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+.. ++.++|||||||++|+|++
T Consensus       125 --~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  202 (332)
T cd05614         125 --GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT  202 (332)
T ss_pred             --CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc
Confidence              999999999999999999999999999876433222 223456899999999987654 7889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      |..||.......  ........+.....+ ..   ...+..+.+++.+||+.||.+||     +++++++
T Consensus       203 g~~pf~~~~~~~--~~~~~~~~~~~~~~~-~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         203 GASPFTLEGERN--TQSEVSRRILKCDPP-FP---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCCCCCC--CHHHHHHHHhcCCCC-CC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            999986432211  111122222222111 11   23455788999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=250.50  Aligned_cols=214  Identities=24%  Similarity=0.383  Sum_probs=172.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------AEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ..+.+|+.+++.++|+||+++++++......+++|||+++++|.+++.....       ...+++..++.++.|++.||.
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  133 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999999999999865322       123678899999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      |||+.   |++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||++
T Consensus       134 ~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  210 (277)
T cd05032         134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV  210 (277)
T ss_pred             HHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHH
Confidence            99999   9999999999999999999999999998765433221  122345678999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +|++++ |..||....      ................+   ...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       211 l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         211 LWEMATLAEQPYQGLS------NEEVLKFVIDGGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHhhccCCCCCccCC------HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            999998 999975322      12222222222222211   2346678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-40  Score=255.80  Aligned_cols=204  Identities=26%  Similarity=0.370  Sum_probs=164.9

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|..++... +||||+++++++..+...|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        41 ~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~--  115 (316)
T cd05592          41 CTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK--  115 (316)
T ss_pred             HHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            455677777655 89999999999999999999999999999999887543   388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       116 -~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~  194 (316)
T cd05592         116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             -CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765433333444578999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ-TIC  223 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il  223 (228)
                      ||....      .......+..... ..+   ...+.++.+++.+||+.||.+||++. +++
T Consensus       195 Pf~~~~------~~~~~~~i~~~~~-~~~---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         195 PFHGED------EDELFDSILNDRP-HFP---RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCC------HHHHHHHHHcCCC-CCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            986432      1222222222211 111   23455688999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=241.29  Aligned_cols=217  Identities=21%  Similarity=0.269  Sum_probs=184.7

Q ss_pred             ChHHHHHHHHHHhcc-CCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            1 DKKEFLREITVLTEI-RHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      |+....+|+++--.. .|+|||.++++|+.    ...+.+|||.+.||.|++.++.++. ..+++.++..++.||..|+.
T Consensus        97 Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~  175 (400)
T KOG0604|consen   97 DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVR  175 (400)
T ss_pred             cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHH
Confidence            455677899887777 59999999999853    3567899999999999999987764 45999999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      |||+.   +|.||||||+|++++.   +..+||+|||.++... ......+++.||.|.|||++...+|+...|+||+|+
T Consensus       176 ~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~-~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgV  251 (400)
T KOG0604|consen  176 YLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ-EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV  251 (400)
T ss_pred             HHHhc---chhhccCChhheeeecCCCCcceEecccccccccC-CCccccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence            99999   9999999999999964   4568999999998644 234456678899999999999999999999999999


Q ss_pred             HHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          153 LALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|-|++|.+||-....  ..-.-....++..+........|...++...++|+++|..+|.+|.|+.++.+
T Consensus       252 imYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  252 IMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHhhcCCCcccccCC--ccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            99999999999854433  22233456677777777778889999999999999999999999999998864

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-40  Score=257.81  Aligned_cols=201  Identities=23%  Similarity=0.310  Sum_probs=163.1

Q ss_pred             HHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREIT-VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|.. +++.++||||+++++.+......|+||||+.+++|..++....   .+++..+..++.|++.||.|||+.  
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  115 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL--  115 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3445544 4577899999999999999999999999999999999887543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       116 -givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~  194 (323)
T cd05575         116 -NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP  194 (323)
T ss_pred             -CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCC
Confidence             9999999999999999999999999998754333333344568999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      ||....      .......+.......    ....+..+.++|.+||+.||.+||++.
T Consensus       195 pf~~~~------~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         195 PFYSRD------TAEMYDNILNKPLRL----KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCC------HHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            985322      222333333322211    123456789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=247.03  Aligned_cols=212  Identities=27%  Similarity=0.418  Sum_probs=171.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++|+||+++++.+......|++||++.+++|.+++....  ..++...+..++.|++.|+.|||+. 
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~-  120 (262)
T cd06613          44 FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET-  120 (262)
T ss_pred             HHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999887542  2388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC---CcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.   .++.++|+||+|+++|+|+
T Consensus       121 --~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~  198 (262)
T cd06613         121 --GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA  198 (262)
T ss_pred             --CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence              99999999999999999999999999987655433233345677889999998776   7888999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||......      ........... +.........+.++.+++.+||..+|.+|||+.++++
T Consensus       199 tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         199 ELQPPMFDLHPM------RALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hCCCCCCCCCHH------HHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999997532211      11111111111 1111122355678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=282.31  Aligned_cols=213  Identities=27%  Similarity=0.448  Sum_probs=178.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----SAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ..+|.+|..+|+.++||||+++++++-+....+|++|||.||+|..+++...    ....+.+...+.++.++|+|..||
T Consensus       739 ~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL  818 (1025)
T KOG1095|consen  739 VSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL  818 (1025)
T ss_pred             HHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH
Confidence            5689999999999999999999999999999999999999999999998751    123488999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCcee--cccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE--FAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      +++   +++||||..+|+|++....+||.|||+++.+.........  -..+..|||||.+....++.++||||||+++|
T Consensus       819 e~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllW  895 (1025)
T KOG1095|consen  819 ESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLW  895 (1025)
T ss_pred             HhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHH
Confidence            999   9999999999999999999999999999965443333211  23467899999999999999999999999999


Q ss_pred             HHHh-CCCCccccccccCCCchhhhh-hhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          156 EVIK-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       156 ~~~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+++ |..||+.....      +... -...+++++    ...++..++++|.+||+.+|.+||++..|++.+.
T Consensus       896 EifslG~~PY~~~~n~------~v~~~~~~ggRL~~----P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  896 EIFSLGATPYPSRSNF------EVLLDVLEGGRLDP----PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             HHHhCCCCCCCCcchH------HHHHHHHhCCccCC----CCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            9998 99998754433      2222 222233332    2467778999999999999999999999998764

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.7e-40  Score=252.34  Aligned_cols=214  Identities=23%  Similarity=0.392  Sum_probs=171.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-------------CCCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-------------TSAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~~~   68 (228)
                      ..+.+|+++++++ +|+||+++++++..+...+++|||+.+++|.+++...             .....+++..++.++.
T Consensus        60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  139 (293)
T cd05053          60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY  139 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence            4578899999999 8999999999999999999999999999999998643             2234588999999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||+|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|
T Consensus       140 qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  216 (293)
T cd05053         140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD  216 (293)
T ss_pred             HHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccc
Confidence            999999999999   9999999999999999999999999998865432211  11123456799999988888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ||||||++|++++ |..||....      ................   ....+..+.+++.+||..||.+|||+.++++.
T Consensus       217 i~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         217 VWSFGVLLWEIFTLGGSPYPGIP------VEELFKLLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             eeehhhHHHHHhcCCCCCCCCCC------HHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999999999997 889875322      1122222222211111   12345578899999999999999999999999


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       288 l~~  290 (293)
T cd05053         288 LDR  290 (293)
T ss_pred             HHH
Confidence            863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.1e-40  Score=251.69  Aligned_cols=218  Identities=24%  Similarity=0.436  Sum_probs=171.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------AEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~   73 (228)
                      ++.+.+|++++++++|+||+++++++..+...++++|++.+++|.+++.....        ...+++..++.++.|++.|
T Consensus        63 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a  142 (296)
T cd05051          63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG  142 (296)
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence            35688999999999999999999999998999999999999999999876431        1247899999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |+|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++||||||
T Consensus       143 l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  219 (296)
T cd05051         143 MRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG  219 (296)
T ss_pred             HHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhH
Confidence            9999999   9999999999999999999999999998764332211  2233456789999998888899999999999


Q ss_pred             HHHHHHHh--CCCCccccccccCCCchhhhhhhcCC----CCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          152 VLALEVIK--GKHPRDFLSNVSSSNPNILVNEMLDP----RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       152 ~~l~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +++|++++  +..||.....      ..........    ............+.++.+++.+||+.||.+|||+.++++.
T Consensus       220 ~~l~el~~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~  293 (296)
T cd05051         220 VTLWEILTLCREQPYEHLTD------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF  293 (296)
T ss_pred             HHHHHHHhcCCCCCCCCcCh------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence            99999997  6677643221      1111111110    0000011112345689999999999999999999999999


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       294 L~~  296 (296)
T cd05051         294 LQR  296 (296)
T ss_pred             hcC
Confidence            874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-41  Score=262.56  Aligned_cols=209  Identities=23%  Similarity=0.301  Sum_probs=170.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++..++|+||+++++.+.++...|+||||+.+++|.+++...   ..++...+..++.|++.||.|||+.  
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~--  120 (350)
T cd05573          46 AHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL--  120 (350)
T ss_pred             HHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            45788999999999999999999999999999999999999999998765   2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC-----------------------------CCceecccccceeCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-----------------------------SNWTEFAGTYGYVAP  133 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------~~~~~~~~~~~y~aP  133 (228)
                       |++||||||+||+++.++.++|+|||++.......                             .......|++.|+||
T Consensus       121 -giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (350)
T cd05573         121 -GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP  199 (350)
T ss_pred             -CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence             99999999999999999999999999988665433                             112345688999999


Q ss_pred             cccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          134 ELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       134 E~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |++.+..++.++|||||||++|+|++|..||....      .......+...............+..+.++|.+||. ||
T Consensus       200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp  272 (350)
T cd05573         200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT------LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DP  272 (350)
T ss_pred             HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC------HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Ch
Confidence            99999999999999999999999999999986432      222222222210000000111256778999999997 99


Q ss_pred             CCCCC-HHHHHH
Q 040501          214 ESRPN-MQTICQ  224 (228)
Q Consensus       214 ~~Rpt-~~~il~  224 (228)
                      .+||+ ++++++
T Consensus       273 ~~R~~s~~~ll~  284 (350)
T cd05573         273 EDRLGSFEEIKS  284 (350)
T ss_pred             hhcCCCHHHHhc
Confidence            99999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.4e-40  Score=246.44  Aligned_cols=214  Identities=24%  Similarity=0.424  Sum_probs=172.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++|+||+++++.+.. ...++++|++.+++|.+++..... ..+++..++.++.|++.||.+||+. 
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~-  116 (257)
T cd05040          40 MDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK-  116 (257)
T ss_pred             HHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC-
Confidence            3578899999999999999999999988 889999999999999999876543 3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++|+|||.+.........   .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       117 --~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~  194 (257)
T cd05040         117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF  194 (257)
T ss_pred             --CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence              9999999999999999999999999998876543222   11234567899999998888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      + |..||.....      ......+...... .. .....+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus       195 t~g~~p~~~~~~------~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         195 TYGEEPWAGLSG------SQILKKIDKEGER-LE-RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             hCCCCCCCCCCH------HHHHHHHHhcCCc-CC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            8 9999753221      1122211111110 00 112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-40  Score=257.91  Aligned_cols=203  Identities=23%  Similarity=0.281  Sum_probs=163.3

Q ss_pred             HHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            5 FLREIT-VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         5 ~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      +..|.. +++.++|+||+++++++......|+||||+.+++|.+++....   .++...+..++.|++.||.|||+.   
T Consensus        42 ~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---  115 (325)
T cd05602          42 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---  115 (325)
T ss_pred             HHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            344443 4677899999999999999999999999999999999887543   277888889999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       116 giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  195 (325)
T cd05602         116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP  195 (325)
T ss_pred             CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCC
Confidence            99999999999999999999999999987543333333445789999999999998899999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |....      .......+.......    ....+..+.+++.+||+.||.+||++.+.+
T Consensus       196 f~~~~------~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         196 FYSRN------TAEMYDNILNKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCC------HHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            85322      222222332222211    124556788999999999999999987443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=271.48  Aligned_cols=210  Identities=23%  Similarity=0.346  Sum_probs=168.7

Q ss_pred             HHHHHHHHHhccC-CCccceeeeee-ee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFC-TH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~-~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+++|+.|+ |+|||.+++.. ..      ...++++||||.|+.|-+++....... +++.++++|++++++|++
T Consensus        80 ~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa  158 (738)
T KOG1989|consen   80 AVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVA  158 (738)
T ss_pred             HHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHH
Confidence            4679999999996 99999999943 21      135789999999999999988654433 999999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---------eecccccceeCCcccc---cCCccc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---------TEFAGTYGYVAPELAY---TMKVTA  143 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---------~~~~~~~~y~aPE~~~---~~~~~~  143 (228)
                      +||.. +..|+|||||-+|||++.+|..||||||.++.........         ....-|+.|+|||++.   +...++
T Consensus       159 ~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~e  237 (738)
T KOG1989|consen  159 AMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGE  237 (738)
T ss_pred             HHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcc
Confidence            99998 2359999999999999999999999999887654333211         1134588999999864   667899


Q ss_pred             chhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |+|||+|||+||-++....||+....          ..++........  ...++..+.+||+.||+.||.+||++.+++
T Consensus       238 KsDIWALGclLYkLCy~t~PFe~sg~----------laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~  305 (738)
T KOG1989|consen  238 KSDIWALGCLLYKLCYFTTPFEESGK----------LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVL  305 (738)
T ss_pred             hhHHHHHHHHHHHHHHhCCCcCcCcc----------eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHH
Confidence            99999999999999999999874322          223333332211  147888899999999999999999999999


Q ss_pred             HHhh
Q 040501          224 QLLC  227 (228)
Q Consensus       224 ~~l~  227 (228)
                      +.+.
T Consensus       306 ~~~~  309 (738)
T KOG1989|consen  306 EEIF  309 (738)
T ss_pred             HHHH
Confidence            8875

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.3e-40  Score=247.29  Aligned_cols=210  Identities=25%  Similarity=0.373  Sum_probs=172.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++.+..+...|+++||+++++|.+++.... ...++...++.++.|++.|+.+||+.  
T Consensus        43 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~--  119 (255)
T cd08219          43 EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK--  119 (255)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence            567889999999999999999999999999999999999999998886432 23378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++++|||.+..............+++.|+|||++.+..++.++|+||+|+++|+|++|..
T Consensus       120 -~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~  198 (255)
T cd08219         120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH  198 (255)
T ss_pred             -CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccC
Confidence             9999999999999999999999999998766543333344567888999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ||....      ................+   ...+..+.+++.+||+.||.+|||+.+++..
T Consensus       199 p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         199 PFQANS------WKNLILKVCQGSYKPLP---SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCC------HHHHHHHHhcCCCCCCC---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            986322      12222233222222221   2344568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.4e-40  Score=255.50  Aligned_cols=204  Identities=25%  Similarity=0.350  Sum_probs=165.0

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|..++... +|++|+++++++......|+||||+.+++|..++....   .++..++..++.|++.||+|||+.  
T Consensus        41 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  115 (316)
T cd05620          41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK--  115 (316)
T ss_pred             HHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            456778888765 89999999999999999999999999999998887543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       116 -~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~  194 (316)
T cd05620         116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             -CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCC
Confidence             9999999999999999999999999988754333333445678999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ-TIC  223 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il  223 (228)
                      ||....      .......+.... +..+   ...+.++.+++.+||+.||.+||++. +++
T Consensus       195 Pf~~~~------~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         195 PFHGDD------EDELFESIRVDT-PHYP---RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCC------HHHHHHHHHhCC-CCCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            986332      122222222111 1111   12455788999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-40  Score=249.22  Aligned_cols=212  Identities=26%  Similarity=0.391  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++++......|+|+||+++++|.+++....   .++...+..++.|++.|+.|||+.  
T Consensus        51 ~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  125 (267)
T cd06646          51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK--  125 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            356789999999999999999999999999999999999999999886543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+|++|+||+++.++.++|+|||.+..............++..|+|||.+.   ...++.++|+||+|+++|+|++
T Consensus       126 -~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~  204 (267)
T cd06646         126 -GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE  204 (267)
T ss_pred             -CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence             999999999999999999999999999886643333333456778999999874   3346789999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |..||........      ......... +.........+..+.+++++||..+|.+|||++++++.|
T Consensus       205 g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         205 LQPPMFDLHPMRA------LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCccccchhhh------heeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            9999753322111      011111111 111111124556789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.2e-40  Score=249.57  Aligned_cols=213  Identities=20%  Similarity=0.346  Sum_probs=172.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVIKG   69 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~~   69 (228)
                      +.+.+|+.++..++||||+++++++......++++||+.+++|.+++....             ....++...+..++.|
T Consensus        53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  132 (283)
T cd05091          53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ  132 (283)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence            567899999999999999999999999999999999999999999985321             1223778888999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhh
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      ++.||.|||+.   |++||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||
T Consensus       133 l~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  209 (283)
T cd05091         133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI  209 (283)
T ss_pred             HHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhH
Confidence            99999999999   9999999999999999999999999988765432211  122345678999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||||+++|+|++ |..||...      ........+.........   ..++..+.+++.+||+.+|.+|||+++++..|
T Consensus       210 ~slG~~l~el~~~g~~p~~~~------~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l  280 (283)
T cd05091         210 WSYGVVLWEVFSYGLQPYCGY------SNQDVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL  280 (283)
T ss_pred             HHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence            999999999998 88887532      222334444343332222   24667789999999999999999999999998


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       281 ~  281 (283)
T cd05091         281 R  281 (283)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=251.23  Aligned_cols=214  Identities=24%  Similarity=0.413  Sum_probs=171.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++++ +|+||+++++++......|++|||+.+++|.+++..... ..+++.++..++.|++.||.|||+. 
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-  160 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK-  160 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4688999999999 799999999999999999999999999999999875332 2378999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        +++|+||+|+||+++.++.++++|||.+.........  .....++..|+|||.+.+..++.++||||+|+++|++++
T Consensus       161 --~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t  238 (302)
T cd05055         161 --NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS  238 (302)
T ss_pred             --CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence              9999999999999999999999999998765433211  112345678999999988889999999999999999998


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||.....      ...............  .....+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       239 ~g~~p~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         239 LGSNPYPGMPV------DSKFYKLIKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CCCCCcCCCCc------hHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence             9999754321      111111111111110  011234578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.2e-40  Score=247.55  Aligned_cols=209  Identities=26%  Similarity=0.390  Sum_probs=167.3

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+.+++.++||||+++++.+......|+++||+.+++|.+++....   .+++.+++.++.|++.++.|||+.   
T Consensus        52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---  125 (267)
T cd06645          52 VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---  125 (267)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46789999999999999999999999999999999999999999986543   388999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHhC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                      |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.   ...++.++|+||||+++|+|++|
T Consensus       126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~  205 (267)
T cd06645         126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL  205 (267)
T ss_pred             CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence            999999999999999999999999999876654333334456888999999874   34578899999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||.......      .......... +........++..+.+++.+||..+|.+|||++++++
T Consensus       206 ~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         206 QPPMFDLHPMR------ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCcccccchh------hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            99975332111      1111111111 1111111234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.8e-40  Score=250.52  Aligned_cols=214  Identities=26%  Similarity=0.445  Sum_probs=171.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC---------------------CCCCCCHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---------------------SAEELGWS   61 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~   61 (228)
                      +++.+|+++++.++||||+++++.+......++++||+.+++|.+++....                     ....++..
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  127 (290)
T cd05045          48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG  127 (290)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence            467889999999999999999999999999999999999999999876421                     11247889


Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccC
Q 040501           62 RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTM  139 (228)
Q Consensus        62 ~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  139 (228)
                      +++.++.|++.||.|||+.   |++|+||+|+||++++++.++|+|||.+.........  .....++..|+|||.+.+.
T Consensus       128 ~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  204 (290)
T cd05045         128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH  204 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence            9999999999999999999   9999999999999999999999999998755332221  1223456689999998888


Q ss_pred             CcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          140 KVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       140 ~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      .++.++||||||+++|+|++ |..||....      ................   ....+.++.+++.+||+.+|.+|||
T Consensus       205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~  275 (290)
T cd05045         205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA------PERLFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPT  275 (290)
T ss_pred             CcchHhHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCC
Confidence            89999999999999999998 999975332      1122222211111111   1245567899999999999999999


Q ss_pred             HHHHHHHhhC
Q 040501          219 MQTICQLLCK  228 (228)
Q Consensus       219 ~~~il~~l~~  228 (228)
                      ++++++.|++
T Consensus       276 ~~~i~~~l~~  285 (290)
T cd05045         276 FADISKELEK  285 (290)
T ss_pred             HHHHHHHHHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=263.22  Aligned_cols=202  Identities=23%  Similarity=0.355  Sum_probs=173.5

Q ss_pred             ChHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            1 DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      |.+..+.|.+++... +||.++.++..|+..+++|+||||+.||++..+++.    ..+++.++..++..|+.||.|||+
T Consensus       411 ~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~  486 (694)
T KOG0694|consen  411 EVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHE  486 (694)
T ss_pred             cHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHh
Confidence            356778899999888 599999999999999999999999999996555442    239999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      .   ||++||||.+||+++.+|.+||.|||+++..........+++|||.|+|||++.+..|+.++|.||||++||+|+.
T Consensus       487 ~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~  563 (694)
T KOG0694|consen  487 N---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV  563 (694)
T ss_pred             c---CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc
Confidence            9   9999999999999999999999999999976655556677999999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      |..||...      +..+....++.....    .....+.+...+++++|.+||.+|.-+
T Consensus       564 Gq~PF~gd------dEee~FdsI~~d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  564 GESPFPGD------DEEEVFDSIVNDEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCCCC------CHHHHHHHHhcCCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence            99997643      344555555444332    124566688999999999999999765

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-39  Score=250.84  Aligned_cols=212  Identities=25%  Similarity=0.375  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~   68 (228)
                      +.+.+|++++.++ +||||+++++++......|+++||+++++|.+++....             ....++...++.++.
T Consensus        47 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  126 (297)
T cd05089          47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS  126 (297)
T ss_pred             HHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHH
Confidence            4678899999999 79999999999999899999999999999999986532             112478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      |++.||++||+.   |++|+||||+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|||
T Consensus       127 qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  202 (297)
T cd05089         127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVW  202 (297)
T ss_pred             HHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHH
Confidence            999999999999   99999999999999999999999999886432111 11112234579999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||+++|+|++ |..||.....      ................   ..++.++.+++.+||+.+|.+|||++++++.|+
T Consensus       203 SlG~il~el~t~g~~pf~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         203 SFGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999997 9999854322      2222223222211111   235567899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-39  Score=244.64  Aligned_cols=212  Identities=25%  Similarity=0.468  Sum_probs=169.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|++++++++|+|++++++++.. ...+++||++.+++|.+++.... ...+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~--  121 (260)
T cd05069          46 EAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM--  121 (260)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            568899999999999999999988754 56889999999999999987543 23478899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||+|+||++++++.++|+|||.+......... .....++..|+|||...+..++.++|+||||+++|++++ |
T Consensus       122 -~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g  200 (260)
T cd05069         122 -NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             -CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999998765433221 122345667999999988889999999999999999999 8


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||.....      ......+........   ....+..+.+++.+||+.||.+|||++++++.|++
T Consensus       201 ~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         201 RVPYPGMVN------REVLEQVERGYRMPC---PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCCCH------HHHHHHHHcCCCCCC---CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            999764321      122222222211111   12456679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.9e-39  Score=245.01  Aligned_cols=213  Identities=25%  Similarity=0.470  Sum_probs=170.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.++++++|++++++++++.. ...|++||++.+++|.+++..... ..+++.+++.++.|++.||.|||+. 
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~-  121 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM-  121 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578999999999999999999998754 568899999999999999875432 3478999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ 
T Consensus       122 --~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~  199 (260)
T cd05070         122 --NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK  199 (260)
T ss_pred             --CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence              9999999999999999999999999999765433221 112234567999999888889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||....      .......+......+..   ...+..+.+++.+||..+|.+|||++++.+.|++
T Consensus       200 g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         200 GRVPYPGMN------NREVLEQVERGYRMPCP---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            899985422      22222333222111111   2455679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=244.84  Aligned_cols=210  Identities=27%  Similarity=0.428  Sum_probs=169.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.+.|+||+++++++. ....+++||++.+++|.+++....   .+++..++.++.|++.++++||+.  
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~--  114 (257)
T cd05060          41 KEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK--  114 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc--
Confidence            56889999999999999999999876 456899999999999999997654   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCcee---cccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE---FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       +++|+||+|+||+++.++.++|+|||.+............   ..++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       115 -~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~  193 (257)
T cd05060         115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS  193 (257)
T ss_pred             -CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence             9999999999999999999999999998866543332111   122457999999988889999999999999999997


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||.....      ......+.......   ....++..+.+++.+||..+|.+|||+.++++.|++
T Consensus       194 ~g~~p~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         194 YGAKPYGEMKG------AEVIAMLESGERLP---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CCCCCcccCCH------HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             9999854321      11222221111111   112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.5e-40  Score=250.57  Aligned_cols=218  Identities=19%  Similarity=0.248  Sum_probs=166.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++++..+...|+||||+. ++|.+++........++...+..++.|++.||.|||+.  
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--  120 (285)
T cd07861          44 STAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--  120 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            467889999999999999999999999999999999997 57888876544445589999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|++++|.
T Consensus       121 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  199 (285)
T cd07861         121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK  199 (285)
T ss_pred             -CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence             99999999999999999999999999987654433333334567889999987654 4688999999999999999999


Q ss_pred             CCccccccccCCCc------------------hhhhhhhcCC-CCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          162 HPRDFLSNVSSSNP------------------NILVNEMLDP-RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       162 ~p~~~~~~~~~~~~------------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .||...........                  .......... ............+.++.++|.+||..||.+|||+.++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l  279 (285)
T cd07861         200 PLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA  279 (285)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            99864321100000                  0000000000 0000011122356678899999999999999999998


Q ss_pred             HH
Q 040501          223 CQ  224 (228)
Q Consensus       223 l~  224 (228)
                      ++
T Consensus       280 l~  281 (285)
T cd07861         280 LN  281 (285)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-40  Score=251.14  Aligned_cols=220  Identities=22%  Similarity=0.385  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------CCCCCHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------AEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~l~~~   73 (228)
                      +.|.+|++++++++|+|++++++++......++||||+.+++|.+++.....         ...+++.+++.++.|++.|
T Consensus        62 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  141 (295)
T cd05097          62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG  141 (295)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence            4688999999999999999999999999999999999999999998864321         1236788899999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |.|||+.   |++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||
T Consensus       142 l~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG  218 (295)
T cd05097         142 MKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG  218 (295)
T ss_pred             HHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHH
Confidence            9999999   9999999999999999999999999998765332211  1123346789999999888899999999999


Q ss_pred             HHHHHHHh--CCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIK--GKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|+|++  +..||.......   ............ ...........+..+.+++.+||+.||.+|||++++++.|++
T Consensus       219 ~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         219 VTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            99999988  566765322111   000000000000 000001112345679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.5e-40  Score=253.52  Aligned_cols=204  Identities=25%  Similarity=0.344  Sum_probs=164.9

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|..+++.. +||||+++++++.+....|+||||+.+++|.+++....   .+++.++..++.|++.||.|||+.  
T Consensus        41 ~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~--  115 (316)
T cd05619          41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK--  115 (316)
T ss_pred             HHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            456788888765 89999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus       116 -~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~  194 (316)
T cd05619         116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             -CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence             9999999999999999999999999998754333333344568899999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ-TIC  223 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il  223 (228)
                      ||....      .......+..... ..+   ...+.++.+++.+||+.||.+||++. +++
T Consensus       195 pf~~~~------~~~~~~~i~~~~~-~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         195 PFHGHD------EEELFQSIRMDNP-CYP---RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCCCCC------HHHHHHHHHhCCC-CCC---ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            986432      1222222211111 111   12455688999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=245.29  Aligned_cols=208  Identities=24%  Similarity=0.335  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++..+...++++|++++++|.+++....   .++...+..++.|++.||.+||+.  
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--  123 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN--  123 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            467889999999999999999999999999999999999999999887543   378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+.........   .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       124 -~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  202 (263)
T cd06625         124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT  202 (263)
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh
Confidence             9999999999999999999999999998754322111   123456788999999998889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCC-CCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDP-RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |+.||.....      .......... .....   ....+..+.+++.+||..+|.+|||+.++++.
T Consensus       203 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         203 EKPPWAEFEA------MAAIFKIATQPTNPQL---PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCccccch------HHHHHHHhccCCCCCC---CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            9999753221      1111111111 11111   12455678999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-39  Score=245.66  Aligned_cols=213  Identities=26%  Similarity=0.481  Sum_probs=172.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.++++++||||+++++++..+...|++|||+++++|.+++.....  .++..+++.++.|++.|+.+||+. 
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~-  125 (267)
T cd05066          49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM-  125 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35788999999999999999999999999999999999999999999976542  378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce---ecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++++|||.+...........   ...++..|++||.+.+..++.++|+||||+++|+++
T Consensus       126 --~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell  203 (267)
T cd05066         126 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  203 (267)
T ss_pred             --CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence              999999999999999999999999999886653322211   112345799999998888999999999999999988


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      + |..||.....      ......+......+.   ....+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       204 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         204 SYGERPYWEMSN------QDVIKAIEEGYRLPA---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             cCCCCCcccCCH------HHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            6 9999753321      112222222211111   12345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-39  Score=250.33  Aligned_cols=221  Identities=23%  Similarity=0.393  Sum_probs=169.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------AEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~   73 (228)
                      ++.+.+|+++++.++|+||+++++++..+...+++|||+.+++|.+++.....        ...+++.+++.++.|++.|
T Consensus        63 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a  142 (296)
T cd05095          63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG  142 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence            35688999999999999999999999999999999999999999999875331        1236778899999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |+|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|++||...+..++.++|+||||
T Consensus       143 l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG  219 (296)
T cd05095         143 MKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG  219 (296)
T ss_pred             HHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHH
Confidence            9999999   9999999999999999999999999998765332211  1122345689999988888899999999999


Q ss_pred             HHHHHHHh--CCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIK--GKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|+|++  |..||.........   .......... ..........++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       220 ~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         220 VTLWEILTLCKEQPYSQLSDEQVI---ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHhCCCCCccccChHHHH---HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            99999998  67787533211100   0000000000 000000012344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=260.34  Aligned_cols=209  Identities=22%  Similarity=0.255  Sum_probs=166.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++..+...|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--  120 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL--  120 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346789999999999999999999999999999999999999999987543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--------------------------------------ceec
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--------------------------------------WTEF  124 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------------------------------------~~~~  124 (228)
                       |++||||||+||+++.++.++|+|||++.........                                      ....
T Consensus       121 -~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (364)
T cd05599         121 -GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST  199 (364)
T ss_pred             -CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence             9999999999999999999999999988754321100                                      0123


Q ss_pred             ccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHH
Q 040501          125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       125 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                      .|++.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+...............+.++.++
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  273 (364)
T cd05599         200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP------QETYRKIINWKETLQFPDEVPLSPEAKDL  273 (364)
T ss_pred             ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH------HHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence            588999999999988899999999999999999999999864322      22222222211111101112345678899


Q ss_pred             HHHhhccCCCCCCC---HHHHHH
Q 040501          205 AFLCLDNNPESRPN---MQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt---~~~il~  224 (228)
                      |.+|+. +|.+|++   ++++++
T Consensus       274 i~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         274 IKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHcc-CHhhcCCCCCHHHHhc
Confidence            999996 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=246.69  Aligned_cols=213  Identities=24%  Similarity=0.380  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++++ +||||+++++++......|++|||+++++|.+++....             ....++..++..++.
T Consensus        40 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  119 (270)
T cd05047          40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  119 (270)
T ss_pred             HHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHH
Confidence            4677899999999 79999999999999999999999999999999986532             122478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      |++.||+|||+.   |++|+||||+||+++.++.++++|||++...... ........+..|+|||++....++.++|+|
T Consensus       120 ~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~  195 (270)
T cd05047         120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVW  195 (270)
T ss_pred             HHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHH
Confidence            999999999999   9999999999999999999999999987532211 111112235579999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||+++|+|++ |..||.....      ......+........   ....+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       196 slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         196 SYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             HHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCCCCCC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            99999999997 9999854321      122222222111111   1234457889999999999999999999999886


Q ss_pred             C
Q 040501          228 K  228 (228)
Q Consensus       228 ~  228 (228)
                      +
T Consensus       267 ~  267 (270)
T cd05047         267 R  267 (270)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-39  Score=246.01  Aligned_cols=215  Identities=27%  Similarity=0.433  Sum_probs=171.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----SAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ...+.+|+++++.++||||+++++++......++++|++++++|.+++....    ....+++.+++.++.|++.|+.||
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  122 (269)
T cd05044          43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL  122 (269)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999999899999999999999999987532    223478899999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCC-----ceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEY-----EAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSF  150 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~-----~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  150 (228)
                      |+.   +++|+||+|+||+++.++     .++++|||++.........  .....++..|+|||.+.+..++.++|||||
T Consensus       123 H~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  199 (269)
T cd05044         123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF  199 (269)
T ss_pred             HhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence            999   999999999999999887     8999999998755322211  122344678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          151 GVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       151 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |+++|+|++ |..||.....      ......+.......   .....+..+.+++.+||..+|.+|||++++++.|++
T Consensus       200 G~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         200 GVLMWEILTLGQQPYPALNN------QEVLQHVTAGGRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHHHHHcCCCCCcccCH------HHHHHHHhcCCccC---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            999999998 9999863321      11222221111111   112456678999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-39  Score=247.81  Aligned_cols=210  Identities=23%  Similarity=0.373  Sum_probs=167.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++......|+++||+++++|..++....  ..+++..+..++.|++.||.|||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--  122 (282)
T cd06643          47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN--  122 (282)
T ss_pred             HHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            467889999999999999999999999999999999999999988876432  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~  157 (228)
                       |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.     +..++.++|+||+|+++|+|
T Consensus       123 -~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el  201 (282)
T cd06643         123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM  201 (282)
T ss_pred             -CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHH
Confidence             999999999999999999999999999876543333333456788999999874     34467899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ............+... ....++.++.++|.+||+.||.+|||+.++++
T Consensus       202 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         202 AQIEPPHHELNP------MRVLLKIAKSEPPTLA-QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccCCCCccccCH------HHHHHHHhhcCCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999754321      1122222211111111 11234567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-40  Score=259.16  Aligned_cols=210  Identities=22%  Similarity=0.264  Sum_probs=168.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++++......|+||||+.+++|.+++....  ..+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~--  121 (330)
T cd05601          46 SFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM--  121 (330)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999997653  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccc------cCCcccchhhhhHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAY------TMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~  155 (228)
                       |++||||||+||+++.++.++|+|||++......... .....+++.|+|||++.      +..++.++||||||+++|
T Consensus       122 -~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~  200 (330)
T cd05601         122 -GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY  200 (330)
T ss_pred             -CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence             9999999999999999999999999999866533322 23346889999999886      345678999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|++|..||.....      ......+...............+.++.+++.+||. +|.+|||+.++++
T Consensus       201 el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         201 EMIYGRSPFHEGTS------AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             eeccCCCCCCCCCH------HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            99999999864322      12222222211110011112456678899999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-40  Score=257.18  Aligned_cols=202  Identities=23%  Similarity=0.327  Sum_probs=163.7

Q ss_pred             HHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREIT-VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|.. +++.++||||+++++.+......|+||||+.+++|..++....   .+++..+..++.|++.||.|||+.  
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~--  115 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI--  115 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3455554 4667899999999999999999999999999999988886543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       116 -givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~  194 (325)
T cd05604         116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             -CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCC
Confidence             9999999999999999999999999998754333333344578999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ||....      .......+........    ...+..+.+++.+||+.+|.+||++.+
T Consensus       195 pf~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         195 PFYCRD------VAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCC------HHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            985322      2223333333222111    234557889999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-40  Score=250.83  Aligned_cols=211  Identities=23%  Similarity=0.247  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.++++++|+||+++++.+..+...++||||+.+++|.+++.... ...+++..+..++.|++.|+.|||+.  
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--  121 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE--  121 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346789999999999999999999999999999999999999998876432 23488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||++++++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       122 -~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~  199 (285)
T cd05605         122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS  199 (285)
T ss_pred             -CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCC
Confidence             99999999999999999999999999987654222 2233467889999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||.......   ...............   .....+..+.+++.+||+.||.+||     +++++++
T Consensus       200 pf~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         200 PFRQRKEKV---KREEVERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CCCCCchhh---HHHHHHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            986432111   101111111111111   1123566789999999999999999     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.7e-40  Score=251.70  Aligned_cols=212  Identities=24%  Similarity=0.373  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|++++.++ +|+||+++++++..+...|+++||+++++|.+++.....             ...++..+++.++.
T Consensus        52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  131 (303)
T cd05088          52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  131 (303)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHH
Confidence            4678899999999 899999999999999999999999999999999875321             23478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVY  148 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  148 (228)
                      |++.|++|||+.   |++||||||+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|||
T Consensus       132 qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  207 (303)
T cd05088         132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVW  207 (303)
T ss_pred             HHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccch
Confidence            999999999999   99999999999999999999999999886322111 11112335679999998888889999999


Q ss_pred             hHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          149 SFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||+++|++++ |..||.....      ...............   ....+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       208 slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         208 SYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             hhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999998 9999853322      122222222111111   1234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-39  Score=253.79  Aligned_cols=201  Identities=22%  Similarity=0.302  Sum_probs=164.1

Q ss_pred             HHHHHHHHHHhccCC-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|.+++..+.| ++|+++++++...+..|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~-  120 (324)
T cd05587          45 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK-  120 (324)
T ss_pred             HHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            456789999999965 568889999999999999999999999999886543   278899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||+||++|+|++|.
T Consensus       121 --~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  198 (324)
T cd05587         121 --GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  198 (324)
T ss_pred             --CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence              999999999999999999999999999875433333344567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||....      .......+.......    ....+.++.+++.+||..||.+|++.
T Consensus       199 ~pf~~~~------~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         199 PPFDGED------EDELFQSIMEHNVSY----PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCC------HHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            9985322      222333333222211    12345678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.8e-39  Score=245.05  Aligned_cols=213  Identities=27%  Similarity=0.484  Sum_probs=171.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+..|+++++.++|+||+++++++......|++||++++++|.+++....  ..+++.++..++.|++.|++|||+. 
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~-  126 (268)
T cd05063          50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM-  126 (268)
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999999999999999999999999999987543  2378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce---ecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++++|||++...........   ....+..|+|||.+.+..++.++|+||||+++|+++
T Consensus       127 --~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell  204 (268)
T cd05063         127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  204 (268)
T ss_pred             --CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence              999999999999999999999999999876543222111   112345799999998888899999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      + |..||....      .......+......+.   ....+..+.+++.+||..+|.+||++.++++.|++
T Consensus       205 ~~g~~p~~~~~------~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         205 SFGERPYWDMS------NHEVMKAINDGFRLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             hCCCCCCCcCC------HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            7 999975322      1222233222211111   12345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-39  Score=249.99  Aligned_cols=208  Identities=27%  Similarity=0.431  Sum_probs=168.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++.+..+...|+|+||+.+++|.+++...    .++..++..++.|++.||.|||+.  
T Consensus        62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~--  135 (296)
T cd06654          62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN--  135 (296)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46788999999999999999999999999999999999999999998643    278889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       136 -gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~  214 (296)
T cd06654         136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP  214 (296)
T ss_pred             -CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999988765433333334567889999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.......     .......... +.. ......+..+.+++.+||..+|.+|||+.++++
T Consensus       215 pf~~~~~~~-----~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         215 PYLNENPLR-----ALYLIATNGT-PEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCCHHH-----hHHHHhcCCC-CCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            985332111     1111111111 111 111245567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-39  Score=258.52  Aligned_cols=216  Identities=24%  Similarity=0.396  Sum_probs=170.6

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      ++.+.+|+++++++. ||||+++++++......|+||||+.+++|.+++.....                          
T Consensus        84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (400)
T cd05105          84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST  163 (400)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence            457889999999995 99999999999999999999999999999988754210                          


Q ss_pred             -------------------------------------------------------------------CCCCCHHHHHHHH
Q 040501           55 -------------------------------------------------------------------AEELGWSRRINVI   67 (228)
Q Consensus        55 -------------------------------------------------------------------~~~~~~~~~~~~~   67 (228)
                                                                                         ...+++..+..++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~  243 (400)
T cd05105         164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT  243 (400)
T ss_pred             cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence                                                                               1236778888999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccch
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKC  145 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  145 (228)
                      .|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++
T Consensus       244 ~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  320 (400)
T cd05105         244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLS  320 (400)
T ss_pred             HHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchh
Confidence            9999999999999   9999999999999999999999999998765432221  1223456789999999888899999


Q ss_pred             hhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          146 DVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       146 DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||||+++|+|++ |..||......     ......+........   ....+..+.+++.+||+.+|.+|||+.++.+
T Consensus       321 DiwSlGvil~ellt~g~~P~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         321 DVWSYGILLWEIFSLGGTPYPGMIVD-----STFYNKIKSGYRMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hHHHHHHHHHHHHHCCCCCCcccchh-----HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            99999999999997 99997643211     111111111111111   1245567899999999999999999999999


Q ss_pred             HhhC
Q 040501          225 LLCK  228 (228)
Q Consensus       225 ~l~~  228 (228)
                      .|++
T Consensus       393 ~l~~  396 (400)
T cd05105         393 IVES  396 (400)
T ss_pred             HHHH
Confidence            8864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-39  Score=249.87  Aligned_cols=214  Identities=22%  Similarity=0.390  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+.+++.+ +|+||+++++++......|++|||+.+++|.+++.....             ...+++.+++.++.
T Consensus        65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (304)
T cd05101          65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY  144 (304)
T ss_pred             HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence            4678999999999 899999999999999999999999999999999875321             23477888999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||.|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||++.+..++.++|
T Consensus       145 qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  221 (304)
T cd05101         145 QVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  221 (304)
T ss_pred             HHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence            999999999999   9999999999999999999999999998866432222  11223456799999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|++++ |..||....      .......+........   ...++..+.+++.+||+.+|.+|||+.++++.
T Consensus       222 i~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         222 VWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            9999999999998 788865322      2222222222221111   12456678999999999999999999999999


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       293 l~~  295 (304)
T cd05101         293 LDR  295 (304)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.1e-40  Score=255.19  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=161.9

Q ss_pred             HHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREIT-VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|.. +++.++|+||+++++.+......|+||||+.+++|...+....   .++..++..++.|++.||.|||+.  
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~--  115 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL--  115 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3455554 5778899999999999999999999999999999988886543   378888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.+||+|||++..............+++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus       116 -~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  194 (321)
T cd05603         116 -NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP  194 (321)
T ss_pred             -CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCC
Confidence             9999999999999999999999999998754322223334568899999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      ||....      .......+....... +   ...+..+.+++.+||+.||.+||++.
T Consensus       195 pf~~~~------~~~~~~~i~~~~~~~-~---~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         195 PFYSRD------VSQMYDNILHKPLQL-P---GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCC------HHHHHHHHhcCCCCC-C---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            985322      222333333322211 1   23455788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.2e-39  Score=244.00  Aligned_cols=213  Identities=25%  Similarity=0.441  Sum_probs=170.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++|+||+++++.+.. ...|++||++.+++|.+++.... ...+++..++.++.|++.||++||+. 
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~-  121 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM-  121 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999998754 56899999999999999997542 23378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+||||+++|++++ 
T Consensus       122 --~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~  199 (262)
T cd05071         122 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  199 (262)
T ss_pred             --CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence              9999999999999999999999999998765433221 122345667999999888889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||....      .......+........   ....+..+.+++.+||+.+|.+|||++++++.|+.
T Consensus       200 g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         200 GRVPYPGMV------NREVLDQVERGYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCCCCCCC------hHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            888875432      1122222222211111   13456678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3e-40  Score=255.76  Aligned_cols=203  Identities=23%  Similarity=0.297  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+..|-.+|....++.||+++..|++...+|+||||++||++..++.+...   +++..+..++.+++.||..+|+.  
T Consensus       186 ~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~--  260 (550)
T KOG0605|consen  186 EHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQL--  260 (550)
T ss_pred             HHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHc--
Confidence            3456788899988999999999999999999999999999999999976554   89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCC-----------------------CC-----C--------------
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-----------------------SS-----N--------------  120 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~-----------------------~~-----~--------------  120 (228)
                       |++||||||+|+|++..|++||+|||++......                       ..     .              
T Consensus       261 -gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~  339 (550)
T KOG0605|consen  261 -GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKR  339 (550)
T ss_pred             -CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHh
Confidence             9999999999999999999999999999643210                       00     0              


Q ss_pred             -----ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhh
Q 040501          121 -----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIR  195 (228)
Q Consensus       121 -----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (228)
                           .....|||.|+|||++.+.+|+..+|.|||||++|||+.|.+||-.      .++......+...+.........
T Consensus       340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s------~tp~~T~rkI~nwr~~l~fP~~~  413 (550)
T KOG0605|consen  340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS------ETPQETYRKIVNWRETLKFPEEV  413 (550)
T ss_pred             hhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHHHhhhccCCCcC
Confidence                 0123689999999999999999999999999999999999999753      44555555555544332222333


Q ss_pred             hhHHHHHHHHHHhhccCCCCCCC
Q 040501          196 GKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       196 ~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ..+.+..+||.+||. ||.+|.-
T Consensus       414 ~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  414 DLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             cccHHHHHHHHHHhc-CHHHhcC
Confidence            455788999999999 9999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=260.81  Aligned_cols=213  Identities=26%  Similarity=0.425  Sum_probs=178.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.|+.|+..+++-+|.||+-+.++|..... .||.-+|.|.+|+.+++...  ..+.+.+.+.|++|+++|+.|||.+  
T Consensus       433 qaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK--  507 (678)
T KOG0193|consen  433 QAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK--  507 (678)
T ss_pred             HHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh--
Confidence            679999999999999999999999988766 89999999999999997654  4499999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCccccc---CCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~~  157 (228)
                       +|+|+|||..|||+.++++|||+|||++...+.-.  .......+...|+|||+++.   ..|+..+||||+|+++|||
T Consensus       508 -~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YEL  586 (678)
T KOG0193|consen  508 -NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYEL  586 (678)
T ss_pred             -hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHH
Confidence             99999999999999999999999999998654321  22345677889999998874   3589999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ++|..||.      ..+....+..+-++.. +........++.++.+|+..||.+++++||++.+|+..|+
T Consensus       587 ltg~lPys------i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  587 LTGELPYS------IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             HhCcCCcC------CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            99999975      2233334444444432 3334445677889999999999999999999999999665

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-39  Score=246.90  Aligned_cols=214  Identities=26%  Similarity=0.383  Sum_probs=169.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS----AEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ..|.+|+.++++++|+||+++++++.+....+++|||+.+++|.+++.....    ...+++.+++.++.|++.|+.|||
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  133 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999988899999999999999999875432    124789999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC---ceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      +.   +++|+||+|+||+++.++   .++|+|||++.........  ......+..|+|||++.+..++.++|||||||+
T Consensus       134 ~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  210 (277)
T cd05036         134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL  210 (277)
T ss_pred             HC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence            99   999999999999998754   5899999998765322111  112233567999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +|+|++ |..||......      .....+........   ....+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       211 l~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         211 LWEIFSLGYMPYPGRTNQ------EVMEFVTGGGRLDP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHHcCCCCCCCCCCHH------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            999996 99998643211      11111111111111   12445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-39  Score=244.02  Aligned_cols=210  Identities=27%  Similarity=0.445  Sum_probs=172.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++......|+++|++.+++|.+++....  ..+++..+..++.|++.|+.+||+.  
T Consensus        43 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--  118 (256)
T cd06612          43 QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN--  118 (256)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            578899999999999999999999999999999999999999999986543  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||+|+||+++.++.++|+|||.+..............++..|+|||++.+..++.++|+||+|+++|+|++|..
T Consensus       119 -~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~  197 (256)
T cd06612         119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP  197 (256)
T ss_pred             -CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998876544333344557889999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.......      ......... .........++..+.+++.+||+.||.+|||+.++++
T Consensus       198 p~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         198 PYSDIHPMR------AIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCcchhh------hhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            986432211      111111111 1111112245567899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-39  Score=247.73  Aligned_cols=214  Identities=24%  Similarity=0.465  Sum_probs=171.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------------CCCCCCHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------------SAEELGWSRR   63 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~   63 (228)
                      +.+.+|+.+++++.|+||+++++++......++++|++++++|.+++....                   ....++...+
T Consensus        53 ~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  132 (288)
T cd05050          53 ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ  132 (288)
T ss_pred             HHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHH
Confidence            468889999999999999999999999899999999999999999986421                   1123678889


Q ss_pred             HHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCc
Q 040501           64 INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKV  141 (228)
Q Consensus        64 ~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  141 (228)
                      +.++.|++.||.+||+.   |++|+||+|+||+++.++.++++|||.+.........  ......+..|+|||.+.+..+
T Consensus       133 ~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  209 (288)
T cd05050         133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY  209 (288)
T ss_pred             HHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC
Confidence            99999999999999999   9999999999999999999999999988754332211  112234567999999988889


Q ss_pred             ccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          142 TAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       142 ~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      +.++|+||||+++|+|++ |..||....      .......+.........   ...+.++.+++.+||+.+|.+|||+.
T Consensus       210 ~~~~Dv~slG~il~el~~~~~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         210 TTESDVWAYGVVLWEIFSYGMQPYYGMA------HEEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHH
Confidence            999999999999999997 878874322      12222333223222111   23456799999999999999999999


Q ss_pred             HHHHHhhC
Q 040501          221 TICQLLCK  228 (228)
Q Consensus       221 ~il~~l~~  228 (228)
                      ++++.|++
T Consensus       281 el~~~l~~  288 (288)
T cd05050         281 SINRILQR  288 (288)
T ss_pred             HHHHHhhC
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-40  Score=260.05  Aligned_cols=208  Identities=23%  Similarity=0.413  Sum_probs=176.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC--eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR--HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .++|..|+.+|+.|+|+||+++++++.+..  .+.+|+|.+..|+|..|+.+...   ++...+..|++||+.||.|||+
T Consensus        85 leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen   85 LERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             HHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhc
Confidence            478999999999999999999999997654  58899999999999999987654   7889999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                      +. +.|+|||||.+|||++.+ |.|||+|+|+++......  .....|||.|||||+.. ..|....||||||+.+.||+
T Consensus       162 ~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv  237 (632)
T KOG0584|consen  162 QD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV  237 (632)
T ss_pred             CC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence            85 489999999999999876 999999999999865433  33478999999999876 77999999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+..||.     ...++.....++..+..|......  -.+++.++|.+||.. ..+|||+.|+|+
T Consensus       238 T~eYPYs-----EC~n~AQIYKKV~SGiKP~sl~kV--~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  238 TSEYPYS-----ECTNPAQIYKKVTSGIKPAALSKV--KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccCChh-----hhCCHHHHHHHHHcCCCHHHhhcc--CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            9999973     455666666666666655432221  134789999999999 999999999986

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.6e-40  Score=257.93  Aligned_cols=209  Identities=20%  Similarity=0.262  Sum_probs=165.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++.+..+...|+||||+.+++|.+++...    .++...+..++.|++.||+|||+.  
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~--  161 (370)
T cd05621          88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM--  161 (370)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            34678999999999999999999999999999999999999999998653    278889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCC----cccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMK----VTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~~  157 (228)
                       ||+||||||+||+++.++.+||+|||++........ ......|++.|+|||++.+..    ++.++|+||+||++|+|
T Consensus       162 -~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel  240 (370)
T cd05621         162 -GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM  240 (370)
T ss_pred             -CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence             999999999999999999999999999986543222 123456899999999987543    67899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+..+.+++.+||..++.+  |+|+.++++
T Consensus       241 l~G~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         241 LVGDTPFYADS------LVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             HhCCCCCCCCC------HHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            99999986432      12223333322211111111245667889999999855543  889999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=242.70  Aligned_cols=211  Identities=27%  Similarity=0.428  Sum_probs=172.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.+++.++|+||+++++++......++|||++++++|.+++..... ..+++..+..++.|++.|+.|||+. 
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~-  121 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK-  121 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            45788999999999999999999999988999999999999999999875442 2489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                        |++|+||+|+||+++.++.++|+|||.+........   ....+..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       122 --~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g  196 (256)
T cd05039         122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG  196 (256)
T ss_pred             --CccchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcC
Confidence              999999999999999999999999999876532221   2234567999999988888999999999999999997 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....      ................   ....+..+.+++.+||..+|.+|||+.++++.|++
T Consensus       197 ~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         197 RVPYPRIP------LKDVVPHVEKGYRMEA---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCCCCCC------HHHHHHHHhcCCCCCC---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            99975332      1122222211111111   12456678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-39  Score=258.26  Aligned_cols=210  Identities=20%  Similarity=0.238  Sum_probs=163.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~--  120 (381)
T cd05626          46 AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM--  120 (381)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            357889999999999999999999999999999999999999999987543   378888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-------------------------------------------
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-------------------------------------------  119 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-------------------------------------------  119 (228)
                       ||+||||||+||+++.++.++|+|||++........                                           
T Consensus       121 -givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (381)
T cd05626         121 -GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ  199 (381)
T ss_pred             -CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence             999999999999999999999999998753210000                                           


Q ss_pred             ----CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhh
Q 040501          120 ----NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIR  195 (228)
Q Consensus       120 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (228)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....      ......+.............
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~  273 (381)
T cd05626         200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP------TETQLKVINWENTLHIPPQV  273 (381)
T ss_pred             ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH------HHHHHHHHccccccCCCCCC
Confidence                01124688999999999888899999999999999999999999864321      11112222111100001112


Q ss_pred             hhHHHHHHHHHHh--hccCCCCCCCHHHHHH
Q 040501          196 GKVISIMEVAFLC--LDNNPESRPNMQTICQ  224 (228)
Q Consensus       196 ~~~~~~~~li~~~--l~~~p~~Rpt~~~il~  224 (228)
                      ..+.++.++|.+|  +..+|..|++++++++
T Consensus       274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         274 KLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             CCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            3456788999984  4566667999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-39  Score=251.64  Aligned_cols=216  Identities=19%  Similarity=0.287  Sum_probs=164.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|++++++++|+||+++++++..+...++||||+.+ +|.+++.....  .++...+..++.|++.||+|||+.  
T Consensus        49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~--  123 (309)
T cd07872          49 CTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR--  123 (309)
T ss_pred             hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3567899999999999999999999999999999999975 77777654432  378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.++|+|||.+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus       124 -~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~  202 (309)
T cd07872         124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR  202 (309)
T ss_pred             -CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999998765433333334467889999998765 45788999999999999999999


Q ss_pred             CCccccccccCCCc---------hhhh---------hhhcCCCCC--CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSSNP---------NILV---------NEMLDPRLP--PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~~~---------~~~~---------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      .||...........         ....         .....+...  .........+.++.++|.+||+.||.+|||+.+
T Consensus       203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  282 (309)
T cd07872         203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE  282 (309)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence            99864322110000         0000         000000000  000111234567889999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       283 ~l~  285 (309)
T cd07872         283 AMK  285 (309)
T ss_pred             Hhc
Confidence            876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.9e-39  Score=242.19  Aligned_cols=210  Identities=27%  Similarity=0.410  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCT-HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.++++++|+|++++++++. .+...++++||+++++|.+++..... ..+++..++.++.|++.||++||+. 
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~-  121 (256)
T cd05082          44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN-  121 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            56889999999999999999999764 45678999999999999999875432 3378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                        |++|+||+|+||+++.++.++++|||++.......   .....+..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus       122 --~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g  196 (256)
T cd05082         122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG  196 (256)
T ss_pred             --CEeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence              99999999999999999999999999887544322   12234567999999988889999999999999999997 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....      .......+.......   .....+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       197 ~~p~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         197 RVPYPRIP------LKDVVPRVEKGYKMD---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCC------HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            99975321      111222221111111   112456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-39  Score=241.00  Aligned_cols=211  Identities=24%  Similarity=0.365  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|++++++++|+||+++++++......++||||+.+++|.+++.....  .+++.+++.++.+++.+|.++|+.  
T Consensus        37 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--  112 (250)
T cd05085          37 IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK--  112 (250)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            4578999999999999999999999999999999999999999998865432  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||+|+||+++.++.++++|||.+.......... ....++..|+|||++.+..++.++|+||||+++|++++ |
T Consensus       113 -~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g  191 (250)
T cd05085         113 -NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLG  191 (250)
T ss_pred             -CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCC
Confidence             99999999999999999999999999887543222111 11233567999999988888999999999999999998 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||......      ..............   ....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       192 ~~p~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         192 VCPYPGMTNQ------QAREQVEKGYRMSC---PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHH------HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            9998643221      11122211111111   1234567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=246.78  Aligned_cols=210  Identities=25%  Similarity=0.428  Sum_probs=170.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+..+...|+||||+++++|.+++.....  .+++..+..++.|++.++.|||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~--  122 (280)
T cd06611          47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH--  122 (280)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678899999999999999999999999999999999999999999875432  389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~  157 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.     ...++.++|+||||+++|+|
T Consensus       123 -~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l  201 (280)
T cd06611         123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL  201 (280)
T ss_pred             -CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHH
Confidence             999999999999999999999999998876544433344456788999999875     33467799999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ............+... .....+.++.+++.+||..+|.+|||+.++++
T Consensus       202 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         202 AQMEPPHHELNP------MRVLLKILKSEPPTLD-QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HhCCCCcccCCH------HHHHHHHhcCCCCCcC-CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            999999864321      1222222222221111 11245567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-39  Score=258.66  Aligned_cols=209  Identities=20%  Similarity=0.250  Sum_probs=162.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++.|.+....|+||||+.+++|.+++.+..   .+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~--  120 (382)
T cd05625          46 AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM--  120 (382)
T ss_pred             HHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            457789999999999999999999999999999999999999999987543   378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC--------------------------------------------
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--------------------------------------------  118 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--------------------------------------------  118 (228)
                       ||+||||||+||+++.+|.++|+|||++.......                                            
T Consensus       121 -~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (382)
T cd05625         121 -GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ  199 (382)
T ss_pred             -CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence             99999999999999999999999999875321000                                            


Q ss_pred             ---CCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhh
Q 040501          119 ---SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIR  195 (228)
Q Consensus       119 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (228)
                         .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+.............
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~p~~~  273 (382)
T cd05625         200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP------LETQMKVINWQTSLHIPPQA  273 (382)
T ss_pred             cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH------HHHHHHHHccCCCcCCCCcc
Confidence               001123588999999999988999999999999999999999999864321      12222222111110011112


Q ss_pred             hhHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 040501          196 GKVISIMEVAFLCLDNNPESRPN---MQTICQ  224 (228)
Q Consensus       196 ~~~~~~~~li~~~l~~~p~~Rpt---~~~il~  224 (228)
                      ..+.+..++|.+|+ .+|.+|++   +.++++
T Consensus       274 ~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         274 KLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            34567788888876 59999987   777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.2e-39  Score=243.91  Aligned_cols=212  Identities=25%  Similarity=0.401  Sum_probs=165.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCT-HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.+++.++||||+++++++. .+...++++||+.+++|.+++.....  ..+...+..++.|++.||.|||+. 
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  117 (262)
T cd05058          41 EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK-  117 (262)
T ss_pred             HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            46788999999999999999999775 45568899999999999999875432  256777888999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        +++|+||+|+||+++.++.++|+|||++.........    .....++..|+|||.+.+..++.++||||||+++|+|
T Consensus       118 --~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  195 (262)
T cd05058         118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL  195 (262)
T ss_pred             --CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence              9999999999999999999999999998754322111    1123446689999999888899999999999999999


Q ss_pred             HhC-CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          158 IKG-KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       158 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ++| .+||....      .............+...   ...+..+.+++.+||..+|++||++.++++.|++
T Consensus       196 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         196 MTRGAPPYPDVD------SFDITVYLLQGRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             HcCCCCCCCCCC------HHHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            994 56654321      22222222222222111   1345578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-39  Score=246.13  Aligned_cols=210  Identities=24%  Similarity=0.396  Sum_probs=167.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++.+..+...|+||||+.+++|..++.....  .++...+..++.|++.++.+||+.  
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~--  129 (292)
T cd06644          54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM--  129 (292)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC--
Confidence            4678899999999999999999999999999999999999999888754332  388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-----CCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~~  157 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+     ..++.++|+||||+++|+|
T Consensus       130 -~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el  208 (292)
T cd06644         130 -KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM  208 (292)
T ss_pred             -CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHH
Confidence             9999999999999999999999999988764433333344567889999998753     3467789999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ............+... .....+.++.+++.+||..+|.+||++.++++
T Consensus       209 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         209 AQIEPPHHELNP------MRVLLKIAKSEPPTLS-QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             hcCCCCCccccH------HHHHHHHhcCCCccCC-CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            999999753221      1222222222211111 11244557889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-40  Score=259.10  Aligned_cols=209  Identities=22%  Similarity=0.267  Sum_probs=163.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||++++++|.+....|+||||+.+++|.+++....   .++...+..++.|++.||+|||+.  
T Consensus        46 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~--  120 (377)
T cd05629          46 AHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL--  120 (377)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            457789999999999999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC------------C------------------------------
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS------------N------------------------------  120 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------------~------------------------------  120 (228)
                       |++||||||+||+++.++.++|+|||+++.......            .                              
T Consensus       121 -givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (377)
T cd05629         121 -GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK  199 (377)
T ss_pred             -CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence             999999999999999999999999998863211000            0                              


Q ss_pred             -----ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhh
Q 040501          121 -----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIR  195 (228)
Q Consensus       121 -----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (228)
                           .....|++.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+.............
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~p~~~  273 (377)
T cd05629         200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS------HETYRKIINWRETLYFPDDI  273 (377)
T ss_pred             cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH------HHHHHHHHccCCccCCCCCC
Confidence                 0023588999999999988899999999999999999999999853322      12222222111000000112


Q ss_pred             hhHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 040501          196 GKVISIMEVAFLCLDNNPESR---PNMQTICQ  224 (228)
Q Consensus       196 ~~~~~~~~li~~~l~~~p~~R---pt~~~il~  224 (228)
                      ..+.++.++|.+||. +|.+|   +|+.++++
T Consensus       274 ~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         274 HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            345678899999997 77765   58888775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.4e-39  Score=247.87  Aligned_cols=209  Identities=27%  Similarity=0.431  Sum_probs=169.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++|+||+++++++......|+|+||+.+++|..++...    .+++.++..++.+++.++.+||+. 
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~-  134 (296)
T cd06655          60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN-  134 (296)
T ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            356788999999999999999999999999999999999999999988643    278899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus       135 --~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~  212 (296)
T cd06655         135 --QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE  212 (296)
T ss_pred             --CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999998876544333333346778999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||......      ...........+. ......++..+.++|.+||..+|.+|||+.++++
T Consensus       213 ~pf~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         213 PPYLNENPL------RALYLIATNGTPE-LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCCCCCCHH------HHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            998543221      1111111111111 1112345567889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.8e-39  Score=244.79  Aligned_cols=214  Identities=23%  Similarity=0.362  Sum_probs=168.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNND---TSAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~~l~~~   73 (228)
                      +.+.+|+++++.++|+||+++++++...      ...++++||+.+++|.+++...   .....+++..+..++.|++.|
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  124 (272)
T cd05075          45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG  124 (272)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHH
Confidence            4678899999999999999999987432      2568999999999998887421   123347899999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |+|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|++||.+.+..++.++|+||||
T Consensus       125 l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG  201 (272)
T cd05075         125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG  201 (272)
T ss_pred             HHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHH
Confidence            9999999   9999999999999999999999999998865433221  1223456789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|++++ |..||.....      ......+........   ....+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       202 ~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         202 VTMWEIATRGQTPYPGVEN------SEIYDYLRQGNRLKQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             HHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            99999998 8889864221      122222222221111   12455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-39  Score=248.82  Aligned_cols=209  Identities=23%  Similarity=0.374  Sum_probs=161.4

Q ss_pred             HHHHHHHHHhcc---CCCccceeeeeee-----ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEI---RHRNIVKFYGFCT-----HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+.+++.+   +||||+++++++.     .....++++|++. ++|.+++..... ..+++..+..++.|++.||.
T Consensus        47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~  124 (290)
T cd07862          47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLD  124 (290)
T ss_pred             HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHH
Confidence            466788877766   6999999999885     2456899999996 588888765432 33789999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      |||+.   |++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|
T Consensus       125 ~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  200 (290)
T cd07862         125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA  200 (290)
T ss_pred             HHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHH
Confidence            99999   9999999999999999999999999998765433 2233456789999999998888999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcC----------------------CCCC-CCchhhhhhHHHHHHHHHHhhccC
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLD----------------------PRLP-PLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|++|.+||.......      ....+.+                      .... .........+..+.+++.+||+.|
T Consensus       201 el~~g~~~f~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  274 (290)
T cd07862         201 EMFRRKPLFRGSSDVD------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN  274 (290)
T ss_pred             HHHcCCCCcCCCCHHH------HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccC
Confidence            9999999986432211      1111100                      0000 000011234566789999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |++|||+.++++
T Consensus       275 P~~R~s~~~~l~  286 (290)
T cd07862         275 PAKRISAYSALS  286 (290)
T ss_pred             chhcCCHHHHhc
Confidence            999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-39  Score=249.57  Aligned_cols=214  Identities=23%  Similarity=0.399  Sum_probs=170.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++.+ +|+||+++++++..+...|++|||+.+++|.+++.....             ...+++.+++.++.
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  147 (307)
T cd05098          68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY  147 (307)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            4577899999999 799999999999999999999999999999999975421             12478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||+|||+.   |++|+||||+||+++.++.++|+|||.+..........  ....++..|+|||.+.+..++.++|
T Consensus       148 qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  224 (307)
T cd05098         148 QVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD  224 (307)
T ss_pred             HHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence            999999999999   99999999999999999999999999987654222111  1122346799999998888899999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +||||+++|+|++ |..||....      .......+........   ....+.++.+++.+||..+|.+|||+.++++.
T Consensus       225 vwslG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         225 VWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHHcCCCCCC---CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999999999998 888875321      1122222212211111   12345678899999999999999999999998


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       296 l~~  298 (307)
T cd05098         296 LDR  298 (307)
T ss_pred             HHH
Confidence            863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6e-40  Score=259.93  Aligned_cols=209  Identities=20%  Similarity=0.238  Sum_probs=164.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+.++..+|+||||+.+++|.+++....   .++...+..++.|++.||+|||+.  
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~--  120 (376)
T cd05598          46 AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM--  120 (376)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999987543   378888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC-------------------------------------------C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-------------------------------------------S  119 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-------------------------------------------~  119 (228)
                       ||+||||||+||+++.++.++|+|||++.......                                           .
T Consensus       121 -~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (376)
T cd05598         121 -GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC  199 (376)
T ss_pred             -CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence             99999999999999999999999999874221000                                           0


Q ss_pred             CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHH
Q 040501          120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVI  199 (228)
Q Consensus       120 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (228)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+...............+.
T Consensus       200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~s~  273 (376)
T cd05598         200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP------AETQLKVINWETTLHIPSQAKLSR  273 (376)
T ss_pred             cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH------HHHHHHHhccCccccCCCCCCCCH
Confidence            01124688999999999998899999999999999999999999864322      111112211111100111123556


Q ss_pred             HHHHHHHHhhccCCCCCC---CHHHHHH
Q 040501          200 SIMEVAFLCLDNNPESRP---NMQTICQ  224 (228)
Q Consensus       200 ~~~~li~~~l~~~p~~Rp---t~~~il~  224 (228)
                      ++.++|.+|+ .+|.+|+   |+.++++
T Consensus       274 ~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         274 EASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             HHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            7788999876 5999999   8888874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-39  Score=255.59  Aligned_cols=210  Identities=20%  Similarity=0.259  Sum_probs=163.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.++..++|++|+++++.+.+....|+||||+++++|.+++....   .++...+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--  120 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL--  120 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            456789999999999999999999999999999999999999999987543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-----------------------------------Cceecccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-----------------------------------NWTEFAGT  127 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------~~~~~~~~  127 (228)
                       ||+||||||+||+++.++.++|+|||++........                                   ......|+
T Consensus       121 -givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt  199 (363)
T cd05628         121 -GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT  199 (363)
T ss_pred             -CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence             999999999999999999999999999875432110                                   01234689


Q ss_pred             cceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHH
Q 040501          128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL  207 (228)
Q Consensus       128 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  207 (228)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||....      .......+...............+.+..++|.+
T Consensus       200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~  273 (363)
T cd05628         200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET------PQETYKKVMNWKETLIFPPEVPISEKAKDLILR  273 (363)
T ss_pred             ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHH
Confidence            99999999998889999999999999999999999986432      222223332211100000112344567788888


Q ss_pred             hhc--cCCCCCCCHHHHHH
Q 040501          208 CLD--NNPESRPNMQTICQ  224 (228)
Q Consensus       208 ~l~--~~p~~Rpt~~~il~  224 (228)
                      |+.  .++..||++.++++
T Consensus       274 l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         274 FCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HcCChhhcCCCCCHHHHhC
Confidence            664  23345689999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-39  Score=245.03  Aligned_cols=215  Identities=24%  Similarity=0.355  Sum_probs=163.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--AEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ..+.+|+++++.++|+||+++++.+......|+||||+.+++|.+++.....  ....+...+..++.|++.||+|||+.
T Consensus        40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  119 (269)
T cd05042          40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA  119 (269)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence            4578899999999999999999999999999999999999999999876432  22346778889999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc-------CCcccchhhhhHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT-------MKVTAKCDVYSFG  151 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG  151 (228)
                         |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||++..       ..++.++||||||
T Consensus       120 ---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  196 (269)
T cd05042         120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG  196 (269)
T ss_pred             ---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHH
Confidence               9999999999999999999999999988653322111  122334567999998643       3467899999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCC--CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLP--PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++ |..||.....      .............  +........+..+.+++..|| .||.+|||++++++.|.
T Consensus       197 ~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         197 VTMWELFTAADQPYPDLSD------EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHHHHhCCCCCCCcCCH------HHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            99999998 7888754321      1111111111110  011112345567788999998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-39  Score=244.30  Aligned_cols=214  Identities=22%  Similarity=0.400  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCe------EEEEEEeecCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDT---SAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~l~~~   73 (228)
                      +.+.+|++.++.++|+||+++++++.....      .++++||+.+++|..++....   ....+++..+..++.|++.|
T Consensus        46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~a  125 (273)
T cd05035          46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG  125 (273)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHH
Confidence            467899999999999999999998865443      799999999999998885421   22358899999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |.|||+.   |++|+||||+||++++++.++|+|||.+..........  .....+..|+|||.+.+..++.++||||||
T Consensus       126 L~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG  202 (273)
T cd05035         126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG  202 (273)
T ss_pred             HHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHH
Confidence            9999999   99999999999999999999999999988654332221  112345679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|+|++ |..||....      .................   ..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       203 ~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         203 VTMWEIATRGQTPYPGVE------NHEIYDYLRHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             HHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            99999998 889975432      12222333222222211   2456679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=243.01  Aligned_cols=214  Identities=25%  Similarity=0.502  Sum_probs=172.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.++++++|+||+++++++......++++|++++++|.+++..... ..++..++..++.+++.|+.+||+. 
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~-  122 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR-  122 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            46788999999999999999999999988899999999999999999876432 3488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++++|||.+......... ......+..|+|||.+.+..++.++|+||+|+++|++++ 
T Consensus       123 --~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~  200 (261)
T cd05034         123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY  200 (261)
T ss_pred             --CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence              9999999999999999999999999998765432111 112234567999999988888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |+.||....      .......+.........   ...+.++.+++.+||..+|.+|||++++++.|+.
T Consensus       201 g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         201 GRVPYPGMT------NREVLEQVERGYRMPRP---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            999975322      22222333222111111   1235678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=244.92  Aligned_cols=207  Identities=27%  Similarity=0.459  Sum_probs=172.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++..+...|+++|++.+++|.+++...    .++...++.++.|++.++.+||+.  
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~--  117 (274)
T cd06609          44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE--  117 (274)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            45788999999999999999999999999999999999999999998754    488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||+|+||+++.++.++++|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       118 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~  196 (274)
T cd06609         118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP  196 (274)
T ss_pred             -CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999999877644333344567788999999988889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||....      .......+.....+....  ..++.++.+++.+||..+|.+|||++++++
T Consensus       197 p~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         197 PLSDLH------PMRVLFLIPKNNPPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccCc------hHHHHHHhhhcCCCCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            985332      112222222222221111  125667899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.1e-39  Score=242.12  Aligned_cols=209  Identities=28%  Similarity=0.421  Sum_probs=170.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|++++++++|+|++++++.+.. +...|+++|++++++|.+++.... ...+++.++..++.+++.++.+||+. 
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~-  121 (257)
T cd08223          44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK-  121 (257)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            467889999999999999999998764 446899999999999999987532 23488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++|+||+|++++++++|.
T Consensus       122 --~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08223         122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK  199 (257)
T ss_pred             --CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCC
Confidence              999999999999999999999999999886654333344456788999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||....      .............+...   ...+..+.+++.+||+.||.+|||+.++++
T Consensus       200 ~~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         200 HAFNAKD------MNSLVYRIIEGKLPPMP---KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCCCCC------HHHHHHHHHhcCCCCCc---cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            9975321      22222233333332221   245567899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=260.57  Aligned_cols=210  Identities=25%  Similarity=0.397  Sum_probs=179.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ++|+-||++|..+.||+|+++++.|+..+.+||+.|||+||..+..+-.-+.  .+.+.++..+++|++.||.|||++  
T Consensus        74 EDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~--  149 (1187)
T KOG0579|consen   74 EDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ--  149 (1187)
T ss_pred             hhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc--
Confidence            5678899999999999999999999999999999999999999888765443  389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~  157 (228)
                       +|+|||||..||+++-+|.++|.|||.+............+.|||+|||||+..     ..+|+.++||||||+.+.+|
T Consensus       150 -~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM  228 (1187)
T KOG0579|consen  150 -NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM  228 (1187)
T ss_pred             -chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence             999999999999999999999999998876554445566789999999999765     44689999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..+.+|.      ...++...+-.+....+|..... ..-+..+.+++++||.+||..||+++++++
T Consensus       229 AqiEPPH------helnpMRVllKiaKSePPTLlqP-S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  229 AQIEPPH------HELNPMRVLLKIAKSEPPTLLQP-SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hccCCCc------cccchHHHHHHHhhcCCCcccCc-chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            9999994      44445555555555555443322 345567899999999999999999999986

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.2e-39  Score=242.57  Aligned_cols=213  Identities=24%  Similarity=0.452  Sum_probs=169.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.++++++|+||+++++++. ....++++|++.+++|.+++..... ..++..++..++.|++.||+|||+. 
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~-  121 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK-  121 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            357889999999999999999999874 4578999999999999998865432 3478899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ 
T Consensus       122 --~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~  199 (260)
T cd05067         122 --NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY  199 (260)
T ss_pred             --CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhC
Confidence              9999999999999999999999999998765422211 122345678999999988888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||....      ..............+..   ...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus       200 g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         200 GRIPYPGMT------NPEVIQNLERGYRMPRP---DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCC------hHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            999985332      11222222222111111   2345679999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.5e-39  Score=249.20  Aligned_cols=213  Identities=22%  Similarity=0.407  Sum_probs=169.5

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++++ +|+||+++++++......|+++||+.+++|.+++....             ....+++.++..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (314)
T cd05099          62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY  141 (314)
T ss_pred             HHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHH
Confidence            3577899999999 69999999999998889999999999999999986532             123478899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||.|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|
T Consensus       142 qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  218 (314)
T cd05099         142 QVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD  218 (314)
T ss_pred             HHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccch
Confidence            999999999999   9999999999999999999999999999765432211  11122345799999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +||||+++|++++ |..||....      .......+........   ...++.++.+++.+||..+|.+|||+.++++.
T Consensus       219 iwslG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         219 VWSFGILMWEIFTLGGSPYPGIP------VEELFKLLREGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             hhHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999998 888875322      1222222222221111   12445578899999999999999999999998


Q ss_pred             hh
Q 040501          226 LC  227 (228)
Q Consensus       226 l~  227 (228)
                      |+
T Consensus       290 l~  291 (314)
T cd05099         290 LD  291 (314)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-39  Score=252.14  Aligned_cols=200  Identities=22%  Similarity=0.309  Sum_probs=164.3

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|..++..+ +|++|+++++++...+..|+||||+.+++|.+.+....   .+++.++..++.|++.||.|||+.  
T Consensus        46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  120 (323)
T cd05616          46 CTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK--  120 (323)
T ss_pred             HHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            456788888877 58999999999999999999999999999998886543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       121 -~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  199 (323)
T cd05616         121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA  199 (323)
T ss_pred             -CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence             9999999999999999999999999998754433333344578999999999999899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      ||....      .......+....... +   ...+.++.+++.+||+.+|.+|+++
T Consensus       200 Pf~~~~------~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         200 PFEGED------EDELFQSIMEHNVAY-P---KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCCC------HHHHHHHHHhCCCCC-C---CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            986432      223333333332211 1   2345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7e-39  Score=243.71  Aligned_cols=215  Identities=26%  Similarity=0.435  Sum_probs=172.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA------EELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|++++++++|+||+++++++......|+||||+.+++|.+++......      ..+++..+..++.|++.+|+|
T Consensus        53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~  132 (275)
T cd05046          53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH  132 (275)
T ss_pred             HHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            56889999999999999999999999989999999999999999998764421      248899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC-CCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++|+||||+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++||||||+++|
T Consensus       133 LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  209 (275)
T cd05046         133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMW  209 (275)
T ss_pred             hhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHH
Confidence            9999   99999999999999999999999999876432221 1123334567799999988888889999999999999


Q ss_pred             HHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          156 EVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       156 ~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ++++ |..||.....      ...............  .....+..+.+++.+||+.+|.+|||+.+++..|.+
T Consensus       210 ~l~~~~~~p~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         210 EVFTQGELPFYGLSD------EEVLNRLQAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHHhCCCCCccccch------HHHHHHHHcCCcCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            9998 7888753221      122222221221111  112455679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-39  Score=243.73  Aligned_cols=204  Identities=24%  Similarity=0.424  Sum_probs=161.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++..+...+++|||+.+++|..++.....  .++...++.++.|++.|++|||+.  
T Consensus        49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--  124 (262)
T cd05077          49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK--  124 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC--
Confidence            3677889999999999999999999998899999999999999988765432  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCc-------eEEeecccccccCCCCCCceecccccceeCCcccc-cCCcccchhhhhHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYE-------AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l  154 (228)
                       |++|+||||+||+++.++.       ++++|||.+......    ....++..|+|||.+. +..++.++||||||+++
T Consensus       125 -~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  199 (262)
T cd05077         125 -DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL  199 (262)
T ss_pred             -CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence             9999999999999987654       899999988654322    2235677899999886 45688899999999999


Q ss_pred             HHHH-hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          155 LEVI-KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       155 ~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |+|+ .|..||......       ............    ....+.++.+++.+||+.||.+||++.++++.+
T Consensus       200 ~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         200 WEICYNGEIPLKDKTLA-------EKERFYEGQCML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHhCCCCCCCCcchh-------HHHHHHhcCccC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            9997 588886532211       011111111111    112345788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.9e-40  Score=240.31  Aligned_cols=214  Identities=23%  Similarity=0.282  Sum_probs=170.1

Q ss_pred             HHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      -.+||.+|.+++|||||.+-++...  -+.+|+|||||.+ +|.+++.+-.  +.+...++..++.|++.|++|||..  
T Consensus       122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~--  196 (419)
T KOG0663|consen  122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN--  196 (419)
T ss_pred             hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc--
Confidence            3799999999999999999988754  3579999999976 8888887644  4589999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~  161 (228)
                       .|+|||||++|++++..|.+||+|||+++..+......+...-|..|+|||.+.+.. |+++.|+||+||++.|++.++
T Consensus       197 -wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k  275 (419)
T KOG0663|consen  197 -WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK  275 (419)
T ss_pred             -eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence             999999999999999999999999999999988877778888899999999988764 899999999999999999999


Q ss_pred             CCccccccccCCCchhhh------------------hhhcCCCCCC--Cchh--hhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILV------------------NEMLDPRLPP--LSVD--IRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~------------------~~~~~~~~~~--~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      +.|+...+.+..+.....                  .....+..+.  ....  ....++.-.+++..+|..||.+|.|+
T Consensus       276 Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA  355 (419)
T KOG0663|consen  276 PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA  355 (419)
T ss_pred             CCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH
Confidence            988755443221111100                  0000000000  0000  01133566799999999999999999


Q ss_pred             HHHHH
Q 040501          220 QTICQ  224 (228)
Q Consensus       220 ~~il~  224 (228)
                      .+.++
T Consensus       356 ~~~L~  360 (419)
T KOG0663|consen  356 EDGLK  360 (419)
T ss_pred             HHhhc
Confidence            99875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-40  Score=232.38  Aligned_cols=206  Identities=26%  Similarity=0.402  Sum_probs=175.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .++.+|+++-+.|+||||++++++|-+....|+++||...|.+...++.... ..+++...+.++.|++.|+.|+|..  
T Consensus        67 ~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k--  143 (281)
T KOG0580|consen   67 HQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK--  143 (281)
T ss_pred             hhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC--
Confidence            4578999999999999999999999999999999999999999888875443 3388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++||||||+|++++..|.+|+.|||-+....  .....+.+||..|.+||+..+...+...|+|++|++.|+++.|.+
T Consensus       144 -~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~p  220 (281)
T KOG0580|consen  144 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLP  220 (281)
T ss_pred             -CcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCC
Confidence             99999999999999999999999999886543  445667899999999999999999999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||....      ..+...++...+....    ...+....++|.+|+..+|.+|.+..++.+
T Consensus       221 pFes~~------~~etYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  221 PFESQS------HSETYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             chhhhh------hHHHHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            986433      2334444433332211    245557889999999999999999998875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.2e-39  Score=241.23  Aligned_cols=204  Identities=26%  Similarity=0.451  Sum_probs=163.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.+++.++|+||+++++++.. ...++|+||+++++|.+++.....  .++...+..++.|++.||+|||+.  
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~--  120 (259)
T cd05037          46 LAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK--  120 (259)
T ss_pred             HHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC--
Confidence            578899999999999999999999987 778999999999999999876543  388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCC-------ceEEeecccccccCCCCCCceecccccceeCCcccccC--CcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEY-------EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~  153 (228)
                       |++|+||||+||+++.++       .++++|||.+.....    .....++..|+|||++.+.  .++.++|+||||++
T Consensus       121 -~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~  195 (259)
T cd05037         121 -KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTT  195 (259)
T ss_pred             -CeecccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence             999999999999999887       799999999876543    1223456779999998876  68899999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|++++ |..||......      ............+..     ....+.+++.+||..+|.+|||+.++++.|+
T Consensus       196 ~~~l~~~~~~p~~~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         196 LLEICSNGEEPLSTLSSS------EKERFYQDQHRLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHHhCCCCCcccCCch------hHHHHHhcCCCCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            999998 57776543211      111111111111111     1157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-39  Score=257.72  Aligned_cols=214  Identities=24%  Similarity=0.288  Sum_probs=165.0

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++++.++|+||+++++.+......|++||++. ++|.+++...   ..+++..++.++.|++.||.|||+.   
T Consensus       132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---  204 (392)
T PHA03207        132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---  204 (392)
T ss_pred             cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            45789999999999999999999999999999999986 5777777433   2388999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                      |++||||||+||+++.++.++|+|||++.........  .....|++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       205 givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~  284 (392)
T PHA03207        205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN  284 (392)
T ss_pred             CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999998765433222  22356899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhh-----------------------hhhcCCCCCCCc----hhhhhhHHHHHHHHHHhhccCCC
Q 040501          162 HPRDFLSNVSSSNPNILV-----------------------NEMLDPRLPPLS----VDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      .||...............                       ........+...    ......+.++.++|++||..||.
T Consensus       285 ~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~  364 (392)
T PHA03207        285 VTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE  364 (392)
T ss_pred             CCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChh
Confidence            998543221100000000                       000000000000    00113355688999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.+++.
T Consensus       365 ~Rpsa~e~l~  374 (392)
T PHA03207        365 FRPSAQDILS  374 (392)
T ss_pred             hCCCHHHHhh
Confidence            9999999985

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.5e-39  Score=249.40  Aligned_cols=210  Identities=22%  Similarity=0.377  Sum_probs=167.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++++... ..+++++++.+++|.+++.....  .++...++.++.|++.||+|||+.  
T Consensus        54 ~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~--  128 (316)
T cd05108          54 KEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER--  128 (316)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc--
Confidence            5688899999999999999999998765 56799999999999999876542  378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce--ecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT--EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++||||||+||+++.++.++|+|||++...........  ....+..|++||.+.+..++.++||||||+++|++++ 
T Consensus       129 -~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~  207 (316)
T cd05108         129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF  207 (316)
T ss_pred             -CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcC
Confidence             999999999999999999999999999987654333221  2233567999999988889999999999999999997 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||......      ............+.   ...++..+.+++.+||..+|.+|||+.+++..|.
T Consensus       208 g~~p~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         208 GSKPYDGIPAS------EISSILEKGERLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCCCCCCCHH------HHHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            99997543211      11111111111111   1234456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-39  Score=244.05  Aligned_cols=214  Identities=24%  Similarity=0.350  Sum_probs=163.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--AEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ..+.+|+.++++++||||+++++.+.+....++||||+++++|.+++.....  ....+...+..++.|++.|+.|||+.
T Consensus        40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  119 (269)
T cd05087          40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN  119 (269)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            4678899999999999999999999988899999999999999999875322  22356677888999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccC-------CcccchhhhhHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTM-------KVTAKCDVYSFG  151 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG  151 (228)
                         |++|+||||+||+++.++.++++|||.+.........  .....++..|+|||++.+.       .++.++|+||||
T Consensus       120 ---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  196 (269)
T cd05087         120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG  196 (269)
T ss_pred             ---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHH
Confidence               9999999999999999999999999988654322211  1223456789999987542       357799999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcC---CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLD---PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++ |..||......      ........   ...+. .......+..+.+++.+|| .+|.+|||+++|+..|+
T Consensus       197 ~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         197 VTIWELFELGSQPYRHLSDE------QVLTYTVREQQLKLPK-PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHHHhCCCCCCCCCChH------HHHHHHhhcccCCCCC-CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            99999996 99998643221      11111111   11111 1111234556889999999 68999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-39  Score=239.64  Aligned_cols=217  Identities=21%  Similarity=0.292  Sum_probs=169.3

Q ss_pred             HHHHHHHHhccCCCc-cceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHH
Q 040501            5 FLREITVLTEIRHRN-IVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSA-EELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ..+|+.+++.++|+| |+.+++++...+      .+++|+|++. .+|..++...... ..++...+..+++|++.||+|
T Consensus        57 aiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~  135 (323)
T KOG0594|consen   57 AIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAF  135 (323)
T ss_pred             hhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHH
Confidence            579999999999999 999999998776      8999999995 5888888765432 347778899999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~  155 (228)
                      ||+.   +|+||||||+|++++++|.+||.|||++...+-+.........|..|+|||++.+. .|++..||||+||++.
T Consensus       136 ~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfa  212 (323)
T KOG0594|consen  136 LHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFA  212 (323)
T ss_pred             HHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHH
Confidence            9999   99999999999999999999999999999776565556667788999999999887 6899999999999999


Q ss_pred             HHHhCCCCccccccccC---------------CCchhhhhhh--cCCCCC---CCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          156 EVIKGKHPRDFLSNVSS---------------SNPNILVNEM--LDPRLP---PLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~---------------~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      ||++++..|+.....+.               ........+.  ..+...   ..............+++.+||+.+|.+
T Consensus       213 Em~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~  292 (323)
T KOG0594|consen  213 EMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAK  292 (323)
T ss_pred             HHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCccc
Confidence            99999998865433211               0000000000  001110   011111222246789999999999999


Q ss_pred             CCCHHHHHHH
Q 040501          216 RPNMQTICQL  225 (228)
Q Consensus       216 Rpt~~~il~~  225 (228)
                      |.|++.+++.
T Consensus       293 R~Sa~~al~h  302 (323)
T KOG0594|consen  293 RISAKGALTH  302 (323)
T ss_pred             CcCHHHHhcC
Confidence            9999998863

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-39  Score=255.13  Aligned_cols=209  Identities=20%  Similarity=0.260  Sum_probs=165.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++.+..+...|+||||+++++|.+++....    ++...+..++.|++.||.|||+.  
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~--  161 (371)
T cd05622          88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSM--  161 (371)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346789999999999999999999999999999999999999999986532    78888899999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCC----cccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMK----VTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~~  157 (228)
                       |++||||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..    ++.++|||||||++|+|
T Consensus       162 -~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel  240 (371)
T cd05622         162 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM  240 (371)
T ss_pred             -CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence             999999999999999999999999999886543322 223456899999999987543    77899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+..+.++|.+||..++.+  |+++.++++
T Consensus       241 l~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         241 LVGDTPFYADS------LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             HhCCCCCCCCC------HHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            99999986432      22223333322211111112345667889999999844433  788888876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.8e-39  Score=250.97  Aligned_cols=215  Identities=27%  Similarity=0.421  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      +.+.+|+++++++ +|+||++++++|.. +..+++++||+.+++|.+++.....                          
T Consensus        55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (337)
T cd05054          55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD  134 (337)
T ss_pred             HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence            4577899999999 79999999998864 4578899999999999998864221                          


Q ss_pred             --------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCc
Q 040501           55 --------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE  102 (228)
Q Consensus        55 --------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~  102 (228)
                                                      ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++.
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~  211 (337)
T cd05054         135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNV  211 (337)
T ss_pred             cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCc
Confidence                                            12478899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhh
Q 040501          103 AHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV  179 (228)
Q Consensus       103 ~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~  179 (228)
                      ++|+|||++.........  .....++..|+|||++.+..++.++|||||||++|++++ |..||.....      ....
T Consensus       212 vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~------~~~~  285 (337)
T cd05054         212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------DEEF  285 (337)
T ss_pred             EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc------cHHH
Confidence            999999999865432221  122344667999999999999999999999999999997 9999853211      1111


Q ss_pred             hhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ............  ....+.++.+++.+||+.+|.+|||+.++++.|++
T Consensus       286 ~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         286 CRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHhccCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111111111110  12345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.4e-39  Score=244.44  Aligned_cols=208  Identities=23%  Similarity=0.393  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......++++||+++++|..+.       .++...+..++.|++.|+.|||+.  
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~--  114 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL--  114 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46889999999999999999999999999999999999999886542       267888899999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       115 -~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~  191 (279)
T cd06619         115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF  191 (279)
T ss_pred             -CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765432  2233567889999999998889999999999999999999999


Q ss_pred             CccccccccCC-CchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSS-NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||......... ..............+...  ....+.++.+++.+||+.+|.+||++.++++
T Consensus       192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         192 PYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             CchhhcccccccchHHHHHHHhccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            98643221111 111111221111111111  1234557889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-38  Score=243.23  Aligned_cols=210  Identities=22%  Similarity=0.361  Sum_probs=165.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+..|+..+.++.||||+++++++.. ...++++|++.+++|.+++.....  .+++..+..++.|++.|+.|||+.  
T Consensus        54 ~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--  128 (279)
T cd05111          54 QEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH--  128 (279)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            356678888899999999999998754 467889999999999999975432  388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++|+||||+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++||||||+++|++++ 
T Consensus       129 -~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~  207 (279)
T cd05111         129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY  207 (279)
T ss_pred             -CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence             9999999999999999999999999999765433221  223345678999999988889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||......      .....+.........   ..++.++.+++.+||..||.+|||+.++++.|.
T Consensus       208 g~~p~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         208 GAEPYAGMRPH------EVPDLLEKGERLAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             CCCCCCCCCHH------HHHHHHHCCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            99998643221      111111111111111   123456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=239.24  Aligned_cols=213  Identities=25%  Similarity=0.391  Sum_probs=170.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+..|+++++++.|+||+++++++......++++|++++++|.+++.....  .++...++.++.+++.++.+||+. 
T Consensus        36 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~-  112 (251)
T cd05041          36 KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK-  112 (251)
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35788999999999999999999999999999999999999999999865432  378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        +++|+||+|+||+++.++.++|+|||.+..........  .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus       113 --~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS  190 (251)
T ss_pred             --CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence              99999999999999999999999999987654222111  11223567999999888889999999999999999998


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||.....      ...............   ....+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       191 ~~~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         191 LGDTPYPGMSN------QQTRERIESGYRMPA---PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCCCccCCH------HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence             8888754321      111111111111111   12345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.2e-39  Score=241.97  Aligned_cols=209  Identities=25%  Similarity=0.402  Sum_probs=172.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+.++++++|+||+++++++......|+|+||+.+++|.+.+..... ..++..+++.++.|++.++.+||+.  
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~--  120 (256)
T cd08218          44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR--  120 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            4688999999999999999999999999999999999999999998865332 2378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++++|||.+..............+++.|+|||.+.+..++.++|+||||++++++++|..
T Consensus       121 -~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~  199 (256)
T cd08218         121 -KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH  199 (256)
T ss_pred             -CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCC
Confidence             9999999999999999999999999998765543333333457788999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||...      +.............+...   ...+.++.++|.+||+.+|.+||++.++++
T Consensus       200 ~~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         200 AFEAG------NMKNLVLKIIRGSYPPVS---SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CccCC------CHHHHHHHHhcCCCCCCc---ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            97532      222333333333332221   245667899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-39  Score=246.92  Aligned_cols=210  Identities=21%  Similarity=0.266  Sum_probs=167.5

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+.++++++|++|+++++.+..+...|++|||+.+++|.+++..... ..++..++..++.|++.||.|||+.   
T Consensus        46 ~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---  121 (285)
T cd05630          46 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---  121 (285)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            467899999999999999999999999999999999999999988864332 3488999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       122 ~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P  200 (285)
T cd05630         122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987644222 22334688999999999888899999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      |.......   ...............   .....+.++.+++.+||+.||.+|||     +.++++
T Consensus       201 f~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         201 FQQRKKKI---KREEVERLVKEVQEE---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CCCCCccc---hHHHHHhhhhhhhhh---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            86432110   001111111111000   11234557889999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-39  Score=244.95  Aligned_cols=214  Identities=22%  Similarity=0.376  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------AEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ..+.+|+.+++.++|+||+++++++......|++|||+.+++|.+++.....       ....+...+..++.|++.||.
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  133 (288)
T cd05061          54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA  133 (288)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999988999999999999999999975321       233567788899999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      |||+.   |++|+||||+||+++.++.++++|||.+.........  .....++..|+|||.+.+..++.++|+||||++
T Consensus       134 ~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~  210 (288)
T cd05061         134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV  210 (288)
T ss_pred             HHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence            99999   9999999999999999999999999988754332221  112234667999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +|+|++ |..||....      .......+.........   ...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       211 l~el~~~~~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         211 LWEITSLAEQPYQGLS------NEQVLKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             HHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            999998 788875322      12222222222222111   1335679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-38  Score=242.02  Aligned_cols=206  Identities=26%  Similarity=0.437  Sum_probs=169.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++++.|+||+++++.+..+...|+||||+++++|.+++..+    .++..++..++.|++.++.+||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~--  120 (277)
T cd06640          47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE--  120 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            45788999999999999999999999999999999999999999988643    278888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       121 -~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06640         121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             -CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence             9999999999999999999999999998766543333334457788999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||......      ...........+.   .....+..+.+++.+||+.+|.+|||+.++++
T Consensus       200 p~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         200 PNSDMHPM------RVLFLIPKNNPPT---LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCCCcChH------hHhhhhhcCCCCC---CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            97543211      1111111111111   12345667899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.9e-39  Score=242.41  Aligned_cols=207  Identities=28%  Similarity=0.465  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++......++++||+++++|.+++....   .++...+..++.|++.||.+||+.  
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~--  125 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR--  125 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc--
Confidence            457889999999999999999999999999999999999999999997643   378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC------ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                       |++|+||+|+||+++.++.++|+|||.+.........      .....++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       126 -~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~  204 (267)
T cd06628         126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE  204 (267)
T ss_pred             -CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence             9999999999999999999999999988766522111      112346788999999988888999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +++|..||.....      ............+...   ...+..+.++|.+||+.+|.+||++.++++
T Consensus       205 l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         205 MLTGKHPFPDCTQ------LQAIFKIGENASPEIP---SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HhhCCCCCCCccH------HHHHHHHhccCCCcCC---cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            9999999864321      1111121111111111   234567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-39  Score=248.08  Aligned_cols=209  Identities=24%  Similarity=0.432  Sum_probs=170.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++..+...|+++||+++++|..++...    .+++..++.++.|++.||.+||+. 
T Consensus        62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~-  136 (297)
T cd06659          62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ-  136 (297)
T ss_pred             HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            356789999999999999999999999999999999999999999887542    378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       137 --~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  214 (297)
T cd06659         137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE  214 (297)
T ss_pred             --CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999876544333334456788999999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+.. ............+..+.+++.+||+.+|.+|||+.++++
T Consensus       215 ~p~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         215 PPYFSDSP------VQAMKRLRD-SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCCCCCH------HHHHHHHhc-cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            99853221      112222111 111111122345567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-40  Score=247.81  Aligned_cols=211  Identities=31%  Similarity=0.512  Sum_probs=168.5

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ..+|+.++++++|+||+++++++......+++||++.+++|.+++...   ..++...++.++.|++.||.+||+.   |
T Consensus        45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~  118 (260)
T PF00069_consen   45 NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---G  118 (260)
T ss_dssp             HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhhhhcccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccc---c
Confidence            355999999999999999999999999999999999999999999732   2389999999999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-cCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      ++|+||||+||+++.++.++|+|||.+..............++..|.|||.+. +..++.++|+||||+++|+|++|..|
T Consensus       119 i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p  198 (260)
T PF00069_consen  119 IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP  198 (260)
T ss_dssp             EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999876433333344567788999999988 77889999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.....   .+..........................+.+++.+||+.||++|||+.++++
T Consensus       199 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  199 FEESNS---DDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             STTSSH---HHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccc---hhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            864411   1111122222111111111111122368999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-38  Score=239.83  Aligned_cols=211  Identities=28%  Similarity=0.473  Sum_probs=169.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|++++++++++......++++||+.+++|.+++.....  .+++..++.++.|++.++++||+.  
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--  119 (256)
T cd05112          44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS--  119 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5788999999999999999999999998999999999999999999875432  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       +++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       120 -~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g  198 (256)
T cd05112         120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEG  198 (256)
T ss_pred             -CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCC
Confidence             9999999999999999999999999988765432211 112234568999999988889999999999999999998 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||....      ................   ....+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       199 ~~p~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         199 KTPYENRS------NSEVVETINAGFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCcCC------HHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            99975322      1122222211111100   0123457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.3e-39  Score=244.66  Aligned_cols=206  Identities=27%  Similarity=0.445  Sum_probs=169.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+..+...|+|+||+++++|.+++..+    .++...+..++.|++.|+.|||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--  120 (277)
T cd06642          47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE--  120 (277)
T ss_pred             HHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC--
Confidence            46889999999999999999999999999999999999999999988642    378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus       121 -~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06642         121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             -CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765543333333457788999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.....      ............+..   ....+.++.+++.+||+.+|.+|||+.++++
T Consensus       200 p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         200 PNSDLHP------MRVLFLIPKNSPPTL---EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCcccch------hhHHhhhhcCCCCCC---CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9753221      111111111111111   1234567889999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-38  Score=241.70  Aligned_cols=213  Identities=27%  Similarity=0.511  Sum_probs=169.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|..|+.+++.++||||+++++++..+...++++||+.+++|.+++....  ..+++.+++.++.|++.||.+||+. 
T Consensus        49 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~-  125 (269)
T cd05065          49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM-  125 (269)
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3578899999999999999999999999999999999999999999987543  2388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecc---cccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~---~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                        |++|+||+|+||+++.++.++++|||.+.........  .....   .+..|+|||.+.+..++.++||||+|+++|+
T Consensus       126 --g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e  203 (269)
T cd05065         126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  203 (269)
T ss_pred             --CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence              9999999999999999999999999988755432211  11111   1347999999988889999999999999999


Q ss_pred             HHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++ |..||.....      ......+......+.   ...++..+.+++.+||..+|.+||++.+++..|++
T Consensus       204 ~l~~g~~p~~~~~~------~~~~~~i~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         204 VMSYGERPYWDMSN------QDVINAIEQDYRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             HhcCCCCCCCCCCH------HHHHHHHHcCCcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            886 9999753321      112222211111111   12445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.5e-38  Score=239.34  Aligned_cols=209  Identities=26%  Similarity=0.413  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+|++++++++..+ ..+++|||+.+++|.+++..... ..++...++.++.|++.|+.+||+.  
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~--  119 (254)
T cd05083          44 QAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK--  119 (254)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5688999999999999999999998654 47999999999999999875432 3478899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~  161 (228)
                       |++||||+|+||+++.++.++|+|||.+......   ......+..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus       120 -~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~  195 (254)
T cd05083         120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR  195 (254)
T ss_pred             -CeeccccCcceEEEcCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999988754322   122234567999999988889999999999999999997 99


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      .||.....      ......+........   ....+..+.+++.+||+.+|.+|||++++++.|++
T Consensus       196 ~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         196 APYPKMSL------KEVKECVEKGYRMEP---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCccCCH------HHHHHHHhCCCCCCC---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            99864322      112222222211111   12456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-38  Score=239.86  Aligned_cols=212  Identities=25%  Similarity=0.439  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+.. ...++++||+++++|.+++..... ...++.+++.++.|++.||.+||+.  
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~--  121 (260)
T cd05073          46 EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR--  121 (260)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC--
Confidence            568899999999999999999999887 778999999999999999876432 3478889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                       |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       122 -~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g  200 (260)
T cd05073         122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG  200 (260)
T ss_pred             -CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcC
Confidence             9999999999999999999999999988765432211 122334567999999988888999999999999999998 9


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||.....      ......+........   ....+.++.+++.+||+.+|++|||+.++++.|+.
T Consensus       201 ~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         201 RIPYPGMSN------PEVIRALERGYRMPR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCCCCH------HHHHHHHhCCCCCCC---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999864321      112222211111111   12455678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-38  Score=246.35  Aligned_cols=213  Identities=23%  Similarity=0.373  Sum_probs=166.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~   81 (228)
                      .++.+|++++++++||||+++++.|..+...++++||+++++|.+++...   ..++...+..++.|+++||.|||+ . 
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~-  119 (308)
T cd06615          44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH-  119 (308)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC-
Confidence            45789999999999999999999999999999999999999999998754   237889999999999999999997 5 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        +++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus       120 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~  195 (308)
T cd06615         120 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR  195 (308)
T ss_pred             --CEEECCCChHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence              89999999999999999999999999886543221  23346788999999988888899999999999999999999


Q ss_pred             CCccccccccCCCch------------------------------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhcc
Q 040501          162 HPRDFLSNVSSSNPN------------------------------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN  211 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  211 (228)
                      .||............                              ...........+..+  ...++.++.+++.+||..
T Consensus       196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~  273 (308)
T cd06615         196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKK  273 (308)
T ss_pred             CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccC
Confidence            997532211000000                              000000000000000  012456789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040501          212 NPESRPNMQTICQL  225 (228)
Q Consensus       212 ~p~~Rpt~~~il~~  225 (228)
                      +|.+|||+.++++.
T Consensus       274 ~P~~Rpt~~~ll~~  287 (308)
T cd06615         274 NPKERADLKELTKH  287 (308)
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.9e-39  Score=243.61  Aligned_cols=205  Identities=25%  Similarity=0.413  Sum_probs=160.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.+++.++|+||+++++++..+...++||||+++++|..++.....  .+++..+..++.|++.||+|||+.  
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--  136 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK--  136 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC--
Confidence            4577899999999999999999999999999999999999999998865332  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCC-------ceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEY-------EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLA  154 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l  154 (228)
                       |++|+||||+||+++..+       .++++|||.+......    ....++..|+|||.+.+ ..++.++|+||||+++
T Consensus       137 -~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l  211 (274)
T cd05076         137 -NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL  211 (274)
T ss_pred             -CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence             999999999999997643       3799999987543221    12346678999998865 4578899999999999


Q ss_pred             HHHH-hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          155 LEVI-KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       155 ~~~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+++ +|..||.......   .......  ....+.      .....+.++|.+||+.+|.+|||+.++++.|+
T Consensus       212 ~el~~~g~~p~~~~~~~~---~~~~~~~--~~~~~~------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         212 LEICFDGEVPLKERTPSE---KERFYEK--KHRLPE------PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHhCCCCCccccChHH---HHHHHHh--ccCCCC------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            9984 6899875332111   0011110  011111      12236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-38  Score=242.08  Aligned_cols=211  Identities=24%  Similarity=0.389  Sum_probs=168.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.+.|+||+++++++.. ...|++||++++++|.+++.....  .+++.+++.++.+++.||+|||+. 
T Consensus        51 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-  126 (270)
T cd05056          51 REKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK-  126 (270)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999998875 457899999999999999976433  378999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++++|||++......... .....++..|+|||.+....++.++|+||||+++|++++ 
T Consensus       127 --~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  204 (270)
T cd05056         127 --RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML  204 (270)
T ss_pred             --CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHc
Confidence              9999999999999999999999999998765433221 112233467999999888888999999999999999986 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||......      .....+........   ....+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       205 g~~pf~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         205 GVKPFQGVKNN------DVIGRIENGERLPM---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CCCCCCCCCHH------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99998643221      11222222111111   1245567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-38  Score=243.72  Aligned_cols=218  Identities=24%  Similarity=0.399  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|+++++.++|+||+++.+++...  ...+++|||+++++|.+++.....  .+++..++.++.|++.||+|||+.
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~  128 (284)
T cd05079          51 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR  128 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4688999999999999999999998764  578999999999999999865432  378999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||+++.++.++|+|||.+.........   .....++..|+|||.+.+..++.++||||||+++|++
T Consensus       129 ---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el  205 (284)
T cd05079         129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL  205 (284)
T ss_pred             ---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhh
Confidence               9999999999999999999999999998865433221   1223456679999998888889999999999999999


Q ss_pred             HhCCCCccccccc--------cC-CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          158 IKGKHPRDFLSNV--------SS-SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       158 ~~g~~p~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++..|.......        .. ................+   ....++..+.+++.+||+.||.+|||++++++.|++
T Consensus       206 lt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         206 LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             hcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            9977653211000        00 00000111111111111   112456689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-39  Score=243.39  Aligned_cols=213  Identities=25%  Similarity=0.433  Sum_probs=172.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      ++.+.+|++++++++|+||+++++.+......++++|++.+++|.+++....  ..++...+..++.|++.++++||+ .
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~  120 (265)
T cd06605          43 QKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH  120 (265)
T ss_pred             HHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC
Confidence            3568899999999999999999999999999999999999999999987643  348889999999999999999999 8


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++|+|||.+.........  ...++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       121 ---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g  195 (265)
T cd06605         121 ---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG  195 (265)
T ss_pred             ---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence               9999999999999999999999999988765322211  15677889999999888899999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||...... ................+.....  ..+..+.++|.+||..||.+|||+.+++.
T Consensus       196 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         196 RFPYPPENDP-PDGIFELLQYIVNEPPPRLPSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCCccccc-cccHHHHHHHHhcCCCCCCChh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            9998643221 1112222333333322222211  25667899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-39  Score=247.64  Aligned_cols=209  Identities=25%  Similarity=0.428  Sum_probs=169.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++.+..+...|+++|++++++|.+++...    .++..++..++.|++.|+.|||+.  
T Consensus        64 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~--  137 (292)
T cd06658          64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ--  137 (292)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46789999999999999999999999999999999999999999988543    378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       138 -~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~  216 (292)
T cd06658         138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP  216 (292)
T ss_pred             -CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765433333344567889999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ||.....      ......... ..+.........+..+.+++.+||..||.+|||+.++++.
T Consensus       217 p~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         217 PYFNEPP------LQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCCCCH------HHHHHHHHh-cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            9853221      111111111 1111111112345578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7e-39  Score=244.96  Aligned_cols=213  Identities=23%  Similarity=0.387  Sum_probs=167.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+|++++++++......++++||+++++|..+.....   .+++..+..++.|++.+|.|||+.  
T Consensus        45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~--  119 (286)
T cd07847          45 KIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH--  119 (286)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457889999999999999999999999999999999999988887765432   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus       120 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~  198 (286)
T cd07847         120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ  198 (286)
T ss_pred             -CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999876544333334456788999998866 45788999999999999999999


Q ss_pred             CCccccccccCCCchhhhhh---------------------hcCCCCC---CCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          162 HPRDFLSNVSSSNPNILVNE---------------------MLDPRLP---PLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      .||........   ......                     ...+...   +........+..+.+++.+||+.+|.+||
T Consensus       199 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  275 (286)
T cd07847         199 PLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL  275 (286)
T ss_pred             CCCCCCChHHH---HHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence            99864332110   000000                     0000000   00011234466789999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.+++.
T Consensus       276 ~~~eil~  282 (286)
T cd07847         276 SCEELLE  282 (286)
T ss_pred             CHHHHhc
Confidence            9999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-38  Score=241.78  Aligned_cols=212  Identities=26%  Similarity=0.372  Sum_probs=166.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++..+...++++|++.+++|.+++.........+...+..++.|++.|++|||+.  
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--  127 (268)
T cd06624          50 QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--  127 (268)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC--
Confidence            467899999999999999999999999999999999999999999987543221237788889999999999999999  


Q ss_pred             CCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccCC--cccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.+..  ++.++|+||+|+++|++++
T Consensus       128 -~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~  206 (268)
T cd06624         128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT  206 (268)
T ss_pred             -CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence             9999999999999976 67899999999876543333333345788999999886543  7889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||.......    ............+..   ......++.+++.+||+.+|.+|||+.++++
T Consensus       207 g~~p~~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         207 GKPPFIELGEPQ----AAMFKVGMFKIHPEI---PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCCCccccChh----hhHhhhhhhccCCCC---CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            999985322111    001111111111111   1234567889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-38  Score=239.96  Aligned_cols=204  Identities=26%  Similarity=0.453  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+..|+.+++.++||||+++++++..+...++||||+.+++|.+++..+..  .+++..++.++.|++.|++|||+.  
T Consensus        44 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--  119 (258)
T cd05078          44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK--  119 (258)
T ss_pred             HHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678899999999999999999999998899999999999999999876543  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCc--------eEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYE--------AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~  153 (228)
                       |++|+||||+||+++.++.        ++++|||.+......    ....++..|+|||.+.+. .++.++|+||||++
T Consensus       120 -~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~  194 (258)
T cd05078         120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTT  194 (258)
T ss_pred             -CeecCCCccceEEEecccccccCCCceEEecccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHH
Confidence             9999999999999987765        589999987654321    224567789999998764 47889999999999


Q ss_pred             HHHHHhCC-CCccccccccCCCchhhhhhh-cCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          154 ALEVIKGK-HPRDFLSNVSSSNPNILVNEM-LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       154 l~~~~~g~-~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|++++|. .|+......      ...... .....+.      ..+.++.+++.+||+.||.+|||++++++.|.
T Consensus       195 l~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         195 LWEIFSGGDKPLSALDSQ------KKLQFYEDRHQLPA------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHcCCCCChhhccHH------HHHHHHHccccCCC------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            99999984 554322111      111100 0111111      23346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-38  Score=244.04  Aligned_cols=208  Identities=23%  Similarity=0.416  Sum_probs=170.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++++......++++||+.+++|.+++...    .++...+..++.|++.++++||+.  
T Consensus        61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~--  134 (285)
T cd06648          61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ--  134 (285)
T ss_pred             HHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            45789999999999999999999999999999999999999999998752    378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       135 -~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~  213 (285)
T cd06648         135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP  213 (285)
T ss_pred             -CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999987765433333334567889999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||....      ............ +.........+..+.+++.+||..+|.+|||+.++++
T Consensus       214 p~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         214 PYFNEP------PLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCcCCC------HHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            975322      112222222221 1111112235567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-38  Score=241.29  Aligned_cols=213  Identities=27%  Similarity=0.466  Sum_probs=172.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++.++.++|+||+++++.+......|+++|++.+++|.+++........+++..+..++.|++.|+.+||+.  
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~--  121 (267)
T cd06610          44 DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--  121 (267)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            567899999999999999999999999999999999999999999997654334588999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC-CcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~  157 (228)
                       |++|+||+|+||++++++.++|+|||.+.........    .....++..|+|||++... .++.++|+||||+++|+|
T Consensus       122 -~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l  200 (267)
T cd06610         122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL  200 (267)
T ss_pred             -CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHH
Confidence             9999999999999999999999999988766543322    1234577889999988776 688899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchh--hhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVD--IRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|+.||......      ...........+.....  ....+..+.+++.+||..||.+|||+.++++
T Consensus       201 ~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         201 ATGAAPYSKYPPM------KVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HhCCCCccccChh------hhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            9999998643221      12222222222111111  2356678899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.1e-39  Score=245.91  Aligned_cols=208  Identities=25%  Similarity=0.416  Sum_probs=168.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++++..+...|+|+||+++++|.+++...    .++..++..++.|++.+|.+||+.  
T Consensus        61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~--  134 (297)
T cd06656          61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN--  134 (297)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46788999999999999999999999999999999999999999998643    278889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       135 -~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~  213 (297)
T cd06656         135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP  213 (297)
T ss_pred             -CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998765443333334567889999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.......      ..........+. .......+..+.+++.+||..+|.+|||++++++
T Consensus       214 pf~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         214 PYLNENPLR------ALYLIATNGTPE-LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCcch------heeeeccCCCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            985332211      111111111111 1112234566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-38  Score=247.01  Aligned_cols=160  Identities=23%  Similarity=0.388  Sum_probs=131.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDT------SAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ..+.+|++++++++||||+++++.+..  +...|+++|++.+ +|.+++....      ....++...+..++.|++.||
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  121 (317)
T cd07868          43 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI  121 (317)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence            357889999999999999999999854  4578999999864 7777765321      122478899999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEE----cCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccC-Ccccchh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTM-KVTAKCD  146 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~D  146 (228)
                      .|||+.   |++||||||+||++    +.++.+||+|||++.........   .....+++.|+|||++.+. .++.++|
T Consensus       122 ~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  198 (317)
T cd07868         122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID  198 (317)
T ss_pred             HHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhh
Confidence            999999   99999999999999    45578999999999765433221   2335678899999998764 5788999


Q ss_pred             hhhHHHHHHHHHhCCCCccc
Q 040501          147 VYSFGVLALEVIKGKHPRDF  166 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~  166 (228)
                      +||+||++|+|++|.+||..
T Consensus       199 iwslG~il~el~~g~~~f~~  218 (317)
T cd07868         199 IWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             HHHHHHHHHHHHhCCCCccC
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-38  Score=239.38  Aligned_cols=212  Identities=29%  Similarity=0.482  Sum_probs=172.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+..|+.+++.++|+||+++++++......+++||++.+++|.+++...... .+++.++..++.|++.+|++||+. 
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~-  122 (258)
T smart00219       45 IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK-  122 (258)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            457889999999999999999999999999999999999999999998754321 278999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce-ecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT-EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++++|||.+........... ...+++.|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       123 --~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~  200 (258)
T smart00219      123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL  200 (258)
T ss_pred             --CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence              999999999999999999999999999887654322211 1235678999999888888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |..||...      ..................   ...+.++.+++.+||..+|.+|||+.++++.|
T Consensus       201 g~~p~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      201 GESPYPGM------SNEEVLEYLKKGYRLPKP---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCC------CHHHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            78887532      222222233222222211   23566799999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-38  Score=248.06  Aligned_cols=214  Identities=23%  Similarity=0.404  Sum_probs=170.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++++ +|+||+++++++......++++||+++++|.+++....             ....+++.+++.++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY  141 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            4678999999999 79999999999999999999999999999999987532             123477888999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||+|||+.   |++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|
T Consensus       142 qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  218 (334)
T cd05100         142 QVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  218 (334)
T ss_pred             HHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhh
Confidence            999999999999   9999999999999999999999999998765432211  11123346799999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|+|++ |..||....      .......+.........   ...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       219 i~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         219 VWSFGVLLWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999999999998 888875332      22222222222211111   2345578899999999999999999999998


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       290 l~~  292 (334)
T cd05100         290 LDR  292 (334)
T ss_pred             HHH
Confidence            863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.5e-39  Score=251.91  Aligned_cols=212  Identities=22%  Similarity=0.343  Sum_probs=159.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.+++.++||||+++++++...      ...|+||||+.+ +|...+..     .++...+..++.|++.||.|
T Consensus        65 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999998644      357999999976 45555432     27788889999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   |++||||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       139 LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e  214 (359)
T cd07876         139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  214 (359)
T ss_pred             HHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHH
Confidence            9999   9999999999999999999999999998754322 12233467889999999999899999999999999999


Q ss_pred             HHhCCCCccccccccC---------CCchh-------hhhhhc--CCCCCC--------------CchhhhhhHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSS---------SNPNI-------LVNEML--DPRLPP--------------LSVDIRGKVISIMEV  204 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~---------~~~~~-------~~~~~~--~~~~~~--------------~~~~~~~~~~~~~~l  204 (228)
                      |++|..||........         .....       ......  .+..+.              ........+..+.++
T Consensus       215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  294 (359)
T cd07876         215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL  294 (359)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence            9999999864322110         00000       000000  000000              000011224568899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||..||.+|||++|+++
T Consensus       295 i~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         295 LSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHhccCcccCCCHHHHhc
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.6e-39  Score=260.50  Aligned_cols=210  Identities=25%  Similarity=0.320  Sum_probs=169.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC--------eEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR--------HSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~   73 (228)
                      ..+.+|+..+..++|+||+++.+.+....        ..++||||+.+++|.+++.... ....+++..+..++.|++.|
T Consensus        76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~a  155 (496)
T PTZ00283         76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA  155 (496)
T ss_pred             HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            46788999999999999999988775322        3689999999999999886532 23458899999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      |.|||+.   |++||||||+||+++.++.+||+|||++........  ......|++.|+|||++.+..++.++||||||
T Consensus       156 L~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlG  232 (496)
T PTZ00283        156 VHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG  232 (496)
T ss_pred             HHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHH
Confidence            9999999   999999999999999999999999999876543211  12345689999999999998899999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +++|+|++|..||...      .................+   ...+.++.+++.+||+.||.+|||+.++++
T Consensus       233 vilyeLltG~~Pf~~~------~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        233 VLLYELLTLKRPFDGE------NMEEVMHKTLAGRYDPLP---PSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHHHHHCCCCCCCC------CHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            9999999999998532      222333333333332221   245667899999999999999999999875

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.6e-38  Score=247.46  Aligned_cols=218  Identities=20%  Similarity=0.283  Sum_probs=162.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||++++++|..+...|+|+||+++++|.+++..+.. ..+++..++.++.|++.||+|||+.  
T Consensus        44 ~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~--  120 (327)
T cd08227          44 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM--  120 (327)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3567899999999999999999999999999999999999999999865432 2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-------ceecccccceeCCccccc--CCcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~  153 (228)
                       |++|+||||+||+++.++.++++||+...........       .....++..|+|||++.+  ..++.++|||||||+
T Consensus       121 -~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~i  199 (327)
T cd08227         121 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT  199 (327)
T ss_pred             -CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHH
Confidence             9999999999999999999999999854432211110       111245667999999876  358899999999999


Q ss_pred             HHHHHhCCCCccccccccCCCch--hhhhhhc-------------------C-----------CCC----CCCchhhhhh
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPN--ILVNEML-------------------D-----------PRL----PPLSVDIRGK  197 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~--~~~~~~~-------------------~-----------~~~----~~~~~~~~~~  197 (228)
                      +|++++|..||............  .......                   +           ...    ..........
T Consensus       200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (327)
T cd08227         200 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTF  279 (327)
T ss_pred             HHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccccc
Confidence            99999999998642211000000  0000000                   0           000    0000011234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          198 VISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       198 ~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +..+.+++.+||+.||.+|||++++++
T Consensus       280 ~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         280 SPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             CHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-38  Score=243.71  Aligned_cols=220  Identities=26%  Similarity=0.418  Sum_probs=171.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.|.+|+++++.+.|+||+++++++..  ....++++||+.+++|.+++.....  .+++..++.++.|++.||++||+
T Consensus        50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~  127 (284)
T cd05038          50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS  127 (284)
T ss_pred             HHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHh
Confidence            3578999999999999999999999877  5688999999999999999976543  38899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce---ecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||+|+||+++.++.++|+|||.+...........   ...++..|++||.+.+..++.++|+||||+++|+
T Consensus       128 ~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~e  204 (284)
T cd05038         128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYE  204 (284)
T ss_pred             C---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhe
Confidence            9   999999999999999999999999999987653322211   1234556999999988888999999999999999


Q ss_pred             HHhCCCCccccccccCC--------CchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIKGKHPRDFLSNVSSS--------NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++|..|+.........        .................  ....++.++.+++.+||+.+|.+|||+.++++.|++
T Consensus       205 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         205 LFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             eeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            99999987532211100        00111111111111100  012345679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-38  Score=245.86  Aligned_cols=216  Identities=18%  Similarity=0.258  Sum_probs=164.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.+++.++|+||+++++++......++|+||+. ++|.+++.....  .+++..+..++.|++.||.+||+.  
T Consensus        49 ~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~--  123 (301)
T cd07873          49 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR--  123 (301)
T ss_pred             hHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            356789999999999999999999999999999999997 478887765432  378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus       124 -~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~  202 (301)
T cd07873         124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR  202 (301)
T ss_pred             -CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987654333333334568899999987654 4788999999999999999999


Q ss_pred             CCccccccccCC---------Cchhhhhhhc------CCCCCCC-----chhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSS---------NPNILVNEML------DPRLPPL-----SVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      +||.........         ..........      ....+..     .......+..+.++|.+||+.||.+|||+++
T Consensus       203 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e  282 (301)
T cd07873         203 PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE  282 (301)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence            998643211000         0000000000      0000100     0011234567889999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       283 il~  285 (301)
T cd07873         283 AMK  285 (301)
T ss_pred             Hhc
Confidence            986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=254.14  Aligned_cols=212  Identities=24%  Similarity=0.415  Sum_probs=180.3

Q ss_pred             ChHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            1 DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      |++.|+.|+.+++.+.||||++++++|.+. ..|||||.++-|.|..++..+...  ++......++.|++.|++|||+.
T Consensus       434 ~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSk  510 (974)
T KOG4257|consen  434 DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESK  510 (974)
T ss_pred             hHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhh
Confidence            467899999999999999999999999875 689999999999999999876654  88899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce-ecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT-EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                         +.+||||...||+++....+|++|||+++.+........ ...-+.-|||||.+.-..++.+||||.||+.+||++.
T Consensus       511 ---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~  587 (974)
T KOG4257|consen  511 ---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS  587 (974)
T ss_pred             ---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHH
Confidence               999999999999999999999999999998876554432 2334668999999999999999999999999999986


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       |..||++...-      +.+..+..+...+.+   .++++.++.++.+||..+|.+||++.++...|.
T Consensus       588 lGvkPfqgvkNs------DVI~~iEnGeRlP~P---~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  588 LGVKPFQGVKNS------DVIGHIENGERLPCP---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             hcCCcccccccc------ceEEEecCCCCCCCC---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence             99998754332      233444444433332   367778999999999999999999999988764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-39  Score=247.79  Aligned_cols=206  Identities=22%  Similarity=0.357  Sum_probs=175.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..++.|+..|+.++|||||+++++...+..+|+|+|.-++|+|+++|-.+..+  +.+.-+.+++.||+.||.|+|+.  
T Consensus        62 ~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL--  137 (864)
T KOG4717|consen   62 GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL--  137 (864)
T ss_pred             hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh--
Confidence            45789999999999999999999999999999999999999999999766544  89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCccc-chhhhhHHHHHHHHHhC
Q 040501           83 PPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKG  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~~~~g  160 (228)
                       .++||||||+||.+. .-|.+||+|||.+....+. ...++.+|+..|-|||++.|..|+. +.||||||+++|.+++|
T Consensus       138 -HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCG  215 (864)
T KOG4717|consen  138 -HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCG  215 (864)
T ss_pred             -hhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence             999999999998664 5599999999999877644 3456678999999999999999874 78999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++||+..+      ..+.+..+++-+....    .-.+.+-.+||..||..||++|.|.++|..
T Consensus       216 q~PFqeAN------DSETLTmImDCKYtvP----shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  216 QPPFQEAN------DSETLTMIMDCKYTVP----SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             CCcccccc------chhhhhhhhcccccCc----hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            99987443      2334445555554332    234556679999999999999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.3e-38  Score=241.55  Aligned_cols=213  Identities=23%  Similarity=0.378  Sum_probs=169.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSA-----EELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.++++++|+||+++++++.. +...+++++++.+++|.+++......     ..++..+++.++.|++.||.|
T Consensus        53 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  132 (280)
T cd05043          53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY  132 (280)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            457889999999999999999998765 56789999999999999998654322     458899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      ||+.   +++|+||+|+||+++.++.++++|||+++........  .....++..|+|||.+.+..++.++||||||+++
T Consensus       133 LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l  209 (280)
T cd05043         133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL  209 (280)
T ss_pred             HHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence            9999   9999999999999999999999999998755322211  1122345679999999888899999999999999


Q ss_pred             HHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          155 LEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       155 ~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++++ |..||.....      ...............   ...++.++.+++.+||..+|++|||+.++++.|+
T Consensus       210 ~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         210 WELMTLGQTPYVEIDP------FEMAAYLKDGYRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             HHHhcCCCCCcCcCCH------HHHHHHHHcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            99998 9999754322      122222212211111   1234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-39  Score=246.29  Aligned_cols=211  Identities=21%  Similarity=0.316  Sum_probs=163.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++.+....++++||+.+ +|.+++....  ..+++..++.++.|+++||.|||+.  
T Consensus        44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~--  118 (284)
T cd07839          44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH--  118 (284)
T ss_pred             cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3567899999999999999999999999999999999975 6777665432  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+.. ++.++||||||+++|+|++|.
T Consensus       119 -~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~  197 (284)
T cd07839         119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  197 (284)
T ss_pred             -CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence             999999999999999999999999999876554333333445678899999887654 688999999999999999998


Q ss_pred             CCccccccccCCCchhhhhhh------------------cC-CCCCCC------chhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          162 HPRDFLSNVSSSNPNILVNEM------------------LD-PRLPPL------SVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~------------------~~-~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      .|+......     ......+                  .. ...+..      .......+.++.++|.+||+.||.+|
T Consensus       198 ~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  272 (284)
T cd07839         198 RPLFPGNDV-----DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR  272 (284)
T ss_pred             CCCcCCCCH-----HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence            885321110     0000000                  00 000000      01112356678899999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||++++++
T Consensus       273 ~t~~~il~  280 (284)
T cd07839         273 ISAEEALQ  280 (284)
T ss_pred             CCHHHHhc
Confidence            99999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.5e-39  Score=248.42  Aligned_cols=201  Identities=21%  Similarity=0.308  Sum_probs=163.8

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|..++..+. |++|+++.+++......|+||||+.+++|.+++....   .+++.++..++.|++.||.|||+. 
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~-  120 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR-  120 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            34677888888885 6888899999999999999999999999999887543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||+|+++|+|++|.
T Consensus       121 --~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~  198 (323)
T cd05615         121 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ  198 (323)
T ss_pred             --CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCC
Confidence              999999999999999999999999999875433333334456889999999998888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||....      .......+.......    ....+.++.+++.+||+.+|.+|++.
T Consensus       199 ~pf~~~~------~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         199 PPFDGED------EDELFQSIMEHNVSY----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCCCCC------HHHHHHHHHhCCCCC----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            9986432      222333333322211    12345578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-38  Score=242.46  Aligned_cols=218  Identities=27%  Similarity=0.429  Sum_probs=165.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++|+||+++++++..  ....++|+||+++++|.+++.....  .+++..++.++.|++.||.|||+.
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~  127 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK  127 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999999999999998743  3568999999999999999865432  378899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---eecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||+++.++.++|+|||++..........   ....++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       128 ---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  204 (284)
T cd05081         128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL  204 (284)
T ss_pred             ---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHH
Confidence               99999999999999999999999999988664332211   111234469999999888899999999999999999


Q ss_pred             HhCCCCcccccccc-----CCCc----hhhhhhhcC-CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          158 IKGKHPRDFLSNVS-----SSNP----NILVNEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       158 ~~g~~p~~~~~~~~-----~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ++|..++.......     ....    ......... ....+   .....+.++.+++.+||..+|.+|||+.++++.|+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         205 FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             hhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            99877653221100     0000    000001111 11111   11234567999999999999999999999999986


Q ss_pred             C
Q 040501          228 K  228 (228)
Q Consensus       228 ~  228 (228)
                      .
T Consensus       282 ~  282 (284)
T cd05081         282 A  282 (284)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-38  Score=244.21  Aligned_cols=211  Identities=23%  Similarity=0.385  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~   81 (228)
                      +.+.+|++++++++|+||+++++.+......|+++||+++++|..++........+++..+..++.|++.|+.|||+ . 
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-  122 (286)
T cd06622          44 NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH-  122 (286)
T ss_pred             HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence            46889999999999999999999999999999999999999999988764333458999999999999999999996 5 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC------cccchhhhhHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK------VTAKCDVYSFGVLAL  155 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~  155 (228)
                        |++|+||+|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+..      ++.++|+||+|+++|
T Consensus       123 --~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~  198 (286)
T cd06622         123 --NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL  198 (286)
T ss_pred             --CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence              99999999999999999999999999887543221  22345677899999885543      478999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++++|..||......   ........+.....+...   ..++.++.++|.+||+.+|.+||++.++++
T Consensus       199 ~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         199 EMALGRYPYPPETYA---NIFAQLSAIVDGDPPTLP---SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHhCCCCCCCcchh---hHHHHHHHHhhcCCCCCC---cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            999999998643211   111122222222222221   235667899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=256.34  Aligned_cols=216  Identities=20%  Similarity=0.263  Sum_probs=163.0

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++|+||+++++++..+...++++|++. ++|.+++.....  .+++.+++.++.|++.||.|||+.   
T Consensus       206 ~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---  279 (461)
T PHA03211        206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---  279 (461)
T ss_pred             CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            46789999999999999999999999999999999995 577777754332  489999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                      ||+||||||+||+++.++.++|+|||++.........  .....|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus       280 gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~  359 (461)
T PHA03211        280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT  359 (461)
T ss_pred             CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence            9999999999999999999999999998765332211  22356899999999999988999999999999999999887


Q ss_pred             CCccccccccC-CCchhhhhhhcCC------CCCC----------------------Cchhh---hhhHHHHHHHHHHhh
Q 040501          162 HPRDFLSNVSS-SNPNILVNEMLDP------RLPP----------------------LSVDI---RGKVISIMEVAFLCL  209 (228)
Q Consensus       162 ~p~~~~~~~~~-~~~~~~~~~~~~~------~~~~----------------------~~~~~---~~~~~~~~~li~~~l  209 (228)
                      .++........ ......+.+++..      ..+.                      ....+   ......+.+||.+||
T Consensus       360 ~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  439 (461)
T PHA03211        360 ASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRAL  439 (461)
T ss_pred             CCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHc
Confidence            65422111100 0000011111000      0000                      00001   123346889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 040501          210 DNNPESRPNMQTICQL  225 (228)
Q Consensus       210 ~~~p~~Rpt~~~il~~  225 (228)
                      +.||.+|||+.|+++.
T Consensus       440 ~~DP~~RPsa~elL~h  455 (461)
T PHA03211        440 TFDGARRPSAAELLRL  455 (461)
T ss_pred             ccChhhCcCHHHHhhC
Confidence            9999999999999873

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-39  Score=249.39  Aligned_cols=209  Identities=26%  Similarity=0.379  Sum_probs=165.1

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.|..|+..|.+|+ |.+|+.+++|-..++.+|+|||+- .-+|..+++.....  .+.-.+..+..|++.++.++|.. 
T Consensus       404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~-  479 (677)
T KOG0596|consen  404 DGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQH-  479 (677)
T ss_pred             HHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHh-
Confidence            45789999999995 999999999998899999999955 56899999865433  33237788999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCC-----------cccchhhh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMK-----------VTAKCDVY  148 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-----------~~~~~Diw  148 (228)
                        ||||.||||.|+++- .|.+||+|||++..+..+...  .....||+.||+||.+....           .+.+||||
T Consensus       480 --gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW  556 (677)
T KOG0596|consen  480 --GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW  556 (677)
T ss_pred             --ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence              999999999999886 479999999999988766554  45678999999999886442           45789999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||++|+|+.|++||+....     ....+..+.++...-.... ..-..++.++++.||..||++|||+.++|+
T Consensus       557 SLGCILYqMvYgktPf~~~~n-----~~aKl~aI~~P~~~Iefp~-~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  557 SLGCILYQMVYGKTPFGQIIN-----QIAKLHAITDPNHEIEFPD-IPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hhhhHHHHHHhcCCchHHHHH-----HHHHHHhhcCCCccccccC-CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            999999999999999974432     2223344444432111111 111223889999999999999999999985

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3e-39  Score=254.56  Aligned_cols=208  Identities=21%  Similarity=0.272  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++..++|++|+++++.+......|+||||+++++|.+++....   .++...+..++.|++.||.|||+.  
T Consensus        46 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~--  120 (360)
T cd05627          46 AHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL--  120 (360)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            456789999999999999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-----------------------------------Cceecccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-----------------------------------NWTEFAGT  127 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------~~~~~~~~  127 (228)
                       |++||||||+||+++.+|.++|+|||++........                                   ......|+
T Consensus       121 -givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  199 (360)
T cd05627         121 -GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT  199 (360)
T ss_pred             -CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence             999999999999999999999999998865422100                                   01124688


Q ss_pred             cceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHH
Q 040501          128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL  207 (228)
Q Consensus       128 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  207 (228)
                      +.|+|||++.+..++.++|+|||||++|+|++|..||.....      ......+...............+.+..++|.+
T Consensus       200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~  273 (360)
T cd05627         200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP------QETYRKVMNWKETLVFPPEVPISEKAKDLILR  273 (360)
T ss_pred             ccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCH------HHHHHHHHcCCCceecCCCCCCCHHHHHHHHH
Confidence            999999999998999999999999999999999999864322      22222222211100000111245567889988


Q ss_pred             hhccCCCCCCC---HHHHH
Q 040501          208 CLDNNPESRPN---MQTIC  223 (228)
Q Consensus       208 ~l~~~p~~Rpt---~~~il  223 (228)
                      |+ .||.+|++   +.+++
T Consensus       274 l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         274 FC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             hc-cChhhcCCCCCHHHHh
Confidence            77 49999986   45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.7e-38  Score=239.66  Aligned_cols=216  Identities=23%  Similarity=0.336  Sum_probs=163.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.+.+|+.+++.++||||+++++.+......|++|||+.+++|.+++..... ....+...+..++.|++.||+|||+.
T Consensus        39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  118 (268)
T cd05086          39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH  118 (268)
T ss_pred             HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            35788999999999999999999999999999999999999999999875432 23366777889999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCccccc-------CCcccchhhhhHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYT-------MKVTAKCDVYSFG  151 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG  151 (228)
                         +++|+||||+||+++.++.++|+|||++.......  .......++..|+|||++..       ..++.++||||||
T Consensus       119 ---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  195 (268)
T cd05086         119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALG  195 (268)
T ss_pred             ---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHH
Confidence               99999999999999999999999999875432111  11223456788999998743       2356789999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCC--CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++ |..||.....      ..............  .+.....+...+.+++..|| .+|.+|||++++++.|.
T Consensus       196 ~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         196 VTLWELFENAAQPYSHLSD------REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHhCCCCCCCCCCH------HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            99999996 5667643221      11222211111100  01111235567889999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-38  Score=241.10  Aligned_cols=207  Identities=25%  Similarity=0.385  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++.+....++++||+++++|.+++.+..   .++...+..++.|++.++++||+.  
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  121 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN--  121 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            457889999999999999999999999999999999999999999987643   278899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC------CCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS------SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                       +++|+||+|+||+++.++.++|+|||.+.......      .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus       122 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~  200 (265)
T cd06631         122 -CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE  200 (265)
T ss_pred             -CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence             99999999999999999999999999887643211      11223457888999999988888999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCC--CCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +++|..||.......      ........  ..+..   ...++.++.++|.+||..+|.+|||+.++++
T Consensus       201 l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         201 MATGKPPLASMDRLA------AMFYIGAHRGLMPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHhCCCccccCChHH------HHHHhhhccCCCCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            999999986432211      11111111  11111   1245667899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-38  Score=242.88  Aligned_cols=214  Identities=27%  Similarity=0.437  Sum_probs=170.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      ++.+.+|+++++.++|+||+++++++......++|+||+++++|.+++....   .++...+..++.+++.++.|||+ .
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~  123 (284)
T cd06620          47 RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH  123 (284)
T ss_pred             HHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            3578899999999999999999999999999999999999999999887543   37899999999999999999997 5


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         +++|+||+|+||+++.++.++|+|||++.......  .....++..|+|||++.+..++.++|+||+||++|++++|
T Consensus       124 ---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg  198 (284)
T cd06620         124 ---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG  198 (284)
T ss_pred             ---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence               89999999999999999999999999876543221  1234678899999998888889999999999999999999


Q ss_pred             CCCccccccccC-----CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          161 KHPRDFLSNVSS-----SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       161 ~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ..||........     ...............+...  ...++..+.+++.+||+.||.+|||+.++++.
T Consensus       199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         199 KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            999874332100     0001122222222221111  11355678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-38  Score=268.45  Aligned_cols=216  Identities=25%  Similarity=0.381  Sum_probs=167.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT--------SAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~   73 (228)
                      ++++.+|++++++++||||+++++++..++..|++|||++|++|.+++....        .....+...++.++.|++.|
T Consensus        46 ~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~A  125 (932)
T PRK13184         46 KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT  125 (932)
T ss_pred             HHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHH
Confidence            3578899999999999999999999999999999999999999999886421        11235567788999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC------------------CceecccccceeCCcc
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS------------------NWTEFAGTYGYVAPEL  135 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------------------~~~~~~~~~~y~aPE~  135 (228)
                      |+|||+.   |++||||||+||+++.++.++|+|||++........                  ......|++.|+|||.
T Consensus       126 L~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~  202 (932)
T PRK13184        126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER  202 (932)
T ss_pred             HHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence            9999999   999999999999999999999999999876521110                  0112458999999999


Q ss_pred             cccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          136 AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       136 ~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      +.+..++.++|||||||++|+|++|..||........    ........+   .........+..+.+++.+||+.||++
T Consensus       203 l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki----~~~~~i~~P---~~~~p~~~iP~~L~~LI~rcL~~DP~k  275 (932)
T PRK13184        203 LLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI----SYRDVILSP---IEVAPYREIPPFLSQIAMKALAVDPAE  275 (932)
T ss_pred             hcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh----hhhhhccCh---hhccccccCCHHHHHHHHHHccCChhh
Confidence            9998899999999999999999999999864221110    000111111   011112355677899999999999999


Q ss_pred             CCC-HHHHHHHhh
Q 040501          216 RPN-MQTICQLLC  227 (228)
Q Consensus       216 Rpt-~~~il~~l~  227 (228)
                      ||+ ++++++.|+
T Consensus       276 R~ss~eeLl~~Le  288 (932)
T PRK13184        276 RYSSVQELKQDLE  288 (932)
T ss_pred             CcCHHHHHHHHHH
Confidence            965 555655553

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=252.01  Aligned_cols=205  Identities=24%  Similarity=0.261  Sum_probs=161.3

Q ss_pred             HHHHHHHHhcc---CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            5 FLREITVLTEI---RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         5 ~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +..|..++...   .||+|+++++.+......|+||||+.+++|.+++....   .+++..+..++.|++.||+|||+. 
T Consensus        40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~-  115 (330)
T cd05586          40 TIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY-  115 (330)
T ss_pred             HHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            34566666655   69999999999999999999999999999998887543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||.+.+. .++.++|||||||++|+|++|
T Consensus       116 --~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG  193 (330)
T cd05586         116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG  193 (330)
T ss_pred             --CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC
Confidence              99999999999999999999999999987543333333445689999999988754 478899999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN----MQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~  224 (228)
                      ..||....      .......+........   ....+.++.+++++||+.||.+||+    +.++++
T Consensus       194 ~~Pf~~~~------~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         194 WSPFYAED------TQQMYRNIAFGKVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCCCCCC------HHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            99985321      2222233322222111   1124557889999999999999984    555553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.2e-38  Score=240.64  Aligned_cols=210  Identities=23%  Similarity=0.388  Sum_probs=166.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++++... ..+++++++++++|.+++..+..  .++..+++.++.|++.||+|||+.  
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~--  128 (279)
T cd05109          54 KEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV--  128 (279)
T ss_pred             HHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678899999999999999999998754 56789999999999999875432  388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++|+||||+||+++.++.++|+|||++..........  ....++..|+|||...+..++.++||||||+++|++++ 
T Consensus       129 -~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~  207 (279)
T cd05109         129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF  207 (279)
T ss_pred             -CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence             99999999999999999999999999988664332211  11234567999999988889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+........   ...++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       208 g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         208 GAKPYDGIPA------REIPDLLEKGERLPQ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             CCCCCCCCCH------HHHHHHHHCCCcCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8999753221      111111111111111   1235567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-38  Score=241.63  Aligned_cols=211  Identities=26%  Similarity=0.456  Sum_probs=172.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++.++.++|+|++++++.+......|+++||+.+++|.+++....  ..++...++.++.|++.+|.+||+. 
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~-  135 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ-  135 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4578899999999999999999999999999999999999999999998654  2489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus       136 --gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~  213 (286)
T cd06614         136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE  213 (286)
T ss_pred             --CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence              999999999999999999999999998876544333333445678899999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ............+... .....+..+.++|.+||+.+|.+|||+.++++
T Consensus       214 ~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         214 PPYLREPP------LRALFLITTKGIPPLK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCCCCCH------HHHHHHHHhcCCCCCc-chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            99753221      1111222122221111 12235667999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-38  Score=239.22  Aligned_cols=208  Identities=26%  Similarity=0.372  Sum_probs=170.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++.+.++...|+++||+.+++|.+++....   .++...+..++.|+++||.+||+.  
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~--  112 (262)
T cd05572          38 EHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR--  112 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC--
Confidence            568899999999999999999999999999999999999999999987643   278899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+....... ......+++.|++||.+.+..++.++|+||+|+++|++++|..
T Consensus       113 -~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~  190 (262)
T cd05572         113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP  190 (262)
T ss_pred             -CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence             99999999999999999999999999988765432 2223467788999999888888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      ||.....    +.......+.... ....+   ...+.++.++|.+||..+|.+||+     ++++++
T Consensus       191 p~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         191 PFGEDDE----DPMEIYNDILKGNGKLEFP---NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CcCCCCC----CHHHHHHHHhccCCCCCCC---cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            9864331    1222333333211 11111   122567899999999999999999     888775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3e-38  Score=239.84  Aligned_cols=211  Identities=26%  Similarity=0.406  Sum_probs=165.4

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ...+..|+.+++++ +|+||+++++++...      ...|+++||+++++|.+++..... ..+++..+..++.|++.|+
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l  124 (272)
T cd06637          46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGL  124 (272)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Confidence            34678999999999 799999999998642      468999999999999999875332 2378899999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-----CCcccchhhhh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-----MKVTAKCDVYS  149 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diws  149 (228)
                      +|||+.   +++|+||+|+||+++.++.++|+|||++..............++..|+|||++.+     ..++.++|+||
T Consensus       125 ~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  201 (272)
T cd06637         125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  201 (272)
T ss_pred             HHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence            999999   9999999999999999999999999998765433333344567889999998763     35778999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|+++|+|++|..||......      .............  ......+..+.+++.+||..+|.+|||+.++++
T Consensus       202 lGv~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         202 LGITAIEMAEGAPPLCDMHPM------RALFLIPRNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHHHHHHhCCCCccccCHH------HHHHHHhcCCCCC--CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            999999999999998532211      1111111111111  111234567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=240.95  Aligned_cols=212  Identities=26%  Similarity=0.403  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +.+.+|+.+++++ .|+||+++++++....      ..|++|||+.+++|.+++.... ....++...+..++.|++.||
T Consensus        47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al  126 (275)
T cd06608          47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL  126 (275)
T ss_pred             HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            5688999999999 7999999999996543      5899999999999999886532 223488999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-----Ccccchhhhh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-----KVTAKCDVYS  149 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diws  149 (228)
                      .|||+.   |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+...     .++.++||||
T Consensus       127 ~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  203 (275)
T cd06608         127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS  203 (275)
T ss_pred             HHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence            999999   99999999999999999999999999987655443334445678899999987542     3677899999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||+++|++++|..||.....      ......+.....+... .....+..+.+++.+||..||.+|||+.++++
T Consensus       204 lG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         204 LGITAIELADGKPPLCDMHP------MRALFKIPRNPPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hHHHHHHHHhCCCCccccch------HHHHHHhhccCCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            99999999999999853211      1222222222222111 12235667899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-38  Score=239.36  Aligned_cols=211  Identities=25%  Similarity=0.422  Sum_probs=172.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++.+..|+++++.++|+||+++++++..  +...|+++||+++++|.+++... .....+++..++.++.|++.||.+||
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  122 (265)
T cd08217          43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH  122 (265)
T ss_pred             HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence            3567889999999999999999998753  45789999999999999998753 22344889999999999999999999


Q ss_pred             -----hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           79 -----HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 -----~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                           +.   +++|+||+|+||+++.++.++++|||.+..............+++.|+|||.+.+..++.++|+||||++
T Consensus       123 ~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~i  199 (265)
T cd08217         123 NRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCL  199 (265)
T ss_pred             cCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHH
Confidence                 77   9999999999999999999999999999876544432344567889999999988888999999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|+|++|..||....      .......+.....+...   ...+..+.+++.+||+.+|.+|||+.++++
T Consensus       200 l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         200 IYELCALSPPFTARN------QLQLASKIKEGKFRRIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHCCCcccCcC------HHHHHHHHhcCCCCCCc---cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            999999999986432      22233333333332222   245567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-38  Score=241.59  Aligned_cols=216  Identities=26%  Similarity=0.388  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ..+.+|++++++++|+||++++++|..  ...+|+||||+++++|.+++... .....++...+..++.|++.+|+|||+
T Consensus        44 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~  123 (287)
T cd06621          44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS  123 (287)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999998854  34789999999999998886542 123347888999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      .   |++|+||+|+||+++.++.++|+|||++........  ....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       124 ~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~  198 (287)
T cd06621         124 R---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ  198 (287)
T ss_pred             C---CcccCCCCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence            9   999999999999999999999999999875442221  22456778999999988889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCC---chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPL---SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...... ................+..   .......+..+.+++.+||..+|.+|||+.++++
T Consensus       199 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         199 NRFPFPPEGEP-PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCcccCC-CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            99998754321 1112222222222121111   1111234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.2e-38  Score=237.95  Aligned_cols=212  Identities=27%  Similarity=0.437  Sum_probs=175.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++...   ..++...++.++.|++.++.+||+ .
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~  119 (264)
T cd06623          43 RKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR  119 (264)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC
Confidence            357889999999999999999999999999999999999999999999765   338899999999999999999999 9


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       120 ---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg  196 (264)
T cd06623         120 ---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG  196 (264)
T ss_pred             ---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence               99999999999999999999999999988765444433345678899999999888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||.....   .........+.....+....  ..++..+.++|.+||..+|.+|||+.++++
T Consensus       197 ~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         197 KFPFLPPGQ---PSFFELMQAICDGPPPSLPA--EEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCCccccc---cCHHHHHHHHhcCCCCCCCc--ccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            999865432   11222233333222222211  115678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-38  Score=244.15  Aligned_cols=212  Identities=22%  Similarity=0.267  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++.+..+...+++||++.+++|.+++....   .+++..+..++.|++.|+.|||+.  
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--  120 (305)
T cd05609          46 QQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY--  120 (305)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999997543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---------------CceecccccceeCCcccccCCcccchhh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---------------NWTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                       |++|+||+|+||+++.++.++++|||.+........               ......++..|+|||.+.+..++.++|+
T Consensus       121 -~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  199 (305)
T cd05609         121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW  199 (305)
T ss_pred             -CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence             999999999999999999999999998763211100               0112346778999999988889999999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||||+++|++++|..||...      .................. .....+..+.++|.+||+.+|.+||+..++.+.|+
T Consensus       200 ~slG~vl~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         200 WAMGIILYEFLVGCVPFFGD------TPEELFGQVISDDIEWPE-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcccCCCC-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            99999999999999998532      122233333222211111 11245667899999999999999999766666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-38  Score=242.37  Aligned_cols=210  Identities=21%  Similarity=0.256  Sum_probs=166.6

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++|++|+++.+.+..++..++++||+.+++|.+++..... ..+++..+..++.|++.||.|||+.   
T Consensus        46 ~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---  121 (285)
T cd05632          46 MALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---  121 (285)
T ss_pred             HHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            467899999999999999999999999999999999999999988865332 2489999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus       122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999886643222 22334678999999999888899999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      |........  ............ ..   .....+..+.+++.+||+.||.+|||     +.++++
T Consensus       201 ~~~~~~~~~--~~~~~~~~~~~~-~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         201 FRGRKEKVK--REEVDRRVLETE-EV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCCCCHHHH--HHHHHHhhhccc-cc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            864321100  011111111111 11   11234557889999999999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=239.09  Aligned_cols=210  Identities=25%  Similarity=0.404  Sum_probs=169.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.++++++|+||+++++++.. ...++++||+.+++|.+++......  +++..++.++.|++.|++|||+.  
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~--  128 (279)
T cd05057          54 KEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK--  128 (279)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhC--
Confidence            467899999999999999999999887 7889999999999999998765432  88999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce--ecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT--EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+...........  ...++..|+|||.+....++.++|+||||+++|++++ 
T Consensus       129 -~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~  207 (279)
T cd05057         129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF  207 (279)
T ss_pred             -CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence             999999999999999999999999999987653332221  1223467999999888888999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||....      .......+.........   ...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       208 g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         208 GAKPYEGIP------AVEIPDLLEKGERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCCCCCCC------HHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            999975432      22222222222211111   123446889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-39  Score=254.61  Aligned_cols=215  Identities=22%  Similarity=0.308  Sum_probs=162.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC-----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +++.+|+++++.++|+||+++++++....     ..|+|+||+. ++|.+.+....   .++...+..++.|++.||.||
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~L  119 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYL  119 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999997765     7899999996 46777665432   388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccC-CcccchhhhhHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~  155 (228)
                      |+.   |++||||||+||+++.++.++|+|||++......... .....+++.|+|||.+.+. .++.++||||+||++|
T Consensus       120 H~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  196 (372)
T cd07853         120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA  196 (372)
T ss_pred             HhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence            999   9999999999999999999999999998765432221 2234567889999998775 4788999999999999


Q ss_pred             HHHhCCCCccccccccCCC----------chh-------hhhhhcCC-CCCCCc----hhhhhhHHHHHHHHHHhhccCC
Q 040501          156 EVIKGKHPRDFLSNVSSSN----------PNI-------LVNEMLDP-RLPPLS----VDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~----------~~~-------~~~~~~~~-~~~~~~----~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      +|++|+.||..........          ...       ........ ..++..    ......+.++.++|.+||+.||
T Consensus       197 el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP  276 (372)
T cd07853         197 ELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP  276 (372)
T ss_pred             HHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence            9999999986433211000          000       00000000 000000    0012235678899999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||+.++++
T Consensus       277 ~~R~t~~e~l~  287 (372)
T cd07853         277 DKRISAADALA  287 (372)
T ss_pred             hhCcCHHHHhc
Confidence            99999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=255.99  Aligned_cols=216  Identities=22%  Similarity=0.275  Sum_probs=157.0

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeec--------CeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHA--------RHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ...+|+.+++.++|+||+++++++...        ..+++||||+++ ++.+++... .....+++..+..++.|++.||
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL  183 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL  183 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            346799999999999999998887432        246799999975 666665431 2233488999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGV  152 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~  152 (228)
                      .|||+.   ||+||||||+||+++.++ .+||+|||++....... ......+++.|+|||++.+. .++.++|||||||
T Consensus       184 ~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv  259 (440)
T PTZ00036        184 AYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGC  259 (440)
T ss_pred             HHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence            999999   999999999999998664 79999999998654322 22335678899999987664 5899999999999


Q ss_pred             HHHHHHhCCCCccccccccCC---------Cchhhhhhh----cCCCCCCCc-hh-----hhhhHHHHHHHHHHhhccCC
Q 040501          153 LALEVIKGKHPRDFLSNVSSS---------NPNILVNEM----LDPRLPPLS-VD-----IRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~-~~-----~~~~~~~~~~li~~~l~~~p  213 (228)
                      ++|+|++|.+||.........         .........    .....+... ..     ....+.++.++|.+||..||
T Consensus       260 il~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP  339 (440)
T PTZ00036        260 IIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP  339 (440)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence            999999999998643221100         000000000    000001000 00     01235678999999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||+.++++
T Consensus       340 ~~R~ta~e~l~  350 (440)
T PTZ00036        340 LKRLNPIEALA  350 (440)
T ss_pred             hHCcCHHHHhC
Confidence            99999999874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3e-38  Score=241.13  Aligned_cols=210  Identities=25%  Similarity=0.398  Sum_probs=165.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ..+..|+.+++++ +|+||+++++++..      ....|++|||+++++|.+++..... ..+++..+..++.|++.|+.
T Consensus        57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~  135 (282)
T cd06636          57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLA  135 (282)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHH
Confidence            4678899999998 69999999999853      4578999999999999999875432 33788889999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSF  150 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  150 (228)
                      |||+.   |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.     +..++.++|+|||
T Consensus       136 ~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvwsl  212 (282)
T cd06636         136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL  212 (282)
T ss_pred             HHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHH
Confidence            99999   999999999999999999999999999876543333334456788999999875     3457789999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+++|+|++|..||......      ...........+  ......++..+.++|.+||..||.+|||+.++++
T Consensus       213 G~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         213 GITAIEMAEGAPPLCDMHPM------RALFLIPRNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHHHHHHHhCCCCccccCHH------hhhhhHhhCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            99999999999998532211      111111111111  1112345678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=255.62  Aligned_cols=213  Identities=26%  Similarity=0.425  Sum_probs=178.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|+.|+.+|+.++|||+|+++++|+....+|||.|||..|+|.++++++... .++.-..+.++.||.+|+.||..+ 
T Consensus       307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk-  384 (1157)
T KOG4278|consen  307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK-  384 (1157)
T ss_pred             HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh-
Confidence            467999999999999999999999999999999999999999999999987643 377778889999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        +++||||...|++++.+..+|+.|||+++.++.+.... .....+.-|.|||.+..+.++.++|||+||+++||+.+ 
T Consensus       385 --nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY  462 (1157)
T KOG4278|consen  385 --NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY  462 (1157)
T ss_pred             --hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhc
Confidence              99999999999999999999999999999987554332 22334678999999999999999999999999999987 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||+...--.       .+..+.....-  ....+|++.+++|++.||+.+|.+||+++|+-+.|+
T Consensus       463 GMsPYPGidlSq-------VY~LLEkgyRM--~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  463 GMSPYPGIDLSQ-------VYGLLEKGYRM--DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCCCccHHH-------HHHHHhccccc--cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            888987543211       11111111110  012378889999999999999999999999988876

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.6e-38  Score=249.65  Aligned_cols=215  Identities=24%  Similarity=0.397  Sum_probs=169.2

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------------------------
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------   54 (228)
                      +.+.+|++++.++. |+||+++++.+......++|+||+.+++|.+++.....                           
T Consensus        85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (401)
T cd05107          85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR  164 (401)
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence            46889999999996 99999999999998999999999999999999864321                           


Q ss_pred             --------------------------------------------------------------------CCCCCHHHHHHH
Q 040501           55 --------------------------------------------------------------------AEELGWSRRINV   66 (228)
Q Consensus        55 --------------------------------------------------------------------~~~~~~~~~~~~   66 (228)
                                                                                          ...+++..++.+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  244 (401)
T cd05107         165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF  244 (401)
T ss_pred             ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence                                                                                123567778899


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAK  144 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  144 (228)
                      +.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.+
T Consensus       245 ~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  321 (401)
T cd05107         245 SYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL  321 (401)
T ss_pred             HHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH
Confidence            99999999999999   999999999999999999999999999876432221  1122345778999999988888999


Q ss_pred             hhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          145 CDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       145 ~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      +|+||||+++|+|++ |..||.....      ...............  .....+.++.+++.+||..+|.+||++++++
T Consensus       322 ~DvwslGvil~e~l~~g~~P~~~~~~------~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell  393 (401)
T cd05107         322 SDVWSFGILLWEIFTLGGTPYPELPM------NEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLV  393 (401)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCCCCCc------hHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999999998 8889754321      111111111111000  0123456789999999999999999999999


Q ss_pred             HHhhC
Q 040501          224 QLLCK  228 (228)
Q Consensus       224 ~~l~~  228 (228)
                      +.|++
T Consensus       394 ~~L~~  398 (401)
T cd05107         394 HLVGD  398 (401)
T ss_pred             HHHHH
Confidence            99874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-38  Score=249.72  Aligned_cols=212  Identities=22%  Similarity=0.307  Sum_probs=159.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.+++.++|+||+++++++...      ...|++|||+.+ ++...+..     .++...+..++.|++.||.|
T Consensus        61 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~  134 (355)
T cd07874          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKH  134 (355)
T ss_pred             HHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHH
Confidence            4677899999999999999999988543      357999999976 55555532     27788899999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   |++||||||+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+
T Consensus       135 LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e  210 (355)
T cd07874         135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  210 (355)
T ss_pred             HHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence            9999   9999999999999999999999999999765432 22233567889999999998889999999999999999


Q ss_pred             HHhCCCCccccccccCCC---------ch-------hhhhhhcCC----------------CCCCCchhhhhhHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSN---------PN-------ILVNEMLDP----------------RLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~---------~~-------~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l  204 (228)
                      |++|..||..........         ..       .........                ..+............+.++
T Consensus       211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  290 (355)
T cd07874         211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL  290 (355)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence            999999986432111000         00       000000000                0000000111234567899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||+.||.+|||+.++++
T Consensus       291 i~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         291 LSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHhcCCchhcCCHHHHhc
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-38  Score=237.74  Aligned_cols=213  Identities=26%  Similarity=0.463  Sum_probs=171.4

Q ss_pred             HHHHHHHHHhc-cCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            4 EFLREITVLTE-IRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         4 ~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      ++..|+.++.+ ++|+||+++++++..+...++++||+.+++|.+++... .....++...++.++.|++.++.+||+ .
T Consensus        54 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~  133 (269)
T cd08528          54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK  133 (269)
T ss_pred             HHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence            46778888875 69999999999999999999999999999999887542 223348889999999999999999996 5


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         +++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|++++|
T Consensus       134 ---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g  209 (269)
T cd08528         134 ---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL  209 (269)
T ss_pred             ---ceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence               89999999999999999999999999987655433 33345678889999999888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....      ..............+..  ....+..+.+++.+||+.||.+|||+.++.+.++.
T Consensus       210 ~~p~~~~~------~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         210 QPPFYSTN------MLSLATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CCcccccC------HHHHHHHHhhccCCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            99975322      22222222222222211  12345678999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-38  Score=242.31  Aligned_cols=215  Identities=20%  Similarity=0.289  Sum_probs=164.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++......+++|||+. ++|.+++..... ..+++..+..++.|++.|++|||+.  
T Consensus        44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~--  119 (284)
T cd07860          44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH--  119 (284)
T ss_pred             hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            468899999999999999999999999999999999996 578888765332 3488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.. ++.++|+||||+++|++++|.
T Consensus       120 -~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  198 (284)
T cd07860         120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  198 (284)
T ss_pred             -CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence             999999999999999999999999999876544333333345677899999887654 578899999999999999999


Q ss_pred             CCccccccccCCCchhhhhhh---------------------cCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEM---------------------LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      .||.........  .......                     ...............+.++.++|.+||+.||.+|||++
T Consensus       199 ~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  276 (284)
T cd07860         199 ALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK  276 (284)
T ss_pred             CCCCCCCHHHHH--HHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence            998643221100  0000000                     00000000001123455678999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       277 ~~l~  280 (284)
T cd07860         277 AALA  280 (284)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.1e-38  Score=241.67  Aligned_cols=215  Identities=23%  Similarity=0.318  Sum_probs=160.5

Q ss_pred             HHHHHHHHHhcc---CCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEI---RHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+.+++.+   +||||+++++++..     ....++++|++.+ +|.+++..... ..++...+..++.|++.||.
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~  122 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLD  122 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Confidence            456788888776   69999999998864     3458999999975 78887765432 34899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      |||+.   |++|+||||+||+++.++.++|+|||.+....... ......++..|+|||++.+..++.++||||+||++|
T Consensus       123 ~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  198 (288)
T cd07863         123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA  198 (288)
T ss_pred             HHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHH
Confidence            99999   99999999999999999999999999987654222 222345788999999998888999999999999999


Q ss_pred             HHHhCCCCccccccccCCCc----------hhhhh------hhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          156 EVIKGKHPRDFLSNVSSSNP----------NILVN------EMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~----------~~~~~------~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      +|++|.+||...........          .....      ....+. ...........+..+.+++.+||+.||.+|||
T Consensus       199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  278 (288)
T cd07863         199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS  278 (288)
T ss_pred             HHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence            99999999853221100000          00000      000000 00011112345567889999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      +.++++
T Consensus       279 ~~~~l~  284 (288)
T cd07863         279 AFRALQ  284 (288)
T ss_pred             HHHHhc
Confidence            999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=243.79  Aligned_cols=210  Identities=23%  Similarity=0.277  Sum_probs=168.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++.+......|++|||+.+++|.+++.... ...+++..+..++.|++.+|+|||+.  
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--  122 (316)
T cd05574          46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL--  122 (316)
T ss_pred             HHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457889999999999999999999999999999999999999999987543 23488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-----------------------------ceecccccceeCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-----------------------------WTEFAGTYGYVAP  133 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----------------------------~~~~~~~~~y~aP  133 (228)
                       |++|+||||+||+++.++.++|+|||++.........                             .....|+..|+||
T Consensus       123 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP  201 (316)
T cd05574         123 -GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP  201 (316)
T ss_pred             -CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence             9999999999999999999999999988754322110                             1123567789999


Q ss_pred             cccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          134 ELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       134 E~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |++.+..++.++||||||+++|++++|..||.....      ......+.........  ....+..+.+++.+||..+|
T Consensus       202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p  273 (316)
T cd05574         202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR------DETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDP  273 (316)
T ss_pred             HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch------HHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCH
Confidence            999888899999999999999999999999853321      2222222222221111  11256789999999999999


Q ss_pred             CCCCC----HHHHHH
Q 040501          214 ESRPN----MQTICQ  224 (228)
Q Consensus       214 ~~Rpt----~~~il~  224 (228)
                      .+|||    ++++++
T Consensus       274 ~~R~s~~~~~~~ll~  288 (316)
T cd05574         274 SKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHCCCchhhHHHHHc
Confidence            99999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=242.41  Aligned_cols=213  Identities=21%  Similarity=0.316  Sum_probs=161.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++|+||+++++++..+...++|+||+.+ +|.+++.....  .++...+..++.|+++||.|||+.   
T Consensus        49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---  122 (291)
T cd07844          49 TAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---  122 (291)
T ss_pred             hHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            467899999999999999999999999999999999975 88888765433  478899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..
T Consensus       123 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~  202 (291)
T cd07844         123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP  202 (291)
T ss_pred             CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998754433222233346788999998865 457889999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhc------------------CCCC-----CCCchhhhhh--HHHHHHHHHHhhccCCCCCC
Q 040501          163 PRDFLSNVSSSNPNILVNEML------------------DPRL-----PPLSVDIRGK--VISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~------------------~~~~-----~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp  217 (228)
                      ||........  ......+..                  ....     ..........  ...+.+++.+||+.+|.+||
T Consensus       203 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp  280 (291)
T cd07844         203 LFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI  280 (291)
T ss_pred             CCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc
Confidence            9854321000  000000000                  0000     0000000111  25678999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.++++
T Consensus       281 s~~e~l~  287 (291)
T cd07844         281 SAAEAMK  287 (291)
T ss_pred             CHHHHhc
Confidence            9999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-38  Score=239.23  Aligned_cols=211  Identities=25%  Similarity=0.430  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++.+....++++||+.+++|.+++....   .+++..++.++.|++.||.+||+.  
T Consensus        48 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~--  122 (268)
T cd06630          48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN--  122 (268)
T ss_pred             HHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            568899999999999999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCC----ceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                       |++|+||+|+||+++.++ .++|+|||.+.........    .....++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       123 -~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l  201 (268)
T cd06630         123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM  201 (268)
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHH
Confidence             999999999999998775 5899999998766543211    1224567889999999888889999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||......   ...............  .......+.++.+++.+||..+|.+|||+.++++
T Consensus       202 ~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         202 ATAKPPWNAEKHS---NHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HhCCCCCCCCCCc---chHHHHHHHhccCCC--CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            9999998533221   111111111111111  1111245567889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.7e-38  Score=242.31  Aligned_cols=159  Identities=23%  Similarity=0.397  Sum_probs=130.6

Q ss_pred             HHHHHHHHHhccCCCccceeeeeee--ecCeEEEEEEeecCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNND------TSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+++++.++||||+++++++.  .+...|+++||+.+ +|.+++...      .....+++..+..++.|++.||.
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~  122 (317)
T cd07867          44 SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH  122 (317)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHH
Confidence            5788999999999999999999985  35678999999865 666665421      11234788899999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEE----cCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccC-Ccccchhh
Q 040501           76 YLHHDCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTM-KVTAKCDV  147 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di  147 (228)
                      |||+.   |++|+||||+||++    +.++.++|+|||++.........   .....+++.|+|||.+.+. .++.++||
T Consensus       123 ~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  199 (317)
T cd07867         123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI  199 (317)
T ss_pred             HHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHH
Confidence            99999   99999999999999    45678999999999865433221   2334678899999988764 47889999


Q ss_pred             hhHHHHHHHHHhCCCCccc
Q 040501          148 YSFGVLALEVIKGKHPRDF  166 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~  166 (228)
                      ||||+++|+|++|.+||..
T Consensus       200 wSlG~il~el~tg~~~f~~  218 (317)
T cd07867         200 WAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             HhHHHHHHHHHhCCCCccc
Confidence            9999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.8e-38  Score=239.94  Aligned_cols=211  Identities=24%  Similarity=0.254  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++.+.+...+..|+|+||+++++|.+++..... ..+++..+..++.|++.++.|||+.  
T Consensus        38 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~--  114 (277)
T cd05577          38 QMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR--  114 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            3567899999999999999999999999999999999999999999875442 3488999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       115 -~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~  192 (277)
T cd05577         115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS  192 (277)
T ss_pred             -CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence             999999999999999999999999998876543 222233456778999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||.......  .......... .....   .....+..+.++|.+||+.||.+||     ++.++++
T Consensus       193 p~~~~~~~~--~~~~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         193 PFRQRKEKV--EKEELKRRTL-EMAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCCCCcccc--cHHHHHhccc-ccccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            986433211  1111111111 11111   1123466789999999999999999     7776764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=238.81  Aligned_cols=211  Identities=25%  Similarity=0.437  Sum_probs=181.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      -+.+..|+.++++++.+++|++++.+.....+|||||||..|+..+.++...  +.+++..+..+++..+.||.|||.. 
T Consensus        72 LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~-  148 (502)
T KOG0574|consen   72 LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL-  148 (502)
T ss_pred             HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH-
Confidence            4678899999999999999999999999999999999999999999997544  4499999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        .=+|||||..||+++.+|..||.|||.+...++.-...++..|||.|+|||++..-.|..++||||||+...+|..|+
T Consensus       149 --~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~  226 (502)
T KOG0574|consen  149 --KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGR  226 (502)
T ss_pred             --HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCC
Confidence              999999999999999999999999999988776666677889999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +||.......      .+.-+. ...++.......-+.++.+++++||.++|++|.|+.++++
T Consensus       227 PPYsDIHPMR------AIFMIP-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  227 PPYSDIHPMR------AIFMIP-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCcccccccc------eeEecc-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            9986554432      222222 2233333333455677899999999999999999998876

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.2e-38  Score=240.31  Aligned_cols=203  Identities=25%  Similarity=0.330  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++++.||||+++++++..+...|++|||+++++|.+++....   .++...+..++.|++.||.+||+.  
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~--  120 (290)
T cd05580          46 EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL--  120 (290)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457889999999999999999999999999999999999999999987653   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||++......   .....+++.|+|||.+.+...+.++|+||||+++|+|++|..
T Consensus       121 -~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  196 (290)
T cd05580         121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP  196 (290)
T ss_pred             -CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999998775433   223467889999999888888899999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+....... +   ...+..+.+++.+||..||.+|+     +++++++
T Consensus       197 p~~~~~------~~~~~~~~~~~~~~~-~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         197 PFFDDN------PIQIYEKILEGKVRF-P---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CCCCCC------HHHHHHHHhcCCccC-C---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            985332      222222332222211 1   12355788999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-39  Score=241.50  Aligned_cols=214  Identities=23%  Similarity=0.336  Sum_probs=162.6

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecC-----eEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+|+++|+.+.|||||++.-+|....     ...+||||++. +|...++.. .....++.-.+.-+.+|++.||+|||+
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            47999999999999999999885432     34589999975 888888742 112336777778899999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~  157 (228)
                      .   ||+||||||.|++++.+ |.+||+|||.++....+... .+...+..|+|||.+.+. .|+.+.||||.||++.||
T Consensus       144 ~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aEL  219 (364)
T KOG0658|consen  144 H---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAEL  219 (364)
T ss_pred             c---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHH
Confidence            9   99999999999999987 99999999999987655443 556778899999988776 589999999999999999


Q ss_pred             HhCCCCccccccccC---------CCchhhhhhhc----C---CCCCC--C-chhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          158 IKGKHPRDFLSNVSS---------SNPNILVNEML----D---PRLPP--L-SVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~---------~~~~~~~~~~~----~---~~~~~--~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      +-|++-|+.....+.         ....+.+..+.    .   +....  . .......+.+..+++.++|..+|.+|.+
T Consensus       220 l~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~  299 (364)
T KOG0658|consen  220 LKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS  299 (364)
T ss_pred             hcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC
Confidence            999999875433211         00111111100    0   11100  0 0123455678899999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      +.+++.
T Consensus       300 ~~~~l~  305 (364)
T KOG0658|consen  300 ALEALA  305 (364)
T ss_pred             HHHHhc
Confidence            998874

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=234.82  Aligned_cols=218  Identities=21%  Similarity=0.337  Sum_probs=184.6

Q ss_pred             ChHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            1 DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .|+++.+|++++.++ .|+||+.++++|+++..+|+|||.+.||+|...|..+..   +++..+..+..+++.||.+||.
T Consensus       118 sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~  194 (463)
T KOG0607|consen  118 SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHT  194 (463)
T ss_pred             HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhh
Confidence            378899999999999 499999999999999999999999999999998876544   8999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCc---eEEeecccccccCCCCC-------CceecccccceeCCcccc---c--CCcccc
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAY---T--MKVTAK  144 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~---~--~~~~~~  144 (228)
                      +   ||.|||+||+||+....+.   +||+||.+..-+.....       ...++.|+..|||||+..   +  ..|+.+
T Consensus       195 k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKr  271 (463)
T KOG0607|consen  195 K---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKR  271 (463)
T ss_pred             c---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccc
Confidence            9   9999999999999977654   69999998775533222       134578889999999753   2  347889


Q ss_pred             hhhhhHHHHHHHHHhCCCCcccccc---------ccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          145 CDVYSFGVLALEVIKGKHPRDFLSN---------VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       145 ~DiwslG~~l~~~~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      .|.||||+++|-|++|++||...-.         .-...+...++.+-.+.......+|...+.+..++|+..|..++.+
T Consensus       272 CDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~  351 (463)
T KOG0607|consen  272 CDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQ  351 (463)
T ss_pred             ccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHh
Confidence            9999999999999999999964322         1223345567788888888888889999999999999999999999


Q ss_pred             CCCHHHHHH
Q 040501          216 RPNMQTICQ  224 (228)
Q Consensus       216 Rpt~~~il~  224 (228)
                      |.++..+++
T Consensus       352 rlsa~~vln  360 (463)
T KOG0607|consen  352 RLSAAQVLN  360 (463)
T ss_pred             hhhhhhccC
Confidence            999988765

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-38  Score=237.65  Aligned_cols=207  Identities=26%  Similarity=0.467  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhccC---CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +.+.+|+.++++++   |+|++++++++..+...|++|||+.+++|.+++...    .+++..++.++.|++.++.+||+
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~  119 (277)
T cd06917          44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK  119 (277)
T ss_pred             HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh
Confidence            46788999999996   999999999999999999999999999999988653    38899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~  158 (228)
                      .   |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus       120 ~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll  196 (277)
T cd06917         120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA  196 (277)
T ss_pred             C---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence            9   99999999999999999999999999988765544334445678899999987654 4688999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||.......      ..........+...  ....+.++.+++.+||+.||.+|||+.++++
T Consensus       197 ~g~~p~~~~~~~~------~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         197 TGNPPYSDVDAFR------AMMLIPKSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             hCCCCCCCCChhh------hhhccccCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            9999986432211      11111111111111  1125667999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.5e-38  Score=236.94  Aligned_cols=210  Identities=25%  Similarity=0.386  Sum_probs=171.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++|+||+++++.+......++++||+.+++|.+++..... ..+++..+..++.|++.|+.|||+. 
T Consensus        43 ~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~-  120 (257)
T cd08225          43 KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR-  120 (257)
T ss_pred             hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35678999999999999999999999999999999999999999999875432 2378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        +++|+||+|+||+++.++ .++++|||.+..............+++.|+|||.+.+..++.++|+||+|++++++++|
T Consensus       121 --~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08225         121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL  198 (257)
T ss_pred             --CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence              999999999999998885 46999999887765433333345678889999998888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||....      .................   ...+..+.+++.+||..+|.+|||+.++++
T Consensus       199 ~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         199 KHPFEGNN------LHQLVLKICQGYFAPIS---PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCcc------HHHHHHHHhcccCCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            99975322      22222333333322221   244567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=268.96  Aligned_cols=213  Identities=24%  Similarity=0.367  Sum_probs=164.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      .+.|..|+.+++.++||||++++++|..  ...+|+||||+.+++|.+++.... ....+++..++.++.||+.||.|||
T Consensus        56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH  135 (1021)
T PTZ00266         56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH  135 (1021)
T ss_pred             HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999998854  457899999999999999987532 2234899999999999999999999


Q ss_pred             hCCC----CCeeecCCCCCceEEcCC-----------------CceEEeecccccccCCCCCCceecccccceeCCcccc
Q 040501           79 HDCI----PPIVHRDISSKNVLLDLE-----------------YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY  137 (228)
Q Consensus        79 ~~~~----~~i~h~di~p~nil~~~~-----------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  137 (228)
                      +.+.    .+|+|+||||+|||++.+                 +.++|+|||++........ .....+++.|+|||++.
T Consensus       136 s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHHh
Confidence            8520    159999999999999642                 3489999999976543322 23456899999999886


Q ss_pred             c--CCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          138 T--MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       138 ~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      +  ..++.++|||||||++|+|++|..||.....     .......+......    .....+.++.+||.+||..+|.+
T Consensus       215 ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~qli~~lk~~p~l----pi~~~S~eL~dLI~~~L~~dPee  285 (1021)
T PTZ00266        215 HETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FSQLISELKRGPDL----PIKGKSKELNILIKNLLNLSAKE  285 (1021)
T ss_pred             ccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HHHHHHHHhcCCCC----CcCCCCHHHHHHHHHHhcCChhH
Confidence            4  3478899999999999999999999863221     11222222111111    11234567899999999999999


Q ss_pred             CCCHHHHHH
Q 040501          216 RPNMQTICQ  224 (228)
Q Consensus       216 Rpt~~~il~  224 (228)
                      |||+.+++.
T Consensus       286 RPSa~QlL~  294 (1021)
T PTZ00266        286 RPSALQCLG  294 (1021)
T ss_pred             CcCHHHHhc
Confidence            999999984

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5e-38  Score=241.69  Aligned_cols=214  Identities=22%  Similarity=0.285  Sum_probs=165.6

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+..|++++++++|+||+++++++.+....++||||+ +++|.+++....  ..+++..++.++.|+++||.|||+.   
T Consensus        48 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---  121 (298)
T cd07841          48 TALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---  121 (298)
T ss_pred             HHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            4678999999999999999999999999999999999 889999987644  2488999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+
T Consensus       122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~  201 (298)
T cd07841         122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP  201 (298)
T ss_pred             CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence            9999999999999999999999999999876544333333456778999998855 356889999999999999999988


Q ss_pred             CccccccccCCCchhhhhhh------------------cCCC--CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEM------------------LDPR--LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~------------------~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      ||........  ........                  ....  ...........+..+.++|.+||+.+|++|||++++
T Consensus       202 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~  279 (298)
T cd07841         202 FLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA  279 (298)
T ss_pred             cccCCccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence            7653221110  00000000                  0000  000011112345678899999999999999999999


Q ss_pred             HHH
Q 040501          223 CQL  225 (228)
Q Consensus       223 l~~  225 (228)
                      ++.
T Consensus       280 l~~  282 (298)
T cd07841         280 LEH  282 (298)
T ss_pred             hhC
Confidence            863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-38  Score=248.40  Aligned_cols=211  Identities=23%  Similarity=0.386  Sum_probs=159.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|++++++++|+||+++++++...      ...|++++++ +++|.+++...    .++...+..++.|++.||.|
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~  133 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKY  133 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999988533      3578999987 67888877532    38899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++||||||+||+++.++.+||+|||++......   .....+++.|+|||.+.+ ..++.++|||||||++|
T Consensus       134 LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  207 (343)
T cd07878         134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  207 (343)
T ss_pred             HHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence            9999   9999999999999999999999999998865432   233567889999999876 46788999999999999


Q ss_pred             HHHhCCCCccccccccC---------CCchhhhhhh--------cC--CCCCC--CchhhhhhHHHHHHHHHHhhccCCC
Q 040501          156 EVIKGKHPRDFLSNVSS---------SNPNILVNEM--------LD--PRLPP--LSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~---------~~~~~~~~~~--------~~--~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      +|++|..||........         .........+        ..  +..+.  ......+....+.+++.+||..||.
T Consensus       208 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~  287 (343)
T cd07878         208 ELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD  287 (343)
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChh
Confidence            99999999864321100         0000000000        00  00000  0001122344578999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       288 ~R~s~~ell~  297 (343)
T cd07878         288 KRISASEALA  297 (343)
T ss_pred             hCCCHHHHhc
Confidence            9999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.4e-38  Score=235.06  Aligned_cols=209  Identities=24%  Similarity=0.395  Sum_probs=169.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++|+|++++++.+......++|+|++++++|.+++.... ...+++..+..++.+++.++++||+. 
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-  120 (256)
T cd08220          43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK-  120 (256)
T ss_pred             HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999997543 23378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||+|+||+++.+ +.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus       121 --~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~  197 (256)
T cd08220         121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL  197 (256)
T ss_pred             --CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence              99999999999999865 4579999999887653322 2234577899999999888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||....      .................   ...+..+.+++.+||..+|.+|||+.+++.
T Consensus       198 ~~~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         198 KRAFEAAN------LPALVLKIMSGTFAPIS---DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCcccCc------hHHHHHHHHhcCCCCCC---CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            99975322      22222233222222111   235567899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.4e-38  Score=240.72  Aligned_cols=208  Identities=23%  Similarity=0.409  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++.+..++..+++|||+++++|.+++...    .+++..+..++.|++.++++||+.  
T Consensus        62 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~--  135 (292)
T cd06657          62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ--  135 (292)
T ss_pred             HHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46788999999999999999999999999999999999999999887543    278899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       136 -givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~  214 (292)
T cd06657         136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP  214 (292)
T ss_pred             -CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999988765433333334567888999999888888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||......      ...... ....+.........+..+.+++.+||..+|.+||++.++++
T Consensus       215 p~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         215 PYFNEPPL------KAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCCCCCHH------HHHHHH-HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            97532211      111111 11111111112234557889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8e-38  Score=242.24  Aligned_cols=213  Identities=21%  Similarity=0.298  Sum_probs=165.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++..+...+++|||+++++|.+++..... ..++...+..++.|++.||+|||+.  
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~--  120 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK--  120 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5788999999999999999999999999999999999999999999875432 2378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-------ceecccccceeCCcccccC--CcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~  153 (228)
                       +++|+||+|+||+++.++.++++||+.+.........       .....++..|+|||.+.+.  .++.++|+||+|++
T Consensus       121 -~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~i  199 (314)
T cd08216         121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT  199 (314)
T ss_pred             -CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHH
Confidence             9999999999999999999999999987654322111       1223456789999988663  47889999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhc---------------------------C--CCCCCCchhhhhhHHHHHHH
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEML---------------------------D--PRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~--~~~~~~~~~~~~~~~~~~~l  204 (228)
                      +|+|++|..||.......     .......                           .  .............+.++.++
T Consensus       200 l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  274 (314)
T cd08216         200 ACELANGHVPFKDMPATQ-----MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF  274 (314)
T ss_pred             HHHHHhCCCCCCCCCHHH-----HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHH
Confidence            999999999986432110     0000000                           0  00000111123445678899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.+||..||.+|||+.++++
T Consensus       275 i~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         275 VELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             HHHHhhcCCCcCcCHHHHhc
Confidence            99999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.3e-38  Score=247.85  Aligned_cols=212  Identities=22%  Similarity=0.317  Sum_probs=159.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.+++.++|+||+++++++...      ...|+||||+.+ +|...+..     .++...+..++.|++.||.|
T Consensus        68 ~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~  141 (364)
T cd07875          68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKH  141 (364)
T ss_pred             HHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999987543      357999999975 66666542     27788899999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   |++||||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+
T Consensus       142 LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e  217 (364)
T cd07875         142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  217 (364)
T ss_pred             HhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHH
Confidence            9999   99999999999999999999999999997654322 2233567889999999999889999999999999999


Q ss_pred             HHhCCCCccccccccCCCc---------hhh-------hhhhcCCCC----------------CCCchhhhhhHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNP---------NIL-------VNEMLDPRL----------------PPLSVDIRGKVISIMEV  204 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~---------~~~-------~~~~~~~~~----------------~~~~~~~~~~~~~~~~l  204 (228)
                      |++|..||...........         ...       .......+.                +............+.++
T Consensus       218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  297 (364)
T cd07875         218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL  297 (364)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHH
Confidence            9999999864322110000         000       000000000                00000001123467899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||+.||.+|||+.++++
T Consensus       298 l~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         298 LSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhcCcCcccCCCHHHHhc
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=244.18  Aligned_cols=211  Identities=22%  Similarity=0.257  Sum_probs=163.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++|+||+++++.+..+...|+||||+.+++|.+++....  ..+++..+..++.|++.||+|||+.  
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--  121 (331)
T cd05597          46 ACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL--  121 (331)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            457789999999999999999999999999999999999999999987533  2388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCccccc-----CCcccchhhhhHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~  156 (228)
                       |++||||||+||+++.++.++|+|||++......... .....|++.|+|||++..     ..++.++||||+||++|+
T Consensus       122 -~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e  200 (331)
T cd05597         122 -GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE  200 (331)
T ss_pred             -CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence             9999999999999999999999999998765433222 223468899999999863     346789999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCC--CCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNP--ESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p--~~Rpt~~~il~  224 (228)
                      |++|..||.....      ......+.... ...........+..+.+++.+||..++  ..|+++.++++
T Consensus       201 l~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         201 MLYGETPFYAESL------VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             HhhCCCCCCCCCH------HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999853221      11222221111 111111122356678899999886543  34788888875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=249.35  Aligned_cols=154  Identities=23%  Similarity=0.362  Sum_probs=132.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      ....|+.++++++|+||+++++++......++|+|++. ++|.+++....  ..+++..++.++.|++.||.|||+.   
T Consensus       103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---  176 (357)
T PHA03209        103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---  176 (357)
T ss_pred             ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            34679999999999999999999999999999999996 47777765433  3388999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++||||||+||+++.++.++|+|||.+...... .......|+..|+|||++.+..++.++|||||||++|+|+++..+
T Consensus       177 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             CeecCCCCHHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            9999999999999999999999999998753322 222345688999999999998899999999999999999985554


Q ss_pred             c
Q 040501          164 R  164 (228)
Q Consensus       164 ~  164 (228)
                      +
T Consensus       256 ~  256 (357)
T PHA03209        256 I  256 (357)
T ss_pred             c
Confidence            3

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-37  Score=238.15  Aligned_cols=213  Identities=25%  Similarity=0.377  Sum_probs=165.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeee-----ecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCT-----HARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ..+.+|+.+++.+ +|+||+++++++.     .+...+++|||+++++|.+++... .....+++..+..++.|++.|+.
T Consensus        59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~  138 (286)
T cd06638          59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ  138 (286)
T ss_pred             HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence            4577899999999 6999999999874     345789999999999999887642 22334788899999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-----CCcccchhhhhH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-----MKVTAKCDVYSF  150 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwsl  150 (228)
                      |||+.   +++|+||+|+||+++.++.++++|||.+..............++..|+|||.+..     ..++.++|+||+
T Consensus       139 ~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  215 (286)
T cd06638         139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL  215 (286)
T ss_pred             HHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence            99999   9999999999999999999999999998766543333344568889999998753     346889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |+++|++++|..||......      ...........+... ....++..+.+++.+||+.||.+|||+.++++.
T Consensus       216 Gvi~~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         216 GITAIELGDGDPPLADLHPM------RALFKIPRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHHHHHhcCCCCCCCCchh------HHHhhccccCCCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            99999999999997643221      111111111111110 111234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-38  Score=243.51  Aligned_cols=216  Identities=25%  Similarity=0.397  Sum_probs=166.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++......|+|+||+.+++|..+.....   .+++.+++.++.|++.+++|||+.  
T Consensus        45 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~--  119 (286)
T cd07846          45 KIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH--  119 (286)
T ss_pred             HHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            467899999999999999999999999999999999999988888765432   278999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++||||||+++|++++|.
T Consensus       120 -~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~  198 (286)
T cd07846         120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE  198 (286)
T ss_pred             -CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence             99999999999999999999999999987655443333445678889999988754 4678999999999999999999


Q ss_pred             CCccccccccCCCc------------------hhhhhhhcCCCCCC---CchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          162 HPRDFLSNVSSSNP------------------NILVNEMLDPRLPP---LSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       162 ~p~~~~~~~~~~~~------------------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      +||...........                  .........+....   ......+.+..+.+++.+||+.+|.+|||+.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  278 (286)
T cd07846         199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS  278 (286)
T ss_pred             CCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH
Confidence            99853321100000                  00000000000000   0011224567799999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       279 ~il~  282 (286)
T cd07846         279 QLLH  282 (286)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-37  Score=236.06  Aligned_cols=206  Identities=28%  Similarity=0.461  Sum_probs=169.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++.+..+...|+|+||+++++|.+++...    .++...+..++.+++.++.+||+.  
T Consensus        47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~--  120 (277)
T cd06641          47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE--  120 (277)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC--
Confidence            46788999999999999999999999999999999999999999988643    378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus       121 -~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~  199 (277)
T cd06641         121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             -CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence             9999999999999999999999999988765543333334567788999999988888899999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.....      ......+.....+..   ....+.++.+++.+||..+|.+||++.++++
T Consensus       200 p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         200 PHSELHP------MKVLFLIPKNNPPTL---EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCccch------HHHHHHHhcCCCCCC---CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9753221      112222211211111   1235567889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.7e-37  Score=237.96  Aligned_cols=212  Identities=26%  Similarity=0.387  Sum_probs=165.2

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      +.+.+|+.+++++ +|+|++++++++...     ...|+|+||+.+++|.+++... .....+++..++.++.|++.||.
T Consensus        63 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  142 (291)
T cd06639          63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ  142 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            4567899999999 799999999998653     3689999999999999988642 12234789999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-----CcccchhhhhH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-----KVTAKCDVYSF  150 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwsl  150 (228)
                      +||+.   |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+...     .++.++|+||+
T Consensus       143 ~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  219 (291)
T cd06639         143 HLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL  219 (291)
T ss_pred             HHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence            99999   99999999999999999999999999987655433333345678889999987543     25789999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+++|+|++|..||.....      ......+.....+... ........+.++|.+||+.+|.+|||+.++++
T Consensus       220 Gvi~~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         220 GITAIELGDGDPPLFDMHP------VKTLFKIPRNPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHHHHhhCCCCCCCCcH------HHHHHHHhcCCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            9999999999999754321      1112222222111111 11234457899999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.4e-38  Score=239.58  Aligned_cols=208  Identities=25%  Similarity=0.424  Sum_probs=169.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++......|+|+||+.+++|.+++...    .++...+..++.|++.|+.+||+.  
T Consensus        61 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~--  134 (293)
T cd06647          61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN--  134 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            46788999999999999999999999999999999999999999998653    267888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|++||.+.+..++.++|+||||+++|++++|..
T Consensus       135 -gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             -CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999988765544333344567788999999888888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.......      ..........+. .......+..+.+++.+||..+|.+||++.++++
T Consensus       214 pf~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         214 PYLNENPLR------ALYLIATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCCCChhh------heeehhcCCCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            986432211      111111111111 1112234557889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-37  Score=236.00  Aligned_cols=210  Identities=26%  Similarity=0.392  Sum_probs=166.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+|++++++++......++|+||+.+++|.+++....   .++...+..++.|++.|+.+||+.  
T Consensus        53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~--  127 (272)
T cd06629          53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK--  127 (272)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC--
Confidence            357789999999999999999999999999999999999999999987653   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCC--cccchhhhhHHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~~~  158 (228)
                       |++|+||+|+||+++.++.++++|||.+........  ......++..|+|||.+....  ++.++|+||||+++|+++
T Consensus       128 -~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~  206 (272)
T cd06629         128 -GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF  206 (272)
T ss_pred             -CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence             999999999999999999999999998876432211  122345678899999887654  788999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhc-CCCCCC-CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEML-DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||.....      ........ ...... ........+.++.+++.+||..+|.+|||++++++
T Consensus       207 ~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         207 AGRRPWSDEEA------IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hCCCCCcCcch------HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            99999753211      11111111 111111 11112345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-37  Score=234.66  Aligned_cols=210  Identities=30%  Similarity=0.460  Sum_probs=168.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+......++++||+.+++|.+++....   .+++..+..++.+++.|+.+||+.  
T Consensus        44 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~--  118 (264)
T cd06626          44 KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH--  118 (264)
T ss_pred             HHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999987543   267888999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce----ecccccceeCCcccccCC---cccchhhhhHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT----EFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLAL  155 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~  155 (228)
                       |++|+||+|+||+++.++.++|+|||.+...........    ...++..|+|||.+.+..   .+.++|+||+|+++|
T Consensus       119 -~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~  197 (264)
T cd06626         119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL  197 (264)
T ss_pred             -CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence             999999999999999999999999999887654333211    245678999999988766   788999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++++|..||.....     .............+..+ .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       198 ~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         198 EMATGKRPWSELDN-----EFQIMFHVGAGHKPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHhCCCCccCCcc-----hHHHHHHHhcCCCCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            99999999863321     11111111111111111 12234667889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-38  Score=238.75  Aligned_cols=217  Identities=21%  Similarity=0.296  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+|++++++++......|+++||++ ++|.+++..... ..+++..++.++.|++.||+|||+.  
T Consensus        43 ~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~--  118 (283)
T cd07835          43 STAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH--  118 (283)
T ss_pred             hHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457889999999999999999999999999999999995 588888865442 3489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       +++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|++++|.
T Consensus       119 -~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  197 (283)
T cd07835         119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR  197 (283)
T ss_pred             -CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987654333323334557889999987664 4688999999999999999999


Q ss_pred             CCccccccccCCC--------ch-----------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          162 HPRDFLSNVSSSN--------PN-----------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       162 ~p~~~~~~~~~~~--------~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .||..........        +.           .....................+..+.++|.+||+.+|.+|||++++
T Consensus       198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  277 (283)
T cd07835         198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA  277 (283)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            9986432210000        00           0000000011111111223455678899999999999999999999


Q ss_pred             HH
Q 040501          223 CQ  224 (228)
Q Consensus       223 l~  224 (228)
                      ++
T Consensus       278 l~  279 (283)
T cd07835         278 LQ  279 (283)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-37  Score=233.61  Aligned_cols=206  Identities=27%  Similarity=0.414  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+||+++++++......|+++||+++++|.+++....   .+++..+..++.|++.++++||+.  
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--  121 (258)
T cd06632          47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR--  121 (258)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            467899999999999999999999999999999999999999999987543   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.... ++.++|+||+|+++|++++|.
T Consensus       122 -~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~  199 (258)
T cd06632         122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK  199 (258)
T ss_pred             -CcccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence             99999999999999999999999999887654332 223456788899999887766 889999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcC-CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......... ...+..   ....+..+.+++.+||..+|.+|||+.++++
T Consensus       200 ~pf~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         200 PPWSQLEG------VAAVFKIGRSKELPPI---PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcccCcH------HHHHHHHHhcccCCCc---CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            99854321      111111111 111111   1234567889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=240.62  Aligned_cols=217  Identities=26%  Similarity=0.368  Sum_probs=166.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++|+||+++++++..+...++++||+.++.+..+....   ..++...++.++.|++.|+.+||+. 
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-  119 (288)
T cd07833          44 KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH-  119 (288)
T ss_pred             hhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            356889999999999999999999999999999999999987776665433   2378999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||++.+. .++.++|+||||+++|++++
T Consensus       120 --~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~  197 (288)
T cd07833         120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD  197 (288)
T ss_pred             --CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence              999999999999999999999999999887654432 23335567889999999887 78899999999999999999


Q ss_pred             CCCCccccccccCCC----------chhhh----hhhcCC-CCCCCc--hh-----hhhhHHHHHHHHHHhhccCCCCCC
Q 040501          160 GKHPRDFLSNVSSSN----------PNILV----NEMLDP-RLPPLS--VD-----IRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       160 g~~p~~~~~~~~~~~----------~~~~~----~~~~~~-~~~~~~--~~-----~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      |..||..........          .....    ...... ..+...  ..     ...++.++.++|++||..+|.+||
T Consensus       198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  277 (288)
T cd07833         198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL  277 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc
Confidence            999986432111000          00000    000000 000000  00     012366789999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |++++++
T Consensus       278 s~~~il~  284 (288)
T cd07833         278 TCDELLQ  284 (288)
T ss_pred             cHHHHhc
Confidence            9999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-37  Score=232.98  Aligned_cols=211  Identities=27%  Similarity=0.435  Sum_probs=175.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+++++.++|+|++++.+.+......++++|++++++|.+++.... ....++...+..++.+++.|+.+||+.
T Consensus        43 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~  122 (258)
T cd08215          43 REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR  122 (258)
T ss_pred             HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            4568899999999999999999999999999999999999999999987642 124589999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||...+..++.++|+||+|+++++|++|
T Consensus       123 ---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  199 (258)
T cd08215         123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL  199 (258)
T ss_pred             ---CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC
Confidence               99999999999999999999999999988765443233345678889999998888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..||....      ................+.   ..+..+.+++.+||..+|.+|||+.++++
T Consensus       200 ~~p~~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         200 KHPFEGEN------LLELALKILKGQYPPIPS---QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCc------HHHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            99975332      223333333333332221   45567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-37  Score=254.51  Aligned_cols=218  Identities=16%  Similarity=0.244  Sum_probs=159.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--AEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ..+.+|++++++++|+||+++++++......|++++++.+ +|..++.....  .......++..++.|++.||.|||+.
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~  286 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK  286 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999999999999999999999999854 56665543211  12234567788999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                         ||+||||||+||+++.++.+||+|||++......... .....|+..|+|||++.+..++.++|||||||++|+|++
T Consensus       287 ---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~  363 (501)
T PHA03210        287 ---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS  363 (501)
T ss_pred             ---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence               9999999999999999999999999999866543222 233568999999999999889999999999999999999


Q ss_pred             CCCC-ccccccccCCCchhhhh-----------------hhcC-CCCC----CCch--hhhhhHHHHHHHHHHhhccCCC
Q 040501          160 GKHP-RDFLSNVSSSNPNILVN-----------------EMLD-PRLP----PLSV--DIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       160 g~~p-~~~~~~~~~~~~~~~~~-----------------~~~~-~~~~----~~~~--~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      |..+ +................                 ..+. ....    ....  .....+..+.++|.+||..||.
T Consensus       364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~  443 (501)
T PHA03210        364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH  443 (501)
T ss_pred             CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence            8754 33211100000000000                 0000 0000    0000  0112344577889999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.|+++
T Consensus       444 ~Rpsa~elL~  453 (501)
T PHA03210        444 LRPGAAELLA  453 (501)
T ss_pred             cCcCHHHHhh
Confidence            9999999986

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-37  Score=236.82  Aligned_cols=214  Identities=22%  Similarity=0.364  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++++..+...++|+|++ +++|.+++....  ..+++.+++.++.|++.+|.|||+.  
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--  118 (286)
T cd07832          44 NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN--  118 (286)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46889999999999999999999999999999999999 999999986544  3489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g  160 (228)
                       |++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+.. ++.++||||+|+++|++++|
T Consensus       119 -~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             -CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence             999999999999999999999999999886654322 123356788999999886544 58899999999999999999


Q ss_pred             CCCccccccccCCCchhhhh--------------------hhcCCCCCC--CchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          161 KHPRDFLSNVSSSNPNILVN--------------------EMLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      .++|.........  .....                    .+.......  ......+.+..+.+++.+||+.+|.+|||
T Consensus       198 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  275 (286)
T cd07832         198 SPLFPGENDIEQL--AIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS  275 (286)
T ss_pred             CcCcCCCCHHHHH--HHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence            8887532211000  00000                    000000000  00011234578899999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      ++++++
T Consensus       276 ~~~~l~  281 (286)
T cd07832         276 AAEALR  281 (286)
T ss_pred             HHHHhh
Confidence            999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-37  Score=231.97  Aligned_cols=210  Identities=29%  Similarity=0.472  Sum_probs=171.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++.++.++|++++++++++......++++|++++++|.+++....  ..++...+..++.|++.++.+||+. 
T Consensus        41 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~-  117 (253)
T cd05122          41 KEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN-  117 (253)
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC-
Confidence            3568899999999999999999999999999999999999999999987653  3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus       118 --~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~  194 (253)
T cd05122         118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK  194 (253)
T ss_pred             --CEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999887654332 23456788899999998888899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ............+... .....+..+.+++.+||..||++|||+.++++
T Consensus       195 ~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         195 PPYSELPP------MKALFKIATNGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCCCCch------HHHHHHHHhcCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99764321      1111111111111111 11123567899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-37  Score=242.61  Aligned_cols=210  Identities=20%  Similarity=0.257  Sum_probs=164.1

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+..|+.++..++|++|+++++.+......|+||||+.+++|.+++.....  .+++..+..++.|++.|+.|||+.   
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---  121 (332)
T cd05623          47 CFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---  121 (332)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            477899999999999999999999999999999999999999999976332  378889999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCccccc-----CCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~~  157 (228)
                      |++||||||+||+++.++.++|+|||++......... .....|++.|+|||++.+     ..++.++|+||||+++|+|
T Consensus       122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el  201 (332)
T cd05623         122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM  201 (332)
T ss_pred             CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence            9999999999999999999999999998754332221 223568999999998863     3578899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCC--CCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPE--SRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~--~Rpt~~~il~  224 (228)
                      ++|..||....      .......+..... ...+......+.++.+++++||..++.  .|+++.++++
T Consensus       202 l~g~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         202 LYGETPFYAES------LVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             hcCCCCCCCCC------HHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            99999985332      2222222322211 111112234567789999999965444  3688888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.4e-38  Score=236.00  Aligned_cols=210  Identities=25%  Similarity=0.365  Sum_probs=169.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++.+..+...|+++|++.+++|.+++....   .+++..++.++.|++.+|.+||+.  
T Consensus        38 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~--  112 (265)
T cd05579          38 DQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSN--  112 (265)
T ss_pred             HHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc--
Confidence            467889999999999999999999999999999999999999999987644   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--------CceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                       |++|+||+|+||+++.++.++|+|||++........        ......++..|++||...+...+.++|+||||+++
T Consensus       113 -~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~  191 (265)
T cd05579         113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL  191 (265)
T ss_pred             -CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence             999999999999999999999999998876543311        12234567789999998888888999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |++++|..||....      .................  ....+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       192 ~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         192 YEFLVGIPPFHGET------PEEIFQNILNGKIEWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             HHHHhCCCCCCCCC------HHHHHHHHhcCCcCCCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            99999999985332      22222222222221111  112366789999999999999999995555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-37  Score=236.60  Aligned_cols=218  Identities=20%  Similarity=0.317  Sum_probs=166.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++...+..++|+||+.+ +|.+++........+++.++..++.|++.||.|||+.  
T Consensus        43 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--  119 (284)
T cd07836          43 STAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN--  119 (284)
T ss_pred             HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4567899999999999999999999999999999999975 7888876655444589999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+. .++.++|+||||+++|++++|.
T Consensus       120 -~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  198 (284)
T cd07836         120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR  198 (284)
T ss_pred             -CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987654333223334567889999987654 4688999999999999999999


Q ss_pred             CCccccccccCCCc---------hhhhhhh-----cCCCCCCCc-----hhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          162 HPRDFLSNVSSSNP---------NILVNEM-----LDPRLPPLS-----VDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       162 ~p~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .||...........         .......     .....+...     ......+..+.+++.+||+.||.+|||++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  278 (284)
T cd07836         199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA  278 (284)
T ss_pred             CCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence            99864321100000         0000000     000001000     0012335568899999999999999999998


Q ss_pred             HH
Q 040501          223 CQ  224 (228)
Q Consensus       223 l~  224 (228)
                      ++
T Consensus       279 l~  280 (284)
T cd07836         279 LQ  280 (284)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.6e-37  Score=237.20  Aligned_cols=215  Identities=22%  Similarity=0.279  Sum_probs=163.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+|++++++++||||+++.+++...  ...|+++||+.+ +|.+++.....  .++...++.++.|++.||+|||+. 
T Consensus        50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~-  125 (293)
T cd07843          50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN-  125 (293)
T ss_pred             hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            467899999999999999999998777  899999999975 88888865433  489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.. ++.++|+||+|+++|+|++|
T Consensus       126 --~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  203 (293)
T cd07843         126 --WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK  203 (293)
T ss_pred             --CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence              999999999999999999999999999887665433333455678899999887654 68899999999999999999


Q ss_pred             CCCccccccccCCCc---------hh------hhh-----hhcCCCCCCCchhhhh--hHHHHHHHHHHhhccCCCCCCC
Q 040501          161 KHPRDFLSNVSSSNP---------NI------LVN-----EMLDPRLPPLSVDIRG--KVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~---------~~------~~~-----~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ..||...........         ..      ...     ................  .+..+.++|.+||+.+|++|||
T Consensus       204 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t  283 (293)
T cd07843         204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS  283 (293)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence            999864321100000         00      000     0000000000001111  3566889999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      +.++++
T Consensus       284 ~~ell~  289 (293)
T cd07843         284 AEDALK  289 (293)
T ss_pred             HHHHhc
Confidence            999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.2e-37  Score=238.58  Aligned_cols=209  Identities=23%  Similarity=0.390  Sum_probs=164.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+.+++.++|+||+++++++... ..+++++++++++|.+++..+..  .++...++.++.|++.||.|||+.   
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---  128 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---  128 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---
Confidence            578899999999999999999998654 46789999999999999875432  378899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-C
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g  160 (228)
                      |++|+||||+||+++.++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|++++ |
T Consensus       129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g  208 (303)
T cd05110         129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG  208 (303)
T ss_pred             CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999865433221  112334668999999988889999999999999999997 8


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||......      ............+.   ...++..+.+++.+||..+|.+||+++++++.|.
T Consensus       209 ~~p~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         209 GKPYDGIPTR------EIPDLLEKGERLPQ---PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCCCCCHH------HHHHHHHCCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8997543211      11111111111111   1123456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=251.60  Aligned_cols=204  Identities=26%  Similarity=0.436  Sum_probs=172.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .++..|+..|++++|||++.+.++|-.....|+|||||- |+-.|++.-+.  +++.+-.+..++.+.+.||+|||+.  
T Consensus        71 qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~--  145 (948)
T KOG0577|consen   71 QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH--  145 (948)
T ss_pred             HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh--
Confidence            467899999999999999999999999999999999995 47777776543  3377888889999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc---CCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~~~~  159 (228)
                       +.+|||||..||++++.|.|||.|||.+....+    ..++.|||.|||||++..   +.|+.++||||||++-.++..
T Consensus       146 -~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE  220 (948)
T KOG0577|consen  146 -NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  220 (948)
T ss_pred             -hHHhhhccccceEecCCCeeeeccccchhhcCc----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhh
Confidence             999999999999999999999999999876543    345799999999998864   469999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .++|...++.+      ..++.+.....|....  ..-+..+..++..||++-|.+|||.+++++
T Consensus       221 RkPPlFnMNAM------SALYHIAQNesPtLqs--~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  221 RKPPLFNMNAM------SALYHIAQNESPTLQS--NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             cCCCccCchHH------HHHHHHHhcCCCCCCC--chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            99996655433      3555665555544432  355667899999999999999999999875

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-37  Score=236.41  Aligned_cols=210  Identities=21%  Similarity=0.294  Sum_probs=160.1

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+++++.++|+||+++.+++..+...|+|+||+. +++.+++....  ..++...+..++.|++.||.|||+.   
T Consensus        49 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---  122 (291)
T cd07870          49 TAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---  122 (291)
T ss_pred             HHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            56789999999999999999999999999999999996 56666654432  2367788889999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|++++|..
T Consensus       123 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  202 (291)
T cd07870         123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP  202 (291)
T ss_pred             CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999887654333333334567889999988654 47889999999999999999999


Q ss_pred             CccccccccCCCchhhhhhh-------------------------cCCCCCCC-ch--hhhhhHHHHHHHHHHhhccCCC
Q 040501          163 PRDFLSNVSSSNPNILVNEM-------------------------LDPRLPPL-SV--DIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ||......     .......                         .....+.. ..  ........+.+++.+||..||+
T Consensus       203 ~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~  277 (291)
T cd07870         203 AFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK  277 (291)
T ss_pred             CCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence            98643211     0000000                         00000000 00  0011245688999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.+++.
T Consensus       278 ~R~t~~~~l~  287 (291)
T cd07870         278 DRISAQDALL  287 (291)
T ss_pred             cCcCHHHHhc
Confidence            9999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-37  Score=242.56  Aligned_cols=210  Identities=21%  Similarity=0.249  Sum_probs=164.4

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|+.++..++|++|+++++++...+..|+||||+.+++|.+++.....  .+++..+..++.|++.||.|||+.   
T Consensus        47 ~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---  121 (331)
T cd05624          47 CFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---  121 (331)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            467899999999999999999999999999999999999999999976332  378899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCccccc-----CCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~~  157 (228)
                      |++||||||+||+++.++.++|+|||++......... .....|++.|+|||++.+     ..++.++|+||+|+++|+|
T Consensus       122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el  201 (331)
T cd05624         122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence            9999999999999999999999999998765433222 223568999999998875     4578899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+..... ...+......+.++.+++.+||..++++  |++++++++
T Consensus       202 l~g~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         202 LYGETPFYAES------LVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             hhCCCCccCCC------HHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            99999985332      1222222222111 1111222345667899999999866544  467777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=260.17  Aligned_cols=213  Identities=26%  Similarity=0.502  Sum_probs=182.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      |.+|+.|+.+|-++.||||+++-++.+..+...||.|||.+|+|+.+++.+..  .+...+...+++.|+.|++||.+. 
T Consensus       674 rrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm-  750 (996)
T KOG0196|consen  674 RRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM-  750 (996)
T ss_pred             HhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc-
Confidence            67899999999999999999999999999999999999999999999987663  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecc--cccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFA--GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |+|||||...|||++.+-.+|++|||+++...++... .+...  -+.+|.|||.+...+++.+|||||+|++|||.+
T Consensus       751 --~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm  828 (996)
T KOG0196|consen  751 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  828 (996)
T ss_pred             --CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence              9999999999999999999999999999987655533 22222  267899999999999999999999999999988


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      + |..||..+.      ..+.+..+.++...+.+   .+++..+.+|+..||++|-.+||++.+|+..|.|
T Consensus       829 SyGERPYWdmS------NQdVIkaIe~gyRLPpP---mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  829 SYGERPYWDMS------NQDVIKAIEQGYRLPPP---MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             ccCCCcccccc------hHHHHHHHHhccCCCCC---CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            6 999965433      33444444444433322   3677789999999999999999999999998864

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=233.47  Aligned_cols=206  Identities=21%  Similarity=0.272  Sum_probs=162.1

Q ss_pred             HHHHHHHHh-ccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            5 FLREITVLT-EIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         5 ~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      +..|..++. ..+|+|++++++.+..+...|+++||+++++|.+++....   .++...+..++.|++.||.|||+.   
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---  116 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---  116 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            344544444 3489999999999999999999999999999999987543   378899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      |++|+||+|+||+++.++.++|+|||.+.....    .....++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus       117 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p  192 (260)
T cd05611         117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP  192 (260)
T ss_pred             CeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCC
Confidence            999999999999999999999999998875432    2234577889999999888889999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |....      .......................+..+.+++.+||..+|.+|||+.++.+.|
T Consensus       193 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         193 FHAET------PDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCCCC------HHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            85322      1222222222221111111224566789999999999999999876665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.9e-37  Score=232.53  Aligned_cols=206  Identities=25%  Similarity=0.373  Sum_probs=161.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|+.++++++|+||+++++++..  ....++++|++.+++|.+++.....   ++....+.++.|++.||++||+.
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~  125 (266)
T cd06651          49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSN  125 (266)
T ss_pred             HHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence            357889999999999999999998865  3678899999999999999875432   78888999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC---CCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS---SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         +++|+||+|+||+++.++.++|+|||++.......   .......++..|+|||.+.+..++.++|+||+|+++|++
T Consensus       126 ---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el  202 (266)
T cd06651         126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM  202 (266)
T ss_pred             ---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence               99999999999999999999999999987543211   111234577889999999888899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ........ ....+..   .......+.+++ +||..+|.+|||++++++
T Consensus       203 ~~g~~pf~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         203 LTEKPPWAEYEA------MAAIFKIATQPTNPQL---PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHCCCCccccch------HHHHHHHhcCCCCCCC---chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            999999863311      11111111 1111111   123344567777 688889999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-37  Score=240.79  Aligned_cols=214  Identities=23%  Similarity=0.389  Sum_probs=164.9

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      +.+.+|+.++.++ +|+||+++++++.. +...+++|||+++++|.+++.....                          
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (343)
T cd05103          55 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL  134 (343)
T ss_pred             HHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence            3578899999999 68999999998854 4567899999999999999864321                          


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceE
Q 040501           55 --------------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVL   96 (228)
Q Consensus        55 --------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil   96 (228)
                                                            ...+++.++..++.|++.||+|||+.   |++|+||||+||+
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil  211 (343)
T cd05103         135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  211 (343)
T ss_pred             hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEE
Confidence                                                  12367788889999999999999999   9999999999999


Q ss_pred             EcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCccccccccCC
Q 040501           97 LDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSS  173 (228)
Q Consensus        97 ~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~  173 (228)
                      ++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.....    
T Consensus       212 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  287 (343)
T cd05103         212 LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----  287 (343)
T ss_pred             EcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----
Confidence            999999999999998765322211  112334567999999988889999999999999999996 9999854221    


Q ss_pred             CchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       ................+   ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       288 -~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         288 -DEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             -cHHHHHHHhccCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             11111111111111111   123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=252.10  Aligned_cols=211  Identities=27%  Similarity=0.397  Sum_probs=173.9

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      -+..||.+-++|+|.|||++++.+.+++++-|.||-++||+|.++++..=..-.=++.+.-.+.+||++||+|||..   
T Consensus       618 PLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---  694 (1226)
T KOG4279|consen  618 PLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---  694 (1226)
T ss_pred             cHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---
Confidence            35689999999999999999999999999999999999999999998643222237888889999999999999999   


Q ss_pred             CeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccC--CcccchhhhhHHHHHHHHHhC
Q 040501           84 PIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~~~~g  160 (228)
                      .|+|||||-+||+++. .|.+||+|||-+++...-.....++.||..|||||++..+  .|..++|||||||++.||.||
T Consensus       695 ~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG  774 (1226)
T KOG4279|consen  695 KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG  774 (1226)
T ss_pred             ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC
Confidence            9999999999999964 6999999999999887666667778999999999998755  588999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++||--.+..    ...++.--.-...|+.+   ...+.+...+|.+|+.++|.+||+++++++
T Consensus       775 rPPF~Elgsp----qAAMFkVGmyKvHP~iP---eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  775 RPPFVELGSP----QAAMFKVGMYKVHPPIP---EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCeeecCCh----hHhhhhhcceecCCCCc---HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            9998533221    11122222222223332   355667889999999999999999999985

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7e-38  Score=236.13  Aligned_cols=208  Identities=27%  Similarity=0.371  Sum_probs=169.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++.+..+...++++||+.+++|.+++...   ..++...+..++.|++++|.|||+.  
T Consensus        45 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~--  119 (258)
T cd05578          45 RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK--  119 (258)
T ss_pred             HHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence            56788999999999999999999999999999999999999999998765   2388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus       120 -~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  197 (258)
T cd05578         120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR  197 (258)
T ss_pred             -CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCC
Confidence             99999999999999999999999999887654332 2234567788999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM--QTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~--~~il~  224 (228)
                      ||......   .............. .   .....+..+.++|.+||..||.+||++  +++++
T Consensus       198 p~~~~~~~---~~~~~~~~~~~~~~-~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         198 PYRGHSRT---IRDQIRAKQETADV-L---YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CCCCCCcc---HHHHHHHHhccccc-c---CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            98644321   11112222111111 1   112345678999999999999999999  76653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-37  Score=247.19  Aligned_cols=155  Identities=26%  Similarity=0.348  Sum_probs=136.1

Q ss_pred             HHHHHHHHhccC-C-----CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            5 FLREITVLTEIR-H-----RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         5 ~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ...|+.+|..++ |     -|+|+++++|...++.|||+|.+. .+|.++++.+.- ..++...+..++.|+++||..||
T Consensus       229 ~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~  306 (586)
T KOG0667|consen  229 AQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH  306 (586)
T ss_pred             HHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            356999999996 4     389999999999999999999884 699999987653 34999999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCC--CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLE--YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      +.   ||+|+||||+|||+...  ..+||+|||.+...+....   ....+..|+|||++.|.+|+.+.|||||||++.|
T Consensus       307 ~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAE  380 (586)
T KOG0667|consen  307 EL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAE  380 (586)
T ss_pred             hC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHh
Confidence            99   99999999999999654  4699999999988654432   5667889999999999999999999999999999


Q ss_pred             HHhCCCCcccc
Q 040501          157 VIKGKHPRDFL  167 (228)
Q Consensus       157 ~~~g~~p~~~~  167 (228)
                      |++|.+.|+..
T Consensus       381 L~tG~PLfpG~  391 (586)
T KOG0667|consen  381 LFTGEPLFPGD  391 (586)
T ss_pred             HhcCccccCCC
Confidence            99999887644

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.9e-37  Score=230.99  Aligned_cols=206  Identities=24%  Similarity=0.320  Sum_probs=163.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++|+||+++++++.+.  ..+++++|++++++|.+++....   .++...+..++.|++.+|.+||+.
T Consensus        49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~  125 (265)
T cd06652          49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN  125 (265)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678899999999999999999988653  56889999999999999987543   278888999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---CceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus       126 ---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  202 (265)
T cd06652         126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM  202 (265)
T ss_pred             ---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence               999999999999999999999999998875432111   12234577889999999888889999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ........ .+..+..   ....+..+.+++.+||. +|++|||++++++
T Consensus       203 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         203 LTEKPPWAEFEA------MAAIFKIATQPTNPVL---PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hhCCCCCCccch------HHHHHHHhcCCCCCCC---chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            999999853211      11111111 1111111   12345567899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3e-37  Score=232.24  Aligned_cols=209  Identities=24%  Similarity=0.333  Sum_probs=172.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ...+.+|+++++.++|+||+++++++......|+++|++++++|.+++.... ....++...++.++.|++.|+.+||+.
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~  122 (256)
T cd08530          43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            3467789999999999999999999999999999999999999999886522 123478899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++++|||++......  ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       123 ---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g  197 (256)
T cd08530         123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF  197 (256)
T ss_pred             ---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC
Confidence               9999999999999999999999999998776544  22234577899999999888889999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.||....      .............+...   ...+.++.+++.+||..+|.+|||+.++++
T Consensus       198 ~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         198 APPFEARS------MQDLRYKVQRGKYPPIP---PIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCCCCC------HHHHHHHHhcCCCCCCc---hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            99975332      22222333333333322   245667999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=229.54  Aligned_cols=207  Identities=26%  Similarity=0.465  Sum_probs=171.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+|++++++++..+...++++|++.+++|.+++...   ..+++..++.++.|++.++.+||+.  
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~--  118 (254)
T cd06627          44 KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ--  118 (254)
T ss_pred             HHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC--
Confidence            56889999999999999999999999999999999999999999998765   2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............++..|+|||...+...+.++|+|++|+++|++++|..
T Consensus       119 -~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~  197 (254)
T cd06627         119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP  197 (254)
T ss_pred             -CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999999877654443344567889999999888778899999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.....      ............+...   ...+..+.+++.+||..+|++|||+.+++.
T Consensus       198 p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         198 PYYDLNP------MAALFRIVQDDHPPLP---EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCccH------HHHHHHHhccCCCCCC---CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            9753321      1111122112222111   234567899999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.5e-37  Score=238.99  Aligned_cols=212  Identities=26%  Similarity=0.321  Sum_probs=161.3

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+|+.++++++|+||+++++++...  ...++|+|++.+ +|.+++....  ..+++.+++.++.|++.||.|||+. 
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~-  127 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN-  127 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            356899999999999999999998754  568999999965 7877776533  3488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus       128 --~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  205 (309)
T cd07845         128 --FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH  205 (309)
T ss_pred             --CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence              9999999999999999999999999998876544333333345678999998865 4578899999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhc-----------------------CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEML-----------------------DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      ..||.........   .......                       ..............+.++.++|.+||+.||++||
T Consensus       206 ~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~  282 (309)
T cd07845         206 KPLLPGKSEIEQL---DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA  282 (309)
T ss_pred             CCCCCCCCHHHHH---HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc
Confidence            9998643221100   0000000                       0000000001122456788999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.++++
T Consensus       283 t~~~il~  289 (309)
T cd07845         283 TAEEALE  289 (309)
T ss_pred             CHHHHhc
Confidence            9999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-37  Score=231.93  Aligned_cols=214  Identities=23%  Similarity=0.388  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDT---SAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~l~~~   73 (228)
                      +++.+|++++++++||||+++++++....      ..+++++|+.+++|.+++....   ....++...++.++.|++.|
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~  125 (273)
T cd05074          46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG  125 (273)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Confidence            45789999999999999999999886432      3478899999999988764321   12237888999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                      ++|||+.   |++|+||||+||+++.++.++++|||.+.........  .....+++.|++||.+.+..++.++||||||
T Consensus       126 l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG  202 (273)
T cd05074         126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG  202 (273)
T ss_pred             HHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHH
Confidence            9999999   9999999999999999999999999998765432211  1223445789999999888889999999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|++++ |..||.....      ......+.........   ...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       203 ~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         203 VTMWEIMTRGQTPYAGVEN------SEIYNYLIKGNRLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             HHHHHHhhCCCCCCCCCCH------HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            99999998 8888753321      1122222222111111   2345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-36  Score=234.99  Aligned_cols=204  Identities=26%  Similarity=0.435  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++.+++..+...|+|+||+.+ ++.+.+....  ..+++..+..++.|++.||.|||+.  
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~--  134 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH--  134 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678999999999999999999999999999999999974 6666665332  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+......    ....++..|+|||.+.   ...++.++||||||+++|+|++
T Consensus       135 -~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t  209 (307)
T cd06607         135 -ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (307)
T ss_pred             -CceecCCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence             9999999999999999999999999988764422    2345678899999874   3457889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||.....      ............+...  ....+..+.+++.+||..+|.+|||+.+++.
T Consensus       210 g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         210 RKPPLFNMNA------MSALYHIAQNDSPTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CCCCCCCccH------HHHHHHHhcCCCCCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            9999753321      1111112111111111  1235567899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-36  Score=236.96  Aligned_cols=212  Identities=20%  Similarity=0.314  Sum_probs=162.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||++++++|..+...++++|++.++++.+++..... ..+++..+..++.|++.||+|||+.  
T Consensus        44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~--  120 (328)
T cd08226          44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN--  120 (328)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5678899999999999999999999999999999999999999999876432 2488899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-------eecccccceeCCcccccC--CcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-------TEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~  153 (228)
                       |++|+||||+||+++.++.++++||+.+..........       ....++..|+|||++.+.  .++.++|+||+||+
T Consensus       121 -~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~  199 (328)
T cd08226         121 -GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT  199 (328)
T ss_pred             -CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHH
Confidence             99999999999999999999999997543322111110       011235569999998764  46889999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCC----------------------------------------CC---CCC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP----------------------------------------RL---PPL  190 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~---~~~  190 (228)
                      +|++++|..||.......      ........                                        ..   ...
T Consensus       200 l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (328)
T cd08226         200 ACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR  273 (328)
T ss_pred             HHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc
Confidence            999999999986432110      00000000                                        00   000


Q ss_pred             chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          191 SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       191 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .......+..+.+++++||..||.+|||++++++
T Consensus       274 ~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            1112345677899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-36  Score=229.19  Aligned_cols=209  Identities=28%  Similarity=0.428  Sum_probs=172.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|++.+++++|+||+++++.+...  ...++++|++.+++|.+++....   .+++..++.++.|++.++.+||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~  119 (260)
T cd06606          43 LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS  119 (260)
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999888  89999999999999999987654   48999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                      .   |++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+...+.++|+||||+++|++
T Consensus       120 ~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l  196 (260)
T cd06606         120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM  196 (260)
T ss_pred             C---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHH
Confidence            9   999999999999999999999999999887664432  13345678899999999888899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcC-CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....     +.......... ...+..+   ...+..+.+++.+||..||.+|||+.+++.
T Consensus       197 ~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         197 ATGKPPWSELG-----NPMAALYKIGSSGEPPEIP---EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HhCCCCCCCCC-----chHHHHHhccccCCCcCCC---cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            99999986443     11122222221 1111111   233567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=234.91  Aligned_cols=216  Identities=22%  Similarity=0.322  Sum_probs=168.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++..+...++++||+.+ ++.+.+....  ..++..+++.++.|++.||.+||+.  
T Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--  117 (283)
T cd05118          43 KTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH--  117 (283)
T ss_pred             HHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678899999999999999999999999999999999975 7777776543  3489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|++++|+
T Consensus       118 -~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~  196 (283)
T cd05118         118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR  196 (283)
T ss_pred             -CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987765443222334567789999998776 6788999999999999999999


Q ss_pred             CCccccccccCCCc---------hhhhh-----------hhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSSNP---------NILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~~~---------~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      .||...........         .....           .................+.++.++|.+||++||.+||++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  276 (283)
T cd05118         197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ  276 (283)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence            99864332110000         00000           00000111111122346778999999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      ++.
T Consensus       277 ll~  279 (283)
T cd05118         277 ALA  279 (283)
T ss_pred             Hhh
Confidence            985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.3e-37  Score=236.17  Aligned_cols=218  Identities=18%  Similarity=0.244  Sum_probs=162.1

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCe-----EEEEEEeecCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARH-----SFLVYEYLENGSLSVILNNDTS--AEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +.+.+|+.++++++ |+||+++++++.....     .|++|||+.+ +|.+++.....  ...+++..++.++.|++.||
T Consensus        45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L  123 (295)
T cd07837          45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV  123 (295)
T ss_pred             hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence            46788999999995 6999999999876655     8999999986 78777754322  23579999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGV  152 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~  152 (228)
                      .|||+.   |++|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||||+
T Consensus       124 ~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  200 (295)
T cd07837         124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC  200 (295)
T ss_pred             HHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence            999999   9999999999999998 889999999998765433333333456778999998765 34688999999999


Q ss_pred             HHHHHHhCCCCccccccccCCC---------chhhhh---------hhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          153 LALEVIKGKHPRDFLSNVSSSN---------PNILVN---------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++|+|++|..||..........         ......         .................+..+.++|.+||..||.
T Consensus       201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  280 (295)
T cd07837         201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA  280 (295)
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence            9999999999986432211000         000000         0000000000111124566789999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.+++.
T Consensus       281 ~R~~~~eil~  290 (295)
T cd07837         281 KRISAKAALT  290 (295)
T ss_pred             hcCCHHHHhc
Confidence            9999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.5e-37  Score=234.44  Aligned_cols=217  Identities=22%  Similarity=0.308  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++|+||+++++++..+...|+|+||+++ +|.+.+..... ..++...+..++.|++.||+|||+.  
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--  121 (294)
T PLN00009         46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH--  121 (294)
T ss_pred             HHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence            4578899999999999999999999999999999999964 77777654332 2367888889999999999999999  


Q ss_pred             CCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhC
Q 040501           83 PPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g  160 (228)
                       |++|+||+|+||+++. ++.+||+|||++..............+++.|+|||.+.+. .++.++|+||+|+++|++++|
T Consensus       122 -~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg  200 (294)
T PLN00009        122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ  200 (294)
T ss_pred             -CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence             9999999999999985 4678999999997654433333334567889999988664 478899999999999999999


Q ss_pred             CCCccccccccCCCch--------hhh-------h--hhcCCCCCC--CchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSSSNPN--------ILV-------N--EMLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~--------~~~-------~--~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ..||............        ...       .  ....+....  ........+..+.+++.+||+.+|.+||++.+
T Consensus       201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~  280 (294)
T PLN00009        201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA  280 (294)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence            9998643221100000        000       0  000000000  01112345567889999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       281 ~l~  283 (294)
T PLN00009        281 ALE  283 (294)
T ss_pred             Hhc
Confidence            875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=269.07  Aligned_cols=208  Identities=28%  Similarity=0.424  Sum_probs=170.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|..++..++|||+|+++++=.+.+..+|.||||.+|+|.+.+.....   .++.....+..|++.|++|||+.   
T Consensus      1280 ~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~--- 1353 (1509)
T KOG4645|consen 1280 LIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH--- 1353 (1509)
T ss_pred             chHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---
Confidence            467899999999999999999999999999999999999999999976543   45555567889999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCC---cccchhhhhHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALE  156 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~  156 (228)
                      |||||||||.||+++.+|.+|++|||.+..+..+...    .....||+.|||||++.+..   ...++|||||||+..|
T Consensus      1354 gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1354 GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred             CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence            9999999999999999999999999999887655322    23467999999999998764   4568999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |+||+.||...+.     .-.....+..+..|..+.   ..+.+-.+++..||..||++|-++.++++.
T Consensus      1434 M~tGkrPW~~~dn-----e~aIMy~V~~gh~Pq~P~---~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1434 MATGKRPWAELDN-----EWAIMYHVAAGHKPQIPE---RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             eecCCCchhhccc-----hhHHHhHHhccCCCCCch---hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            9999999864332     112233333333333332   366678899999999999999999988863

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-37  Score=239.77  Aligned_cols=216  Identities=21%  Similarity=0.308  Sum_probs=162.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|+.+++.++|+||+++++++...     ...|+++||+. ++|.+++....   .++...+..++.|++.||.+|
T Consensus        49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~L  124 (337)
T cd07858          49 KRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYI  124 (337)
T ss_pred             HHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999988644     35799999996 57888776543   388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~  156 (228)
                      |+.   +++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.. ..++.++|+||||+++|+
T Consensus       125 H~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  201 (337)
T cd07858         125 HSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE  201 (337)
T ss_pred             HhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHH
Confidence            999   9999999999999999999999999998765433222334457788999998765 458899999999999999


Q ss_pred             HHhCCCCccccccccC---------------------CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          157 VIKGKHPRDFLSNVSS---------------------SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      |++|..||........                     ...............+.........+.++.++|.+||+.+|.+
T Consensus       202 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  281 (337)
T cd07858         202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK  281 (337)
T ss_pred             HHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhh
Confidence            9999999864321000                     0000000000000001111112345677899999999999999


Q ss_pred             CCCHHHHHHH
Q 040501          216 RPNMQTICQL  225 (228)
Q Consensus       216 Rpt~~~il~~  225 (228)
                      |||++++++.
T Consensus       282 Rps~~ell~h  291 (337)
T cd07858         282 RITVEEALAH  291 (337)
T ss_pred             ccCHHHHHcC
Confidence            9999998863

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.8e-36  Score=233.15  Aligned_cols=205  Identities=26%  Similarity=0.427  Sum_probs=162.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+|++++++++..+...|+|+||+.+ ++.+.+....  ..+++.++..++.|++.++.+||+.  
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--  144 (317)
T cd06635          70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH--  144 (317)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3578899999999999999999999999999999999975 6666665432  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++.++.++|+|||++......    ....++..|+|||.+.   ...++.++|+||+|+++|+|++
T Consensus       145 -~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~  219 (317)
T cd06635         145 -NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  219 (317)
T ss_pred             -CcccCCCCcccEEECCCCCEEEecCCCccccCCc----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence             9999999999999999999999999988654322    2345778899999874   3457889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |..||...      ........+.....+...  ....+..+.+++.+||+.+|.+|||+.++++.
T Consensus       220 g~~p~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         220 RKPPLFNM------NAMSALYHIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             CCCCCCCc------cHHHHHHHHHhccCCCCC--CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence            99997532      111222222222221111  12345578999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-37  Score=239.26  Aligned_cols=215  Identities=25%  Similarity=0.372  Sum_probs=166.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC-----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|+.+++.++|+||+++.+++....     ..|+++||+. ++|.+++....   .+++..++.++.|++.||++|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~L  119 (330)
T cd07834          44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYL  119 (330)
T ss_pred             hhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHH
Confidence            56889999999999999999999987764     7899999997 47888876543   489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---CceecccccceeCCcccccC-CcccchhhhhHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVL  153 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~  153 (228)
                      |+.   |++|+||||+||+++.++.++|+|||.+........   ......++..|+|||.+.+. .++.++|+||+|++
T Consensus       120 H~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i  196 (330)
T cd07834         120 HSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI  196 (330)
T ss_pred             HhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence            999   999999999999999999999999999987655431   22334567889999999887 78999999999999


Q ss_pred             HHHHHhCCCCccccccccCCC---------chh--------hhhhhcC----CCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSN---------PNI--------LVNEMLD----PRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~---------~~~--------~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|.+||..........         ...        .......    ...........+.+..+.++|.+||+.+
T Consensus       197 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  276 (330)
T cd07834         197 FAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD  276 (330)
T ss_pred             HHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC
Confidence            999999999986433211000         000        0000000    0000001111235667899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||+.++++
T Consensus       277 P~~Rpt~~~ll~  288 (330)
T cd07834         277 PKKRITADEALA  288 (330)
T ss_pred             hhhCCCHHHHHh
Confidence            999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=244.25  Aligned_cols=199  Identities=24%  Similarity=0.308  Sum_probs=164.6

Q ss_pred             HHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            5 FLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         5 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      -.+|+.++... .||||+++.+.+.++...|+|||.+.|+-+.+.+.....   .. ..+..|+++++.|+.|||++   
T Consensus       362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---  434 (612)
T KOG0603|consen  362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---  434 (612)
T ss_pred             cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---
Confidence            45677777777 699999999999999999999999999888887765442   22 77788999999999999999   


Q ss_pred             CeeecCCCCCceEE-cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLL-DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      |++|||+||+|||+ +..|.++|+|||.+......   ...+.-|..|.|||++....++.++|+||||+++|+|++|+.
T Consensus       435 gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~t  511 (612)
T KOG0603|consen  435 GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRT  511 (612)
T ss_pred             CeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Confidence            99999999999999 68899999999998865543   334566788999999999899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||..-...     .+...++..+...      ...+.+..+|+.+||+.||.+||++.++..
T Consensus       512 p~~~~P~~-----~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  512 LFAAHPAG-----IEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccCCch-----HHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            98643222     3334444333322      466778899999999999999999999864

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.6e-37  Score=233.48  Aligned_cols=214  Identities=25%  Similarity=0.357  Sum_probs=163.3

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +..+.+|+.++.++. |+||+++++++......+++||++.. ++.++...  ......+++..+..++.+++.|++|||
T Consensus        46 ~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh  124 (288)
T cd06616          46 QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK  124 (288)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence            356788999999995 99999999999988899999999864 55443321  111234889999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC---CcccchhhhhHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~  155 (228)
                      +..  +++||||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.   .++.++|+||+|+++|
T Consensus       125 ~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~  201 (288)
T cd06616         125 EEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY  201 (288)
T ss_pred             hcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence            732  999999999999999999999999999876543221 2234577889999998766   5888999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCc-hhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLS-VDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++++|..||....     .......+......+... .....++.++.+++.+||+.+|.+|||+.++++
T Consensus       202 el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         202 EVATGKFPYPKWN-----SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHHhCCCCchhcc-----hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999986432     111222222222221111 111346678999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-36  Score=232.10  Aligned_cols=205  Identities=19%  Similarity=0.175  Sum_probs=159.2

Q ss_pred             HHHHHHHHhc---cCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            5 FLREITVLTE---IRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         5 ~~~E~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+|..+++.   ..|++|+++.+++...+..++||||+.+++|.+++..+.   .+++..+..++.|++.||.|||+. 
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~-  116 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR-  116 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3445444444   369999999999998899999999999999999887543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-cCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||||+||+++.++.++++|||++.......  .....++..|+|||.+. +..++.++|+||+|+++|++++|
T Consensus       117 --~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g  192 (279)
T cd05633         117 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG  192 (279)
T ss_pred             --CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence              99999999999999999999999999886543222  22346788999999876 45578999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ..||.......   . .............   .....+.++.++|.+||+.||.+||     |++++++
T Consensus       193 ~~pf~~~~~~~---~-~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         193 HSPFRQHKTKD---K-HEIDRMTLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCCcCCCCCcC---H-HHHHHHhhcCCcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            99986432111   1 1111111111111   1123566789999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3e-36  Score=232.80  Aligned_cols=205  Identities=26%  Similarity=0.433  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+++++.++|+|++++.+++......|+|+||+. +++.+.+....  ..++..++..++.|++.++.|||+.  
T Consensus        60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~--  134 (308)
T cd06634          60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH--  134 (308)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            357789999999999999999999999999999999996 47777665433  2378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       +++|+||+|+||+++.++.++++|||++......    ....++..|+|||.+.   ...++.++||||||+++|++++
T Consensus       135 -~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  209 (308)
T cd06634         135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (308)
T ss_pred             -CcccCCCCHHhEEECCCCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence             9999999999999999999999999988764422    2245678899999874   3457889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |..||....      .............+...  ....+..+.++|.+||..+|.+||++.++++.
T Consensus       210 g~~p~~~~~------~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         210 RKPPLFNMN------AMSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CCCCCcccc------HHHHHHHHhhcCCCCcC--cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            999975321      11122222222222111  12455678999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=244.44  Aligned_cols=219  Identities=24%  Similarity=0.410  Sum_probs=175.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      |.+|.+|+++|.+|+||||+.+++.|..++.+++++||+..|+|..++..+.... ..-.....++.||++|++||.+. 
T Consensus       579 r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~-  656 (807)
T KOG1094|consen  579 RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL-  656 (807)
T ss_pred             HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh-
Confidence            6789999999999999999999999999999999999999999999998775432 45556677999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--eecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        +++|||+.+.|++++.++++||+|||.++.........  .....+.+|+|||.+.-.+++++||+|++|+++||+++
T Consensus       657 --nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~  734 (807)
T KOG1094|consen  657 --NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM  734 (807)
T ss_pred             --chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence              99999999999999999999999999998654333322  22345789999999999999999999999999999864


Q ss_pred             --CCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 --GKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 --g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                        ...||........   .+......+... ........-++..+++++.+||+.+..+|||++++...|+
T Consensus       735 ~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  735 LCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             HHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence              7778754432211   111112222111 1111223456778999999999999999999999988876

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-36  Score=229.70  Aligned_cols=208  Identities=22%  Similarity=0.323  Sum_probs=168.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|+.+++.++||||+++++++.+....++++||+++++|.+++... .....+++..++.++.|++.|+.+||+.  
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--  125 (260)
T cd08222          48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR--  125 (260)
T ss_pred             HHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--
Confidence            4667999999999999999999999889999999999999999988642 2234589999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++. +.++++|||.+..............+++.|+|||...+..++.++|+||+|+++|++++|..
T Consensus       126 -~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~  203 (260)
T cd08222         126 -RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAH  203 (260)
T ss_pred             -CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999975 57999999988766544333344567888999999888788889999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||....      .............+..   ....+.++.++|.+||..+|.+||++.++++
T Consensus       204 ~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         204 AFEGQN------FLSVVLRIVEGPTPSL---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcc------HHHHHHHHHcCCCCCC---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            975221      1222223322222222   1355668899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=236.92  Aligned_cols=212  Identities=22%  Similarity=0.279  Sum_probs=162.1

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++|+||+++++++......+++||++. ++|.+++....   .++...+..++.|++.||.+||+.   
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---  138 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---  138 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            47789999999999999999999999999999999997 58888876433   388899999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCC--------------CCCceecccccceeCCcccccC-Ccccchhhh
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD--------------SSNWTEFAGTYGYVAPELAYTM-KVTAKCDVY  148 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diw  148 (228)
                      |++|+||+|+||+++.++.++++|||.+......              ........++..|+|||.+.+. .++.++|+|
T Consensus       139 ~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  218 (335)
T PTZ00024        139 YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW  218 (335)
T ss_pred             CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence            9999999999999999999999999998765411              1112223457789999988764 368899999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCC--------------------CCCCCchhhhhhHHHHHHHHHHh
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP--------------------RLPPLSVDIRGKVISIMEVAFLC  208 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~li~~~  208 (228)
                      |||+++|+|++|..||.........  .........+                    ............+..+.+++.+|
T Consensus       219 slG~~l~el~tg~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  296 (335)
T PTZ00024        219 SVGCIFAELLTGKPLFPGENEIDQL--GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL  296 (335)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHH
Confidence            9999999999999998643321100  0000000000                    00000011123456788999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |+.+|.+|||+++++.
T Consensus       297 l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        297 LKLNPLERISAKEALK  312 (335)
T ss_pred             cCCCchhccCHHHHhc
Confidence            9999999999999985

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-36  Score=237.50  Aligned_cols=212  Identities=23%  Similarity=0.360  Sum_probs=160.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.++++++|+||++++++|...      ...|+|+||+.+ +|.+.+...     ++...+..++.|++.||++
T Consensus        60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~  133 (353)
T cd07850          60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKH  133 (353)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999988643      357999999965 777766432     7888899999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   |++|+||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+
T Consensus       134 LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~  209 (353)
T cd07850         134 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  209 (353)
T ss_pred             HHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHH
Confidence            9999   99999999999999999999999999997654322 2233456788999999998889999999999999999


Q ss_pred             HHhCCCCccccccccC---------CCchhh-------hhhhcCCCC----------------CC-CchhhhhhHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSS---------SNPNIL-------VNEMLDPRL----------------PP-LSVDIRGKVISIME  203 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~---------~~~~~~-------~~~~~~~~~----------------~~-~~~~~~~~~~~~~~  203 (228)
                      |++|..||...+....         ......       .........                +. ........+..+.+
T Consensus       210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
T cd07850         210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD  289 (353)
T ss_pred             HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence            9999999864321100         000000       000000000                00 00001234556889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|.+||+.||++|||+.++++
T Consensus       290 li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         290 LLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHcCCChhhCcCHHHHhc
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-36  Score=229.08  Aligned_cols=193  Identities=25%  Similarity=0.383  Sum_probs=156.7

Q ss_pred             CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCce
Q 040501           16 RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV   95 (228)
Q Consensus        16 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~ni   95 (228)
                      +|+||+++++.|......|+||||+++++|.+++....   .+++..+..++.|+++||.+||+.   |++|+||+|+||
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~ni  140 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENV  140 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            69999999999999999999999999999999997654   489999999999999999999999   999999999999


Q ss_pred             EEcCCC-ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCC
Q 040501           96 LLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN  174 (228)
Q Consensus        96 l~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~  174 (228)
                      +++.++ .++++|||.+.......    ...++..|+|||++.+..++.++|+||+|+++|+|++|..||....... ..
T Consensus       141 l~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~  215 (267)
T PHA03390        141 LYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD  215 (267)
T ss_pred             EEeCCCCeEEEecCccceecCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh
Confidence            999998 99999999887654322    2357789999999988889999999999999999999999986332111 11


Q ss_pred             chhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 040501          175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-MQTICQ  224 (228)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~il~  224 (228)
                      ........ ....    ......+..+.++|.+||+.+|.+||+ ++++++
T Consensus       216 ~~~~~~~~-~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        216 LESLLKRQ-QKKL----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHhh-cccC----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11111111 1111    112256667899999999999999996 588874

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=233.10  Aligned_cols=218  Identities=19%  Similarity=0.278  Sum_probs=161.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.+.+|+.+++.++||||+++++++...  ...++|+|++.+ ++.+.+....  ....++...++.++.|++.||.|||
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH  125 (316)
T cd07842          47 QSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH  125 (316)
T ss_pred             HHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999887  789999999975 6666654322  1225889999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcC----CCceEEeecccccccCCCCC---CceecccccceeCCcccccC-CcccchhhhhH
Q 040501           79 HDCIPPIVHRDISSKNVLLDL----EYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTM-KVTAKCDVYSF  150 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~----~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  150 (228)
                      +.   +++|+||+|+||+++.    ++.++|+|||++........   ......++..|+|||.+.+. .++.++|+|||
T Consensus       126 ~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  202 (316)
T cd07842         126 SN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI  202 (316)
T ss_pred             hC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence            99   9999999999999999    89999999999886543322   12234567889999987664 47889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCc-------hhhhh------------------------hhcCCCCCCCch-h----h
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNP-------NILVN------------------------EMLDPRLPPLSV-D----I  194 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~-------~~~~~------------------------~~~~~~~~~~~~-~----~  194 (228)
                      |+++|+|++|..||...........       .....                        .......+.... .    .
T Consensus       203 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (316)
T cd07842         203 GCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH  282 (316)
T ss_pred             HHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence            9999999999999864432210000       00000                        000000000000 0    0


Q ss_pred             hhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          195 RGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       195 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ...+..+.+++.+||+.||++|||+.++++
T Consensus       283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         283 KKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             cCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            033456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-36  Score=232.33  Aligned_cols=213  Identities=23%  Similarity=0.307  Sum_probs=167.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++++ +|++|+++.+.+..+...|+|+||+.+++|.+++....   .+++..+..++.|++.+|.+||+. 
T Consensus        49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~-  124 (288)
T cd05583          49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL-  124 (288)
T ss_pred             HHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4577899999999 59999999999999999999999999999999886532   378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCC--cccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++++|||++......... .....++..|++||.+.+..  .+.++|+||||+++|+|+
T Consensus       125 --~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~  202 (288)
T cd05583         125 --GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL  202 (288)
T ss_pred             --CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence              9999999999999999999999999988765433222 22345788999999887654  678999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|..||.......  ..............+ .   ....+..+.+++.+||+.||.+|||+.++.+.|+
T Consensus       203 tg~~p~~~~~~~~--~~~~~~~~~~~~~~~-~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         203 TGASPFTVDGEQN--SQSEISRRILKSKPP-F---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             hCCCCcccCcccc--hHHHHHHHHHccCCC-C---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            9999986332211  111112222222111 1   1234457889999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-36  Score=231.25  Aligned_cols=212  Identities=21%  Similarity=0.290  Sum_probs=159.7

Q ss_pred             HHHHHHHHhccC-CCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            5 FLREITVLTEIR-HRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         5 ~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+|+..++++. |+|++++++++.++  +..++|+||+.+ ++.+.+....  ..+++.+++.++.|++.||.+||+. 
T Consensus        44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~-  119 (282)
T cd07831          44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN-  119 (282)
T ss_pred             HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            457899999985 99999999999877  889999999975 7777765433  2489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||+|+||+++. +.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||+|+++|+|++|
T Consensus       120 --~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~  195 (282)
T cd07831         120 --GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL  195 (282)
T ss_pred             --CceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcC
Confidence              9999999999999999 9999999999876543322 223456788999997654 4468899999999999999999


Q ss_pred             CCCccccccccC---------CCchhhhhhhcCC-----CCCC-----CchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSS---------SNPNILVNEMLDP-----RLPP-----LSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~---------~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      ..||...+....         .............     ..+.     ........+..+.++|.+||+++|.+|||+.+
T Consensus       196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  275 (282)
T cd07831         196 FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ  275 (282)
T ss_pred             CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence            999864332110         0000000000000     0000     00111245678999999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       276 ~l~  278 (282)
T cd07831         276 ALR  278 (282)
T ss_pred             Hhh
Confidence            985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.2e-36  Score=231.14  Aligned_cols=204  Identities=25%  Similarity=0.418  Sum_probs=161.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++|+|++++++++.++...|++|||+.+ ++.+++....  ..+++.+++.++.|++.++.|||+.  
T Consensus        66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~--  140 (313)
T cd06633          66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH--  140 (313)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4578899999999999999999999999999999999965 6666665433  2378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+.....    .....++..|+|||.+.   ...++.++|+||||+++|+|++
T Consensus       141 -gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~  215 (313)
T cd06633         141 -NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  215 (313)
T ss_pred             -CeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence             999999999999999999999999998764322    22346778899999874   3457889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||.....      ............+...  ....+..+.+++.+||+.+|.+||++.+++.
T Consensus       216 g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         216 RKPPLFNMNA------MSALYHIAQNDSPTLQ--SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCCCCCCCh------HHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999753321      1122222222222111  1234456889999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=226.08  Aligned_cols=205  Identities=28%  Similarity=0.353  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+..|++++++++|+||+++++.+..+...+++||++.+++|.+++....   .++...+..++.|++.++.+||+.  
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~--  112 (250)
T cd05123          38 EHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL--  112 (250)
T ss_pred             HHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            367889999999999999999999999999999999999999999987653   378999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       +++|+||+|+||+++.++.++|+|||.+..............++..|++||...+...+.++|+||||+++|++++|..
T Consensus       113 -~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~  191 (250)
T cd05123         113 -GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP  191 (250)
T ss_pred             -CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence             9999999999999999999999999998876543333344567788999999988888899999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH---HHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM---QTIC  223 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~---~~il  223 (228)
                      ||.....      ............+. +   ...+..+.+++++||..||.+|||+   .+++
T Consensus       192 p~~~~~~------~~~~~~~~~~~~~~-~---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~  245 (250)
T cd05123         192 PFYAEDR------KEIYEKILKDPLRF-P---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIK  245 (250)
T ss_pred             CCCCCCH------HHHHHHHhcCCCCC-C---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence            9853321      22223332222211 1   1235678899999999999999999   5554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=223.31  Aligned_cols=210  Identities=23%  Similarity=0.353  Sum_probs=168.0

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++...+.++..-+ +|+||+.+++|..+...++.||.+.. .++.++.+-.  +++++..+-++...+++||.||..+.
T Consensus       135 kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH  211 (391)
T KOG0983|consen  135 KRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH  211 (391)
T ss_pred             HHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc
Confidence            56777788777664 89999999999999999999998843 4555555432  23888888899999999999999875


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC---CcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~~~  158 (228)
                        ||+|||+||+||+++..|.+|++|||++.++..... .+...|-+.|||||-+...   +|+.++||||||+.++|+.
T Consensus       212 --~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLa  288 (391)
T KOG0983|consen  212 --GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELA  288 (391)
T ss_pred             --ceeecccCccceEEccCCCEEeecccccceeecccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhh
Confidence              999999999999999999999999999988764433 3335677899999988654   5888999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||..||..-     ....+....+++...|... ...+++..+.+++..||.+|+.+||.+.++++
T Consensus       289 Tg~yPy~~c-----~tdFe~ltkvln~ePP~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  289 TGQYPYKGC-----KTDFEVLTKVLNEEPPLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cccCCCCCC-----CccHHHHHHHHhcCCCCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            999998632     2233444555554433332 33458889999999999999999999999876

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.1e-36  Score=236.44  Aligned_cols=214  Identities=24%  Similarity=0.390  Sum_probs=161.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ..+.+|+.+++++ +|+||++++++|...  ...|+|+|++.+ +|..++...    .+++..+..++.|++.||.|||+
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~  125 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS  125 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999 999999999998643  468999999974 888887654    37888889999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-----CceecccccceeCCccccc-CCcccchhhhhHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-----NWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVL  153 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~  153 (228)
                      .   |++|+||+|+||+++.++.++|+|||.+........     ......++..|+|||.+.+ ..++.++|+||||++
T Consensus       126 ~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~  202 (337)
T cd07852         126 G---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI  202 (337)
T ss_pred             C---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence            9   999999999999999999999999998876543321     1223457888999998765 457889999999999


Q ss_pred             HHHHHhCCCCccccccccC---------CC------------chhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSS---------SN------------PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~---------~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|+.||........         ..            .......................+.++.++|.+||+.+
T Consensus       203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  282 (337)
T cd07852         203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN  282 (337)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence            9999999999854321100         00            00000001111111111122335667899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||+.++++
T Consensus       283 P~~Rps~~~il~  294 (337)
T cd07852         283 PNKRLTAEEALE  294 (337)
T ss_pred             cccccCHHHHhh
Confidence            999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-36  Score=237.78  Aligned_cols=215  Identities=24%  Similarity=0.389  Sum_probs=162.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.+.+|+.++++++|+||+++++++..    ....++|+||+. ++|.+++....   .+++..+..++.|++.||.|||
T Consensus        49 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH  124 (334)
T cd07855          49 KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH  124 (334)
T ss_pred             HHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            457789999999999999999998753    357899999996 57888876433   3899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCccccc-CCcccchhhhhHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~  153 (228)
                      +.   |++|+||+|+||+++.++.++|+|||.+.........    .....++..|+|||.+.+ ..++.++|+||||++
T Consensus       125 ~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~  201 (334)
T cd07855         125 SA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI  201 (334)
T ss_pred             HC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence            99   9999999999999999999999999998765432221    123467888999998765 457889999999999


Q ss_pred             HHHHHhCCCCccccccccC---------CCchhh--------hhhhcC--CCC--CCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSS---------SNPNIL--------VNEMLD--PRL--PPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~---------~~~~~~--------~~~~~~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|..||........         ......        ......  +..  ..........+.++.++|.+||+.+
T Consensus       202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  281 (334)
T cd07855         202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD  281 (334)
T ss_pred             HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence            9999999999854321100         000000        000000  000  0001112345678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||+++++.
T Consensus       282 P~~Rpt~~~~l~  293 (334)
T cd07855         282 PEERITVEQALQ  293 (334)
T ss_pred             hhhCcCHHHHHh
Confidence            999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=225.09  Aligned_cols=206  Identities=25%  Similarity=0.353  Sum_probs=164.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++|+||+++++++...  ..+++++|++++++|.+++....   .++...+..++.|++.|+.+||+.
T Consensus        49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~  125 (264)
T cd06653          49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN  125 (264)
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678899999999999999999998653  46889999999999999987543   278889999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC---CCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS---SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||+|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||||+++|++
T Consensus       126 ---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  202 (264)
T cd06653         126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM  202 (264)
T ss_pred             ---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHH
Confidence               99999999999999999999999999987653211   112234578889999999888889999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcC-CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLD-PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ......... +..+..   ....+..+.+++.+||. +|..|||+.++++
T Consensus       203 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         203 LTEKPPWAEYEA------MAAIFKIATQPTKPML---PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HhCCCCCCccCH------HHHHHHHHcCCCCCCC---CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            999999863321      112222221 111111   23456678999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.7e-36  Score=229.07  Aligned_cols=210  Identities=24%  Similarity=0.391  Sum_probs=160.5

Q ss_pred             HHHHHHHH-HhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITV-LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+..|+.. ++.++|+||+++++++..+...|+++||++ ++|.+++... .....+++..++.++.|++.|+.|||+.+
T Consensus        45 ~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  123 (283)
T cd06617          45 RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL  123 (283)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            45566665 555689999999999999999999999996 5777776542 22345899999999999999999999853


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc----CCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT----MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~~  157 (228)
                        +++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+    ..++.++|+||+|+++|+|
T Consensus       124 --~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l  200 (283)
T cd06617         124 --SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL  200 (283)
T ss_pred             --CeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHH
Confidence              89999999999999999999999999987654221 1223457788999998865    3467899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....     .............+...  ...++.++.++|.+||..+|.+|||+.++++
T Consensus       201 ~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         201 ATGRFPYDSWKT-----PFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HhCCCCCCcccc-----CHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999853211     11122222222222111  1235667999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.1e-36  Score=243.95  Aligned_cols=211  Identities=18%  Similarity=0.227  Sum_probs=153.3

Q ss_pred             HHHHHHHHHhccCC------Cccceeeeeeeec-CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRH------RNIVKFYGFCTHA-RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         4 ~~~~E~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+..|+++++.++|      .++++++++|... .+.|+||+++ +++|.+++....   .+++..+..++.|++.||.|
T Consensus       171 ~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~y  246 (467)
T PTZ00284        171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDY  246 (467)
T ss_pred             HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHH
Confidence            45668888877754      4588888888654 5789999988 567877776543   38889999999999999999


Q ss_pred             hhh-CCCCCeeecCCCCCceEEcCCC----------------ceEEeecccccccCCCCCCceecccccceeCCcccccC
Q 040501           77 LHH-DCIPPIVHRDISSKNVLLDLEY----------------EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM  139 (228)
Q Consensus        77 lh~-~~~~~i~h~di~p~nil~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  139 (228)
                      ||+ .   ||+||||||+||+++.++                .+||+|||.+....   .......+++.|+|||++.+.
T Consensus       247 LH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~  320 (467)
T PTZ00284        247 FHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGL  320 (467)
T ss_pred             HHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcC
Confidence            997 6   999999999999998765                49999999875422   223346789999999999999


Q ss_pred             CcccchhhhhHHHHHHHHHhCCCCccccccccCC---------Cchhhh--------hhhcCC----CCCCCc-------
Q 040501          140 KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS---------NPNILV--------NEMLDP----RLPPLS-------  191 (228)
Q Consensus       140 ~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~---------~~~~~~--------~~~~~~----~~~~~~-------  191 (228)
                      .++.++|||||||++|+|++|+.||.........         .+....        ......    ......       
T Consensus       321 ~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (467)
T PTZ00284        321 GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIA  400 (467)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhh
Confidence            9999999999999999999999998643221100         000000        000000    000000       


Q ss_pred             ----hhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          192 ----VDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       192 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                          .........+.+||.+||+.||.+|||++|+++
T Consensus       401 ~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        401 RARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             cccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                000011345779999999999999999999986

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-37  Score=239.87  Aligned_cols=206  Identities=26%  Similarity=0.383  Sum_probs=172.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +..+.+|+++++.++||||++++.+......+|+||||+.++.+++++..++..   ....+...+.|+.+|++|||++ 
T Consensus        99 ~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~---~e~~ar~~F~q~vsaveYcH~k-  174 (596)
T KOG0586|consen   99 RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRM---KEKEARAKFRQIVSAVEYCHSK-  174 (596)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccc---hhhhhhhhhHHHHHHHHHHhhc-
Confidence            345889999999999999999999999999999999999999999999987764   4477888999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~~~~g  160 (228)
                        +++|||||++|++++.+..+||+|||.++.... .....+++|++.|.|||++.+..+. ..+|+||+|+++|.+++|
T Consensus       175 --~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G  251 (596)
T KOG0586|consen  175 --NIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG  251 (596)
T ss_pred             --ceeccccchhhcccccccceeeeccccceeecc-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence              999999999999999999999999999998873 3445668999999999999998874 589999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .+||+..      +......+.+..+..-..    ..+-+-.++|+++|.++|.+|++.+++-+
T Consensus       252 sLPFDG~------~lk~Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  252 SLPFDGQ------NLKELRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ccccCCc------ccccccchheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhh
Confidence            9997632      223333344443332111    11223458999999999999999998754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=228.92  Aligned_cols=216  Identities=25%  Similarity=0.354  Sum_probs=163.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++|+|++++++++...  ...++|+||+++ +|.+++....  ..+++..++.++.|++.|+++||+.
T Consensus        43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~  119 (287)
T cd07840          43 ITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN  119 (287)
T ss_pred             HHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4578899999999999999999999887  899999999975 7888876543  3489999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccC-CcccchhhhhHHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~  158 (228)
                         |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++||||||+++|+++
T Consensus       120 ---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  196 (287)
T cd07840         120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF  196 (287)
T ss_pred             ---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence               9999999999999999999999999998876544321 2234557789999977653 5788999999999999999


Q ss_pred             hCCCCccccccccCCCch---------hhh--------hhhcCCCCC---CCchhhhh-hHHHHHHHHHHhhccCCCCCC
Q 040501          159 KGKHPRDFLSNVSSSNPN---------ILV--------NEMLDPRLP---PLSVDIRG-KVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~---------~~~--------~~~~~~~~~---~~~~~~~~-~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      +|..||............         ...        .........   ........ .+..+.+++.+||..+|.+||
T Consensus       197 t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  276 (287)
T cd07840         197 LGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI  276 (287)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence            999998543221100000         000        000000000   00001111 256789999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.++++
T Consensus       277 ~~~~~l~  283 (287)
T cd07840         277 SADQALQ  283 (287)
T ss_pred             CHHHHhh
Confidence            9999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=229.98  Aligned_cols=216  Identities=25%  Similarity=0.334  Sum_probs=166.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+..|++++++++|+|++++++++......++++|++. ++|.+++....  ..+++..+..++.|++.+|.+||+.  
T Consensus        43 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--  117 (282)
T cd07829          43 STALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH--  117 (282)
T ss_pred             HHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            456789999999999999999999999999999999997 48999987653  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|++++|.
T Consensus       118 -~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         118 -RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             -CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999987665433333334456789999988766 6888999999999999999999


Q ss_pred             CCccccccccCCC---------chhhh--------hhhcCCCCC--CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          162 HPRDFLSNVSSSN---------PNILV--------NEMLDPRLP--PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       162 ~p~~~~~~~~~~~---------~~~~~--------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .||..........         .....        .....+...  .........+..+.+++.+||..+|.+||++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  276 (282)
T cd07829         197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA  276 (282)
T ss_pred             CCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence            9986432211000         00000        000000000  0011122335678999999999999999999998


Q ss_pred             HH
Q 040501          223 CQ  224 (228)
Q Consensus       223 l~  224 (228)
                      ++
T Consensus       277 l~  278 (282)
T cd07829         277 LK  278 (282)
T ss_pred             hh
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.4e-36  Score=232.02  Aligned_cols=212  Identities=23%  Similarity=0.346  Sum_probs=156.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecC--------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHAR--------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|++++++++||||+++++++....        ..++|+||+.+ +|.+.+....  ..+++.+++.++.|++.||.
T Consensus        57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~  133 (310)
T cd07865          57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLY  133 (310)
T ss_pred             HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHH
Confidence            4568999999999999999999886543        45999999965 7777765433  23899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCC-cccchhhhhH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMK-VTAKCDVYSF  150 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  150 (228)
                      |||+.   |++|+||+|+||+++.++.++|+|||.+.........    .....++..|+|||.+.+.. ++.++|+||+
T Consensus       134 ~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  210 (310)
T cd07865         134 YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA  210 (310)
T ss_pred             HHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence            99999   9999999999999999999999999998765432221    12335677899999876654 6889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCC------------------CCCCC-----chh--hhhhHHHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP------------------RLPPL-----SVD--IRGKVISIMEVA  205 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-----~~~--~~~~~~~~~~li  205 (228)
                      |+++|+|++|..||.........   .....+...                  ..+..     ...  .......+.++|
T Consensus       211 G~~l~el~t~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli  287 (310)
T cd07865         211 GCIMAEMWTRSPIMQGNTEQHQL---TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLI  287 (310)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHH
Confidence            99999999999998543211000   000000000                  00000     000  001134567999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 040501          206 FLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       206 ~~~l~~~p~~Rpt~~~il~  224 (228)
                      .+||..||.+|||++++++
T Consensus       288 ~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         288 DKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHhcCChhhccCHHHHhc
Confidence            9999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=236.05  Aligned_cols=215  Identities=21%  Similarity=0.353  Sum_probs=159.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .++.+|+.++++++|+||+++++++...     ...|+++|++.+ ++.+.+...    .+++..+..++.|++.||.+|
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~L  122 (336)
T cd07849          48 QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYI  122 (336)
T ss_pred             HHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999887543     358999999965 777766532    388899999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCccccc-CCcccchhhhhHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVL  153 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~  153 (228)
                      |+.   |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus       123 H~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvi  199 (336)
T cd07849         123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI  199 (336)
T ss_pred             HhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHH
Confidence            999   9999999999999999999999999998765432221   122456888999998654 457889999999999


Q ss_pred             HHHHHhCCCCccccccccC---------CCchhhhhhhcC------------CCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSS---------SNPNILVNEMLD------------PRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|+.||........         .........+..            .............+.++.+++.+||+.+
T Consensus       200 l~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  279 (336)
T cd07849         200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN  279 (336)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence            9999999999854221100         000000000000            0000001111234567899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 040501          213 PESRPNMQTICQL  225 (228)
Q Consensus       213 p~~Rpt~~~il~~  225 (228)
                      |.+|||+.++++.
T Consensus       280 P~~Rpt~~e~l~h  292 (336)
T cd07849         280 PHKRITVEEALAH  292 (336)
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=244.32  Aligned_cols=210  Identities=24%  Similarity=0.399  Sum_probs=174.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++|.+|+.+|.+|+|+|+++++++.-+ ....+|+|.+..|+|.+.++. .....+.......++.||+.|+.||.++ 
T Consensus       155 mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk-  231 (1039)
T KOG0199|consen  155 MDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK-  231 (1039)
T ss_pred             HHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh-
Confidence            3689999999999999999999999877 677899999999999999987 4445588899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCcee---cccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE---FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        +.||||+...|+++.....+||+|||+.+..+.+...+..   ..-+..|.|||.+.-.+++.+||+|++|+++|||+
T Consensus       232 --rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF  309 (1039)
T KOG0199|consen  232 --RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF  309 (1039)
T ss_pred             --hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence              9999999999999999999999999999988766554322   23356799999999999999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      + |..||......      ..+..+-.+.....   ...+++.++++++.||..+|.+|||+..|.+.
T Consensus       310 tyGEePW~G~~g~------qIL~~iD~~erLpR---Pk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  310 TYGEEPWVGCRGI------QILKNIDAGERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccCCCCCCCCCHH------HHHHhccccccCCC---CCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            8 88897644332      23333322222111   23677889999999999999999999999743

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-35  Score=225.93  Aligned_cols=199  Identities=18%  Similarity=0.198  Sum_probs=157.1

Q ss_pred             HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 040501           11 VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDI   90 (228)
Q Consensus        11 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di   90 (228)
                      .++...|++|+++.+.+......++|+||+.+++|.+++....   .+++..+..++.|++.|+.|||+.   +++|+||
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di  123 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDL  123 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCC
Confidence            3444579999999999999999999999999999998886543   389999999999999999999999   9999999


Q ss_pred             CCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCCCCcccccc
Q 040501           91 SSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKHPRDFLSN  169 (228)
Q Consensus        91 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~  169 (228)
                      +|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.....
T Consensus       124 ~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~  201 (278)
T cd05606         124 KPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (278)
T ss_pred             CHHHEEECCCCCEEEccCcCccccCccC--CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999999887543222  2234678899999998754 578999999999999999999999864322


Q ss_pred             ccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ....   .. ............   ...+..+.+++.+||..+|.+||     ++.++++
T Consensus       202 ~~~~---~~-~~~~~~~~~~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         202 KDKH---EI-DRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cchH---HH-HHHhhccCCCCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1111   11 111111111111   12356789999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.9e-36  Score=229.00  Aligned_cols=208  Identities=20%  Similarity=0.251  Sum_probs=154.2

Q ss_pred             HHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            8 EITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         8 E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      +...+..+.|++++++++.+....    ..+++++++. .++.+.+....   ..+...+..++.|++.|+.|||+.   
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---  145 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---  145 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            334455678999999998765433    3467777664 35555554332   146778889999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCC-------CceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      +++||||||+||+++.++.++|+|||+++.......       ......|++.|+|||.+.+..++.++|||||||++|+
T Consensus       146 ~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e  225 (294)
T PHA02882        146 GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK  225 (294)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence            999999999999999999999999999876542221       1123468899999999999899999999999999999


Q ss_pred             HHhCCCCccccccccCC---CchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSS---NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||.........   .......++..+..     .....+.++.+++..||..+|.+||+++++++.|+
T Consensus       226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            99999998654221100   00011122222211     12344567999999999999999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=259.99  Aligned_cols=211  Identities=30%  Similarity=0.554  Sum_probs=162.2

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      ..|++.+++++||||++++++|.+....|+||||+++++|.++++.      +++.++..++.|++.|++|||..+..++
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~i  804 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV  804 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence            4678999999999999999999999999999999999999999852      7888999999999999999995544599


Q ss_pred             eecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           86 VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      +||||||+||+++.++..++. ++.......    .....+++.|+|||++.+..++.++||||+|+++|||++|+.||.
T Consensus       805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             ecCCCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            999999999999988877764 444332211    112356789999999998889999999999999999999999984


Q ss_pred             ccccccCCCchhh---------hhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          166 FLSNVSSSNPNIL---------VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       166 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ....... .....         .....++..............++.+++.+||+.||.+|||+.++++.|++
T Consensus       880 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  950 (968)
T PLN00113        880 AEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES  950 (968)
T ss_pred             cccCCCC-cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence            3211111 00000         11122222221111123445568899999999999999999999999874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=224.99  Aligned_cols=197  Identities=26%  Similarity=0.283  Sum_probs=166.4

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      ..|-++|+..+||.+..+...|+.+.++|+||||..||.|+-.+++..   .+++.....+...|+.||.|||++   +|
T Consensus       216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~i  289 (516)
T KOG0690|consen  216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NI  289 (516)
T ss_pred             hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---Ce
Confidence            458889999999999999999999999999999999999988877643   388999999999999999999999   99


Q ss_pred             eecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           86 VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      +.||+|.+|.+++.+|.+||+|||+++..........+++|+|.|+|||++....|..+.|.|.+|+++|+|++|+.||-
T Consensus       290 vYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  290 VYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            99999999999999999999999999977666666778999999999999999999999999999999999999999974


Q ss_pred             ccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ...      -...+.-++-..+..    .+..+++...|+...|.+||++|.-
T Consensus       370 n~d------h~kLFeLIl~ed~kF----Pr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  370 NKD------HEKLFELILMEDLKF----PRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ccc------hhHHHHHHHhhhccC----CccCCHHHHHHHHHHhhcChHhhcC
Confidence            322      222222222222111    1245557789999999999999953

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=227.22  Aligned_cols=209  Identities=22%  Similarity=0.334  Sum_probs=162.1

Q ss_pred             HHHHHHHHHhcc---CCCccceeeeeeeecCe-----EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEI---RHRNIVKFYGFCTHARH-----SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+.+++++   +|+|++++++++.....     .++++|++.+ +|.+++..... ..+++..++.++.|++.||.
T Consensus        44 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~  121 (287)
T cd07838          44 STLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVD  121 (287)
T ss_pred             hHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHH
Confidence            466788877766   59999999999987766     9999999975 78888765432 24899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      +||+.   +++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++|
T Consensus       122 ~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~  197 (287)
T cd07838         122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA  197 (287)
T ss_pred             HHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence            99999   9999999999999999999999999998776433221 2234677899999998888999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcC-----------------------CCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLD-----------------------PRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|++|.+||......      ....++.+                       .............+..+.+++.+||+.|
T Consensus       198 ~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  271 (287)
T cd07838         198 ELFRRRPLFRGTSEA------DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFN  271 (287)
T ss_pred             HHHhCCCcccCCChH------HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccC
Confidence            999999997643211      11111100                       0001111112345567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+||++.+++.
T Consensus       272 p~~Rp~~~~il~  283 (287)
T cd07838         272 PHKRISAFEALQ  283 (287)
T ss_pred             CccCCCHHHHhc
Confidence            999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-36  Score=246.73  Aligned_cols=216  Identities=27%  Similarity=0.447  Sum_probs=176.3

Q ss_pred             ChHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-----C------C--CCCCHHHHHHH
Q 040501            1 DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-----S------A--EELGWSRRINV   66 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~------~--~~~~~~~~~~~   66 (228)
                      +++.+..|+++++.+ +|+||+.+++.+..+...++|+||+..|+|.++++.+.     .      .  ..++....+.+
T Consensus       344 ~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsf  423 (609)
T KOG0200|consen  344 EKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSF  423 (609)
T ss_pred             HHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHH
Confidence            367899999999999 79999999999999999999999999999999998655     0      0  12788899999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc-eecc--cccceeCCcccccCCccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW-TEFA--GTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~  143 (228)
                      +.||+.|++||++.   +.+|||+..+||+++.+..+||+|||+++......... ....  -+..|+|||.+....++.
T Consensus       424 a~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~  500 (609)
T KOG0200|consen  424 AYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTS  500 (609)
T ss_pred             HHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccc
Confidence            99999999999999   99999999999999999999999999998655433332 1111  355799999999999999


Q ss_pred             chhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          144 KCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      +|||||+|+++||+++ |..||+....     .......+.++.....+   ..+..+++++++.||+.+|.+||++.++
T Consensus       501 kSDVWSfGI~L~EifsLG~~PYp~~~~-----~~~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~  572 (609)
T KOG0200|consen  501 KSDVWSFGILLWEIFTLGGTPYPGIPP-----TEELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSEC  572 (609)
T ss_pred             cchhhHHHHHHHHHhhCCCCCCCCCCc-----HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            9999999999999998 8899864211     11223333333332222   2446689999999999999999999999


Q ss_pred             HHHhh
Q 040501          223 CQLLC  227 (228)
Q Consensus       223 l~~l~  227 (228)
                      .+.|+
T Consensus       573 ~~~~~  577 (609)
T KOG0200|consen  573 VEFFE  577 (609)
T ss_pred             HHHHH
Confidence            99886

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-35  Score=230.70  Aligned_cols=211  Identities=24%  Similarity=0.384  Sum_probs=160.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++.++||||+++.++|.. ....|+++|++ +++|..++...    .++...+..++.|+++||.+||+. 
T Consensus        54 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~-  127 (328)
T cd07856          54 KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA-  127 (328)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            567889999999999999999999865 56789999998 45888877543    267788889999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||.+.+ ..++.++|+||||+++|++++|
T Consensus       128 --~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg  202 (328)
T cd07856         128 --GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG  202 (328)
T ss_pred             --CcccCCCCHHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhC
Confidence              9999999999999999999999999998754322   223456778999998765 5678999999999999999999


Q ss_pred             CCCccccccccC---------CCchhhh------------hhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          161 KHPRDFLSNVSS---------SNPNILV------------NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       161 ~~p~~~~~~~~~---------~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      ..||........         ..+....            .........+........+..+.++|.+||+.+|.+|||+
T Consensus       203 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  282 (328)
T cd07856         203 KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA  282 (328)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence            999864322100         0000000            0110001111111122455789999999999999999999


Q ss_pred             HHHHH
Q 040501          220 QTICQ  224 (228)
Q Consensus       220 ~~il~  224 (228)
                      .+++.
T Consensus       283 ~ell~  287 (328)
T cd07856         283 AEALA  287 (328)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-35  Score=227.82  Aligned_cols=209  Identities=25%  Similarity=0.392  Sum_probs=160.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      ..+.+|+.++.+. .|+||+++++++......|++||++. +++.+++.....  .+++..+..++.|++.++.|||+ .
T Consensus        58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~  134 (296)
T cd06618          58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH  134 (296)
T ss_pred             HHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            3456777777777 49999999999999999999999985 467776654332  48889999999999999999997 6


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC----cccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK----VTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~  156 (228)
                         |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..    ++.++|+||||+++|+
T Consensus       135 ---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~e  210 (296)
T cd06618         135 ---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE  210 (296)
T ss_pred             ---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHH
Confidence               999999999999999999999999999876543222 22235677899999987553    7889999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||.....     .............+.... ...++.++.+++.+||..||.+|||+.++++
T Consensus       211 l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         211 LATGQFPYKNCKT-----EFEVLTKILQEEPPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             HHhCCCCCCcchh-----HHHHHHHHhcCCCCCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999853211     112222222222221111 1135667899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=228.64  Aligned_cols=204  Identities=24%  Similarity=0.221  Sum_probs=169.1

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      .+.|-++|++++.+.||.+-..|+..+.+++|+..|+||+|.-.|.+.+. +.++++.++.++.+|+-||.+||+.   +
T Consensus       232 aLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~  307 (591)
T KOG0986|consen  232 ALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---R  307 (591)
T ss_pred             hhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---c
Confidence            46799999999999999999999999999999999999999988877654 5599999999999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCc
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPR  164 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~  164 (228)
                      ||+||+||+||++|+.|+++|+|+|++..+..... .....||..|||||++.+..|+.+.|.|||||++|+|+.|+.||
T Consensus       308 iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  308 IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             eeeccCChhheeeccCCCeEeeccceEEecCCCCc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence            99999999999999999999999999998765443 34458999999999999999999999999999999999999998


Q ss_pred             cccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      ..-..-.   ..+.+.+........   .....+++..++.+..|.+||.+|.-.
T Consensus       387 r~~KeKv---k~eEvdrr~~~~~~e---y~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  387 RQRKEKV---KREEVDRRTLEDPEE---YSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hhhhhhh---hHHHHHHHHhcchhh---cccccCHHHHHHHHHHHccCHHHhccC
Confidence            6432211   111111111111111   124667788899999999999999653

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9e-36  Score=227.03  Aligned_cols=206  Identities=27%  Similarity=0.401  Sum_probs=168.1

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++++. |+||+++++++..+...+++||++.+++|.+++....   .+++..++.++.|++.||.+||+. 
T Consensus        46 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~-  121 (280)
T cd05581          46 KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK-  121 (280)
T ss_pred             HHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            45788999999998 9999999999999999999999999999999987653   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--------------------CceecccccceeCCcccccCCc
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--------------------NWTEFAGTYGYVAPELAYTMKV  141 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~  141 (228)
                        |++|+||+|+||+++.++.++++|||++........                    ......++..|+|||...+..+
T Consensus       122 --~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  199 (280)
T cd05581         122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA  199 (280)
T ss_pred             --CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence              999999999999999999999999999886654321                    1122356788999999888888


Q ss_pred             ccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH--
Q 040501          142 TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM--  219 (228)
Q Consensus       142 ~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~--  219 (228)
                      +.++|+||||++++++++|..||.....      .............. +   ...+..+.+++.+||+.+|.+|||+  
T Consensus       200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~---~~~~~~~~~li~~~l~~~p~~R~~~~~  269 (280)
T cd05581         200 GKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQKILKLEYSF-P---PNFPPDAKDLIEKLLVLDPQDRLGVNE  269 (280)
T ss_pred             ChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhcCCCC-C---CccCHHHHHHHHHHhcCCHhhCCCccc
Confidence            9999999999999999999999864431      11222222211111 1   1335578899999999999999999  


Q ss_pred             --HHHHH
Q 040501          220 --QTICQ  224 (228)
Q Consensus       220 --~~il~  224 (228)
                        .++++
T Consensus       270 ~~~~ll~  276 (280)
T cd05581         270 GYDELKA  276 (280)
T ss_pred             CHHHHhc
Confidence              77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-35  Score=227.84  Aligned_cols=213  Identities=23%  Similarity=0.343  Sum_probs=160.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC----------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR----------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAH   72 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~   72 (228)
                      ..+.+|++++++++||||+++++++.+..          ..++++||+++ ++...+....  ..+++..++.++.|++.
T Consensus        51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~  127 (302)
T cd07864          51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLE  127 (302)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHH
Confidence            35678999999999999999999886544          78999999976 6666665432  24899999999999999


Q ss_pred             HHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccC-CcccchhhhhH
Q 040501           73 ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM-KVTAKCDVYSF  150 (228)
Q Consensus        73 ~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  150 (228)
                      ||.|||+.   |++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|||||
T Consensus       128 aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl  204 (302)
T cd07864         128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC  204 (302)
T ss_pred             HHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence            99999999   999999999999999999999999999876543332 12223456789999987654 46889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCC-----------------------CCCchhhhhhHHHHHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-----------------------PPLSVDIRGKVISIMEVAFL  207 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~li~~  207 (228)
                      |+++|++++|++||.......   .............                       ..........+..+.+++.+
T Consensus       205 G~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  281 (302)
T cd07864         205 GCILGELFTKKPIFQANQELA---QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH  281 (302)
T ss_pred             HHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHH
Confidence            999999999999986432111   0000000000000                       00001112346678999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 040501          208 CLDNNPESRPNMQTICQ  224 (228)
Q Consensus       208 ~l~~~p~~Rpt~~~il~  224 (228)
                      ||+.+|.+|||+.++++
T Consensus       282 ~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         282 MLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-35  Score=226.48  Aligned_cols=210  Identities=23%  Similarity=0.295  Sum_probs=163.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++++ +|++|+++.+.+..+...|+|+|++.+++|.+++....   .++...+..++.|++.||.+||+. 
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~-  124 (290)
T cd05613          49 EHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL-  124 (290)
T ss_pred             HHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4577899999999 58999999999999999999999999999999987543   378888899999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccC--CcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+.  .++.++|+||+|+++|+++
T Consensus       125 --~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll  202 (290)
T cd05613         125 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL  202 (290)
T ss_pred             --CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence              9999999999999999999999999988765432211 2234578889999988753  3678899999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      +|..||......  ...............+ .+   ...+..+.+++.+||+.+|.+||     ++.++++
T Consensus       203 ~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         203 TGASPFTVDGEK--NSQAEISRRILKSEPP-YP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             cCCCCCCcCCcc--ccHHHHHHHhhccCCC-CC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            999998632211  1111122222221111 11   23455688999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.5e-35  Score=228.49  Aligned_cols=215  Identities=23%  Similarity=0.320  Sum_probs=158.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|+.+++++ .|+||+++++.+..    ....|++++++. ++|.+++....   .+++..+..++.|++.||.||
T Consensus        46 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~L  121 (332)
T cd07857          46 KRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYI  121 (332)
T ss_pred             HHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHH
Confidence            4678899999999 59999999987543    245788999886 57888875433   388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCccccc-CCcccchhhhhHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGV  152 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~  152 (228)
                      |+.   |++|+||||+||+++.++.++|+|||.+.........    .....++..|+|||.+.+ ..++.++|+||+|+
T Consensus       122 H~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv  198 (332)
T cd07857         122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC  198 (332)
T ss_pred             HhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHH
Confidence            999   9999999999999999999999999998765432211    123457888999998765 45788999999999


Q ss_pred             HHHHHHhCCCCccccccccC---------CCchhhhhhhcC------------CCCCCCchhhhhhHHHHHHHHHHhhcc
Q 040501          153 LALEVIKGKHPRDFLSNVSS---------SNPNILVNEMLD------------PRLPPLSVDIRGKVISIMEVAFLCLDN  211 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~  211 (228)
                      ++|++++|.+||........         .........+..            .............+..+.+++.+||+.
T Consensus       199 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  278 (332)
T cd07857         199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF  278 (332)
T ss_pred             HHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC
Confidence            99999999999864321100         000000000000            000011111123456789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 040501          212 NPESRPNMQTICQ  224 (228)
Q Consensus       212 ~p~~Rpt~~~il~  224 (228)
                      ||.+|||+.++++
T Consensus       279 ~P~~R~t~~~ll~  291 (332)
T cd07857         279 DPTKRISVEEALE  291 (332)
T ss_pred             CcccCCCHHHHhc
Confidence            9999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-35  Score=220.58  Aligned_cols=192  Identities=22%  Similarity=0.224  Sum_probs=153.3

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      +..|...+....||||+++++++......+++|||+.+++|.+++....   .++...+..++.|++.||.|||+.   |
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~  105 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL---NIPEECVKRWAAEMVVALDALHRE---G  105 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3455555555679999999999999999999999999999999987543   288899999999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCc
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPR  164 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~  164 (228)
                      ++|+||||+||+++.++.++++|||.+......   .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+
T Consensus       106 i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~  182 (237)
T cd05576         106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLV  182 (237)
T ss_pred             eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchh
Confidence            999999999999999999999999987655432   12234566799999988888899999999999999999999886


Q ss_pred             cccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .......        ........+      ...+..+.++|.+||+.||.+|||+
T Consensus       183 ~~~~~~~--------~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         183 ECHPSGI--------NTHTTLNIP------EWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             hcCchhc--------ccccccCCc------ccCCHHHHHHHHHHccCCHHHhcCC
Confidence            4221100        000000111      1245578899999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-35  Score=229.58  Aligned_cols=215  Identities=22%  Similarity=0.320  Sum_probs=156.5

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeec--------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHA--------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|++++++++|+||+++++.+...        ..+++++||+.+ ++...+....  ..+++.++..++.|+++||.
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~  129 (311)
T cd07866          53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGIN  129 (311)
T ss_pred             hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHH
Confidence            567899999999999999999887543        357999999865 5665554322  34899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-----------ceecccccceeCCcccccC-Cccc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-----------WTEFAGTYGYVAPELAYTM-KVTA  143 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-~~~~  143 (228)
                      |||+.   |++|+||+|+||+++.++.++|+|||++.........           .....+++.|+|||.+.+. .++.
T Consensus       130 ~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (311)
T cd07866         130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT  206 (311)
T ss_pred             HHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCc
Confidence            99999   9999999999999999999999999988765432211           1123456789999987654 4788


Q ss_pred             chhhhhHHHHHHHHHhCCCCccccccccCCCchhh---------------hhh----hcCCCCC-CCchhhhhhHHHHHH
Q 040501          144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL---------------VNE----MLDPRLP-PLSVDIRGKVISIME  203 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~---------------~~~----~~~~~~~-~~~~~~~~~~~~~~~  203 (228)
                      ++|+||+|+++|+|++|.+||..............               ...    ......+ ............+.+
T Consensus       207 ~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (311)
T cd07866         207 AVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD  286 (311)
T ss_pred             hhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHH
Confidence            99999999999999999999854322110000000               000    0000000 000011223356889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++.+||+.||.+|||+.++++
T Consensus       287 ~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         287 LLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHcccCcccCcCHHHHhc
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=232.50  Aligned_cols=211  Identities=21%  Similarity=0.340  Sum_probs=159.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCe------EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.+++.++|+|++++.+++.....      .++|+|++ +++|.+++..    ..+++..++.++.|++.|+.+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~  133 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKY  133 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999988865544      89999998 5689888864    238999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus       134 LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~  207 (343)
T cd07851         134 IHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  207 (343)
T ss_pred             HHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHH
Confidence            9999   9999999999999999999999999998765432   223456788999998765 35788999999999999


Q ss_pred             HHHhCCCCccccccccCCC---------chhhhhhh------------cCCCCCCCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          156 EVIKGKHPRDFLSNVSSSN---------PNILVNEM------------LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~---------~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++++|..||..........         ........            ...............+..+.++|.+||+.+|.
T Consensus       208 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~  287 (343)
T cd07851         208 ELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD  287 (343)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh
Confidence            9999999986432211000         00000000            00000000011123466789999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       288 ~Rpt~~ell~  297 (343)
T cd07851         288 KRITAAEALA  297 (343)
T ss_pred             hCCCHHHHhc
Confidence            9999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-35  Score=229.42  Aligned_cols=211  Identities=22%  Similarity=0.334  Sum_probs=159.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|++++++++|+||+++++++....      ..++|+|++ +++|.+++...    .+++..+..++.|++.|+.|
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~  133 (343)
T cd07880          59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKY  133 (343)
T ss_pred             HHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999986543      458999998 66888887532    38899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++|+||+|+||+++.++.++++|||.+......   .....+++.|++||.+.+ ..++.++|+||||+++|
T Consensus       134 LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~  207 (343)
T cd07880         134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA  207 (343)
T ss_pred             HHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence            9999   9999999999999999999999999998765322   223456788999998876 35788999999999999


Q ss_pred             HHHhCCCCccccccccC---------CCchhhhhhhc------------CCCCCCCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          156 EVIKGKHPRDFLSNVSS---------SNPNILVNEML------------DPRLPPLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~---------~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++++|..||........         .........+.            ..............+..+.++|.+||+.||.
T Consensus       208 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  287 (343)
T cd07880         208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE  287 (343)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh
Confidence            99999999864321100         00000000000            0000000111124455688999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       288 ~R~t~~~~l~  297 (343)
T cd07880         288 SRITAAEALA  297 (343)
T ss_pred             hCCCHHHHhc
Confidence            9999999874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=221.30  Aligned_cols=215  Identities=22%  Similarity=0.354  Sum_probs=162.4

Q ss_pred             HHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ...+|+..+++++ |+|++++++++..+...|+||||+ +++|.+.+.... ...+++.++..++.|++.+|.|||+.  
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~--  118 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH--  118 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3467999999998 999999999999999999999999 678888776543 23489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||++++++++|.
T Consensus       119 -~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~  196 (283)
T cd07830         119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR  196 (283)
T ss_pred             -CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence             99999999999999999999999999987654322 2223456788999998754 45788999999999999999999


Q ss_pred             CCccccccccCCCc---------------hhhhhhhcCCCCCCC-----chhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSSNP---------------NILVNEMLDPRLPPL-----SVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      .||...........               ............+..     .......+..+.+++.+||..+|.+|||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  276 (283)
T cd07830         197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ  276 (283)
T ss_pred             CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence            99864322110000               000000000000000     0001122456889999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       277 i~~  279 (283)
T cd07830         277 ALQ  279 (283)
T ss_pred             Hhh
Confidence            875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=216.12  Aligned_cols=210  Identities=30%  Similarity=0.460  Sum_probs=171.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++.....   ++..+++.++.+++.++.+||+. 
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~-  106 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEARFYARQILSALEYLHSN-  106 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHc-
Confidence            46789999999999999999999999998999999999999999999875443   78899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        +++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+..++.++|+|++|++++++++|.
T Consensus       107 --~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~  183 (244)
T smart00220      107 --GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK  183 (244)
T ss_pred             --CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence              99999999999999999999999999988765432 223345678899999998888888999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||...     ................ ........+.++.+++.+||..+|.+||++.++++
T Consensus       184 ~p~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      184 PPFPGD-----DQLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCCCCC-----CcHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            997542     1122222222222221 11111115567899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=227.43  Aligned_cols=211  Identities=21%  Similarity=0.352  Sum_probs=157.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.++++++|+||+++++++...      ...|++++++ +++|.+++...    .+++..++.++.|++.|++|
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~  135 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKY  135 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999988543      3478888877 67888877543    38889999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++|+||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus       136 LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~  209 (345)
T cd07877         136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  209 (345)
T ss_pred             HHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHH
Confidence            9999   9999999999999999999999999998754322   233456788999998766 45788999999999999


Q ss_pred             HHHhCCCCccccccccCC---------CchhhhhhhcC----------CCCCC--CchhhhhhHHHHHHHHHHhhccCCC
Q 040501          156 EVIKGKHPRDFLSNVSSS---------NPNILVNEMLD----------PRLPP--LSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~---------~~~~~~~~~~~----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++++|..||.........         ...........          +..+.  ........+..+.++|.+||+.||.
T Consensus       210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  289 (345)
T cd07877         210 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  289 (345)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChh
Confidence            999999998543221100         00000000000          00000  0001113455688999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       290 ~R~t~~e~l~  299 (345)
T cd07877         290 KRITAAQALA  299 (345)
T ss_pred             hcCCHHHHhc
Confidence            9999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-34  Score=227.36  Aligned_cols=210  Identities=22%  Similarity=0.377  Sum_probs=156.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ..+.+|+++++.++|+||+++++++...      ...|+++|++.. +|..+..     ..++...+..++.|++.|++|
T Consensus        59 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~  132 (342)
T cd07879          59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKY  132 (342)
T ss_pred             hHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999998654      346899999864 6665542     237889999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      ||+.   |++||||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus       133 LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~  206 (342)
T cd07879         133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA  206 (342)
T ss_pred             HHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHH
Confidence            9999   9999999999999999999999999998754321   223456788999998866 45788999999999999


Q ss_pred             HHHhCCCCccccccccCCCc---------hhh--------hhhhcC--CCCCC--CchhhhhhHHHHHHHHHHhhccCCC
Q 040501          156 EVIKGKHPRDFLSNVSSSNP---------NIL--------VNEMLD--PRLPP--LSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~---------~~~--------~~~~~~--~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++++|+.||...........         ...        ......  +..+.  ........+..+.++|.+||+.||.
T Consensus       207 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  286 (342)
T cd07879         207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD  286 (342)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh
Confidence            99999999864321110000         000        000000  00000  0011123455688999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.+++.
T Consensus       287 ~R~~~~e~l~  296 (342)
T cd07879         287 KRLTATEALE  296 (342)
T ss_pred             hCcCHHHHhc
Confidence            9999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.3e-35  Score=229.40  Aligned_cols=214  Identities=24%  Similarity=0.365  Sum_probs=155.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec--------------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA--------------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~   68 (228)
                      +.+.+|++++++++|+||+++++.+...              ...|+++||+. ++|.+++...    .++...+..++.
T Consensus        47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~  121 (342)
T cd07854          47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMY  121 (342)
T ss_pred             HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHH
Confidence            4678999999999999999999776543              35789999997 4888777532    378899999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCC---ceecccccceeCCccccc-CCccc
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYT-MKVTA  143 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~  143 (228)
                      |++.|+.|||+.   |++|+||||+||+++. ++.++++|||.+.........   .....++..|+|||.+.+ ..++.
T Consensus       122 qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  198 (342)
T cd07854         122 QLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK  198 (342)
T ss_pred             HHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCc
Confidence            999999999999   9999999999999975 567899999998765322111   122346778999997654 45788


Q ss_pred             chhhhhHHHHHHHHHhCCCCccccccccCCC-------------chhh---hhhhcC--CCCCC--CchhhhhhHHHHHH
Q 040501          144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSN-------------PNIL---VNEMLD--PRLPP--LSVDIRGKVISIME  203 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~-------------~~~~---~~~~~~--~~~~~--~~~~~~~~~~~~~~  203 (228)
                      ++|||||||++|+|++|..||..........             ....   ......  .....  ........+.++.+
T Consensus       199 ~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (342)
T cd07854         199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALD  278 (342)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHH
Confidence            9999999999999999999985332110000             0000   000000  00000  00111234567889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++.+||+.||.+|||+.++++
T Consensus       279 li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         279 FLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHhCCCchhccCHHHHhC
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=231.88  Aligned_cols=162  Identities=34%  Similarity=0.514  Sum_probs=143.1

Q ss_pred             ChHHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            1 DKKEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ++++..+|++++++++|+|||+++++=++.      ....++||||+||+|...+.+......+++.+.+.++.++..|+
T Consensus        54 ~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al  133 (732)
T KOG4250|consen   54 PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSAL  133 (732)
T ss_pred             hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHH
Confidence            467889999999999999999999886443      35789999999999999999877777799999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcC--CC--ceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDL--EY--EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYS  149 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~--~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws  149 (228)
                      .|||..   ||+||||||.||++..  +|  .-||+|||.++...++. ...+..||..|++||.... ..|+..+|.||
T Consensus       134 ~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS  209 (732)
T KOG4250|consen  134 RHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWS  209 (732)
T ss_pred             HHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence            999999   9999999999999843  33  35999999999877554 6677899999999999884 67888999999


Q ss_pred             HHHHHHHHHhCCCCccc
Q 040501          150 FGVLALEVIKGKHPRDF  166 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~  166 (228)
                      +||++|+.+||..||..
T Consensus       210 ~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  210 FGVTLYECATGELPFIP  226 (732)
T ss_pred             hhhHHHHHhccCCCCCc
Confidence            99999999999999853

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-34  Score=210.28  Aligned_cols=217  Identities=21%  Similarity=0.320  Sum_probs=162.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNND--TSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.-+|+.+++.++|+|++.++.+|-. +..+|+++||... +|...|+-+  ...+.++...+..++.|++.|+.|||+.
T Consensus        73 SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N  151 (438)
T KOG0666|consen   73 SACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN  151 (438)
T ss_pred             HHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh
Confidence            45689999999999999999999966 7899999999976 676666532  2234588899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCC----CceEEeecccccccCCCCCC---ceecccccceeCCcccccCC-cccchhhhhHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGV  152 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~  152 (228)
                         =+.||||||.||++..+    |.+||.|+|+++.....-..   .....-|..|+|||.+.|.. |+.+.|+|++||
T Consensus       152 ---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC  228 (438)
T KOG0666|consen  152 ---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC  228 (438)
T ss_pred             ---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence               89999999999999887    99999999999987654433   22345688999999988875 899999999999


Q ss_pred             HHHHHHhCCCCccccccccCCC-c--hhhhhhhcC-------CCCCC------C-------------c-------hhhhh
Q 040501          153 LALEVIKGKHPRDFLSNVSSSN-P--NILVNEMLD-------PRLPP------L-------------S-------VDIRG  196 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~~~-~--~~~~~~~~~-------~~~~~------~-------------~-------~~~~~  196 (228)
                      ++.|+++..+.|.....-.... +  .....++..       ..++.      -             .       .....
T Consensus       229 IfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~  308 (438)
T KOG0666|consen  229 IFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKV  308 (438)
T ss_pred             HHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcC
Confidence            9999999888764322211110 0  001111110       00000      0             0       00111


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          197 KVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       197 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .++.-.+|+.+||..||.+|.|+.+.++
T Consensus       309 k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  309 KDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             CCchHHHHHHHHhccCchhhccHHHHhc
Confidence            2233679999999999999999999886

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=216.61  Aligned_cols=212  Identities=21%  Similarity=0.321  Sum_probs=161.2

Q ss_pred             hHHHHHHHHHHhccC-C-C----ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIR-H-R----NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h-~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      |++.+-|+++|+++. + |    -++.+.++|...++.+||+|.+ |.++++++..+.. .+++...+..+++|++++++
T Consensus       129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~  206 (415)
T KOG0671|consen  129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVA  206 (415)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHH
Confidence            456678999999993 2 2    3577788899999999999988 5689999987654 34899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcC--------------------CCceEEeecccccccCCCCCCceecccccceeCCcc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDL--------------------EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL  135 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~--------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~  135 (228)
                      +||+.   +++|-||||+||++.+                    +..++++|||.++......   .....|..|+|||+
T Consensus       207 fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEV  280 (415)
T KOG0671|consen  207 FLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEV  280 (415)
T ss_pred             HHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchh
Confidence            99999   9999999999999832                    2358999999998754332   44677889999999


Q ss_pred             cccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCC---------------------------
Q 040501          136 AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLP---------------------------  188 (228)
Q Consensus       136 ~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------  188 (228)
                      +.+.+++.++||||+||+++|+.+|...|+.-....   -..+.++++.+.+.                           
T Consensus       281 iLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E---HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~  357 (415)
T KOG0671|consen  281 ILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE---HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK  357 (415)
T ss_pred             eeccCcCCccCceeeeeEEEEeeccceecccCCcHH---HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc
Confidence            999999999999999999999999999876422110   00111111111000                           


Q ss_pred             ---------CC---chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          189 ---------PL---SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       189 ---------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                               +.   ..........+.+|+++||..||.+|+|+.|++.
T Consensus       358 ~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  358 SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence                     00   0000112335899999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=228.67  Aligned_cols=201  Identities=25%  Similarity=0.371  Sum_probs=170.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+..|-.+|..++.|.|++++-.|.++..+|++||-|-||.+-..++..++   ++..++..++..+++|+.|||++  
T Consensus       465 eHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k--  539 (732)
T KOG0614|consen  465 EHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK--  539 (732)
T ss_pred             HHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc--
Confidence            3456788999999999999999999999999999999999999999887665   78888899999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       ||++|||||+|.+++.+|-+||.|||.++.++.....|+ ++|||+|.|||++.....+.++|.||||+++||+++|.+
T Consensus       540 -~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p  617 (732)
T KOG0614|consen  540 -GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP  617 (732)
T ss_pred             -CceeccCChhheeeccCCceEEeehhhHHHhccCCceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence             999999999999999999999999999999987776665 799999999999999999999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ||...+++.      ....++.+.- .... .+.......++|++....+|.+|.-
T Consensus       618 PFs~~dpmk------tYn~ILkGid-~i~~-Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  618 PFSGVDPMK------TYNLILKGID-KIEF-PRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             CCCCCchHH------HHHHHHhhhh-hhhc-ccccchhHHHHHHHHHhcCcHhhhc
Confidence            987655443      3232322211 0000 1234445679999999999999965

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=234.30  Aligned_cols=208  Identities=25%  Similarity=0.373  Sum_probs=161.0

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA-EELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      -..+|++.|+.- +||||+++++.=.++...||..|.|.. +|.+++...... ....-...+..+.|+++||++||+. 
T Consensus       548 ~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-  625 (903)
T KOG1027|consen  548 FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-  625 (903)
T ss_pred             HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-
Confidence            357899999988 699999999998899999999999965 999999764111 1111134567899999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC---C--CceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           82 IPPIVHRDISSKNVLLDL---E--YEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~---~--~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                        +|+||||||.||+++.   +  .+++|+|||+++........   .....|+..|+|||++.....+.++|||||||+
T Consensus       626 --~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv  703 (903)
T KOG1027|consen  626 --KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV  703 (903)
T ss_pred             --ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence              9999999999999976   3  45789999999988765544   234678999999999999888889999999999


Q ss_pred             HHHHHhC-CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          154 ALEVIKG-KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       154 l~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|+.++| ..||+....        ....++............... +..+||.+|++++|..||++.+++.
T Consensus       704 fyYvltgG~HpFGd~~~--------R~~NIl~~~~~L~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  704 FYYVLTGGSHPFGDSLE--------RQANILTGNYTLVHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             EEEEecCCccCCCchHH--------hhhhhhcCccceeeeccCchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            9999985 999874322        222233322221111111111 6789999999999999999999874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=229.19  Aligned_cols=211  Identities=24%  Similarity=0.389  Sum_probs=177.5

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+..|.++++.+ .|||++.++++|.-     ++.+|+|||||++|+..|+++... +..+.+..+..+++.++.|+.+
T Consensus        60 eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~H  138 (953)
T KOG0587|consen   60 EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAH  138 (953)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHH
Confidence            5678899999998 69999999999853     468999999999999999998755 5668999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-----CcccchhhhhHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-----KVTAKCDVYSFG  151 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG  151 (228)
                      ||..   .++|||||-.||+++.++.+|++|||.+...+.......+..|++.|||||++...     .|+..+|+||||
T Consensus       139 LH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG  215 (953)
T KOG0587|consen  139 LHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG  215 (953)
T ss_pred             Hhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence            9999   99999999999999999999999999998887766667788999999999998654     367789999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++..||..|.+|+-.+..      ....-.+.+.. ++....+..-+.++.++|..||.+|..+||+..++++
T Consensus       216 ITaIEladG~PPl~DmHP------mraLF~IpRNP-PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  216 ITAIEMAEGAPPLCDMHP------MRALFLIPRNP-PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ceeehhcCCCCCccCcch------hhhhccCCCCC-CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            999999999999654433      22333332222 2333334566778999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-32  Score=231.09  Aligned_cols=104  Identities=30%  Similarity=0.444  Sum_probs=96.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+..|+.++..++|+||+++++.+......|+||||+.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~--  123 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH--  123 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            567889999999999999999999999999999999999999999987543   378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeeccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAK  112 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~  112 (228)
                       ||+|+||||+|||++.++.++|+|||++.
T Consensus       124 -gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             -CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence             99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=211.13  Aligned_cols=215  Identities=24%  Similarity=0.334  Sum_probs=167.8

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++++..|.+...+- ++|+||++++.+...+..||.||.++ .+++.+...  .-....+++...-.+....+.||.||.
T Consensus       106 q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK  184 (361)
T KOG1006|consen  106 QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK  184 (361)
T ss_pred             HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH
Confidence            56788888876665 79999999999999999999999995 466554432  111223788888888888999999998


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC--CcccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~  156 (228)
                      ..-  .|+|||+||+||+++..|.+||+|||++...-. +...+...|-..|+|||-+...  .|+.+||+||||+++||
T Consensus       185 ~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~E  261 (361)
T KOG1006|consen  185 EEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYE  261 (361)
T ss_pred             HHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEee
Confidence            763  899999999999999999999999999876532 2223445677889999988654  48899999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCC--chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPL--SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      +.+|..||.....     ..+.+..+..+..+..  ......++..+..+|.-||.+|-..||.+.++++.
T Consensus       262 vAtG~fPyr~w~s-----vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  262 VATGNFPYRKWDS-----VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             eecCCCCcchHHH-----HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            9999999875443     2334444444554433  23335678889999999999999999999998753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-33  Score=199.95  Aligned_cols=214  Identities=22%  Similarity=0.353  Sum_probs=159.8

Q ss_pred             HHHHHHHHhccCCCccceeeeeeee--------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTH--------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ..+|+++|+.++|+|++.+++.|..        ...+|+||++|.. +|.-++....  ..++...+..++.++++||.|
T Consensus        63 alreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~  139 (376)
T KOG0669|consen   63 ALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYY  139 (376)
T ss_pred             HHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHH
Confidence            4689999999999999999998843        2358999999976 6777776442  338899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC-CcccchhhhhHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM-KVTAKCDVYSFG  151 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG  151 (228)
                      +|+.   .|+|||+||+|++++.+|.++|.|||+++........    .+....|..|++||.+.|. .++++.|+|+.|
T Consensus       140 iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg  216 (376)
T KOG0669|consen  140 IHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG  216 (376)
T ss_pred             HHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence            9999   9999999999999999999999999999655433222    3344568899999988776 589999999999


Q ss_pred             HHHHHHHhCCCCcccccccc------------------CCCchhhhhhhcCCCCCCCch-hhhhh------HHHHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVS------------------SSNPNILVNEMLDPRLPPLSV-DIRGK------VISIMEVAF  206 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~li~  206 (228)
                      |++.+|+++.+-++...+..                  ..+.......+..+.++.... ...+.      ..+..+++.
T Consensus       217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle  296 (376)
T KOG0669|consen  217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE  296 (376)
T ss_pred             HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence            99999999988865432211                  011111112221111111100 01111      125679999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 040501          207 LCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       207 ~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.+|++++++++
T Consensus       297 ~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  297 KLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHhccCcccCcchHhhhc
Confidence            999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-34  Score=207.31  Aligned_cols=212  Identities=22%  Similarity=0.333  Sum_probs=162.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ++..+|..++..++|+||++++++|....      ..|+|||++. .+|...+.     ..++-.++..++.|++.|++|
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~  133 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKH  133 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHH
Confidence            56789999999999999999999997543      5799999996 47777765     226778889999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   ||+||||||+||++..++.+||.|||++...+.. ...+....+..|+|||++.+..+.+.+||||+||++.|
T Consensus       134 lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gE  209 (369)
T KOG0665|consen  134 LHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  209 (369)
T ss_pred             HHhc---ceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHH
Confidence            9999   9999999999999999999999999999876544 33444567788999999999999999999999999999


Q ss_pred             HHhCCCCccccccccCCC----------------------------chhh---hhh-hcCCCCCCCchhhhhhHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSN----------------------------PNIL---VNE-MLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~----------------------------~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                      |+.|...|+.....+...                            +...   +.+ ..+..++.......-...-..++
T Consensus       210 li~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardl  289 (369)
T KOG0665|consen  210 LILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDL  289 (369)
T ss_pred             HhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHH
Confidence            999999875322111100                            0000   000 01111111111111223347899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.+||..||++|.|++++|.
T Consensus       290 l~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  290 LSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHhhccChhhcccHHHHhc
Confidence            99999999999999999885

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-33  Score=211.96  Aligned_cols=212  Identities=28%  Similarity=0.415  Sum_probs=164.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCT-HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ...+|..+-+.|.||.||+++++|. +...+|-|+|||+|.+|+-++..+..   +++..+..++.|++.||.||... +
T Consensus       513 HAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-k  588 (775)
T KOG1151|consen  513 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-K  588 (775)
T ss_pred             HHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-C
Confidence            4568999999999999999999996 45678899999999999999987654   89999999999999999999986 3


Q ss_pred             CCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCC-------ceecccccceeCCcccccC----Ccccchhhh
Q 040501           83 PPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTM----KVTAKCDVY  148 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~----~~~~~~Diw  148 (228)
                      ..|+|.||||.||++-.+   |.+||+|||+++.+..+...       .....||..|++||++.-.    +.+.++|||
T Consensus       589 pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW  668 (775)
T KOG1151|consen  589 PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW  668 (775)
T ss_pred             CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeE
Confidence            489999999999999544   88999999999988765443       2235789999999987533    468899999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |+|+++|..+.|+.||+........-....+-....-.+|+.    +.++.+..++|++||++.-.+|.++.++.
T Consensus       669 SvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  669 SVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             eeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            999999999999999975433211111111111111111221    23455678999999999999998877664

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=210.84  Aligned_cols=196  Identities=24%  Similarity=0.336  Sum_probs=166.2

Q ss_pred             HHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            7 REITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         7 ~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      .|-++|... +-|.++.+...|+.-+++|+||||+.||+|-..++.-+.   +.+..+..++.+++-||-+||++   ||
T Consensus       398 ~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gI  471 (683)
T KOG0696|consen  398 VEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GI  471 (683)
T ss_pred             hhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---Ce
Confidence            344555544 568889999999999999999999999999988876554   67788899999999999999999   99


Q ss_pred             eecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           86 VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      ++||||.+|||++.+|.+||.|||+++..-.......+++|||.|+|||++....|+.++|.||+|+++|||+.|++||+
T Consensus       472 iYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  472 IYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             eeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999999876656666678999999999999999999999999999999999999999975


Q ss_pred             ccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                            ..+..+....+......-    ....+.+..++++..|.++|.+|.-
T Consensus       552 ------GeDE~elF~aI~ehnvsy----PKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  552 ------GEDEDELFQAIMEHNVSY----PKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------CCCHHHHHHHHHHccCcC----cccccHHHHHHHHHHhhcCCccccC
Confidence                  344556666665554432    2355667889999999999999954

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=206.38  Aligned_cols=212  Identities=21%  Similarity=0.320  Sum_probs=173.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEeecCCChhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCT-HARHSFLVYEYLENGSLSVILN-----NDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .+..|.-.+..+.|||+.++.+++. +....++++++.+.++|..++.     .......++..+...++.|++.|++||
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl  412 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL  412 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence            4567777888889999999999985 4568889999999999999998     333445577888889999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      |+.   |++|.||..+|+++++.-.+||+|-.+++..-+....  ......+..||+||.+....|+.++|+||||+++|
T Consensus       413 h~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  413 HNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             Hhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence            999   9999999999999999999999999998865433322  22234567899999999999999999999999999


Q ss_pred             HHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          156 EVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       156 ~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+++ |+.||...      ++.+...-+.++.....+   .++++++..++.-||+..|++||+.+++..=|.
T Consensus       490 ELmtlg~~PyaeI------DPfEm~~ylkdGyRlaQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  490 ELMTLGKLPYAEI------DPFEMEHYLKDGYRLAQP---FNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HHHhcCCCCcccc------CHHHHHHHHhccceecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            9997 99997544      344455555444433222   478889999999999999999999999987664

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=228.84  Aligned_cols=211  Identities=25%  Similarity=0.411  Sum_probs=177.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+..|.++.|||++++++++..+. +-||++|++.|+|.++++.+...  +..+..+.|+.||++|+.|||.+  
T Consensus       743 ~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~q--  817 (1177)
T KOG1025|consen  743 IELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQ--  817 (1177)
T ss_pred             HHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhc--
Confidence            56889999999999999999999998765 77899999999999999876544  88899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecc--cccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA--GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       +++||||-.+|||+.....+|+.|||++..............  -++.|+|-|.+....++.++||||+|+++||++| 
T Consensus       818 -rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTF  896 (1177)
T KOG1025|consen  818 -RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTF  896 (1177)
T ss_pred             -chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhc
Confidence             999999999999999999999999999998776655543333  3567999999999999999999999999999987 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..|++.....+..+..+...+...+         +-++.+++.++.+||..|+..||+++++.+.+.+
T Consensus       897 Ga~Py~gi~~~eI~dlle~geRLsqP---------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  897 GAKPYDGIPAEEIPDLLEKGERLSQP---------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCCccCCCCHHHhhHHHhccccCCCC---------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            99998766554444333333332222         2456679999999999999999999999887753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-32  Score=207.52  Aligned_cols=220  Identities=27%  Similarity=0.403  Sum_probs=165.9

Q ss_pred             ChHHHHHHHHHHhcc--CCCccceeeeeeeec----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            1 DKKEFLREITVLTEI--RHRNIVKFYGFCTHA----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      |.+++.+|.++++.+  +|+||+.+++....+    ..+|+|.+|-+.|+|+|++.+..    ++....++++..++.||
T Consensus       246 dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGL  321 (513)
T KOG2052|consen  246 DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGL  321 (513)
T ss_pred             chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhH
Confidence            457889999999985  999999999886433    36899999999999999998743    88899999999999999


Q ss_pred             HHhhhC-----CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC----CceecccccceeCCcccccCC----c
Q 040501           75 SYLHHD-----CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS----NWTEFAGTYGYVAPELAYTMK----V  141 (228)
Q Consensus        75 ~~lh~~-----~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----~  141 (228)
                      +|||..     +++.|.|||||..||++.++|.+-|.|+|++........    ..+...||.+|||||++...-    +
T Consensus       322 aHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~F  401 (513)
T KOG2052|consen  322 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHF  401 (513)
T ss_pred             HHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhh
Confidence            999954     677899999999999999999999999999987654422    245578999999999986532    2


Q ss_pred             -c-cchhhhhHHHHHHHHHh----------CCCCccccccccCCCchh-hhh----hhcCCCCCCCchhhhhhHHHHHHH
Q 040501          142 -T-AKCDVYSFGVLALEVIK----------GKHPRDFLSNVSSSNPNI-LVN----EMLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       142 -~-~~~DiwslG~~l~~~~~----------g~~p~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                       + ..+||||||+++||+..          -++||-..  +......+ +..    +.+++..+..... ......+.++
T Consensus       402 esyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~--Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~kl  478 (513)
T KOG2052|consen  402 ESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV--VPSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKL  478 (513)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC--CCCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHH
Confidence             2 35899999999999973          23354221  11111111 111    1222222222111 2345568899


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhh
Q 040501          205 AFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ++.||..||..|.|+-.+.+.|.
T Consensus       479 MkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  479 MKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             HHHhhcCCchhhhHHHHHHHHHH
Confidence            99999999999999988877765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=218.19  Aligned_cols=207  Identities=23%  Similarity=0.308  Sum_probs=170.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++..|+.+|+.+.||+||.+-.-|+..++.++|||.+.|.-|.-.+.....  .+++.....++.||+.||.|||-+  
T Consensus       608 sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k--  683 (888)
T KOG4236|consen  608 SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK--  683 (888)
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc--
Confidence            4677899999999999999999999999999999999977666666654332  388888888999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       ||+|+||||+||++...   -.+||+|||.++.++.. .-.....|||.|+|||++....|....|+||+|+++|--++
T Consensus       684 -nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS  761 (888)
T KOG4236|consen  684 -NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS  761 (888)
T ss_pred             -ceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence             99999999999999654   57899999999988743 33456789999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |..||.-..     +..+   ++-...+.-.+..|.+.+....++|...|+..=++|-|++..+
T Consensus       762 GTFPFNEdE-----dInd---QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  762 GTFPFNEDE-----DIND---QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ccccCCCcc-----chhH---HhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            999985321     1112   2222223333445778888899999999999999999887654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-32  Score=201.71  Aligned_cols=205  Identities=24%  Similarity=0.345  Sum_probs=165.6

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.|-.+..+- +||.+|-+...|....++++|.||++||+|.-.+++..   .++++.+..+...++.||.|||++  
T Consensus       296 wvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r--  370 (593)
T KOG0695|consen  296 WVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER--  370 (593)
T ss_pred             hHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc--
Confidence            446677777776 79999999999999999999999999999876665443   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       ||+.||+|.+|++++..|.+|++|+|.++..-.+.....+++|||.|.|||++.+..|..+.|.|+||+++++|+.|+.
T Consensus       371 -giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrs  449 (593)
T KOG0695|consen  371 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS  449 (593)
T ss_pred             -CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCC
Confidence             9999999999999999999999999999876666666677899999999999999999999999999999999999999


Q ss_pred             CccccccccC--CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          163 PRDFLSNVSS--SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       163 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ||+.....+.  ......++-++.......    +..+.....+++..|++||++|.-
T Consensus       450 pfdivgm~n~d~ntedylfqvilekqirip----rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  450 PFDIVGMDNPDMNTEDYLFQVILEKQIRIP----RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             CcceecCCCcccchhHHHHHHHhhhccccc----ceeehhhHHHHHHhhcCCcHHhcC
Confidence            9986542211  112223333333332110    122334567899999999999964

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=226.80  Aligned_cols=206  Identities=25%  Similarity=0.279  Sum_probs=164.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      -|..|-.+|-.-..+=|+.++-.|.+..++|+||||++||+|-.++....   .+++..+..++..+..||..+|+.   
T Consensus       121 ~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---  194 (1317)
T KOG0612|consen  121 CFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---  194 (1317)
T ss_pred             HHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---
Confidence            46677778887788999999999999999999999999999999998665   389999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCccccc-----CCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYT-----MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~~  157 (228)
                      |+|||||||+||+++..|++||.|||.+-.+..++.. .....|||.|.+||++..     ..|+...|.||+|+++|||
T Consensus       195 gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM  274 (1317)
T KOG0612|consen  195 GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM  274 (1317)
T ss_pred             cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence            9999999999999999999999999999888755444 556789999999998853     3578899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPN---MQTIC  223 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il  223 (228)
                      +.|..||-...-+      .....+.+-.- ...+ +...++.+..+||.+.+. +|..|..   +.++.
T Consensus       275 lyG~TPFYadslv------eTY~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  275 LYGETPFYADSLV------ETYGKIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HcCCCcchHHHHH------HHHHHHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            9999998432221      22233332211 1112 233477788899988775 5666665   55553

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=182.50  Aligned_cols=216  Identities=21%  Similarity=0.310  Sum_probs=164.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..+|+-+++.++|.||+++++..-.+..+.+|+|+|.. +|..+......  .++.+.+..++.|++.|+.++|+.  
T Consensus        46 ssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh--  120 (292)
T KOG0662|consen   46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH--  120 (292)
T ss_pred             HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh--
Confidence            3568999999999999999999999999999999999964 78777765443  388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHh-C
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK-G  160 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~-g  160 (228)
                       ++.|||+||.|.+++.+|.+|+.|||+++..+-+.........+..|++|.++.+.+ |+++.|+||.||++.|+.. |
T Consensus       121 -nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag  199 (292)
T KOG0662|consen  121 -NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_pred             -hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence             999999999999999999999999999998776655555556788999999998876 7899999999999999986 6


Q ss_pred             CCCccccccccCCCchh-hhhhhcCCCCC--------------CCchhhhhhHHH----HHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSSSNPNI-LVNEMLDPRLP--------------PLSVDIRGKVIS----IMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~--------------~~~~~~~~~~~~----~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      .+.|+.....+...... .........+|              +....+.+..+.    =.+++.+.|.-+|.+|.++++
T Consensus       200 rplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea  279 (292)
T KOG0662|consen  200 RPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA  279 (292)
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence            66665432211100000 00000000001              111223333322    378999999999999999998


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      .++
T Consensus       280 alq  282 (292)
T KOG0662|consen  280 ALQ  282 (292)
T ss_pred             Hhc
Confidence            765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=5.3e-32  Score=226.84  Aligned_cols=179  Identities=23%  Similarity=0.405  Sum_probs=140.2

Q ss_pred             EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeeccccc
Q 040501           33 SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK  112 (228)
Q Consensus        33 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~  112 (228)
                      +||=||||...++.++++++....  ....+|+++++|++||.|+|++   |++||||||.|||++.++.|||+|||+++
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt  745 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLAT  745 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccch
Confidence            689999999988999888765321  4678899999999999999999   99999999999999999999999999998


Q ss_pred             ccC------------------CCCCCceecccccceeCCcccccCC---cccchhhhhHHHHHHHHHhCCCCcccccccc
Q 040501          113 FIQ------------------PDSSNWTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSNVS  171 (228)
Q Consensus       113 ~~~------------------~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~  171 (228)
                      ...                  .+....+...||.-|+|||.+.+..   |+.|+|+||||++++||+.   ||+.     
T Consensus       746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----  817 (1351)
T KOG1035|consen  746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-----  817 (1351)
T ss_pred             hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc-----
Confidence            721                  0111245578999999999987654   8999999999999999983   4532     


Q ss_pred             CCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          172 SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..+....+...-++..|....-..+..+.-..+|.+|++.||.+||||.|+|+
T Consensus       818 sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  818 SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            22233444455455555442223333444568999999999999999999986

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.1e-32  Score=234.49  Aligned_cols=197  Identities=18%  Similarity=0.188  Sum_probs=139.6

Q ss_pred             HHhccCC-Cccceeeeee-------eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501           11 VLTEIRH-RNIVKFYGFC-------THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus        11 ~l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.++| +||++++++|       .....++.++|++ +++|.+++....  ..++...++.++.|++.||.|||++  
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~--   99 (793)
T PLN00181         25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ--   99 (793)
T ss_pred             ccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence            3455667 7899999988       2334677888877 569999997432  3389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCc-------------------eEEeecccccccCCCC----------------CCceecccc
Q 040501           83 PPIVHRDISSKNVLLDLEYE-------------------AHVSDFGIAKFIQPDS----------------SNWTEFAGT  127 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~-------------------~~l~df~~~~~~~~~~----------------~~~~~~~~~  127 (228)
                       ||+||||||+|||++..|.                   +|++|||++.......                .......++
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             9999999999999965444                   4555555544321000                000113467


Q ss_pred             cceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHH
Q 040501          128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL  207 (228)
Q Consensus       128 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  207 (228)
                      +.|+|||++.+..++.++|||||||++|||++|..|+.....        ..........+..   ..........++.+
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~~  247 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------TMSSLRHRVLPPQ---ILLNWPKEASFCLW  247 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------HHHHHHHhhcChh---hhhcCHHHHHHHHH
Confidence            789999999998999999999999999999998888642111        1111111111110   01112345688899


Q ss_pred             hhccCCCCCCCHHHHHH
Q 040501          208 CLDNNPESRPNMQTICQ  224 (228)
Q Consensus       208 ~l~~~p~~Rpt~~~il~  224 (228)
                      ||+++|.+|||+.++++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1e-30  Score=190.69  Aligned_cols=179  Identities=35%  Similarity=0.614  Sum_probs=157.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++.++.++|++++++++++......++++|++.+++|.+++....  ..++...++.++.+++.++.+||+. 
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-  111 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN-  111 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3678999999999999999999999999899999999999899999987653  2378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++|+||+|.||+++. ++.++|+||+.+..............+...|.+||..... ..+.++|+|++|++++++  
T Consensus       112 --~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--  187 (215)
T cd00180         112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--  187 (215)
T ss_pred             --CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--
Confidence              9999999999999999 8999999999988765443223334567889999988776 778899999999999998  


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                                                             ..+.+++.+|+..||.+||++.++++.+
T Consensus       188 ---------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                                   4688999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.5e-31  Score=208.22  Aligned_cols=193  Identities=20%  Similarity=0.265  Sum_probs=151.5

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ++.|-.||..-.++-||+++-.|.+.+.+|+||+|++||++-.++-+.+-   +.+..+..++.+|..|+.+.|..   |
T Consensus       676 VKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---G  749 (1034)
T KOG0608|consen  676 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---G  749 (1034)
T ss_pred             hhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---c
Confidence            45688888888899999999999999999999999999999998866543   88899999999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCC---------CC---------------------------------Cce
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---------SS---------------------------------NWT  122 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~---------~~---------------------------------~~~  122 (228)
                      ++||||||+||||+.+|.+||+|||+|+-+...         ..                                 ...
T Consensus       750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah  829 (1034)
T KOG0608|consen  750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH  829 (1034)
T ss_pred             ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence            999999999999999999999999999854210         00                                 011


Q ss_pred             ecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHH
Q 040501          123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIM  202 (228)
Q Consensus       123 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (228)
                      ...||+.|+|||++....++..+|.||.|++||+|+.|++||-.................++-..      ..+.+.+..
T Consensus       830 slvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~------~~~ls~e~~  903 (1034)
T KOG0608|consen  830 SLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY------QGNLSKEAL  903 (1034)
T ss_pred             hhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccc------ccccCHHHH
Confidence            23688999999999999999999999999999999999999865544433333333333322221      123444555


Q ss_pred             HHHHHhh
Q 040501          203 EVAFLCL  209 (228)
Q Consensus       203 ~li~~~l  209 (228)
                      ++|.++.
T Consensus       904 ~li~kLc  910 (1034)
T KOG0608|consen  904 DLIQKLC  910 (1034)
T ss_pred             HHHHHHh
Confidence            6665543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=185.76  Aligned_cols=161  Identities=23%  Similarity=0.402  Sum_probs=134.0

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-DTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +++..+|+.+..+. .+|.+|.+++........||.||.++. +|+.+.+. -.....+++..+-+++..+.+|+.|||+
T Consensus        88 q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~  166 (282)
T KOG0984|consen   88 QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS  166 (282)
T ss_pred             HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH
Confidence            45678888887776 799999999999888999999999964 67666543 2223448889999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc----CCcccchhhhhHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT----MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~  155 (228)
                      +-  .++|||+||+||+++.+|.+|++|||++....+. ...+...|-..|+|||.+..    ..|+.+|||||||+.+.
T Consensus       167 kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmi  243 (282)
T KOG0984|consen  167 KL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMI  243 (282)
T ss_pred             Hh--hhhhccCCcceEEEccCCcEEEcccccceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhh
Confidence            84  8999999999999999999999999999766532 22333567788999998754    36889999999999999


Q ss_pred             HHHhCCCCccc
Q 040501          156 EVIKGKHPRDF  166 (228)
Q Consensus       156 ~~~~g~~p~~~  166 (228)
                      ||.+++.||+.
T Consensus       244 ElA~lr~PY~~  254 (282)
T KOG0984|consen  244 EMAILRFPYES  254 (282)
T ss_pred             hhhhccccccc
Confidence            99999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=202.84  Aligned_cols=222  Identities=26%  Similarity=0.439  Sum_probs=167.1

Q ss_pred             ChHHHHHHHHHHhcc--CCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            1 DKKEFLREITVLTEI--RHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ++++|..|-.+++..  +|+||+.+++.-+...    .+++|++|-+.|+|.+++..+.    +++....+++..++.||
T Consensus       245 ~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGL  320 (534)
T KOG3653|consen  245 EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGL  320 (534)
T ss_pred             HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHH
Confidence            467888888888875  7999999998865544    8999999999999999998665    89999999999999999


Q ss_pred             HHhhhCC------CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCc-c---
Q 040501           75 SYLHHDC------IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKV-T---  142 (228)
Q Consensus        75 ~~lh~~~------~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~---  142 (228)
                      +|||+.-      ++.|+|||||..|||+..|++..|.|||++.........  .....||.+|||||++.+.-. .   
T Consensus       321 a~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~  400 (534)
T KOG3653|consen  321 AHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRD  400 (534)
T ss_pred             HHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHH
Confidence            9999763      457999999999999999999999999999887644332  334789999999999876532 2   


Q ss_pred             --cchhhhhHHHHHHHHHhCCCCc--------ccc--ccccC-CCchh----hhhhhcCCCCCCCchhhhhhHHHHHHHH
Q 040501          143 --AKCDVYSFGVLALEVIKGKHPR--------DFL--SNVSS-SNPNI----LVNEMLDPRLPPLSVDIRGKVISIMEVA  205 (228)
Q Consensus       143 --~~~DiwslG~~l~~~~~g~~p~--------~~~--~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li  205 (228)
                        .+.||||+|.++|||++.-...        +..  .+... ....+    +..+..++.++..-... ....-+.+.+
T Consensus       401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~  479 (534)
T KOG3653|consen  401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETI  479 (534)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHH
Confidence              3689999999999998733221        100  00000 11111    22333334433322222 3455689999


Q ss_pred             HHhhccCCCCCCCHHHHHHHhh
Q 040501          206 FLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       206 ~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||..||..|.|+.=+.+++.
T Consensus       480 EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  480 EECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             HHHcCCchhhhhhhHHHHHHHH
Confidence            9999999999999987776653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.3e-30  Score=185.71  Aligned_cols=164  Identities=23%  Similarity=0.243  Sum_probs=123.2

Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce
Q 040501           43 GSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT  122 (228)
Q Consensus        43 ~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  122 (228)
                      |+|.+++....  ..+++.+++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||.+.......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            57888887533  2389999999999999999999999   7      999999999999998  99887654322    


Q ss_pred             ecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHH--H
Q 040501          123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVI--S  200 (228)
Q Consensus       123 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  200 (228)
                       ..+++.|+|||++.+..++.++||||+|+++|+|++|..||........ ......... ....+...........  .
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  140 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGM-PADDPRDRSNLESVSAARS  140 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHh-ccCCccccccHHHHHhhhh
Confidence             2578999999999999999999999999999999999999854322110 000111111 1111111111223333  6


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          201 IMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       201 ~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      +.+++.+||..+|.+|||+.++++.+
T Consensus       141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~  166 (176)
T smart00750      141 FADFMRVCASRLPQRREAANHYLAHC  166 (176)
T ss_pred             HHHHHHHHHhcccccccCHHHHHHHH
Confidence            89999999999999999999999865

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.7e-31  Score=184.85  Aligned_cols=213  Identities=21%  Similarity=0.298  Sum_probs=158.3

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++.+.+|+.+|+.|+ ||||++++++..+  +..+.+++|++.+.+...+..      .++.-.+...+.+++.||.|||
T Consensus        76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH  149 (338)
T KOG0668|consen   76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH  149 (338)
T ss_pred             HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH
Confidence            467899999999996 9999999999864  457889999998877766542      2566677889999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~  156 (228)
                      +.   ||.|||+||.|++++.. ..++|+|+|++.+..+... ......+..|--||.+...+ |+.+.|+|||||++..
T Consensus       150 S~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~  225 (338)
T KOG0668|consen  150 SM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS  225 (338)
T ss_pred             hc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHH
Confidence            99   99999999999999875 6789999999998765433 34456677888999887654 7889999999999999


Q ss_pred             HHhCCCCccccccccC-----------------------C---CchhhhhhhcCCCCCC-Cchhh-hhhHHHHHHHHHHh
Q 040501          157 VIKGKHPRDFLSNVSS-----------------------S---NPNILVNEMLDPRLPP-LSVDI-RGKVISIMEVAFLC  208 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~-----------------------~---~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~li~~~  208 (228)
                      |+..+.||.....-..                       .   .......+..+..+.. ..... .-.+++..+++.+.
T Consensus       226 miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldkl  305 (338)
T KOG0668|consen  226 MIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKL  305 (338)
T ss_pred             HHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHH
Confidence            9999999742211000                       0   0000011111111111 11111 12346788999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |..|-++|+|++|...
T Consensus       306 LrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  306 LRYDHQERLTAKEAMA  321 (338)
T ss_pred             HhhccccccchHHHhc
Confidence            9999999999998753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.4e-31  Score=206.26  Aligned_cols=211  Identities=22%  Similarity=0.275  Sum_probs=165.9

Q ss_pred             HHHHHHHhccCC------CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            6 LREITVLTEIRH------RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         6 ~~E~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +.|+++|++|+.      -|+++++-+|...+++|+|||.+. .+|.+.+...+..-.+....+..+++|+.-||..|..
T Consensus       476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~  554 (752)
T KOG0670|consen  476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK  554 (752)
T ss_pred             hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh
Confidence            579999999952      489999999999999999999884 5899999887766678899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                      .   |++|.||||+|||++.. ..+||||||.+...+.+..  +....+-.|.|||++.|..|+...|+||+||.|||+.
T Consensus       555 c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY  629 (752)
T KOG0670|consen  555 C---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY  629 (752)
T ss_pred             c---CeeecccCccceEeccCcceeeeccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEee
Confidence            8   99999999999999877 5679999999987664432  2234456799999999999999999999999999999


Q ss_pred             hCCCCccccccc---------cC------------------------------------------CCc-hhhhhhhcCCC
Q 040501          159 KGKHPRDFLSNV---------SS------------------------------------------SNP-NILVNEMLDPR  186 (228)
Q Consensus       159 ~g~~p~~~~~~~---------~~------------------------------------------~~~-~~~~~~~~~~~  186 (228)
                      ||+..|+....-         .+                                          ..+ ......+..  
T Consensus       630 tGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~--  707 (752)
T KOG0670|consen  630 TGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA--  707 (752)
T ss_pred             ccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc--
Confidence            999987532110         00                                          000 000000000  


Q ss_pred             CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          187 LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       187 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .+..+.+.......+.+|+.+||..||.+|.|+.++|.
T Consensus       708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            01123344556677999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=207.49  Aligned_cols=151  Identities=26%  Similarity=0.414  Sum_probs=136.5

Q ss_pred             HHHHHHHhccC---CCccceeeeeeeecCeEEEEEEee-cCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            6 LREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYL-ENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         6 ~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      -.||++|.+++   |+||+|++++|++++.+|+++|.- +|.+|+++|..+.+   +++..+..++.|++.|+++||++ 
T Consensus       614 p~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~-  689 (772)
T KOG1152|consen  614 PSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ-  689 (772)
T ss_pred             chhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc-
Confidence            46999999997   999999999999999999999964 57789999987665   88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~~~~g  160 (228)
                        ||+|||||-+|+.++.+|-+||+|||.+......  +...+.||..|.|||++.|.+|- ..-|||+||+++|.++..
T Consensus       690 --~ivhrdikdenvivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyk  765 (772)
T KOG1152|consen  690 --GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYK  765 (772)
T ss_pred             --CceecccccccEEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEec
Confidence              9999999999999999999999999998876533  34567899999999999999985 468999999999999998


Q ss_pred             CCCc
Q 040501          161 KHPR  164 (228)
Q Consensus       161 ~~p~  164 (228)
                      ..||
T Consensus       766 enpy  769 (772)
T KOG1152|consen  766 ENPY  769 (772)
T ss_pred             cCCC
Confidence            8886

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=3e-30  Score=212.26  Aligned_cols=194  Identities=19%  Similarity=0.198  Sum_probs=128.5

Q ss_pred             eecCeEEEEEEeecCCChhhhhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCC
Q 040501           28 THARHSFLVYEYLENGSLSVILNNDTSA-----------------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDI   90 (228)
Q Consensus        28 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di   90 (228)
                      ......++|+||+.+++|.+++......                 .......+..++.|++.||.|||+.   ||+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            3456789999999999999988653211                 0112344567999999999999999   9999999


Q ss_pred             CCCceEEcC-CCceEEeecccccccCCCCC-CceecccccceeCCcccccC----------------------Ccccchh
Q 040501           91 SSKNVLLDL-EYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM----------------------KVTAKCD  146 (228)
Q Consensus        91 ~p~nil~~~-~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  146 (228)
                      ||+|||++. ++.+||+|||++........ ......+++.|+|||.+...                      .+..++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 57899999999975432221 12345678899999965322                      1234569


Q ss_pred             hhhHHHHHHHHHhCCCCcccccc-----ccC-CCchhhhhhhcCCCCCCC-c---hhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          147 VYSFGVLALEVIKGKHPRDFLSN-----VSS-SNPNILVNEMLDPRLPPL-S---VDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      |||+||++|+|+++..++.....     ... .................. .   ...........+||.+||++||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999999987766432100     000 000001111111110000 0   0000112235589999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||++++++
T Consensus       442 ~ta~e~L~  449 (566)
T PLN03225        442 ISAKAALA  449 (566)
T ss_pred             CCHHHHhC
Confidence            99999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=5.7e-29  Score=200.53  Aligned_cols=215  Identities=18%  Similarity=0.219  Sum_probs=146.5

Q ss_pred             HHHHHHHhccCCCcc-----ceeeeeeee--------cCeEEEEEEeecCCChhhhhhcCCC------------------
Q 040501            6 LREITVLTEIRHRNI-----VKFYGFCTH--------ARHSFLVYEYLENGSLSVILNNDTS------------------   54 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~------------------   54 (228)
                      ..|+.++.+++|.++     ++++++|..        ....|+|+||+.+++|.+++.....                  
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346677777766544     667777643        3468999999999999998864211                  


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccce
Q 040501           55 ---AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGY  130 (228)
Q Consensus        55 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y  130 (228)
                         ....++..+..++.|++.+|.|||+.   +++||||||+||+++.++.++|+|||++......... .....+++.|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence               11245677888999999999999999   9999999999999999999999999998654322211 1122347899


Q ss_pred             eCCcccccCCc----------------------ccchhhhhHHHHHHHHHhCCC-CccccccccCC----Cchhhhhhhc
Q 040501          131 VAPELAYTMKV----------------------TAKCDVYSFGVLALEVIKGKH-PRDFLSNVSSS----NPNILVNEML  183 (228)
Q Consensus       131 ~aPE~~~~~~~----------------------~~~~DiwslG~~l~~~~~g~~-p~~~~~~~~~~----~~~~~~~~~~  183 (228)
                      +|||.+.....                      ..+.|+||+||++|+|++|.. |+.........    .......+..
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~  456 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY  456 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence            99998754321                      124699999999999999876 65432211110    0000001111


Q ss_pred             CCCCCCCchhhhhhHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 040501          184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNP---ESRPNMQTICQ  224 (228)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rpt~~~il~  224 (228)
                      .......+ .....+....+++.+||..+|   .+|+|++++++
T Consensus       457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111111 233456678999999999766   68999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-31  Score=189.34  Aligned_cols=216  Identities=24%  Similarity=0.319  Sum_probs=157.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+++.+|+++|..++|.|++..+++....     ..+|++.|.+. .+|...|-.   ...++...+.-+++|++.||+|
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKY  171 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKY  171 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHH
Confidence            46789999999999999999999887543     25678888774 467666643   3347778888899999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCC-cccchhhhhHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLA  154 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l  154 (228)
                      ||+.   ||.||||||.|.+++.+..+||+|||+++....+... .+...-|..|+|||.+.|.. |+.+.||||.||++
T Consensus       172 LHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF  248 (449)
T KOG0664|consen  172 LHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF  248 (449)
T ss_pred             Hhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence            9999   9999999999999999999999999999876544332 34455688999999998875 89999999999999


Q ss_pred             HHHHhCCCCccccccccCCC-----------------chhhhhhhcCCCC--CCCch-----hhhhhHHHHHHHHHHhhc
Q 040501          155 LEVIKGKHPRDFLSNVSSSN-----------------PNILVNEMLDPRL--PPLSV-----DIRGKVISIMEVAFLCLD  210 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~  210 (228)
                      .|++..+..|+..+.....+                 .......+++...  +....     ......-+-..+..+++.
T Consensus       249 aELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~  328 (449)
T KOG0664|consen  249 AELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLH  328 (449)
T ss_pred             HHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhC
Confidence            99998888775433221100                 0011112222211  11100     000112235678888999


Q ss_pred             cCCCCCCCHHHHHH
Q 040501          211 NNPESRPNMQTICQ  224 (228)
Q Consensus       211 ~~p~~Rpt~~~il~  224 (228)
                      ++|..|.+..+.+.
T Consensus       329 ~d~dkris~~~A~~  342 (449)
T KOG0664|consen  329 FDPDKRISVEEALQ  342 (449)
T ss_pred             CCCcccccHhhhcc
Confidence            99999999888764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=188.51  Aligned_cols=91  Identities=29%  Similarity=0.535  Sum_probs=78.5

Q ss_pred             HHHHHHHHHHhccC-C-------Cccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR-H-------RNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGI   70 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h-------~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l   70 (228)
                      +....||++|++++ +       .+||++++.|..    +.++++|+|++ |.+|..+|...... .++...+.++++||
T Consensus       119 EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qv  196 (590)
T KOG1290|consen  119 EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQV  196 (590)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHH
Confidence            46688999999984 2       489999999964    56999999999 55777777765543 38999999999999


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEE
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLL   97 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~   97 (228)
                      +.||.|||..|  ||+|.||||+|||+
T Consensus       197 L~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  197 LTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHHHHhc--CccccCCCcceeee
Confidence            99999999998  99999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7e-30  Score=202.92  Aligned_cols=210  Identities=28%  Similarity=0.394  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +-++.|+-+++..+|+||+.+++.+......||.||||.||+|.+...-.+.   +++.++..+++..+.+++|||+.  
T Consensus        57 ~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~--  131 (829)
T KOG0576|consen   57 SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQ--  131 (829)
T ss_pred             cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcC--
Confidence            3456788899999999999999999999999999999999999998765443   88899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |=+|||||-.||++++.|.+|+.|||.+..++..-.....+.|++.|+|||+..   ...|...+|||++|+...++-.
T Consensus       132 -gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e  210 (829)
T KOG0576|consen  132 -GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE  210 (829)
T ss_pred             -CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence             999999999999999999999999999988877767778899999999999764   4457889999999999999988


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .++|-...      .+.....-+-.... ++.-.+...-...+.++++.+|-+||++|||+..++.
T Consensus       211 Lqpplfdl------hpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  211 LQPPLFDL------HPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCccccc------chHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            88884322      22222222211111 2222222344556889999999999999999987653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=179.75  Aligned_cols=202  Identities=22%  Similarity=0.362  Sum_probs=156.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeee-eeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGF-CTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++|.+|...--.| .|.||+..++. |+..+.+++++|+++-|+|.+-+...+    +.+.....++.|+++||.|||+.
T Consensus        65 ~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk  140 (378)
T KOG1345|consen   65 ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK  140 (378)
T ss_pred             HHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc
Confidence            5688888877777 58999998876 456667789999999999988876533    77788889999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcC--CCceEEeecccccccCCCCCCceecccccceeCCcccccC-----CcccchhhhhHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDL--EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-----KVTAKCDVYSFGVL  153 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~  153 (228)
                         +++|||||.+||++-.  .-++|++|||.+...+.....   ......|.+||.....     .....+|+|+||++
T Consensus       141 ---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi  214 (378)
T KOG1345|consen  141 ---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII  214 (378)
T ss_pred             ---chhhcccccceEEEecCCccEEEeeecccccccCceehh---hhhhcccCCcHHHhhccccceEecccccchheeee
Confidence               9999999999999943  358999999998875533222   2233457888865322     24568999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      +|.+++|..||+.....+  ..............+..+......++.+..+.++-|..+|++|
T Consensus       215 ~f~cltG~~PWQka~~~d--~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  215 FFYCLTGKFPWQKASIMD--KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             eeeeecCCCcchhhhccC--chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence            999999999998443322  2233344445555566666667777888999999999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=6.5e-27  Score=172.55  Aligned_cols=159  Identities=36%  Similarity=0.572  Sum_probs=138.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++.++.++|+|++++++++......++++|++.+++|.+++......  ++...++.++.+++.++.+||+. 
T Consensus        41 ~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~-  117 (225)
T smart00221       41 REEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL-  117 (225)
T ss_pred             HHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC-
Confidence            457889999999999999999999999889999999999999999998764322  68889999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCC-CCceecccccceeCCccc-ccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-SNWTEFAGTYGYVAPELA-YTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        +++|+|++|.||+++.++.++|+|||.+....... .......+...|++||.+ ....++.++|+|+||++++++++
T Consensus       118 --~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~  195 (225)
T smart00221      118 --GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW  195 (225)
T ss_pred             --CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH
Confidence              99999999999999999999999999888765432 112234567789999988 56667789999999999999999


Q ss_pred             CCCCcc
Q 040501          160 GKHPRD  165 (228)
Q Consensus       160 g~~p~~  165 (228)
                      |+.||.
T Consensus       196 g~~pf~  201 (225)
T smart00221      196 GPEPFS  201 (225)
T ss_pred             CCCCcc
Confidence            999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.5e-26  Score=175.32  Aligned_cols=154  Identities=27%  Similarity=0.421  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++..|+++|..+ -+.||+++.+.+..++...+|+||+++....++...      ++...+..+++.++.||+++|+. 
T Consensus        79 ~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~-  151 (418)
T KOG1167|consen   79 SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN-  151 (418)
T ss_pred             hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc-
Confidence            4578999999999 599999999999999999999999999998888753      67788999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC-CceEEeecccccccCCCC--------------C----------------C----------
Q 040501           82 IPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDS--------------S----------------N----------  120 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~--------------~----------------~----------  120 (228)
                        ||+||||||+|++++.. +.-.|+|||++.......              .                .          
T Consensus       152 --GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~  229 (418)
T KOG1167|consen  152 --GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDG  229 (418)
T ss_pred             --CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCC
Confidence              99999999999999865 677899999998211000              0                0          


Q ss_pred             ----ceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCCCCcc
Q 040501          121 ----WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus       121 ----~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                          .....||+.|+|||++..-+ .+++.||||.|+++..++++..||.
T Consensus       230 r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  230 RPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence                01135789999999987654 5789999999999999999999974

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.2e-27  Score=194.23  Aligned_cols=212  Identities=18%  Similarity=0.230  Sum_probs=164.3

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      +..|+-+-..++|+|++..+..+.+....+-.||||+. +|..++....   .+....+-.++.|++.|++|+|+.   |
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---G  440 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---G  440 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---C
Confidence            44566667778999999888888776666666999998 9999887652   277788899999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCCccc-chhhhhHHHHHHHHHh
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIK  159 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~~~~  159 (228)
                      +.|||+|++|+++..+|.+||+|||.+.........    .....|+..|+|||.+.+..|.. ..||||.|+++..|.+
T Consensus       441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~  520 (601)
T KOG0590|consen  441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL  520 (601)
T ss_pred             ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence            999999999999999999999999988765433322    44578899999999999999876 5899999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+.||.................. ..........+...+.....+|.+||+.+|.+|.|+++|++
T Consensus       521 ~~~~Wk~a~~~~~~~~~~~~~~~-~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  521 GRFPWKVAKKSDNSFKTNNYSDQ-RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             CCCccccccccccchhhhccccc-cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            99999765443322100000000 01111112224455667789999999999999999999986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2e-23  Score=161.93  Aligned_cols=214  Identities=20%  Similarity=0.229  Sum_probs=161.5

Q ss_pred             HHHHHHHHHhccC----CCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            4 EFLREITVLTEIR----HRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         4 ~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      .+..|..++..+.    ..++..+++.+ .....-|+||+.+ |.+|.++..... ...++..+++.++.|++.+|.++|
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH  139 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH  139 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH
Confidence            4678999999986    26999999999 5777889999977 779999887665 456999999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCC-----CceEEeeccccc--ccCCCCC-----C---ceecccccceeCCcccccCCccc
Q 040501           79 HDCIPPIVHRDISSKNVLLDLE-----YEAHVSDFGIAK--FIQPDSS-----N---WTEFAGTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~-----~~~~l~df~~~~--~~~~~~~-----~---~~~~~~~~~y~aPE~~~~~~~~~  143 (228)
                      +.   |++||||||+|++++..     ..+.+.|||+++  .......     .   .....||..|.++.+..+...+.
T Consensus       140 ~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r  216 (322)
T KOG1164|consen  140 SK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR  216 (322)
T ss_pred             hc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC
Confidence            99   99999999999999865     468999999998  3211111     1   12345899999999999999999


Q ss_pred             chhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      +.|+||++.++.+++.|..||........   ...............  .....+.++.++...+-..+..++|.+..+.
T Consensus       217 ~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~  291 (322)
T KOG1164|consen  217 RDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA  291 (322)
T ss_pred             chhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence            99999999999999999999865432211   111111111111100  1122344566666666678999999999998


Q ss_pred             HHhh
Q 040501          224 QLLC  227 (228)
Q Consensus       224 ~~l~  227 (228)
                      +.|+
T Consensus       292 ~~l~  295 (322)
T KOG1164|consen  292 ELLK  295 (322)
T ss_pred             HHHH
Confidence            8764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4e-23  Score=152.97  Aligned_cols=216  Identities=18%  Similarity=0.243  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++..|...++.| ..++|..++-+..++.+-.+|+|.+ |-+|.|++.-++..  ++..++..++.|++.-+.++|++ 
T Consensus        68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k-  143 (449)
T KOG1165|consen   68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEK-  143 (449)
T ss_pred             chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhc-
Confidence            3567899999999 5799999999999988888999988 67899988776654  99999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC-----CceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhh
Q 040501           82 IPPIVHRDISSKNVLLDLE-----YEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~-----~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                        .++.|||||+|+||...     +.+.++|||+++...++...       .....||.+||+-....+..-|.+.|+-|
T Consensus       144 --~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEa  221 (449)
T KOG1165|consen  144 --DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEA  221 (449)
T ss_pred             --ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHH
Confidence              99999999999999754     45899999999977655443       34567899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||-++.+++-|..||+...........+.+.+.  .+..+......+++.++..-+.-.-+.+-.+-|+++-+...+
T Consensus       222 LGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~--Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  222 LGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET--KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             hhhhhhhhccCCCccccccCcchHHHHHHhccc--cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            999999999999999876554333222222222  333445555678888998988888888999999998777665

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-23  Score=165.12  Aligned_cols=208  Identities=26%  Similarity=0.468  Sum_probs=160.4

Q ss_pred             HhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe-eecCC
Q 040501           12 LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI-VHRDI   90 (228)
Q Consensus        12 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i-~h~di   90 (228)
                      |+.+.|.|+.++++.+..+...++|.++|..|+|.|.+....  ..+++.....+.++++.|+.|+|+.   .+ +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            467899999999999999999999999999999999998633  3378888889999999999999998   54 99999


Q ss_pred             CCCceEEcCCCceEEeecccccccCC--CCCCceecccccceeCCcccccCC-------cccchhhhhHHHHHHHHHhCC
Q 040501           91 SSKNVLLDLEYEAHVSDFGIAKFIQP--DSSNWTEFAGTYGYVAPELAYTMK-------VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        91 ~p~nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~~l~~~~~g~  161 (228)
                      +..|++++....+|++|||+......  ............-|.|||.+....       .+.+.|+||+|++++++++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999887642  111122223455699999887642       355799999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcC-CC---CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLD-PR---LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      .||+........  .+....+.+ +.   .|..... ....+++..++..||..+|.+||+++.+...++
T Consensus       156 ~~~~~~~~~~~~--~eii~~~~~~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILRVKKGGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             CccccccccCCh--HHHHHHHHhcCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            998764433322  333333222 11   1222211 155557999999999999999999999987764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-24  Score=154.40  Aligned_cols=209  Identities=25%  Similarity=0.418  Sum_probs=161.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      +|..|.-.|+.+.||||+++++.|.....+.++..|++-++|+..+....+ -.++..++.+++.+++.|++|||+..  
T Consensus       233 dfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--  309 (448)
T KOG0195|consen  233 DFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--  309 (448)
T ss_pred             hhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--
Confidence            578899999999999999999999999999999999999999999986543 33678899999999999999999984  


Q ss_pred             Ceeec-CCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc---ccchhhhhHHHHHHHHHh
Q 040501           84 PIVHR-DISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV---TAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        84 ~i~h~-di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~~~~  159 (228)
                      .++-+ -++...++++++-+.+|. .+-+++.-..    ....-.|.|++||.+...+-   -.++|+|||++++||+.+
T Consensus       310 p~ipr~~lns~hvmidedltaris-mad~kfsfqe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t  384 (448)
T KOG0195|consen  310 PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT  384 (448)
T ss_pred             hhhhhhhcccceEEecchhhhhee-cccceeeeec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence            45444 689999999998777663 2212211111    11233578999999877653   357999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ...||...........  ..-+-++...|+      +.+..+..++.-|++.||.+||.++.++-.|+|
T Consensus       385 revpfadlspmecgmk--ialeglrv~ipp------gis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  385 REVPFADLSPMECGMK--IALEGLRVHIPP------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cccccccCCchhhhhh--hhhccccccCCC------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            9999876655443222  222333344443      556678899999999999999999999988875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=7.8e-22  Score=153.35  Aligned_cols=218  Identities=30%  Similarity=0.455  Sum_probs=164.3

Q ss_pred             hHHHHHHHHHHhccCCC-ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ...+.+|+.++..+.|+ +++++.+.+......+++++++.++++.+++........+.......++.|++.++.++|+.
T Consensus        41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~  120 (384)
T COG0515          41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK  120 (384)
T ss_pred             HHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            35688999999999887 79999999987777899999999999997766543212478899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCC------CceecccccceeCCccccc---CCcccchhhhhH
Q 040501           81 CIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSS------NWTEFAGTYGYVAPELAYT---MKVTAKCDVYSF  150 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  150 (228)
                         +++|||+||+||+++..+ .++++|||.+........      ......++..|++||.+.+   ...+...|+|++
T Consensus       121 ---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~  197 (384)
T COG0515         121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL  197 (384)
T ss_pred             ---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence               999999999999999988 799999999875543332      2355678999999999887   467889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhh-----hhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDI-----RGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+++++++.|..||......  .........+.....+......     ......+.+++..++..+|..|.+..+...
T Consensus       198 g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         198 GITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            99999999999996543321  0011111111111111000000     111246789999999999999998876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4e-23  Score=146.82  Aligned_cols=214  Identities=20%  Similarity=0.281  Sum_probs=172.2

Q ss_pred             HHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|..+++.|+ ..+|+.+..++.+...-.+||+.+ |-+|.+++.-+...  +++.+++.++-|++.-++|+|.+  
T Consensus        56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r--  130 (341)
T KOG1163|consen   56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLR--  130 (341)
T ss_pred             chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhh--
Confidence            4567999999996 488888889999998999999988 67999998765544  89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           83 PPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                       +++||||||+|++..-+   +.+.++|||+++..-+....       .....||.+|.+-....+..-+.+.|+-|+|.
T Consensus       131 -~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgY  209 (341)
T KOG1163|consen  131 -NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGY  209 (341)
T ss_pred             -ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcc
Confidence             99999999999999754   56899999999876543322       33467899999988887777889999999999


Q ss_pred             HHHHHHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          153 LALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ++.++--|..||+.....+.....   +.+...+. .+......+++.++.-.+.-|-...-.+-|+..-+.+.+
T Consensus       210 vLmYfnrG~LPWQglka~tk~QKy---EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  210 VLMYFNRGSLPWQGLKAATKKQKY---EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             eeeeeecCCCcccccchhhHHHHH---HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            999999999999876554433222   22322232 233444678888999999999999999999988777655

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-21  Score=148.89  Aligned_cols=194  Identities=22%  Similarity=0.316  Sum_probs=137.5

Q ss_pred             CCCccceeeeeeee---------------------------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 040501           16 RHRNIVKFYGFCTH---------------------------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIK   68 (228)
Q Consensus        16 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~   68 (228)
                      +|||||.++..|.+                           ...+|+||..++. +|..++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            69999999887742                           3468999998865 8888886543    45566677899


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEc--CCC--ceEEeecccccccCCCC------CCceecccccceeCCccccc
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLD--LEY--EAHVSDFGIAKFIQPDS------SNWTEFAGTYGYVAPELAYT  138 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~--~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~  138 (228)
                      |+++|+.|||++   |+.|||+|.+||++.  +|+  .+.+.|||.+---....      .......|+-.-+|||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   999999999999994  343  35788999775322211      01122456778899998764


Q ss_pred             CC------cccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          139 MK------VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       139 ~~------~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      ..      .-.++|.|+.|.+.||++....||-.-.+..-...     ..-...+|..+   ..++..+.+++...|+.|
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-----~Yqe~qLPalp---~~vpp~~rqlV~~lL~r~  497 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-----TYQESQLPALP---SRVPPVARQLVFDLLKRD  497 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-----hhhhhhCCCCc---ccCChHHHHHHHHHhcCC
Confidence            32      12489999999999999999999854222211111     12222333333   245566889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 040501          213 PESRPNMQTICQL  225 (228)
Q Consensus       213 p~~Rpt~~~il~~  225 (228)
                      |++|++..-..+.
T Consensus       498 pskRvsp~iAANv  510 (598)
T KOG4158|consen  498 PSKRVSPNIAANV  510 (598)
T ss_pred             ccccCCccHHHhH
Confidence            9999997544443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=170.42  Aligned_cols=197  Identities=20%  Similarity=0.263  Sum_probs=144.6

Q ss_pred             HHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 040501            7 REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIV   86 (228)
Q Consensus         7 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~   86 (228)
                      .|++ ....++||.+++.-.-..+...|+|-+|..+ +|.|++...+-   +...+...++.|++.||+.+|..   ||+
T Consensus        71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVc  142 (1431)
T KOG1240|consen   71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVC  142 (1431)
T ss_pred             HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---Ccc
Confidence            3444 4445899999998887778888899898865 88888876543   66777778999999999999999   999


Q ss_pred             ecCCCCCceEEcCCCceEEeecccccccCCCCC---Cc----eecccccceeCCcccccC----------C-cccchhhh
Q 040501           87 HRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NW----TEFAGTYGYVAPELAYTM----------K-VTAKCDVY  148 (228)
Q Consensus        87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~----~~~~~~~~y~aPE~~~~~----------~-~~~~~Diw  148 (228)
                      |||||.+|||++.=+=+.|+||..-+..--+..   ..    .+...-.+|.|||-+...          . .+.+-|||
T Consensus       143 HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIF  222 (1431)
T KOG1240|consen  143 HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIF  222 (1431)
T ss_pred             ccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhh
Confidence            999999999999877788999986654321111   11    122334689999966431          1 45788999


Q ss_pred             hHHHHHHHHHh-CCCCcccccc-----ccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          149 SFGVLALEVIK-GKHPRDFLSN-----VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       149 slG~~l~~~~~-g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      |+||++.|+++ |.++|....-     ....+.....+.+.+.              .+..+|..|++.||..|.++++.
T Consensus       223 S~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedy  288 (1431)
T KOG1240|consen  223 SAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDY  288 (1431)
T ss_pred             hhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHH
Confidence            99999999987 7888753211     1122233333333222              36799999999999999999999


Q ss_pred             HHH
Q 040501          223 CQL  225 (228)
Q Consensus       223 l~~  225 (228)
                      |+.
T Consensus       289 L~~  291 (1431)
T KOG1240|consen  289 LQK  291 (1431)
T ss_pred             HHh
Confidence            874

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.87  E-value=5.9e-23  Score=160.29  Aligned_cols=172  Identities=22%  Similarity=0.361  Sum_probs=136.4

Q ss_pred             eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccc
Q 040501           32 HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA  111 (228)
Q Consensus        32 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~  111 (228)
                      .+||.|++|...+|.+|+.+.......++.....++.|++.++.|   +   +.+|+|+||.||++..+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999876666678889999999999999999   6   9999999999999999999999999998


Q ss_pred             cccCCCCC------CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcC
Q 040501          112 KFIQPDSS------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLD  184 (228)
Q Consensus       112 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~  184 (228)
                      +.......      ..+...|+..|++||.+.+..|+.++||||||++++|++. -..++.         .......+-+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d~r~  474 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTDIRD  474 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhhhhc
Confidence            87654441      2456789999999999999999999999999999999986 222321         2223334444


Q ss_pred             CCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          185 PRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      +.+++..  ..+++. -+.|+.+++.+.|.+||++.+
T Consensus       475 g~ip~~~--~~d~p~-e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  475 GIIPPEF--LQDYPE-EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CCCChHH--hhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence            4544221  122332 358999999999999995544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=3.5e-22  Score=149.18  Aligned_cols=162  Identities=21%  Similarity=0.280  Sum_probs=105.9

Q ss_pred             EEEEEeecCCChhhhhhc---C-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecc
Q 040501           34 FLVYEYLENGSLSVILNN---D-TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG  109 (228)
Q Consensus        34 ~lv~e~~~~~~L~~~~~~---~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~  109 (228)
                      +++|+-+ .++|.+++..   . ...........+.+..|++..+++||+.   |++|+||+|+|++++.+|.++|+||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChH
Confidence            6677866 4577776542   1 1122244555567779999999999999   99999999999999999999999998


Q ss_pred             cccccCCCCCCceecccccceeCCcccccC--------CcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhh
Q 040501          110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTM--------KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE  181 (228)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~  181 (228)
                      .....+..   ......+..|.|||.....        .++.+.|.|+||+++|.++++..||+..........      
T Consensus       191 ~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------  261 (288)
T PF14531_consen  191 SLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------  261 (288)
T ss_dssp             GEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------
T ss_pred             HHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------
Confidence            77654421   1113345678899865432        367789999999999999999999875543322211      


Q ss_pred             hcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                             ... .+.+.++.+..||.++|++||.+|
T Consensus       262 -------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 -------DFS-RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             -------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence                   111 122677789999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=9.2e-22  Score=156.53  Aligned_cols=188  Identities=27%  Similarity=0.331  Sum_probs=154.4

Q ss_pred             HHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            6 LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         6 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ..|-.++..++ ||.++++...|+.+...++++++..|+.+...+.....   +.+.....+...++-++.++|+.   +
T Consensus        44 ~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~  117 (612)
T KOG0603|consen   44 KQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---G  117 (612)
T ss_pred             ccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---H
Confidence            34677788885 99999999999999999999999999988877654433   67777778889999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCc
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPR  164 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~  164 (228)
                      ++++|+|++||+++.+|.+++.|||+++..-.....    +|+..|+|||++.  ....++|.||+|+++++|++|..||
T Consensus       118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf  191 (612)
T KOG0603|consen  118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF  191 (612)
T ss_pred             HHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence            999999999999999999999999999865433322    8899999999987  5677899999999999999999998


Q ss_pred             cccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      ..          +....+....+..    .........+++.+++..+|..|.-.
T Consensus       192 ~~----------~~~~~Il~~~~~~----p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  192 GG----------DTMKRILKAELEM----PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ch----------HHHHHHhhhccCC----chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            64          3344444433322    23555677899999999999999554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.4e-20  Score=146.27  Aligned_cols=122  Identities=23%  Similarity=0.232  Sum_probs=94.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++|+|+++.+..   ....|+||||+.|++|... .  .    ..   ...++.+++++|.+||+. 
T Consensus        65 ~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~-  130 (365)
T PRK09188         65 RHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRA-  130 (365)
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHC-
Confidence            3568999999999999999853322   2457999999999999632 1  1    11   135788999999999999 


Q ss_pred             CCCeeecCC-CCCceEEcCCCceEEeecccccccCCCCCC--------ceecccccceeCCcccccC
Q 040501           82 IPPIVHRDI-SSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--------WTEFAGTYGYVAPELAYTM  139 (228)
Q Consensus        82 ~~~i~h~di-~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~  139 (228)
                        |++|||| ||+||+++.++.++|+|||++.........        .....+++.|.+||.+...
T Consensus       131 --gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        131 --GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             --CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence              9999999 999999999999999999999876543321        1234567778999987643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3.1e-20  Score=132.28  Aligned_cols=146  Identities=14%  Similarity=0.104  Sum_probs=108.3

Q ss_pred             HHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|+++|++|. |+++++++++    ...+++|+|+.|.+|......          ....++.|++.+|.++|+.  
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~--  110 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC--  110 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC--
Confidence            5789999999995 5889999886    346899999999888654311          1134778999999999999  


Q ss_pred             CCeeecCC-CCCceEEcCCCceEEeecccccccCCCCCC----c---------eecccccceeCCcccccC-Ccc-cchh
Q 040501           83 PPIVHRDI-SSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----W---------TEFAGTYGYVAPELAYTM-KVT-AKCD  146 (228)
Q Consensus        83 ~~i~h~di-~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~---------~~~~~~~~y~aPE~~~~~-~~~-~~~D  146 (228)
                       |++|||| ||+||+++.+|.++|+|||++.........    .         .....++.+++|+...-. ..+ ...+
T Consensus       111 -GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~  189 (218)
T PRK12274        111 -GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIREL  189 (218)
T ss_pred             -cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHH
Confidence             9999999 799999999999999999999865433311    0         001124455555532221 223 4567


Q ss_pred             hhhHHHHHHHHHhCCCCccc
Q 040501          147 VYSFGVLALEVIKGKHPRDF  166 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~  166 (228)
                      .++.|+.+|.++|+..+.-.
T Consensus       190 w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        190 WFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHhcchHHHHHhccCCccc
Confidence            88999999999999998543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.8e-20  Score=136.12  Aligned_cols=128  Identities=15%  Similarity=0.202  Sum_probs=98.8

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeec--------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHA--------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|++.+.++.|++|..+.+++...        ...+++|||++|.+|.++..       ++.    ....+++.++.
T Consensus        81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~  149 (232)
T PRK10359         81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIE  149 (232)
T ss_pred             HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHH
Confidence            368999999999999999999886533        35889999999999987632       222    24569999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      .+|+.   |++|+|++|+||+++.+| ++++|||...........            ........+..++|+|+||+++.
T Consensus       150 ~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~  213 (232)
T PRK10359        150 SLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLL  213 (232)
T ss_pred             HHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeeh
Confidence            99999   999999999999999988 999999987644211110            00233334667899999999876


Q ss_pred             HHH
Q 040501          156 EVI  158 (228)
Q Consensus       156 ~~~  158 (228)
                      .+.
T Consensus       214 ~~~  216 (232)
T PRK10359        214 IYK  216 (232)
T ss_pred             HHH
Confidence            553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=2.4e-18  Score=123.37  Aligned_cols=101  Identities=17%  Similarity=0.158  Sum_probs=79.5

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCC
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPP   84 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~~~~   84 (228)
                      ..|++.+.++.++++.....+.. . ..++||||++|+++.......   ..++...+..++.|++.+|.++ |+.   |
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---g  138 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---R  138 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence            45999999998887744433222 2 238999999987765543222   2378899999999999999999 788   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      ++||||||+||+++ ++.++|+|||++....
T Consensus       139 iiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         139 LVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             cccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            99999999999998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=1.1e-18  Score=146.21  Aligned_cols=139  Identities=23%  Similarity=0.294  Sum_probs=109.9

Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---------------ceecccccceeCCc
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---------------WTEFAGTYGYVAPE  134 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------~~~~~~~~~y~aPE  134 (228)
                      ++.+++|+|+.   ||+|||+||+|.+++.-|.+|++|||+++........               ....+|++.|.|||
T Consensus       152 mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            37889999999   9999999999999999999999999998865432111               23458999999999


Q ss_pred             ccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          135 LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       135 ~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ++....|...+|.|++|+++|+++.|..||..      ..+.+.+...+.-....... -...+.+..+++.++|+.+|.
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffG------dtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~  301 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG------DTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPL  301 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccC------CCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChH
Confidence            99999999999999999999999999999753      33444444444433322222 234556789999999999999


Q ss_pred             CCCC
Q 040501          215 SRPN  218 (228)
Q Consensus       215 ~Rpt  218 (228)
                      .|.-
T Consensus       302 ~Rlg  305 (1205)
T KOG0606|consen  302 CRLG  305 (1205)
T ss_pred             hhcc
Confidence            9943

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=2e-17  Score=118.88  Aligned_cols=101  Identities=16%  Similarity=0.185  Sum_probs=80.8

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI-LNNDTSAEELGWSRRINVIKGIAHALSYLHH-DCI   82 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~   82 (228)
                      +.+|++.+.++.|+++.....+...  ..|+||||++|+++... +..    ..++...+..++.|++.++.++|+ .  
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--  137 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA--  137 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            4679999999999887544443332  24899999988755433 322    226778889999999999999999 8  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                       |++|+||||+||+++ ++.++|+|||++....
T Consensus       138 -givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         138 -GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence             999999999999999 8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.3e-17  Score=119.38  Aligned_cols=101  Identities=17%  Similarity=0.215  Sum_probs=80.2

Q ss_pred             hHHHHHHHHHHhcc-----CCCccceeeeeeeecC---e-EEEEEEe--ecCCChhhhhhcCCCCCCCCHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-----RHRNIVKFYGFCTHAR---H-SFLVYEY--LENGSLSVILNNDTSAEELGWSRRINVIKGI   70 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l   70 (228)
                      .+.+.+|+++++.+     .||||++++++++++.   . +.+|+||  +.+++|.+++.+..    +++.  ..++.++
T Consensus        40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~  113 (210)
T PRK10345         40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQL  113 (210)
T ss_pred             HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHH
Confidence            45689999999999     5799999999998764   3 3378999  44789999997532    4444  3457777


Q ss_pred             HHHH-HHhhhCCCCCeeecCCCCCceEEcCC----CceEEeecccc
Q 040501           71 AHAL-SYLHHDCIPPIVHRDISSKNVLLDLE----YEAHVSDFGIA  111 (228)
Q Consensus        71 ~~~l-~~lh~~~~~~i~h~di~p~nil~~~~----~~~~l~df~~~  111 (228)
                      +.++ +|||+.   +|+||||||+||+++..    +.++|+|++.+
T Consensus       114 L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        114 LKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            7777 999999   99999999999999743    37999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=9.7e-18  Score=142.09  Aligned_cols=197  Identities=20%  Similarity=0.144  Sum_probs=142.1

Q ss_pred             HHHhccC---CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 040501           10 TVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIV   86 (228)
Q Consensus        10 ~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~   86 (228)
                      +++.+|+   -+.|..+.......+..++|++|.+.|+|.+++..   .+.+++.-++.+..|++..+.+||..   +||
T Consensus       743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~II  816 (974)
T KOG1166|consen  743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GII  816 (974)
T ss_pred             HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---cee
Confidence            4555665   24455555555667788999999999999999983   34488899999999999999999999   999


Q ss_pred             ecCCCCCceEEcC-------CCceEEeecccccccCCC--CCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           87 HRDISSKNVLLDL-------EYEAHVSDFGIAKFIQPD--SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        87 h~di~p~nil~~~-------~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                      ||||||+|+++..       ..-++|+|||.+-.+..-  ........++..+-.+|+..|..++...|.|.|+.+++.|
T Consensus       817 HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~m  896 (974)
T KOG1166|consen  817 HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVM  896 (974)
T ss_pred             cccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHH
Confidence            9999999999943       245899999998766432  2345667788899999999999999999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +.|+..-...  ....        .....++.   .  -...-+.+++..+|+.|-..=|...++...|+
T Consensus       897 LFG~y~q~~~--g~~~--------~~~~~~~R---y--~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~  951 (974)
T KOG1166|consen  897 LFGKYMEVKN--GSSW--------MVKTNFPR---Y--WKRDMWNKFFDLLLNPDCDTLPNLQELRTELE  951 (974)
T ss_pred             HHHHHHHhcC--Ccce--------eccccchh---h--hhHHHHHHHHHHHhCcCcccchhHHHHHHHHH
Confidence            9988762000  0000        00000000   0  01112456777788855544577777766654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.70  E-value=2.3e-16  Score=127.24  Aligned_cols=147  Identities=20%  Similarity=0.264  Sum_probs=115.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      ...+.++-|+.++||+|+++++.++.....|+|+|.+  ..|..++.+.      ....+..-+.||+.||.+||+.|  
T Consensus        55 ~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~v~~Gl~qIl~AL~FL~~d~--  124 (690)
T KOG1243|consen   55 LAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEEVCLGLFQILAALSFLNDDC--  124 (690)
T ss_pred             HHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHHHHHHHHHHHHHHHHHhccC--
Confidence            4567889999999999999999999999999999988  3666666543      24556667899999999999775  


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                      +++|++++-+.|+++..|.+||++|.++................-.|..|+.+....  -..|.|.|||++++++.|..
T Consensus       125 ~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  125 NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            999999999999999999999999998876543332222223333466666543332  35699999999999999833

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=1.6e-17  Score=123.57  Aligned_cols=198  Identities=23%  Similarity=0.342  Sum_probs=138.8

Q ss_pred             HhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501           12 LTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus        12 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      |.++-|.||++++.|+.+.     .+..++.||+..+++..++++.. ....+......+|+-|++.||.|||+. .+.+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            3445699999999998543     45788999999999999998633 233467777789999999999999995 5689


Q ss_pred             eecCCCCCceEEcCCCceEEeecccccccCCCC-----CCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           86 VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                      +|++++.+.|++..+|.+|++.-.-... ....     .......+.+.|.+||.-.....+.++|||++|....+|..+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999999863221110 0000     001123456789999987666778899999999999999877


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      ..--  .+..+.......+.+.....-...          =..++.+|++..|..||++.+++
T Consensus       279 Eiq~--tnseS~~~~ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  279 EIQS--TNSESKVEVEENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             eecc--CCCcceeehhhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhh
Confidence            6641  122222223333333222211110          13678899999999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.5e-18  Score=141.15  Aligned_cols=207  Identities=23%  Similarity=0.330  Sum_probs=157.4

Q ss_pred             HHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCC
Q 040501            7 REITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-NDTSAEELGWSRRINVIKGIAHALSYLH-HDCIP   83 (228)
Q Consensus         7 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~   83 (228)
                      .|..+-+.+. |.|++.+++.....+..+++.++..|+++.+.+. ...  ...+...+-..+.|+..++.|+| ..   
T Consensus        69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---  143 (601)
T KOG0590|consen   69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---  143 (601)
T ss_pred             ccccccccccccccccccCCccCCCcccccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---
Confidence            3666666675 9999999999999999999999999999998883 322  12555666789999999999999 77   


Q ss_pred             CeeecCCCCCceEEcCCC-ceEEeecccccccCC-CCCC--ceeccc-ccceeCCcccccCC-cccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQP-DSSN--WTEFAG-TYGYVAPELAYTMK-VTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~-~~~~--~~~~~~-~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~  157 (228)
                      ++.|+|++|+|.+++..+ .+++.|||+++.... ....  .....| ++.|.|||...+.. .....|+||.|+++..+
T Consensus       144 ~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~  223 (601)
T KOG0590|consen  144 GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAM  223 (601)
T ss_pred             ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccc
Confidence            999999999999999999 999999999987765 2222  233566 89999999988854 45678999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      ++|..||.................     .......+........+++.+++..+|..|.+.+++.
T Consensus       224 ~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  224 LTGELPWDFPSRKDGRYSSWKSNK-----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccCCCCccccccccccceeecccc-----cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            999999875544332211111111     1111222334455677899999999999999988764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=4.5e-16  Score=113.89  Aligned_cols=100  Identities=22%  Similarity=0.419  Sum_probs=87.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|++++..+.|+++.....++......+++|||++|++|.+++....      . ....++.+++.++.++|+.  
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~--  114 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA--  114 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC--
Confidence            457889999999999998887777777778899999999999999886422      1 6778999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                       |++|+|++|.||+++ ++.++++|||.+..
T Consensus       115 -~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        115 -GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             -CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence             999999999999999 78899999998765

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=1.1e-15  Score=110.94  Aligned_cols=97  Identities=21%  Similarity=0.419  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+++++.++|+++....-++......+++||+++|++|.+.+.....          .++.+++.+|.++|+.  
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~--  109 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND----------ELLREIGRLVGKLHKA--  109 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC--
Confidence            4567899999999888766555555666677899999999999988753210          6889999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                       |++|+|++|.||+++ ++.++++|||.+..
T Consensus       110 -gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       110 -GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             -CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence             999999999999999 78999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=1e-15  Score=126.46  Aligned_cols=96  Identities=21%  Similarity=0.380  Sum_probs=85.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+++++.++|++++....++......++||||+++++|.+++.           ....++.+++.++.+||+.  
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~--  447 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA--  447 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC--
Confidence            467899999999999999888777777777899999999999998874           3457899999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                       |++|||+||+||++ .++.++|+|||++..
T Consensus       448 -giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        448 -GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             -CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence             99999999999999 578899999999875

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=1.8e-15  Score=112.33  Aligned_cols=100  Identities=17%  Similarity=0.281  Sum_probs=80.3

Q ss_pred             HHHHHHHHHHhccCCCcc--ceeeeeeeecC----eEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNI--VKFYGFCTHAR----HSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .++.+|++++..++|++|  ++.+++.....    ..++|+|+++| .+|.+++....    ++..    .+.+++.++.
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~  156 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIA  156 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHH
Confidence            567889999999988775  66776654322    23599999987 68888875421    3433    3578999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      +||+.   ||+|+||||.||+++.++.++|+|||.+..
T Consensus       157 ~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        157 RFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            99999   999999999999999999999999998875

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=1.6e-15  Score=112.37  Aligned_cols=101  Identities=19%  Similarity=0.243  Sum_probs=79.2

Q ss_pred             HHHHHHHHHhccCCC--ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+|++.++++.+.  .++++++.    ...++|||++++.+|........   .....++..++.|++.++.+||+. 
T Consensus        96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-  167 (237)
T smart00090       96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE-  167 (237)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc-
Confidence            356899999999753  34455543    23489999999988866542222   245566778999999999999999 


Q ss_pred             CCC-eeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           82 IPP-IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        82 ~~~-i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                        | ++|+||||+||+++ ++.++++|||.+...+
T Consensus       168 --g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      168 --GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             --CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence              9 99999999999999 8899999999887543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.55  E-value=2.9e-14  Score=103.27  Aligned_cols=96  Identities=18%  Similarity=0.209  Sum_probs=77.3

Q ss_pred             HHHHHHHHHhccCCC--ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            4 EFLREITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+|+.++..+.++  .+++.++.    ...+++|||++|++|......         .....++.+++.++.++|+. 
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~-  144 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH-  144 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC-
Confidence            467899999999776  44444442    345899999999988765321         23457889999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                        |++|+||+|+||+++.++.++|+|||.+....
T Consensus       145 --gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         145 --GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             --CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence              99999999999999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=1.2e-13  Score=95.48  Aligned_cols=101  Identities=20%  Similarity=0.298  Sum_probs=85.4

Q ss_pred             HHHHHHHHHHhccCC--CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ..+.+|+..++.+++  .++++++.++..++..++++|++.+..+..+          +......++.+++++++.+|..
T Consensus        36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~  105 (155)
T cd05120          36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQL  105 (155)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCC
Confidence            468899999999976  5899999988887889999999988766543          3455567889999999999996


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      ...+++|+|++|.||+++..+.++++||+.+..
T Consensus       106 ~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            323799999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.50  E-value=1.6e-12  Score=100.52  Aligned_cols=193  Identities=17%  Similarity=0.237  Sum_probs=136.6

Q ss_pred             CeEEEEEEeecCC-Chhhhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEe
Q 040501           31 RHSFLVYEYLENG-SLSVIL---NNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS  106 (228)
Q Consensus        31 ~~~~lv~e~~~~~-~L~~~~---~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~  106 (228)
                      ....++|+.+++. ....+.   .+..+.+.+++...++.++.++.+.+.||..   |.+-+|++++|+|+++++.+.+.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEE
Confidence            3477888887663 233333   2345556688999999999999999999999   99999999999999999999998


Q ss_pred             ecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHHHhC-CCCccccccccCC-Cchh--
Q 040501          107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEVIKG-KHPRDFLSNVSSS-NPNI--  177 (228)
Q Consensus       107 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~~~g-~~p~~~~~~~~~~-~~~~--  177 (228)
                      |-..-... .+......+.|...|.+||.-.     +..-+..+|.|.||+++++++.| ..||......... ++.+  
T Consensus       160 dsDsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         160 DSDSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             cccceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            75543332 3444456678899999999644     23345679999999999999876 9998655432211 1111  


Q ss_pred             --------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhcc--CCCCCCCHHHHHHHhh
Q 040501          178 --------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN--NPESRPNMQTICQLLC  227 (228)
Q Consensus       178 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--~p~~Rpt~~~il~~l~  227 (228)
                              ...+..-.+.++....+.-.+.++..++.+|+..  ++.-|||++.++..|.
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence                    0011111222334444566777889999999964  4778999999887763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=1.1e-13  Score=110.67  Aligned_cols=203  Identities=26%  Similarity=0.240  Sum_probs=146.8

Q ss_pred             HHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhhhC
Q 040501            6 LREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAH----ALSYLHHD   80 (228)
Q Consensus         6 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~----~l~~lh~~   80 (228)
                      .+|+..-+.+ .|++.++....++..+..++=.|.++ .+|..+......  .++...++..+.+...    |+.++|+.
T Consensus       165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~  241 (524)
T KOG0601|consen  165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN  241 (524)
T ss_pred             cchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC
Confidence            3566666667 48999998888888899999999885 577666654322  2566777777788777    99999999


Q ss_pred             CCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCcee-----cccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTE-----FAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                         +++|.|++|.||+...+ ...+++||++...++........     ..+...|++||...+ .++..+|++++|.++
T Consensus       242 ---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~  317 (524)
T KOG0601|consen  242 ---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVI  317 (524)
T ss_pred             ---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhh
Confidence               99999999999999999 88899999999988766644322     367788999997554 478899999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .+...+..+.-.. ..........      ...+.  ....+...++...+.+|++.+|..|++++.+..
T Consensus       318 l~~~l~~~~~~~g-~~~~W~~~r~------~~ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  318 LEAILGSHLPSVG-KNSSWSQLRQ------GYIPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             HhhHhhcccccCC-CCCCcccccc------ccCch--hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            9988776653211 0011111111      11111  111233345566899999999999999887754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=2.6e-12  Score=89.03  Aligned_cols=98  Identities=23%  Similarity=0.419  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+-.+|+.++.+++-.+|....-++.+.....|+|||+.|..|.+.+...          ...++..+-.-+.-||.. 
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~-  111 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA-  111 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc-
Confidence            345678999999998777777666677777788999999999999888654          135777888889999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                        ||+|+|++++||+++.++ +.++|||++..
T Consensus       112 --givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         112 --GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             --CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence              999999999999998765 89999999875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=9.2e-12  Score=88.85  Aligned_cols=99  Identities=15%  Similarity=0.180  Sum_probs=74.2

Q ss_pred             HHHHHHHHhccCC--CccceeeeeeeecCeEEEEEEeecCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhC
Q 040501            5 FLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRINVIKGIAHALSYL-HHD   80 (228)
Q Consensus         5 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~   80 (228)
                      ..+|++.|+++..  -++++++++    ..-++|||++.+..+.. .+..    ..++..+...+..+++.++..| |+.
T Consensus        73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3489999999953  566777764    45679999997653321 1221    1144456667889999999998 888


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                         |++|+|+++.||++. ++.+.|+||+.+....
T Consensus       145 ---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 ---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence               999999999999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.34  E-value=7.2e-12  Score=89.90  Aligned_cols=97  Identities=21%  Similarity=0.249  Sum_probs=70.3

Q ss_pred             HHHHHHHhccCCC--ccceeeeeeeecCeEEEEEEeecCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 040501            6 LREITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DC   81 (228)
Q Consensus         6 ~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~   81 (228)
                      ..|.+.+..+.+.  .+.++++.    ...+++|||++++++.. .+....    .. ..+..++.+++.++.++|+ . 
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~-  134 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA-  134 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc-
Confidence            3566666666443  34444443    23589999999854321 111110    11 5677899999999999999 8 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                        |++|+||+|+||+++ ++.++++|||.+....
T Consensus       135 --~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         135 --GLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             --CcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence              999999999999999 8899999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=1.4e-12  Score=106.02  Aligned_cols=150  Identities=17%  Similarity=0.245  Sum_probs=103.9

Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ce-----ecccccceeCCcccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WT-----EFAGTYGYVAPELAY  137 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~-----~~~~~~~y~aPE~~~  137 (228)
                      +.+++.|+.++|..  ++++|++|.|++|.++..|.+|+..|+.+.....+...    +.     .......|.+||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34566889999998  69999999999999999999999999987655432221    11     012245699999999


Q ss_pred             cCCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          138 TMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       138 ~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      ....+.++|+||+|+++|.+.. |+.-+...+.........   ..  .... ......+.+.++.+=+.+++..++.-|
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---~~--~~~~-~~~~s~~~p~el~~~l~k~l~~~~~~r  256 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---NL--LNAG-AFGYSNNLPSELRESLKKLLNGDSAVR  256 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---cc--cccc-cccccccCcHHHHHHHHHHhcCCcccC
Confidence            9888899999999999999984 444433221111110000   00  0110 111114667789999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      |++..+..
T Consensus       257 p~~~~l~~  264 (700)
T KOG2137|consen  257 PTLDLLLS  264 (700)
T ss_pred             cchhhhhc
Confidence            98776654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=9.4e-11  Score=81.23  Aligned_cols=109  Identities=17%  Similarity=0.269  Sum_probs=85.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +++-.+|++.|.+++--+|.-..-+|.+...-.|+|||+.| .++.+++........ .......++..+-+.+..||..
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n  132 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN  132 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC
Confidence            56778999999999766776666667666667799999977 478888776544432 2233367889999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCc---eEEeeccccccc
Q 040501           81 CIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFI  114 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~  114 (228)
                         +++|+||+.+||++..++.   +.++|||++...
T Consensus       133 ---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  133 ---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence               9999999999999976643   478999998754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.25  E-value=7.5e-11  Score=88.67  Aligned_cols=106  Identities=23%  Similarity=0.227  Sum_probs=82.1

Q ss_pred             HHHHHHHHHhccCCCcc--ceeeeeeee-----cCeEEEEEEeecCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNI--VKFYGFCTH-----ARHSFLVYEYLENG-SLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|...+.++...+|  ++++.+++.     ....++|+|++++. +|.+++..... ...+......++.+++..+.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHH
Confidence            47899999999964444  444666643     23578999999875 78888754221 22456677789999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcC-------CCceEEeecccccc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDL-------EYEAHVSDFGIAKF  113 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~-------~~~~~l~df~~~~~  113 (228)
                      .||..   |++|+|+++.||+++.       +..+.++||+.+..
T Consensus       153 ~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        153 DMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999   9999999999999975       46789999998753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=3.4e-11  Score=84.97  Aligned_cols=96  Identities=23%  Similarity=0.215  Sum_probs=70.3

Q ss_pred             HHHHHHHHHhccCCCcc-ceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q 040501            4 EFLREITVLTEIRHRNI-VKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC-   81 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-   81 (228)
                      .+.+|+.+++.+.+.++ ++++....  ...++|||+++|.++...-        .   .....+.+++.+++.||+.. 
T Consensus        38 ~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~  104 (170)
T cd05151          38 NRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED--------F---SDPENLEKIAKLLKKLHSSPL  104 (170)
T ss_pred             CHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc--------c---cCHHHHHHHHHHHHHHhCCCC
Confidence            46789999999965444 45555433  3457999999998775430        1   11235678999999999982 


Q ss_pred             -CCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           82 -IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        82 -~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                       ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus       105 ~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         105 PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence             11259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.23  E-value=4.6e-12  Score=107.30  Aligned_cols=191  Identities=22%  Similarity=0.283  Sum_probs=139.6

Q ss_pred             CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceE
Q 040501           17 HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVL   96 (228)
Q Consensus        17 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil   96 (228)
                      +|-++...-.+......+++++++.+++|...++..+.   .+..-+......+..+..+||+.   .+.|+|++|.|.+
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l  936 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLL  936 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchh
Confidence            34444444445556778999999999999998876442   34444555677788999999998   8999999999999


Q ss_pred             EcCCCceEEeecccccccCCC----------C---------------------CCceecccccceeCCcccccCCcccch
Q 040501           97 LDLEYEAHVSDFGIAKFIQPD----------S---------------------SNWTEFAGTYGYVAPELAYTMKVTAKC  145 (228)
Q Consensus        97 ~~~~~~~~l~df~~~~~~~~~----------~---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~  145 (228)
                      ...+|..++.||+.....+..          .                     .......+++.|.+||...+......+
T Consensus       937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen  937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred             hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence            999999999999733322210          0                     001224578899999999999999999


Q ss_pred             hhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          146 DVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       146 DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      |.|+.|+.+++.++|.+||..      ......+..+.....+... .....+....+++...+..+|.+|..+.
T Consensus      1017 d~~~~g~~l~e~l~g~pp~na------~tpq~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNA------ETPQQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhhhhhhhhcCCCCCCC------cchhhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            999999999999999999753      3334445555554443322 2233445677899999999999997765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=1.4e-10  Score=82.41  Aligned_cols=101  Identities=25%  Similarity=0.333  Sum_probs=67.6

Q ss_pred             hHHHHHHHHHHhccCCC--ccceeeeeeeecCeEEEEEEeec--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-
Q 040501            2 KKEFLREITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLE--NGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY-   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~-   76 (228)
                      +.+..+|++.|+++...  ++++++++-    .-.+||||++  |..+..+....     ++......++.+++..+.. 
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHH
Confidence            35678999999999765  566766552    2359999998  65565544322     1123445677788885555 


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      +|..   |++|||+++.||+++.+ .+.++|||.+....
T Consensus       123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHhc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            5788   99999999999999987 89999999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.19  E-value=7.4e-11  Score=95.02  Aligned_cols=104  Identities=21%  Similarity=0.269  Sum_probs=72.3

Q ss_pred             HHHHHHHHHhccC----CCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHh
Q 040501            4 EFLREITVLTEIR----HRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAH-ALSYL   77 (228)
Q Consensus         4 ~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~-~l~~l   77 (228)
                      +|.+|++.+.+++    +.+-+.+-..+ ......++||||++|.+|.+........  .+   ...++..++. .+..+
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQV  273 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHH
Confidence            4667777777763    22222222222 2234568999999999998876532111  22   2345555555 46788


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      |..   |++|+|++|.||+++.+|.++++|||++...+
T Consensus       274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            998   99999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.17  E-value=4.6e-10  Score=81.71  Aligned_cols=107  Identities=22%  Similarity=0.309  Sum_probs=84.7

Q ss_pred             hHHHHHHHHHHhccCCC--ccceeeeeeeec----CeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHR--NIVKFYGFCTHA----RHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +.+..+|...+..+...  .+++++++.+..    ...++|+|.+++ .+|.+++.....   .+......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            34678899999988543  345666766543    356899999987 478888875332   45566778999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCC---ceEEeeccccccc
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFI  114 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~  114 (228)
                      +-||..   |++|+|+++.|||++.++   .+.++||+.+...
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   999999999999999887   7899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=6.2e-11  Score=95.06  Aligned_cols=198  Identities=20%  Similarity=0.258  Sum_probs=140.0

Q ss_pred             HHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            6 LREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         6 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ..|+.+...+ .|.+++.+...+......|+=.|||+++++...+....   -+.+...+.+..|++.++.++|+.   .
T Consensus       313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~---~  386 (524)
T KOG0601|consen  313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSK---L  386 (524)
T ss_pred             hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccch---h
Confidence            3566666666 58999999888888888889999999988776663322   266778889999999999999999   9


Q ss_pred             eeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceeccccccee--CCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           85 IVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYV--APELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        85 i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                      ++|.|++|+||++..+ +..+++||+..+........   ......+.  ++.......+..+.|+++||.-+.+..++.
T Consensus       387 ~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~  463 (524)
T KOG0601|consen  387 FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS  463 (524)
T ss_pred             hhcccccccceeeccchhhhhccccccccccceeccc---ccccccccccchhhccccccccccccccccccccccccCc
Confidence            9999999999999886 66788999988753322211   12222333  444444556778999999999999998876


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ..-...         .....+..+..+...    +....+..+.+.++.+++..||.+.++...
T Consensus       464 ~ls~~~---------~~~~~i~~~~~p~~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  464 PLSESG---------VQSLTIRSGDTPNLP----GLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ccCccc---------ccceeeecccccCCC----chHHhhhhhhhhhcCCccccchhhhhhccc
Confidence            642111         111222222222222    222456778888999999999998876543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.09  E-value=8e-10  Score=90.47  Aligned_cols=101  Identities=15%  Similarity=0.199  Sum_probs=62.6

Q ss_pred             HHHHHHHHhccC----CCccceeeeeee-ecCeEEEEEEeecCCChhhhh--hcCC-CCCCCCHHHHHHHHHHHHHHHHH
Q 040501            5 FLREITVLTEIR----HRNIVKFYGFCT-HARHSFLVYEYLENGSLSVIL--NNDT-SAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         5 ~~~E~~~l~~l~----h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~--~~~~-~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      |.+|+..+.+++    +...+.+-.++. ....-++||||+.|+.+.+.-  ...+ ..+.+....+..++.|+      
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------  276 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------  276 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH------
Confidence            445555555552    333333333332 234567999999999997742  2211 11112223333333443      


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCC----ceEEeecccccccC
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQ  115 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~  115 (228)
                       ...   |++|+|++|.||+++.+|    .++++|||++...+
T Consensus       277 -f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence             456   999999999999999888    99999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=1.4e-09  Score=80.14  Aligned_cols=99  Identities=22%  Similarity=0.238  Sum_probs=76.0

Q ss_pred             hHHHHHHHHHHhccCCC--ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      |....+|.++|++|...  .+++.+++    ++-.+|||++.|..|...-        ++....-.++..++..+...-.
T Consensus       153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~  220 (304)
T COG0478         153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR  220 (304)
T ss_pred             HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH
Confidence            56788999999999654  78888776    4566999999987665432        1223334456666666666667


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      .   |++|+|+++-||+++.+|.+.++||..+...+
T Consensus       221 ~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         221 R---GIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             c---CccccCCchheEEEecCCCEEEEeCcccccCC
Confidence            7   99999999999999999999999999876544

>PRK09902 hypothetical protein; Provisional

Probab=98.99  E-value=5e-09  Score=75.17  Aligned_cols=107  Identities=18%  Similarity=0.197  Sum_probs=82.0

Q ss_pred             hHHHHHHHHHHhccCC--Cccceeeeeee-e----cCeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRH--RNIVKFYGFCT-H----ARHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h--~~i~~~~~~~~-~----~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~   73 (228)
                      +..|.+|+..++++..  -.+++++ ++. .    ....+||+|-+++ .+|.+++..... ...+......++.+++.+
T Consensus        63 ~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~  140 (216)
T PRK09902         63 RPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALA  140 (216)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHH
Confidence            4679999999999953  3355555 332 1    2357899997754 588888765432 235677778899999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCc--eEEeecccccc
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYE--AHVSDFGIAKF  113 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~  113 (228)
                      ++-||+.   |+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       141 ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        141 FKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9999999   9999999999999987777  89999986654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=3e-08  Score=79.11  Aligned_cols=181  Identities=16%  Similarity=0.204  Sum_probs=126.1

Q ss_pred             HHHHHhccCCCccceeeeeee----ecCeEEEEEEeecC-CChhhhhhcCC------------CCCCCCHHHHHHHHHHH
Q 040501            8 EITVLTEIRHRNIVKFYGFCT----HARHSFLVYEYLEN-GSLSVILNNDT------------SAEELGWSRRINVIKGI   70 (228)
Q Consensus         8 E~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~~~~~~------------~~~~~~~~~~~~~~~~l   70 (228)
                      -++.++++.|.|+|++.++|.    .+..+++|++|.++ .+|.++.-...            .....++..+|.++.|+
T Consensus       323 lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QL  402 (655)
T KOG3741|consen  323 LVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQL  402 (655)
T ss_pred             HHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHH
Confidence            478899999999999999986    34578899999875 56766653321            12246789999999999


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhH
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF  150 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  150 (228)
                      ..||.++|+.   |..-+-+.|.+|+++.+.+++|..-|.......+.            .  +-+.+   ..+.|.-.|
T Consensus       403 taaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le~---~Qq~D~~~l  462 (655)
T KOG3741|consen  403 TAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLES---QQQNDLRDL  462 (655)
T ss_pred             HHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchhH---HhhhhHHHH
Confidence            9999999999   99999999999999998889988666554433222            0  11111   236788899


Q ss_pred             HHHHHHHHhCCCCccccccccCCCchhh-hhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNPNIL-VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |.++..+.+|..--.     ........ ...           -...++.++.++|.-....++++ -++.+++..
T Consensus       463 G~ll~aLAt~~~ns~-----~~d~~~~s~~~~-----------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  463 GLLLLALATGTENSN-----RTDSTQSSHLTR-----------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHhhcccccc-----cccchHHHHHHH-----------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999855410     00000001 111           11345667778888888888887 566666543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.92  E-value=1.3e-08  Score=74.81  Aligned_cols=107  Identities=26%  Similarity=0.337  Sum_probs=78.6

Q ss_pred             HHHHHHHHHHhccCC--Cccceeeeeeeec---CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRH--RNIVKFYGFCTHA---RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ..+.+|+++++.+++  ..+++++.+....   ...+++||++.|.++.+.+..    ..++..+...++.+++.++..|
T Consensus        40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~l  115 (223)
T cd05154          40 HDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAAL  115 (223)
T ss_pred             ccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHH
Confidence            457899999999965  3457777776654   267899999999888765421    1245556666677777777777


Q ss_pred             hhCC-----------------------------------------------------CCCeeecCCCCCceEEcC--CCc
Q 040501           78 HHDC-----------------------------------------------------IPPIVHRDISSKNVLLDL--EYE  102 (228)
Q Consensus        78 h~~~-----------------------------------------------------~~~i~h~di~p~nil~~~--~~~  102 (228)
                      |+..                                                     +..++|+|+.|.||+++.  ++.
T Consensus       116 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~  195 (223)
T cd05154         116 HSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRV  195 (223)
T ss_pred             hCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcE
Confidence            6421                                                     235799999999999998  667


Q ss_pred             eEEeecccccc
Q 040501          103 AHVSDFGIAKF  113 (228)
Q Consensus       103 ~~l~df~~~~~  113 (228)
                      +.|+||+.+..
T Consensus       196 ~~iID~e~~~~  206 (223)
T cd05154         196 VAVLDWELATL  206 (223)
T ss_pred             EEEEecccccc
Confidence            89999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.73  E-value=6.8e-08  Score=69.73  Aligned_cols=67  Identities=22%  Similarity=0.286  Sum_probs=52.4

Q ss_pred             CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeeccc
Q 040501           31 RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI  110 (228)
Q Consensus        31 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~  110 (228)
                      ...+++|||++|..|.+...       ++.    .+...+.+++..+|+.   |++|+|.+|.|++++.+ .++++|++.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~  180 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQG  180 (229)
T ss_pred             eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcc
Confidence            35568999999988766532       222    2445677889999999   99999999999999865 489999986


Q ss_pred             cc
Q 040501          111 AK  112 (228)
Q Consensus       111 ~~  112 (228)
                      ..
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2.2e-06  Score=63.32  Aligned_cols=110  Identities=13%  Similarity=0.163  Sum_probs=64.6

Q ss_pred             HHHHHHHHHHhccCCCc--cceeeeeeeecCeEEEEEEeecCCC-hhhhh--------------hc-----CC-CCCCCC
Q 040501            3 KEFLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGS-LSVIL--------------NN-----DT-SAEELG   59 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~~--------------~~-----~~-~~~~~~   59 (228)
                      ....+|.++++.+..-+  +++++.+.......+++||+++|.+ +....              ..     +. .....+
T Consensus        37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~  116 (226)
T TIGR02172        37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTST  116 (226)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            45788999999996433  5778888888888889999999863 11111              10     10 000111


Q ss_pred             HHHHHH-HHH----------HHHH-HHHHhhhC-CCCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           60 WSRRIN-VIK----------GIAH-ALSYLHHD-CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        60 ~~~~~~-~~~----------~l~~-~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      ...... +..          .+.. ...+|.+. ....++|+|+.|.||+++.++ +.++||+.+..
T Consensus       117 l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       117 FQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            111110 000          0111 11222211 122579999999999999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.50  E-value=1.3e-06  Score=62.40  Aligned_cols=105  Identities=21%  Similarity=0.235  Sum_probs=80.2

Q ss_pred             HHHHHHHhccCC-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            6 LREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         6 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ..|.-+++.+++ +++++++|+|-.    +++.|+.+.+++......-...-..++.++.+++.++++.+.+++..-...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999965 799999999953    368899976655322110001112689999999999999999999853336


Q ss_pred             eeecCCCCCceEEcCCCceEEeeccccccc
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~  114 (228)
                      +.-.|++++|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            788899999999999999999999876654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.46  E-value=8.7e-07  Score=77.16  Aligned_cols=194  Identities=19%  Similarity=0.182  Sum_probs=130.5

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCe----EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARH----SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .-|+..+..+.|+|+..++.+..+...    ..+..+++...++.+.+.....   ++..+.+.+..++..|+.++|+. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~-  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSL-  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHh-
Confidence            457777888899999999988755432    2345577888888877765443   78899999999999999999998 


Q ss_pred             CCCeeecCCCCC---ceEEcCCCceEEe--ecccccccCCCCCCceecccccceeCCcccccCCcc--cchhhhhHHHHH
Q 040501           82 IPPIVHRDISSK---NVLLDLEYEAHVS--DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT--AKCDVYSFGVLA  154 (228)
Q Consensus        82 ~~~i~h~di~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~DiwslG~~l  154 (228)
                        ...|.-+..+   +.-.+..+.+.++  ||+.+........ ......+..+.++|........  ...|+|.+|.+.
T Consensus       306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             --ccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence              6666655555   3333445566666  8887766553322 2223344556777766555443  347999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ..+..|..+-..             .......++.....      ...+...+|+..++++|+++.+++..
T Consensus       383 ~~~~~~~~i~~~-------------~~~~~~~l~~~~~~------~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  383 LQLSQGEDISEK-------------SAVPVSLLDVLSTS------ELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhhcCccccc-------------ccchhhhhccccch------hhhhhhhhhcchhhhhccchhhhhhc
Confidence            998877665211             11111111111110      46688899999999999999998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.31  E-value=7.9e-06  Score=61.16  Aligned_cols=109  Identities=13%  Similarity=0.122  Sum_probs=65.8

Q ss_pred             HHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhh-------------------hcCCC-CCCCCH--
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------------------NNDTS-AEELGW--   60 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------------------~~~~~-~~~~~~--   60 (228)
                      .+.+|+++++.+. +--+++++.+.......++||++++|.++....                   +.... ...+..  
T Consensus        37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~  116 (244)
T cd05150          37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRL  116 (244)
T ss_pred             chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhH
Confidence            4678999999983 555677888777666789999999987765432                   00000 000110  


Q ss_pred             HHHHHHHH--------------------HHHHHHHHhhhC----CCCCeeecCCCCCceEEcCCCceEEeeccccc
Q 040501           61 SRRINVIK--------------------GIAHALSYLHHD----CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK  112 (228)
Q Consensus        61 ~~~~~~~~--------------------~l~~~l~~lh~~----~~~~i~h~di~p~nil~~~~~~~~l~df~~~~  112 (228)
                      ........                    .+...+..|-..    .+..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         117 DRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            00000000                    011112222111    12368999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=6.3e-06  Score=60.49  Aligned_cols=100  Identities=19%  Similarity=0.243  Sum_probs=70.2

Q ss_pred             HHHHHHHhccC--CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            6 LREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         6 ~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+|+.-|+++.  +-.+++.+.+..    -.+|||+++...+   -......-.+....+..+..++++.+.-|-..  +
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--A  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--c
Confidence            57888888884  445566666543    3489999965411   11111111123335667788888888888774  2


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      +++|+||+.-||++. ++.+.|+|++.+....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            999999999999999 8899999999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.28  E-value=4.6e-07  Score=74.32  Aligned_cols=148  Identities=22%  Similarity=0.234  Sum_probs=107.8

Q ss_pred             HHHHHHHhccCCCc-cceeeeeeeecCeEEEEEEeecCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            6 LREITVLTEIRHRN-IVKFYGFCTHARHSFLVYEYLENG-SLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         6 ~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .-++++|.+++||| .+..++-++.....++.++++.++ +.....  ..+...+..-+....++.-..+++++|+.   
T Consensus       281 rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~---  355 (829)
T KOG0576|consen  281 RLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS---  355 (829)
T ss_pred             HHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc---
Confidence            45889999999999 777777777778899999998776 222111  11111233444556677777889999987   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      --+|+|    ||+.++ +..+.++|+......... ..+...+++.++|||......+..+.|.|++|.-..++.-|.+|
T Consensus       356 ~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  356 YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            557887    666654 678888998776554332 34556789999999999999999999999999877777777776


Q ss_pred             c
Q 040501          164 R  164 (228)
Q Consensus       164 ~  164 (228)
                      .
T Consensus       430 r  430 (829)
T KOG0576|consen  430 R  430 (829)
T ss_pred             C
Confidence            4

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=2.7e-05  Score=57.92  Aligned_cols=31  Identities=29%  Similarity=0.397  Sum_probs=26.3

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+++|+|+.+.||+++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3689999999999998776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=2.3e-05  Score=64.34  Aligned_cols=105  Identities=18%  Similarity=0.259  Sum_probs=66.5

Q ss_pred             HHHHHHHHHhccC-----CCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            4 EFLREITVLTEIR-----HRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         4 ~~~~E~~~l~~l~-----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ++.+|+..+.+++     .+++ ++=.++ +-...-.++|||+.|..+.+...-....  .+...+...+.++  .+..+
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~--f~~q~  281 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRA--FLRQL  281 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHH--HHHHH
Confidence            3556777766663     2333 222222 2334567999999998888875332221  4433333222221  12233


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCC
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP  116 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~  116 (228)
                      =..   |+.|+|..|.||++..+|++-+.|||+......
T Consensus       282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             Hhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            335   999999999999999999999999999877653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00013  Score=52.54  Aligned_cols=98  Identities=22%  Similarity=0.331  Sum_probs=71.5

Q ss_pred             HHHHHHHHHHhccC------CCccceeeeeeeecCeEEEEEEeecC------CChhhhhhcCCCCCCCCHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR------HRNIVKFYGFCTHARHSFLVYEYLEN------GSLSVILNNDTSAEELGWSRRINVIKGI   70 (228)
Q Consensus         3 ~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~~~~l   70 (228)
                      ++..+|+.....+.      +.+|.+++++.+++....+|+|.+.+      -+|.+++....    ++.    .+...+
T Consensus        56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~----~~~~~L  127 (199)
T PF10707_consen   56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE----ELRQAL  127 (199)
T ss_pred             HHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH----HHHHHH
Confidence            45667777777766      88999999999999999999998743      26777775443    333    344445


Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCC--C--ceEEee-cccc
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLE--Y--EAHVSD-FGIA  111 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~--~--~~~l~d-f~~~  111 (228)
                      -+-..+|-+.   +|+.+|++|.||++...  +  .+.++| ||..
T Consensus       128 ~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  128 DEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            5666777888   99999999999999644  2  466666 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.94  E-value=0.00014  Score=63.79  Aligned_cols=113  Identities=21%  Similarity=0.329  Sum_probs=68.6

Q ss_pred             HHHHHHHHHHhccC-CCcc--ceeeeeeeec---CeEEEEEEeecCCChhhh--------------------hhc-CC-C
Q 040501            3 KEFLREITVLTEIR-HRNI--VKFYGFCTHA---RHSFLVYEYLENGSLSVI--------------------LNN-DT-S   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L~~~--------------------~~~-~~-~   54 (228)
                      ..+.+|+++++.+. |.++  ++++.++.+.   ...|+|||+++|..+.+.                    +.. +. .
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd  162 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSAD  162 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            35789999999995 6655  7778877654   467899999988653211                    100 00 0


Q ss_pred             C---------C--CCCHHHHHHHHHH---------------HHHHHHHhhhCCC--------CCeeecCCCCCceEEcCC
Q 040501           55 A---------E--ELGWSRRINVIKG---------------IAHALSYLHHDCI--------PPIVHRDISSKNVLLDLE  100 (228)
Q Consensus        55 ~---------~--~~~~~~~~~~~~~---------------l~~~l~~lh~~~~--------~~i~h~di~p~nil~~~~  100 (228)
                      .         .  .....++..|..+               +...+.+|....+        ..++|+|+++.|++++.+
T Consensus       163 ~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~  242 (822)
T PLN02876        163 VDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT  242 (822)
T ss_pred             chhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC
Confidence            0         0  0111222222222               2234566644322        259999999999999853


Q ss_pred             -Cc-eEEeecccccccC
Q 040501          101 -YE-AHVSDFGIAKFIQ  115 (228)
Q Consensus       101 -~~-~~l~df~~~~~~~  115 (228)
                       +. .-|+||+.+....
T Consensus       243 ~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        243 EDRVIGILDWELSTLGN  259 (822)
T ss_pred             CCeEEEEEeeeccccCC
Confidence             33 5689999887643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.82  E-value=0.00029  Score=52.05  Aligned_cols=45  Identities=22%  Similarity=0.418  Sum_probs=30.7

Q ss_pred             HHHHHHHHHHhccCCC--ccceeeeeee---ecCeEEEEEEeecCCChhh
Q 040501            3 KEFLREITVLTEIRHR--NIVKFYGFCT---HARHSFLVYEYLENGSLSV   47 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~~~L~~   47 (228)
                      ..+.+|..+++.+...  .+++++....   .....+++|+++.|..+..
T Consensus        35 ~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   35 ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             HHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            4677899999988533  3566666442   3345789999999987776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00016  Score=54.57  Aligned_cols=29  Identities=17%  Similarity=0.222  Sum_probs=25.8

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            689999999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.74  E-value=0.00019  Score=59.03  Aligned_cols=86  Identities=17%  Similarity=0.237  Sum_probs=54.7

Q ss_pred             cceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCCeeecCCCCCceEEc
Q 040501           20 IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY-LHHDCIPPIVHRDISSKNVLLD   98 (228)
Q Consensus        20 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~-lh~~~~~~i~h~di~p~nil~~   98 (228)
                      |++++-.+.  ..-.++|||++|..+.|.-.-..  ..++...   ++..+.++... +=..   |.+|+|-.|.||++.
T Consensus       266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~qIf~~---GffHaDPHPGNilv~  335 (538)
T KOG1235|consen  266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQIFKT---GFFHADPHPGNILVR  335 (538)
T ss_pred             CCeehhhcC--cceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHHHHhc---CCccCCCCCCcEEEe
Confidence            455544333  34569999999987766532111  1144443   33333333222 2233   999999999999998


Q ss_pred             C----CCceEEeecccccccC
Q 040501           99 L----EYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        99 ~----~~~~~l~df~~~~~~~  115 (228)
                      .    ++.+.+.|||+.....
T Consensus       336 ~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  336 PNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCCCCccEEEEccccccccc
Confidence            4    5678999999987655

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.70  E-value=7.6e-05  Score=57.22  Aligned_cols=98  Identities=12%  Similarity=0.128  Sum_probs=72.4

Q ss_pred             hHHHHHHHHHHhccC-C-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIR-H-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      |=+..+|+..|+.|. | =-+++.+++    .+-++|||++.|.+|...-.-      .+.   -.+...++.-|--|..
T Consensus       154 Rlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  154 RLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLAN  220 (465)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHH
Confidence            445678999999994 3 345566655    456789999988877644321      111   2355567777778888


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      .   |++|+|.+-=||++..++.+.++||.......
T Consensus       221 ~---GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  221 H---GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             c---CceecccchheeEEecCCCEEEeechHhhccC
Confidence            8   99999999999999999999999999765544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.59  E-value=6.6e-06  Score=74.08  Aligned_cols=158  Identities=15%  Similarity=0.030  Sum_probs=109.6

Q ss_pred             HHHHHhccCCCccceeeeeee--ecCeEEEEEEeecCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCC-
Q 040501            8 EITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSA-EELGWSRRINVIKGIAHALSYLHHDCIP-   83 (228)
Q Consensus         8 E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~-   83 (228)
                      |..-++...|+++.....-..  ++..-|..++++.+|.+++.+-.+... +..+..-+...-.+......-+|+...- 
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            444444557777766655443  334568889999999999988654322 2233333333333335556666655311 


Q ss_pred             -CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           84 -PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        84 -~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       -.+|+++++.|.++..+-.+++.++|+.+.............+++.|+.|+......++.++|+|..|+.+|....|..
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence             2589999999999999999999999998843333333445567888999998888888888999999999999988888


Q ss_pred             Ccc
Q 040501          163 PRD  165 (228)
Q Consensus       163 p~~  165 (228)
                      +|-
T Consensus      1439 ~fi 1441 (2724)
T KOG1826|consen 1439 YFI 1441 (2724)
T ss_pred             HHH
Confidence            753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.45  E-value=0.00026  Score=51.80  Aligned_cols=30  Identities=27%  Similarity=0.519  Sum_probs=21.4

Q ss_pred             CeeecCCCCCceEE-cCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLL-DLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~-~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57999999999999 8889999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.41  E-value=0.0015  Score=50.60  Aligned_cols=32  Identities=25%  Similarity=0.363  Sum_probs=28.5

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      .++|+|+.+.|++++.++-+-++||+.+....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            47999999999999999889999999987643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.35  E-value=0.0011  Score=46.51  Aligned_cols=96  Identities=16%  Similarity=0.226  Sum_probs=68.0

Q ss_pred             hHHHHHHHHHHhccCCCcc-ceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNI-VKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      |.++..|+++|+.+.-.++ .+++.+..+.    +.|||+.|..|.++....      +.    +-+..+++.---|...
T Consensus        59 r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~  124 (201)
T COG2112          59 RRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLEIGG------DR----KHLLRVLEKAYKLDRL  124 (201)
T ss_pred             hhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhhhcc------cH----HHHHHHHHHHHHHHHh
Confidence            6788999999999976555 4555554443    559999998887765321      11    2334455665567777


Q ss_pred             CCCCeeecCCC-CCceEEcCCCceEEeeccccccc
Q 040501           81 CIPPIVHRDIS-SKNVLLDLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        81 ~~~~i~h~di~-p~nil~~~~~~~~l~df~~~~~~  114 (228)
                         ||-|+.|+ |....+..++.+.|+||..++..
T Consensus       125 ---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         125 ---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             ---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence               99999986 66666666779999999988743

>PRK10593 hypothetical protein; Provisional

Probab=97.31  E-value=0.0037  Score=48.29  Aligned_cols=43  Identities=23%  Similarity=0.241  Sum_probs=33.8

Q ss_pred             HHHHHHHHHHhccC-C--Cccceeeeeeee---cCeEEEEEEeecCCCh
Q 040501            3 KEFLREITVLTEIR-H--RNIVKFYGFCTH---ARHSFLVYEYLENGSL   45 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h--~~i~~~~~~~~~---~~~~~lv~e~~~~~~L   45 (228)
                      ..+.+|.+.++.+. +  -.++++++++..   .+..++|||+++|.++
T Consensus        52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            46889999999994 3  468888987754   3568999999988654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.21  E-value=0.0029  Score=48.77  Aligned_cols=31  Identities=32%  Similarity=0.348  Sum_probs=27.1

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3799999999999999887778999997754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PLN02236 choline kinase

Probab=97.07  E-value=0.0032  Score=49.70  Aligned_cols=30  Identities=20%  Similarity=0.434  Sum_probs=26.3

Q ss_pred             CeeecCCCCCceEEcC-CCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDL-EYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~  113 (228)
                      .++|+|+++.||++++ ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986 46799999998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.96  E-value=0.0016  Score=53.15  Aligned_cols=160  Identities=19%  Similarity=0.243  Sum_probs=88.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++..-+++++.+.|+|...++++-... .+..+|+|+++ .+|.+....+. ....+.         +        .. 
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~---------~--------~~-   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESL---------L--------AH-   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhh---------c--------cc-
Confidence            3566778899999999999999887543 45778999884 58888876543 111000         0        11 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |+.|-     |       .++.+|    ...+..               |-     ....++|||++|.++.++.-|.
T Consensus        87 --~~~~~-----~-------~~~~td----~~~t~~---------------~~-----~~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   87 --GVLHL-----N-------IIYITD----HFLTKY---------------PS-----PIGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             --cccee-----h-------hhhccc----cccccC---------------CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence              22221     1       222223    000000               00     0113999999999999999888


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCC--CCc---hhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLP--PLS---VDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      ..++......   ....+.........  ...   .-.......+.++..+|+-..|..||...+..
T Consensus       129 ~l~~~~~~s~---~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  129 SLEAELTESE---YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHH---HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            7765322111   11111111111110  000   01123344567889999999999999766554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.87  E-value=0.0039  Score=48.93  Aligned_cols=30  Identities=27%  Similarity=0.396  Sum_probs=26.0

Q ss_pred             CeeecCCCCCceEEcC-CCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDL-EYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~  113 (228)
                      -.+|+|+.+.||++++ ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            3799999999999975 47899999998865

>PTZ00384 choline kinase; Provisional

Probab=96.72  E-value=0.009  Score=47.81  Aligned_cols=29  Identities=28%  Similarity=0.235  Sum_probs=24.7

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      ..+|+|+.+.||+.+. +.+.++||..+..
T Consensus       228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            6799999999998764 4699999998764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.64  E-value=0.013  Score=46.30  Aligned_cols=103  Identities=17%  Similarity=0.202  Sum_probs=71.4

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      ...|+.-|++++..+|+-.--+..  ..-.+||+++.....   -......-.++...+..+-.+++.-+.-|-+.|  +
T Consensus       213 AEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~  285 (520)
T KOG2270|consen  213 AEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--R  285 (520)
T ss_pred             HHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--c
Confidence            357888888887766542222222  233589999964332   222222333666677778888888888888876  9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccC
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ  115 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~  115 (228)
                      +||.||+--|+++- +|.+.++|-+.+....
T Consensus       286 LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  286 LVHADLSEFNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             eeccchhhhhheEE-CCEEEEEEccccccCC
Confidence            99999999999996 4689999999876543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.46  E-value=0.019  Score=45.23  Aligned_cols=75  Identities=19%  Similarity=0.324  Sum_probs=56.4

Q ss_pred             cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecc
Q 040501           30 ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG  109 (228)
Q Consensus        30 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~  109 (228)
                      +...|++|++- |+++...       +....+++..++.+.+..+.-+...=  ..-||++...||+++ +|.+-|+||.
T Consensus       298 ~~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            34556677644 3444321       22567888899999888888887752  678999999999999 8999999999


Q ss_pred             cccccC
Q 040501          110 IAKFIQ  115 (228)
Q Consensus       110 ~~~~~~  115 (228)
                      +++...
T Consensus       367 lsRl~~  372 (488)
T COG5072         367 LSRLSY  372 (488)
T ss_pred             eeeccc
Confidence            998544

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.45  E-value=0.0058  Score=45.37  Aligned_cols=30  Identities=20%  Similarity=0.388  Sum_probs=26.7

Q ss_pred             CeeecCCCCCceEEcC-CCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDL-EYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~  113 (228)
                      +++|+|+.+.||+++. ++.+.++||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            7999999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.28  E-value=0.013  Score=45.29  Aligned_cols=32  Identities=25%  Similarity=0.304  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCceEEcCC----CceEEeecccccc
Q 040501           82 IPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKF  113 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~  113 (228)
                      +.+++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            3478999999999999985    8899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.27  E-value=0.032  Score=42.86  Aligned_cols=41  Identities=24%  Similarity=0.345  Sum_probs=27.5

Q ss_pred             HHHHHHHHHHhccC---CCccceeeeeeeecCeEEEEEEeecCC
Q 040501            3 KEFLREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENG   43 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~   43 (228)
                      ..|..|++-|+.|.   .-.+++++.+.......++++||++.+
T Consensus        54 ~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   54 DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            46889999999993   456889999988777889999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.20  E-value=0.0098  Score=46.18  Aligned_cols=31  Identities=32%  Similarity=0.356  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+++|+|+.+.|++++.++...++||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            4899999999999999888778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.09  E-value=0.0048  Score=48.13  Aligned_cols=32  Identities=25%  Similarity=0.255  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      +.+++|+|+.|.||+++.+...-++||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            34899999999999999766668999997753

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=96.01  E-value=0.016  Score=44.10  Aligned_cols=47  Identities=23%  Similarity=0.246  Sum_probs=34.6

Q ss_pred             HHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           66 VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        66 ~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+..+-..+.-.+.. ..-++|+|+.|+|++.++.|.++|+||..+..
T Consensus       137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            444444444444442 01589999999999999999999999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.00  E-value=0.02  Score=44.43  Aligned_cols=28  Identities=32%  Similarity=0.424  Sum_probs=24.9

Q ss_pred             CeeecCCCCCceEEcCCCceEEeeccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAK  112 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~  112 (228)
                      +++|+|+.+.||+++. +.+.++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            8999999999999987 678899999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.82  E-value=0.0081  Score=42.80  Aligned_cols=29  Identities=17%  Similarity=0.179  Sum_probs=25.5

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      ..+|+|+.|.|++++++| ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            459999999999998877 88999998864

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=95.79  E-value=0.033  Score=42.51  Aligned_cols=29  Identities=24%  Similarity=0.430  Sum_probs=24.9

Q ss_pred             eeecCCCCCceEEcCC-CceEEeecccccc
Q 040501           85 IVHRDISSKNVLLDLE-YEAHVSDFGIAKF  113 (228)
Q Consensus        85 i~h~di~p~nil~~~~-~~~~l~df~~~~~  113 (228)
                      .+|+||=..||++++. +.+.++||..+..
T Consensus       250 FcHNDLL~~Niiy~~~~~~v~fIDYEYa~y  279 (391)
T KOG4720|consen  250 FCHNDLLCGNIIYDSEKGSVEFIDYEYAGY  279 (391)
T ss_pred             EeecchhhcceeeccccCcEEEEeeccccc
Confidence            5899999999999765 8899999987753

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.70  E-value=0.11  Score=38.52  Aligned_cols=44  Identities=30%  Similarity=0.406  Sum_probs=36.1

Q ss_pred             HHHHHHHHHHhccC---CCccceeeeeeeecCeEEEEEEeecCCChh
Q 040501            3 KEFLREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENGSLS   46 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   46 (228)
                      ..|..|+.-|+.+.   .-.+.+++.+.....+.|+|+||++.+.+.
T Consensus        53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            45778888888873   357889999999999999999999876654

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.31  E-value=0.055  Score=42.39  Aligned_cols=28  Identities=36%  Similarity=0.537  Sum_probs=25.2

Q ss_pred             eeecCCCCCceEEcCCCc-eEEeeccccc
Q 040501           85 IVHRDISSKNVLLDLEYE-AHVSDFGIAK  112 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~-~~l~df~~~~  112 (228)
                      ++|+|+.|.||+++.++. .-++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 7899999775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.15  E-value=0.044  Score=42.64  Aligned_cols=31  Identities=26%  Similarity=0.323  Sum_probs=27.9

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+++|+|+.+.|++++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3899999999999999999999999997754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.14  E-value=0.036  Score=44.90  Aligned_cols=30  Identities=27%  Similarity=0.371  Sum_probs=24.1

Q ss_pred             eeecCCCCCceEEcCCCc-----eEEeeccccccc
Q 040501           85 IVHRDISSKNVLLDLEYE-----AHVSDFGIAKFI  114 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~-----~~l~df~~~~~~  114 (228)
                      ++|||+..+|||++.++.     ..|+||..+...
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G  304 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRG  304 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhcC
Confidence            699999999999988533     358899887654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.99  E-value=0.029  Score=41.17  Aligned_cols=38  Identities=18%  Similarity=0.132  Sum_probs=31.0

Q ss_pred             HHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecc
Q 040501           71 AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG  109 (228)
Q Consensus        71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~  109 (228)
                      +.+|.-.|+. ..+..|||-+|+|||-+..|.+||.|=+
T Consensus       151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence            3556667853 2389999999999999999999999865

The function of this family is unknown.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=94.79  E-value=0.031  Score=40.37  Aligned_cols=30  Identities=17%  Similarity=0.493  Sum_probs=25.4

Q ss_pred             CeeecCCCCCceEEcCCC-----ceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEY-----EAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~-----~~~l~df~~~~~  113 (228)
                      .++|||+.+.|+++..++     .+.++||..+..
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            789999999999997653     588999998754

subfamily of choline kinases

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.41  E-value=0.21  Score=40.33  Aligned_cols=28  Identities=25%  Similarity=0.361  Sum_probs=23.3

Q ss_pred             CeeecCCCCCceEEcCCCceEEeeccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAK  112 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~  112 (228)
                      .++|||+.+.||+++.++ .+++|-..+.
T Consensus       231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        231 ALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            689999999999999875 7888866554

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.18  E-value=0.049  Score=41.65  Aligned_cols=30  Identities=27%  Similarity=0.438  Sum_probs=25.3

Q ss_pred             CeeecCCCCCceEEcCCCc-eEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYE-AHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~-~~l~df~~~~~  113 (228)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK06148 hypothetical protein; Provisional

Probab=93.78  E-value=0.18  Score=45.92  Aligned_cols=31  Identities=29%  Similarity=0.500  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCceEEcCCC--ceE-Eeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEY--EAH-VSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~--~~~-l~df~~~~~  113 (228)
                      .+++|+|+++.||+++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3899999999999999875  554 899997754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=93.62  E-value=0.67  Score=33.65  Aligned_cols=84  Identities=21%  Similarity=0.326  Sum_probs=56.5

Q ss_pred             HHHHHHHHHhccC---CCcc--ceeeeeeeec------------------CeEEEEEEeecCCChhhhhhcCCCCCCCCH
Q 040501            4 EFLREITVLTEIR---HRNI--VKFYGFCTHA------------------RHSFLVYEYLENGSLSVILNNDTSAEELGW   60 (228)
Q Consensus         4 ~~~~E~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   60 (228)
                      -|..|-+..-+|+   +.++  ++++++..-.                  ....||.||.....            .+..
T Consensus       100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~  167 (207)
T PF13095_consen  100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI  167 (207)
T ss_pred             hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence            4667777777774   4566  8888887311                  12346667665432            1222


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccc
Q 040501           61 SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA  111 (228)
Q Consensus        61 ~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~  111 (228)
                          .-+.++.+-+..+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       168 ----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 ----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence                3456677788899999   9999999999985     2378898854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	228
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-34
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-23
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
3soa_A	444	Full-Length Human Camkii Length = 444		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  143 bits (361), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 80/235 (34%), Positives = 133/235 (56%), Gaps = 13/235 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-LGWSR 62
           +F  E+ +++   HRN+++  GFC       LVY Y+ NGS++  L     ++  L W +
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSSNW 121
           R  +  G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   D    
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT G++APE   T K + K DV+ +GV+ LE+I G+   D L+ +++ +  +L++ 
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDW 259
Query: 182 ----MLDPRLPPL-SVDIRG-----KVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               + + +L  L  VD++G     +V  +++VA LC  ++P  RP M  + ++L
Sbjct: 260 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 132/235 (56%), Gaps = 13/235 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-LGWSR 62
           +F  E+ +++   HRN+++  GFC       LVY Y+ NGS++  L     ++  L W +
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSSNW 121
           R  +  G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   D    
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               G  G++APE   T K + K DV+ +GV+ LE+I G+   D L+ +++ +  +L++ 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD-LARLANDDDVMLLDW 251
Query: 182 ----MLDPRLPPL-SVDIRG-----KVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               + + +L  L  VD++G     +V  +++VA LC  ++P  RP M  + ++L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 117/224 (52%), Gaps = 11/224 (4%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EFLRE+ ++  +RH NIV F G  T   +  +V EYL  GSL  +L+   + E+L   RR
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +++   +A  ++YLH+   PPIVHRD+ S N+L+D +Y   V DFG+++           
Sbjct: 140 LSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKX 198
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM- 182
            AGT  ++APE+        K DVYSFGV+  E+   + P   L      NP  +V  + 
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVG 252
Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +   +  ++  +V +I+E    C  N P  RP+  TI  LL
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 118/224 (52%), Gaps = 11/224 (4%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EFLRE+ ++  +RH NIV F G  T   +  +V EYL  GSL  +L+   + E+L   RR
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +++   +A  ++YLH+   PPIVHR++ S N+L+D +Y   V DFG+++       +   
Sbjct: 140 LSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM- 182
            AGT  ++APE+        K DVYSFGV+  E+   + P   L      NP  +V  + 
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVG 252
Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +   +  ++  +V +I+E    C  N P  RP+  TI  LL
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLL 293

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 121/237 (51%), Gaps = 21/237 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++F +EI V+ + +H N+V+  GF +      LVY Y+ NGSL   L+       L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
            R  + +G A+ +++LH +     +HRDI S N+LLD  + A +SDFG+A    KF Q  
Sbjct: 134 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG-------KHPRDFL-SN 169
           +   +   GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +    + + +D ++          V ++  VA  CL      RP+++ + QLL
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 120/237 (50%), Gaps = 21/237 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++F +EI V+ + +H N+V+  GF +      LVY Y+ NGSL   L+       L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
            R  + +G A+ +++LH +     +HRDI S N+LLD  + A +SDFG+A    KF Q  
Sbjct: 134 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG-------KHPRDFL-SN 169
           +       GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +    + + +D ++          V ++  VA  CL      RP+++ + QLL
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 119/237 (50%), Gaps = 21/237 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++F +EI V+ + +H N+V+  GF +      LVY Y+ NGSL   L+       L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
            R  + +G A+ +++LH +     +HRDI S N+LLD  + A +SDFG+A    KF Q  
Sbjct: 128 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 182
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG-------KHPRDFL-SN 169
                   GT  Y+APE A   ++T K D+YSFGV+ LE+I G       + P+  L   
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +    + + +D ++          V ++  VA  CL      RP+++ + QLL
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 114/224 (50%), Gaps = 19/224 (8%)
Query: 12  LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRINVIKGI 70
           L+  RH ++V   GFC       L+Y+Y+ENG+L   +  +D     + W +R+ +  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 71  AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQPDSSNWTEFA-GTY 128
           A  L YLH      I+HRD+ S N+LLD  +   ++DFGI+ K  + D ++      GT 
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTL 205
Query: 129 GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH------PRDFLSNVS---SSNPNILV 179
           GY+ PE     ++T K DVYSFGV+  EV+  +       PR+ ++       S+ N  +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 180 NEMLDPRLPPLSVDIRGKVI-SIMEVAFLCLDNNPESRPNMQTI 222
            +++DP L      IR + +    + A  CL  + E RP+M  +
Sbjct: 266 EQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 115/237 (48%), Gaps = 21/237 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++F +EI V  + +H N+V+  GF +      LVY Y  NGSL   L+       L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
            R  + +G A+ +++LH +     +HRDI S N+LLD  + A +SDFG+A    KF Q  
Sbjct: 125 XRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 179
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG-------KHPRDFL-SN 169
               +   GT  Y APE A   ++T K D+YSFGV+ LE+I G       + P+  L   
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +    + + +D +           V +   VA  CL      RP+++ + QLL
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDAD---STSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 112/231 (48%), Gaps = 33/231 (14%)
Query: 12  LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRINVIKGI 70
           L+  RH ++V   GFC       L+Y+Y+ENG+L   +  +D     + W +R+ +  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 71  AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA----- 125
           A  L YLH      I+HRD+ S N+LLD  +   ++DFGI+K         TE       
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK-------KGTELGQTHLX 198
Query: 126 ----GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH------PRDFLSNVS---S 172
               GT GY+ PE     ++T K DVYSFGV+  EV+  +       PR+ ++       
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVI-SIMEVAFLCLDNNPESRPNMQTI 222
           S+ N  + +++DP L      IR + +    + A  CL  + E RP+M  +
Sbjct: 259 SHNNGQLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 112/223 (50%), Gaps = 20/223 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF +E   + ++ H  +VKFYG C+     ++V EY+ NG L   L +     E   S+ 
Sbjct: 49  EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQL 106
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---SSN 120
           + +   +   +++L        +HRD++++N L+D +    VSDFG+ +++  D   SS 
Sbjct: 107 LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
            T+F   +   APE+ +  K ++K DV++FG+L  EV   GK P D  +N   S   + V
Sbjct: 164 GTKFPVKWS--APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKV 218
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           ++      P L+ D      +I ++ + C    PE RP  Q +
Sbjct: 219 SQGHRLYRPHLASD------TIYQIMYSCWHELPEKRPTFQQL 255

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 22/234 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-NDTSAEELGW 60
           ++EFL E +++ +  H NI++  G  T++    ++ E++ENG+L   L  ND     +  
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI-- 118
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++F++ +SS+
Sbjct: 119 -QLVGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD 174
Query: 121 WTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSN 174
            TE +   G     + APE     K T+  D +S+G++  EV+  G+ P         SN
Sbjct: 175 PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMSN 229
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            +++     D RLPP          S+ ++   C   +  +RP    +   L K
Sbjct: 230 QDVINAIEQDYRLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDK 279

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++ FL+E+ V+  + H N++KF G     +    + EY++ G+L  I+ +  S  +  WS
Sbjct: 51  QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWS 108
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI------- 114
           +R++  K IA  ++YLH      I+HRD++S N L+       V+DFG+A+ +       
Sbjct: 109 QRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 115 -------QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDF 166
                  +PD        G   ++APE+        K DV+SFG++  E+I +     D+
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
Query: 167 LSNVSSSNPNI--LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
           L        N+   ++    P  PP          S   +   C D +PE RP+
Sbjct: 226 LPRTMDFGLNVRGFLDRYCPPNCPP----------SFFPITVRCCDLDPEKRPS 269

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 117/235 (49%), Gaps = 22/235 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-NDTSAEELG 59
            ++EFL E +++ +  H NI++  G  T++    ++ E++ENG+L   L  ND     + 
Sbjct: 58  QRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI- 116
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++F++ +SS
Sbjct: 117 --QLVGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 171
Query: 120 NWTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSS 173
           + T  +   G     + APE     K T+  D +S+G++  EV+  G+ P         S
Sbjct: 172 DPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP-----YWDMS 226
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           N +++     D RLPP          S+ ++   C   +  +RP    +   L K
Sbjct: 227 NQDVINAIEQDYRLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDK 277

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND------TS 54
           ++K F+ E+  L+ + H NIVK YG C +     LV EY E GSL  +L+        T+
Sbjct: 45  ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTA 102
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
           A  + W   +   +G+A    YLH      ++HRD+   N+LL        + DFG A  
Sbjct: 103 AHAMSWC--LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 156
Query: 114 IQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
           IQ   ++ T   G+  ++APE+      + KCDV+S+G++  EVI  + P D +   +  
Sbjct: 157 IQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 213
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               ++  + +   PPL  ++   + S+M     C   +P  RP+M+ I +++
Sbjct: 214 ----IMWAVHNGTRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 112/243 (46%), Gaps = 32/243 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND--------- 52
           +K+F RE  +LT ++H +IVKFYG C       +V+EY+++G L+  L            
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 53  ----TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDF 108
                +  ELG S+ +++   IA  + YL        VHRD++++N L+       + DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDF 177
Query: 109 GIAKFIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           G+++ +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 178 GMSRDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
              LSN            +  PR+ P  V          +V   C    P+ R N++ I 
Sbjct: 236 WFQLSNTEVIECITQGRVLERPRVCPKEV---------YDVMLGCWQREPQQRLNIKEIY 286
Query: 224 QLL 226
           ++L
Sbjct: 287 KIL 289

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND------TS 54
           ++K F+ E+  L+ + H NIVK YG C +     LV EY E GSL  +L+        T+
Sbjct: 44  ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTA 101
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
           A  + W   +   +G+A    YLH      ++HRD+   N+LL        + DFG A  
Sbjct: 102 AHAMSWC--LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
Query: 114 IQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
           IQ   ++ T   G+  ++APE+      + KCDV+S+G++  EVI  + P D +   +  
Sbjct: 156 IQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               ++  + +   PPL  ++   + S+M     C   +P  RP+M+ I +++
Sbjct: 213 ----IMWAVHNGTRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+A+ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 115/233 (49%), Gaps = 20/233 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H N++   G  T +    ++ E++ENGSL   L  +    +    
Sbjct: 78  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVI 135
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++F++ D+S+ 
Sbjct: 136 QLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 192
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNP 175
           T  +   G     + APE     K T+  DV+S+G++  EV+  G+ P         +N 
Sbjct: 193 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-----WDMTNQ 247
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           +++     D RLPP  +D    +  +M     C   +   RP    I   L K
Sbjct: 248 DVINAIEQDYRLPP-PMDCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLDK 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 33/239 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN---------- 51
           +++F RE  +LT ++H++IV+F+G CT  R   +V+EY+ +G L+  L +          
Sbjct: 58  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 117
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D +   LG  + + V   +A  + YL        VHRD++++N L+       + DFG
Sbjct: 118 GEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFG 174
Query: 110 IAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPR 164
           +++ I   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P 
Sbjct: 175 MSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 232
Query: 165 DFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             LSN  + +      E+  PR  PP       +V +IM     C    P+ R +++ +
Sbjct: 233 YQLSNTEAIDCITQGRELERPRACPP-------EVYAIMRG---CWQREPQQRHSIKDV 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 33/239 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN---------- 51
           +++F RE  +LT ++H++IV+F+G CT  R   +V+EY+ +G L+  L +          
Sbjct: 64  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 123
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D +   LG  + + V   +A  + YL        VHRD++++N L+       + DFG
Sbjct: 124 GEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFG 180
Query: 110 IAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPR 164
           +++ I   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P 
Sbjct: 181 MSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 238
Query: 165 DFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             LSN  + +      E+  PR  PP       +V +IM     C    P+ R +++ +
Sbjct: 239 YQLSNTEAIDCITQGRELERPRACPP-------EVYAIMRG---CWQREPQQRHSIKDV 287

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 33/239 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN---------- 51
           +++F RE  +LT ++H++IV+F+G CT  R   +V+EY+ +G L+  L +          
Sbjct: 87  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D +   LG  + + V   +A  + YL        VHRD++++N L+       + DFG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 110 IAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPR 164
           +++ I   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P 
Sbjct: 204 MSRDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 165 DFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             LSN  + +      E+  PR  PP       +V +IM     C    P+ R +++ +
Sbjct: 262 YQLSNTEAIDCITQGRELERPRACPP-------EVYAIMRG---CWQREPQQRHSIKDV 310

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 118
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 229
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 230 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 277

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 145
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 146 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 256
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 257 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 78  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 135
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 136 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 246
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 247 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 294

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 96/179 (53%), Gaps = 15/179 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T  R + +V EY+ENGSL   L   T   +    
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIM 151
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++G+   + YL        VHRD++++NVL+D      VSDFG+++ ++ D  + 
Sbjct: 152 QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP------RDFLSNV 170
           +T   G     + APE       ++  DV+SFGV+  EV+  G+ P      RD +S+V
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 117/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+ + ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 96/179 (53%), Gaps = 15/179 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T  R + +V EY+ENGSL   L   T   +    
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIM 151
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ--PDSS 119
           + + +++G+   + YL        VHRD++++NVL+D      VSDFG+++ ++  PD++
Sbjct: 152 QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 120 NWTEFAGT-YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP------RDFLSNV 170
             T        + APE       ++  DV+SFGV+  EV+  G+ P      RD +S+V
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 21/233 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EF RE+ +++ + H NIVK YG   +     +V E++  G L   L +   A  + WS 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSV 123
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPD 117
           ++ ++  IA  + Y+ +   PPIVHRD+ S N+ L    E     A V+DFG++   Q  
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQS 179
Query: 118 SSNWTEFAGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
             + +   G + ++APE   A     T K D YSF ++   ++ G+ P D  S       
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           N++  E L P +P    D   ++ +++E   LC   +P+ RP+   I + L +
Sbjct: 240 NMIREEGLRPTIPE---DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EF RE+ +++ + H NIVK YG   +     +V E++  G L   L +   A  + WS 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSV 123
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPD 117
           ++ ++  IA  + Y+ +   PPIVHRD+ S N+ L    E     A V+DFG +   Q  
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQS 179
Query: 118 SSNWTEFAGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
             + +   G + ++APE   A     T K D YSF ++   ++ G+ P D  S       
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           N++  E L P +P    D   ++ +++E   LC   +P+ RP+   I + L +
Sbjct: 240 NMIREEGLRPTIPE---DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +E  GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 173 RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L       +AE L
Sbjct: 44  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 103
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL   C   ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 104 -----LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 156 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +  PRL    V          ++   C    PE RP    + + L +
Sbjct: 214 DISTGFRLYKPRLASTHV---------YQIMNHCWKERPEDRPAFSRLLRQLAE 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L       +AE L
Sbjct: 46  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 105
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL   C   ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 106 -----LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 157
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 158 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 215
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +  PRL    V          ++   C    PE RP    + + L +
Sbjct: 216 DISTGFRLYKPRLASTHV---------YQIMNHCWKERPEDRPAFSRLLRQLAE 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 114/233 (48%), Gaps = 20/233 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H N++   G  T +    ++ E++ENGSL   L  +    +    
Sbjct: 52  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVI 109
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           + + +++GIA  + YL        VHR ++++N+L++      VSDFG+++F++ D+S+ 
Sbjct: 110 QLVGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 166
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNP 175
           T  +   G     + APE     K T+  DV+S+G++  EV+  G+ P         +N 
Sbjct: 167 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-----WDMTNQ 221
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           +++     D RLPP  +D    +  +M     C   +   RP    I   L K
Sbjct: 222 DVINAIEQDYRLPP-PMDCPSALHQLM---LDCWQKDRNHRPKFGQIVNTLDK 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L       +AE L
Sbjct: 49  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 108
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL   C   ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 109 -----LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 161 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +  PRL    V          ++   C    PE RP    + + L +
Sbjct: 219 DISTGFRLYKPRLASTHV---------YQIMNHCWRERPEDRPAFSRLLRQLAE 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           + +F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L       +AE L
Sbjct: 66  EDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 125
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL   C   ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 126 -----LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 177
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 178 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 235
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +  PRL    V          ++   C    PE RP    + + L +
Sbjct: 236 DISTGFRLYKPRLASTHV---------YQIMNHCWKERPEDRPAFSRLLRQLAE 280

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-NNDTSAEELGW 60
           +++FL E +++ +  H NI+   G  T  +   ++ EY+ENGSL   L  ND     +  
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SS 119
            + + +++GI   + YL        VHRD++++N+L++      VSDFG+++ ++ D  +
Sbjct: 132 -QLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 187
Query: 120 NWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
            +T   G     + APE     K T+  DV+S+G++  EV+  G+ P         SN +
Sbjct: 188 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQD 242
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           ++       RLPP  +D     I++ ++   C       RP    I  +L K
Sbjct: 243 VIKAIEEGYRLPP-PMDC---PIALHQLMLDCWQKERSDRPKFGQIVNMLDK 290

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E     +   +
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE----FQIATM 125
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           +K I   L YLH +     +HRDI + NVLL  + +  ++DFG+A  +         F G
Sbjct: 126 LKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 182
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ KG+      HP   L  +  +NP  LV 
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVG 242
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +                  S  E    CL+ +P  RP  + + +
Sbjct: 243 DFTK---------------SFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-NNDTSAEELGW 60
           +++FL E +++ +  H NI+   G  T  +   ++ EY+ENGSL   L  ND     +  
Sbjct: 53  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 110
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SS 119
            + + +++GI   + YL        VHRD++++N+L++      VSDFG+++ ++ D  +
Sbjct: 111 -QLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 166
Query: 120 NWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
            +T   G     + APE     K T+  DV+S+G++  EV+  G+ P         SN +
Sbjct: 167 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQD 221
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           ++       RLPP  +D     I++ ++   C       RP    I  +L K
Sbjct: 222 VIKAIEEGYRLPP-PMDC---PIALHQLMLDCWQKERSDRPKFGQIVNMLDK 269

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-NNDTSAEELGW 60
           +++FL E +++ +  H NI+   G  T  +   ++ EY+ENGSL   L  ND     +  
Sbjct: 59  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SS 119
            + + +++GI   + YL        VHRD++++N+L++      VSDFG+++ ++ D  +
Sbjct: 117 -QLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 172
Query: 120 NWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
            +T   G     + APE     K T+  DV+S+G++  EV+  G+ P         SN +
Sbjct: 173 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWDMSNQD 227
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           ++       RLPP  +D     I++ ++   C       RP    I  +L K
Sbjct: 228 VIKAIEEGYRLPP-PMDC---PIALHQLMLDCWQKERSDRPKFGQIVNMLDK 275

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 117/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V E +ENGSL   L    +  +    
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVI 118
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 229
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 230 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 277

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 29/240 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL----------SVILNN 51
           +K+F RE  +LT ++H +IVKFYG C       +V+EY+++G L          +V++  
Sbjct: 59  RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 118
Query: 52  DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
                EL  S+ +++ + IA  + YL        VHRD++++N L+       + DFG++
Sbjct: 119 GNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS 175
Query: 112 KFIQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDF 166
           + +   S+++    G       ++ PE     K T + DV+S GV+  E+   GK P   
Sbjct: 176 RDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233
Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LSN            +  PR  P  V          E+   C    P  R N++ I  LL
Sbjct: 234 LSNNEVIECITQGRVLQRPRTCPQEV---------YELMLGCWQREPHMRKNIKGIHTLL 284

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 117/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V E +ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 117/233 (50%), Gaps = 22/233 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI++  G  T ++   +V E +ENGSL   L    +  +    
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVI 147
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + +PE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------ 258
Query: 178 LVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            V + +D   RLPP  +D    +  +M     C   +  +RP  + I  +L K
Sbjct: 259 -VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 112/231 (48%), Gaps = 18/231 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H NI+   G  T ++   +V EY+ENGSL   L  +    +    
Sbjct: 67  RRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG--QFTVI 124
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GI+  + YL        VHRD++++N+L++      VSDFG+++ ++ D  + 
Sbjct: 125 QLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 181
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + APE     K T+  DV+S+G++  EV+  G+ P   ++N        
Sbjct: 182 YTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQD------ 235
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           ++  + +    P  +D    +  +M     C      SRP    I  +L K
Sbjct: 236 VIKAVEEGYRLPSPMDCPAALYQLM---LDCWQKERNSRPKFDEIVNMLDK 283

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EF RE+ +++ + H NIVK YG   +     +V E++  G L   L +   A  + WS 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSV 123
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPD 117
           ++ ++  IA  + Y+ +   PPIVHRD+ S N+ L    E     A V+DF ++   Q  
Sbjct: 124 KLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQS 179
Query: 118 SSNWTEFAGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
             + +   G + ++APE   A     T K D YSF ++   ++ G+ P D  S       
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           N++  E L P +P    D   ++ +++E   LC   +P+ RP+   I + L +
Sbjct: 240 NMIREEGLRPTIPE---DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG C       LV E++E+G LS  L       +AE L
Sbjct: 47  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL 106
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL   C   ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 107 -----LGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 159 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
                  +  PRL    V          ++   C    PE RP    + + L +
Sbjct: 217 DISTGFRLYKPRLASTHV---------YQIMNHCWRERPEDRPAFSRLLRQLAE 261

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  TE
Sbjct: 111 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTE 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 173 RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 117 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 173
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 174 RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 107
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---SSN 120
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D   SS 
Sbjct: 108 LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR 164
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
            ++F   +    PE+    K ++K D+++FGVL  E+   GK P +  +N  ++     +
Sbjct: 165 GSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---I 219
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 220 AQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 256

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 18/229 (7%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +FL E  ++ +  H NI++  G  +  +   ++ EY+ENG+L   L       E    + 
Sbjct: 92  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQL 149
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSNWT 122
           + +++GIA  + YL +      VHRD++++N+L++      VSDFG+++ ++ D  + +T
Sbjct: 150 VGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 123 EFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     + APE     K T+  DV+SFG++  EV+  G+ P   LSN      + ++
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVM 260
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
             + D    P  +D    +  +M     C       RP    I  +L K
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSILDK 306

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 49  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 106
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D     E
Sbjct: 107 LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----E 158
Query: 124 FAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
           +  + G      +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++   
Sbjct: 159 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 217
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 218 --IAQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 56  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D     E
Sbjct: 114 LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----E 165
Query: 124 FAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
           +  + G      +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++   
Sbjct: 166 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 224
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 225 --IAQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 262

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 45  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 102
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D     E
Sbjct: 103 LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----E 154
Query: 124 FAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
           +  + G      +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++   
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 213
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 214 --IAQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 251

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 107
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D     E
Sbjct: 108 LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----E 159
Query: 124 FAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
           +  + G      +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++   
Sbjct: 160 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 218
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 219 --IAQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 256

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 122
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D     E
Sbjct: 123 LEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----E 174
Query: 124 FAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPN 176
           +  + G      +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++   
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH- 233
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             + + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 234 --IAQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 271

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T+
Sbjct: 111 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTD 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T+
Sbjct: 111 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTD 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T+
Sbjct: 112 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTD 166
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 222
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 223 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 257

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G +   L   +  +E    R 
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRT 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 170
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 226
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 227 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T+
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTD 170
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 226
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 227 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAEEL 58
           +++F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L       +AE L
Sbjct: 46  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 105
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
                + +   +   ++YL       ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 106 -----LGMCLDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 157
Query: 118 --SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
             SS  T+F     + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN     
Sbjct: 158 YTSSTGTKFP--VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 215
Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  +  PRL    V          ++   C    PE RP    + + L
Sbjct: 216 DISTGFRLYKPRLASTHV---------YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L            + 
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQL 122
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---SSN 120
           + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D   SS 
Sbjct: 123 LEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
            ++F   +    PE+    K ++K D+++FGVL  E+   GK P +  +N  ++     +
Sbjct: 180 GSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---I 234
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            + L    P L+ +   KV +IM   + C     + RP  + +
Sbjct: 235 AQGLRLYRPHLASE---KVYTIM---YSCWHEKADERPTFKIL 271

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 136
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 137 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 191
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + GK P
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 111 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTX 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 110 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 164
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 220
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 221 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 255

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E    ++   +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATI 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +         F G
Sbjct: 110 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 166
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ +G+      HP   L  +  +NP  L  
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 226
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
               P               + E    CL+  P  RP  + + +
Sbjct: 227 NYSKP---------------LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 88/163 (53%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           KKE +  EI V+ E ++ NIV +          ++V EYL  GSL+ ++  +T  +E   
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE--- 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH +    ++HR+I S N+LL ++    ++DFG    I P+ S 
Sbjct: 117 GQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 173
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 174 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +E  +   ++H NI+   G C    +  LV E+   G L+ +L+      ++     +N 
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNW 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE--------AHVSDFGIAKFIQPDS 118
              IA  ++YLH + I PI+HRD+ S N+L+  + E          ++DFG+A+  +   
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHR 168
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
           +     AG Y ++APE+      +   DV+S+GVL  E++ G+ P   +  ++ +   + 
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-GVA 227
Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +N++  P +P    +   K++        C + +P SRP+   I   L
Sbjct: 228 MNKLALP-IPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQL 268

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E    ++   +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATI 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +         F G
Sbjct: 110 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVG 166
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ +G+      HP   L  +  +NP  L  
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 226
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
               P               + E    CL+  P  RP  + + +
Sbjct: 227 NYSKP---------------LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 107
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 108 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 162
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 218
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 219 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 253

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 114 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E    ++   +
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATI 124
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +         F G
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVG 181
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ +G+      HP   L  +  +NP  L  
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 241
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
               P               + E    CL+  P  RP  + + +
Sbjct: 242 NYSKP---------------LKEFVEACLNKEPSFRPTAKELLK 270

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 111 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + GK P
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     + K+YG        +++ EYL  GS   +L      E    ++   +
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATI 129
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +         F G
Sbjct: 130 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 186
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+       +K D++S G+ A+E+ +G+      HP   L  +  +NP  L  
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 246
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
               P               + E    CL+  P  RP  + + +
Sbjct: 247 NYSKP---------------LKEFVEACLNKEPSFRPTAKELLK 275

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 114
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 115 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 169
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 225
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 226 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 170
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 226
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 227 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 127
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 128 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 182
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + GK P
Sbjct: 183 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 116 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT 170
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE         K D++S GVL  E + GK P  F +N        +    +
Sbjct: 171 LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 226
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 227 EFTFPDFVTEGARDLISRL------LKHNPSQRPXLREVLE 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 136
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS   +
Sbjct: 137 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDD 191
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + GK P
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  ++DFG +      SS  T 
Sbjct: 112 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT 166
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
            +GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 222
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 223 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 257

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G +   L   +  +E    R 
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRT 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 116 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXX 170
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 171 LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 226
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 227 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 261

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 110/231 (47%), Gaps = 18/231 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL E +++ +  H N+V   G  T  +   +V E++ENG+L   L       +    
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--QFTVI 145
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SSN 120
           + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++ I+ D  + 
Sbjct: 146 QLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 121 WTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
           +T   G     + APE     K T+  DV+S+G++  EV+  G+ P   +SN        
Sbjct: 203 YTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------ 256
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
           ++  + +    P  +D    +  +M     C       RP  + I  +L K
Sbjct: 257 VIKAIEEGYRLPAPMDCPAGLHQLM---LDCWQKERAERPKFEQIVGILDK 304

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS   +
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDD 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 111 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 114 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXX 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 111 ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXX 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H   +   +HRDI  +N+LL    E  +++FG +  +   SS  T 
Sbjct: 114 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 114 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA 168
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 224
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 225 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 113 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXX 167
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 223
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 224 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 258

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  +++FG +  +   SS  T 
Sbjct: 113 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT 167
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 223
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 224 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRT 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 112 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT 166
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQETYKRISR--V 222
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 223 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   +   +L+ EY   G++   L   +  +E    R 
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRT 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 111 ATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA 165
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++S GVL  E + GK P  F +N        +    +
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEANTYQDTYKRISR--V 221
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P    +    +IS +      L +NP  RP ++ + +
Sbjct: 222 EFTFPDFVTEGARDLISRL------LKHNPSQRPMLREVLE 256

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 34/233 (14%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLV 114
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I  + + WT  
Sbjct: 115 DMSAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTAR 169
Query: 125 AGT---YGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVN 180
            G      + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  
Sbjct: 170 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNR 219
Query: 181 EMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 220 EVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRT 114
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS  T 
Sbjct: 115 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT 169
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + G  P
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 85/163 (52%), Gaps = 8/163 (4%)
Query: 2   KKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++E L  E+ ++ + +H N+V+ Y         +++ E+L+ G+L+ I++     EE   
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE--- 141
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V + +  AL+YLH   +   +HRDI S ++LL L+    +SDFG    I  D   
Sbjct: 142 -QIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT  ++APE+        + D++S G++ +E++ G+ P
Sbjct: 198 RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 5/162 (3%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEE- 57
           +K+  + E+ +L E++H NIV++Y       ++  ++V EY E G L+ ++   T   + 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 58  LGWSRRINVIKGIAHALSYLHH--DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           L     + V+  +  AL   H   D    ++HRD+   NV LD +    + DFG+A+ + 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
            D     EF GT  Y++PE    M    K D++S G L  E+
Sbjct: 168 HDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 5/162 (3%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEE- 57
           +K+  + E+ +L E++H NIV++Y       ++  ++V EY E G L+ ++   T   + 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 58  LGWSRRINVIKGIAHALSYLHH--DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           L     + V+  +  AL   H   D    ++HRD+   NV LD +    + DFG+A+ + 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
            D+S    F GT  Y++PE    M    K D++S G L  E+
Sbjct: 168 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 17/224 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ +  H N+V  Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 84  QRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 141
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALSYLH+  +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 142 --QIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 196
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APE+   +    + D++S G++ +E+I G+ P         + P +  
Sbjct: 197 KRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP-------YFNEPPLQA 249
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAF-LCLDNNPESRPNMQTI 222
              +   LPP   D+  KV S++     L L   P  R   Q +
Sbjct: 250 MRRIRDSLPPRVKDLH-KVSSVLRGFLDLMLVREPSQRATAQEL 292

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 5/162 (3%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEE- 57
           +K+  + E+ +L E++H NIV++Y       ++  ++V EY E G L+ ++   T   + 
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 58  LGWSRRINVIKGIAHALSYLHH--DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           L     + V+  +  AL   H   D    ++HRD+   NV LD +    + DFG+A+ + 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
            D+S    F GT  Y++PE    M    K D++S G L  E+
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EITVL++     I +++G    +   +++ EYL  GS   +L      E    +    +
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATI 121
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ I   L YLH +     +HRDI + NVLL  + +  ++DFG+A  +         F G
Sbjct: 122 LREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVG 178
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSSNPNILVN 180
           T  ++APE+        K D++S G+ A+E+ KG+      HP   L  +  ++P  L  
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 238
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +   P                 E    CL+ +P  RP  + + +
Sbjct: 239 QHSKP---------------FKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 9/165 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI--LNNDTSAEEL 58
           D +E ++EI+++ +    ++VK+YG        ++V EY   GS+S I  L N T  E+ 
Sbjct: 67  DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED- 125
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                  +++     L YLH       +HRDI + N+LL+ E  A ++DFG+A  +    
Sbjct: 126 ---EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXM 179
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +      GT  ++APE+   +      D++S G+ A+E+ +GK P
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 26/232 (11%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----L 58
           E L+EI  +++  H NIV +Y         +LV + L  GS+  I+ +  +  E     L
Sbjct: 54  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 113
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
             S    +++ +   L YLH +     +HRD+ + N+LL  +    ++DFG++ F+    
Sbjct: 114 DESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 170
Query: 119 -----SNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
                     F GT  ++APE+   ++    K D++SFG+ A+E+  G  P      +  
Sbjct: 171 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 230
Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVI------SIMEVAFLCLDNNPESRPN 218
               +++    DP  P L   ++ K +      S  ++  LCL  +PE RP 
Sbjct: 231 ----LMLTLQNDP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVV 117
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 118 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 172
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 173 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 222
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 223 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 116
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 117 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 171
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 172 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 221
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 222 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 117
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 118 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 172
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 173 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 222
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 223 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 59  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 116
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 117 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +  
Sbjct: 172 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKA 224
Query: 180 NEMLDPRLPP 189
            +M+   LPP
Sbjct: 225 MKMIRDNLPP 234

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----L 58
           E L+EI  +++  H NIV +Y         +LV + L  GS+  I+ +  +  E     L
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
             S    +++ +   L YLH +     +HRD+ + N+LL  +    ++DFG++ F+    
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175
Query: 119 -----SNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
                     F GT  ++APE+   ++    K D++SFG+ A+E+  G  P      +  
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVI------SIMEVAFLCLDNNPESRPNMQTICQLL 226
               +++    DP  P L   ++ K +      S  ++  LCL  +PE RP   T  +LL
Sbjct: 236 ----LMLTLQNDP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---TAAELL 286

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 110
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +  + +N
Sbjct: 111 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN 164
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
             EF GT  Y++PE       + + D++S G+  +E+  G++PR          P + + 
Sbjct: 165 --EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR----------PPMAIF 212
Query: 181 EMLD-------PRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
           E+LD       P+LP         V S+    F+  CL  NP  R +++ +
Sbjct: 213 ELLDYIVNEPPPKLP-------SAVFSLEFQDFVNKCLIKNPAERADLKQL 256

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 70  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 127
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 128 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 182
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +  
Sbjct: 183 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKA 235
Query: 180 NEMLDPRLPP 189
            +M+   LPP
Sbjct: 236 MKMIRDNLPP 245

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 68  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 125
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 126 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 180
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +  
Sbjct: 181 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKA 233
Query: 180 NEMLDPRLPP 189
            +M+   LPP
Sbjct: 234 MKMIRDNLPP 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 117
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 118 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 172
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 173 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 222
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 223 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 63  QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 120
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 121 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 175
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +  
Sbjct: 176 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKA 228
Query: 180 NEMLDPRLPP 189
            +M+   LPP
Sbjct: 229 MKMIRDNLPP 238

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 114
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 115 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 169
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 170 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 219
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 220 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 114
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 115 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 169
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 170 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 219
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 220 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 54  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 113 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 167
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 217
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 218 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 117
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 118 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 172
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 173 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 222
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 223 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 46/249 (18%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAE--- 56
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY   G L   L     A+   
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 143
Query: 57  ----ELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
                L     ++    +A  +++L   +CI    HRD++++NVLL   + A + DFG+A
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLA 199
Query: 112 KFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           + I  DS+   +        ++APE  +    T + DV+S+G+L  E+   G +P     
Sbjct: 200 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY---- 255
Query: 169 NVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                 P ILVN           +M  P   P +      + SIM+    C    P  RP
Sbjct: 256 ------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA---CWALEPTHRP 300
Query: 218 NMQTICQLL 226
             Q IC  L
Sbjct: 301 TFQQICSFL 309

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 113 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 170
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 171 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  ++APEL   +    + D++S G++ +E++ G+ P         + P +  
Sbjct: 226 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------YFNEPPLKA 278
Query: 180 NEMLDPRLPP 189
            +M+   LPP
Sbjct: 279 MKMIRDNLPP 288

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 67  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 126 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 180
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 181 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 230
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 231 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 277

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 112/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 117
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+   T
Sbjct: 118 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--T 172
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 173 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 222
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 223 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E    R 
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRT 114
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +  +   SS    
Sbjct: 115 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT 169
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT  Y+ PE+        K D++S GVL  E + G  P
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 8/164 (4%)
Query: 1   DKKEFL-REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
            ++E L  E+ ++ + +H N+V+ Y         ++V E+LE G+L+ I+ +    EE  
Sbjct: 190 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-- 247
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +   V   +  ALS LH   +   +HRDI S ++LL  +    +SDFG    +  +  
Sbjct: 248 --QIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                 GT  ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 303 RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 112/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVV 113
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+   T
Sbjct: 114 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--T 168
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 169 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 218
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 219 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 109/249 (43%), Gaps = 46/249 (18%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAE--- 56
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY   G L   L     A+   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 57  ----ELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
                L     ++    +A  +++L   +CI    HRD++++NVLL   + A + DFG+A
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLA 207
Query: 112 KFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           + I  DS+   +        ++APE  +    T + DV+S+G+L  E+   G +P     
Sbjct: 208 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY---- 263
Query: 169 NVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                 P ILVN           +M  P   P +      + SIM+    C    P  RP
Sbjct: 264 ------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA---CWALEPTHRP 308
Query: 218 NMQTICQLL 226
             Q IC  L
Sbjct: 309 TFQQICSFL 317

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 55  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 113
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 114 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 168
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 169 APAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 218
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 219 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 120
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 121 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 178 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 232
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 233 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 56  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 114
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 115 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 169
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 170 APAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 219
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 220 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 118
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 119 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 176 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 230
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 231 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 56  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 113
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 114 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 171 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 225
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 226 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 21/227 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVV 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+   T
Sbjct: 111 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--T 165
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
             AG      + APE LAY  K + K DV++FGVL  E+   G  P      +  S    
Sbjct: 166 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYE 221
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L+ +      P       G    + E+   C   NP  RP+   I Q
Sbjct: 222 LLEKDYRMERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 64  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 121
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 122 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 179 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 233
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 234 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 112
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 113 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 224
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 225 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 57  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 114
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 115 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 172 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 226
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 227 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 16/224 (7%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H  +V+ Y   +     ++V EY+  GSL   L  D     L     +
Sbjct: 51  FLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLV 108
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   +A  ++Y+        +HRD+ S N+L+       ++DFG+A+ I+ +     + 
Sbjct: 109 DMAAQVAAGMAYIERMNY---IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG 165
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E++ KG+ P   ++N            M
Sbjct: 166 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 225
Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             P+  P         IS+ E+   C   +PE RP  + +   L
Sbjct: 226 PCPQDCP---------ISLHELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 40/236 (16%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLV 283
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     E+
Sbjct: 284 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 335
Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGM 385
Query: 178 LVNEMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 386 VNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 53  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLV 110
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 111 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 167
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 168 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 217
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 218 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 262

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 60/258 (23%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEY----------------LENG 43
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY                LE  
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 44  SLSVILNNDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYE 102
               I N+  S  +L     ++    +A  +++L   +CI    HRD++++NVLL   + 
Sbjct: 152 PAFAIANSTASTRDL-----LHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHV 202
Query: 103 AHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK- 159
           A + DFG+A+ I  DS+   +        ++APE  +    T + DV+S+G+L  E+   
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 160 GKHPRDFLSNVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLC 208
           G +P           P ILVN           +M  P   P +      + SIM+    C
Sbjct: 263 GLNPY----------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA---C 303
Query: 209 LDNNPESRPNMQTICQLL 226
               P  RP  Q IC  L
Sbjct: 304 WALEPTHRPTFQQICSFL 321

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 112
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 113 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 224
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 225 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 21/227 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+   T
Sbjct: 111 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--T 165
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
             AG      + APE LAY  K + K DV++FGVL  E+   G  P      +  S    
Sbjct: 166 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYE 221
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L+ +      P       G    + E+   C   NP  RP+   I Q
Sbjct: 222 LLEKDYRMERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 40/236 (16%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLV 283
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     E+
Sbjct: 284 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 335
Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGM 385
Query: 178 LVNEMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 386 VNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 35/237 (14%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K +FL+E  +L +  H NIV+  G CT  +  ++V E ++ G     L   T    L   
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVK 213
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             + ++   A  + YL   C    +HRD++++N L+  +    +SDFG+++         
Sbjct: 214 TLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR--------- 261
Query: 122 TEFAGTYG-----------YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSN 169
            E  G Y            + APE     + +++ DV+SFG+L  E    G  P   LSN
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +         +  P L P        V  +ME    C    P  RP+  TI Q L
Sbjct: 322 QQTREFVEKGGRLPCPELCP------DAVFRLMEQ---CWAYEPGQRPSFSTIYQEL 369

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 40/236 (16%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLV 366
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     E+
Sbjct: 367 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 418
Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGM 468
Query: 178 LVNEMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 469 VNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 518

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 25/231 (10%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 108 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
              F GT  Y++PE       + + D++S G+  +E+  G++P         S P + + 
Sbjct: 162 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIF 219
Query: 181 EMLD-------PRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
           E+LD       P+LP         V S+    F+  CL  NP  R +++ +
Sbjct: 220 ELLDYIVNEPPPKLP-------SGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+++       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P    S VS +  ++
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                 DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 233 ----REDP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 272

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 52  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 111 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FT 165
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
             AG      + APE LAY  K + K DV++FGVL  E+   G  P      +  S    
Sbjct: 166 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPSQVYE 221
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L+ +      P       G    + E+   C   NP  RP+   I Q
Sbjct: 222 LLEKDYRMERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 50  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 107
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 108 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 165 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 219
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 220 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 40/236 (16%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLV 283
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     E+
Sbjct: 284 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EY 335
Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGM 385
Query: 178 LVNEMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 386 VNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 118 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 175 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 229
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 230 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 118
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 119 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 175
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 176 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 230
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 231 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 112
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 113 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 224
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 225 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 122
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 123 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 179
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 180 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 234
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 235 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 34/233 (14%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L   + +
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLV 114
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I  + + +T  
Sbjct: 115 DMSAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTAR 169
Query: 125 AGT---YGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVN 180
            G      + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  
Sbjct: 170 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNR 219
Query: 181 EMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           E+LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 220 EVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ +IRH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+++       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P  F  +   S    
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPDSVAYQ 230
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
            V E  DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 231 HVRE--DP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 272

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 112
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+       E 
Sbjct: 113 DMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 224
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 225 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 60/258 (23%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEY----------------LENG 43
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY                LE  
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 44  SLSVILNNDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYE 102
               I N+  S  +L     ++    +A  +++L   +CI    HRD++++NVLL   + 
Sbjct: 152 PAFAIANSTLSTRDL-----LHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHV 202
Query: 103 AHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK- 159
           A + DFG+A+ I  DS+   +        ++APE  +    T + DV+S+G+L  E+   
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 160 GKHPRDFLSNVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLC 208
           G +P           P ILVN           +M  P   P +      + SIM+    C
Sbjct: 263 GLNPY----------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA---C 303
Query: 209 LDNNPESRPNMQTICQLL 226
               P  RP  Q IC  L
Sbjct: 304 WALEPTHRPTFQQICSFL 321

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+++       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P    S VS +  ++
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                 DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 233 ----REDP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 272

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+++ N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+++       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P    S VS +  ++
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                 DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 233 ----REDP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 272

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +      +V EY+  GSL   L  +T  + L   + +
Sbjct: 50  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLV 107
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 108 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 165 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 214
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C    PE RP  + +   L
Sbjct: 215 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFL 259

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 52/255 (20%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND------- 52
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY   G L   L          
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 53  ------TSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                    E+L     ++    +A  +++L   +CI    HRD++++NVLL   + A +
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKI 207
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKH 162
            DFG+A+ I  DS+   +        ++APE  +    T + DV+S+G+L  E+   G +
Sbjct: 208 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 267
Query: 163 PRDFLSNVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDN 211
           P           P ILVN           +M  P   P +      + SIM+    C   
Sbjct: 268 PY----------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA---CWAL 308
Query: 212 NPESRPNMQTICQLL 226
            P  RP  Q IC  L
Sbjct: 309 EPTHRPTFQQICSFL 323

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 113/231 (48%), Gaps = 29/231 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 300 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV 358
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HR+++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 359 LLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 413
Query: 123 EFAGTY---GYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             AG      + APE LAY  K + K DV++FGVL  E+          +   S  P I 
Sbjct: 414 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIA---------TYGMSPYPGID 463
Query: 179 VNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 464 LSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 510

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 113/232 (48%), Gaps = 31/232 (13%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+    
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVV 319
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HR+++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 320 LLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YT 374
Query: 123 EFAGTY---GYVAPE-LAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
             AG      + APE LAY  K + K DV++FGVL  E+   G  P           P I
Sbjct: 375 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPY----------PGI 423
Query: 178 LVNEMLDPRLPPLSVDIR-----GKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            ++++ +     L  D R     G    + E+   C   NP  RP+   I Q
Sbjct: 424 DLSQVYE----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 51  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 108
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 109 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 165
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 166 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 215
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 216 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 260

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN-- 65
           E  +L+ + H  I++ +G    A+  F++ +Y+E G L  +L           S+R    
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNP 106
Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           V K  A     AL YLH      I++RD+  +N+LLD      ++DFG AK++ PD +  
Sbjct: 107 VAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT-- 160
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  Y+APE+  T       D +SFG+L  E++ G  P  + SN   +   IL  E
Sbjct: 161 YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAE 219
Query: 182 MLDPRLPPL 190
           +   R PP 
Sbjct: 220 L---RFPPF 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K +FL+E  +L +  H NIV+  G CT  +  ++V E ++ G     L   T    L   
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVK 213
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             + ++   A  + YL   C    +HRD++++N L+  +    +SDFG+++    ++   
Sbjct: 214 TLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGV 267
Query: 122 TEFAGTY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNP 175
              +G        + APE     + +++ DV+SFG+L  E    G  P   LSN  +   
Sbjct: 268 XAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 +  P L P        V  +ME    C    P  RP+  TI Q L
Sbjct: 328 VEKGGRLPCPELCP------DAVFRLMEQ---CWAYEPGQRPSFSTIYQEL 369

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 31/231 (13%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 127 KVSIAVIKG----LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 180
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
              F GT  Y++PE       + + D++S G+  +E+  G++P      + S + ++ + 
Sbjct: 181 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP------IGSGSGSMAIF 232
Query: 181 EMLD-------PRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
           E+LD       P+LP         V S+    F+  CL  NP  R +++ +
Sbjct: 233 ELLDYIVNEPPPKLPS-------GVFSLEFQDFVNKCLIKNPAERADLKQL 276

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+++       V DFGIA+ I    ++
Sbjct: 133 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P    S VS +  ++
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 249
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                 DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 250 ----REDP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 289

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 49  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 106
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 107 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 163
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 164 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 213
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 214 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 258

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 112 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 11/159 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EFL+E  V+ EI+H N+V+  G CT     ++V EY+  G+L   L  + + EE+    
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVV 131
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  +T
Sbjct: 132 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YT 186
Query: 123 EFAGT---YGYVAPE-LAYTMKVTAKCDVYSFGVLALEV 157
             AG      + APE LAY    + K DV++FGVL  E+
Sbjct: 187 AHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEI 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  ++ +
Sbjct: 51  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLL 108
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++++        +HR++ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 109 DMAAQIAEGMAFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 165
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN-- 180
           A     + APE       T K DV+SFG+L  E++  G+ P   +     +NP ++ N  
Sbjct: 166 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE 220
Query: 181 ---EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               M+ P   P           + ++  LC    PE RP    +  +L
Sbjct: 221 RGYRMVRPDNCPE---------ELYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y        +    ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H + I   +HRD+   N+L+       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
             + A   GT  Y++PE A    V A+ DVYS G +  EV+ G+ P    S VS +  ++
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                 DP +PP S    G    +  V    L  NPE+R   QT  ++
Sbjct: 233 ----REDP-IPP-SARHEGLSADLDAVVLKALAKNPENR--YQTAAEM 272

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + FL E  ++  ++H  +V+ Y   T     +++ EY+  GSL   L +D   + L   +
Sbjct: 53  QAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPK 111
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            I+    IA  ++Y+        +HRD+ + NVL+       ++DFG+A+ I+ +     
Sbjct: 112 LIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 168
Query: 123 EFAG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN 180
           E A     + APE       T K DV+SFG+L  E++  GK P         +N +++  
Sbjct: 169 EGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYP-----GRTNADVMTA 223
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                R+P +  +   ++  IM+   +C     E RP    +  +L
Sbjct: 224 LSQGYRMPRVE-NCPDELYDIMK---MCWKEKAEERPTFDYLQSVL 265

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  V+  ++H  +VK +   T     +++ E++  GSL   L +D  +++    + I
Sbjct: 57  FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLI 114
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           +    IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 115 DFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 171
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE       T K DV+SFG+L +E++  G+ P   +     SNP ++    
Sbjct: 172 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALE 226
Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              R+ P   +   ++ +IM     C  N PE RP  + I  +L
Sbjct: 227 RGYRM-PRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 266

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 118 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 175 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 128 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 128 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 185 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 112 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 169 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 107
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 108 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 165 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 105
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 106 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 163 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 125
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 126 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 183 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +   + L   + +
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLV 284
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+ + I+ +     E+
Sbjct: 285 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLGRLIEDN-----EY 336
Query: 125 AGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNI 177
               G      + APE A   + T K DV+SFG+L  E+  KG+ P           P +
Sbjct: 337 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGM 386
Query: 178 LVNEMLDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E+LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 387 VNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 436

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L     AE +  
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDH 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 117 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 174 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 233
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  G L   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 35/235 (14%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +++E  RE+ VL  ++H NIV++       R SF      ENGSL ++++     +    
Sbjct: 66  EREESRREVAVLANMKHPNIVQY-------RESFE-----ENGSLYIVMDYCEGGDLF-- 111
Query: 61  SRRINVIKGIA----HALSYLHHDCIP-------PIVHRDISSKNVLLDLEYEAHVSDFG 109
            +RIN  KG+       L +    C+         I+HRDI S+N+ L  +    + DFG
Sbjct: 112 -KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFG 170
Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           IA+ +           GT  Y++PE+        K D+++ G +  E+   KH  +    
Sbjct: 171 IARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---- 226
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            + S  N LV +++    PP+S+     + S++   F     NP  RP++ +I +
Sbjct: 227 -AGSMKN-LVLKIISGSFPPVSLHYSYDLRSLVSQLF---KRNPRDRPSVNSILE 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  V+  ++H  +VK +   T     +++ E++  GSL   L +D  +++    + I
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLI 287
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           +    IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +     E 
Sbjct: 288 DFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE       T K DV+SFG+L +E++  G+ P   +     SNP ++    
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALE 399
Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              R+ P   +   ++ +IM     C  N PE RP  + I  +L
Sbjct: 400 RGYRM-PRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 469
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 470 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 527 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           K F RE+   +++ H+NIV            +LV EY+E  +LS  +    S   L    
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDT 112
Query: 63  RIN----VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            IN    ++ GI HA     HD    IVHRDI  +N+L+D      + DFGIAK +   S
Sbjct: 113 AINFTNQILDGIKHA-----HDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165
Query: 119 SNWTEFA-GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
              T    GT  Y +PE A         D+YS G++  E++ G+ P +  + VS     I
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----I 220
Query: 178 LVNEMLDPRLPPLSVDIRGKV 198
            +  + D  +P ++ D+R  +
Sbjct: 221 AIKHIQDS-VPNVTTDVRKDI 240

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL+E  V+ ++RH  +V+ Y   +     ++V EY+  G L   L  +   + L   + +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEM-GKYLRLPQLV 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           ++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +     + 
Sbjct: 118 DMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 125 AG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEV-IKGKHPRDFLSNVSSSNPNILVNEM 182
           A     + APE A   + T K DV+SFG+L  E+  KG+ P           P ++  E+
Sbjct: 175 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----------YPGMVNREV 224
Query: 183 LDP-----RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           LD      R+  PP   +      S+ ++   C   +PE RP  + +   L
Sbjct: 225 LDQVERGYRMPCPPECPE------SLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  REI + + +RH NI++ Y +    +  +L+ E+   G L   L      +E    R 
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRS 117
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              ++ +A AL Y H      ++HRDI  +N+L+  + E  ++DFG +  +   S     
Sbjct: 118 ATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRX 172
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++  GVL  E + G  P D  S+  +     +VN  +
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--RRIVN--V 228
Query: 184 DPRLPPLSVDIRGKVIS 200
           D + PP   D    +IS
Sbjct: 229 DLKFPPFLSDGSKDLIS 245

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K E L E  V+ ++ +  IV+  G C  A    LV E  E G L+  L  +   ++    
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 470
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + +
Sbjct: 471 NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 122 TEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
              A T+G     + APE     K ++K DV+SFGVL  E    G+ P
Sbjct: 528 K--AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWS 61
           + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +   +  LG  
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 102
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +     +  A+ YL  +     VHRD++++NVL+  +  A VSDFG+ K      ++ 
Sbjct: 103 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASS 154
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           T+  G     + APE     K + K DV+SFG+L  E+
Sbjct: 155 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  REI + + +RH NI++ Y +    +  +L+ E+   G L   L      +E    R 
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRS 116
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
              ++ +A AL Y H      ++HRDI  +N+L+  + E  ++DFG +  +   S     
Sbjct: 117 ATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRX 171
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++  GVL  E + G  P D  S+  +     +VN  +
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--RRIVN--V 227
Query: 184 DPRLPPLSVDIRGKVIS 200
           D + PP   D    +IS
Sbjct: 228 DLKFPPFLSDGSKDLIS 244

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 118/239 (49%), Gaps = 41/239 (17%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++++ EI +L    H  IVK  G   H    +++ E+   G++ +++L  D    E    
Sbjct: 53  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---- 108
Query: 62  RRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQP 116
            +I V+ + +  AL++LH   I   +HRD+ + NVL+ LE +  ++DFG++    K +Q 
Sbjct: 109 PQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 165
Query: 117 DSSNWTEFAGTYGYVAPELAY--TMKVTA---KCDVYSFGVLALEV--IKGKH----PRD 165
             S    F GT  ++APE+    TMK T    K D++S G+  +E+  I+  H    P  
Sbjct: 166 RDS----FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 221
Query: 166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            L  ++ S+P  L    L P     SV+ R       +   + LD NPE+RP+   + +
Sbjct: 222 VLLKIAKSDPPTL----LTPS--KWSVEFR-------DFLKIALDKNPETRPSAAQLLE 267

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWS 61
           + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +   +  LG  
Sbjct: 59  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +     +  A+ YL  +     VHRD++++NVL+  +  A VSDFG+ K      ++ 
Sbjct: 118 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASS 169
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           T+  G     + APE     K + K DV+SFG+L  E+
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 19/227 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T A    +V ++ E  SL   L+   +  E+   +
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEM--KK 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 122 LIDIARQTARGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 121 WTEFAGTYGYVAPE---LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP-- 175
           + + +G+  ++APE   +  +   + + DVY+FG++  E++ G+ P    SN+++ +   
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQII 235
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            ++    L P L  +  +   ++  +M     CL    + RP+   I
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRI 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 111/227 (48%), Gaps = 19/227 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KK 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 122 LIDIARQTARGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 121 WTEFAGTYGYVAPE---LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP-- 175
           + + +G+  ++APE   +  +   + + DVY+FG++  E++ G+ P    SN+++ +   
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQII 235
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            ++    L P L  +  +   ++  +M     CL    + RP+   I
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRI 279

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 118/239 (49%), Gaps = 41/239 (17%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++++ EI +L    H  IVK  G   H    +++ E+   G++ +++L  D    E    
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---- 116
Query: 62  RRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQP 116
            +I V+ + +  AL++LH   I   +HRD+ + NVL+ LE +  ++DFG++    K +Q 
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 117 DSSNWTEFAGTYGYVAPELAY--TMKVTA---KCDVYSFGVLALEV--IKGKH----PRD 165
             S    F GT  ++APE+    TMK T    K D++S G+  +E+  I+  H    P  
Sbjct: 174 RDS----FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229
Query: 166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            L  ++ S+P  L    L P     SV+ R       +   + LD NPE+RP+   + +
Sbjct: 230 VLLKIAKSDPPTL----LTPS--KWSVEFR-------DFLKIALDKNPETRPSAAQLLE 275

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 111/227 (48%), Gaps = 19/227 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 53  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KK 109
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 110 LIDIARQTARGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQ 166
Query: 121 WTEFAGTYGYVAPE---LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP-- 175
           + + +G+  ++APE   +  +   + + DVY+FG++  E++ G+ P    SN+++ +   
Sbjct: 167 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQII 223
Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            ++    L P L  +  +   ++  +M     CL    + RP+   I
Sbjct: 224 EMVGRGSLSPDLSKVRSNCPKRMKRLMAE---CLKKKRDERPSFPRI 267

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWS 61
           + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +   +  LG  
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 289
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +     +  A+ YL  +     VHRD++++NVL+  +  A VSDFG+ K      ++ 
Sbjct: 290 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASS 341
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           T+  G     + APE     K + K DV+SFG+L  E+
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 113
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 114 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
           +           + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 108/262 (41%), Gaps = 59/262 (22%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA---- 55
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY   G L   L     A    
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 56  ----------------EELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLD 98
                             L     ++    +A  +++L   +CI    HRD++++NVLL 
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLT 192
Query: 99  LEYEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALE 156
             + A + DFG+A+ I  DS+   +        ++APE  +    T + DV+S+G+L  E
Sbjct: 193 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 252
Query: 157 VIK-GKHPRDFLSNVSSSNPNILVN-----------EMLDPRLPPLSVDIRGKVISIMEV 204
           +   G +P           P ILVN           +M  P   P +      + SIM+ 
Sbjct: 253 IFSLGLNPY----------PGILVNSKFYKLVKDGYQMAQPAFAPKN------IYSIMQA 296
Query: 205 AFLCLDNNPESRPNMQTICQLL 226
              C    P  RP  Q IC  L
Sbjct: 297 ---CWALEPTHRPTFQQICSFL 315

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 55  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 112
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 113 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 169
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 170 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 229
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 230 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 282

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 113
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 114 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 170
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 171 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 60  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 117
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 118 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 174
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 175 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 234
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 235 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 287

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 132 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 189 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 248
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 62  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 119
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 120 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 176
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 177 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 236
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 237 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 117 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 174 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 233
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 54  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 111
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 112 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 168
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 169 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 228
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 229 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 281

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 74  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 132 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 189 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 248
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 301

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 61  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 118
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 119 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 175
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 176 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 235
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 236 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 288

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 113
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 114 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 170
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 171 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 283

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 63  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 121 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 177
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 178 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 237
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 238 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 144
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 145 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 201
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 202 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 314

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWS 61
           + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +   +  LG  
Sbjct: 50  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 108
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             +     +  A+ YL  +     VHRD++++NVL+  +  A VSDFG+ K      ++ 
Sbjct: 109 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASS 160
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           T+  G     + APE       + K DV+SFG+L  E+
Sbjct: 161 TQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFY----GFCTHARHSF--LVYEYLENGSLSVILNNDTS 54
           +++ +  EI ++ ++ H N+V       G    A +    L  EY E G L   LN   +
Sbjct: 56  NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 115
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIA 111
              L       ++  I+ AL YLH +    I+HRD+  +N++L    +     + D G A
Sbjct: 116 CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 172
Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           K +       TEF GT  Y+APEL    K T   D +SFG LA E I G  P  FL N
Sbjct: 173 KELD-QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP--FLPN 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFY----GFCTHARHSF--LVYEYLENGSLSVILNNDTS 54
           +++ +  EI ++ ++ H N+V       G    A +    L  EY E G L   LN   +
Sbjct: 55  NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIA 111
              L       ++  I+ AL YLH +    I+HRD+  +N++L    +     + D G A
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           K +       TEF GT  Y+APEL    K T   D +SFG LA E I G  P  FL N
Sbjct: 172 KELD-QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP--FLPN 226

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSF--LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H NIVK+ G CT    +   L+ E+L +GSL   L  + +  ++   +++
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQL 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT-- 122
                I   + YL        VHRD++++NVL++ E++  + DFG+ K I+ D    T  
Sbjct: 118 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174
Query: 123 -EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKHPRD-FLSNVSSSNPN 176
            +      + APE     K     DV+SFGV   E++        P   FL  +  ++  
Sbjct: 175 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 234
Query: 177 I----LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +    LVN + + +  P   +   +V  +M     C +  P +R + Q + +
Sbjct: 235 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK---CWEFQPSNRTSFQNLIE 283

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ EYL  GSL   L      E +  
Sbjct: 57  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDH 114
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HR+++++N+L++ E    + DFG+ K +  D   
Sbjct: 115 IKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
           +           + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 172 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 231
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 232 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 284

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + FL E  ++  ++H  +V+ Y   T     +++ E++  GSL   L +D   + L   +
Sbjct: 52  QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPK 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            I+    IA  ++Y+        +HRD+ + NVL+       ++DFG+A+ I+ +     
Sbjct: 111 LIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 167
Query: 123 EFAG-TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN 180
           E A     + APE       T K +V+SFG+L  E++  GK P         +N +++  
Sbjct: 168 EGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYP-----GRTNADVMSA 222
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                R+P +  +   ++  IM+   +C     E RP    +  +L
Sbjct: 223 LSQGYRMPRME-NCPDELYDIMK---MCWKEKAEERPTFDYLQSVL 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSF--LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H NIVK+ G CT    +   L+ E+L +GSL   L  + +  ++   +++
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQL 129
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT-- 122
                I   + YL        VHRD++++NVL++ E++  + DFG+ K I+ D    T  
Sbjct: 130 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186
Query: 123 -EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
            +      + APE     K     DV+SFGV   E++
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           FL E  V+  ++H  +VK +   T     +++ E++  GSL   L +D  +++    + I
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLI 281
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           +    IA  ++++        +HRD+ + N+L+       ++DFG+A+        WT  
Sbjct: 282 DFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT-- 336
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEML 183
                  APE       T K DV+SFG+L +E++  G+ P   +     SNP ++     
Sbjct: 337 -------APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALER 384
Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             R+ P   +   ++ +IM     C  N PE RP  + I  +L
Sbjct: 385 GYRM-PRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 423

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 26/198 (13%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI  L   RH +I+K Y   +     F+V EY+  G L   +      EE+   R   +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---L 116
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H   +   VHRD+  +NVLLD    A ++DFG++  +  D     +  G
Sbjct: 117 FQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCG 172
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP 185
           +  Y APE ++  +    + D++S GV+   ++ G  P D                  D 
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD------------------DE 214
Query: 186 RLPPLSVDIRGKVISIME 203
            +P L   IRG V  I E
Sbjct: 215 HVPTLFKKIRGGVFYIPE 232

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGS-LSVILNNDTSAEELGWSRRINV 66
           EI VL  + H NI+K +       + ++V E  E G  L  I++     + L       +
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFIQPDSSNWT 122
           +K + +AL+Y H      +VH+D+  +N+L   +   H    + DFG+A+  + D  + T
Sbjct: 130 MKQMMNALAYFHSQH---VVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-T 184
Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVSSSNPN 176
             AGT  Y+APE+ +   VT KCD++S GV+   ++ G  P       +     +   PN
Sbjct: 185 NAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             V     P L P +VD+  ++++           +PE RP+   +
Sbjct: 244 YAVE--CRP-LTPQAVDLLKQMLT----------KDPERRPSAAQV 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 105
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 106 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F REI +L  ++H NIVK+ G C  A  R+  L+ E+L  GSL   L      E +  
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDH 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + +     I   + YL        +HRD++++N+L++ E    + DFG+ K +  D   
Sbjct: 117 IKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 121 WT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGKH-PRDFLSNVSS 172
                       + APE     K +   DV+SFGV+  E+     K K  P +F+  + +
Sbjct: 174 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 233
Query: 173 SNPNILVN----EML--DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                ++     E+L  + RLP       G    I  +   C +NN   RP+ + + 
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLA 286

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       EE+  
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG 117
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I V++G+A+ L   H      I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 118 KVSIAVLRGLAY-LREKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 171
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y+APE       + + D++S G+  +E+  G++P
Sbjct: 172 --SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T A    +V ++ E  SL   L+   +  E+   +
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEM--IK 105
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 106 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 111 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 167
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 168 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 51  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 107
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 108 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 164
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 165 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 105
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 106 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQ 162
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  +++++ H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 77  DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 194 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 247
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 248 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 298

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  +++++ H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 91  DELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 150
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 208 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 261
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 262 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 310

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 110
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 111 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 167
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 168 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 76  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 132
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 133 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 189
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 190 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 69  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 126 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQ 182
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 183 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 133
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 134 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 190
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 191 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  E+   +
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IK 133
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L  +    + DFG+A  K     S  
Sbjct: 134 LIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQ 190
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N
Sbjct: 191 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +E   EI++L  + H NI+K +      ++ +LV E+ E G L   + N    +E   + 
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA- 149
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSS 119
             N++K I   + YLH      IVHRDI  +N+LL+ +       + DFG++ F   D  
Sbjct: 150 --NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              +  GT  Y+APE+    K   KCDV+S GV+   ++ G  P
Sbjct: 205 -LRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 68  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 127
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 128 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 184
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 185 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 238
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 239 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 287

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 76  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 193 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 246
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 247 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 295

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 76  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 135
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 193 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 246
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 247 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 295

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 43/247 (17%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHS-------------FLVYEYLENGSLSVILNND 52
           L E+ +L  + H+ +V++Y      R+              F+  EY ENG+L  +++++
Sbjct: 50  LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
              ++     R+   + I  ALSY+H   I   +HRD+   N+ +D      + DFG+AK
Sbjct: 110 NLNQQRDEYWRL--FRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAK 164
Query: 113 FIQ-------------PDSS-NWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEV 157
            +              P SS N T   GT  YVA E L  T     K D+YS G++  E+
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 158 IKGKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           I       +  +      NIL     +    PP   D + KV    ++  L +D++P  R
Sbjct: 225 I-------YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK--KIIRLLIDHDPNKR 275
Query: 217 PNMQTIC 223
           P  +T+ 
Sbjct: 276 PGARTLL 282

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 91  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 150
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 208 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 261
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 262 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 310

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 26  FCTHARHS--FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP 83
           FCT       F V EYL  G L   + +  S  +   SR       I   L +LH   I 
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI- 140
Query: 84  PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
             V+RD+   N+LLD +    ++DFG+ K      +   EF GT  Y+APE+    K   
Sbjct: 141 --VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNH 198
Query: 144 KCDVYSFGVLALEVIKGKHP 163
             D +SFGVL  E++ G+ P
Sbjct: 199 SVDWWSFGVLLYEMLIGQSP 218

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D +E +RE  ++ ++ +  IV+  G C  A    LV E    G L   L      EE+  
Sbjct: 53  DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPV 109
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    ++  ++  + YL        VHRD++++NVLL   + A +SDFG++K +  D S 
Sbjct: 110 SNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
Query: 121 WT-EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           +T   AG +   + APE     K +++ DV+S+GV   E +  G+ P
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 91  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 150
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 207
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 208 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 261
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 262 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 312

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 94  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 153
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 154 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 210
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    + +    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 211 IY--RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 264
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 265 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 315

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 77  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 193
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 194 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 247
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 248 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 298

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 93  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 152
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 153 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 209
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 210 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 263
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 264 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAII 312

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 83  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 142
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 143 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 199
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 200 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 253
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 254 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 304

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    + +    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 234 IY--RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 287
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 288 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 338

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 26/198 (13%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI  L   RH +I+K Y   +     F+V EY+  G L   +      EE+   R   +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---L 116
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H   +   VHRD+  +NVLLD    A ++DFG++  +  D        G
Sbjct: 117 FQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCG 172
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP 185
           +  Y APE ++  +    + D++S GV+   ++ G  P D                  D 
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD------------------DE 214
Query: 186 RLPPLSVDIRGKVISIME 203
            +P L   IRG V  I E
Sbjct: 215 HVPTLFKKIRGGVFYIPE 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 77  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 136
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD 193
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 194 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 247
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 248 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 298

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
            +E+ ++  + H  +V  +         F+V + L  G L   L  +   +E        
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL--- 119
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            I  +  AL YL +     I+HRD+   N+LLD     H++DF IA  + P  +  T  A
Sbjct: 120 FICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMA 175
Query: 126 GTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
           GT  Y+APE+  + K        D +S GV A E+++G+ P    S+ SS 
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND----TSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 103 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 162
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKF 113
            L     ++V + IA    YL  +     +HRDI+++N LL        A + DFG+A+ 
Sbjct: 163 SLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 219
Query: 114 IQPDSSNWTEFAG----TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           I    +++    G       ++ PE       T+K D +SFGVL  E+        ++  
Sbjct: 220 IY--RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPY 273
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            S SN  +L       R+ P   +  G V  IM     C  + PE RPN   I +
Sbjct: 274 PSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQ---CWQHQPEDRPNFAIILE 324

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 169
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 170 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 223
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 224 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 108 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 162 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 108 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 162 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+  LRE+ +L ++ H NI+K Y F     + +LV E    G L   + +     E+  
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +R   +I+ +   ++Y+H +    IVHRD+  +N+LL+ + +     + DFG++   +  
Sbjct: 129 AR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S    +  GT  Y+APE+ +      KCDV+S GV+   ++ G  P
Sbjct: 182 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 136 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 119 S----NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 187 XXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++   Q   S 
Sbjct: 108 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 159
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++   Q   S 
Sbjct: 108 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 159
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+  LRE+ +L ++ H NI+K Y F     + +LV E    G L   + +     E+  
Sbjct: 75  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 134
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPD 117
           +R   +I+ +   ++Y+H +    IVHRD+  +N+LL+ + +     + DFG++   +  
Sbjct: 135 AR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 187
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S    +  GT  Y+APE+ +      KCDV+S GV+   ++ G  P
Sbjct: 188 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRI 64
           E  +L E+ H  IVK  Y F T  +  +L+ ++L  G L   L+ +   + E++ +    
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF---- 130
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +A AL +LH   I   ++RD+  +N+LLD E    ++DFG++K           F
Sbjct: 131 -YLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+      T   D +SFGVL  E++ G  P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRI 64
           E  +L E+ H  IVK  Y F T  +  +L+ ++L  G L   L+ +   + E++ +    
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF---- 130
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +A AL +LH   I   ++RD+  +N+LLD E    ++DFG++K           F
Sbjct: 131 -YLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+      T   D +SFGVL  E++ G  P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ ++E+  L ++RH N +++ G       ++LV EY   GS S +L  +   + L    
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVE 155
Query: 63  RINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
              V  G    L+YLH H+    ++HRD+ + N+LL       + DFG A  + P +   
Sbjct: 156 IAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-- 209
Query: 122 TEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I 
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIA 266
Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            NE    +    S   R  V S       CL   P+ RP  + + +
Sbjct: 267 QNESPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 305

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRI 64
           E  +L E+ H  IVK  Y F T  +  +L+ ++L  G L   L+ +   + E++ +    
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF---- 131
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +A AL +LH   I   ++RD+  +N+LLD E    ++DFG++K           F
Sbjct: 132 -YLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+      T   D +SFGVL  E++ G  P
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 95  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 154
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 155 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 205
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 206 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 9/163 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGW 60
           + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E++  
Sbjct: 75  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 134
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I VIKG    L+YL       I+HRD+   N+L++   E  + DFG++  +    +N
Sbjct: 135 KVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              F GT  Y++PE       + + D++S G+  +E+  G++P
Sbjct: 189 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 137 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++ ++E+  L ++RH N +++ G       ++LV EY   GS S +L  +   + L    
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVE 116
Query: 63  RINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
              V  G    L+YLH H+    ++HRD+ + N+LL       + DFG A  + P +   
Sbjct: 117 IAAVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-- 170
Query: 122 TEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
             F GT  ++APE+   M   +   K DV+S G+  +E+ + K P  F  N  S+  +I 
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIA 227
Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            NE    +    S   R  V S       CL   P+ RP  + + +
Sbjct: 228 QNESPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 96  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 155
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 156 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 206
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 207 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 134 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+  LRE+ +L ++ H NI+K Y F     + +LV E    G L   + +     E+  
Sbjct: 92  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 151
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +R   +I+ +   ++Y+H +    IVHRD+  +N+LL+ + +     + DFG++   +  
Sbjct: 152 AR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 204
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S    +  GT  Y+APE+ +      KCDV+S GV+   ++ G  P
Sbjct: 205 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 69  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 128
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 129 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 179
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 180 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 72  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 132 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSS 173
                N T       ++A E   T K T K DV+SFGVL  E++ +G  P   ++    +
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              +    +L P   P           + EV   C     E RP+   +
Sbjct: 243 VYLLQGRRLLQPEYCP---------DPLYEVMLKCWHPKAEMRPSFSEL 282

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 52  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 108
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 109 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 137 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+  LRE+ +L ++ H NI+K Y F     + +LV E    G L   + +     E+  
Sbjct: 93  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 152
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +R   +I+ +   ++Y+H +    IVHRD+  +N+LL+ + +     + DFG++   +  
Sbjct: 153 AR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 205
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S    +  GT  Y+APE+ +      KCDV+S GV+   ++ G  P
Sbjct: 206 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D +E +RE  ++ ++ +  IV+  G C  A    LV E    G L   L      EE+  
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPV 435
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    ++  ++  + YL        VHR+++++NVLL   + A +SDFG++K +  D S 
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492
Query: 121 WT-EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
           +T   AG +   + APE     K +++ DV+S+GV   E +  G+ P
Sbjct: 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 76  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 135
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 136 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSS 173
                N T       ++A E   T K T K DV+SFGVL  E++ +G  P   ++    +
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 246
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              +    +L P   P           + EV   C     E RP+   +
Sbjct: 247 VYLLQGRRLLQPEYCP---------DPLYEVMLKCWHPKAEMRPSFSEL 286

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G+   + V KG+ +  S          VHRD++++N +LD ++   V+DFG+A+ +    
Sbjct: 135 GFG--LQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 119 ----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSS 173
                N T       ++A E   T K T K DV+SFGVL  E++ +G  P   ++    +
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 245
Query: 174 NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              +    +L P   P           + EV   C     E RP+   +
Sbjct: 246 VYLLQGRRLLQPEYCP---------DPLYEVMLKCWHPKAEMRPSFSEL 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 8/221 (3%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           + + ++EI +L ++ H N++K+Y          +V E  + G LS ++ +    + L   
Sbjct: 76  RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE 135
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           R   V K      S L H     ++HRDI   NV +       + D G+ +F    ++  
Sbjct: 136 R--TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
               GT  Y++PE  +      K D++S G L  E+   + P  F  +    N   L  +
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGD--KMNLYSLCKK 249
Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           +     PPL  D   +   + ++  +C++ +PE RP++  +
Sbjct: 250 IEQCDYPPLPSDHYSE--ELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 138 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE 188
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 8/140 (5%)
Query: 26  FCTHARHS--FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP 83
           FCT       F V EYL  G L   + +  S  +   SR       I   L +LH   I 
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI- 139
Query: 84  PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
             V+RD+   N+LLD +    ++DFG+ K      +    F GT  Y+APE+    K   
Sbjct: 140 --VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 144 KCDVYSFGVLALEVIKGKHP 163
             D +SFGVL  E++ G+ P
Sbjct: 198 SVDWWSFGVLLYEMLIGQSP 217

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI +   + H N+VKFYG        +L  EY   G L   +  D    E    R    
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---F 109
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEF 124
              +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++      + 
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 125 AGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHPRDFLSN 169
            GT  YVAPEL    +  A+  DV+S G++   ++ G+ P D  S+
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 82  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 141
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 142 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 192
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 193 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 78  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 137
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 138 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 188
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 24/177 (13%)
Query: 1   DKKEFLREITV--LTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           DK+ +  E  V  L  ++H NI++F G            +L+  + E GSLS  L     
Sbjct: 59  DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---- 114
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDC-------IPPIVHRDISSKNVLLDLEYEAHVSD 107
           A  + W+   ++ + +A  L+YLH D         P I HRDI SKNVLL     A ++D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 108 FGIA-KFIQPDSSNWTEF-AGTYGYVAPE-----LAYTMKVTAKCDVYSFGVLALEV 157
           FG+A KF    S+  T    GT  Y+APE     + +      + D+Y+ G++  E+
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 75  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 134
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 135 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 186 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 137 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 8/196 (4%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +  REI +   + H NI++ Y +    R  +L+ EY   G L   L    + +E    R 
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE---QRT 125
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++ +A AL Y H      ++HRDI  +N+LL L+ E  ++DFG +  +   S     
Sbjct: 126 ATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT 180
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
             GT  Y+ PE+        K D++  GVL  E++ G  P +  S+  +    + V+   
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKF 240
Query: 184 DPRLPPLSVDIRGKVI 199
              +P  + D+  K++
Sbjct: 241 PASVPTGAQDLISKLL 256

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 77  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 136
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 137 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 18/169 (10%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTS----AEEL 58
           +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T      + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI---Q 115
           G+   + V KG+    S          VHRD++++N +LD ++   V+DFG+A+ +   +
Sbjct: 196 GFG--LQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 116 PDS-SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DS  N T       ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL      +   D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
            EF G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           RE  V++ + H   VK Y FC       +    Y +NG L   +    S +E     R  
Sbjct: 86  RERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFY 142
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTE 123
             + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    
Sbjct: 143 TAE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 198
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           F GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 199 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           + L E+ VL  + H NI+K Y F    R+ +LV E  + G L   + +     E+  +  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV- 140
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLD-LEYEA--HVSDFGIAKFIQPDSSN 120
             +IK +   ++YLH      IVHRD+  +N+LL+  E +A   + DFG++   + +   
Sbjct: 141 --IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKK 194
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             E  GT  Y+APE+    K   KCDV+S GV+   ++ G  P
Sbjct: 195 MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 116
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 117 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL-GWSRRI 64
           +REI++L E++H NIVK Y      +   LV+E+L+     ++   +   E +   S  +
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            ++ GIA+      HD    ++HRD+  +N+L++ E E  ++DFG+A+        +T  
Sbjct: 108 QLLNGIAYC-----HD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 125 AGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG 160
             T  Y AP+ L  + K +   D++S G +  E++ G
Sbjct: 161 VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL-GWSRRI 64
           +REI++L E++H NIVK Y      +   LV+E+L+     ++   +   E +   S  +
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            ++ GIA+      HD    ++HRD+  +N+L++ E E  ++DFG+A+        +T  
Sbjct: 108 QLLNGIAYC-----HD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 125 AGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG 160
             T  Y AP+ L  + K +   D++S G +  E++ G
Sbjct: 161 VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 115
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 116 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 43/247 (17%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHS-------------FLVYEYLENGSLSVILNND 52
           L E+ +L  + H+ +V++Y      R+              F+  EY EN +L  +++++
Sbjct: 50  LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE 109
Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
              ++     R+   + I  ALSY+H   I   +HRD+   N+ +D      + DFG+AK
Sbjct: 110 NLNQQRDEYWRL--FRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAK 164
Query: 113 FIQ-------------PDSS-NWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEV 157
            +              P SS N T   GT  YVA E L  T     K D+YS G++  E+
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 158 IKGKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           I       +  +      NIL     +    PP   D + KV    ++  L +D++P  R
Sbjct: 225 I-------YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK--KIIRLLIDHDPNKR 275
Query: 217 PNMQTIC 223
           P  +T+ 
Sbjct: 276 PGARTLL 282

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 139
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 140 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 114
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 115 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 113
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 114 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI  L   RH +I+K Y   +     F+V EY+  G L   +  +   +E   SRR+  
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-KESRRL-- 121
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I   + Y H   +   VHRD+  +NVLLD    A ++DFG++  +  D        G
Sbjct: 122 FQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCG 177
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  Y APE ++  +    + D++S GV+   ++ G  P D
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 139
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 140 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL-GWSRRI 64
           +REI++L E++H NIVK Y      +   LV+E+L+     ++   +   E +   S  +
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            ++ GIA+      HD    ++HRD+  +N+L++ E E  ++DFG+A+        +T  
Sbjct: 108 QLLNGIAYC-----HD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 125 AGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG 160
             T  Y AP+ L  + K +   D++S G +  E++ G
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 136
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 137 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 141
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 142 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 136
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 137 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 136
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 137 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 136
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 137 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 138
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 139 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 120
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 121 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 135
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 136 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 123
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH +    ++HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 124 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR- 186
             Y+APE+      + + DV+S G +   ++ GK P +  S +  +   I  NE   P+ 
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKH 239
Query: 187 LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           + P++  +  K+          L  +P +RP   TI +LL
Sbjct: 240 INPVAASLIQKM----------LQTDPTARP---TINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 123
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH +    ++HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 124 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR- 186
             Y+APE+      + + DV+S G +   ++ GK P +  S +  +   I  NE   P+ 
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKH 239
Query: 187 LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           + P++  +  K+          L  +P +RP   TI +LL
Sbjct: 240 INPVAASLIQKM----------LQTDPTARP---TINELL 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 121
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH +    ++HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 122 RQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR- 186
             Y+APE+      + + DV+S G +   ++ GK P +  S +  +   I  NE   P+ 
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIPKH 237
Query: 187 LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           + P++  +  K+          L  +P +RP +  +
Sbjct: 238 INPVAASLIQKM----------LQTDPTARPTINEL 263

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 6/156 (3%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 127
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH + +   +HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 128 RQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE  V++ + H   VK Y         +    Y +NG L   +    S +E     R   
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET--CTRFYT 135
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEF 124
            + I  AL YLH   I   +HRD+  +N+LL+ +    ++DFG AK + P+S  +    F
Sbjct: 136 AE-IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+  LRE+ +L ++ H NI K Y F     + +LV E    G L   + +     E+  
Sbjct: 69  DKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +R   +I+ +   ++Y H +    IVHRD+  +N+LL+ + +     + DFG++   +  
Sbjct: 129 AR---IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S    +  GT  Y+APE+ +      KCDV+S GV+   ++ G  P
Sbjct: 182 SKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 14/167 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   L         GW +
Sbjct: 51  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH------GWMK 104
Query: 63  RINV---IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
                   + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +
Sbjct: 105 EKEARAKFRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GN 160
Query: 120 NWTEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
               F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 161 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI- 64
           +REI++L E+ H NIV         R   LV+E++E     V+  N T  ++      + 
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            +++G+AH   +        I+HRD+  +N+L++ +    ++DFG+A+       ++T  
Sbjct: 127 QLLRGVAHCHQHR-------ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 125 AGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
             T  Y AP+ L  + K +   D++S G +  E+I GK
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI- 64
           +REI++L E+ H NIV         R   LV+E++E     V+  N T  ++      + 
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
            +++G+AH   +        I+HRD+  +N+L++ +    ++DFG+A+       ++T  
Sbjct: 127 QLLRGVAHCHQHR-------ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 125 AGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
             T  Y AP+ L  + K +   D++S G +  E+I GK
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 6/156 (3%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 145
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH + +   +HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 146 RQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 202
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 6/156 (3%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI++   + H+++V F+GF       F+V E     SL   L      + L        +
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 147
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGT 127
           + I     YLH + +   +HRD+   N+ L+ + E  + DFG+A  ++ D        GT
Sbjct: 148 RQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 128 YGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +L+ EY   G +   ++ +    E+   S
Sbjct: 56  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H      IVHRD+ ++N+LLD +    ++DFG +          
Sbjct: 116 K----FRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKL 167
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 168 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI VL +I+H NIV          H +L+ + +  G L   +       E   SR   +I
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LI 122
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVL---LDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH      IVHRD+  +N+L   LD + +  +SDFG++K   P S   T  
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA- 178
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT GYVAPE+      +   D +S GV+A  ++ G  P
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 44/246 (17%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI-LNNDTSAEELGW 60
           KK  +REI +L ++RH N+V     C   +  +LV+E++++  L  + L  +    ++  
Sbjct: 68  KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ 127
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I GI    S+        I+HRDI  +N+L+       + DFG A+ +      
Sbjct: 128 KYLFQIINGIGFCHSH-------NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180
Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG------------------- 160
           + +   T  Y APE L   +K     DV++ G L  E+  G                   
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 161 ------KHPRDFLSNVSSSN---PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN 211
                 +H   F  N   +    P I   E L+ R P LS         ++++A  CL  
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE-------VVIDLAKKCLHI 293
Query: 212 NPESRP 217
           +P+ RP
Sbjct: 294 DPDKRP 299

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 11/172 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T    + +V ++ E  SL   L+   +  ++   +
Sbjct: 77  QAFRNEVAVLRKTRHVNILLFMGYMTKDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQ 133
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA--KFIQPDSSN 120
            I++ +  A  + YLH   I   +HRD+ S N+ L       + DFG+A  K     S  
Sbjct: 134 LIDIARQTAQGMDYLHAKNI---IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 121 WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
             +  G+  ++APE+         + + DVYS+G++  E++ G+ P   ++N
Sbjct: 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +L+ EY   G +   ++ +    E+   S
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H      IVHRD+ ++N+LLD +    ++DFG +          
Sbjct: 119 K----FRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKL 170
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G   Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 24/236 (10%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDT 53
           +++E  +EI +L +   HRNI  +YG              +LV E+   GS++ ++ N T
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-T 121
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
               L       + + I   LS+LH      ++HRDI  +NVLL    E  + DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEVIKGKHPRDFLS 168
           +         F GT  ++APE+             K D++S G+ A+E+ +G  P   L 
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LC 235
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++       L+     PRL   S     K  S +E    CL  N   RP  + + +
Sbjct: 236 DMHPMRALFLIPRNPAPRLK--SKKWSKKFQSFIES---CLVKNHSQRPATEQLMK 286

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI VL +I+H NIV          H +L+ + +  G L   +       E   SR   +I
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LI 122
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVL---LDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH      IVHRD+  +N+L   LD + +  +SDFG++K   P S   T  
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA- 178
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT GYVAPE+      +   D +S GV+A  ++ G  P
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI VL +I+H NIV          H +L+ + +  G L   +       E   SR   +I
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LI 122
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVL---LDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH      IVHRD+  +N+L   LD + +  +SDFG++K   P S   T  
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA- 178
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT GYVAPE+      +   D +S GV+A  ++ G  P
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI VL +I+H NIV          H +L+ + +  G L   +       E   SR   +I
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LI 122
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVL---LDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH      IVHRD+  +N+L   LD + +  +SDFG++K   P S   T  
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA- 178
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT GYVAPE+      +   D +S GV+A  ++ G  P
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 43/247 (17%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHS-------------FLVYEYLENGSLSVILNND 52
           L E+ +L  + H+ +V++Y      R+              F+  EY EN +L  +++++
Sbjct: 50  LSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE 109
Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
              ++     R+   + I  ALSY+H   I   +HR++   N+ +D      + DFG+AK
Sbjct: 110 NLNQQRDEYWRL--FRQILEALSYIHSQGI---IHRNLKPXNIFIDESRNVKIGDFGLAK 164
Query: 113 FIQ-------------PDSS-NWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEV 157
            +              P SS N T   GT  YVA E L  T     K D YS G++  E 
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX 224
Query: 158 IKGKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           I       +  +      NIL     +    PP   D + KV    ++  L +D++P  R
Sbjct: 225 I-------YPFSTGXERVNILKKLRSVSIEFPPDFDDNKXKVEK--KIIRLLIDHDPNKR 275
Query: 217 PNMQTIC 223
           P  +T+ 
Sbjct: 276 PGARTLL 282

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 9/166 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +     +LV++ +  G L      D  A E  +
Sbjct: 46  DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF----EDIVARE--Y 99
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
               +    I   L  ++H  +  IVHRD+  +N+LL  + +     ++DFG+A  +Q D
Sbjct: 100 YSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD 159
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 9/166 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +     +LV++ +  G L     +  + E    
Sbjct: 46  DHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSE 102
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  A+ + H      +VHRD+  +N+LL  + +     ++DFG+A  +Q D
Sbjct: 103 ADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G   Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 9/166 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +     +LV++ +  G L      D  A E  +
Sbjct: 46  DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF----EDIVARE--Y 99
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
               +    I   L  ++H  +  IVHRD+  +N+LL  + +     ++DFG+A  +Q D
Sbjct: 100 YSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD 159
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ ++  + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 119 K----FRQIVSAVQYCHQKYI---VHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKL 170
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G+  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 171 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 10/161 (6%)
Query: 7   REITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +EIT L     H NIVK +       H+FLV E L  G L   +       E   S    
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY--- 110
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWT 122
           +++ +  A+S++H      +VHRD+  +N+L   E    E  + DFG A+   PD+    
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               T  Y APEL         CD++S GV+   ++ G+ P
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEELGWSR 62
            L E+ VL ++ H NI+K Y F    R+ +LV E    G L   +IL    S  +     
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA--- 124
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSS 119
              ++K +    +YLH      IVHRD+  +N+LL+ +       + DFG++   +    
Sbjct: 125 --VIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GG 178
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              E  GT  Y+APE+    K   KCDV+S GV+   ++ G  P
Sbjct: 179 KMKERLGTAYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 7/159 (4%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E+ +  +++H +I++ Y +   + + +LV E   NG ++  L N         +R  + +
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFM 118
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDSSNWTEFAG 126
             I   + YLH      I+HRD++  N+LL       ++DFG+A  ++ P   ++T   G
Sbjct: 119 HQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCG 174
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           T  Y++PE+A       + DV+S G +   ++ G+ P D
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  ++  + H ++V+  G C       LV + + +G L   ++     + +G    
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLL 142
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +N    IA  + YL    +   VHRD++++NVL+       ++DFG+A+ ++ D   +  
Sbjct: 143 LNWCVQIAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199
Query: 124 FAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN 180
             G     ++A E  +  K T + DV+S+GV   E++  G  P D +   +   P++L  
Sbjct: 200 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEK 257
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
               P+ P  ++D       +  V   C   + +SRP  + + 
Sbjct: 258 GERLPQPPICTID-------VYMVMVKCWMIDADSRPKFKELA 293

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           EF+ E  ++  + H ++V+  G C       LV + + +G L   ++     + +G    
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLL 119
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           +N    IA  + YL       +VHRD++++NVL+       ++DFG+A+ ++ D   +  
Sbjct: 120 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176
Query: 124 FAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVN 180
             G     ++A E  +  K T + DV+S+GV   E++  G  P D +   +   P++L  
Sbjct: 177 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEK 234
Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
               P+ P  ++D+   ++        C   + +SRP  + + 
Sbjct: 235 GERLPQPPICTIDVYMVMVK-------CWMIDADSRPKFKELA 270

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEELGWSR 62
            L E+ VL ++ H NI+K Y F    R+ +LV E    G L   +IL    S  +     
Sbjct: 51  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA--- 107
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPDSS 119
              ++K +    +YLH      IVHRD+  +N+LL+ +       + DFG++   +    
Sbjct: 108 --VIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GG 161
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
              E  GT  Y+APE+    K   KCDV+S GV+
Sbjct: 162 KMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVI 194

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI+ L  +RH +I+K Y          +V EY  N     I+  D  +E+   +RR   
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF-- 112
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H      IVHRD+  +N+LLD      ++DFG++  I  D +      G
Sbjct: 113 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCG 168
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI+ L  +RH +I+K Y          +V EY  N     I+  D  +E+   +RR   
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF-- 108
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H      IVHRD+  +N+LLD      ++DFG++  I  D +      G
Sbjct: 109 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCG 164
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI+ L  +RH +I+K Y          +V EY  N     I+  D  +E+   +RR   
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF-- 118
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H      IVHRD+  +N+LLD      ++DFG++  I  D +      G
Sbjct: 119 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCG 174
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI+ L  +RH +I+K Y          +V EY  N     I+  D  +E+   +RR   
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRF-- 117
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H      IVHRD+  +N+LLD      ++DFG++  I  D +      G
Sbjct: 118 FQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDGNFLKTSCG 173
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
           +  Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 11/167 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +     +LV++ +  G L     +  + E    
Sbjct: 73  DHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSE 129
Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQP 116
           +   + I  I  +++++H HD    IVHRD+  +N+LL  + +     ++DFG+A  +Q 
Sbjct: 130 ADASHCIHQILESVNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 7   REITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           RE  +L ++  H +I+        +   FLV++ +  G L   L    +  E       +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRS 204
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           +++ +  A+S+LH + I   VHRD+  +N+LLD   +  +SDFG +  ++P      E  
Sbjct: 205 IMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC 260
Query: 126 GTYGYVAPE-LAYTMKVT-----AKCDVYSFGVLALEVIKGKHP 163
           GT GY+APE L  +M  T      + D+++ GV+   ++ G  P
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           D+K + RE  +   +  RH NI+ F      +RHS    +L+  Y E GSL   L   T 
Sbjct: 72  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT- 130
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
              L     + ++  IA  L++LH +       P I HRD+ SKN+L+    +  ++D G
Sbjct: 131 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 187
Query: 110 IAKFIQPDSSNWTEFA-----GTYGYVAPE-LAYTMKVTA-----KCDVYSFGVLALEVI 158
           +A  +   S+N  +       GT  Y+APE L  T++V       + D+++FG++  EV 
Sbjct: 188 LA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246
Query: 159 K 159
           +
Sbjct: 247 R 247

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           D+K + RE  +   +  RH NI+ F      +RHS    +L+  Y E GSL   L   T 
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT- 101
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
              L     + ++  IA  L++LH +       P I HRD+ SKN+L+    +  ++D G
Sbjct: 102 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 110 IAKFIQPDSSNWTEFA-----GTYGYVAPE-LAYTMKVTA-----KCDVYSFGVLALEVI 158
           +A  +   S+N  +       GT  Y+APE L  T++V       + D+++FG++  EV 
Sbjct: 159 LA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 159 K 159
           +
Sbjct: 218 R 218

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           D+K + RE  +   +  RH NI+ F      +RHS    +L+  Y E GSL   L   T 
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT- 101
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
              L     + ++  IA  L++LH +       P I HRD+ SKN+L+    +  ++D G
Sbjct: 102 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 110 IAKFIQPDSSNWTEFA-----GTYGYVAPE-LAYTMKVTA-----KCDVYSFGVLALEVI 158
           +A  +   S+N  +       GT  Y+APE L  T++V       + D+++FG++  EV 
Sbjct: 159 LA-VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 159 K 159
           +
Sbjct: 218 R 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN----------- 51
           ++ L E  VL ++ H +++K YG C+      L+ EY + GSL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 52  ------------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
                       D  A  +G    I+    I+  + YL       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185
Query: 100 EYEAHVSDFGIAKFIQPDSSNWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 158 I 158
           +
Sbjct: 246 V 246

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 27/173 (15%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTSAEELGW 60
           REI     ++H N+++F       R S      +L+  + + GSL+  L  +     + W
Sbjct: 58  REIFSTPGMKHENLLQF--IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITW 111
Query: 61  SRRINVIKGIAHALSYLHHDC--------IPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           +   +V + ++  LSYLH D          P I HRD  SKNVLL  +  A ++DFG+A 
Sbjct: 112 NELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171
Query: 113 FIQPDS--SNWTEFAGTYGYVAPE-----LAYTMKVTAKCDVYSFGVLALEVI 158
             +P     +     GT  Y+APE     + +      + D+Y+ G++  E++
Sbjct: 172 RFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 21/175 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+ I       N T       ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 ADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI 85
           F T +R  F V EY+  G L   +       E            I+ AL+YLH   I   
Sbjct: 79  FQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNYLHERGI--- 131
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+   NVLLD E    ++D+G+ K         + F GT  Y+APE+          
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 191
Query: 146 DVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
           D ++ GVL  E++ G+ P D +   SS NP+
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVG--SSDNPD 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI 85
           F T +R  F V EY+  G L   +       E     R    + I+ AL+YLH   I   
Sbjct: 122 FQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEE--HARFYSAE-ISLALNYLHERGI--- 174
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAK 144
           ++RD+   NVLLD E    ++D+G+ K  ++P  +  T F GT  Y+APE+         
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFS 233
Query: 145 CDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            D ++ GVL  E++ G+ P D +   SS NP+
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVG--SSDNPD 263

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDT--SAEELGWSRRI 64
           E  +L ++ H  +VK  Y F T  +  +L+ ++L  G L   L+ +   + E++ +    
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF---- 134
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +A  L +LH   I   ++RD+  +N+LLD E    ++DFG++K           F
Sbjct: 135 -YLAELALGLDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF 190
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+      +   D +S+GVL  E++ G  P
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN----------- 51
           ++ L E  VL ++ H +++K YG C+      L+ EY + GSL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 52  ------------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
                       D  A  +G    I+    I+  + YL       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAE 185
Query: 100 EYEAHVSDFGIAKFIQPDSSNWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 158 I 158
           +
Sbjct: 246 V 246

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI 85
           F T +R  F V EY+  G L   +       E            I+ AL+YLH   I   
Sbjct: 75  FQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNYLHERGI--- 127
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+   NVLLD E    ++D+G+ K         + F GT  Y+APE+          
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 187
Query: 146 DVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
           D ++ GVL  E++ G+ P D +   SS NP+
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVG--SSDNPD 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 29/178 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 244
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 245 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 10/165 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           ++  RE+ +   + H NIVK +      +  +LV EY   G +   ++ +    E+   +
Sbjct: 58  QKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA 117
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +     + I  A+ Y H   I   VHRD+ ++N+LLD +    ++DFG +       +  
Sbjct: 118 K----FRQIVSAVQYCHQKFI---VHRDLKAENLLLDADXNIKIADFGFSNEFTF-GNKL 169
Query: 122 TEFAGTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHPRD 165
             F G   Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 26  FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI 85
           F T +R  F V EY+  G L   +       E            I+ AL+YLH   I   
Sbjct: 90  FQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLALNYLHERGI--- 142
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+   NVLLD E    ++D+G+ K         + F GT  Y+APE+          
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 202
Query: 146 DVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
           D ++ GVL  E++ G+ P D +   SS NP+
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVG--SSDNPD 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 22/232 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 56  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 115
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 116 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 172
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I           G     +++PE       T   DV+SFGV+  E+    + P   LSN 
Sbjct: 173 IXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                 ++   +LD   P    D+      ++E+  +C   NP+ RP+   I
Sbjct: 233 QVLR-FVMEGGLLDK--PDNCPDM------LLELMRMCWQYNPKMRPSFLEI 275

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFL--VYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H +I+K+ G C  A  + L  V EY+  GSL   L   +    +G ++ +
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLL 137
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--- 121
              + I   ++YLH       +HRD++++NVLLD +    + DFG+AK +      +   
Sbjct: 138 LFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVR 194
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
            +      + APE     K     DV+SFGV   E++
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +   ++H+NIV++ G  +      +  E +  GSLS +L +     +          
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA--HVSDFGIAKFIQPDSSNWTEFA 125
           K I   L YLH +    IVHRDI   NVL++  Y     +SDFG +K +   +     F 
Sbjct: 129 KQILEGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 126 GTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT  Y+APE+            D++S G   +E+  GK P
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +   H +L+++ +  G L     +  + E    
Sbjct: 64  DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSE 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  A+ + H      +VHRD+  +N+LL  + +     ++DFG+A  ++ +
Sbjct: 121 ADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 70  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 129
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 130 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLTARNVLVTENNVMKI 185
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 186 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR--IN 65
           EI VL +I+H NIV          H +LV + +  G L      D   E+  ++ +    
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELF-----DRIVEKGFYTEKDAST 124
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWT 122
           +I+ +  A+ YLH      IVHRD+  +N+L    D E +  +SDFG++K ++      +
Sbjct: 125 LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMS 180
Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              GT GYVAPE+      +   D +S GV+A  ++ G  P
Sbjct: 181 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 9   ITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIK 68
           +  +  + H +IV+  G C  +    LV +YL  GSL   +     A  LG    +N   
Sbjct: 84  MLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGV 140
Query: 69  GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAG 126
            IA  + YL    +   VHR+++++NVLL    +  V+DFG+A  + PD     ++E   
Sbjct: 141 QIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 197
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
              ++A E  +  K T + DV+S+GV   E++
Sbjct: 198 PIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFC--THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +RE  VL ++ H+NIVK +     T  RH  L+ E+   GSL  +L   ++A  L  S  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSS 119
           + V++ +   +++L  +    IVHR+I   N++     D +    ++DFG A+ ++ D  
Sbjct: 115 LIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDE 170
Query: 120 NWTEFAGTYGYVAPEL--------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +    GT  Y+ P++         +  K  A  D++S GV       G  P
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEX 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQ--PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I         T       ++APE  +    T + DV+SFGVL  E+
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMRI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFC--THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +RE  VL ++ H+NIVK +     T  RH  L+ E+   GSL  +L   ++A  L  S  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSS 119
           + V++ +   +++L  +    IVHR+I   N++     D +    ++DFG A+ ++ D  
Sbjct: 115 LIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDE 170
Query: 120 NWTEFAGTYGYVAPEL--------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +    GT  Y+ P++         +  K  A  D++S GV       G  P
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 30/181 (16%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN----------- 51
           ++ L E  VL ++ H +++K YG C+      L+ EY + GSL   L             
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 52  ------------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
                       D  A  +G    I+    I+  + YL       +VHRD++++N+L+  
Sbjct: 131 GGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAE 185
Query: 100 EYEAHVSDFGIAKFIQPDSSNWTEFAGT--YGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
             +  +SDFG+++ +  + S      G     ++A E  +    T + DV+SFGVL  E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 158 I 158
           +
Sbjct: 246 V 246

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 115
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 116 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI+ L  +RH +I+K Y   T      +V EY        I+      E+ G  RR   
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEG--RRF-- 113
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + I  A+ Y H      IVHRD+  +N+LLD      ++DFG++  I  D +      G
Sbjct: 114 FQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCG 169
Query: 127 TYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRD--FLSNV 170
           +  Y APE +   +    + DV+S G++   ++ G+ P D  F+ N+
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 75  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 134
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 135 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 190
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 191 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 8/161 (4%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
            EI +   ++H+NIV++ G  +      +  E +  GSLS +L +     +         
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA--HVSDFGIAKFIQPDSSNWTEF 124
            K I   L YLH +    IVHRDI   NVL++  Y     +SDFG +K +   +     F
Sbjct: 114 TKQILEGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETF 169
Query: 125 AGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+            D++S G   +E+  GK P
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 72  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 131
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 132 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 187
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 188 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 29/178 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 9   ITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIK 68
           +  +  + H +IV+  G C  +    LV +YL  GSL   +     A  LG    +N   
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGV 122
Query: 69  GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAG 126
            IA  + YL    +   VHR+++++NVLL    +  V+DFG+A  + PD     ++E   
Sbjct: 123 QIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
              ++A E  +  K T + DV+S+GV   E++
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 110
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R    
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE---ERARFY 113
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
              I  AL YLH      +V+RDI  +N++LD +    ++DFG+ K    D +    F G
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 170
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 22/220 (10%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++  +EI +L ++ H N+VK        +  H ++V+E +  G +  +      +E+   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
               ++IKGI     YLH+     I+HRDI   N+L+  +    ++DFG++   +   + 
Sbjct: 141 FYFQDLIKGI----EYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 121 WTEFAGTYGYVAPE-LAYTMKVTA--KCDVYSFGVLALEVIKGKHPRDFLSN-VSSSNPN 176
            +   GT  ++APE L+ T K+ +    DV++ GV     + G+ P  F+   +   +  
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDERIMCLHSK 251
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           I    +  P  P ++ D++  +  +       LD NPESR
Sbjct: 252 IKSQALEFPDQPDIAEDLKDLITRM-------LDKNPESR 284

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 56  LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 111
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 112 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 169
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 58  LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 113
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 114 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 171
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 172 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 22/232 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I           G     +++PE       T   DV+SFGV+  E+    + P   LSN 
Sbjct: 182 IXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                 ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 242 QVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 284

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 251
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 252 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 57  LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 112
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 113 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 7/159 (4%)
Query: 6   LREITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L E  VL   RH  +    Y F TH R  F V EY   G L   L+ +    E    R  
Sbjct: 199 LTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE---DRAR 254
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
                I  AL YLH +    +V+RD+  +N++LD +    ++DFG+ K    D +    F
Sbjct: 255 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+          D +  GV+  E++ G+ P
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSL------SVILNND- 52
           D ++F  E+ VL ++ H  NI+   G C H  + +L  EY  +G+L      S +L  D 
Sbjct: 68  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 127
Query: 53  ------TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                 ++A  L   + ++    +A  + YL        +HRD++++N+L+   Y A ++
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 184
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           DFG+++  +                   L Y++  T   DV+S+GVL  E++
Sbjct: 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSL------SVILNND- 52
           D ++F  E+ VL ++ H  NI+   G C H  + +L  EY  +G+L      S +L  D 
Sbjct: 58  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 117
Query: 53  ------TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                 ++A  L   + ++    +A  + YL        +HRD++++N+L+   Y A ++
Sbjct: 118 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 174
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           DFG+++  +                   L Y++  T   DV+S+GVL  E++
Sbjct: 175 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 225

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L     +  + E    
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSE 104
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  +++Y H +    IVHR++  +N+LL  + +     ++DFG+A  +  D
Sbjct: 105 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 160
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S  W  FAGT GY++PE+      +   D+++ GV+   ++ G  P
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L     +  + E    
Sbjct: 47  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSE 103
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  +++Y H +    IVHR++  +N+LL  + +     ++DFG+A  +  D
Sbjct: 104 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 159
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S  W  FAGT GY++PE+      +   D+++ GV+   ++ G  P
Sbjct: 160 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L     +  + E    
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSE 104
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  +++Y H + I   VHR++  +N+LL  + +     ++DFG+A  +  D
Sbjct: 105 ADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 160
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S  W  FAGT GY++PE+      +   D+++ GV+   ++ G  P
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L     +  + E    
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSE 127
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  +++Y H + I   VHR++  +N+LL  + +     ++DFG+A  +  D
Sbjct: 128 ADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-D 183
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           S  W  FAGT GY++PE+      +   D+++ GV+   ++ G  P
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR-- 63
           +REI+++ E++H NIV+ Y          LV+E+++N      L     +  +G + R  
Sbjct: 51  IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGL 105
Query: 64  -INVIK----GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            +N++K     +   L++ H +    I+HRD+  +N+L++   +  + DFG+A+      
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162
Query: 119 SNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
           + ++    T  Y AP+ L  +   +   D++S G +  E+I GK
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  +L E++H  IV   Y F T  +  +L+ EYL  G L + L  +    E         
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFY 126
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           +  I+ AL +LH   I   ++RD+  +N++L+ +    ++DFG+ K    D +    F G
Sbjct: 127 LAEISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +S G L  +++ G  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENG-------SLSVILNNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G       SL   + N+ 
Sbjct: 61  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 177
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 178 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 235
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 236 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  +L E++H  IV   Y F T  +  +L+ EYL  G L + L  +    E         
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFY 126
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           +  I+ AL +LH   I   ++RD+  +N++L+ +    ++DFG+ K    D +    F G
Sbjct: 127 LAEISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           T  Y+APE+          D +S G L  +++ G  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENG-------SLSVILNNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G       SL   + N+ 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 188 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 246 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 290

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFC-THARHSF-LVYEYLENGSLSVILNNDTSAEELG 59
           +++F REI +L  +    IVK+ G      R S  LV EYL +G L   L    +   L 
Sbjct: 55  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLD 112
Query: 60  WSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            SR +     I   + YL    C    VHRD++++N+L++ E    ++DFG+AK +  D 
Sbjct: 113 ASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168
Query: 119 SNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
             +           + APE       + + DV+SFGV+  E+ 
Sbjct: 169 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFC-THARHSF-LVYEYLENGSLSVILNNDTSAEELG 59
           +++F REI +L  +    IVK+ G      R S  LV EYL +G L   L    +   L 
Sbjct: 56  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLD 113
Query: 60  WSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            SR +     I   + YL    C    VHRD++++N+L++ E    ++DFG+AK +  D 
Sbjct: 114 ASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169
Query: 119 SNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
             +           + APE       + + DV+SFGV+  E+ 
Sbjct: 170 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFC-THARHSF-LVYEYLENGSLSVILNNDTSAEELG 59
           +++F REI +L  +    IVK+ G      R S  LV EYL +G L   L    +   L 
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLD 125
Query: 60  WSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            SR +     I   + YL    C    VHRD++++N+L++ E    ++DFG+AK +  D 
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
Query: 119 SNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
             +           + APE       + + DV+SFGV+  E+ 
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           + V EY+  G L   +      +E    + +     I+  L +LH   I   ++RD+   
Sbjct: 96  YFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISIGLFFLHKRGI---IYRDLKLD 149
Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           NV+LD E    ++DFG+ K    D     EF GT  Y+APE+          D +++GVL
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 209
Query: 154 ALEVIKGKHPRD 165
             E++ G+ P D
Sbjct: 210 LYEMLAGQPPFD 221

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 179 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 236
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 237 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 181 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 239 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 283

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 182 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 240 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 181 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 239 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 283

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRINV 66
           EI VL +I+H NIV          H +LV + +  G L   IL      E+        V
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK----DASLV 111
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWTE 123
           I+ +  A+ YLH +    IVHRD+  +N+L    +   +  ++DFG++K  Q  +   + 
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMST 166
Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             GT GYVAPE+      +   D +S GV+   ++ G  P
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + REI +L  + H +IVK+ G C     +   LV EY+  GSL   L        +G ++
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQ 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW- 121
            +   + I   ++YLH       +HR ++++NVLLD +    + DFG+AK + P+   + 
Sbjct: 113 LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYY 168
Query: 122 ---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               +      + APE     K     DV+SFGV   E++
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H   +   +HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 129 -----FLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDH 180
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + REI +L  + H +IVK+ G C     +   LV EY+  GSL   L        +G ++
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQ 113
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW- 121
            +   + I   ++YLH       +HR ++++NVLLD +    + DFG+AK + P+   + 
Sbjct: 114 LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYY 169
Query: 122 ---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               +      + APE     K     DV+SFGV   E++
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 129 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 76  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEF 135
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 136 SFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 191
Query: 106 SDFGIAKFIQ--PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I         T       ++APE  +    T + DV+SFGVL  E+
Sbjct: 192 ADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 130
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 188 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 246 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 290

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 118 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 174
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 175 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 232
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 233 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 277

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 88/188 (46%), Gaps = 31/188 (16%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------------ 49
           + +F RE  ++ E  + NIVK  G C   +   L++EY+  G L+  L            
Sbjct: 94  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 50  NNDTSAEE---------LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
           ++D S            L  + ++ + + +A  ++YL        VHRD++++N L+   
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTYG----YVAPELAYTMKVTAKCDVYSFGVLALE 156
               ++DFG+++ I   S+++ +  G       ++ PE  +  + T + DV+++GV+  E
Sbjct: 211 MVVKIADFGLSRNIY--SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268
Query: 157 VIK-GKHP 163
           +   G  P
Sbjct: 269 IFSYGLQP 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +   ++H NIV+ +   +   H +L+++ +  G L     +  + E    
Sbjct: 53  DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSE 109
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA---HVSDFGIAKFIQPD 117
           +   + I+ I  A+ + H      +VHR++  +N+LL  + +     ++DFG+A  ++ +
Sbjct: 110 ADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
              W  FAGT GY++PE+          D+++ GV+   ++ G  P
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 93  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N ++  ++   + DFG+ + 
Sbjct: 153 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 209
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 210 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 267
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      + E+  +C   NP+ RP+   I
Sbjct: 268 NEQVLR-FVMEGGLLDK--PDNCPDM------LFELMRMCWQYNPKMRPSFLEI 312

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H   +   +HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 129 -----FLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL-------NNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 58  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+ +     VHRD++++N  +  ++   + DFG+ + 
Sbjct: 118 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRD 174
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       +++PE       T   DV+SFGV+  E+    + P   LS
Sbjct: 175 IY--ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 232
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           N       ++   +LD   P    D+      ++E+  +C   NP+ RP+   I
Sbjct: 233 NEQVLR-FVMEGGLLDK--PDNCPDM------LLELMRMCWQYNPKMRPSFLEI 277

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 129 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 7   REITVLTEIRHRNIVKFYGFCT-HARHSF-LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H +I+K+ G C      S  LV EY+  GSL   L   +    +G ++ +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLL 120
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--- 121
              + I   ++YLH       +HR+++++NVLLD +    + DFG+AK + P+   +   
Sbjct: 121 LFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 176
Query: 122 -TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
             +      + APE     K     DV+SFGV   E++
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++  Y   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 77  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 136
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 137 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 189 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 128
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 129 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGF--CTHARHSFLVYEYLENGSLSVILNNDTSAEE 57
           D +   REI +LTE+  H NIV         + R  +LV++Y+E    +VI      A  
Sbjct: 51  DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI-----RANI 105
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK----- 112
           L    +  V+  +   + YLH   +   +HRD+   N+LL+ E    V+DFG+++     
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 113 ---------FIQPDSSNW-------TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLAL 155
                     I  ++ N+       T++  T  Y APE L  + K T   D++S G +  
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 156 EVIKGK 161
           E++ GK
Sbjct: 223 EILCGK 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 127 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 127 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 133
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 134 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 186 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 71  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 131 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 7   REITVLTEIRHRNIVKFYGFCT-HARHSF-LVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  + H +I+K+ G C      S  LV EY+  GSL   L   +    +G ++ +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGLAQLL 120
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--- 121
              + I   ++YLH       +HR+++++NVLLD +    + DFG+AK + P+   +   
Sbjct: 121 LFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 176
Query: 122 -TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
             +      + APE     K     DV+SFGV   E++
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 75  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 134
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 135 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 186
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 187 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 66  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 125
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 126 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 177
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 178 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D    LRE+ +L ++ H NI+K +     +   ++V E    G L   +       E   
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPD 117
           +R   +IK +   ++Y+H      IVHRD+  +N+LL+ +    +  + DFG++   Q +
Sbjct: 124 AR---IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   +  GT  Y+APE+        KCDV+S GV+   ++ G  P
Sbjct: 178 -TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+ +L EIRH NI+  +    +     L+ E +  G L   L      E L   
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTED 129
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I   + YLH      I H D+  +N+ LLD         + DFGIA  I+  
Sbjct: 130 EATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 185
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
            + +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N+S
Sbjct: 186 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 245
Query: 172 SSN 174
           + N
Sbjct: 246 AVN 248

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+ +L EIRH NI+  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTED 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I   + YLH      I H D+  +N+ LLD         + DFGIA  I+  
Sbjct: 116 EATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
            + +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N+S
Sbjct: 172 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 231
Query: 172 SSN 174
           + N
Sbjct: 232 AVN 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+ +L EIRH NI+  +    +     L+ E +  G L   L      E L   
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTED 108
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I   + YLH      I H D+  +N+ LLD         + DFGIA  I+  
Sbjct: 109 EATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 164
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
            + +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N+S
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
Query: 172 SSN 174
           + N
Sbjct: 225 AVN 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 148
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 149 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 131 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH 182
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 29/179 (16%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++  Y   G+L   L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEY 142
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               N    E++ +   ++    +A  + YL    CI    HRD++++NVL+       +
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKI 198
Query: 106 SDFGIAKFIQPDSSNWTEFAGTYG------YVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+    D +N   +  T        ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 199 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++   EI +   + + ++V F+GF       ++V E     SL  +     +  E    
Sbjct: 70  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---P 126
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                ++     + YLH++    ++HRD+   N+ L+ + +  + DFG+A  I+ D    
Sbjct: 127 EARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 183
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +  GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 184 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 51  NDTSA----------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
             + A           E   S    V KG+A   S    +CI    HRD++++N+LL   
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI----HRDLAARNILLTHG 204
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               + DFG+A+ I+ DS+   +        ++APE  +    T + DV+S+G+   E+ 
Sbjct: 205 RITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 159 K-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             G  P   +   S     I     ML P   P       ++  IM+    C D +P  R
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP------AEMYDIMKT---CWDADPLKR 315
Query: 217 PNMQTICQLLCK 228
           P  + I QL+ K
Sbjct: 316 PTFKQIVQLIEK 327

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D    LRE+ +L ++ H NI+K +     +   ++V E    G L   +       E   
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPD 117
           +R   +IK +   ++Y+H      IVHRD+  +N+LL   + + +  + DFG++   Q +
Sbjct: 124 AR---IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   +  GT  Y+APE+        KCDV+S GV+   ++ G  P
Sbjct: 178 -TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSL------SVILNND- 52
           D ++F  E+ VL ++ H  NI+   G C H  + +L  EY  +G+L      S +L  D 
Sbjct: 65  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 124
Query: 53  ------TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                 ++A  L   + ++    +A  + YL        +HR+++++N+L+   Y A ++
Sbjct: 125 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIA 181
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           DFG+++  +                   L Y++  T   DV+S+GVL  E++
Sbjct: 182 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 232

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D    LRE+ +L ++ H NI+K +     +   ++V E    G L   +       E   
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPD 117
           +R   +IK +   ++Y+H      IVHRD+  +N+LL   + + +  + DFG++   Q +
Sbjct: 124 AR---IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +   +  GT  Y+APE+        KCDV+S GV+   ++ G  P
Sbjct: 178 -TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 131 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++   EI +   + + ++V F+GF       ++V E     SL  +     +  E    
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---P 142
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                ++     + YLH++ +   +HRD+   N+ L+ + +  + DFG+A  I+ D    
Sbjct: 143 EARYFMRQTIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            +  GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 200 KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 13/175 (7%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI +L   RH NI+             +   YL    +   L      + L       
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 148
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WT 122
            +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +    T
Sbjct: 149 FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 123 EFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
           E+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 61  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 121 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 176
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE+  T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 7/154 (4%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI +L E+ H NI+       H  +  LV++++E   L VI+ +++    L  S    
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKA 116
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +      L YLH   I   +HRD+   N+LLD      ++DFG+AK     +  +    
Sbjct: 117 YMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV 173
Query: 126 GTYGYVAPELAYTMKVTA-KCDVYSFGVLALEVI 158
            T  Y APEL +  ++     D+++ G +  E++
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 76  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 135
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 136 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 191
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 192 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 36/239 (15%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++++ EI +L    H NIVK      +  + +++ E+   G++  ++      E      
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTES 135
Query: 63  RINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
           +I V+ K    AL+YLH +    I+HRD+ + N+L  L+ +  ++DFG++    + IQ  
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 118 SSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEV--IKGKH----PRDF 166
            S    F GT  ++APE+     +       K DV+S G+  +E+  I+  H    P   
Sbjct: 193 DS----FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 167 LSNVSSSNPNILVN---------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           L  ++ S P  L           + L   L   +VD R     +++  F+ +D+N   R
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK-NVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 6/158 (3%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRIN 65
           E  +L ++  R IV   Y F T      LV   +  G +   I N D         R I 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
               I   L +LH   I   ++RD+  +NVLLD +    +SD G+A  ++   +    +A
Sbjct: 294 YTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 126 GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT G++APEL    +     D ++ GV   E+I  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 14/168 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DKK    EI VL  + H NI+K            LV E +  G L      D   E+  +
Sbjct: 91  DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF-----DRIVEKGYY 145
Query: 61  SRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQ 115
           S R   + +K I  A++YLH + I   VHRD+  +N+L      +    ++DFG++K ++
Sbjct: 146 SERDAADAVKQILEAVAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                 T   GT GY APE+        + D++S G++   ++ G  P
Sbjct: 203 HQVLMKT-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 6/158 (3%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRIN 65
           E  +L ++  R IV   Y F T      LV   +  G +   I N D         R I 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
               I   L +LH   I   ++RD+  +NVLLD +    +SD G+A  ++   +    +A
Sbjct: 294 YTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 126 GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT G++APEL    +     D ++ GV   E+I  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 6/158 (3%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRIN 65
           E  +L ++  R IV   Y F T      LV   +  G +   I N D         R I 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
               I   L +LH   I   ++RD+  +NVLLD +    +SD G+A  ++   +    +A
Sbjct: 294 YTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 126 GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT G++APEL    +     D ++ GV   E+I  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 76  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 135
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 191
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 192 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 65  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 124
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 125 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 180
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 181 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           D++ + RE  +   +  RH NI+ F      +R+S    +L+  Y E+GSL   L   T 
Sbjct: 43  DEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTL 102
Query: 55  AEELGWSRRINVIKGIAHA-LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
              L     ++   G+AH  +        P I HRD  S+NVL+    +  ++D G+A  
Sbjct: 103 EPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-V 161
Query: 114 IQPDSSNWTEFA-----GTYGYVAPELAYTMKVTAKC-------DVYSFGVLALEVIK 159
           +    S++ +       GT  Y+APE+    ++   C       D+++FG++  E+ +
Sbjct: 162 MHSQGSDYLDIGNNPRVGTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIAR 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 6/158 (3%)
Query: 8   EITVLTEIRHRNIVKF-YGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRRIN 65
           E  +L ++  R IV   Y F T      LV   +  G +   I N D         R I 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
               I   L +LH   I   ++RD+  +NVLLD +    +SD G+A  ++   +    +A
Sbjct: 294 YTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 126 GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           GT G++APEL    +     D ++ GV   E+I  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 76  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEY 135
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 191
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 192 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 69  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 128
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 129 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 184
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 185 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 68  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 127
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 128 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 183
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+
Sbjct: 184 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 36/239 (15%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++++ EI +L    H NIVK      +  + +++ E+   G++  ++      E      
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTES 135
Query: 63  RINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA----KFIQPD 117
           +I V+ K    AL+YLH +    I+HRD+ + N+L  L+ +  ++DFG++    + IQ  
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192
Query: 118 SSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEV--IKGKH----PRDF 166
            S    F GT  ++APE+     +       K DV+S G+  +E+  I+  H    P   
Sbjct: 193 DS----FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 248
Query: 167 LSNVSSSNPNILVN---------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           L  ++ S P  L           + L   L   +VD R     +++  F+ +D+N   R
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK-NVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 51  NDTSA----------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
             + A           E   S    V KG+A   S    +CI    HRD++++N+LL   
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI----HRDLAARNILLTHG 204
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               + DFG+A+ I+ DS+   +        ++APE  +    T + DV+S+G+   E+ 
Sbjct: 205 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 159 K-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             G  P   +   S     I     ML P   P       ++  IM+    C D +P  R
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP------AEMYDIMKT---CWDADPLKR 315
Query: 217 PNMQTICQLLCK 228
           P  + I QL+ K
Sbjct: 316 PTFKQIVQLIEK 327

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           ++++ EI +L    H NIVK      +  + +++ E+   G++  ++      E      
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTES 135
Query: 63  RINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +I V+ K    AL+YLH +    I+HRD+ + N+L  L+ +  ++DFG++          
Sbjct: 136 QIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR 192
Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEV--IKGKH----PRDFLSNV 170
             F GT  ++APE+     +       K DV+S G+  +E+  I+  H    P   L  +
Sbjct: 193 DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252
Query: 171 SSSNPNILVN---------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           + S P  L           + L   L   +VD R     +++  F+ +D+N   R
Sbjct: 253 AKSEPPTLAQPSRWSSNFKDFLKKCLEK-NVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--------- 50
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 51  ----NDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
               +    E+L     ++    +A  + YL    CI    HRD++++NVL+  +    +
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKI 232
Query: 106 SDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +DFG+A+ I           G     ++APE  +    T + DV+SFGVL  E+ 
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 51  NDTSA----------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
             + A           E   S    V KG+A   S    +CI    HRD++++N+LL   
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI----HRDLAARNILLTHG 181
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               + DFG+A+ I+ DS+   +        ++APE  +    T + DV+S+G+   E+ 
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 159 K-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             G  P   +   S     I     ML P   P       ++  IM+    C D +P  R
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP------AEMYDIMKT---CWDADPLKR 292
Query: 217 PNMQTICQLLCK 228
           P  + I QL+ K
Sbjct: 293 PTFKQIVQLIEK 304

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 87  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 146
Query: 51  NDTSA----------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
             + A           E   S    V KG+A   S    +CI    HRD++++N+LL   
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI----HRDLAARNILLTHG 199
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               + DFG+A+ I+ DS+   +        ++APE  +    T + DV+S+G+   E+ 
Sbjct: 200 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 159 K-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             G  P   +   S     I     ML P   P       ++  IM+    C D +P  R
Sbjct: 260 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP------AEMYDIMKT---CWDADPLKR 310
Query: 217 PNMQTICQLLCK 228
           P  + I QL+ K
Sbjct: 311 PTFKQIVQLIEK 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 40/252 (15%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 85  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 51  NDTSA----------EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE 100
             + A           E   S    V KG+A   S    +CI    HRD++++N+LL   
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI----HRDLAARNILLTHG 197
Query: 101 YEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               + DFG+A+ I+ DS+   +        ++APE  +    T + DV+S+G+   E+ 
Sbjct: 198 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 159 K-GKHPRDFLSNVSSSNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             G  P   +   S     I     ML P   P       ++  IM+    C D +P  R
Sbjct: 258 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP------AEMYDIMKT---CWDADPLKR 308
Query: 217 PNMQTICQLLCK 228
           P  + I QL+ K
Sbjct: 309 PTFKQIVQLIEK 320

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 22/236 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I           G     ++APE       T   D++SFGV+  E+    + P   LSN 
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 240 Q------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 286

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-------SVILNNDTSAE 56
           +F  E+ ++T+I++   +   G  T+    +++YEY+EN S+        V+  N T   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            +   + I  IK + ++ SY+H++    I HRD+   N+L+D      +SDFG ++++  
Sbjct: 149 PIQVIKCI--IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKV--TAKCDVYSFGV 152
                +   GTY ++ PE          AK D++S G+
Sbjct: 205 KKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYG--FCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           +++F REI +L  +    IVK+ G  +        LV EYL +G L   L    +   L 
Sbjct: 52  QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLD 109
Query: 60  WSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            SR +     I   + YL    C    VHRD++++N+L++ E    ++DFG+AK +  D 
Sbjct: 110 ASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165
Query: 119 SNWT---EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
                         + APE       + + DV+SFGV+  E+ 
Sbjct: 166 DXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 6/162 (3%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++   EI +   + + ++V F+GF       ++V E     SL  +     +  E    
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---P 142
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                ++     + YLH++ +   +HRD+   N+ L+ + +  + DFG+A  I+ D    
Sbjct: 143 EARYFMRQTIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 200 KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 22/236 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 60  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 119
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 120 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 176
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I           G     ++APE       T   D++SFGV+  E+    + P   LSN 
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 236
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 237 Q------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 283

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 6/162 (3%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++   EI +   + + ++V F+GF       ++V E     SL  +     +  E    
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---P 142
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                ++     + YLH++ +   +HRD+   N+ L+ + +  + DFG+A  I+ D    
Sbjct: 143 EARYFMRQTIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK 199
Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 200 KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D   + L     I     +A  + +L        +HRD++++N+LL  +    + DFG
Sbjct: 133 YKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFG 189
Query: 110 IAK--FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFL 167
           +A+  +  PD     +      ++APE  +    T + DV+SFGVL  E+          
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------F 240
Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLD---NNPESRPNMQTICQ 224
           S  +S  P + ++E    RL      +R    +  E+    LD     P  RP    + +
Sbjct: 241 SLGASPYPGVKIDEEFXRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 299
Query: 225 LL 226
            L
Sbjct: 300 HL 301

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           KK  LREI +L +++H N+V         R   LV+EY ++  L  +        E    
Sbjct: 46  KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE---- 101
Query: 62  RRINVIKGIA----HALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
              +++K I      A+++ H H+CI    HRD+  +N+L+       + DFG A+ +  
Sbjct: 102 ---HLVKSITWQTLQAVNFCHKHNCI----HRDVKPENILITKHSVIKLCDFGFARLLTG 154
Query: 117 DSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKG 160
            S  + +   T  Y +PE L    +     DV++ G +  E++ G
Sbjct: 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 22/236 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I           G     ++APE       T   D++SFGV+  E+    + P   LSN 
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  ++  ++D        +   +V  +M    +C   NP  RP    I  LL
Sbjct: 240 Q------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPNMRPTFLEIVNLL 286

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 6/130 (4%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           F V E++  G L   +      +E   +R       I  AL +LH   I   ++RD+   
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEIISALMFLHDKGI---IYRDLKLD 153
Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           NVLLD E    ++DFG+ K    +      F GT  Y+APE+   M      D ++ GVL
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213
Query: 154 ALEVIKGKHP 163
             E++ G  P
Sbjct: 214 LYEMLCGHAP 223

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 12/167 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           DK+E   EI+V+ ++ H N+++ Y          LV EY++ G L   I++   +  EL 
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD 188
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQP 116
               I  +K I   + ++H      I+H D+  +N+L    D + +  + DFG+A+  +P
Sbjct: 189 ---TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKP 241
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                  F GT  ++APE+     V+   D++S GV+A  ++ G  P
Sbjct: 242 REKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 26/238 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       ++APE       T   D++SFGV+  E+    + P   LS
Sbjct: 180 IY--ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N        ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 238 NEQ------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 286

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 22/236 (9%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 114 IQPDSSNWTEFAG--TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNV 170
           I   +       G     ++APE       T   D++SFGV+  E+    + P   LSN 
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 171 SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 240 Q------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 286

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 28/183 (15%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR- 63
           L EI +LTE   H N++++Y   T  R  ++  E        ++ + + S E L   +  
Sbjct: 74  LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 64  --INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL--------DLEYEAH-----VSDF 108
             I++++ IA  +++LH      I+HRD+  +N+L+        D +  A      +SDF
Sbjct: 134 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 109 GIAKFIQPDS----SNWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVI-KG 160
           G+ K +         N    +GT G+ APEL   +   ++T   D++S G +   ++ KG
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 161 KHP 163
           KHP
Sbjct: 251 KHP 253

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 28/183 (15%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR- 63
           L EI +LTE   H N++++Y   T  R  ++  E        ++ + + S E L   +  
Sbjct: 74  LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 64  --INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL--------DLEYEAH-----VSDF 108
             I++++ IA  +++LH      I+HRD+  +N+L+        D +  A      +SDF
Sbjct: 134 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 109 GIAKFIQPDS----SNWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVI-KG 160
           G+ K +         N    +GT G+ APEL   +   ++T   D++S G +   ++ KG
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 161 KHP 163
           KHP
Sbjct: 251 KHP 253

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E+     +    IV  YG         +  E LE GSL  ++       E    R +  +
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYL 191
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAG 126
                 L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD    +   G
Sbjct: 192 GQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 127 TY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            Y      ++APE+       AK DV+S   + L ++ G HP
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 26/238 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 62  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 121
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 122 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 178
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       ++APE       T   D++SFGV+  E+    + P   LS
Sbjct: 179 IY--ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 236
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N        ++  ++D        +   +V  +M    +C   NP+ RP    I  LL
Sbjct: 237 NEQ------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 285

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           S
Sbjct: 232 S 232

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 32/187 (17%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR- 63
           L EI +LTE   H N++++Y   T  R  ++  E        ++ + + S E L   +  
Sbjct: 56  LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 64  --INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL--------DLEYEAH-----VSDF 108
             I++++ IA  +++LH      I+HRD+  +N+L+        D +  A      +SDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 109 GIAKFIQPDSS----NWTEFAGTYGYVAPE-------LAYTMKVTAKCDVYSFGVLALEV 157
           G+ K +    S    N    +GT G+ APE       L    ++T   D++S G +   +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 158 I-KGKHP 163
           + KGKHP
Sbjct: 233 LSKGKHP 239

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 34/246 (13%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 74  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 133
Query: 52  -----DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                D   + L     I     +A  + +L    CI    HRD++++N+LL  +    +
Sbjct: 134 YKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKI 189
Query: 106 SDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+      
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------ 243
Query: 164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNMQ 220
               S  +S  P + ++E    RL      +R        + +    C    P  RP   
Sbjct: 244 ---FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 221 TICQLL 226
            + + L
Sbjct: 300 ELVEHL 305

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 31/242 (12%)
Query: 3   KEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN--------- 51
           +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +         
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D   + L     I     +A  + +L        +HRD++++N+LL  +    + DFG
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFG 193
Query: 110 IAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFL 167
           +A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+          
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------F 244
Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLD---NNPESRPNMQTICQ 224
           S  +S  P + ++E    RL      +R    +  E+    LD     P  RP    + +
Sbjct: 245 SLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 225 LL 226
            L
Sbjct: 304 HL 305

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH N++        +     R  ++V + +E     ++ +   S + + +
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY 148
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H   +   +HRD+   N+L++   +  + DFG+A+   P+  +
Sbjct: 149 -----FLYQILRGLKYIHSANV---LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
               TE   T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 201 TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           S
Sbjct: 232 S 232

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 101/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 188
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 189 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 243
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLD---NNPESRPNM 219
                S  +S  P + ++E    RL      +R    +  E+    LD     P  RP  
Sbjct: 244 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 220 QTICQLL 226
             + + L
Sbjct: 299 SELVEHL 305

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           S
Sbjct: 232 S 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 188
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 189 ICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 243
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 244 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 220 QTICQLL 226
             + + L
Sbjct: 299 SELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 123
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 179
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 180 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 234
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 235 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 220 QTICQLL 226
             + + L
Sbjct: 290 SELVEHL 296

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 12/164 (7%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           + E+     +    IV  YG         +  E LE GSL  ++       E    R + 
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALY 154
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEF 124
            +      L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD    +  
Sbjct: 155 YLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 125 AGTY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            G Y      ++APE+       AK D++S   + L ++ G HP
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVY-EYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 179
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 180 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 234
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 235 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 220 QTICQLL 226
             + + L
Sbjct: 290 SELVEHL 296

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 52  --DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             D   + L     I     +A  + +L        +HRD++++N+LL  +    + DFG
Sbjct: 133 YKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFG 189
Query: 110 IAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFL 167
           +A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+          
Sbjct: 190 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------F 240
Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLD---NNPESRPNMQTICQ 224
           S  +S  P + ++E    RL      +R    +  E+    LD     P  RP    + +
Sbjct: 241 SLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 299
Query: 225 LL 226
            L
Sbjct: 300 HL 301

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  +    + +  G C  +    LV + +  G L   +  +     LG   
Sbjct: 64  KEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRG--RLGSQD 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  +SYL       +VHRD++++NVL+       ++DFG+A+ +  D + + 
Sbjct: 121 LLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E     + T + DV+S+GV   E++  G  P D +   +   P++L 
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE 235
Query: 180 NEMLDPRLPPLSVDI 194
                P+ P  ++D+
Sbjct: 236 KGERLPQPPICTIDV 250

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 12/164 (7%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           + E+     +    IV  YG         +  E LE GSL  ++       E    R + 
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALY 168
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEF 124
            +      L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD    +  
Sbjct: 169 YLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 225
Query: 125 AGTY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            G Y      ++APE+       AK D++S   + L ++ G HP
Sbjct: 226 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           E+     +    IV  YG         +  E LE GSL  ++       E    R +  +
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYL 172
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAG 126
                 L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD        G
Sbjct: 173 GQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 127 TY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            Y      ++APE+       AK DV+S   + L ++ G HP
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
                E   T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 185 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 23/180 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFC-----THARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+              +  ++V + +E     ++     S + + +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 133
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 134 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 121 ---WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIK------GKHPRDFLSNV 170
                E   T  Y APE+    K  T   D++S G +  E++       GKH  D L+++
Sbjct: 186 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 188
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 243
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 244 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 220 QTICQLL 226
             + + L
Sbjct: 299 SELVEHL 305

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 169
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 170 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 225
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 280
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 281 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 335
Query: 220 QTICQLL 226
             + + L
Sbjct: 336 SELVEHL 342

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 12/164 (7%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           + E+     +    IV  YG         +  E LE GSL  ++       E    R + 
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALY 170
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEF 124
            +      L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD    +  
Sbjct: 171 YLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 227
Query: 125 AGTY-----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            G Y      ++APE+       AK D++S   + L ++ G HP
Sbjct: 228 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVY-EYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 179
Query: 105 VSDFGIAK--FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+  +  PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 180 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 234
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 235 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 220 QTICQLL 226
             + + L
Sbjct: 290 SELVEHL 296

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLV-YEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 75  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 135 YKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 190
Query: 105 VSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I   PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 191 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 245
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 246 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 300
Query: 220 QTICQLL 226
             + + L
Sbjct: 301 SELVEHL 307

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           +
Sbjct: 232 A 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVY-EYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT      +V  E+ + G+LS  L +       
Sbjct: 64  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVP 123
Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                 D   + L     I     +A  + +L    CI    HRD++++N+LL  +    
Sbjct: 124 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVK 179
Query: 105 VSDFGIAK--FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+  +  PD     +      ++APE  +    T + DV+SFGVL  E+     
Sbjct: 180 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI----- 234
Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVISIMEVAFLCLDNNPESRPNM 219
                S  +S  P + ++E    RL      +R        + +    C    P  RP  
Sbjct: 235 ----FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 289
Query: 220 QTICQLL 226
             + + L
Sbjct: 290 SELVEHL 296

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           +
Sbjct: 232 A 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 26/181 (14%)
Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---SAE 56
           +++  + E+ ++T++  H NIV   G CT +   +L++EY   G L   L +     S +
Sbjct: 91  EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 57  ELGWSRR--------INVIK---------GIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
           E+ +  +        +NV+           +A  + +L        VHRD++++NVL+  
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTH 207
Query: 100 EYEAHVSDFGIAKFIQPDSSNWTEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEV 157
                + DFG+A+ I  DS+            ++APE  +    T K DV+S+G+L  E+
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
Query: 158 I 158
Sbjct: 268 F 268

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++E  RE+++L ++ H NI+  +    +     L+ E +  G L   L      E L   
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEE 115
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEYE-AHVS--DFGIAKFIQPD 117
              + IK I   ++YLH      I H D+  +N+ LLD      H+   DFG+A  I+ D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
              +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+N++
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
Query: 172 S 172
           +
Sbjct: 232 A 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--A 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYY 167
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    + + 
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
              F  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 182 ---FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKXQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    + + 
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
              F  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 182 ---FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 167
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 130 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDE 183
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 184 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 130 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDE 183
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 184 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+     +  
Sbjct: 132 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADE 185
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    + + 
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
              F  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 178 ---FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+     +  
Sbjct: 132 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADE 185
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 19/184 (10%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNV 170
             N +    GT  +VAPE+     +  + D++S GV+   ++ G  P      ++ L+NV
Sbjct: 170 FGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229
Query: 171 SSSN 174
           S+ N
Sbjct: 230 SAVN 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           + V EY+  G L   +      +E      +     IA  L +L    I   ++RD+   
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGLFFLQSKGI---IYRDLKLD 150
Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           NV+LD E    ++DFG+ K    D      F GT  Y+APE+          D ++FGVL
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 210
Query: 154 ALEVIKGKHP 163
             E++ G+ P
Sbjct: 211 LYEMLAGQAP 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 167
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 1   DKKEFLREITVLTE-IRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           ++K  + E  VL + ++H  +V  +     A   + V +Y+  G L   L  +    E  
Sbjct: 81  EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-- 138
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             R       IA AL YLH   I   V+RD+  +N+LLD +    ++DFG+ K     +S
Sbjct: 139 -PRARFYAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             + F GT  Y+APE+ +        D +  G +  E++ G  P
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 32/187 (17%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR- 63
           L EI +LTE   H N++++Y   T  R  ++  E        ++ + + S E L   +  
Sbjct: 56  LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 64  --INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL--------DLEYEAH-----VSDF 108
             I++++ IA  +++LH      I+HRD+  +N+L+        D +  A      +SDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 109 GIAKFIQPDS----SNWTEFAGTYGYVAPE-------LAYTMKVTAKCDVYSFGVLALEV 157
           G+ K +         N    +GT G+ APE       L    ++T   D++S G +   +
Sbjct: 173 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 158 I-KGKHP 163
           + KGKHP
Sbjct: 233 LSKGKHP 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 77  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 135
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 136 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHT---DDE 189
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 190 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 25/230 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFY----GFCTHARHSFLVYEYLENGSLSVILNNDTSAE 56
           +++ F  E   L  ++H NIV+FY          +   LV E   +G+L   L      +
Sbjct: 68  ERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXK 127
Query: 57  ---ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAK 112
                 W R+I  +KG    L +LH    PPI+HRD+   N+ +     +  + D G+A 
Sbjct: 128 IKVLRSWCRQI--LKG----LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
             +  +S      GT  + APE  Y  K     DVY+FG   LE    ++P     N + 
Sbjct: 181 LKR--ASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237
Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                 +   +   + P S D +  +  + E+   C+  N + R +++ +
Sbjct: 238 ------IYRRVTSGVKPASFD-KVAIPEVKEIIEGCIRQNKDERYSIKDL 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 106/242 (43%), Gaps = 38/242 (15%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++EF  E  +   ++H N+V   G  T  +   +++ Y  +G L   L   +   ++G +
Sbjct: 73  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 132
Query: 62  RR-------------INVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                          ++++  IA  + YL  HH     +VH+D++++NVL+  +    +S
Sbjct: 133 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKIS 187
Query: 107 DFGIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK 161
           D G+  F +  ++++ +  G       ++APE     K +   D++S+GV+  EV   G 
Sbjct: 188 DLGL--FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245
Query: 162 HPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
            P    SN         V EM+  R + P   D    V ++M     C +  P  RP  +
Sbjct: 246 QPYCGYSNQD-------VVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFK 295
Query: 221 TI 222
            I
Sbjct: 296 DI 297

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 52  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 108
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 109 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 164
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+     +  
Sbjct: 132 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADE 185
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 83  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 139
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 140 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 195
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 196 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 106/242 (43%), Gaps = 38/242 (15%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           ++EF  E  +   ++H N+V   G  T  +   +++ Y  +G L   L   +   ++G +
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 62  RR-------------INVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                          ++++  IA  + YL  HH     +VH+D++++NVL+  +    +S
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKIS 170
Query: 107 DFGIAKFIQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GK 161
           D G+  F +  ++++ +  G       ++APE     K +   D++S+GV+  EV   G 
Sbjct: 171 DLGL--FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 162 HPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
            P    SN         V EM+  R + P   D    V ++M     C +  P  RP  +
Sbjct: 229 QPYCGYSNQD-------VVEMIRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFK 278
Query: 221 TI 222
            I
Sbjct: 279 DI 280

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYE-YLENGSLSVILNNDTSAEELGWSRRIN 65
           RE+ +L  ++H N++      T A       E YL    +   LNN   ++ L       
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF 135
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           ++  +   L Y+H   I   +HRD+   NV ++ + E  + DFG+A+  Q D    T + 
Sbjct: 136 LVYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLAR--QAD-EEMTGYV 189
Query: 126 GTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+    M      D++S G +  E+++GK
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 60  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 116
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 117 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 172
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 131 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDE 184
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 117 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 169
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 127 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHT---DDE 180
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 181 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 57  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 113
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 114 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 169
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 170 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 42/239 (17%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
           D +EFLRE   + E  H ++ K  G    +R         ++  ++++G L   L     
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 55  AEE---LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
            E    L     +  +  IA  + YL        +HRD++++N +L  +    V+DFG++
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 112 KFIQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYSFGVLALEVI-K 159
           + I         ++G Y            ++A E       T   DV++FGV   E++ +
Sbjct: 185 RKI---------YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235
Query: 160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
           G+ P   + N    N  I  N +   + PP  ++       + ++ + C   +P+ RP+
Sbjct: 236 GQTPYAGIENAEIYNYLIGGNRL---KQPPECME------EVYDLMYQCWSADPKQRPS 285

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 130 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 183
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 184 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           + V EY+  G L   +      +E      +     IA  L +L    I   ++RD+   
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGLFFLQSKGI---IYRDLKLD 471
Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           NV+LD E    ++DFG+ K    D      F GT  Y+APE+          D ++FGVL
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 154 ALEVIKGKHP 163
             E++ G+ P
Sbjct: 532 LYEMLAGQAP 541

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +R +     I   L  LH +    IV+RD+  +N+LLD      +SD G+A  + P+   
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQT 341
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 58  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--A 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 115 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 170
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 171 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 130 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 183
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 184 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 65  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 123
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 124 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 177
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 178 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 114 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 166
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHR+++++N ++  ++   + DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       ++APE       T   D++SFGV+  E+    + P   LS
Sbjct: 180 IY--ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N        ++  ++D        +   +V  +M    +C   NP  RP    I  LL
Sbjct: 238 NEQ------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPNMRPTFLEIVNLL 286

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 127 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 180
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 181 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++ EFL E +V+      ++V+  G  +  + + +V E + +G L   L +     E   
Sbjct: 64  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 123
Query: 61  SR-------RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            R        I +   IA  ++YL+       VHR+++++N ++  ++   + DFG+ + 
Sbjct: 124 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRD 180
Query: 114 IQPDSSNWTEFAGT----YGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLS 168
           I    +++    G       ++APE       T   D++SFGV+  E+    + P   LS
Sbjct: 181 IY--ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 238
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N        ++  ++D        +   +V  +M    +C   NP  RP    I  LL
Sbjct: 239 NEQ------VLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPNMRPTFLEIVNLL 287

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 89  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 147
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 148 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 201
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 202 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 132 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 185
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 137 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 190
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 191 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 117 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 169
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 137 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 190
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 191 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 122 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 175
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 176 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 145 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 198
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 199 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 77  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 135
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 136 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 189
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 190 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKXQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 145 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 198
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 199 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 137 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 190
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 191 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 174
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 143
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 144 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 197
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 198 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 76  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 134
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 135 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 188
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 189 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 143
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 144 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 197
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 198 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 113
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 169 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 227 NVSAVN 232

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +R +     I   L  LH +    IV+RD+  +N+LLD      +SD G+A  + P+   
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQT 341
Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                GT GY+APE+    + T   D ++ G L  E+I G+ P
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 122 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 175
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 176 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 113
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 169 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 227 NVSAVN 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 131 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 184
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 131 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 184
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 127 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 180
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 181 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 127 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 180
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 181 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 131 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 184
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 185 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 46/256 (17%)
Query: 15  IRHRNIVKFY----GFCTHARHSFL-VYEYLENGSLSVILNNDTSAEELGWSRRINVIKG 69
           + H NI +F           R  +L V EY  NGSL   L+  TS     W     +   
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHS 119
Query: 70  IAHALSYLHHDC------IPPIVHRDISSKNVLLDLEYEAHVSDFGIA------KFIQPD 117
           +   L+YLH +        P I HRD++S+NVL+  +    +SDFG++      + ++P 
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 118 SSNWTEFA--GTYGYVAPE-------LAYTMKVTAKCDVYSFGVLALEVIKG-------- 160
             +    +  GT  Y+APE       L        + D+Y+ G++  E+           
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 161 ---KHPRDFLSNVSS----SNPNILVN-EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN 212
              ++   F + V +     +  +LV+ E   P+ P    +    V S+ E    C D +
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 213 PESRPNMQTICQLLCK 228
            E+R   Q   + + +
Sbjct: 300 AEARLTAQXAEERMAE 315

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 122
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 123 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 176
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 177 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 111 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 163
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 174
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYE-YLENGSLSVILNNDTSAEELGWSRRIN 65
           RE+ +L  ++H N++      T A       E YL    +   LNN    + L       
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF 135
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           ++  +   L Y+H   I   +HRD+   NV ++ + E  + DFG+A+  Q D    T + 
Sbjct: 136 LVYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLAR--QAD-EEMTGYV 189
Query: 126 GTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+    M      D++S G +  E+++GK
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 22/232 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F  E   L    H N++   G C    A H  L+  ++  GSL  +L+  T+   +  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQ 110
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRD-ISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           S+ +     +A  +++LH   + P++ R  ++S++V++D +  A +S   +    Q    
Sbjct: 111 SQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 120 NWTEFAGTYGYVAPE-LAYTMKVTAK--CDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            +        +VAPE L    + T +   D++SF VL  E++  + P   LSN+      
Sbjct: 169 MYAP-----AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223
Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
            L  E L P +PP    I   V  +M++   C++ +P  RP    I  +L K
Sbjct: 224 AL--EGLRPTIPP---GISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEK 267

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 79/188 (42%), Gaps = 18/188 (9%)
Query: 2   KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           K++   EI +L    +H NI+         +H +LV E +  G L   ++     S  E 
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA 123
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE----AHVSDFGIAKFI 114
            +     V+  I   + YLH   +   VHRD+   N+L   E        + DFG AK +
Sbjct: 124 SF-----VLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN 174
           + ++        T  +VAPE+         CD++S G+L   ++ G  P    +N  S  
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP---FANGPSDT 232
Query: 175 PNILVNEM 182
           P  ++  +
Sbjct: 233 PEEILTRI 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  +RH N++      T       F  + YL    +   L      E+LG 
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF-YLVMPFMGTDLGKLMKHEKLGE 127
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R   ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+  Q DS  
Sbjct: 128 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS-- 180
Query: 121 WTEFAG---TYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
             E  G   T  Y APE+    M+ T   D++S G +  E+I GK
Sbjct: 181 --EMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L   +  +
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--S 107
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +  +   LS+ H   +   +HRD+  +N+L++ E    ++DFG+A+        +T   
Sbjct: 108 YLFQLLQGLSFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 164
Query: 126 GTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
            T  Y APE+    K  +   D++S G +  E++
Sbjct: 165 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--A 111
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+  
Sbjct: 112 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXX 167
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--A 491
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 492 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYY 547
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 28/240 (11%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           K F RE+    + RH N+V F G C    H  ++    +  +L  ++ +     ++  +R
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           +I   + I   + YLH      I+H+D+ SKNV  D   +  ++DFG+        +   
Sbjct: 134 QI--AQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187
Query: 123 EFA-----GTYGYVAPELAYTMK---------VTAKCDVYSFGVLALEVIKGKHPRDFLS 168
           E       G   ++APE+   +           +   DV++ G +  E+    H R++  
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL----HAREW-- 241
Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
              +     ++ +M     P LS    GK IS  ++   C     E RP    +  +L K
Sbjct: 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEK 299

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYE-YLENGSLSVILNNDTSAEELGWSRRIN 65
           RE+ +L  ++H N++      T A       E YL    +   LNN    + L       
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF 127
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
           ++  +   L Y+H   I   +HRD+   NV ++ + E  + DFG+A+  Q D    T + 
Sbjct: 128 LVYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLAR--QAD-EEMTGYV 181
Query: 126 GTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APE+    M      D++S G +  E+++GK
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++  RE+++L EI+H N++  +    +     L+ E +  G L   L      E L   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEE 114
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNV-LLDLEY---EAHVSDFGIAKFIQPD 117
                +K I + + YLH      I H D+  +N+ LLD         + DFG+A  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 SSNWTEFAGTYG---YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLS 168
             N  EF   +G   +VAPE+     +  + D++S GV+   ++ G  P      ++ L+
Sbjct: 170 FGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
Query: 169 NVSSSN 174
           NVS+ N
Sbjct: 228 NVSAVN 233

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN   +++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKSQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+ +        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 79/188 (42%), Gaps = 18/188 (9%)
Query: 2   KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           K++   EI +L    +H NI+         +H +LV E +  G L   ++     S  E 
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREA 123
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE----AHVSDFGIAKFI 114
            +     V+  I   + YLH   +   VHRD+   N+L   E        + DFG AK +
Sbjct: 124 SF-----VLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN 174
           + ++        T  +VAPE+         CD++S G+L   ++ G  P    +N  S  
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP---FANGPSDT 232
Query: 175 PNILVNEM 182
           P  ++  +
Sbjct: 233 PEEILTRI 240

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     + +L  +
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDL--A 491
Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++ DS+ +
Sbjct: 492 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 547
Query: 122 TEFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
               G     ++APE     + T+  DV+ FGV   E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + D+G+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L+E+ +L ++  H NI++           FLV++ ++ G L   L    +  E    + +
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +  AL  L+      IVHRD+  +N+LLD +    ++DFG +  + P      E 
Sbjct: 118 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 170
Query: 125 AGTYGYVAPEL----------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 89  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 147
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    +   
Sbjct: 148 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 204
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
              +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 205 ---YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN     +L  
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCAKLTD 120
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 174
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 18/227 (7%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  ++  
Sbjct: 116 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
                  + + APE   T   +   D + FGV   E+   G+ P   L+     +     
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            E L PR      DI   ++        C  + PE RP    +   L
Sbjct: 231 GERL-PRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFL 269

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 73/167 (43%), Gaps = 24/167 (14%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  +V EY   G L   I N    +E+        
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 123
Query: 66  VIKGI--AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPD 117
           +I G+  AHA+          + HRD+  +N LLD        ++DFG +K      QP 
Sbjct: 124 LISGVSYAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPK 174
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
           S+      GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 175 SA-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 64  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 123
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 124 TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 179
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 180 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237
Query: 158 IK 159
            +
Sbjct: 238 AR 239

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 77  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 136
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 137 TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 193 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 158 IK 159
            +
Sbjct: 251 AR 252

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 18/227 (7%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  ++  
Sbjct: 116 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
                  + + APE   T   +   D + FGV   E+   G+ P   L+     +     
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            E L PR      DI   ++        C  + PE RP    +   L
Sbjct: 231 GERL-PRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFL 269

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----LGW 60
           +REI++L E+ H NIVK           +LV+E+L   S+ +    D SA       L  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIK 109
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        
Sbjct: 110 SYLFQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 121 WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
           +     T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T    T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 44  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 103
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 104 TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 159
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 160 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217
Query: 158 IK 159
            +
Sbjct: 218 AR 219

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L     + +  +  +   L    S  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 113 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E++     + +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +T 
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/181 (22%), Positives = 78/181 (43%), Gaps = 27/181 (14%)
Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHAR-------HSFLVYEYLE-----NGSLSVIL 49
           +++ +RE+  L ++ H  IV+++               S  VY Y++       +L   +
Sbjct: 47  REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 50  NNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
           N   + EE   S  +++   IA A+ +LH   +   +HRD+   N+   ++    V DFG
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 110 IAKFIQPDSSNWTEFA------------GTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
           +   +  D    T               GT  Y++PE  +    + K D++S G++  E+
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 158 I 158
           +
Sbjct: 224 L 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 38  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 97
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 98  TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 154 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
Query: 158 IK 159
            +
Sbjct: 212 AR 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----LGW 60
           +REI++L E+ H NIVK           +LV+E+L   S+ +    D SA       L  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIK 109
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        
Sbjct: 110 SYLFQLLQGLAFCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 121 WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
           +     T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 18/227 (7%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  ++  
Sbjct: 120 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
                  + + APE   T   +   D + FGV   E+   G+ P   L+     +     
Sbjct: 175 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 234
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            E L PR      D       I  V   C  + PE RP    +   L
Sbjct: 235 GERL-PRPEDCPQD-------IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 39  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 98
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 99  TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 154
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 155 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212
Query: 158 IK 159
            +
Sbjct: 213 AR 214

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 29/182 (15%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHSF----LVYEYLENGSLSVILNNDTS 54
           +++ + RE  +   +  RH NI+ F         ++    LV +Y E+GSL   LN  T 
Sbjct: 41  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 100
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             E      I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 101 TVE----GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 156
Query: 110 IAKFIQPDSSNWT------EFAGTYGYVAPEL---AYTMK---VTAKCDVYSFGVLALEV 157
           +A  ++ DS+  T         GT  Y+APE+   +  MK      + D+Y+ G++  E+
Sbjct: 157 LA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214
Query: 158 IK 159
            +
Sbjct: 215 AR 216

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 18/227 (7%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  ++  
Sbjct: 126 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
                  + + APE   T   +   D + FGV   E+   G+ P   L+     +     
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            E L PR      DI   ++        C  + PE RP    +   L
Sbjct: 241 GERL-PRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFL 279

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           +EI++L   RHRNI+  +          +++E++    L +    +TSA EL     ++ 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFI--SGLDIFERINTSAFELNEREIVSY 107
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS--DFGIAKFIQPDSSNWTEF 124
           +  +  AL +LH   I    H DI  +N++      + +   +FG A+ ++P   N+   
Sbjct: 108 VHQVCEALQFLHSHNIG---HFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLL 163
Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM 182
                Y APE+     V+   D++S G L   ++ G +P  FL+    +N  I+ N M
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLAE---TNQQIIENIM 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 10/164 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  ++  
Sbjct: 120 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
                  + + APE   T   +   D + FGV   E+   G+ P
Sbjct: 175 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----LGW 60
           +REI++L E+ H NIVK           +LV+E+L   S+ +    D SA       L  
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIK 107
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        
Sbjct: 108 SYLFQLLQGLAFCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 121 WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
           +     T  Y APE+    K  +   D++S G +  E++
Sbjct: 161 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L+E+ +L ++  H NI++           FLV++ ++ G L   L    +  E    + +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +  AL  L+      IVHRD+  +N+LLD +    ++DFG +  + P      E 
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 183
Query: 125 AGTYGYVAPEL----------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI--LNNDTSAEELGWSRR 63
           LREI +L E++H+NIV+ +      +   LV+E+ +          N D   E +  S  
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-SFL 107
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             ++KG+    S         ++HRD+  +N+L++   E  ++DFG+A+        ++ 
Sbjct: 108 FQLLKGLGFCHSR-------NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160
Query: 124 FAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHP 163
              T  Y  P++ +  K+ +   D++S G +  E+     P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-----LGW 60
           +REI++L E+ H NIVK           +LV+E+L   S+ +    D SA       L  
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIK 108
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        
Sbjct: 109 SYLFQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 121 WTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
           +     T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 234 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 269

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 59  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 115
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 116 LLNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 173 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 230
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 231 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 266

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 113 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 113 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 112 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 63  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 119
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 120 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 234
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 235 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 270

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 112 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 114 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 166
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 109 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 161
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F    ++++++ H+++V  YG C     + LV E+++ GSL   L  + +   + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA--------HVSDFGIAKFIQP 116
            V K +A A+ +L  +    ++H ++ +KN+LL  E +          +SD GI+  + P
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 117 DSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG 160
                        +V PE     K +    D +SFG    E+  G
Sbjct: 174 KDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM   ++    + +SRP  + +
Sbjct: 234 KGERLPQPPICTID----VYMIMRKCWMI---DADSRPKFREL 269

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 56  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 112
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 113 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 227
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 228 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 263

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+   +EI  ++ +RH  +V  +          ++YE++  G L   + ++ +  ++  
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSE 254
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY--EAHVSDFGIAKFIQPDS 118
              +  ++ +   L ++H +     VH D+  +N++   +   E  + DFG+   + P  
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVSS 172
           S      GT  + APE+A    V    D++S GVL+  ++ G  P       + L NV S
Sbjct: 312 SVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
Query: 173 SNPNI 177
            + N+
Sbjct: 371 CDWNM 375

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 121 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 235
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 236 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 271

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 32  HSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRD 89
           H +LV +Y   G L  +L+   D   E++       ++  I  ++  LH+      VHRD
Sbjct: 148 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DSIHQLHY------VHRD 200
Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   NVLLD+     ++DFG    +  D +  +  A GT  Y++PE+   M     K   
Sbjct: 201 IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 260
Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 261 ECDWWSLGVCMYEMLYGETP 280

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 2   KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           K++   EI +L    +H NI+         ++ ++V E ++ G L   IL     +E   
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQ 115
            +    V+  I   + YLH   +   VHRD+   N+L   E        + DFG AK ++
Sbjct: 119 SA----VLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            ++        T  +VAPE+       A CD++S GVL   ++ G  P
Sbjct: 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 111 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 65  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 122 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 236
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 237 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 240
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 241 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 276

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 111 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 63  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVRE--HKDNIGSQY 119
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 120 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 234
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 235 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 234 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 269

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 66  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 122
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 123 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 179
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 237
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 238 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 273

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 112 FQLLQGLAFCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 68  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 124
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 125 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 181
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 182 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 239
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 240 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+   +EI  ++ +RH  +V  +          ++YE++  G L   + ++ +  ++  
Sbjct: 91  DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSE 148
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY--EAHVSDFGIAKFIQPDS 118
              +  ++ +   L ++H +     VH D+  +N++   +   E  + DFG+   + P  
Sbjct: 149 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA------LEVIKGKHPRDFLSNVSS 172
           S      GT  + APE+A    V    D++S GVL+      L    G++  + L NV S
Sbjct: 206 SVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 264
Query: 173 SNPNI 177
            + N+
Sbjct: 265 CDWNM 269

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 72  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 128
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 129 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 186 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 243
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM   ++    + +SRP  + +
Sbjct: 244 KGERLPQPPICTID----VYMIMRKCWMI---DADSRPKFREL 279

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 234 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 269

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 240
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 241 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 276

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 240
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 241 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 276

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 65  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 122 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 236
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 237 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 272

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 65  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 122 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 236
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM   ++    + +SRP  + +
Sbjct: 237 KGERLPQPPICTID----VYMIMRKCWMI---DADSRPKFREL 272

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 65  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 121
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 122 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 236
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 237 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 272

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 32  HSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRD 89
           H +LV +Y   G L  +L+   D   E++       ++  I  ++  LH+      VHRD
Sbjct: 164 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DSIHQLHY------VHRD 216
Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   NVLLD+     ++DFG    +  D +  +  A GT  Y++PE+   M     K   
Sbjct: 217 IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP 276
Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 277 ECDWWSLGVCMYEMLYGETP 296

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 234 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 269

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL 109
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 110 FQLLQGLAFCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 121 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 235
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 236 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 271

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 19/140 (13%)
Query: 34  FLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGI--AHALSYLHHDCIPPIVHRD 89
           +LV +Y   G L  +L+   D   EE+       ++  I   H L Y         VHRD
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY---------VHRD 200
Query: 90  ISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTM-----KVTA 143
           I   N+L+D+     ++DFG    +  D +  +  A GT  Y++PE+   M     +   
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 144 KCDVYSFGVLALEVIKGKHP 163
           +CD +S GV   E++ G+ P
Sbjct: 261 ECDWWSLGVCMYEMLYGETP 280

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+L       +  +  +   L    S  
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 111 FQLLQGLAFCHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +K++F+ E  ++  + H +IVK  G       ++++ E    G L   L  + ++  L  
Sbjct: 52  NKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNS--LKV 108
Query: 61  SRRINVIKGIAHALSYLHH-DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDS 118
              +     I  A++YL   +C    VHRDI+ +N+L+       + DFG++++I+  D 
Sbjct: 109 LTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 164
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
              +       +++PE     + T   DV+ F V   E++  GK P  +L N       I
Sbjct: 165 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV----I 220
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-QTICQL 225
            V E  D RLP    D+   V+  +     C D +P  RP   + +C L
Sbjct: 221 GVLEKGD-RLP--KPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSL 264

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 96  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 152
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 153 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 209
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 210 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 267
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 268 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 303

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +K++F+ E  ++  + H +IVK  G       ++++ E    G L   L  + ++  L  
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNS--LKV 112
Query: 61  SRRINVIKGIAHALSYLHH-DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDS 118
              +     I  A++YL   +C    VHRDI+ +N+L+       + DFG++++I+  D 
Sbjct: 113 LTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
              +       +++PE     + T   DV+ F V   E++  GK P  +L N       I
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV----I 224
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-QTICQL 225
            V E  D RLP    D+   V+  +     C D +P  RP   + +C L
Sbjct: 225 GVLEKGD-RLP--KPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSL 268

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLVGIKH----LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S GV+  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +K++F+ E  ++  + H +IVK  G       ++++ E    G L   L  + ++  L  
Sbjct: 68  NKEKFMSEAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNS--LKV 124
Query: 61  SRRINVIKGIAHALSYLHH-DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ-PDS 118
              +     I  A++YL   +C    VHRDI+ +N+L+       + DFG++++I+  D 
Sbjct: 125 LTLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 180
Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNI 177
              +       +++PE     + T   DV+ F V   E++  GK P  +L N       I
Sbjct: 181 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV----I 236
Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-QTICQL 225
            V E  D RLP    D+   V+  +     C D +P  RP   + +C L
Sbjct: 237 GVLEKGD-RLP--KPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSL 280

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 87  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 143
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   + 
Sbjct: 144 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 201 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 258
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 259 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 294

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  +  FG+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
            RE+  L + + ++NI++   F       +LV+E L+ GS+   +       E   SR  
Sbjct: 58  FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR-- 115
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSS-- 119
            V++ +A AL +LH      I HRD+  +N+L +   +     + DF +   ++ ++S  
Sbjct: 116 -VVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 120 -----NWTEFAGTYGYVAPEL--AYTMKVT---AKCDVYSFGVLALEVIKGKHP 163
                  T   G+  Y+APE+   +T + T    +CD++S GV+   ++ G  P
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           E  VL  IR     +   Y F T  +   L+ +Y+  G L   L    S  E      + 
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHL----SQRERFTEHEVQ 162
Query: 66  VIKG-IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-FIQPDSSNWTE 123
           +  G I  AL +LH      I++RDI  +N+LLD      ++DFG++K F+  ++    +
Sbjct: 163 IYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 124 FAGTYGYVAPELAYTMKVT--AKCDVYSFGVLALEVIKGKHP 163
           F GT  Y+AP++            D +S GVL  E++ G  P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLVGIKH----LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S GV+  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F    ++++++ H+++V  YG C     + LV E+++ GSL   L  + +   + W  ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA--------HVSDFGIAKFIQP 116
            V K +A A+ +L  +    ++H ++ +KN+LL  E +          +SD GI+  + P
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 117 DSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG 160
                        +V PE     K +    D +SFG    E+  G
Sbjct: 174 KDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + D G+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+    +   
Sbjct: 145 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 201
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
                 T  Y APE+    M      D++S G +  E++ G+
Sbjct: 202 ---XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 10/164 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  +   
Sbjct: 116 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 170
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
                  + + APE   T   +   D + FGV   E+   G+ P
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + D G+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 21  VKFYGFCTHARHSFLVYEYLENG----SLSVILNNDTSAEELGWSRRINVIKGIAHALSY 76
           V FYG        ++  E ++         VI    T  E++     ++++K + H  S 
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 77  LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELA 136
           L       ++HRD+   NVL++   +  + DFGI+ ++  DS   T  AG   Y+APE  
Sbjct: 173 LS------VIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYMAPERI 225
Query: 137 ----YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSV 192
                    + K D++S G+  +E+   + P D     S   P   + ++++   P L  
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----SWGTPFQQLKQVVEEPSPQLPA 280
Query: 193 DIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           D        ++    CL  N + RP    + Q
Sbjct: 281 DKFS--AEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW--SRR 63
           +REI++L E+ H NIVK           +LV+E+++      +  +  +   L    S  
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL 112
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             +++G+A   S+        ++HRD+  +N+L++ E    ++DFG+A+        +  
Sbjct: 113 FQLLQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 124 FAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVI 158
              T  Y APE+    K  +   D++S G +  E++
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 62/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 183
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++   + WT   GT  Y+APE+  +       
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLAPEIILSKGYNKAV 240
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + D G+A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 10/164 (6%)
Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG   R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT- 122
             V   +A  + YL        +HRD++++N+LL       + DFG+ + +  +  +   
Sbjct: 126 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 123 --EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHP 163
                  + + APE   T   +   D + FGV   E+   G+ P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T A  S   +   YL    +   LNN    ++L  
Sbjct: 95  KRTYRELRLLKHMKHENVIGLLDVFTPAT-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 153
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+        
Sbjct: 154 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 207
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 208 MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 98/245 (40%), Gaps = 43/245 (17%)
Query: 1   DKKEFLREITVLTEIRHRN---IVKFYGFCTHARHSFLVYEYLENG-------SLSVILN 50
           ++K+ L ++ V+  +R  +   IV+FYG        ++  E +            SV+  
Sbjct: 63  EQKQLLMDLDVV--MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL-- 118
Query: 51  NDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
           +D   EE+     +  +K + H    L       I+HRDI   N+LLD      + DFGI
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK------IIHRDIKPSNILLDRSGNIKLCDFGI 172
Query: 111 AKFIQPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPR-- 164
           +  +  DS   T  AG   Y+APE     A       + DV+S G+   E+  G+ P   
Sbjct: 173 SGQLV-DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 165 -----DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
                D L+ V   +P  L N            + R    S +    LCL  +   RP  
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNS-----------EEREFSPSFINFVNLCLTKDESKRPKY 280
Query: 220 QTICQ 224
           + + +
Sbjct: 281 KELLK 285

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  +V EY   G L   I N    +E+        
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 123
Query: 66  VIKGIA--HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPD 117
           +I G++  HA+          + HRD+  +N LLD        + DFG +K      QP 
Sbjct: 124 LISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 174
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
           S+      GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 175 ST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYE--YLENGSLSVILNNDTSAEELGW 60
           K   RE+ +L  ++H N++      T AR S   +   YL    +   LNN    ++L  
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  I   L Y+H      I+HRD+   N+ ++ + E  + DF +A+        
Sbjct: 125 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHT---DDE 178
Query: 121 WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 179 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 21  VKFYGFCTHARHSFLVYEYLENG----SLSVILNNDTSAEELGWSRRINVIKGIAHALSY 76
           V FYG        ++  E ++         VI    T  E++     ++++K + H  S 
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 77  LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELA 136
           L       ++HRD+   NVL++   +  + DFGI+ ++  D +   + AG   Y+APE  
Sbjct: 129 LS------VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPERI 181
Query: 137 ----YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSV 192
                    + K D++S G+  +E+   + P D     S   P   + ++++   P L  
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----SWGTPFQQLKQVVEEPSPQLPA 236
Query: 193 DIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           D        ++    CL  N + RP    + Q
Sbjct: 237 DKFSA--EFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 58/107 (54%), Gaps = 11/107 (10%)
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL--DLEYEAHVSDFGIAK-FIQPDSSNW 121
           N+++ I  AL YLH+     I HRDI  +N L   +  +E  + DFG++K F + ++  +
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 122 ---TEFAGTYGYVAPELAYTMKVT--AKCDVYSFGVLALEVIKGKHP 163
              T  AGT  +VAPE+  T   +   KCD +S GVL   ++ G  P
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  +V EY   G L   I N    +E+        
Sbjct: 63  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 122
Query: 66  VIKGIA--HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPD 117
           +I G++  HA+          + HRD+  +N LLD        + DFG +K      QP 
Sbjct: 123 LISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 173
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
           S+      GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 174 ST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  ++ EY   G L   I N    +E+        
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPDSS 119
           ++ G+++  S         I HRD+  +N LLD        + DFG +K      QP S+
Sbjct: 125 LLSGVSYCHSM-------QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 120 NWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
                 GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 178 -----VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 66  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 122
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 123 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 237
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 238 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 273

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W   AGT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI--LNNDTSAEELGWSRR 63
           LREI +L E++H+NIV+ +      +   LV+E+ +          N D   E +  S  
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-SFL 107
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
             ++KG+    S         ++HRD+  +N+L++   E  +++FG+A+        ++ 
Sbjct: 108 FQLLKGLGFCHSR-------NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 124 FAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHP 163
              T  Y  P++ +  K+ +   D++S G +  E+     P
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 6   LREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           L+E+ +L ++  H NI++           FLV++ ++ G L   L    +  E    + +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
             +  +  AL  L+      IVHRD+  +N+LLD +    ++DFG +  + P        
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSV 183
Query: 125 AGTYGYVAPEL----------AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+           Y  +V    D++S GV+   ++ G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 121 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 235
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM   ++    + +SRP  + +
Sbjct: 236 KGERLPQPPICTID----VYMIMRKCWMI---DADSRPKFREL 271

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQY 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 121 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 235
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 236 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 271

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 148
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     WT   GT  Y+APE+  +       
Sbjct: 149 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKAV 205
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 206 DWWALGVLIYEMAAGYPP 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 118
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 119 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 233
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 234 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 26/231 (11%)
Query: 2   KKEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + E L EI VL   +    ++  +    +     L+ EY   G +  +   +  AE +  
Sbjct: 72  RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSE 130
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPD 117
           +  I +IK I   + YLH +    IVH D+  +N+LL   Y   +  + DFG+++ I   
Sbjct: 131 NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GH 186
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
           +    E  GT  Y+APE+     +T   D+++ G++A  ++    P      V   N   
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF-----VGEDNQET 241
Query: 178 LVNEMLDPRLPPLSVDIRGKV---ISIMEVAFL--CLDNNPESRPNMQTIC 223
            +N      +  ++VD   +    +S +   F+   L  NPE RP  + IC
Sbjct: 242 YLN------ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE-IC 285

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 32  HSFLVYEYLENGSLSVILNNDTS----AEELGWSRRINVIKGIAHALSYLH-HDCIPPIV 86
            SF    + E+ SLS +   + S     E +     I+    +A  + +L    CI    
Sbjct: 166 ESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCI---- 221
Query: 87  HRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAK 144
           HRD++++N+LL       + DFG+A+ I   PD     +      ++APE  +    + K
Sbjct: 222 HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTK 281
Query: 145 CDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEV 204
            DV+S+GVL  E+          S   S  P + ++E    RL    + +R    S  E+
Sbjct: 282 SDVWSYGVLLWEI---------FSLGGSPYPGVQMDEDFCSRLRE-GMRMRAPEYSTPEI 331
Query: 205 AFLCLD---NNPESRPNMQTICQLL 226
             + LD    +P+ RP    + + L
Sbjct: 332 YQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 39/187 (20%)
Query: 1   DKKEFLREITVLTEI--RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           ++  + RE  +   +  RH NI+ F         S    +L+ +Y ENGSL   L + T 
Sbjct: 72  EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL 131
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
             +       + + G+ H    LH +       P I HRD+ SKN+L+       ++D G
Sbjct: 132 DAKSMLKLAYSSVSGLCH----LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187
Query: 110 IA-KFIQPDSSNWTEF-----AGTYGYVAPEL-----------AYTMKVTAKCDVYSFGV 152
           +A KFI    +N  +       GT  Y+ PE+           +Y M      D+YSFG+
Sbjct: 188 LAVKFI--SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGL 240
Query: 153 LALEVIK 159
           +  EV +
Sbjct: 241 ILWEVAR 247

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 10/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           DK     EI+++ ++ H  ++  +          L+ E+L  G L   I   D    E  
Sbjct: 91  DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-- 148
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS--DFGIAKFIQPD 117
            +  IN ++     L ++H   I   VH DI  +N++ + +  + V   DFG+A  + PD
Sbjct: 149 -AEVINYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                  A T  + APE+     V    D+++ GVL   ++ G  P
Sbjct: 205 EIVKVTTA-TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 120
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 121 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 235
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D    V  IM   ++    + +SRP  + +
Sbjct: 236 KGERLPQPPICTID----VYMIMRKCWMI---DADSRPKFREL 271

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 97/258 (37%), Gaps = 77/258 (29%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR-------------------HSFLVYEYLENG 43
           +EFL E   + +  H N+++  G C                       H++L+Y  LE G
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 44  SLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA 103
              + L              +  +  IA  + YL +      +HRD++++N +L  +   
Sbjct: 141 PKHIPLQT-----------LLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186
Query: 104 HVSDFGIAKFIQPDSSNWTEFAGTY-----------GYVAPELAYTMKVTAKCDVYSFGV 152
            V+DFG++K I         ++G Y            ++A E       T+K DV++FGV
Sbjct: 187 CVADFGLSKKI---------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 153 LALEV-IKGKHPRDFLSNVSSSNPNILVNEMLDPRL-------PPLSVDIRGKVISIMEV 204
              E+  +G  P           P +  +EM D  L       P   +D       + E+
Sbjct: 238 TMWEIATRGMTP----------YPGVQNHEMYDYLLHGHRLKQPEDCLD------ELYEI 281
Query: 205 AFLCLDNNPESRPNMQTI 222
            + C   +P  RP    +
Sbjct: 282 MYSCWRTDPLDRPTFSVL 299

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 18/223 (8%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           KE L E  V+  + + ++ +  G C  +    L+ + +  G L   +      + +G   
Sbjct: 69  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQY 125
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
            +N    IA  ++YL       +VHRD++++NVL+       ++DFG AK +  +   + 
Sbjct: 126 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 182
Query: 123 EFAGTY--GYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILV 179
              G     ++A E       T + DV+S+GV   E++  G  P D +   +S   +IL 
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE 240
Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                P+ P  ++D+   ++        C   + +SRP  + +
Sbjct: 241 KGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFREL 276

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 13/168 (7%)
Query: 2   KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           K++   EI +L    +H NI+         ++ ++V E  + G L   IL     +E   
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA 118
Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQ 115
            +    V+  I   + YLH   +   VHRD+   N+L   E        + DFG AK ++
Sbjct: 119 SA----VLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            ++        T  +VAPE+       A CD++S GVL    + G  P
Sbjct: 172 AENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     WT   GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 98/241 (40%), Gaps = 43/241 (17%)
Query: 7   REITVLTEIRHRNIVKFYGFC---------THARHS--------FLVYEYLENGSLSVIL 49
           RE+  L ++ H NIV + G C         T +++S        F+  E+ + G+L   +
Sbjct: 53  REVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 50  NNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
                 E+L     + + + I   + Y+H      +++RD+   N+ L    +  + DFG
Sbjct: 112 EK-RRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFG 167
Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           +   ++ D        GT  Y++PE   +     + D+Y+ G++  E++   H  D    
Sbjct: 168 LVTSLKNDGKR-XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFE 223
Query: 170 VSSSNPNI---LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            S    ++   +++++ D +   L   +              L   PE RPN   I + L
Sbjct: 224 TSKFFTDLRDGIISDIFDKKEKTLLQKL--------------LSKKPEDRPNTSEILRTL 269
Query: 227 C 227
Sbjct: 270 T 270

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 6   LREITVLTEIRHRNIVKFYGF-----CTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   +H NI+  +         +    +++ E ++     VI     S + + +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-- 118
                 I     A+  LH   +   +HRD+   N+L++   +  V DFG+A+ I   +  
Sbjct: 117 -----FIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 119 --------SNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEV 157
                   S  TE+  T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/196 (20%), Positives = 81/196 (41%), Gaps = 25/196 (12%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           F+  E+ + G+L   +      E+L     + + + I   + Y+H      ++HRD+   
Sbjct: 110 FIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPS 165
Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           N+ L    +  + DFG+   ++ D    T   GT  Y++PE   +     + D+Y+ G++
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 224
Query: 154 ALEVIKGKHPRDFLSNVSSSNPNI---LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLD 210
             E++   H  D     S    ++   +++++ D +   L   +              L 
Sbjct: 225 LAELL---HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKL--------------LS 267
Query: 211 NNPESRPNMQTICQLL 226
             PE RPN   I + L
Sbjct: 268 KKPEDRPNTSEILRTL 283

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH-SFLVYEYLENGSLSVILNN---DTSAEEL 58
           + FLRE  ++  + H N++   G          ++  Y+ +G L   + +   + + ++L
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                I+    +A  + YL        VHRD++++N +LD  +   V+DFG+A+ I  D 
Sbjct: 127 -----ISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL-DR 177
Query: 119 SNWTEFAGTYG-----YVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSS 172
             ++     +      + A E   T + T K DV+SFGVL  E++ +G  P   +     
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           ++       +  P   P          S+ +V   C + +P  RP  + +
Sbjct: 238 THFLAQGRRLPQPEYCP---------DSLYQVMQQCWEADPAVRPTFRVL 278

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ +L  ++H N++      T A         +LV  +++   L  I+  + S E
Sbjct: 86  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGMEFSEE 144
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           ++ +     ++  +   L Y+H   +   VHRD+   N+ ++ + E  + DFG+A+    
Sbjct: 145 KIQY-----LVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHA-- 194
Query: 117 DSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK---HPRDFLSNVSS 172
             +  T +  T  Y APE+  + M      D++S G +  E++ GK     +D+L  ++ 
Sbjct: 195 -DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 253

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
           FY F    R+ ++V EY+  G L  +++N    E+  W+R       +  AL  +H    
Sbjct: 135 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHS--- 186
Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTMKV 141
              +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 142 TA----KCDVYSFGVLALEVIKGKHP 163
                 +CD +S GV   E++ G  P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
           FY F    R+ ++V EY+  G L  +++N    E+  W+R       +  AL  +H    
Sbjct: 140 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHS--- 191
Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTMKV 141
              +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 142 TA----KCDVYSFGVLALEVIKGKHP 163
                 +CD +S GV   E++ G  P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 23  FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI 82
           FY F    R+ ++V EY+  G L  +++N    E+  W+R       +  AL  +H    
Sbjct: 140 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHS--- 191
Query: 83  PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA-GTYGYVAPELAYTMKV 141
              +HRD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 142 TA----KCDVYSFGVLALEVIKGKHP 163
                 +CD +S GV   E++ G  P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 15/146 (10%)
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL  +    + DFG+A+ I   PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVIS 200
           + DV+SFGVL  E+          S  +S  P + ++E    RL      +R        
Sbjct: 273 QSDVWSFGVLLWEI---------FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPE 322
Query: 201 IMEVAFLCLDNNPESRPNMQTICQLL 226
           + +    C    P  RP    + + L
Sbjct: 323 MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 6   LREITVLTEIRHRNIVKFYGF-----CTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   +H NI+  +         +    +++ E ++     VI     S + + +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-- 118
                 I     A+  LH   +   +HRD+   N+L++   +  V DFG+A+ I   +  
Sbjct: 117 -----FIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 119 --------SNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEV 157
                   S   EF  T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLVGIKH----LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H N+V+    C  +R        LV+E+++   L   L+       
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPG 116
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L      ++++     L +LH +CI   VHRD+  +N+L+       ++DFG+A+ I   
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR-IYSY 172
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
               T    T  Y APE+          D++S G +  E+ + K
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 3   KEFLREITVLTEIRHRNIVKFY--------------GFCTHARHSFLVYEYLENGSLSVI 48
           K  LREI ++  + H NIVK +              G  T     ++V EY+E   L+ +
Sbjct: 53  KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANV 111
Query: 49  LNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSD 107
           L      EE        +++G    L Y+H      ++HRD+   N+ ++ E     + D
Sbjct: 112 LEQGPLLEEHARLFMYQLLRG----LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 108 FGIAKFIQPDSS---NWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
           FG+A+ + P  S   + +E   T  Y +P L  +    T   D+++ G +  E++ GK
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 2   KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +    RE+ +L + + HRN+++   F       +LV+E +  GS+   ++      EL  
Sbjct: 54  RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQ-- 115
           S    V++ +A AL +LH+     I HRD+  +N+L +   +     + DFG+   I+  
Sbjct: 114 SV---VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 116 ----PDSS-NWTEFAGTYGYVAPELAYTMKVTA-----KCDVYSFGVLALEVIKGKHP 163
               P S+       G+  Y+APE+       A     +CD++S GV+   ++ G  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 15/146 (10%)
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAK--FIQPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRG---KVIS 200
           + DV+SFGVL  E+          S  +S  P + ++E    RL      +R        
Sbjct: 275 QSDVWSFGVLLWEI---------FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPE 324
Query: 201 IMEVAFLCLDNNPESRPNMQTICQLL 226
           + +    C    P  RP    + + L
Sbjct: 325 MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 15/146 (10%)
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL  +    + DFG+A+ I   PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIME 203
           + DV+SFGVL  E+          S  +S  P + ++E    RL      +R    +  E
Sbjct: 282 QSDVWSFGVLLWEI---------FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPE 331
Query: 204 VAFLCLD---NNPESRPNMQTICQLL 226
           +    LD     P  RP    + + L
Sbjct: 332 MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L Y + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L Y + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 15/146 (10%)
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTA 143
           +HRD++++N+LL  +    + DFG+A+ I   PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIME 203
           + DV+SFGVL  E+          S  +S  P + ++E    RL      +R    +  E
Sbjct: 280 QSDVWSFGVLLWEI---------FSLGASPYPGVKIDEEFCRRLKE-GTRMRAPDYTTPE 329
Query: 204 VAFLCLD---NNPESRPNMQTICQLL 226
           +    LD     P  RP    + + L
Sbjct: 330 MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 37/241 (15%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVIL------N 50
           D++E  RE  +     H NI++   +C   R     ++L+  + + G+L   +       
Sbjct: 69  DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 51  NDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
           N  + +++ W     ++ GI   L  +H        HRD+   N+LL  E +  + D G 
Sbjct: 129 NFLTEDQILW-----LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 111 --AKFIQPDSS-------NWTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVI 158
                I  + S       +W     T  Y APEL        +  + DV+S G +   ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
            G+ P D +     S    + N++  P+ P  S  +   + S+M V       +P  RP+
Sbjct: 241 FGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV-------DPHQRPH 293
Query: 219 M 219
           +
Sbjct: 294 I 294

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L Y + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 24/213 (11%)
Query: 21  VKFYGFCTHARHSFLVYEYLENGSL-----SVILNNDTSAEELGWSRRINVIKGIAHALS 75
           V FYG        ++  E L + SL      VI    T  E++     ++++K + H  S
Sbjct: 96  VTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 76  YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL 135
            L       ++HRD+   NVL++   +    DFGI+ ++  D +   + AG   Y APE 
Sbjct: 155 KLS------VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKPYXAPER 207
Query: 136 A----YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLS 191
                     + K D++S G+  +E+   + P D     S   P   + ++++   P L 
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYD-----SWGTPFQQLKQVVEEPSPQLP 262
Query: 192 VDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            D        ++    CL  N + RP    + Q
Sbjct: 263 ADKFSA--EFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLCGIKH----LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 23/169 (13%)
Query: 7   REITVLTEIRHRNIVKFYG--FCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L  +RH+N+++     +    +  ++V EY   G   ++   D+  E     +R 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPE-----KRF 106
Query: 65  NVIKGIAH------ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            V +   +       L YLH   I   VH+DI   N+LL       +S  G+A+ + P +
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 119 SNWT--EFAGTYGYVAPELAYTMKVTA--KCDVYSFGVLALEVIKGKHP 163
           ++ T     G+  +  PE+A  +   +  K D++S GV    +  G +P
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 120
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  ++S     
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 176
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 120
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  ++S     
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 176
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 119
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  ++S     
Sbjct: 120 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 175
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L ++L      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 120
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  ++S     
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 176
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 157
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 158 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 214
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 215 DWWALGVLIYEMAAGYPP 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 126
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  ++S     
Sbjct: 127 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTL 182
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ +L  + H+NI+      T  +        +LV E L + +L  +++ +   E
Sbjct: 68  KRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 175
Query: 117 DSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
             +N+  T +  T  Y APE+   M   A  D++S G +  E++KG
Sbjct: 176 ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLCGIKH----LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG+AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 149
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 150 IYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 206
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 207 DWWALGVLIYEMAAGYPP 224

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 6   LREITVLTEIRHRNIVKFYGF-----CTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   +H NI+  +         +    +++ E ++     VI     S + + +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-- 118
                 I     A+  LH   +   +HRD+   N+L++   +  V DFG+A+ I   +  
Sbjct: 117 -----FIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 119 --------SNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEV 157
                   S  TE   T  Y APE+  T  K +   DV+S G +  E+
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 245
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K I  ++S     
Sbjct: 246 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTL 301
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 155
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 212
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 155
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 212
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 183
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 240
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI 67
           EI +L ++ H  I+K   F   A   ++V E +E G L    +     + L  +      
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL---FDKVVGNKRLKEATCKLYF 259
Query: 68  KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEF 124
             +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K I  ++S     
Sbjct: 260 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTL 315
Query: 125 AGTYGYVAPELAYTMKVTA---KCDVYSFGVLALEVIKGKHP 163
            GT  Y+APE+  ++         D +S GV+    + G  P
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E L + +LS ++  +   E
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQMELDHE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 127 RMSY-LLYQMLCGIKH----LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ +L  ++H N++      T A         +LV  +++   L  I+    S E
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE 126
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           ++ +     ++  +   L Y+H   +   VHRD+   N+ ++ + E  + DFG+A+    
Sbjct: 127 KIQY-----LVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHA-- 176
Query: 117 DSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK---HPRDFLSNVSS 172
             +  T +  T  Y APE+  + M      D++S G +  E++ GK     +D+L  ++ 
Sbjct: 177 -DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG+AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 89  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 144
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  TE   T  YVAPE+    K    CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 204 GVIMYILLCGYPP--FYSN 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 24/167 (14%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  +V EY   G L   I N    +E+        
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 123
Query: 66  VIKGIA--HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPD 117
           +I G++  HA+          + HRD+  +N LLD        +  FG +K      QP 
Sbjct: 124 LISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK 174
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
           S+      GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 175 ST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 183
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 240
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ +L  + H+NI+      T  +        +LV E L + +L  +++ +   E
Sbjct: 66  KRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHMELDHE 124
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            + +     ++ GI H    LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 125 RMSY-LLYQMLCGIKH----LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 173
Query: 117 DSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S+N+  T +  T  Y APE+   M      D++S G +  E++KG
Sbjct: 174 ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 24/176 (13%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF---------YGFCTHARHSFLVYEYLENGSLSVILNN 51
           + K  LRE+ +L   +H NI+           YG     +  ++V + +E+    +I   
Sbjct: 97  NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLMESDLHQII--- 150
Query: 52  DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
             S++ L        +  +   L Y+H   +   +HRD+   N+L++   E  + DFG+A
Sbjct: 151 -HSSQPLTLEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMA 206
Query: 112 KFI--QPDSSNW--TEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH 162
           + +   P    +  TE+  T  Y APEL  ++ + T   D++S G +  E++  + 
Sbjct: 207 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/157 (21%), Positives = 72/157 (45%), Gaps = 7/157 (4%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L +++H NIV  +      +   LV+EYL+      +   D     +       
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKL 104
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +  +   L+Y H      ++HRD+  +N+L++   E  ++DFG+A+     +  +    
Sbjct: 105 FLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 126 GTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGK 161
            T  Y  P+ L  +   + + D++  G +  E+  G+
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D   F  E  ++       +V+ +      ++ ++V EY+  G L  +++N    E+  W
Sbjct: 118 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--W 175
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-KFIQPDSS 119
           ++       +  AL  +H      ++HRD+   N+LLD      ++DFG   K  +    
Sbjct: 176 AKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 120 NWTEFAGTYGYVAPELAYTMKVTA----KCDVYSFGVLALEVIKGKHP 163
           +     GT  Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 231 HCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L E++HRNI++      H     L++EY EN     +  N   +  +  S    
Sbjct: 81  IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-----VSDFGIAKFIQPDSSN 120
           +I G+    S     C+    HRD+  +N+LL +   +      + DFG+A+        
Sbjct: 141 LINGVNFCHS---RRCL----HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVI 158
           +T    T  Y  PE L  +   +   D++S   +  E++
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H N+V+    C  +R        LV+E+++   L   L+       
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPG 108
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L      ++++     L +LH +CI   VHRD+  +N+L+       ++DFG+A+ I   
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR-IYSY 164
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                    T  Y APE+          D++S G +  E+ + K
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 21/171 (12%)
Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN--NDTSAEELGWSR 62
           F  E  VL     R I + +       + +LV EY   G L  +L+   +    E+    
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 63  RINVIKGI--AHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              ++  I   H L Y         VHRDI   N+LLD      ++DFG    ++ D + 
Sbjct: 168 LAEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 121 WTEFA-GTYGYVAPELAYTMKVTA-------KCDVYSFGVLALEVIKGKHP 163
            +  A GT  Y++PE+   +           +CD ++ GV A E+  G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  ++  G  P
Sbjct: 220 DWWALGVLIYQMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 15/125 (12%)
Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I  AL YL       ++HRD+   N+LLD   +  + DFGI+  +  D +     AG   
Sbjct: 133 IVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAA 189
Query: 130 YVAPELAYTMKVTA-----KCDVYSFGVLALEVIKGKHP-----RDF--LSNVSSSNPNI 177
           Y+APE       T      + DV+S G+  +E+  G+ P      DF  L+ V    P +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249
Query: 178 LVNEM 182
           L   M
Sbjct: 250 LPGHM 254

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +      +VY     +Y+      V  +   +
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRA 115
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 173 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 163
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 220
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 24/176 (13%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF---------YGFCTHARHSFLVYEYLENGSLSVILNN 51
           + K  LRE+ +L   +H NI+           YG     +  ++V + +E+    +I   
Sbjct: 96  NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLMESDLHQII--- 149
Query: 52  DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
             S++ L        +  +   L Y+H   +   +HRD+   N+L++   E  + DFG+A
Sbjct: 150 -HSSQPLTLEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMA 205
Query: 112 KFI--QPDSSNW--TEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGKH 162
           + +   P    +  TE+  T  Y APEL  ++ + T   D++S G +  E++  + 
Sbjct: 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+++D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIISKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 95  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 150
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 209
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 210 GVIMYILLCGYPP--FYSN 226

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 122
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 178
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 96  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 151
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 210
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 211 GVIMYILLCGYPP--FYSN 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 97  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 152
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 211
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 212 GVIMYILLCGYPP--FYSN 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVI------QM 114
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 170
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H N+V+    C  +R        LV+E+++   L   L+       
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPG 108
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L      ++++     L +LH +CI   VHRD+  +N+L+       ++DFG+A+     
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQ 165
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            + +     T  Y APE+          D++S G +  E+ + K
Sbjct: 166 MALFPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 135 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 190
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 249
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 250 GVIMYILLCGYPP--FYSN 266

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 89  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 144
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 203
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 204 GVIMYILLCGYPP--FYSN 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H N+V+    C  +R        LV+E+++   L   L+       
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPG 108
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L      ++++     L +LH +CI   VHRD+  +N+L+       ++DFG+A+ I   
Sbjct: 109 LPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR-IYSY 164
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                    T  Y APE+          D++S G +  E+ + K
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S   T +  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ VL  +    H N+V+ +  CT +R        LV+E+++   L+  L+      E
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPE 114
Query: 58  LGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
            G       +++  +   L +LH      +VHRD+  +N+L+    +  ++DFG+A+ I 
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IY 170
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                 T    T  Y APE+          D++S G +  E+ + K
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 91  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 146
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 205
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 206 GVIMYILLCGYPP--FYSN 222

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 90  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 145
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 204
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 205 GVIMYILLCGYPP--FYSN 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 105 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 160
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 219
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 220 GVIMYILLCGYPP--FYSN 236

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 91  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 146
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 205
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 206 GVIMYILLCGYPP--FYSN 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         ++K I  A+ YLH   I    HRD+  +
Sbjct: 141 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPE 196
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD++S 
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 255
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 256 GVIMYILLCGYPP--FYSN 272

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 70  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 123
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 124 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 179
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
            S     F  T  Y APE+   M      D++S G +  E+IKG
Sbjct: 180 TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ VL  +    H N+V+ +  CT +R        LV+E+++   L+  L+      E
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPE 114
Query: 58  LGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
            G       +++  +   L +LH      +VHRD+  +N+L+    +  ++DFG+A+ I 
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IY 170
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                 T    T  Y APE+          D++S G +  E+ + K
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ VL  +    H N+V+ +  CT +R        LV+E+++   L+  L+      E
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPE 114
Query: 58  LGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
            G       +++  +   L +LH      +VHRD+  +N+L+    +  ++DFG+A+ I 
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IY 170
Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
                 T    T  Y APE+          D++S G +  E+ + K
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 2   KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +    RE+ +L + + HRN+++   F       +LV+E +  GS+   ++      EL  
Sbjct: 54  RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQ-- 115
           S    V++ +A AL +LH+     I HRD+  +N+L +   +     + DF +   I+  
Sbjct: 114 SV---VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 116 ----PDSS-NWTEFAGTYGYVAPELAYTMKVTA-----KCDVYSFGVLALEVIKGKHP 163
               P S+       G+  Y+APE+       A     +CD++S GV+   ++ G  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 20/173 (11%)
Query: 1   DKKEFLREITVLTEIRHRNIVK----FYGFCTHARHSFL--VYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++  ++H N+V     FY         FL  V EY+       +      
Sbjct: 75  DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRH 130
Query: 55  AEELGWSRRINVIK----GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFG 109
             +L  +  + +IK     +  +L+Y+H   I    HRDI  +N+LLD       + DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
            AK +     N +     Y Y APEL +     T   D++S G +  E+++G+
Sbjct: 188 SAKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D   F +EI ++  + H NI++ Y         +LV E    G L   + +     E   
Sbjct: 49  DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA 108
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPD 117
           +R   ++K +  A++Y H      + HRD+  +N L      +    + DFG+A   +P 
Sbjct: 109 AR---IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               T+  GT  YV+P++   +    +CD +S GV+   ++ G  P
Sbjct: 163 KMMRTK-VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 24/167 (14%)
Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  +V EY   G L   I N    +E+        
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 123
Query: 66  VIKGIA--HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAK----FIQPD 117
           +I G++  HA+          + HRD+  +N LLD        +  FG +K      QP 
Sbjct: 124 LISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK 174
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVIKGKHP 163
            +      GT  Y+APE+    +   K  DV+S GV    ++ G +P
Sbjct: 175 DT-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I     YLH      +++RD+  +N+L+D +    V+DFG AK ++     W    GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 203
Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           Y+APE+  +       D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYG 129
           I     YLH      +++RD+  +N+L+D +    V+DFG AK ++     W    GT  
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPE 203
Query: 130 YVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           Y+APE+  +       D ++ GVL  E+  G  P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D   F +EI ++  + H NI++ Y         +LV E    G L   + +     E   
Sbjct: 66  DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA 125
Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPD 117
           +R   ++K +  A++Y H      + HRD+  +N L      +    + DFG+A   +P 
Sbjct: 126 AR---IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 179
Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               T+  GT  YV+P++   +    +CD +S GV+   ++ G  P
Sbjct: 180 KMMRTK-VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT  Y+AP +  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPAIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 57  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 116
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 117 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 173
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 174 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 7   REITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG--WSRR 63
           RE+ +L E   H N++++  FCT     F   +Y+     +  L      ++        
Sbjct: 66  REVQLLRESDEHPNVIRY--FCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEP 120
Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL-----EYEAHVSDFGIAKFIQPDS 118
           I +++     L++LH      IVHRD+   N+L+ +     + +A +SDFG+ K +    
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 119 SNWTEFA---GTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVS 171
            +++  +   GT G++APE+         T   D++S G +   VI +G HP        
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP---FGKSL 234
Query: 172 SSNPNILVNEM-LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
               NIL+    LD   P    D+  + +    +A      +P+ RP+ + +
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM-----DPQKRPSAKHV 281

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 159
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 215
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 67  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 120
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 121 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 176
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 177 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 16/164 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        ++V E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
                 E    Y Y APE+   M      D++S G +  E+IKG
Sbjct: 179 SFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 173 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 115
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 171
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 172 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 62  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 115
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 171
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 172 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 114
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 170
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 122
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 178
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 173 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 68  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 121
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 177
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 69  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 122
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+    
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 178
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 176
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 177 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 64  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 123
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 124 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 180
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 181 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 75  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 134
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 135 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 191
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 192 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 90/188 (47%), Gaps = 25/188 (13%)
Query: 7   REITVLTEIRHRNIVKFYG-FCTHA-RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           REI +L E++H N++     F +HA R  +L+++Y E+    +I  +  S       + +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPV 123
Query: 65  NVIKGIAHALSY-----LHHDCIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKF-- 113
            + +G+  +L Y     +H+     ++HRD+   N+L+  E        ++D G A+   
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 114 --IQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK---HPRDFL 167
             ++P  ++      T+ Y APEL    +  T   D+++ G +  E++  +   H R   
Sbjct: 184 SPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ-- 240
Query: 168 SNVSSSNP 175
            ++ +SNP
Sbjct: 241 EDIKTSNP 248

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 128 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 184
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 185 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVK----FYGFCTHARHSFL--VYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+    FY         +L  V +Y+      V  +   +
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 128 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 184
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 185 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAE 56
           K   RE+ ++  + H+NI+      T  +        +LV E ++     VI        
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QM 159
Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
           EL   R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+    
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAG 215
Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
            S   T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 5   FLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +  EI  L +++  +  I++ Y +    ++ ++V E   N  L+  L    S +   W R
Sbjct: 57  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WER 113
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           + +  K +  A+  +H   I   VH D+   N L+ ++    + DFGIA  +QPD+++  
Sbjct: 114 K-SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 168
Query: 123 EFA--GTYGYVAPELAYTMKVTAK-----------CDVYSFGVLALEVIKGKHPRDFLSN 169
           + +  GT  Y+ PE    M  + +            DV+S G +   +  GK P   + N
Sbjct: 169 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 228
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             S      ++ ++DP       DI  K   + +V   CL  +P+ R
Sbjct: 229 QISK-----LHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 268

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 156 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 208
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 209 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 173 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVK----FYGFCTHARHSFL--VYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+    FY         +L  V +Y+      V  +   +
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 207 LVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 60/139 (43%), Gaps = 10/139 (7%)
Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
            +V E L+ G L   +  D   +         + K I  A+ YLH   I    HRD+  +
Sbjct: 135 LIVXECLDGGELFSRIQ-DRGDQAFTEREASEIXKSIGEAIQYLHSINI---AHRDVKPE 190
Query: 94  NVLLDLEYEAHV---SDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSF 150
           N+L   +    +   +DFG AK     +S  T     Y YVAPE+    K    CD +S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWSL 249
Query: 151 GVLALEVIKGKHPRDFLSN 169
           GV+   ++ G  P  F SN
Sbjct: 250 GVIXYILLCGYPP--FYSN 266

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 15/138 (10%)
Query: 35  LVYEYLENGSLSVILNNDTSAEELGWSRRINVIK---------GIAHALSYLHHDCIPPI 85
           L + + +N +L +++      E     RRI              I     YLH      +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 86  VHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKC 145
           ++RD+  +N+L+D +    V+DFG AK ++     W    GT   +APE+  +       
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALAPEIILSKGYNKAV 219
Query: 146 DVYSFGVLALEVIKGKHP 163
           D ++ GVL  E+  G  P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 69  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 128
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 129 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 185
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 186 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 5   FLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +  EI  L +++  +  I++ Y +    ++ ++V E   N  L+  L    S +   W R
Sbjct: 53  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WER 109
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           + +  K +  A+  +H   I   VH D+   N L+ ++    + DFGIA  +QPD+++  
Sbjct: 110 K-SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 164
Query: 123 EFA--GTYGYVAPELAYTMKVTAK-----------CDVYSFGVLALEVIKGKHPRDFLSN 169
           + +  GT  Y+ PE    M  + +            DV+S G +   +  GK P   + N
Sbjct: 165 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 224
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             S      ++ ++DP       DI  K   + +V   CL  +P+ R
Sbjct: 225 QISK-----LHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 264

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF--------LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C      +        LV+++ E+  L+ +L+N      
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFT 123
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           L   +R  V++ + + L Y+H +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 124 LSEIKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF--------LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C      +        LV+++ E+  L+ +L+N      
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 123
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           L   +R  V++ + + L Y+H +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 124 LSEIKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 9/83 (10%)
Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 9/83 (10%)
Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L   + 
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 366
Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 367 YDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF--------LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C      +        LV+++ E+  L+ +L+N      
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           L   +R  V++ + + L Y+H +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 123 LSEIKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 141 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 193
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 194 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 9/83 (10%)
Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 9/83 (10%)
Query: 85  IVHRDISSKNVLLDLEYEAHVSDFGIA---KFIQPDSSNWTEFAGTYGYVAPE-LAYTMK 140
           +V+RD+   N+LLD      +SD G+A      +P +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 141 VTAKCDVYSFGVLALEVIKGKHP 163
             +  D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 5   FLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +  EI  L +++  +  I++ Y +    ++ ++V E   N  L+  L    S +   W R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WER 129
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           + +  K +  A+  +H   I   VH D+   N L+ ++    + DFGIA  +QPD+++  
Sbjct: 130 K-SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 123 EFA--GTYGYVAPELAYTMKVTAK-----------CDVYSFGVLALEVIKGKHPRDFLSN 169
           + +  GT  Y+ PE    M  + +            DV+S G +   +  GK P   + N
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             S      ++ ++DP       DI  K   + +V   CL  +P+ R
Sbjct: 245 QISK-----LHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 142 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 194
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 195 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 114 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 166
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 167 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 141 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 193
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 194 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSF--------LVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C      +        LV+++ E+  L+ +L+N      
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 123
Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           L   +R  V++ + + L Y+H +    I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 124 LSEIKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 104 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 156
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 157 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 212

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 156 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 208
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 209 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 142 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 194
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 195 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 156 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 208
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 209 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 113 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 165
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 166 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 141 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 193
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 194 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 142 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 194
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 195 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 141 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 193
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 194 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 153
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 154 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 113 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 165
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 166 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 161 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 213
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 214 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 261

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 142 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 194
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 195 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 128 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 180
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 181 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 101 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 153
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 154 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 158
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 159 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 128 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 180
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 181 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVK----FYGFCTHARHSFL--VYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+    FY         +L  V +Y+      V  +   +
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 177
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 178 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVK----FYGFCTHARHSFL--VYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+    FY         +L  V +Y+      V  +   +
Sbjct: 92  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 151
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 152 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 208
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 209 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 128 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 180
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 181 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 140 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 192
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 193 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 84  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 143
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 144 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 200
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 201 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 129 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 181
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 182 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 129 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 181
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 182 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 5   FLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +  EI  L +++  +  I++ Y +    ++ ++V E   N  L+  L    S +   W R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP--WER 157
Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           + +  K +  A+  +H   I   VH D+   N L+ ++    + DFGIA  +QPD+++  
Sbjct: 158 K-SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 212
Query: 123 EFA--GTYGYVAPELAYTMKVTAK-----------CDVYSFGVLALEVIKGKHPRDFLSN 169
           + +  GT  Y+ PE    M  + +            DV+S G +   +  GK P   + N
Sbjct: 213 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
             S      ++ ++DP       DI  K   + +V   CL  +P+ R
Sbjct: 273 QISK-----LHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENG-SLSVILNNDTSAEELGWSRRINV 66
           EI +L+ + H NI+K      +     LV E   +G  L   ++     +E   S    +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---I 135
Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
            + +  A+ YL    +  I+HRDI  +N+++  ++   + DFG A +++     +T F G
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCG 191
Query: 127 TYGYVAPELAYTMKVTA-KCDVYSFGVLALEVIKGKHP 163
           T  Y APE+         + +++S GV    ++  ++P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 11/118 (9%)
Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVS 106
           I       EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + 
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLI 158
Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG    ++   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 159 DFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 207 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFI 114
           EEL  S    V++ + H      H+C   ++HRDI  +N+L+DL   E  + DFG    +
Sbjct: 129 EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL 181
Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +   + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 182 K--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 1   DKKEFLREITVLTEIRHRNIVKF-YGFCTHARHSFLVY-----EYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+  Y F +       VY     +Y+      V  +   +
Sbjct: 94  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 153
Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEA-HVSDFGIAKF 113
            + L        +  +  +L+Y+H   I    HRDI  +N+LLD +     + DFG AK 
Sbjct: 154 KQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 210
Query: 114 IQPDSSNWTEFAGTYGYVAPELAY-TMKVTAKCDVYSFGVLALEVIKGK 161
           +     N +     Y Y APEL +     T+  DV+S G +  E++ G+
Sbjct: 211 LVRGEPNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	228
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-82
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-69
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-66
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-58
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-48
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-45
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-36
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  246 bits (631), Expect = 5e-82
 Identities = 77/238 (32%), Positives = 124/238 (52%), Gaps = 15/238 (6%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGW 60
           + +F  E+ +++   HRN+++  GFC       LVY Y+ NGS+ S +     S   L W
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +R  +  G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +    ++
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 121 -WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL- 178
             T   GT G++APE   T K + K DV+ +GV+ LE+I G+   D     +  +  +L 
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 179 ----------VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                     +  ++D  L         +V  +++VA LC  ++P  RP M  + ++L
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  213 bits (545), Expect = 3e-69
 Identities = 74/240 (30%), Positives = 119/240 (49%), Gaps = 27/240 (11%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           K++F +EI V+ + +H N+V+  GF +      LVY Y+ NGSL   L+       L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD--SS 119
            R  + +G A+ +++LH +     +HRDI S N+LLD  + A +SDFG+A+  +    + 
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
             +   GT  Y+APE A   ++T K D+YSFGV+ LE+I G    D         P +L+
Sbjct: 191 MTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE-----HREPQLLL 244

Query: 180 -------------NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                         + +D ++          V ++  VA  CL      RP+++ + QLL
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  207 bits (528), Expect = 1e-66
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 23/239 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWS 61
           +EF  EI  L+  RH ++V   GFC       L+Y+Y+ENG+L   +  +D     + W 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           +R+ +  G A  L YLH   I   +HRD+ S N+LLD  +   ++DFGI+K    +    
Sbjct: 140 QRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISK-KGTELDQT 195

Query: 122 ---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              T   GT GY+ PE     ++T K DVYSFGV+  EV+  +       ++     N+ 
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV--QSLPREMVNLA 253

Query: 179 -----------VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                      + +++DP L    +     +    + A  CL  + E RP+M  +   L
Sbjct: 254 EWAVESHNNGQLEQIVDPNLAD-KIRPES-LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  188 bits (479), Expect = 4e-59
 Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 37/255 (14%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAEELG 59
           +   E+  L  ++H NI++F G            +L+  + E GSLS  L  +     + 
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VS 119

Query: 60  WSRRINVIKGIAHALSYLHHDCI-------PPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
           W+   ++ + +A  L+YLH D         P I HRDI SKNVLL     A ++DFG+A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 113 FIQPDSSNW--TEFAGTYGYVAPELA-----YTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
             +   S        GT  Y+APE+      +      + D+Y+ G++  E+       D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 166 F--------LSNVSSSNPNIL------VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDN 211
                           +P++       V++   P L          +  + E    C D+
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD-YWQKHAGMAMLCETIEECWDH 298

Query: 212 NPESRPNMQTICQLL 226
           + E+R +   + + +
Sbjct: 299 DAEARLSAGCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 2e-58
 Identities = 63/227 (27%), Positives = 110/227 (48%), Gaps = 13/227 (5%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++K F+ E+  L+ + H NIVK YG C +     LV EY E GSL  +L+          
Sbjct: 44  ERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTA 101

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-AHVSDFGIAKFIQPDSS 119
           +  ++     +  ++YLH      ++HRD+   N+LL        + DFG A  IQ   +
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---T 158

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
           + T   G+  ++APE+      + KCDV+S+G++  EVI  + P D +          ++
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIM 214

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             + +   PPL  ++   + S+M     C   +P  RP+M+ I +++
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (465), Expect = 3e-57
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 9/224 (4%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
            EFLRE+ ++  +RH NIV F G  T   +  +V EYL  GSL  +L+   + E+L   R
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
           R+++   +A  ++YLH+   PPIVHR++ S N+L+D +Y   V DFG+++       +  
Sbjct: 139 RLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197

Query: 123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM 182
             AGT  ++APE+        K DVYSFGV+  E+   + P   L+         +  + 
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AAVGFKC 255

Query: 183 LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
               +P    ++  +V +I+E    C  N P  RP+  TI  LL
Sbjct: 256 KRLEIPR---NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  177 bits (451), Expect = 2e-55
 Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 21/231 (9%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +EF RE+ +++ + H NIVK YG   +     +V E++  G L   L +   A  + WS 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSV 123

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPD 117
           ++ ++  IA  + Y+ +   PPIVHRD+ S N+ L    E     A V+DFG+++     
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182

Query: 118 SSNWTEFAGTYGYVAPEL--AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
               +   G + ++APE   A     T K D YSF ++   ++ G+ P D  S       
Sbjct: 183 V---SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N++  E L P +P    D   ++ +++E   LC   +P+ RP+   I + L
Sbjct: 240 NMIREEGLRPTIPE---DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  175 bits (445), Expect = 1e-54
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 24/233 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +   +E  +   ++H NI+   G C    +  LV E+   G L+ +L+     + +    
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDI 106

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--------VSDFGIAKFI 114
            +N    IA  ++YLH + I PI+HRD+ S N+L+  + E          ++DFG+A+  
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166

Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN 174
              +      AG Y ++APE+      +   DV+S+GVL  E++ G+ P   +  ++   
Sbjct: 167 HRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--- 221

Query: 175 PNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +   +   +L  P+          +ME    C + +P SRP+   I   L
Sbjct: 222 ---VAYGVAMNKLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  167 bits (425), Expect = 3e-51
 Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 26/240 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++ FL+E+ V+  + H N++KF G     +    + EY++ G+L  I+ +     +  W
Sbjct: 50  TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPW 107

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ----- 115
           S+R++  K IA  ++YLH      I+HRD++S N L+       V+DFG+A+ +      
Sbjct: 108 SQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164

Query: 116 ---------PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDF 166
                    PD        G   ++APE+        K DV+SFG++  E+I   +    
Sbjct: 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP- 223

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +      +  +N            +       I      C D +PE RP+   +   L
Sbjct: 224 --DYLPRTMDFGLNVRGFLD-RYCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  164 bits (417), Expect = 2e-50
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 20/229 (8%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++F  E   L    H N++   G C    A H  L+  ++  GSL  +L+  T+   +  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQ 110

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S+ +     +A  +++LH    P I    ++S++V++D +  A +S   +    Q     
Sbjct: 111 SQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---- 165

Query: 121 WTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
                    +VAPE              D++SF VL  E++  + P   LSN+       
Sbjct: 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--MK 222

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  E L P +PP    I   V  +M+   +C++ +P  RP    I  +L
Sbjct: 223 VALEGLRPTIPP---GISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (409), Expect = 4e-49
 Identities = 55/229 (24%), Positives = 106/229 (46%), Gaps = 15/229 (6%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           + F  E+ VL + RH NI+ F G+ T  + + +V ++ E  SL   L+   +  +    +
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASET--KFEMKK 121

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ--PDSSN 120
            I++ +  A  + YLH      I+HRD+ S N+ L  +    + DFG+A        S  
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178

Query: 121 WTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
           + + +G+  ++APE+     +   + + DVY+FG++  E++ G+ P   ++N       +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                L P L  +  +   ++  +M     CL    + RP+   I   +
Sbjct: 239 -GRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  159 bits (405), Expect = 4e-48
 Identities = 46/238 (19%), Positives = 88/238 (36%), Gaps = 28/238 (11%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           K F RE+    + RH N+V F G C    H  ++    +  +L  ++ +      L  ++
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNK 131

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP-----D 117
              + + I   + YLH      I+H+D+ SKNV  D   +  ++DFG+            
Sbjct: 132 TRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

Query: 118 SSNWTEFAGTYGYVAPEL---------AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS 168
                   G   ++APE+            +  +   DV++ G +  E+   + P     
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FK 244

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +      +   + P L  + +    ++  I+     C     E RP    +  +L
Sbjct: 245 TQPAEAIIWQMGTGMKPNLSQIGMG--KEISDILL---FCWAFEQEERPTFTKLMDML 297

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  157 bits (398), Expect = 6e-47
 Identities = 59/270 (21%), Positives = 98/270 (36%), Gaps = 48/270 (17%)

Query: 1   DKKEFLRE--ITVLTEIRHRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDT 53
           +++ F+ E  I  +  + H NI +F                LV EY  NGSL   L+  T
Sbjct: 48  NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHD------CIPPIVHRDISSKNVLLDLEYEAHVSD 107
                 W     +   +   L+YLH +        P I HRD++S+NVL+  +    +SD
Sbjct: 108 ----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 108 FGIAKFIQPDSSNWTEF--------AGTYGYVAPE-------LAYTMKVTAKCDVYSFGV 152
           FG++  +  +                GT  Y+APE       L        + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 153 LALEVIKGKHPRDFLSNVS----------SSNPNIL------VNEMLDPRLPPLSVDIRG 196
           +  E+           +V            ++P           E   P+ P    +   
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 197 KVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            V S+ E    C D + E+R   Q   + +
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERM 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (381), Expect = 8e-45
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 43/262 (16%)

Query: 1   DKKEFLRE--ITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           D+K + RE  +     +RH NI+ F      +RHS    +L+  Y E GSL   L   T 
Sbjct: 43  DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT- 101

Query: 55  AEELGWSRRINVIKGIAHALSYLHHD-----CIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
              L     + ++  IA  L++LH +       P I HRD+ SKN+L+    +  ++D G
Sbjct: 102 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158

Query: 110 IAKFIQPDSS----NWTEFAGTYGYVAPEL------AYTMKVTAKCDVYSFGVLALEVIK 159
           +A      ++          GT  Y+APE+              + D+++FG++  EV +
Sbjct: 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

Query: 160 GKHPRDFL-------SNVSSSNPNIL------VNEMLDPRLPP--LSVDIRGKVISIMEV 204
                  +        +V  ++P+          +   P +P    S      +  +M+ 
Sbjct: 219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK- 277

Query: 205 AFLCLDNNPESRPNMQTICQLL 226
              C   NP +R     I + L
Sbjct: 278 --ECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  149 bits (378), Expect = 5e-44
 Identities = 60/262 (22%), Positives = 101/262 (38%), Gaps = 43/262 (16%)

Query: 1   DKKEFLRE--ITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           ++  + RE  I     +RH NI+ F         S    +L+ +Y ENGSL   L + T 
Sbjct: 72  EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT- 130

Query: 55  AEELGWSRRINVIKGIAHALSYLH-----HDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
              L     + +       L +LH         P I HRD+ SKN+L+       ++D G
Sbjct: 131 ---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187

Query: 110 IAKFIQPDSSNW----TEFAGTYGYVAPEL------AYTMKVTAKCDVYSFGVLALEVIK 159
           +A     D++          GT  Y+ PE+          +     D+YSFG++  EV +
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247

Query: 160 GKHPRDFL-------SNVSSSNPNI------LVNEMLDPRLPP--LSVDIRGKVISIMEV 204
                  +        ++  S+P+       +  + L P  P    S +   ++  +M  
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307

Query: 205 AFLCLDNNPESRPNMQTICQLL 226
              C  +NP SR     + + L
Sbjct: 308 ---CWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  146 bits (371), Expect = 6e-43
 Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 43/262 (16%)

Query: 1   DKKEFLRE--ITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           +++ + RE  I     +RH NI+ F         +    +LV +Y E+GSL   LN  T 
Sbjct: 77  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT- 135

Query: 55  AEELGWSRRINVIKGIAHALSYLHHD-----CIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
              +     I +    A  L++LH +       P I HRD+ SKN+L+       ++D G
Sbjct: 136 ---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192

Query: 110 IAKFIQPDSS----NWTEFAGTYGYVAPEL------AYTMKVTAKCDVYSFGVLALEVIK 159
           +A      +           GT  Y+APE+          +   + D+Y+ G++  E+ +
Sbjct: 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

Query: 160 GKHPRDFL-------SNVSSSNPNI------LVNEMLDPRLPP--LSVDIRGKVISIMEV 204
                           ++  S+P++      +  + L P +P    S +    +  IM  
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR- 311

Query: 205 AFLCLDNNPESRPNMQTICQLL 226
              C   N  +R     I + L
Sbjct: 312 --ECWYANGAARLTALRIKKTL 331

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  128 bits (323), Expect = 3e-36
 Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 26/233 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYG----FCTHARHSFLVYEYLENGSLSVILNNDTSAE 56
           +++ F  E  +L  ++H NIV+FY          +   LV E + +G+L   L      +
Sbjct: 68  ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK 127

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQ 115
                      + I   L +L H   PPI+HRD+   N+ +        + D G+A   +
Sbjct: 128 IKVLRS---WCRQILKGLQFL-HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
              +      GT  ++APE+ Y  K     DVY+FG+  LE+   ++P     N +    
Sbjct: 184 ASFAK--AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-- 238

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
              V   + P           K         +  C+  N + R    +I  LL
Sbjct: 239 YRRVTSGVKPASFDKVAIPEVK-------EIIEGCIRQNKDERY---SIKDLL 281

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (322), Expect = 2e-35
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 39/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K +FL+E  +L +  H NIV+  G CT  +  ++V E ++ G     L  +     L  
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRV 212

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              + ++   A  + YL        +HRD++++N L+  +    +SDFG+++        
Sbjct: 213 KTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269

Query: 121 -----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
                      WT         APE     + +++ DV+SFG+L  E    G  P   LS
Sbjct: 270 ASGGLRQVPVKWT---------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N           E ++   RLP         V  +ME    C    P  RP+  TI Q L
Sbjct: 321 NQQ-------TREFVEKGGRLPCPE-LCPDAVFRLME---QCWAYEPGQRPSFSTIYQEL 369

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (314), Expect = 8e-35
 Identities = 51/235 (21%), Positives = 101/235 (42%), Gaps = 28/235 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA----- 55
            + + ++EI +L ++ H N++K+Y          +V E  + G LS ++ +         
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           E   W         +  AL ++H   +   +HRDI   NV +       + D G+ +F  
Sbjct: 135 ERTVW----KYFVQLCSALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
             ++      GT  Y++PE  +      K D++S G L  E+   + P  F  +    N 
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGD--KMNL 243

Query: 176 NILVNEMLDPRLPPL-----SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
             L  ++     PPL     S ++R ++++      +C++ +PE RP++  +  +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELR-QLVN------MCINPDPEKRPDVTYVYDV 291

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  123 bits (311), Expect = 5e-34
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 19/227 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA---EE 57
           +++E  RE+ VL  ++H NIV++          ++V +Y E G L   +N        E+
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
                  +    I  AL ++H      I+HRDI S+N+ L  +    + DFGIA+ +   
Sbjct: 126 QIL----DWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
                   GT  Y++PE+        K D+++ G +  E+   KH   F     + +   
Sbjct: 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F----EAGSMKN 232

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           LV +++    PP+S+     + S++         NP  RP++ +I +
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  121 bits (305), Expect = 1e-33
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 30/238 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYG--FCTHARHSFLVYEYLENGSLSVILNNDTSA--- 55
           +K+  + E+ +L E++H NIV++Y           ++V EY E G L+ ++   T     
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107

Query: 56  --EELGWSRRINVIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
             EE        V+  +  AL   H   D    ++HRD+   NV LD +    + DFG+A
Sbjct: 108 LDEEFVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
           + +  D+S    F GT  Y++PE    M    K D++S G L  E+     P  F    +
Sbjct: 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----T 217

Query: 172 SSNPNILVNEMLDPRLPPL----SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           + +   L  ++ + +   +    S ++  ++I+ M      L+     RP+++ I + 
Sbjct: 218 AFSQKELAGKIREGKFRRIPYRYSDELN-EIITRM------LNLKDYHRPSVEEILEN 268

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  117 bits (294), Expect = 1e-31
 Identities = 50/246 (20%), Positives = 96/246 (39%), Gaps = 29/246 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAE 56
           D++E  RE  +     H NI++   +C   R +    +L+  + + G+L   +       
Sbjct: 69  DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128

Query: 57  ELGWSRRI-NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
                 +I  ++ GI   L  +H        HRD+   N+LL  E +  + D G      
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185

Query: 116 PDSSN---------WTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKH 162
                         W     T  Y APEL    ++ + +  + DV+S G +   ++ G+ 
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEG 244

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
           P D +     S    + N++  P+ P  S  +  ++++ M      +  +P  RP++  +
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALW-QLLNSM------MTVDPHQRPHIPLL 297

Query: 223 CQLLCK 228
              L  
Sbjct: 298 LSQLEA 303

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  117 bits (295), Expect = 1e-31
 Identities = 51/219 (23%), Positives = 79/219 (36%), Gaps = 23/219 (10%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
            E+     +    IV  YG         +  E LE GSL  ++       E    R +  
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYY 155

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTE-- 123
           +      L YLH      I+H D+ + NVLL  +   A + DFG A  +QPD    +   
Sbjct: 156 LGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212

Query: 124 ---FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  ++APE+       AK D++S   + L ++ G HP             +   
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LC-- 265

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRP 217
            +     PP   +I     + +    +   L   P  R 
Sbjct: 266 -LKIASEPPPIREIPPS-CAPLTAQAIQEGLRKEPVHRA 302

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (289), Expect = 3e-31
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 24/231 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +    EI +   ++H+NIV++ G  +      +  E +  GSLS +L +     +     
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSSN 120
                K I   L YLH +    IVHRDI   NVL++  Y   +  SDFG +K +   +  
Sbjct: 124 IGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPC 179

Query: 121 WTEFAGTYGYVAPE--LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              F GT  Y+APE             D++S G   +E+  GK P   L    ++   + 
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239

Query: 179 VNEMLDPRLPP-LSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
           + + + P +P  +S + +         AF+  C + +P+ R        LL
Sbjct: 240 MFK-VHPEIPESMSAEAK---------AFILKCFEPDPDKRA---CANDLL 277

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (289), Expect = 4e-31
 Identities = 45/248 (18%), Positives = 98/248 (39%), Gaps = 38/248 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------------FLVYEYLENGSLSVI 48
            +++ +RE+  L ++ H  IV+++        +            ++  +     +L   
Sbjct: 46  AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW 105

Query: 49  LNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDF 108
           +N   + EE   S  +++   IA A+ +LH      ++HRD+   N+   ++    V DF
Sbjct: 106 MNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162

Query: 109 GIAKFI------------QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE 156
           G+   +             P  +  T   GT  Y++PE  +    + K D++S G++  E
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

Query: 157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           ++   +P       +       + ++ + + PPL          +++     L  +P  R
Sbjct: 223 LL---YPFS-----TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMER 271

Query: 217 PNMQTICQ 224
           P    I +
Sbjct: 272 PEAINIIE 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (288), Expect = 4e-31
 Identities = 42/244 (17%), Positives = 90/244 (36%), Gaps = 43/244 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGF----------------CTHARHSFLVYEYLENGS 44
           + ++  RE+  L ++ H NIV + G                  +  +  F+  E+ + G+
Sbjct: 47  NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106

Query: 45  LSVILNNDTSA---EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY 101
           L   +         + L       + + I   + Y+H   +   ++RD+   N+ L    
Sbjct: 107 LEQWIEKRRGEKLDKVLAL----ELFEQITKGVDYIHSKKL---INRDLKPSNIFLVDTK 159

Query: 102 EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +  + DFG+   ++ D        GT  Y++PE   +     + D+Y+ G++  E++   
Sbjct: 160 QVKIGDFGLVTSLKNDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC 218

Query: 162 HPRDFLSNVSSSNPNILVNEMLDPRLPPL-SVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
                 S            ++ D  +  +     +  ++  +      L   PE RPN  
Sbjct: 219 DTAFETSK--------FFTDLRDGIISDIFDKKEK-TLLQKL------LSKKPEDRPNTS 263

Query: 221 TICQ 224
            I +
Sbjct: 264 EILR 267

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  112 bits (283), Expect = 2e-30
 Identities = 62/241 (25%), Positives = 101/241 (41%), Gaps = 42/241 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++F+ E  V+ ++ H  +V+ YG C       LV E++E+G LS  L           
Sbjct: 46  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAA 103

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
              + +   +   ++YL         ++HRD++++N L+       VSDFG+ +F+  D 
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

Query: 118 ---SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFL 167
              S+       W          +PE+    + ++K DV+SFGVL  EV  +GK P +  
Sbjct: 159 YTSSTGTKFPVKWA---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

Query: 168 SNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           SN         V E +    RL          V  IM     C    PE RP    + + 
Sbjct: 210 SNSE-------VVEDISTGFRLYKPR-LASTHVYQIMN---HCWRERPEDRPAFSRLLRQ 258

Query: 226 L 226
           L
Sbjct: 259 L 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  113 bits (284), Expect = 2e-30
 Identities = 50/245 (20%), Positives = 101/245 (41%), Gaps = 50/245 (20%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
            + F    ++++++ H+++V  YG C     + LV E+++ GSL   L    +   +   
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINIL 113

Query: 62  RRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAH--------VSDFGIA 111
            ++ V K +A A+ +L  +      ++H ++ +KN+LL  E +          +SD GI+
Sbjct: 114 WKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

Query: 112 KFIQPDSS-----NWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVI-KGKHPR 164
             + P         W           PE +     +    D +SFG    E+   G  P 
Sbjct: 169 ITVLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

Query: 165 DFLSNVSSSNPNILVNEMLDP--RLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT 221
             L +           +  +   +LP P + ++     +++     C+D  P+ RP+ + 
Sbjct: 220 SALDSQR-------KLQFYEDRHQLPAPKAAELA----NLIN---NCMDYEPDHRPSFRA 265

Query: 222 ICQLL 226
           I + L
Sbjct: 266 IIRDL 270

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (289), Expect = 2e-30
 Identities = 52/244 (21%), Positives = 94/244 (38%), Gaps = 37/244 (15%)

Query: 2   KKEFL----REITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAE 56
             E      RE+ +L E   H N+++++      +  ++  E         +   D +  
Sbjct: 57  LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL 116

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-----DLEYEAHVSDFGIA 111
            L     I +++     L++LH   I   VHRD+   N+L+       + +A +SDFG+ 
Sbjct: 117 GL---EPITLLQQTTSGLAHLHSLNI---VHRDLKPHNILISMPNAHGKIKAMISDFGLC 170

Query: 112 KFIQPDSS---NWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVI-KGKHPR 164
           K +          +   GT G++APE+         T   D++S G +   VI +G HP 
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

Query: 165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
                      NIL+       L P       K   ++    +   +  +P+ RP   + 
Sbjct: 231 G---KSLQRQANILLGACSLDCLHPE------KHEDVIARELIEKMIAMDPQKRP---SA 278

Query: 223 CQLL 226
             +L
Sbjct: 279 KHVL 282

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  112 bits (283), Expect = 3e-30
 Identities = 57/256 (22%), Positives = 100/256 (39%), Gaps = 54/256 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEEL 58
              +  +EI +L  + H NIVK+ G CT    +   L+ E+L +GSL   L  +    ++
Sbjct: 66  HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKI 123

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
              +++     I   + YL     +    HRD++++NVL++ E++  + DFG+ K I+ D
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIETD 179

Query: 118 SSN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPR 164
                          W          APE     K     DV+SFGV   E++       
Sbjct: 180 KEYYTVKDDRDSPVFWY---------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230

Query: 165 DFLSNVSSSN----PNILVNEMLDP-----RLP-----PLSVDIRGKVISIMEVAFLCLD 210
             ++            + V  +++      RLP     P  V        +M     C +
Sbjct: 231 SPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY------QLMR---KCWE 281

Query: 211 NNPESRPNMQTICQLL 226
             P +R + Q + +  
Sbjct: 282 FQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  112 bits (281), Expect = 8e-30
 Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 54/256 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEEL 58
            +++F REI +L  +    IVK+ G           LV EYL +G L   L        L
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARL 124

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
             SR +     I   + YL    C+    HRD++++N+L++ E    ++DFG+AK +  D
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLD 180

Query: 118 SS------------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHP- 163
                          W          APE       + + DV+SFGV+  E+        
Sbjct: 181 KDYYVVREPGQSPIFWY---------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

Query: 164 ---RDFLSNVSSSNPNILVNEMLDP-----RLP-----PLSVDIRGKVISIMEVAFLCLD 210
               +FL  +        ++ +L+      RLP     P  V        +M+   LC  
Sbjct: 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH------ELMK---LCWA 282

Query: 211 NNPESRPNMQTICQLL 226
            +P+ RP+   +   L
Sbjct: 283 PSPQDRPSFSALGPQL 298

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (279), Expect = 1e-29
 Identities = 64/257 (24%), Positives = 103/257 (40%), Gaps = 55/257 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEEL 58
             ++F REI +L  ++H NIVK+ G C  A      L+ EYL  GSL   L      E +
Sbjct: 54  HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERI 111

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
              + +     I   + YL     I    HRD++++N+L++ E    + DFG+ K +  D
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQD 167

Query: 118 SSN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGK 161
                          W          APE     K +   DV+SFGV+  E+     K K
Sbjct: 168 KEFFKVKEPGESPIFWY---------APESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218

Query: 162 HPRDFLSNVSSSNP--NILVNEMLDP-----RLP-----PLSVDIRGKVISIMEVAFLCL 209
            P      +  ++    ++V  +++      RLP     P  +        IM     C 
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY------MIMT---ECW 269

Query: 210 DNNPESRPNMQTICQLL 226
           +NN   RP+ + +   +
Sbjct: 270 NNNVNQRPSFRDLALRV 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (277), Expect = 2e-29
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 32/225 (14%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + ++  +EITVL++     + K+YG        +++ EYL  GS   +L      E    
Sbjct: 63  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-- 120

Query: 61  SRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              I  I + I   L YLH +     +HRDI + NVLL    E  ++DFG+A  +     
Sbjct: 121 ---IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSS 173
               F GT  ++APE+       +K D++S G+ A+E+ +G+      HP   L  +  +
Sbjct: 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234

Query: 174 NPNILVNEMLDPRLP-PLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           NP         P L    S  ++  V         CL+  P  RP
Sbjct: 235 NP---------PTLEGNYSKPLKEFVE-------ACLNKEPSFRP 263

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (275), Expect = 3e-29
 Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 42/241 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L           
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQT 119

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD- 117
            + + + K +  A+ YL          +HRD++++N L++ +    VSDFG+++++  D 
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

Query: 118 ---SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFL 167
              S        W+          PE+    K ++K D+++FGVL  E+   GK P +  
Sbjct: 175 YTSSVGSKFPVRWS---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

Query: 168 SNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
           +N           E +    RL         KV +IM     C     + RP  + +   
Sbjct: 226 TNSE-------TAEHIAQGLRLYRPH-LASEKVYTIMY---SCWHEKADERPTFKILLSN 274

Query: 226 L 226
           +
Sbjct: 275 I 275

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 3e-29
 Identities = 64/257 (24%), Positives = 103/257 (40%), Gaps = 55/257 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEEL 58
             ++F REI +L  ++H NIVK+ G C  A      L+ EYL  GSL   L      E +
Sbjct: 85  HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERI 142

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
              + +     I   + YL     I    HRD++++N+L++ E    + DFG+ K +  D
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQD 198

Query: 118 SSN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI----KGK 161
                          W          APE     K +   DV+SFGV+  E+     K K
Sbjct: 199 KEYYKVKEPGESPIFWY---------APESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249

Query: 162 HPRDFLSNVSSSNP--NILVNEMLDP-----RLP-----PLSVDIRGKVISIMEVAFLCL 209
            P      +  ++    ++V  +++      RLP     P  +        IM     C 
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY------MIMT---ECW 300

Query: 210 DNNPESRPNMQTICQLL 226
           +NN   RP+ + +   +
Sbjct: 301 NNNVNQRPSFRDLALRV 317

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  109 bits (274), Expect = 4e-29
 Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 40/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + EF +E   + ++ H  +VKFYG C+     ++V EY+ NG L   L +    + L  
Sbjct: 46  SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEP 103

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-- 117
           S+ + +   +   +++L  H  I    HRD++++N L+D +    VSDFG+ +++  D  
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQFI----HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159

Query: 118 --SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
             S        W+         APE+ +  K ++K DV++FG+L  EV   GK P D  +
Sbjct: 160 VSSVGTKFPVKWS---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N         V   +    RL          +  IM     C    PE RP  Q +   +
Sbjct: 211 NSE-------VVLKVSQGHRLYRPH-LASDTIYQIMY---SCWHELPEKRPTFQQLLSSI 259

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (282), Expect = 5e-29
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 29/235 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L    + +E+  
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSA 317

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-- 117
              + +   I+ A+ YL   + I    HR+++++N L+   +   V+DFG+++ +  D  
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFI----HRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373

Query: 118 -SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNP 175
            +    +F     + APE     K + K DV++FGVL  E+   G  P   +        
Sbjct: 374 TAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---- 427

Query: 176 NILVNEMLDP--RL--PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              V E+L+   R+  P    +   KV  +M     C   NP  RP+   I Q  
Sbjct: 428 ---VYELLEKDYRMERPEGCPE---KVYELM---RACWQWNPSDRPSFAEIHQAF 473

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (276), Expect = 5e-29
 Identities = 61/243 (25%), Positives = 106/243 (43%), Gaps = 44/243 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL E +++ +  H NI++  G  T  R + +V EY+ENGSL   L       +   
Sbjct: 93  QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTI 150

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            + + +++G+   + YL          VHRD++++NVL+D      VSDFG+++ ++ D 
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

Query: 119 SN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
                         WT         APE       ++  DV+SFGV+  EV+  G+ P  
Sbjct: 206 DAAYTTTGGKIPIRWT---------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256

Query: 166 FLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
            ++N         V   ++   RLP   +     +  +M     C   +   RP    I 
Sbjct: 257 NMTNRD-------VISSVEEGYRLPA-PMGCPHALHQLM---LDCWHKDRAQRPRFSQIV 305

Query: 224 QLL 226
            +L
Sbjct: 306 SVL 308

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (275), Expect = 5e-29
 Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 42/249 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSLSVILNNDTSAEEL 58
            +  + +EI +L  + H +I+K+ G C  A  +   LV EY+  GSL   L        +
Sbjct: 76  HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SI 131

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           G ++ +   + I   ++YLH    I    HRD++++NVLLD +    + DFG+AK +   
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYI----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

Query: 118 SSNWTEFAGTYGYV-----APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVS 171
              +       G       APE     K     DV+SFGV   E++      +   +   
Sbjct: 188 HEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245

Query: 172 SSN----PNILVNEMLDP-----RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                    + V  + +      RLP     P  V        +M+    C +     RP
Sbjct: 246 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY------HLMK---NCWETEASFRP 296

Query: 218 NMQTICQLL 226
             + +  +L
Sbjct: 297 TFENLIPIL 305

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (272), Expect = 9e-29
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 39/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L    + +E+  
Sbjct: 52  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSA 110

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-- 117
              + +   I+ A+ YL   + I    HRD++++N L+   +   V+DFG+++ +  D  
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFI----HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166

Query: 118 --SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
              +       WT         APE     K + K DV++FGVL  E+   G  P   + 
Sbjct: 167 TAHAGAKFPIKWT---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                     V E+L+   R+         KV  +M     C   NP  RP+   I Q  
Sbjct: 218 LSQ-------VYELLEKDYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 266

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  109 bits (274), Expect = 1e-28
 Identities = 62/243 (25%), Positives = 107/243 (44%), Gaps = 44/243 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + +FL E  ++ +  H NI++  G  +  +   ++ EY+ENG+L   L       E   
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSV 146

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            + + +++GIA  + YL   +      VHRD++++N+L++      VSDFG+++ ++ D 
Sbjct: 147 LQLVGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201

Query: 119 SN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
                         WT         APE     K T+  DV+SFG++  EV+  G+ P  
Sbjct: 202 EATYTTSGGKIPIRWT---------APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252

Query: 166 FLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
            LSN         V + ++   RLP   +D    +  +M     C       RP    I 
Sbjct: 253 ELSNHE-------VMKAINDGFRLPT-PMDCPSAIYQLMM---QCWQQERARRPKFADIV 301

Query: 224 QLL 226
            +L
Sbjct: 302 SIL 304

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 1e-28
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 38/229 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K+  + EI V+ E ++ NIV +          ++V EYL  GSL+ ++      E    
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116

Query: 61  SRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +I  + +    AL +LH +    ++HRDI S N+LL ++    ++DFG    I P+ S
Sbjct: 117 --QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSS 173
             +   GT  ++APE+        K D++S G++A+E+I+G+      +P   L  ++++
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 174 NPNILVNEMLDPRLPP---LSVDIRGKVISIMEVAFL--CLDNNPESRP 217
                      P L     LS   R          FL  CL+ + E R 
Sbjct: 232 GT---------PELQNPEKLSAIFRD---------FLNRCLEMDVEKRG 262

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (273), Expect = 2e-28
 Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 44/245 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL E +++ +  H NI++  G  T ++   +V EY+ENGSL   L       +   
Sbjct: 89  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTV 146

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
            + + +++GIA  + YL          VHRD++++N+L++      VSDFG+ + ++ D 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

Query: 119 SN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
                         WT         +PE     K T+  DV+S+G++  EV+  G+ P  
Sbjct: 202 EAAYTTRGGKIPIRWT---------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

Query: 166 FLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
            +SN         V + +D   RLPP  +D    +  +M     C   +  +RP  + I 
Sbjct: 253 EMSNQD-------VIKAVDEGYRLPP-PMDCPAALYQLM---LDCWQKDRNNRPKFEQIV 301

Query: 224 QLLCK 228
            +L K
Sbjct: 302 SILDK 306

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (269), Expect = 2e-28
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 55/248 (22%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D +E +RE  ++ ++ +  IV+  G C       LV E    G L   L      EE+  
Sbjct: 53  DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG--KREEIPV 109

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           S    ++  ++  + YL   +      VHRD++++NVLL   + A +SDFG++K +  D 
Sbjct: 110 SNVAELLHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

Query: 119 SN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
           S             W          APE     K +++ DV+S+GV   E +  G+ P  
Sbjct: 165 SYYTARSAGKWPLKWY---------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

Query: 166 FLSNVSSSNPNILVNEMLDP--RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
            +           V   ++   R+      P        + ++M     C     E RP+
Sbjct: 216 KMKGPE-------VMAFIEQGKRMECPPECPPE------LYALM---SDCWIYKWEDRPD 259

Query: 219 MQTICQLL 226
             T+ Q +
Sbjct: 260 FLTVEQRM 267

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  107 bits (269), Expect = 3e-28
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 56/248 (22%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K E L E  V+ ++ +  IV+  G C       LV E  E G L+  L  +     +  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKD 116

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
              I ++  ++  + YL   +      VHRD++++NVLL  ++ A +SDFG++K ++ D 
Sbjct: 117 KNIIELVHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

Query: 119 SN------------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
           +             W          APE     K ++K DV+SFGVL  E    G+ P  
Sbjct: 172 NYYKAQTHGKWPVKWY---------APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222

Query: 166 FLSNVSSSNPNILVNEMLDP--RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
            +           V  ML+   R+      P        +  +M    LC   + E+RP 
Sbjct: 223 GMKGSE-------VTAMLEKGERMGCPAGCPRE------MYDLM---NLCWTYDVENRPG 266

Query: 219 MQTICQLL 226
              +   L
Sbjct: 267 FAAVELRL 274

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (269), Expect = 3e-28
 Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 41/238 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++    E+ ++ + +H N+V+ Y         +++ E+L+ G+L+ I++     EE   
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE--- 141

Query: 61  SRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             +I  + + +  AL+YLH      ++HRDI S ++LL L+    +SDFG    I  D  
Sbjct: 142 --QIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSSS 173
                 GT  ++APE+        + D++S G++ +E++ G+       P   +  +  S
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256

Query: 174 NPNILVNEMLDPRLP---PLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
            P         P+L     +S  +R          FL   L  +P+ R    T  +LL
Sbjct: 257 PP---------PKLKNSHKVSPVLRD---------FLERMLVRDPQERA---TAQELL 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (273), Expect = 5e-28
 Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 36/236 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSF-LVYEYLENGSLSVILNNDTSAEELGW 60
            + FL E +V+T++RH N+V+  G     +    +V EY+  GSL   L +      LG 
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGG 288

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              +     +  A+ YL  ++ +    HRD++++NVL+  +  A VSDFG+ K       
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344

Query: 120 N------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSS 172
                  WT         APE     K + K DV+SFG+L  E+   G+ P   +     
Sbjct: 345 TGKLPVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD- 394

Query: 173 SNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 V   ++   ++          V  +M     C   +  +RP    + + L
Sbjct: 395 ------VVPRVEKGYKMDAPD-GCPPAVYDVM---KNCWHLDAATRPTFLQLREQL 440

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (266), Expect = 6e-28
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 36/236 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGW 60
            + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +      LG 
Sbjct: 58  AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGG 116

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              +     +  A+ YL  ++ +    HRD++++NVL+  +  A VSDFG+ K       
Sbjct: 117 DCLLKFSLDVCEAMEYLEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172

Query: 120 N------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSS 172
                  WT         APE     K + K DV+SFG+L  E+   G+ P   +     
Sbjct: 173 TGKLPVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD- 222

Query: 173 SNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                 V   ++   ++          V  +M+    C   +   RP+   + + L
Sbjct: 223 ------VVPRVEKGYKMDAPD-GCPPAVYEVMK---NCWHLDAAMRPSFLQLREQL 268

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (267), Expect = 1e-27
 Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 46/243 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             KE L E  V+  + + ++ +  G C       L+ + +  G L   +  +    + +G
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK---DNIG 115

Query: 60  WSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
               +N    IA  ++YL         +VHRD++++NVL+       ++DFG+AK +  +
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

Query: 118 SS-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRD 165
                         W          A E       T + DV+S+GV   E++  G  P D
Sbjct: 171 EKEYHAEGGKVPIKWM---------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

Query: 166 FLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
            +           ++ +L+   RLP         V  IM     C   + +SRP  + + 
Sbjct: 222 GIPASE-------ISSILEKGERLPQPP-ICTIDVYMIM---RKCWMIDADSRPKFRELI 270

Query: 224 QLL 226
              
Sbjct: 271 IEF 273

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (270), Expect = 1e-27
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 26/233 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + FL E  V+  ++H  +VK +   T     +++ E++  GSL   L +D    +   
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPL 283

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + I+    IA  ++++   + I    HRD+ + N+L+       ++DFG+A+ I+ +  
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYI----HRDLRAANILVSASLVCKIADFGLARVIEDNE- 338

Query: 120 NWTEFAGTYGYV---APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNP 175
            +T   G    +   APE       T K DV+SFG+L +E++  G+ P   +SN      
Sbjct: 339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---- 393

Query: 176 NILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              V   L+   R+P    +   ++ +IM     C  N PE RP  + I  +L
Sbjct: 394 ---VIRALERGYRMPRPE-NCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (264), Expect = 2e-27
 Identities = 47/231 (20%), Positives = 80/231 (34%), Gaps = 32/231 (13%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA--EE 57
           D+   L E+    ++ +H   V+           +L  E     SL        ++  E 
Sbjct: 99  DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEA 157

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
             W      ++    AL++LH      +VH D+   N+ L       + DFG+   +   
Sbjct: 158 QVW----GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210

Query: 118 SSNWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN 174
            +      G   Y+APEL   +Y        DV+S G+  LEV                 
Sbjct: 211 GAGEV-QEGDPRYMAPELLQGSYGTAA----DVFSLGLTILEVACNMELPHGGEGW---- 261

Query: 175 PNILVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              L    L P     LS ++R  V+       + L+ +P+ R   + +  
Sbjct: 262 -QQLRQGYLPPEFTAGLSSELRS-VLV------MMLEPDPKLRATAEALLA 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  108 bits (272), Expect = 2e-27
 Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 35/218 (16%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEELG 59
            + E   L E+ H +IV+ + F  H         ++V EY+   SL          ++L 
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLP 180

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            +  I  +  I  ALSYLH      +V+ D+  +N++L  E +  + D G    I     
Sbjct: 181 VAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY 236

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT G+ APE+  T   T   D+Y+ G     +      R+          + L 
Sbjct: 237 ----LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRN------GRYVDGLP 285

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
            +    +    S            +    +D +P  R 
Sbjct: 286 EDDPVLKTYD-SYG---------RLLRRAIDPDPRQRF 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  105 bits (263), Expect = 2e-27
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 49/256 (19%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-------------FLVYEYLENGSLSV 47
                L E+ +L  + H+ +V++Y      R+              F+  EY ENG+L  
Sbjct: 45  KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD 104

Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSD 107
           +++++   ++     R+   + I  ALSY+H   I   +HRD+   N+ +D      + D
Sbjct: 105 LIHSENLNQQRDEYWRL--FRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGD 159

Query: 108 FGIAKFIQPDSSNW--------------TEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGV 152
           FG+AK +                     T   GT  YVA E L  T     K D+YS G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219

Query: 153 LALEVIK----GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLC 208
           +  E+I     G    + L  + S +          P      + +  K+I       L 
Sbjct: 220 IFFEMIYPFSTGMERVNILKKLRSVSIEF------PPDFDDNKMKVEKKIIR------LL 267

Query: 209 LDNNPESRPNMQTICQ 224
           +D++P  RP  +T+  
Sbjct: 268 IDHDPNKRPGARTLLN 283

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (260), Expect = 4e-27
 Identities = 58/240 (24%), Positives = 107/240 (44%), Gaps = 40/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
               FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTI 108

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-- 117
           ++ +++   IA  ++++   + I    HRD+ + N+L+       ++DFG+A+ I+ +  
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYI----HRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

Query: 118 --SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
                      WT         APE       T K DV+SFG+L  E++  G+ P   ++
Sbjct: 165 TAREGAKFPIKWT---------APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N         V + L+   R+     +   ++  +M    LC    PE RP    +  +L
Sbjct: 216 NPE-------VIQNLERGYRMVRPD-NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (261), Expect = 5e-27
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 41/239 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLS-VILNNDTSAEELG 59
           D +E ++EI+++ +    ++VK+YG        ++V EY   GS+S +I   + +  E  
Sbjct: 67  DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-- 124

Query: 60  WSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
               I  I +     L YLH       +HRDI + N+LL+ E  A ++DFG+A  +    
Sbjct: 125 --DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK------HPRDFLSNVSS 172
           +      GT  ++APE+   +      D++S G+ A+E+ +GK      HP   +  + +
Sbjct: 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239

Query: 173 SNPNILVNEMLDPRLP---PLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTICQLL 226
           + P         P        S +            F+  CL  +PE R    T  QLL
Sbjct: 240 NPP---------PTFRKPELWSDNFTD---------FVKQCLVKSPEQRA---TATQLL 277

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (265), Expect = 5e-27
 Identities = 58/254 (22%), Positives = 107/254 (42%), Gaps = 43/254 (16%)

Query: 3   KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLS-VILNNDTSAEELGW 60
              L EI +LTE   H N++++Y   T  R  ++  E     +L  ++ + + S E L  
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111

Query: 61  SRR---INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH------------- 104
            +    I++++ IA  +++LH      I+HRD+  +N+L+                    
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168

Query: 105 VSDFGIAKFIQPDSSNWT----EFAGTYGYVAPEL-------AYTMKVTAKCDVYSFGVL 153
           +SDFG+ K +    S++       +GT G+ APEL           ++T   D++S G +
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

Query: 154 ALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLD 210
              ++ KGKHP  F     S   NI+        +  L      + +       +   +D
Sbjct: 229 FYYILSKGKHP--FGDK-YSRESNIIRGIFSLDEMKCL----HDRSLIAEATDLISQMID 281

Query: 211 NNPESRPNMQTICQ 224
           ++P  RP    + +
Sbjct: 282 HDPLKRPTAMKVLR 295

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  106 bits (266), Expect = 8e-27
 Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 40/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  + + + L  
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRL 362

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + +++   IA  ++Y+   + +    HRD+ + N+L+       V+DFG+A+ I+ +  
Sbjct: 363 PQLVDMAAQIASGMAYVERMNYV----HRDLRAANILVGENLVCKVADFGLARLIEDNEY 418

Query: 120 N----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
                      WT         APE A   + T K DV+SFG+L  E+  KG+ P   + 
Sbjct: 419 TARQGAKFPIKWT---------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N         V + ++   R+P    +    +  +M     C    PE RP  + +   L
Sbjct: 470 NRE-------VLDQVERGYRMPCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (260), Expect = 9e-27
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 20/225 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGW 60
           +++   EI++   + H+++V F+GF       F+V E     SL  +        E    
Sbjct: 85  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-- 142

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +R    ++ I     YLH +    ++HRD+   N+ L+ + E  + DFG+A  ++ D   
Sbjct: 143 ARYY--LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  Y+APE+      + + DV+S G +   ++ GK P +  S +  +   I  N
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 256

Query: 181 EMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           E     +P  ++      +I  M      L  +P +RP +  +  
Sbjct: 257 EY---SIPKHINPVAA-SLIQKM------LQTDPTARPTINELLN 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  102 bits (257), Expect = 1e-26
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +  +E   +     
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-QRTATY-- 114

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +      SS  T+  G
Sbjct: 115 ITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLCG 169

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML--D 184
           T  Y+ PE+        K D++S GVL  E + GK P +      ++        +   +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVE 223

Query: 185 PRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              P  ++   R  +IS +      L +NP  RP ++ +
Sbjct: 224 FTFPDFVTEGAR-DLISRL------LKHNPSQRPMLREV 255

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  106 bits (266), Expect = 1e-26
 Identities = 56/240 (23%), Positives = 103/240 (42%), Gaps = 39/240 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D +E +RE  ++ ++ +  IV+  G C       LV E    G L   ++      EE+ 
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR---EEIP 434

Query: 60  WSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
            S    ++  ++  + YL   +      VHR+++++NVLL   + A +SDFG++K +  D
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

Query: 118 SSNWTEFAGT---YGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSS 173
            S +T  +       + APE     K +++ DV+S+GV   E +  G+ P   +      
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-- 547

Query: 174 NPNILVNEMLDP--RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                V   ++   R+      P        + ++M     C     E RP+  T+ Q +
Sbjct: 548 -----VMAFIEQGKRMECPPECPPE------LYALM---SDCWIYKWEDRPDFLTVEQRM 593

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  105 bits (264), Expect = 1e-26
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 26/233 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  + + + L  
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRL 279

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            + +++   IA  ++Y+   + +    HRD+ + N+L+       V+DFG+A+ I+ +  
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYV----HRDLRAANILVGENLVCKVADFGLARLIEDNE- 334

Query: 120 NWTEFAGT---YGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNP 175
            +T   G      + APE A   + T K DV+SFG+L  E+  KG+ P   + N      
Sbjct: 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---- 389

Query: 176 NILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              V + ++   R+P    +    +  +M     C    PE RP  + +   L
Sbjct: 390 ---VLDQVERGYRMPCPP-ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 2e-26
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 20/225 (8%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGW 60
           +++   EI++   + H+++V F+GF       F+V E     SL  +        E    
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-- 116

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +R    ++ I     YLH +    ++HRD+   N+ L+ + E  + DFG+A  ++ D   
Sbjct: 117 ARYY--LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  Y+APE+      + + DV+S G +   ++ GK P +  S +  +   I  N
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN 230

Query: 181 EMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           E     +P  ++      +I  M      L  +P +RP +  +  
Sbjct: 231 EY---SIPKHINPVAA-SLIQKM------LQTDPTARPTINELLN 265

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  103 bits (258), Expect = 2e-26
 Identities = 49/251 (19%), Positives = 88/251 (35%), Gaps = 36/251 (14%)

Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGFCTHARHS-------FLVYEYLENGSLSVILNND 52
             +  ++E+  + ++  H NIV+F    +  +         FL+   L  G L   L   
Sbjct: 68  KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
            S   L     + +      A+ ++H    PPI+HRD+  +N+LL  +    + DFG A 
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

Query: 113 FIQPDSSN------------WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEV 157
            I                        T  Y  PE+        +  K D+++ G +   +
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
              +HP +       +   I+  +   P            +I  M      L  NPE R 
Sbjct: 247 CFRQHPFE-----DGAKLRIVNGKYSIPPHDTQYTVFH-SLIRAM------LQVNPEERL 294

Query: 218 NMQTICQLLCK 228
           ++  +   L +
Sbjct: 295 SIAEVVHQLQE 305

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  102 bits (257), Expect = 2e-26
 Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 11/162 (6%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
             RE      ++  ++V  + F       ++    +    L+ +L        L   R +
Sbjct: 81  MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAV 137

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE- 123
            +++ I  AL   H        HRD+  +N+L+  +  A++ DFGIA          T+ 
Sbjct: 138 AIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQL 192

Query: 124 --FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
               GT  Y+APE       T + D+Y+   +  E + G  P
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (263), Expect = 2e-26
 Identities = 53/256 (20%), Positives = 88/256 (34%), Gaps = 39/256 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFY------GFCTHARHSFLVYEYLENGSLSVILNNDTS 54
           +++ +  EI ++ ++ H N+V                   L  EY E G L   LN   +
Sbjct: 55  NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIA 111
              L       ++  I+ AL YLH + I   +HRD+  +N++L    +     + D G A
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYA 171

Query: 112 KFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA----------------- 154
           K +         F GT  Y+APEL    K T   D +SFG LA                 
Sbjct: 172 KELDQGELCTE-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230

Query: 155 --LEVIKGKHPRDFLSNVSSSNPNILVNEMLDP-RLPPLSVDIRGKVISIMEVAFLCLDN 211
                ++ K     +     +      + +  P  L  +      + +  M      L  
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMW 284

Query: 212 NPESRPNMQTICQLLC 227
           +   R        + C
Sbjct: 285 HQRQRGTDPQNPNVGC 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (256), Expect = 2e-26
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 22/219 (10%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           F RE+   +++ H+NIV            +LV EY+E  +LS  + +      L     I
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAI 114

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
           N    I   + + H      IVHRDI  +N+L+D      + DFGIAK +   S   T  
Sbjct: 115 NFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171

Query: 125 A-GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS-----SSNPNIL 178
             GT  Y +PE A         D+YS G++  E++ G+ P +  + VS       +    
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           V   +   +P  S+           V     + +  +R 
Sbjct: 232 VTTDVRKDIPQ-SLS---------NVILRATEKDKANRY 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  102 bits (257), Expect = 2e-26
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 38/244 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL----NNDTSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 76  DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135

Query: 57  ELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHV---SDFGIA 111
            L     ++V + IA    YL  +H      +HRDI+++N LL       V    DFG+A
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

Query: 112 KFIQPDSSNWTEFAGTYGYV-----APE-LAYTMKVTAKCDVYSFGVLALEVI-KGKHPR 164
           + I    +++    G    +      PE        T+K D +SFGVL  E+   G  P 
Sbjct: 191 RDIY--RASYYR-KGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY 246

Query: 165 DFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              SN         V E +    R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 247 PSKSNQE-------VLEFVTSGGRMDP-PKNCPGPVYRIMT---QCWQHQPEDRPNFAII 295

Query: 223 CQLL 226
            + +
Sbjct: 296 LERI 299

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (258), Expect = 2e-26
 Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 43/231 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             ++ ++E+  L ++RH N +++ G       ++LV EY    +  ++  +    +E   
Sbjct: 97  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--- 153

Query: 61  SRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              I  +  G    L+YLH      ++HRD+ + N+LL       + DFG A  + P +S
Sbjct: 154 -VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209

Query: 120 NWTEFAGTYGYVAPELAYTMKVT---AKCDVYSFGVLALEVIKGK------HPRDFLSNV 170
               F GT  ++APE+   M       K DV+S G+  +E+ + K      +    L ++
Sbjct: 210 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265

Query: 171 SSSNPNILVNEMLDPRL--PPLSVDIRGKVISIMEVAFL--CLDNNPESRP 217
           + +           P L     S   R          F+  CL   P+ RP
Sbjct: 266 AQNES---------PALQSGHWSEYFRN---------FVDSCLQKIPQDRP 298

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (255), Expect = 4e-26
 Identities = 39/236 (16%), Positives = 87/236 (36%), Gaps = 26/236 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
                  +I  +     +N V      +   + ++  +     +L   +N   S E+   
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS- 119
              +++   IA A+ +LH   +   +HRD+   N+   ++    V DFG+   +  D   
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 120 -----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS 168
                        T   GT  Y++PE  +    + K D++S G++  E++   +      
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFS--- 274

Query: 169 NVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             +      ++ ++ + + P L      +   +++     L  +P  RP    I +
Sbjct: 275 --TQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  101 bits (254), Expect = 4e-26
 Identities = 50/239 (20%), Positives = 88/239 (36%), Gaps = 38/239 (15%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
             +F+RE+  +  + HRN+++ YG         +V E    GSL   L            
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKH--QGHFLLG 121

Query: 62  RRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
                   +A  + YL          +HRD++++N+LL       + DFG+ + +  +  
Sbjct: 122 TLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

Query: 120 NWTEFAGT---YGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNP 175
           ++         + + APE   T   +   D + FGV   E+   G+ P   L+       
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---- 232

Query: 176 NILVNEMLDP---RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +   +D    RLP     P        + ++M     C  + PE RP    +   L
Sbjct: 233 ---ILHKIDKEGERLPRPEDCPQD------IYNVMV---QCWAHKPEDRPTFVALRDFL 279

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (256), Expect = 6e-26
 Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 38/244 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL----NNDTSAE 56
           D+ +FL E  ++++  H+NIV+  G    +   F++ E +  G L   L       +   
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176

Query: 57  ELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHV---SDFGIA 111
            L     ++V + IA    YL  +H      +HRDI+++N LL       V    DFG+A
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

Query: 112 KFIQPDSSNWTEFAGTYGYV-----APE-LAYTMKVTAKCDVYSFGVLALEVI-KGKHPR 164
           + I    + +    G    +      PE        T+K D +SFGVL  E+   G  P 
Sbjct: 232 RDIY--RAGYYR-KGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY 287

Query: 165 DFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
              SN         V E +    R+ P   +  G V  IM     C  + PE RPN   I
Sbjct: 288 PSKSNQE-------VLEFVTSGGRMDP-PKNCPGPVYRIMT---QCWQHQPEDRPNFAII 336

Query: 223 CQLL 226
            + +
Sbjct: 337 LERI 340

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (255), Expect = 6e-26
 Identities = 51/235 (21%), Positives = 89/235 (37%), Gaps = 21/235 (8%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
            E+ ++T+I++   +   G  T+    +++YEY+EN S+           +       I 
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 66  V----IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           V    IK + ++ SY+H++    I HRD+   N+L+D      +SDFG ++    D    
Sbjct: 152 VIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIK 208

Query: 122 TEFAGTYGYVAPELAYTMKVT--AKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
               GTY ++ PE          AK D++S G+    +     P     ++     NI  
Sbjct: 209 G-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFL----------CLDNNPESRPNMQTICQ 224
             +  P      +       S     FL           L  NP  R   +   +
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (255), Expect = 6e-26
 Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 43/246 (17%)

Query: 1   DKKEFLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
               +  EI  L +++     I++ Y +    ++ ++V E   N  L+  L    S +  
Sbjct: 50  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW 108

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQ 115
              +     K +  A+  +H H     IVH D+   N L+    +  +   DFGIA  +Q
Sbjct: 109 -ERKSY--WKNMLEAVHTIHQHG----IVHSDLKPANFLIV---DGMLKLIDFGIANQMQ 158

Query: 116 PDSSNW--TEFAGTYGYVAPEL-----------AYTMKVTAKCDVYSFGVLALEVIKGKH 162
           PD+++       GT  Y+ PE                K++ K DV+S G +   +  GK 
Sbjct: 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQ 220
           P   + N  S    I ++   +   P         +        L  CL  +P+ R    
Sbjct: 219 PFQQIINQISKLHAI-IDPNHEIEFPD--------IPEKDLQDVLKCCLKRDPKQRI--- 266

Query: 221 TICQLL 226
           +I +LL
Sbjct: 267 SIPELL 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  101 bits (253), Expect = 8e-26
 Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 39/244 (15%)

Query: 1   DKKEFLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
               +  EI  L +++  +  I++ Y +    ++ ++V E   N  L+  L    S +  
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW 127

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
              +     K +  A+  +H H     IVH D+   N L+  +    + DFGIA  +QPD
Sbjct: 128 -ERKSY--WKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179

Query: 118 SSNW--TEFAGTYGYVAPEL-----------AYTMKVTAKCDVYSFGVLALEVIKGKHPR 164
           +++       GT  Y+ PE                K++ K DV+S G +   +  GK P 
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

Query: 165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
             + N  S    I ++   +   P         +        L  CL  +P+ R    +I
Sbjct: 240 QQIINQISKLHAI-IDPNHEIEFPD--------IPEKDLQDVLKCCLKRDPKQRI---SI 287

Query: 223 CQLL 226
            +LL
Sbjct: 288 PELL 291

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  101 bits (253), Expect = 9e-26
 Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 42/241 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             KE L E  V+  + + ++ +  G C       L+ + +  G L   +  +    + +G
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK---DNIG 115

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
               +N    IA  ++YL    +   VHRD++++NVL+       ++DFG+AK +  +  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

Query: 120 -----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFL 167
                       W          A E       T + DV+S+GV   E++  G  P D +
Sbjct: 173 EYHAEGGKVPIKWM---------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

Query: 168 SNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL 225
                      ++ +L+   RLP         V  IM     C   + +SRP  + +   
Sbjct: 224 PASE-------ISSILEKGERLPQPP-ICTIDVYMIM---VKCWMIDADSRPKFRELIIE 272

Query: 226 L 226
            
Sbjct: 273 F 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (253), Expect = 1e-25
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 17/225 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE--L 58
            + + +RE+ VL E     IV FYG         +  E+++ GSL  +L       E  L
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL 133

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
           G      V   +   L+YL       I+HRD+   N+L++   E  + DFG++   Q   
Sbjct: 134 G-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLID 184

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVSS 172
           S    F GT  Y++PE       + + D++S G+  +E+  G++P      ++       
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                       PR P   ++  G         F  LD      P
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (250), Expect = 2e-25
 Identities = 50/242 (20%), Positives = 99/242 (40%), Gaps = 20/242 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGF--CTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
                +RE  VL ++ H+NIVK +     T  RH  L+ E+   GSL  +L   ++A  L
Sbjct: 50  PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFI 114
             S  + V++ +   +++L  +    IVHR+I   N++  +  +      ++DFG A+ +
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 115 QPDSSNWTEFAGTYGYVAPEL--------AYTMKVTAKCDVYSFGVLALEVIKGKHPRDF 166
           + D   +    GT  Y+ P++         +  K  A  D++S GV       G  P  F
Sbjct: 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--F 223

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                      ++ +++  +       ++      ++ +     +   SR     +  +L
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283

Query: 227 CK 228
             
Sbjct: 284 AN 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 99.6 bits (249), Expect = 2e-25
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 55/247 (22%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELG 59
           +K++F+ E  ++  + H +IVK  G         +++ E    G L   L  +     L 
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLK 111

Query: 60  WSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
               +     I  A++YL   +      VHRDI+ +N+L+       + DFG++++I+ +
Sbjct: 112 VLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

Query: 118 SSN----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDF 166
                        W          +PE     + T   DV+ F V   E++  GK P  +
Sbjct: 167 DYYKASVTRLPIKWM---------SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

Query: 167 LSNVSSSNPNILVNEMLDP--RLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPNM 219
           L N         V  +L+   RLP     P        + ++M     C D +P  RP  
Sbjct: 218 LENKD-------VIGVLEKGDRLPKPDLCPPV------LYTLMT---RCWDYDPSDRPRF 261

Query: 220 QTICQLL 226
             +   L
Sbjct: 262 TELVCSL 268

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.7 bits (249), Expect = 3e-25
 Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 43/235 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLS-VILNNDTSAEELG 59
           + ++++ EI +L    H  IVK  G   H    +++ E+   G++  ++L  D    E  
Sbjct: 59  ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-- 116

Query: 60  WSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
              +I V+ + +  AL++LH      I+HRD+ + NVL+ LE +  ++DFG++       
Sbjct: 117 --PQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171

Query: 119 SNWTEFAGTYGYVAPELAYTMKVT-----AKCDVYSFGVLALEVIKGK------HPRDFL 167
                F GT  ++APE+     +       K D++S G+  +E+ + +      +P   L
Sbjct: 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

Query: 168 SNVSSSNPNILVNEMLDPRLPP---LSVDIRGKVISIMEVAFL--CLDNNPESRP 217
             ++ S+P         P L      SV+ R          FL   LD NPE+RP
Sbjct: 232 LKIAKSDP---------PTLLTPSKWSVEFRD---------FLKIALDKNPETRP 268

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 99.3 bits (248), Expect = 3e-25
 Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 36/239 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
              E L+EI  +++  H NIV +Y         +LV + L  GS+  I+ +  +  E   
Sbjct: 56  SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115

Query: 61  S----RRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
                  I  I + +   L YLH +     +HRD+ + N+LL  +    ++DFG++ F+ 
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172

Query: 116 PDSSNWTE-----FAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK---- 161
                        F GT  ++APE+      Y      K D++SFG+ A+E+  G     
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYH 228

Query: 162 --HPRDFLSNVSSSNPNILVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRP 217
              P   L     ++P  L   + D  +        R K+IS      LCL  +PE RP
Sbjct: 229 KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR-KMIS------LCLQKDPEKRP 280

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  100 bits (251), Expect = 4e-25
 Identities = 54/244 (22%), Positives = 95/244 (38%), Gaps = 39/244 (15%)

Query: 1   DKKEFLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
               +  EI  L +++     I++ Y +    ++ ++V E   N  L+  L    S +  
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW 155

Query: 59  GWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
              +     K +  A+  +H H     IVH D+   N L+  +    + DFGIA  +QPD
Sbjct: 156 -ERKSY--WKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207

Query: 118 SSNWTE--FAGTYGYVAPEL-----------AYTMKVTAKCDVYSFGVLALEVIKGKHPR 164
           +++  +    G   Y+ PE                K++ K DV+S G +   +  GK P 
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

Query: 165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTI 222
             + N  S    I ++   +   P         +        L  CL  +P+ R    +I
Sbjct: 268 QQIINQISKLHAI-IDPNHEIEFPD--------IPEKDLQDVLKCCLKRDPKQRI---SI 315

Query: 223 CQLL 226
            +LL
Sbjct: 316 PELL 319

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.9 bits (247), Expect = 7e-25
 Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 44/242 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +     +  +  + H +IV+  G C       LV +YL  GSL   +        LG 
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGP 114

Query: 61  SRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
              +N    IA  + YL  H      +VHR+++++NVLL    +  V+DFG+A  + PD 
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 119 S-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDF 166
                        W          A E  +  K T + DV+S+GV   E++  G  P   
Sbjct: 170 KQLLYSEAKTPIKWM---------ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

Query: 167 LSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L           V ++L+   RL          V  +M     C   +   RP  + +  
Sbjct: 221 LRLAE-------VPDLLEKGERLAQPQ-ICTIDVYMVM---VKCWMIDENIRPTFKELAN 269

Query: 225 LL 226
             
Sbjct: 270 EF 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =   99 bits (249), Expect = 7e-25
 Identities = 50/242 (20%), Positives = 99/242 (40%), Gaps = 20/242 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGF--CTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
                +RE  VL ++ H+NIVK +     T  RH  L+ E+   GSL  +L   ++A  L
Sbjct: 50  PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFI 114
             S  + V++ +   +++L  +    IVHR+I   N++  +  +      ++DFG A+ +
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166

Query: 115 QPDSSNWTEFAGTYGYVAPEL--------AYTMKVTAKCDVYSFGVLALEVIKGKHPRDF 166
           + D   +    GT  Y+ P++         +  K  A  D++S GV       G  P  F
Sbjct: 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--F 223

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                      ++ +++  +       ++      ++ +     +   SR     +  +L
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283

Query: 227 CK 228
             
Sbjct: 284 AN 285

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 98.9 bits (247), Expect = 7e-25
 Identities = 64/249 (25%), Positives = 111/249 (44%), Gaps = 43/249 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL------------SVI 48
            +++F RE  +LT ++H++IV+F+G CT  R   +V+EY+ +G L             + 
Sbjct: 86  ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145

Query: 49  LNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
              D +   LG  + + V   +A  + YL   H      VHRD++++N L+       + 
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIG 200

Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYV-----APE-LAYTMKVTAKCDVYSFGVLALEVI-K 159
           DFG+++ I   S+++    G    +      PE + Y  K T + DV+SFGV+  E+   
Sbjct: 201 DFGMSRDIY--STDYYR-VGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTY 256

Query: 160 GKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           GK P   LSN           + +     L         +V +IM     C    P+ R 
Sbjct: 257 GKQPWYQLSNTE-------AIDCITQGRELER-PRACPPEVYAIMR---GCWQREPQQRH 305

Query: 218 NMQTICQLL 226
           +++ +   L
Sbjct: 306 SIKDVHARL 314

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.1 bits (245), Expect = 9e-25
 Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 54/255 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------SV 47
            +K+F RE  +LT ++H +IVKFYG C       +V+EY+++G L              V
Sbjct: 60  ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                 +  ELG S+ +++   IA  + YL   H      VHRD++++N L+       +
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKI 174

Query: 106 SDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA 154
            DFG+++ +          +      W           PE     K T + DV+SFGV+ 
Sbjct: 175 GDFGMSRDVYSTDYYRVGGHTMLPIRWM---------PPESIMYRKFTTESDVWSFGVIL 225

Query: 155 LEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDN 211
            E+   GK P   LSN         V E +     L         +V  +M     C   
Sbjct: 226 WEIFTYGKQPWFQLSNTE-------VIECITQGRVLERPR-VCPKEVYDVML---GCWQR 274

Query: 212 NPESRPNMQTICQLL 226
            P+ R N++ I ++L
Sbjct: 275 EPQQRLNIKEIYKIL 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 97.2 bits (243), Expect = 1e-24
 Identities = 50/226 (22%), Positives = 102/226 (45%), Gaps = 21/226 (9%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA--EELG 59
            +    E+ +  +++H +I++ Y +   + + +LV E   NG ++  L N      E   
Sbjct: 55  VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE- 113

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            +R    +  I   + YLH   I   +HRD++  N+LL       ++DFG+A  ++    
Sbjct: 114 -ARHF--MHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                 GT  Y++PE+A       + DV+S G +   ++ G+ P D    V ++   +++
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD-TDTVKNTLNKVVL 226

Query: 180 NEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            +     +P  LS++ +  +I  +      L  NP  R ++ ++  
Sbjct: 227 ADY---EMPSFLSIEAK-DLIHQL------LRRNPADRLSLSSVLD 262

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.8 bits (244), Expect = 2e-24
 Identities = 64/251 (25%), Positives = 103/251 (41%), Gaps = 53/251 (21%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYG------FCTHARHSFLVYEYLENGSLSVILNNDT 53
           +++E  +EI +L +   HRNI  +YG              +LV E+   GS++ ++ N  
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 54  SA--EELGWSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
               +E      I  I + I   LS+LH   +   +HRDI  +NVLL    E  + DFG+
Sbjct: 123 GNTLKE----EWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-----AKCDVYSFGVLALEVIKGK---- 161
           +  +         F GT  ++APE+    +        K D++S G+ A+E+ +G     
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

Query: 162 --HPRDFLSNVSSSNPNILVNEMLDPRLPP--LSVDIRGKVISIMEVAFL--CLDNNPES 215
             HP   L  +  +           PRL     S   +          F+  CL  N   
Sbjct: 236 DMHPMRALFLIPRNPA---------PRLKSKKWSKKFQS---------FIESCLVKNHSQ 277

Query: 216 RPNMQTICQLL 226
           RP  +   QL+
Sbjct: 278 RPATE---QLM 285

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 97.3 bits (243), Expect = 2e-24
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           REI + + +RH NI++ Y +    +  +L+ E+   G L   L      +E   S     
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSATF-- 119

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAG 126
           ++ +A AL Y H      ++HRDI  +N+L+  + E  ++DFG +    P     T   G
Sbjct: 120 MEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRT-MCG 174

Query: 127 TYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML--D 184
           T  Y+ PE+        K D++  GVL  E + G  P D      S +       ++  D
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD------SPSHTETHRRIVNVD 228

Query: 185 PRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            + PP LS   +  +IS +      L  +P  R  ++ +
Sbjct: 229 LKFPPFLSDGSK-DLISKL------LRYHPPQRLPLKGV 260

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 97.7 bits (244), Expect = 2e-24
 Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 47/234 (20%)

Query: 5   FLREITVLTEIRHRNIVKFY--GF--CTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           F RE      + H  IV  Y  G          ++V EY++  +L  I++ +     +  
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R I VI     AL++ H +    I+HRD+   N+++       V DFGIA+ I    ++
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172

Query: 121 WTEFA---GTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG--------------KHP 163
            T+ A   GT  Y++PE A    V A+ DVYS G +  EV+ G              +H 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232

Query: 164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
           R+     S+ +  +              +D          V    L  NPE+R 
Sbjct: 233 REDPIPPSARHEGL-----------SADLD---------AVVLKALAKNPENRY 266

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.8 bits (246), Expect = 2e-24
 Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 21/176 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN---NDTSAEE 57
                  E+ V     H NIV +          ++V  ++  GS   ++     D   E 
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128

Query: 58  LGWSRRINVI-KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
                 I  I +G+  AL Y+HH      VHR + + ++L+ ++ + ++S       +  
Sbjct: 129 A-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

Query: 117 DSSN-------WTEFAGTYGYVAPELAYTMKV--TAKCDVYSFGVLALEVIKGKHP 163
                               +++PE+         AK D+YS G+ A E+  G  P
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.1 bits (242), Expect = 3e-24
 Identities = 55/243 (22%), Positives = 87/243 (35%), Gaps = 43/243 (17%)

Query: 1   DKKEFLREITVL-TEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-- 57
           + K  L ++ V+        IV+ +G        F+  E +   +  +         E  
Sbjct: 66  ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI 125

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           LG      +   I  AL YL       ++HRD+   N+LLD   +  + DFGI+  +  D
Sbjct: 126 LG-----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-D 177

Query: 118 SSNWTEFAGTYGYVAPE-----LAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RD 165
                  AG   Y+APE              + DV+S G+  +E+  G+ P        +
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237

Query: 166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTIC 223
            L+ V    P         P LP           S    +F+  CL  +   RP      
Sbjct: 238 VLTKVLQEEP---------PLLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYN--- 279

Query: 224 QLL 226
           +LL
Sbjct: 280 KLL 282

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.1 bits (240), Expect = 4e-24
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 41/240 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL+E   + +  H +IVK  G  T     +++ E    G L   L        L  
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR--KYSLDL 115

Query: 61  SRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-- 117
           +  I     ++ AL+YL     +    HRDI+++NVL+       + DFG++++++    
Sbjct: 116 ASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171

Query: 118 --SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLS 168
             +S       W          APE     + T+  DV+ FGV   E++  G  P   + 
Sbjct: 172 YKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 169 NVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           N         V   ++   RLP    +    + S+M     C   +P  RP    +   L
Sbjct: 223 NND-------VIGRIENGERLPM-PPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 271

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.1 bits (240), Expect = 4e-24
 Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 54/255 (21%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------SV 47
            ++EF  E  +   ++H N+V   G  T  +   +++ Y  +G L               
Sbjct: 55  LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114

Query: 48  ILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHV 105
             ++ T    L     ++++  IA  + YL  HH     +VH+D++++NVL+  +    +
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKI 169

Query: 106 SDFGIAKFIQPDS-----SN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA 154
           SD G+ + +          N      W          APE     K +   D++S+GV+ 
Sbjct: 170 SDLGLFREVYAADYYKLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVL 220

Query: 155 LEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDN 211
            EV   G  P    SN         V EM+     LP    D    V ++M     C + 
Sbjct: 221 WEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLPCPD-DCPAWVYALMI---ECWNE 269

Query: 212 NPESRPNMQTICQLL 226
            P  RP  + I   L
Sbjct: 270 FPSRRPRFKDIHSRL 284

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.5 bits (243), Expect = 4e-24
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 32/238 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSL-SVILNNDTSAEEL 58
           +  +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L + I N        
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNP 189

Query: 59  GWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
                I     +A  + +L          VHRD++++N +LD ++   V+DFG+A+ +  
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244

Query: 117 DSSNWTEFAGTYGYV-----APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNV 170
              +      T   +     A E   T K T K DV+SFGVL  E++ +G  P   ++  
Sbjct: 245 KEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

Query: 171 SSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                   +   L    RL          +  +M     C     E RP+   +   +
Sbjct: 304 D-------ITVYLLQGRRLLQPE-YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 350

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 96.6 bits (241), Expect = 5e-24
 Identities = 51/251 (20%), Positives = 96/251 (38%), Gaps = 48/251 (19%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-------SVILNNDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L          + N+ 
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130

Query: 54  SAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA 111
                  S+ I +   IA  ++YL  +       VHRD++++N ++  ++   + DFG+ 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMT 185

Query: 112 KFIQPDSS-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-K 159
           + I                 W          +PE       T   DV+SFGV+  E+   
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWM---------SPESLKDGVFTTYSDVWSFGVVLWEIATL 236

Query: 160 GKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
            + P   LSN         V   +     L     +    +  +M    +C   NP+ RP
Sbjct: 237 AEQPYQGLSNEQ-------VLRFVMEGGLLDKPD-NCPDMLFELMR---MCWQYNPKMRP 285

Query: 218 NMQTICQLLCK 228
           +   I   + +
Sbjct: 286 SFLEIISSIKE 296

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 96.6 bits (241), Expect = 5e-24
 Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 60/258 (23%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL---------- 49
           +K+  + E+ +++ + +H NIV   G CTH     ++ EY   G L   L          
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151

Query: 50  -NNDTSAEELGWSRRINVIKGIAHALSYL-HHDCIPPIVHRDISSKNVLLDLEYEAHVSD 107
                +         ++    +A  +++L   +CI    HRD++++NVLL   + A + D
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGD 207

Query: 108 FGIAKFIQPDS-----SN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE 156
           FG+A+ I  DS      N      W          APE  +    T + DV+S+G+L  E
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWM---------APESIFDCVYTVQSDVWSYGILLWE 258

Query: 157 VI-KGKHP-------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLC 208
           +   G +P         F   V          +M  P   P        + SIM+    C
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDG------YQMAQPAFAP------KNIYSIMQ---AC 303

Query: 209 LDNNPESRPNMQTICQLL 226
               P  RP  Q IC  L
Sbjct: 304 WALEPTHRPTFQQICSFL 321

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.1 bits (237), Expect = 9e-24
 Identities = 40/247 (16%), Positives = 88/247 (35%), Gaps = 43/247 (17%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           D++  LRE+     + +H ++V+++       H  +  EY   GSL+  ++ +       
Sbjct: 53  DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF 112

Query: 60  WSRRI-NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS------------ 106
               + +++  +   L Y+H      +VH DI   N+ +      + +            
Sbjct: 113 KEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169

Query: 107 -------DFGIAKFIQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVI 158
                  D G    I    S+     G   ++A E L        K D+++  +  +   
Sbjct: 170 KVMFKIGDLGHVTRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225

Query: 159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRP 217
             +              + +    L PR+P  LS +   +++       + +  +PE RP
Sbjct: 226 GAEPLPRNGDQW-----HEIRQGRL-PRIPQVLSQEFT-ELLK------VMIHPDPERRP 272

Query: 218 NMQTICQ 224
           +   + +
Sbjct: 273 SAMALVK 279

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 96.6 bits (240), Expect = 1e-23
 Identities = 29/178 (16%), Positives = 56/178 (31%), Gaps = 18/178 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +     + +  L        +KFY        S LV E    G+L   +N   +  E   
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 61  S--RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-----------VSD 107
                I+    + + +  +H      I+H DI   N +L   +              + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 108 FGIAKFI--QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            G +  +   P  + +T    T G+   E+        + D +        ++ G + 
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             +E   EI++L  + H NI+K +      ++ +LV E+ E G L   I+N     E   
Sbjct: 89  FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQP 116
                N++K I   + YLH      IVHRDI  +N+LL   +      + DFG++ F   
Sbjct: 149 ----ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA 154
           D     +  GT  Y+APE     K   KCDV+S GV+ 
Sbjct: 202 DYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 13/167 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
              + L E+ VL  + H NI+K Y F    R+ +LV E  + G L   I++     E   
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA 138

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQP 116
                 +IK +   ++YLH      IVHRD+  +N+LL+ + +     + DFG++   + 
Sbjct: 139 ----AVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                 E  GT  Y+APE+    K   KCDV+S GV+   ++ G  P
Sbjct: 192 QKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.2 bits (242), Expect = 1e-23
 Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 31/235 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL+E   + +  H +IVK  G  T     +++ E    G L   L        L  
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ--VRKFSLDL 490

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           +  I     ++ AL+YL         VHRDI+++NVL+       + DFG++++++  + 
Sbjct: 491 ASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 545

Query: 120 NWTEFAGTYGYV-----APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSS 173
               +  + G +     APE     + T+  DV+ FGV   E++  G  P   + N    
Sbjct: 546 ---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-- 600

Query: 174 NPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                V   ++   RLP    +    + S+M     C   +P  RP    +   L
Sbjct: 601 -----VIGRIENGERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 646

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.8 bits (239), Expect = 1e-23
 Identities = 33/158 (20%), Positives = 68/158 (43%), Gaps = 9/158 (5%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             ++  RE ++   ++H +IV+     +     ++V+E+++   L   I+    +     
Sbjct: 69  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128

Query: 60  WSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQ 115
            +   + ++ I  AL Y H ++    I+HRD+    VLL  +  +    +  FG+A  + 
Sbjct: 129 EAVASHYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
                     GT  ++APE+          DV+  GV+
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 96.3 bits (240), Expect = 2e-23
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 13/167 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           DK+  LRE+ +L ++ H NI+K Y F     + +LV E    G L   I++    +E   
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQP 116
                 +I+ +   ++Y+H +    IVHRD+  +N+LL+ + +     + DFG++   + 
Sbjct: 129 ----ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                 +  GT  Y+APE+        KCDV+S GV+   ++ G  P
Sbjct: 182 SKK-MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.9 bits (234), Expect = 3e-23
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 32/238 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSL-SVILNNDTSAEEL 58
           +  +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L + I N        
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNP 125

Query: 59  GWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
                I     +A  + YL          VHRD++++N +LD ++   V+DFG+A+ +  
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMY- 179

Query: 117 DSSNWTEFAGTYGYV-----APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNV 170
           D   ++    T   +     A E   T K T K DV+SFGVL  E++ +G  P   ++  
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

Query: 171 SSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                   +   L    RL          +  +M     C     E RP+   +   +
Sbjct: 240 D-------ITVYLLQGRRLLQ-PEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 286

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 4e-23
 Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 30/237 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELG 59
             + FLRE  ++  + H N++   G          ++  Y+ +G L   + +        
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPT 122

Query: 60  WSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
               I+    +A  + YL          VHRD++++N +LD  +   V+DFG+A+ I  D
Sbjct: 123 VKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDIL-D 176

Query: 118 SSNWTEFAGTYGYV-----APELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVS 171
              ++     +  +     A E   T + T K DV+SFGVL  E++ +G  P   +    
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

Query: 172 SSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  +   L    RLP         +  +M+    C + +P  RP  + +   +
Sbjct: 237 -------LTHFLAQGRRLPQPE-YCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEV 282

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.5 bits (233), Expect = 8e-23
 Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 61/259 (23%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------S 46
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L              
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142

Query: 47  VILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAH 104
               N    E++ +   ++    +A  + YL          +HRD++++NVL+       
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMK 197

Query: 105 VSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           ++DFG+A+ I        ++N      W          APE  +    T + DV+SFGVL
Sbjct: 198 IADFGLARDINNIDYYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVL 248

Query: 154 ALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP-----RLPPLSVDIRGKVISIMEVAFL 207
             E+   G  P           P I V E+        R+   + +   ++  +M     
Sbjct: 249 MWEIFTLGGSPY----------PGIPVEELFKLLKEGHRMDKPA-NCTNELYMMMR---D 294

Query: 208 CLDNNPESRPNMQTICQLL 226
           C    P  RP  + + + L
Sbjct: 295 CWHAVPSQRPTFKQLVEDL 313

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 48/214 (22%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D ++  RE  +   ++H NIV+ +   +   H +L+++ +  G L   I+  +  +E   
Sbjct: 53  DHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA-- 110

Query: 60  WSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQ 115
                + I+ I  A+ + H       +VHR++  +N+LL  + +     ++DFG+A  ++
Sbjct: 111 --DASHCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV-------------------LALE 156
            +   W  FAGT GY++PE+          D+++ GV                   L  +
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224

Query: 157 VIKGKH--PRDFLSNVSSSNPNILVNEML--DPR 186
           +  G +  P      V+    + L+N+ML  +P 
Sbjct: 225 IKAGAYDFPSPEWDTVTPEAKD-LINKMLTINPS 257

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.9 bits (229), Expect = 1e-22
 Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 34/239 (14%)

Query: 1   DKKEFLREITV-LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           ++K  L ++ + +  +     V FYG        ++  E + + SL          + + 
Sbjct: 48  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVID 101

Query: 60  WSRRI--NVIKGIA----HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
             + I  +++  IA     AL +LH      ++HRD+   NVL++   +  + DFGI+ +
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159

Query: 114 IQPDSSNWTEFAGTYGYVAPE----LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           +  D       AG   Y+APE           + K D++S G+  +E+   + P D    
Sbjct: 160 LV-DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

Query: 170 VSSSNPNILVNEMLDPRLPP--LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                  ++      P+LP    S +              CL  N + RP      +L+
Sbjct: 219 PFQQLKQVVEEP--SPQLPADKFSAEFVDFTSQ-------CLKKNSKERPTYP---ELM 265

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.5 bits (235), Expect = 1e-22
 Identities = 35/158 (22%), Positives = 71/158 (44%), Gaps = 12/158 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           DK+   +EI  ++ +RH  +V  +          ++YE++  G L   V   ++  +E+ 
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED- 255

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQP 116
                +  ++ +   L ++H +     VH D+  +N++   +    +   DFG+   + P
Sbjct: 256 ---EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA 154
              +     GT  + APE+A    V    D++S GVL+
Sbjct: 310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.4 bits (230), Expect = 2e-22
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 36/242 (14%)

Query: 1   DKKEFLREITV-LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           ++K+ L ++ V +       IV+FYG        ++  E + + S         S  +  
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDV 121

Query: 60  WSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
               I   +      AL++L  +    I+HRDI   N+LLD      + DFGI+  +  D
Sbjct: 122 IPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-D 178

Query: 118 SSNWTEFAGTYGYVAPE----LAYTMKVTAKCDVYSFGVLALEVIKGKHP-------RDF 166
           S   T  AG   Y+APE     A       + DV+S G+   E+  G+ P        D 
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAF--LCLDNNPESRPNMQTICQ 224
           L+ V   +P         P+L     +   +  S   + F  LCL  +   RP  +   +
Sbjct: 239 LTQVVKGDP---------PQLS----NSEEREFSPSFINFVNLCLTKDESKRPKYK---E 282

Query: 225 LL 226
           LL
Sbjct: 283 LL 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D    LRE+ +L ++ H NI+K +     +   ++V E    G L   I+     +E   
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-DLEYEAH--VSDFGIAKFIQP 116
                 +IK +   ++Y+H      IVHRD+  +N+LL   E +    + DFG++   Q 
Sbjct: 124 ----ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
           ++    +  GT  Y+APE+        KCDV+S GV
Sbjct: 177 NTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.5 bits (228), Expect = 3e-22
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 66/265 (24%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL---------SVILN 50
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L         S I +
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128

Query: 51  NDTSAEELGWSRRINVIK------GIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYE 102
             + A        +++         +A  +++L   +      +HRD++++N+LL     
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRI 183

Query: 103 AHVSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG 151
             + DFG+A+ I+ D       N      W          APE  +    T + DV+S+G
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWM---------APESIFNCVYTFESDVWSYG 234

Query: 152 VLALEVI-KGKHP-------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIME 203
           +   E+   G  P         F   +           ML P   P  +        IM+
Sbjct: 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEG------FRMLSPEHAPAEMY------DIMK 282

Query: 204 VAFLCLDNNPESRPNMQTICQLLCK 228
               C D +P  RP  + I QL+ K
Sbjct: 283 ---TCWDADPLKRPTFKQIVQLIEK 304

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.8 bits (226), Expect = 3e-22
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
             ++   EI VL  + H NI+K +       + ++V E  E G L   I++     + L 
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS 122

Query: 60  WSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQ 115
                 ++K + +AL+Y H       +VH+D+  +N+L           + DFG+A+  +
Sbjct: 123 EGYVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 116 PDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGV 152
            D    T  AGT  Y+APE       VT KCD++S GV
Sbjct: 179 SDEH-STNAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 61/259 (23%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------S 46
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L              
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188

Query: 47  VILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAH 104
               N    E++ +   ++    +A  + YL          +HRD++++NVL+       
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMK 243

Query: 105 VSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           ++DFG+A+ I        ++N      W          APE  +    T + DV+SFGVL
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVL 294

Query: 154 ALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP-----RLPPLSVDIRGKVISIMEVAFL 207
             E+   G  P           P I V E+        R+   + +   ++  +M     
Sbjct: 295 MWEIFTLGGSPY----------PGIPVEELFKLLKEGHRMDKPA-NCTNELYMMMR---D 340

Query: 208 CLDNNPESRPNMQTICQLL 226
           C    P  RP  + + + L
Sbjct: 341 CWHAVPSQRPTFKQLVEDL 359

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 14/157 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DKK    EI VL  + H NI+K            LV E +  G L      D   E+  +
Sbjct: 91  DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF-----DRIVEKGYY 145

Query: 61  SRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-DLEYEAHV--SDFGIAKFIQ 115
           S R   + +K I  A++YLH + I   VHRD+  +N+L      +A +  +DFG++K ++
Sbjct: 146 SERDAADAVKQILEAVAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
                     GT GY APE+        + D++S G+
Sbjct: 203 HQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 91.6 bits (228), Expect = 4e-22
 Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 68/261 (26%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------S 46
           D ++F  E+ VL ++  H NI+   G C H  + +L  EY  +G+L              
Sbjct: 68  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 127

Query: 47  VILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAH 104
                +++A  L   + ++    +A  + YL          +HRD++++N+L+   Y A 
Sbjct: 128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAK 182

Query: 105 VSDFGIAKFIQPDSSN------------WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFG 151
           ++DFG+++                    W          A E L Y+   T   DV+S+G
Sbjct: 183 IADFGLSR----GQEVYVKKTMGRLPVRWM---------AIESLNYS-VYTTNSDVWSYG 228

Query: 152 VLALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP-----RLPPLSVDIRGKVISIMEVA 205
           VL  E++  G  P             +   E+ +      RL    ++   +V  +M   
Sbjct: 229 VLLWEIVSLGGTPY----------CGMTCAELYEKLPQGYRLEK-PLNCDDEVYDLM--- 274

Query: 206 FLCLDNNPESRPNMQTICQLL 226
             C    P  RP+   I   L
Sbjct: 275 RQCWREKPYERPSFAQILVSL 295

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.2 bits (227), Expect = 4e-22
 Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 49/250 (19%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCT-----HARHSFLVYEYLENGSLSVIL---NND 52
           + +EFL E   + +  H N+++  G C            ++  +++ G L   L     +
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138

Query: 53  TSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGI 110
           T  + +     +  +  IA  + YL   +      +HRD++++N +L  +    V+DFG+
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGL 193

Query: 111 AKFIQPDSS-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI- 158
           +K I                 W          A E       T+K DV++FGV   E+  
Sbjct: 194 SKKIYSGDYYRQGRIAKMPVKWI---------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

Query: 159 KGKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
           +G  P   + N         + + L    RL     D   ++  IM     C   +P  R
Sbjct: 245 RGMTPYPGVQNHE-------MYDYLLHGHRLKQ-PEDCLDELYEIMY---SCWRTDPLDR 293

Query: 217 PNMQTICQLL 226
           P    +   L
Sbjct: 294 PTFSVLRLQL 303

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.1 bits (229), Expect = 5e-22
 Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 16/160 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
                  EI +L ++ H  I+K   F   A   ++V E +E G L   ++ N    E   
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT- 240

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQP 116
             +       +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +K +  
Sbjct: 241 -CKLY--FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 117 DSSNWTEFAGTYGYVAPE-LAYTMKV--TAKCDVYSFGVL 153
            S       GT  Y+APE L            D +S GV+
Sbjct: 295 TSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.9 bits (226), Expect = 8e-22
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++E  RE+++L ++ H NI+  +    +     L+ E +  G L      D  A++   
Sbjct: 58  CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESL 112

Query: 61  SRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFI 114
           S     + IK I   ++YLH      I H D+  +N++L  +        + DFG+A  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           +     +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 170 EDGVE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 91.3 bits (227), Expect = 9e-22
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 20/162 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           DK     EI+++ ++ H  ++  +          L+ E+L  G L   +       AE+ 
Sbjct: 91  DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA------AEDY 144

Query: 59  GWSRR--INVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKF 113
             S    IN ++     L ++H H     IVH DI  +N++ + +  + V   DFG+A  
Sbjct: 145 KMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATK 200

Query: 114 IQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           + PD         T  + APE +     V    D+++ GVL 
Sbjct: 201 LNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 91.3 bits (226), Expect = 9e-22
 Identities = 23/259 (8%), Positives = 55/259 (21%), Gaps = 46/259 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFC--------------------------THARHSF 34
           + +           +   +  +                                   +  
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164

Query: 35  LVYEYLENGSLSVILN----NDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDI 90
           L+        L ++ +          + G      +   +    + L       +VH   
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHF 220

Query: 91  SSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL--AYTMKVTAKCDVY 148
           +  N+ +  +    + D           +     +    Y   E   A T   T   + +
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALW---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAW 277

Query: 149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL- 207
             G+    V     P  F         +     +  P    L+      +     V  L 
Sbjct: 278 QLGLSIYRVWCLFLP--FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD--FVKTLI 333

Query: 208 --CLDNNPESRPNMQTICQ 224
              L+ +   R       +
Sbjct: 334 GRFLNFDRRRRLLPLEAME 352

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.4 bits (225), Expect = 1e-21
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 32/226 (14%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           RE+ ++  + H NIVK +      +  +L+ EY   G +   ++ +    E+   +R   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE--ARSK- 119

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
             + I  A+ Y H      IVHRD+ ++N+LLD +    ++DFG +            F 
Sbjct: 120 -FRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FC 174

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           G   Y APEL     Y      + DV+S GV+   ++ G  P D        N   L   
Sbjct: 175 GAPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRER 225

Query: 182 MLDP--RLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +L    R+P  +S D    ++         L  NP  R  ++ I +
Sbjct: 226 VLRGKYRIPFYMSTDCE-NLLKRF------LVLNPIKRGTLEQIMK 264

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 89.6 bits (223), Expect = 1e-21
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 19/159 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D    LRE+ +L ++ H NI+K +     +   ++V E    G L   I+     +E   
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQP 116
                 +IK +   ++Y+H   I   VHRD+  +N+LL+ + +     + DFG++   Q 
Sbjct: 124 ----ARIIKQVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 117 DSSNWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGV 152
           ++    +  GT  Y+APE+    Y      KCDV+S GV
Sbjct: 177 NTK-MKDRIGTAYYIAPEVLRGTYDE----KCDVWSAGV 210

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.9 bits (226), Expect = 1e-21
 Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 61/259 (23%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------S 46
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L              
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176

Query: 47  VILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAH 104
               +    E+L     ++    +A  + YL          +HRD++++NVL+  +    
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMK 231

Query: 105 VSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           ++DFG+A+ I        ++N      W          APE  +    T + DV+SFGVL
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVL 282

Query: 154 ALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP-----RLPPLSVDIRGKVISIMEVAFL 207
             E+   G  P           P + V E+        R+   S +   ++  +M     
Sbjct: 283 LWEIFTLGGSPY----------PGVPVEELFKLLKEGHRMDKPS-NCTNELYMMMR---D 328

Query: 208 CLDNNPESRPNMQTICQLL 226
           C    P  RP  + + + L
Sbjct: 329 CWHAVPSQRPTFKQLVEDL 347

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 89.9 bits (224), Expect = 1e-21
 Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 27/163 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILN------NDT 53
                  EI VL +I+H NIV          H +LV + +  G L   IL        D 
Sbjct: 49  RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA 108

Query: 54  SAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLL-DLEYEAHV--SDFG 109
           S           VI+ +  A+ YLH +     IVHRD+  +N+L    E  + +  +DFG
Sbjct: 109 S----------LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFG 154

Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
           ++K  Q      +   GT GYVAPE+      +   D +S GV
Sbjct: 155 LSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.5 bits (225), Expect = 1e-21
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           DK+E   EI+V+ ++ H N+++ Y          LV EY++ G L   +I       E  
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII------DESY 182

Query: 59  GWSRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFI 114
             +    I  +K I   + ++H      I+H D+  +N+L        +   DFG+A+  
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239

Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           +P       F GT  ++APE + Y   V+   D++S GV+A
Sbjct: 240 KPREKLKVNF-GTPEFLAPEVVNYD-FVSFPTDMWSVGVIA 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 89.2 bits (222), Expect = 1e-21
 Identities = 48/214 (22%), Positives = 96/214 (44%), Gaps = 38/214 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L   I+  +  +E   
Sbjct: 48  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-- 105

Query: 60  WSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQ 115
                + I+ I  +++Y H +     IVHR++  +N+LL  + +     ++DFG+A  + 
Sbjct: 106 --DASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV-------------------LALE 156
              + W  FAGT GY++PE+      +   D+++ GV                   L  +
Sbjct: 160 DSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218

Query: 157 VIKGKH--PRDFLSNVSSSNPNILVNEML--DPR 186
           +  G +  P      V+    + L++ ML  +P+
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKS-LIDSMLTVNPK 251

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 89.7 bits (223), Expect = 1e-21
 Identities = 51/251 (20%), Positives = 92/251 (36%), Gaps = 50/251 (19%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCT------HARHSFLVYEYLENGSLSVIL---NN 51
           D +EFLRE   + E  H ++ K  G               ++  ++++G L   L     
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127

Query: 52  DTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFG 109
             +   L     +  +  IA  + YL   +      +HRD++++N +L  +    V+DFG
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFG 182

Query: 110 IAKFIQPDSS-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI 158
           +++ I                 W          A E       T   DV++FGV   E++
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWL---------ALESLADNLYTVHSDVWAFGVTMWEIM 233

Query: 159 -KGKHPRDFLSNVSSSNPNILVNEMLDP--RLPPLSVDIRGKVISIMEVAFLCLDNNPES 215
            +G+ P   + N         +   L    RL     +   +V  +M     C   +P+ 
Sbjct: 234 TRGQTPYAGIENAE-------IYNYLIGGNRLKQPP-ECMEEVYDLMY---QCWSADPKQ 282

Query: 216 RPNMQTICQLL 226
           RP+   +   L
Sbjct: 283 RPSFTCLRMEL 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.2 bits (222), Expect = 2e-21
 Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 17/161 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++E  RE+ +L EIRH NI+  +    +     L+ E +  G L      D  AE+   
Sbjct: 51  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF-----DFLAEKESL 105

Query: 61  SRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL-DLEYEAH---VSDFGIAKFI 114
           +       +K I   + YLH      I H D+  +N++L D         + DFGIA  I
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162

Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           +  +  +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 163 EAGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 89.6 bits (223), Expect = 2e-21
 Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 20/162 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEEL 58
           D+    +EI++L   RHRNI+  +          +++E++    +   +           
Sbjct: 44  DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN------TSAF 97

Query: 59  GWSRR--INVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKF 113
             + R  ++ +  +  AL +LH H+    I H DI  +N++      + +   +FG A+ 
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153

Query: 114 IQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           ++P  +    F     Y APE   + + V+   D++S G L 
Sbjct: 154 LKPGDNFRLLF-TAPEYYAPEVHQHDV-VSTATDMWSLGTLV 193

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.6 bits (223), Expect = 2e-21
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            ++E  RE+++L ++ H N++  +    +     L+ E +  G L      D  A++   
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESL 112

Query: 61  SRR--INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKFI 114
           S     + IK I   ++YLH      I H D+  +N++L  +        + DFG+A  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           +     +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 170 EDGVE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.8 bits (221), Expect = 2e-21
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 21/160 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           D   F +EI ++  + H NI++ Y         +LV E    G L   +++     E   
Sbjct: 49  DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD- 107

Query: 60  WSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFIQ 115
            + RI  +K +  A++Y H  +    + HRD+  +N L   +       + DFG+A   +
Sbjct: 108 -AARI--MKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160

Query: 116 PDSSNWTEFAGTYGYVAPEL---AYTMKVTAKCDVYSFGV 152
           P         GT  YV+P++    Y      +CD +S GV
Sbjct: 161 PG-KMMRTKVGTPYYVSPQVLEGLYGP----ECDEWSAGV 195

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.1 bits (224), Expect = 2e-21
 Identities = 47/215 (21%), Positives = 94/215 (43%), Gaps = 40/215 (18%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D ++  RE  +  +++H NIV+ +         +LV++ +  G L      +       +
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFY 125

Query: 61  SRR--INVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFI 114
           S     + I+ I  +++Y H +     IVHR++  +N+LL  + +     ++DFG+A  +
Sbjct: 126 SEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV-------------------LAL 155
               + W  FAGT GY++PE+      +   D+++ GV                   L  
Sbjct: 182 NDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240

Query: 156 EVIKGKH--PRDFLSNVSSSNPNILVNEML--DPR 186
           ++  G +  P      V+    + L++ ML  +P+
Sbjct: 241 QIKAGAYDYPSPEWDTVTPEAKS-LIDSMLTVNPK 274

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.3 bits (222), Expect = 3e-21
 Identities = 55/270 (20%), Positives = 97/270 (35%), Gaps = 71/270 (26%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-------------- 45
           +++  + E+ ++T++  H NIV   G CT +   +L++EY   G L              
Sbjct: 91  EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150

Query: 46  ------SVILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLL 97
                    L  +     L +   +     +A  + +L          VHRD++++NVL+
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLV 205

Query: 98  DLEYEAHVSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCD 146
                  + DFG+A+ I  D       N      W          APE  +    T K D
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM---------APESLFEGIYTIKSD 256

Query: 147 VYSFGVLALEVI-KGKHP-------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKV 198
           V+S+G+L  E+   G +P        +F   + +        +M  P      +      
Sbjct: 257 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG------FKMDQPFYATEEIY----- 305

Query: 199 ISIMEVAFLCLDNNPESRPNMQTICQLLCK 228
             IM+    C   +   RP+   +   L  
Sbjct: 306 -IIMQ---SCWAFDSRKRPSFPNLTSFLGC 331

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 88.8 bits (221), Expect = 4e-21
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 19/162 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++  RE+++L EI+H N++  +    +     L+ E +  G L      D  AE+   
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF-----DFLAEKESL 111

Query: 61  SRR--INVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLL-DLEYEAH---VSDFGIAKF 113
           +       +K I + + YLH       I H D+  +N++L D         + DFG+A  
Sbjct: 112 TEEEATEFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167

Query: 114 IQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
           I   +  +    GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 168 IDFGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.4 bits (220), Expect = 4e-21
 Identities = 56/267 (20%), Positives = 101/267 (37%), Gaps = 70/267 (26%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--------------- 45
           + ++ L E  VL ++ H +++K YG C+      L+ EY + GSL               
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128

Query: 46  ------SVILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLL 97
                 +    +      L     I+    I+  + YL         +VHRD++++N+L+
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILV 183

Query: 98  DLEYEAHVSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPELAYTMKVTAKCD 146
               +  +SDFG+++ +  +      S       W          A E  +    T + D
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM---------AIESLFDHIYTTQSD 234

Query: 147 VYSFGVLALEVI-KGKHPRDFLSNVSSSNPNILVNEMLDP-----RLP-PLSVDIRGKVI 199
           V+SFGVL  E++  G +P           P I    + +      R+  P +     ++ 
Sbjct: 235 VWSFGVLLWEIVTLGGNPY----------PGIPPERLFNLLKTGHRMERPDNCS--EEMY 282

Query: 200 SIMEVAFLCLDNNPESRPNMQTICQLL 226
            +M     C    P+ RP    I + L
Sbjct: 283 RLML---QCWKQEPDKRPVFADISKDL 306

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 4e-21
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 26/164 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDTS 54
                  EI +L ++ H  I+K   F   A   ++V E +E G L      +  L   T 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATC 116

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIA 111
                          +  A+ YLH +    I+HRD+  +NVLL  + E     ++DFG +
Sbjct: 117 K---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164

Query: 112 KFIQPDSSNWTEFAGTYGYVAPE-LAYTMKV--TAKCDVYSFGV 152
           K +   S       GT  Y+APE L            D +S GV
Sbjct: 165 KILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.1 bits (219), Expect = 6e-21
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 15/161 (9%)

Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSL--SVILNNDTSAEE 57
            + E L EI VL   +    ++  +    +     L+ EY   G +    +        E
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGIAKFI 114
              +  I +IK I   + YLH +    IVH D+  +N+LL   Y      + DFG+++ I
Sbjct: 131 ---NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 115 QPDSSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLA 154
                   E  GT  Y+APE L Y   +T   D+++ G++A
Sbjct: 185 GHACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 88.5 bits (220), Expect = 6e-21
 Identities = 53/268 (19%), Positives = 101/268 (37%), Gaps = 72/268 (26%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--------------- 45
            + +F RE  ++ E  + NIVK  G C   +   L++EY+  G L               
Sbjct: 93  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 152

Query: 46  ------SVILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLL 97
                 +    +      L  + ++ + + +A  ++YL          VHRD++++N L+
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLV 207

Query: 98  DLEYEAHVSDFGIAKFIQPD-----SSN------WTEFAGTYGYVAPE-LAYTMKVTAKC 145
                  ++DFG+++ I          N      W           PE + Y  + T + 
Sbjct: 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM---------PPESIFYN-RYTTES 257

Query: 146 DVYSFGVLALEVI-KGKHP------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKV 198
           DV+++GV+  E+   G  P       + +  V   N            L     +   ++
Sbjct: 258 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-----------ILACPE-NCPLEL 305

Query: 199 ISIMEVAFLCLDNNPESRPNMQTICQLL 226
            ++M    LC    P  RP+  +I ++L
Sbjct: 306 YNLMR---LCWSKLPADRPSFCSIHRIL 330

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.7 bits (218), Expect = 6e-21
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 16/160 (10%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEEL 58
            ++  L+E+ +L ++  H NI++           FLV++ ++ G L   +    T +E+ 
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK- 124

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                  +++ +   +  LH   I   VHRD+  +N+LLD +    ++DFG +  + P  
Sbjct: 125 ---ETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178

Query: 119 SNWTEFAGTYGYVAPE-LAYTMKVTAK-----CDVYSFGV 152
               E  GT  Y+APE +  +M           D++S GV
Sbjct: 179 K-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 87.7 bits (218), Expect = 9e-21
 Identities = 53/262 (20%), Positives = 88/262 (33%), Gaps = 65/262 (24%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHA-RHSFLVYEYLENGSL------------- 45
           + +  + E+ +L  I  H N+V   G CT       ++ E+ + G+L             
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

Query: 46  SVILNNDTSAEELGWSRRINVIKGIAHALSYL--HHDCIPPIVHRDISSKNVLLDLEYEA 103
             +   D   + L     I     +A  + +L          +HRD++++N+LL  +   
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVV 187

Query: 104 HVSDFGIAKFIQPDSS-----------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV 152
            + DFG+A+ I  D              W          APE  +    T + DV+SFGV
Sbjct: 188 KICDFGLARDIYKDPDYVRKGDARLPLKWM---------APETIFDRVYTIQSDVWSFGV 238

Query: 153 LALEVI-KGKHP-------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEV 204
           L  E+   G  P        +F   +           M  P      +         M  
Sbjct: 239 LLWEIFSLGASPYPGVKIDEEFCRRLKEG------TRMRAPDYTTPEMY------QTML- 285

Query: 205 AFLCLDNNPESRPNMQTICQLL 226
              C    P  RP    + + L
Sbjct: 286 --DCWHGEPSQRPTFSELVEHL 305

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.0 bits (216), Expect = 2e-20
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 27/165 (16%)

Query: 2   KKEFLREITVL-TEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILN------NDT 53
           K++   EI +L    +H NI+         ++ ++V E ++ G L   IL        + 
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 54  SAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH----VSDF 108
           SA          V+  I   + YLH       +VHRD+   N+L   E        + DF
Sbjct: 119 SA----------VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDF 164

Query: 109 GIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           G AK ++ ++        T  +VAPE+       A CD++S GVL
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 86.7 bits (215), Expect = 3e-20
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 26/165 (15%)

Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDT 53
            ++   RE  +L ++  H +I+        +   FLV++ +  G L       V L+   
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE 201

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
           +           +++ +  A+S+LH + I   VHRD+  +N+LLD   +  +SDFG +  
Sbjct: 202 TRS---------IMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCH 249

Query: 114 IQPDSSNWTEFAGTYGYVAPE-LAYTMKVTAK-----CDVYSFGV 152
           ++P      E  GT GY+APE L  +M  T        D+++ GV
Sbjct: 250 LEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 86.2 bits (214), Expect = 3e-20
 Identities = 46/163 (28%), Positives = 67/163 (41%), Gaps = 34/163 (20%)

Query: 7   REITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI- 64
           +EIT L     H NIVK +       H+FLV E L  G L                 RI 
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF---------------ERIK 98

Query: 65  -----------NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGI 110
                       +++ +  A+S++H   +   VHRD+  +N+L   E +     + DFG 
Sbjct: 99  KKKHFSETEASYIMRKLVSAVSHMHDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGF 155

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           A+   PD+        T  Y APEL         CD++S GV+
Sbjct: 156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.6 bits (214), Expect = 4e-20
 Identities = 30/234 (12%), Positives = 69/234 (29%), Gaps = 37/234 (15%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYL----ENGSL----SVILNNDTSAEE 57
           LR I     ++     K        R  +++  +        +L     V+L++ ++ + 
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD 117
           L    R+ +   +   L+ LHH  +   VH  +   +++LD      ++ F      +  
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLV--RDG 262

Query: 118 SSNWTEFAGTYG---YVAPELAY-----TMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
           +S  +     +      A  +          +T   D ++ G+    +     P     +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDD 320

Query: 170 VSSSNPNILVNEMLDPRLPPLSVD-IRGKVISIMEVAFLCLDNNPESRPNMQTI 222
            +      +        +P      + G            L    E R      
Sbjct: 321 AALGGSEWIFRS--CKNIPQPVRALLEG-----------FLRYPKEDRLLPLQA 361

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.4 bits (212), Expect = 5e-20
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 22/224 (9%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRI 64
           +EI +L ++ H N+VK           H ++V+E +  G +  +      +E+   +R  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ--ARFY 142

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
              + +   + YLH+  I   +HRDI   N+L+  +    ++DFG++   +   +  +  
Sbjct: 143 --FQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197

Query: 125 AGTYGYVAPELAYTMKVT---AKCDVYSFGVLALEVIKGKHPRDFL-SNVSSSNPNILVN 180
            GT  ++APE     +        DV++ GV     + G+ P  F+   +   +  I   
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDERIMCLHSKIKSQ 255

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            +  P  P ++ D++  +I+ M      LD NPESR  +  I  
Sbjct: 256 ALEFPDQPDIAEDLK-DLITRM------LDKNPESRIVVPEIKL 292

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.5 bits (212), Expect = 9e-20
 Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 59/235 (25%)

Query: 6   LREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL------SVILNNDTS---- 54
            +E+ ++  + H  +V  +Y F       F+V + L  G L      +V    +T     
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 55  AEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            E             +  AL YL        I+HRD+   N+LLD     H++DF IA  
Sbjct: 122 CE-------------LVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAM 164

Query: 114 IQPDSSNWTEFAGTYGYVAPEL-------AYTMKVTAKCDVYSFGVLALEVIKGKHPRDF 166
           +  ++   T  AGT  Y+APE+        Y+  V    D +S GV A E+++G+ P  +
Sbjct: 165 LPRETQITT-MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--Y 217

Query: 167 LSNVSSSNPNILVNEML--DPRLPP-LSVDIRGKVISIMEVAFL--CLDNNPESR 216
               SS++   +V+         P   S ++          + L   L+ NP+ R
Sbjct: 218 HIR-SSTSSKEIVHTFETTVVTYPSAWSQEMV---------SLLKKLLEPNPDQR 262

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 83.5 bits (206), Expect = 4e-19
 Identities = 29/236 (12%), Positives = 73/236 (30%), Gaps = 41/236 (17%)

Query: 5   FLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSV---ILNNDTSAEELG 59
           F+    ++ + + + +++             F +Y  +++   +    +L++ ++ + L 
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
              R+ +   +   L+ LHH  +   VH  +   +++LD      ++ F           
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-- 259

Query: 120 NWTEFAGTYGYVAPEL-----------AYTMKVTAKCDVYSFGVLALEVIKGKHPRDF-L 167
                + + G+  PEL                +T   D ++ G++   +     P     
Sbjct: 260 --VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITK 315

Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVD-IRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                 +  I  +      +P      + G            L    E R      
Sbjct: 316 DAALGGSEWIFRS---CKNIPQPVRALLEG-----------FLRYPKEDRLLPLQA 357

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.0 bits (205), Expect = 5e-19
 Identities = 44/199 (22%), Positives = 69/199 (34%), Gaps = 48/199 (24%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL--------------- 45
           D +    E+ ++ ++ H NI + Y      ++  LV E    G L               
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 46  ------------SVILNNDTSAEELGWSRRIN----------VIKGIAHALSYLHHDCIP 83
                               +    G+   ++          +++ I  AL YLH+    
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--- 187

Query: 84  PIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQP----DSSNWTEFAGTYGYVAPEL-- 135
            I HRDI  +N L        +   DFG++K        +    T  AGT  +VAPE+  
Sbjct: 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247

Query: 136 AYTMKVTAKCDVYSFGVLA 154
                   KCD +S GVL 
Sbjct: 248 TTNESYGPKCDAWSAGVLL 266

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.3 bits (201), Expect = 1e-18
 Identities = 26/214 (12%), Positives = 48/214 (22%), Gaps = 38/214 (17%)

Query: 4   EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           E L     L+ I    + +            +V E++  GSL  +               
Sbjct: 77  ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGA 131

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTE 123
           I  ++ +A A    H      +         V         VS  G              
Sbjct: 132 IRAMQSLAAAADAAHRA---GVALSIDHPSRVR--------VSIDGDVV----------- 169

Query: 124 FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML 183
                  +            + D+   G     ++  + P   L      +         
Sbjct: 170 -LAYPATMPD-------ANPQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAERDT 218

Query: 184 DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
             +    +   R     I  VA   +  +   R 
Sbjct: 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 81.7 bits (202), Expect = 2e-18
 Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 35/225 (15%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGS--LSVILNNDTSAEELGWSRRI 64
            EI +L+ + H NI+K      +     LV E   +G    + I  +    E L  +  I
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL--ASYI 135

Query: 65  NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEF 124
              + +  A+ YL    I   +HRDI  +N+++  ++   + DFG A +++     +T F
Sbjct: 136 --FRQLVSAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-F 189

Query: 125 AGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
            GT  Y APE+     Y      + +++S GV    ++  ++P   L     +       
Sbjct: 190 CGTIEYCAPEVLMGNPYR---GPELEMWSLGVTLYTLVFEENPFCELEETVEA------- 239

Query: 181 EMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                  P  +S ++   ++S +      L   PE R  ++ +  
Sbjct: 240 ---AIHPPYLVSKELM-SLVSGL------LQPVPERRTTLEKLVT 274

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 19/164 (11%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFC----THARHSFLVYEYLENGSL-SVILNNDTS 54
           D  +  RE+ +     +  +IV+            +   +V E L+ G L S I +    
Sbjct: 97  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 156

Query: 55  AEELGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFG 109
           A    ++ R    ++K I  A+ YLH   I    HRD+  +N+L   +       ++DFG
Sbjct: 157 A----FTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFG 209

Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
            AK     +S  T    T  YVAPE+    K    CD++S GV+
Sbjct: 210 FAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.7 bits (192), Expect = 3e-17
 Identities = 49/230 (21%), Positives = 82/230 (35%), Gaps = 41/230 (17%)

Query: 7   REITVLTEIR----HRNIVKFYGFCTHARHSFLVYEYLENGS--LSVILNNDTSAEELGW 60
            E+ +L ++     H  +++   +        LV E           I       E    
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-- 140

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSS 119
           SR       +  A+ + H   +   VHRDI  +N+L+DL    A + DFG    +     
Sbjct: 141 SRCF--FGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLH--DE 193

Query: 120 NWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
            +T+F GT  Y  PE      Y         V+S G+L  +++ G  P +    +  +  
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYH---ALPATVWSLGILLYDMVCGDIPFERDQEILEA-- 248

Query: 176 NILVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                   +   P  +S D    +I         L   P SRP+++ I  
Sbjct: 249 --------ELHFPAHVSPDCC-ALIRRC------LAPKPSSRPSLEEILL 283

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.2 bits (191), Expect = 3e-17
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 26/226 (11%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           +EI +   + H N+VKFYG        +L  EY   G L   I  +    E    ++R  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRF- 110

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---T 122
               +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++       
Sbjct: 111 -FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 123 EFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              GT  YVAPEL     +        DV+S G++   ++ G+ P D  S+      +  
Sbjct: 167 -MCGTLPYVAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             +        +       ++  +      L  NP +R  +  I +
Sbjct: 223 EKKTYLNPWKKIDSAPL-ALLHKI------LVENPSARITIPDIKK 261

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.8 bits (192), Expect = 3e-17
 Identities = 37/163 (22%), Positives = 68/163 (41%), Gaps = 18/163 (11%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSA 55
           D  +  +E+    +     +IV       +  H      ++ E +E G L    +     
Sbjct: 64  DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQER 120

Query: 56  EELGWSRRI--NVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFGI 110
            +  ++ R    +++ I  A+ +LH   I    HRD+  +N+L   + +     ++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           AK    ++        T  YVAPE+    K    CD++S GV+
Sbjct: 178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 4e-17
 Identities = 45/228 (19%), Positives = 82/228 (35%), Gaps = 39/228 (17%)

Query: 7   REITVLTEIRHR--NIVKFYGFCTHARHSFLVYEYLENGS--LSVILNNDTSAEELGWSR 62
            E+ +L ++      +++   +        L+ E  E        I       EEL  +R
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL--AR 152

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNW 121
                  +  A+ + H+  +   +HRDI  +N+L+DL   E  + DFG    ++   + +
Sbjct: 153 SF--FWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY 205

Query: 122 TEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
           T+F GT  Y  PE      Y         V+S G+L  +++ G  P +    +       
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYH---GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG---- 258

Query: 178 LVNEMLDPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                        +S + +  +I         L   P  RP  + I  
Sbjct: 259 ------QVFFRQRVSSECQ-HLIRWC------LALRPSDRPTFEEIQN 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.9 bits (190), Expect = 7e-17
 Identities = 41/176 (23%), Positives = 74/176 (42%), Gaps = 36/176 (20%)

Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNN------D 52
            +    RE+ +L + + HRN+++   F       +LV+E +  GS+ S I         +
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE 112

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH---VSDFG 109
            S           V++ +A AL +LH+     I HRD+  +N+L +   +     + DF 
Sbjct: 113 AS----------VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFD 159

Query: 110 IAKFIQPDSS-------NWTEFAGTYGYVAPELAYTMKVTAK-----CDVYSFGVL 153
           +   I+ +               G+  Y+APE+       A      CD++S GV+
Sbjct: 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.5 bits (189), Expect = 8e-17
 Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 36/174 (20%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL------SVILNNDTS----A 55
            RE  V++ + H   VK Y         +    Y +NG L          +   +    A
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137

Query: 56  EELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK 112
           E             I  AL YLH       I+HRD+  +N+LL+   + H+  +DFG AK
Sbjct: 138 E-------------IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAK 178

Query: 113 FIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            + P+S      + F GT  YV+PEL          D+++ G +  +++ G  P
Sbjct: 179 VLSPESKQARANS-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.9 bits (185), Expect = 2e-16
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 32/226 (14%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI  L   RH +I+K Y   +     F+V EY+  G L   I  +    E    +RR+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME--ARRL- 116

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
             + I  A+ Y H   +   VHRD+  +NVLLD    A ++DFG++  +       T   
Sbjct: 117 -FQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SC 171

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           G+  Y APE+     Y      + D++S GV+   ++ G  P D        +   L  +
Sbjct: 172 GSPNYAAPEVISGRLYA---GPEVDIWSCGVILYALLCGTLPFD------DEHVPTLFKK 222

Query: 182 ML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +      +P  L+  +   ++  M      L  +P  R  ++ I +
Sbjct: 223 IRGGVFYIPEYLNRSVA-TLLMHM------LQVDPLKRATIKDIRE 261

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 2e-16
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 26/226 (11%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           +EI +   + H N+VKFYG        +L  EY   G L   I  +    E    ++R  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRF- 110

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---T 122
               +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++       
Sbjct: 111 -FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 123 EFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
              GT  YVAPEL     +        DV+S G++   ++ G+ P D  S+      +  
Sbjct: 167 -MCGTLPYVAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             +        +       ++  +      L  NP +R  +  I +
Sbjct: 223 EKKTYLNPWKKIDSAPL-ALLHKI------LVENPSARITIPDIKK 261

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.5 bits (186), Expect = 3e-16
 Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 28/228 (12%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI     +RH NIV+F        H  ++ EY   G L   I N    +E+   +R   
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE--ARFF- 121

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAKFIQPDSSNWTE 123
             + +   +SY H      I HRD+  +N LLD        + DFG +K     S   + 
Sbjct: 122 -FQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS- 176

Query: 124 FAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP---RDFLSNVSSSNPN 176
             GT  Y+APE+     Y        DV+S GV    ++ G +P    +   +   +   
Sbjct: 177 TVGTPAYIAPEVLLRQEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           IL  +   P    +S +    +IS +         +P +R ++  I  
Sbjct: 234 ILSVKYSIPDDIRISPECC-HLISRI------FVADPATRISIPEIKT 274

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 73.8 bits (182), Expect = 8e-16
 Identities = 47/230 (20%), Positives = 90/230 (39%), Gaps = 33/230 (14%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSV---ILNNDTSAEELGWS 61
           +EI +L  +RH+N+++      +   +  ++V EY   G   +   +        +   +
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ---A 111

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
                   +   L YLH   I   VH+DI   N+LL       +S  G+A+ + P +++ 
Sbjct: 112 HGY--FCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166

Query: 122 T--EFAGTYGYVAPELAYTMKV--TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
           T     G+  +  PE+A  +      K D++S GV    +  G +P +        N   
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYK 220

Query: 178 LVNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L   +      +P      +   ++  M      L+  P  R +++ I Q
Sbjct: 221 LFENIGKGSYAIPGDCGPPLS-DLLKGM------LEYEPAKRFSIRQIRQ 263

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 56/227 (24%), Positives = 84/227 (37%), Gaps = 43/227 (18%)

Query: 6   LREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSA--EELGWSR 62
           L E  +L ++  R +V   Y + T      LV   +  G L   + +   A   E   +R
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPE---AR 287

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSSN 120
            +     I   L  LH + I   V+RD+  +N+LLD     H+  SD G+A  +    + 
Sbjct: 288 AVFYAAEICCGLEDLHRERI---VYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTI 342

Query: 121 WTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
                GT GY+APE+     YT       D ++ G L  E+I G+ P  F          
Sbjct: 343 KG-RVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP--F----QQRKKK 391

Query: 177 ILVNEMLD------PRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           I   E+               S   R    S+       L  +P  R
Sbjct: 392 IKREEVERLVKEVPEEYSERFSPQAR----SLCS---QLLCKDPAER 431

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 58/227 (25%), Positives = 85/227 (37%), Gaps = 40/227 (17%)

Query: 6   LREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSV-ILNNDTSAEELGWSRR 63
           + E  +L ++  R IV   Y F T      LV   +  G +   I N D         R 
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSN 120
           I     I   L +LH   I   ++RD+  +NVLLD   + +V  SD G+A       +  
Sbjct: 292 IFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKT 346

Query: 121 WTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
              +AGT G++APEL     Y   V    D ++ GV   E+I  + P  F     +    
Sbjct: 347 KG-YAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP--F----RARGEK 395

Query: 177 ILVNEMLD------PRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           +   E+           P   S   +       E     L  +PE R
Sbjct: 396 VENKELKQRVLEQAVTYPDKFSPASK----DFCE---ALLQKDPEKR 435

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.7 bits (176), Expect = 8e-15
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 16/152 (10%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI  L   RH +I+K Y   +     F+V EY+  G L   I  N    E+   SRR+ 
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE--SRRL- 121

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
             + I   + Y H   +   VHRD+  +NVLLD    A ++DFG++  +       T   
Sbjct: 122 -FQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SC 176

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVL 153
           G+  Y APE+     Y      + D++S GV+
Sbjct: 177 GSPNYAAPEVISGRLYA---GPEVDIWSSGVI 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 44/180 (24%), Positives = 68/180 (37%), Gaps = 41/180 (22%)

Query: 5   FLREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL-------SVILNNDTS-- 54
           F  E  VL     + I    Y F     + +LV +Y   G L          L  + +  
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179

Query: 55  --AEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFG 109
             AE             +  A+  +H        VHRDI   N+L+D     H+  +DFG
Sbjct: 180 YLAE-------------MVIAIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFG 220

Query: 110 IAKFIQPDSSNWTE-FAGTYGYVAPELAYTMKVTAK-----CDVYSFGVLALEVIKGKHP 163
               +  D +  +    GT  Y++PE+   M+         CD +S GV   E++ G+ P
Sbjct: 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 71.1 bits (174), Expect = 1e-14
 Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 26/169 (15%)

Query: 6   LREITVLTEI---RHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWS 61
           L E  +L+ +       IV   Y F T       + + +  G L   L+      E   +
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSE---A 292

Query: 62  RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSS 119
                   I   L ++H+  +   V+RD+   N+LLD     HV  SD G+A        
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLD--EHGHVRISDLGLACDFSKKKP 347

Query: 120 NWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +     GT+GY+APE+     AY        D +S G +  ++++G  P
Sbjct: 348 H--ASVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 19/170 (11%)

Query: 5   FLREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           F  E  VL     R I +  + F     + +LV EY   G L  +L+          +R 
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSSNW 121
              +  I  A+  +H       VHRDI   N+LLD     H+  +DFG    ++ D +  
Sbjct: 167 --YLAEIVMAIDSVHRLGY---VHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVR 219

Query: 122 TE-FAGTYGYVAPELAYTMKVTAK-------CDVYSFGVLALEVIKGKHP 163
           +    GT  Y++PE+   +            CD ++ GV A E+  G+ P
Sbjct: 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)

Query: 7   REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELGWSRRIN 65
           REI+ L  +RH +I+K Y   T      +V EY   G L   I+      E+    RR  
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE--GRRF- 113

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
             + I  A+ Y H   I   VHRD+  +N+LLD      ++DFG++  +   +   T   
Sbjct: 114 -FQQIICAIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SC 168

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           G+  Y APE+     Y      + DV+S G++   ++ G+ P D            L  +
Sbjct: 169 GSPNYAAPEVINGKLYA---GPEVDVWSCGIVLYVMLVGRLPFD------DEFIPNLFKK 219

Query: 182 ML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +      +P  LS   +  +I  M      +  +P  R  +Q I +
Sbjct: 220 VNSCVYVMPDFLSPGAQ-SLIRRM------IVADPMQRITIQEIRR 258

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.0 bits (169), Expect = 7e-14
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 20/168 (11%)

Query: 5   FLREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           F  E  ++       +V+ FY F    R+ ++V EY+  G L  +++N    E+  W+R 
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARF 172

Query: 64  INVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDSSN 120
                 +  AL  +H        +HRD+   N+LLD     H+  +DFG    +  +   
Sbjct: 173 --YTAEVVLALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMV 224

Query: 121 WTE-FAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             +   GT  Y++PE+            +CD +S GV   E++ G  P
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 32/179 (17%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSF------LVYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+   F   +          LV +Y+      V  +   +
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149

Query: 55  AEELGWSRRINVIKGIAH----ALSYLH-HDCIPPIVHRDISSKNVLLDLE-YEAHVSDF 108
            + L     +  +K   +    +L+Y+H       I HRDI  +N+LLD +     + DF
Sbjct: 150 KQTLP----VIYVKLYMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDF 201

Query: 109 GIAKFIQPDSSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
           G AK +     N   +  +  Y APEL      YT  +    DV+S G VLA E++ G+
Sbjct: 202 GSAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV 66
           E  VL   RH  +    Y F TH      V EY   G L   L+ +    E    R    
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSE---DRARFY 253

Query: 67  IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTE 123
              I  AL YLH +    +V+RD+  +N++LD   + H+  +DFG+ K  I+  ++  T 
Sbjct: 254 GAEIVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKT- 308

Query: 124 FAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
           F GT  Y+APE+     Y   V    D +  GV+  E++ G+ P  F     + +   L 
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--F----YNQDHEKLF 358

Query: 180 NEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
             +L  + R P  L  + +    S++      L  +P+ R
Sbjct: 359 ELILMEEIRFPRTLGPEAK----SLLS---GLLKKDPKQR 391

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 66.5 bits (163), Expect = 4e-13
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L E++HRNI++      H     L++EY EN  L   ++ +             
Sbjct: 81  IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM-------R 132

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-----VSDFGIAKFIQP 116
           VIK   +     +++ H       +HRD+  +N+LL +   +      + DFG+A+    
Sbjct: 133 VIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189

Query: 117 DSSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
               +T    T  Y  PE+      Y+  V    D++S   +  E++   
Sbjct: 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.0 bits (162), Expect = 4e-13
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 36/178 (20%)

Query: 1   DKKEFLREITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL------SVILNNDT 53
           D+     E  +L E+ H  IVK  Y F T  +  +L+ ++L  G L       V+   + 
Sbjct: 69  DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED 127

Query: 54  S----AEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--S 106
                AE             +A AL +LH       I++RD+  +N+LLD   E H+  +
Sbjct: 128 VKFYLAE-------------LALALDHLHSLG----IIYRDLKPENILLD--EEGHIKLT 168

Query: 107 DFGIAK-FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           DFG++K  I  +   ++ F GT  Y+APE+      T   D +SFGVL  E++ G  P
Sbjct: 169 DFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.3 bits (162), Expect = 6e-13
 Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 16/162 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCT--HARHSF----LVYEYLENGSLSVILNNDTSAEELG 59
            RE+ ++  + H+NI+      T   +   F    +V E ++  +L  ++  +   E   
Sbjct: 72  YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE--- 127

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
             R   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A+       
Sbjct: 128 --RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
             T +  T  Y APE+   M      D++S G +  E+IKG 
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.4 bits (160), Expect = 7e-13
 Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 35/178 (19%)

Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGFCTHARHSF---LVYEYLENGSLSVILNNDTSAE 56
            KK+  REI +L  +R   NI+           S    LV+E++ N     +    T  +
Sbjct: 73  KKKKIKREIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD 131

Query: 57  ELGWSRRINVIK----GIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGI 110
                     I+     I  AL Y H       I+HRD+   NV++D E+ +  + D+G+
Sbjct: 132 ----------IRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGL 177

Query: 111 AKFIQPDSSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           A+F  P    +     +  +  PEL      Y   +    D++S G +   +I  K P
Sbjct: 178 AEFYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.0 bits (161), Expect = 8e-13
 Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 28/166 (16%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRR 63
            REI +L E++H N++     F +HA    +L+++Y E+  L  I+    +++      +
Sbjct: 66  CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ 124

Query: 64  IN--VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH----VSDFGIAKF 113
           +   ++K + +     + YLH +    ++HRD+   N+L+  E        ++D G A+ 
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

Query: 114 IQPDSSNWTEFAG---TYGYVAPEL-----AYTMKVTAKCDVYSFG 151
                    +      T+ Y APEL      YT  +    D+++ G
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIG 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 15/161 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI +L ++RH N+V     C   +  +LV+E++++  L  +   +     L +     
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQK 128

Query: 66  VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFA 125
            +  I + + + H      I+HRDI  +N+L+       + DFG A+ +      + +  
Sbjct: 129 YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185

Query: 126 GTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
            T  Y APEL      Y   V    DV++ G L  E+  G+
Sbjct: 186 ATRWYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 1e-12
 Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 43/173 (24%)

Query: 8   EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL------NNDTS----AEE 57
           E  +L  +    +VK         + ++V EY+  G +   L      +   +    A+ 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ- 149

Query: 58  LGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFI 114
                       I     YLH  D    +++RD+  +N+L+D   + ++  +DFG AK +
Sbjct: 150 ------------IVLTFEYLHSLD----LIYRDLKPENLLID--QQGYIQVTDFGFAKRV 191

Query: 115 QPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                 WT   GT   +APE+     Y   V    D ++ GVL  E+  G  P
Sbjct: 192 --KGRTWT-LCGTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.9 bits (159), Expect = 1e-12
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 52/227 (22%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDT----------SAE 56
           E  +L E++H  IV   Y F T  +  +L+ EYL  G L + L  +            AE
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129

Query: 57  ELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK- 112
                        I+ AL +LH       I++RD+  +N++L+  ++ HV  +DFG+ K 
Sbjct: 130 -------------ISMALGHLHQKG----IIYRDLKPENIMLN--HQGHVKLTDFGLCKE 170

Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
            I   +   T F GT  Y+APE+          D +S G L  +++ G  P  F      
Sbjct: 171 SIHDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGE--- 224

Query: 173 SNPNILVNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
            N    ++++L     LPP L+ + R     +++     L  N  SR
Sbjct: 225 -NRKKTIDKILKCKLNLPPYLTQEAR----DLLK---KLLKRNAASR 263

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 36/162 (22%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 6   LREITVLTEIRHRNIVKFYGFCT--HARHSF----LVYEYLENGSLSVILNNDTSAEELG 59
            RE+ ++  + H+NI+      T       F    LV E ++  +L  ++  +   E + 
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMS 167

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           +     ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+     S 
Sbjct: 168 Y-----LLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSF 218

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
             T +  T  Y APE+   M      D++S G +  E+++ K
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 64.5 bits (158), Expect = 2e-12
 Identities = 40/165 (24%), Positives = 81/165 (49%), Gaps = 18/165 (10%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI+++ E++H NIV+ Y          LV+E+++N  L   + +  +         +N
Sbjct: 51  IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELN 108

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           ++K         L++ H +    I+HRD+  +N+L++   +  + DFG+A+      + +
Sbjct: 109 LVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           +    T  Y AP++      Y+  +    D++S G +  E+I GK
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.5 bits (158), Expect = 2e-12
 Identities = 64/231 (27%), Positives = 95/231 (41%), Gaps = 60/231 (25%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDT----------SAE 56
           E  VL   RH  +    Y F TH      V EY   G L   L+ +            AE
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113

Query: 57  ELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK- 112
                        I  AL YLH  D    +V+RDI  +N++LD   + H+  +DFG+ K 
Sbjct: 114 -------------IVSALEYLHSRD----VVYRDIKLENLMLD--KDGHIKITDFGLCKE 154

Query: 113 FIQPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLS 168
            I   ++  T F GT  Y+APE+     Y   V    D +  GV+  E++ G+ P  F  
Sbjct: 155 GISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--F-- 205

Query: 169 NVSSSNPNILVNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
              + +   L   +L  + R P  LS + +    S++      L  +P+ R
Sbjct: 206 --YNQDHERLFELILMEEIRFPRTLSPEAK----SLLA---GLLKKDPKQR 247

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 30/178 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++  ++H N+V    F              LV EY+         +    
Sbjct: 75  DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL 134

Query: 55  AEELGWSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFG 109
            + +     + +IK   +    +L+Y+H      I HRDI  +N+LLD       + DFG
Sbjct: 135 KQTMP----MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187

Query: 110 IAKFIQPDSSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
            AK +     N   +  +  Y APEL      YT  +    D++S G V+A E+++G+
Sbjct: 188 SAKILIAGEPN-VSYICSRYYRAPELIFGATNYTTNI----DIWSTGCVMA-ELMQGQ 239

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI +L +++H N+V         R   LV+EY ++  L  +        E       +
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE-------H 102

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           ++K I      A+++ H       +HRD+  +N+L+       + DFG A+ +   S  +
Sbjct: 103 LVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
            +   T  Y +PEL      Y   V    DV++ G +  E++ G 
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 51/213 (23%)

Query: 8   EITVLTEIRHRN-IVK-FYGFCTHARHSFLVYEYLENGSL------SVILNNDTS----A 55
           E  VL  IR    +V   Y F T  +   L+ +Y+  G L                    
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166

Query: 56  EELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK 112
           E             I  AL +LH       I++RDI  +N+LLD     HV  +DFG++K
Sbjct: 167 E-------------IVLALEHLHKLG----IIYRDIKLENILLD--SNGHVVLTDFGLSK 207

Query: 113 -FIQPDSSNWTEFAGTYGYVAPEL------AYTMKVTAKCDVYSFGVLALEVIKGKHPRD 165
            F+  ++    +F GT  Y+AP++       +   V    D +S GVL  E++ G  P  
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP-- 261

Query: 166 FLSNVSSSNPNILVNEML--DPRLPP-LSVDIR 195
           F  +   ++   +   +L  +P  P  +S   +
Sbjct: 262 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 29/179 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVK-FYGFCTHARHSF------LVYEYLENGSLSVILNNDT 53
            +   L+ +  L  + H NIV+    F T            +V EY+ +       N   
Sbjct: 62  FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYR 121

Query: 54  SAEELGWSRRINVIKG----IAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDF 108
                       +IK     +  ++  LH   +  + HRDI   NVL++       + DF
Sbjct: 122 RQVAP----PPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 109 GIAKFIQPDSSNWTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
           G AK + P   N   +  +  Y APEL      YT  V    D++S G + A E++ G+
Sbjct: 177 GSAKKLSPSEPN-VAYICSRYYRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 63.3 bits (155), Expect = 3e-12
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E++H NIVK Y      +   LV+E+L+   L  +L  D     L       
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLE----SV 100

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
             K         ++Y H      ++HRD+  +N+L++ E E  ++DFG+A+        +
Sbjct: 101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           T    T  Y AP++      Y+  +    D++S G +  E++ G 
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 63.7 bits (156), Expect = 3e-12
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 45/174 (25%)

Query: 8   EITVLTEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSL------SVILNNDTS----AE 56
           E  +L+ + H  I++ +  F    +  F++ +Y+E G L      S    N  +    AE
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE 114

Query: 57  ELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKF 113
                        +  AL YLH  D    I++RD+  +N+LLD     H+  +DFG AK+
Sbjct: 115 -------------VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAKY 155

Query: 114 IQPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +      +T   GT  Y+APE+     Y   +    D +SFG+L  E++ G  P
Sbjct: 156 V--PDVTYT-LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 63.3 bits (155), Expect = 3e-12
 Identities = 37/167 (22%), Positives = 74/167 (44%), Gaps = 23/167 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI +L E++H+NIV+ +      +   LV+E+ +   L      D+   +L       
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD----PE 101

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
           ++K         L + H      ++HRD+  +N+L++   E  +++FG+A+        +
Sbjct: 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGKHP 163
           +    T  Y  P++      Y+  +    D++S G +  E+     P
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.4 bits (155), Expect = 4e-12
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 32/161 (19%)

Query: 70  IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTEFA 125
           I+ AL+YLH       I++RD+   NVLLD   E H+  +D+G+ K  ++P  +  T F 
Sbjct: 119 ISLALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FC 171

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP---RDFLSNVSSSNPNIL 178
           GT  Y+APE+     Y   V    D ++ GVL  E++ G+ P        N   +  + L
Sbjct: 172 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227

Query: 179 VNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
              +L    R+P  LSV       S+++     L+ +P+ R
Sbjct: 228 FQVILEKQIRIPRSLSVKAA----SVLK---SFLNKDPKER 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.4 bits (155), Expect = 5e-12
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 35/158 (22%)

Query: 70  IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTEFA 125
           IA AL YLH  +    IV+RD+  +N+LLD   + H+  +DFG+ K  I+ +S+  T F 
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST-FC 200

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           GT  Y+APE+     Y   V    D +  G +  E++ G  P  F     S N   + + 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP--F----YSRNTAEMYDN 250

Query: 182 ML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           +L    +L P ++   R     ++E     L  +   R
Sbjct: 251 ILNKPLQLKPNITNSAR----HLLE---GLLQKDRTKR 281

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 63.0 bits (154), Expect = 6e-12
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +REI++L E+ H NIV         R   LV+E++E   L  +L  D +   L      +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ----DS 119

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            IK   +     +++ H      I+HRD+  +N+L++ +    ++DFG+A+       ++
Sbjct: 120 QIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           T    T  Y AP++      Y+  V    D++S G +  E+I GK
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.1 bits (154), Expect = 6e-12
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 32/161 (19%)

Query: 70  IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTEFA 125
           I+ AL+YLH       I++RD+   NVLLD   E H+  +D+G+ K  ++P  +  T F 
Sbjct: 162 ISLALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FC 214

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHP---RDFLSNVSSSNPNIL 178
           GT  Y+APE+     Y   V    D ++ GVL  E++ G+ P        N   +  + L
Sbjct: 215 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

Query: 179 VNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
              +L    R+P  LSV       S+++     L+ +P+ R
Sbjct: 271 FQVILEKQIRIPRSLSVKAA----SVLK---SFLNKDPKER 304

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 60/218 (27%), Positives = 88/218 (40%), Gaps = 33/218 (15%)

Query: 8   EITVL-TEIRHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           E  VL     H  +   F  F T     F V EYL  G L   + +    +    SR   
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDL---SRATF 122

Query: 66  VIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNW 121
               I   L +LH       IV+RD+   N+LLD   + H+  +DFG+ K  +  D+   
Sbjct: 123 YAAEIILGLQFLHSKG----IVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTN 176

Query: 122 TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           T F GT  Y+APE+    K     D +SFGVL  E++ G+ P  F       +   L + 
Sbjct: 177 T-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--F----HGQDEEELFHS 229

Query: 182 ML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           +   +P  P  L  + +     ++          PE R
Sbjct: 230 IRMDNPFYPRWLEKEAK----DLLVK---LFVREPEKR 260

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.9 bits (150), Expect = 1e-11
 Identities = 53/308 (17%), Positives = 91/308 (29%), Gaps = 107/308 (34%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYG--------------FCTH---------ARHSFLV 36
           + +  + E+ +L  I  H N+V   G              FC            R+ F+ 
Sbjct: 68  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

Query: 37  Y-----------EYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP- 84
           Y           +Y+    + +    D+       +    V +     +           
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 85  --------------------------IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS 118
                                      +HRD++++N+LL  +    + DFG+A+ I  D 
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 119 SN-----------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDF 166
                        W          APE  +    T + DV+SFGVL  E+   G  P   
Sbjct: 248 DYVRKGDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 296

Query: 167 LSNVSSSNPNILVNEMLDPRL--------PPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
                   P + ++E    RL        P  +     ++   M     C    P  RP 
Sbjct: 297 --------PGVKIDEEFCRRLKEGTRMRAPDYTTP---EMYQTML---DCWHGEPSQRPT 342

Query: 219 MQTICQLL 226
              + + L
Sbjct: 343 FSELVEHL 350

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 61.8 bits (151), Expect = 2e-11
 Identities = 37/165 (22%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           +RE+++L +++H NIV  +      +   LV+EYL+   L   L  D     +     ++
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIIN----MH 100

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            +K         L+Y H      ++HRD+  +N+L++   E  ++DFG+A+     +  +
Sbjct: 101 NVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
                T  Y  P++      Y+ ++    D++  G +  E+  G+
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 37/178 (20%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHS--------FLVYEYLENGSLSVILNNDTSAEE 57
           LREI +L  ++H N+V     C              +LV+++ E+    ++ N       
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123

Query: 58  LGWSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIA-K 112
                  + IK +       L Y+H +    I+HRD+ + NVL+  +    ++DFG+A  
Sbjct: 124 -------SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 113 FIQPDSSNWTEFAG---TYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
           F    +S    +     T  Y  PEL      Y   +    D++  G ++A E+    
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 61.1 bits (149), Expect = 3e-11
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 25/166 (15%)

Query: 6   LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRIN 65
           LREI +L E+ H NI+       H  +  LV++++E   L VI+    ++  L      +
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PS 112

Query: 66  VIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW 121
            IK         L YLH      I+HRD+   N+LLD      ++DFG+AK     +  +
Sbjct: 113 HIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 122 TEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
           T    T  Y APEL      Y + V    D+++ G +LA E++   
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGV----DMWAVGCILA-ELLLRV 210

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 18/168 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCT--HARHSF----LVYEYLENGSLSVILNNDTS 54
             K   RE+ +L  +RH N++      T       F    LV  ++    L  ++     
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----K 121

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
            E+LG  R   ++  +   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+  
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178

Query: 115 QPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
             +    T +  T  Y APE+    M+ T   D++S G +  E+I GK
Sbjct: 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 39/223 (17%)

Query: 6   LREITVLTEI-RHRNIVK-FYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRR 63
           + E  VL    +   + +    F T  R  + V EY+  G L   +      +E      
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKE---PHA 444

Query: 64  INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSN 120
           +     IA  L +L       I++RD+   NV+LD   E H+  +DFG+ K  I    + 
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTT 499

Query: 121 WTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            T F GT  Y+APE+     Y   V    D ++FGVL  E++ G+ P  F       + +
Sbjct: 500 KT-FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--FEGE----DED 548

Query: 177 ILVNEML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
            L   ++  +   P  +S +      +I +     +  +P  R
Sbjct: 549 ELFQSIMEHNVAYPKSMSKEAV----AICK-GL--MTKHPGKR 584

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 36/163 (22%), Positives = 71/163 (43%), Gaps = 18/163 (11%)

Query: 6   LREITVLTEIRHRNIVKFYGFCT--HARHSF----LVYEYLENGSLSVILNNDTSAEELG 59
            RE+ +L  ++H N++      T   +   F    LV   +     +++     + + + 
Sbjct: 76  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
           +     +I  I   L Y+H      I+HRD+   N+ ++ + E  + DFG+A+     + 
Sbjct: 136 F-----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTAD 184

Query: 120 NWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
             T +  T  Y APE+    M      D++S G +  E++ G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 60.3 bits (147), Expect = 5e-11
 Identities = 48/158 (30%), Positives = 69/158 (43%), Gaps = 35/158 (22%)

Query: 70  IAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTEFA 125
           I  AL +LH       I++RD+   NVLLD  +E H   +DFG+ K  I    +  T F 
Sbjct: 133 IISALMFLHDKG----IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTAT-FC 185

Query: 126 GTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
           GT  Y+APE+     Y   V    D ++ GVL  E++ G  P  F     + N + L   
Sbjct: 186 GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP--F----EAENEDDLFEA 235

Query: 182 ML--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           +L  +   P  L  D       I++     +  NP  R
Sbjct: 236 ILNDEVVYPTWLHEDAT----GILKS---FMTKNPTMR 266

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 60.0 bits (146), Expect = 6e-11
 Identities = 40/168 (23%), Positives = 76/168 (45%), Gaps = 19/168 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
             K   RE+ +L  ++H N++      T A         +LV  +++   L  I+    S
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS 124

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
            E++ +     ++  +   L Y+H      +VHRD+   N+ ++ + E  + DFG+A+  
Sbjct: 125 EEKIQY-----LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176

Query: 115 QPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
             +    T +  T  Y APE+  + M      D++S G +  E++ GK
Sbjct: 177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 33/157 (21%)

Query: 70  IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAK-FIQPDSSNWTEFAG 126
           IA  L +L       I++RD+   NV+LD   E H+  +DFG+ K  I    +  T F G
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCG 183

Query: 127 TYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM 182
           T  Y+APE+     Y   V    D ++FGVL  E++ G+ P  F       + + L   +
Sbjct: 184 TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--FEGE----DEDELFQSI 233

Query: 183 L--DPRLPP-LSVDIRGKVISIMEVAFLCLDNNPESR 216
           +  +   P  +S +      +I +     +  +P  R
Sbjct: 234 MEHNVAYPKSMSKEAV----AICKG---LMTKHPGKR 263

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 42/167 (25%), Positives = 65/167 (38%), Gaps = 13/167 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYG-FCTHARHSF----LVYEYLENGSLSVILNNDTSA 55
             K  LREI +L    H NI+     F      +     LV E +    L+ +++     
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQR 128

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
             +        +  I   L  LH      +VHRD+   N+LL    +  + DF +A+   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 116 PDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK 161
            D +N T +     Y APEL       T   D++S G +  E+   K
Sbjct: 186 AD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 27/170 (15%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHSF----LVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   RH NI+                  +V + +E     ++     S + + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 133 -----FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 121 ---WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLALEVIKGK 161
               TE+  T  Y APE+      YT  +    D++S G +LA E++  +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.5 bits (137), Expect = 8e-10
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 35/179 (19%)

Query: 6   LREITVLTEIRHRNIVKFY----------GFCTHARHSF----LVYEYLENGSLSVILNN 51
           LREI ++  + H NIVK +               +        +V EY+E    +V+   
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115

Query: 52  DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGI 110
               E          +  +   L Y+H      ++HRD+   N+ ++ E     + DFG+
Sbjct: 116 PLLEEHARL-----FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 111 AKFIQPDSSN---WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
           A+ + P  S+    +E   T  Y +P L      YT  +    D+++ G +  E++ GK
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.8 bits (130), Expect = 7e-09
 Identities = 41/176 (23%), Positives = 74/176 (42%), Gaps = 32/176 (18%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHSF----LVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L   +H NI+  +      +  +F    ++ E ++     VI     S + + +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 I     A+  LH      ++HRD+   N+L++   +  V DFG+A+ I   +++
Sbjct: 117 -----FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 121 ----------WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFGVLALEVIKGK 161
                       EF  T  Y APE+      Y+  +    DV+S G +  E+   +
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 8e-09
 Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 36/182 (19%)

Query: 6   LREITVLTEIR-----------HRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILN 50
             EI +L  +              +I+K      H      H  +V+E L    L++I  
Sbjct: 63  EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK 122

Query: 51  NDTSAEELGWSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-- 104
            +      G    +  +K I+      L Y+H  C   I+H DI  +NVL+++       
Sbjct: 123 YEHR----GIP--LIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174

Query: 105 ----VSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG 160
               ++D G A +      ++T    T  Y +PE+          D++S   L  E+I G
Sbjct: 175 IQIKIADLGNACW---YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

Query: 161 KH 162
             
Sbjct: 232 DF 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.3 bits (129), Expect = 1e-08
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 30/172 (17%)

Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ +L  +    H N+V+    C  +R        LV+E+++   L   L+       
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-- 115

Query: 58  LGWSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                    IK +       L +LH +CI   VHRD+  +N+L+       ++DFG+A+ 
Sbjct: 116 ---GLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARI 169

Query: 114 IQPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGK 161
                   T    T  Y APE+     Y   V    D++S G +  E+ + K
Sbjct: 170 YSYQ-MALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 37/165 (22%), Positives = 62/165 (37%), Gaps = 42/165 (25%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFC----THARHSFLVYEYLENGSL-SVILNNDTS 54
           D  +  RE+ +     +  +IV+            +   +V E L+ G L S I +    
Sbjct: 53  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112

Query: 55  AEELGWSRRI--NVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAH---VSDF 108
           A    ++ R    ++K I  A+ YLH  +    I HRD+  +N+L   +       ++DF
Sbjct: 113 A----FTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 109 GIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL 153
           G AK               Y                CD++S GV+
Sbjct: 165 GFAKETT---------GEKYD-------------KSCDMWSLGVI 187

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 42/206 (20%), Positives = 71/206 (34%), Gaps = 54/206 (26%)

Query: 1   DKKEFLREITVLTEIRHRNIV--KFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           D +   RE+ ++  + H NI+    Y + T            ++  L    N   +  + 
Sbjct: 43  DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKS 102

Query: 59  GWSRRIN-----------------VIKGIAH-------------------ALSYLHHDCI 82
                                   V+K                       A+ ++H    
Sbjct: 103 VIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159

Query: 83  PPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPEL-----A 136
             I HRDI  +N+L++ +     + DFG AK + P   +   +  +  Y APEL      
Sbjct: 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATE 218

Query: 137 YTMKVTAKCDVYSFG-VLALEVIKGK 161
           YT  +    D++S G V   E+I GK
Sbjct: 219 YTPSI----DLWSIGCVFG-ELILGK 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.1 bits (123), Expect = 6e-08
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 30/172 (17%)

Query: 6   LREITVLTEIR---HRNIVKFYGFCTHARHS-----FLVYEYLENGSLSVILNNDTSAEE 57
           +RE+ VL  +    H N+V+ +  CT +R        LV+E+++   L+  L+      E
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPE 114

Query: 58  LGWSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
            G       IK +       L +LH   +   VHRD+  +N+L+    +  ++DFG+A+ 
Sbjct: 115 PGVP--TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARI 169

Query: 114 IQPDSSNWTEFAGTYGYVAPEL----AYTMKVTAKCDVYSFGVLALEVIKGK 161
                   T    T  Y APE+    +Y   V    D++S G +  E+ + K
Sbjct: 170 YSFQ-MALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 37/166 (22%), Positives = 63/166 (37%), Gaps = 20/166 (12%)

Query: 6   LREITVLTEIRHR------NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
             EI +L  +R +      N++      T   H  + +E L      +I  N      L 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAKFIQPD 117
             R+      I   L  LH      I+H D+  +N+LL  +  +   V DFG + +    
Sbjct: 201 LVRKF--AHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 118 SSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
              +  + F     Y APE+    +     D++S G +  E++ G 
Sbjct: 256 VYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.9 bits (109), Expect = 4e-06
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 30/172 (17%)

Query: 6   LREITVLTEIRHR------NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
             E+ +L  +          IV          H  LV+E L      ++ N +      G
Sbjct: 98  QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN----FRG 153

Query: 60  WSRRINVIKGIAH----ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH--VSDFGIAKF 113
            S  +N+ +  A     AL +L    +  I+H D+  +N+LL     +   + DFG +  
Sbjct: 154 VS--LNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210

Query: 114 IQPDSSNWTEFAGTY----GYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK 161
           +        +    Y     Y +PE+   M      D++S G + +E+  G+
Sbjct: 211 L-------GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 25/135 (18%), Positives = 51/135 (37%), Gaps = 14/135 (10%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHSF----LVYEYLENGSLSVILNNDTSAEELGW 60
           LREI +L  + H ++VK            F    +V E  ++     +     +   L  
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR---TPVYLTE 155

Query: 61  SRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
                ++  +   + Y+H       I+HRD+   N L++ +    V DFG+A+ +    +
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 120 NWTEFAGTYGYVAPE 134
             ++   +       
Sbjct: 212 GNSQLPISPREDDMN 226

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 39/219 (17%), Positives = 70/219 (31%), Gaps = 68/219 (31%)

Query: 6   LREITVLTEIRHRNIV-KFYGFCTHARHSF-----------LVYEYLENGSLSVILNNDT 53
           L EI +L  +R+ +               F           +V+E L +  L  I+ ++ 
Sbjct: 81  LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNY 140

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE------------- 100
               L   ++I  I+ +   L YLH  C   I+H DI  +N+LL +              
Sbjct: 141 QGLPLPCVKKI--IQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATE 196

Query: 101 ------------------------------------YEAHVSDFGIAKFIQPDSSNWTEF 124
                                                +  ++D G A +      ++TE 
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTED 253

Query: 125 AGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
             T  Y + E+          D++S   +A E+  G + 
Sbjct: 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 41/191 (21%), Positives = 70/191 (36%), Gaps = 45/191 (23%)

Query: 6   LREITVLTEIRHRNIVKFYG-FCTHARHSF----LVYEYLENGSLSVILNNDTSAEELGW 60
           LREIT+L  ++   I++ Y          F    +V E  ++  L  +     +   L  
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK---TPIFLTE 128

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                ++  +    +++H      I+HRD+   N LL+ +    V DFG+A+ I  +   
Sbjct: 129 EHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 121 ----------------------WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-V 152
                                  T    T  Y APEL      YT  +    D++S G +
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCI 241

Query: 153 LALEVIKGKHP 163
            A E++     
Sbjct: 242 FA-ELLNMLQS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 40.4 bits (95), Expect = 3e-04
 Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 43/186 (23%)

Query: 6   LREITVLTEIR-HRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
            REI +LTE+  H NIV         + R  +LV++Y+E    +VI  N        +  
Sbjct: 56  FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-- 113

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-- 120
              V+  +   + YLH      ++HRD+   N+LL+ E    V+DFG+++          
Sbjct: 114 ---VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 121 -------------------WTEFAGTYGYVAPEL-----AYTMKVTAKCDVYSFG-VLAL 155
                               T++  T  Y APE+      YT  +    D++S G +L  
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG- 222

Query: 156 EVIKGK 161
           E++ GK
Sbjct: 223 EILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 39.3 bits (92), Expect = 5e-04
 Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 24/122 (19%)

Query: 2   KKEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENG-SLSVILNNDTSAEELG 59
           K   + +   L       I    GF  H  ++ FLV   L  G SL   L+         
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVS------- 151

Query: 60  WSRRINVIKGIA-------HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGI 110
             + +   + +         AL +LH +     VH +++++N+ +D E ++ V  + +G 
Sbjct: 152 -PKHVLSERSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGF 207

Query: 111 AK 112
           A 
Sbjct: 208 AF 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.1 bits (90), Expect = 6e-04
 Identities = 15/97 (15%), Positives = 27/97 (27%), Gaps = 6/97 (6%)

Query: 34  FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSK 93
           F+V E+   G            +    +   +++  +  +L+           HRD+   
Sbjct: 138 FIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWG 191

Query: 94  NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGY 130
           NVLL       +      K     S         Y  
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	228
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.44
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.91
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.5
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.13
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.94
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.09
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.95
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.95
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.44
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.36
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.12
3mes_A	424	Choline kinase; malaria, structural genomics, stru	89.74
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.19

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.9e-56  Score=341.76  Aligned_cols=209  Identities=23%  Similarity=0.396  Sum_probs=180.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++|||||+++++|.+++.+|+|||||+||+|.+++...    .+++..+..++.|++.||+|||++ 
T Consensus       115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~-  189 (346)
T 4fih_A          115 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ-  189 (346)
T ss_dssp             GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            467889999999999999999999999999999999999999999999753    389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||++..............||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus       190 --~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  267 (346)
T 4fih_A          190 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  267 (346)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence              999999999999999999999999999988766555566788999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +||....      .......+..... .........+.++.+||.+||..||++|||++|+++
T Consensus       268 ~PF~~~~------~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          268 PPYFNEP------PLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CTTTTSC------HHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCcC------HHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9986432      2233333322222 222233567788999999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-56  Score=345.60  Aligned_cols=210  Identities=25%  Similarity=0.402  Sum_probs=180.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++|||||+++++|.+++.+|+|||||+||+|.+++..... ..+++.+++.++.|++.||.|||++ 
T Consensus        67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~-  144 (350)
T 4b9d_A           67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR-  144 (350)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            46789999999999999999999999999999999999999999999975432 2378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||+++.............||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus       145 --~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~  222 (350)
T 4b9d_A          145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK  222 (350)
T ss_dssp             --TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             --CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence              999999999999999999999999999987543222234567999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||...      +.......+.....++..   ..++.++.+||.+||++||.+|||++++++
T Consensus       223 ~PF~~~------~~~~~~~~i~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          223 HAFEAG------SMKNLVLKIISGSFPPVS---LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CSCCCS------SHHHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCc------CHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            998643      334455555555544332   346678999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-55  Score=333.97  Aligned_cols=215  Identities=25%  Similarity=0.403  Sum_probs=170.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++|.+|++++++++|||||++++++.+ +.+|+||||+++|+|.+++.....  .+++.+++.++.|++.||+|||+. 
T Consensus        76 ~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~-  151 (307)
T 3omv_A           76 FQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK-  151 (307)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999998865 568999999999999999975432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccC---CcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~  156 (228)
                        +|+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+.   .++.++|||||||++||
T Consensus       152 --~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~E  229 (307)
T 3omv_A          152 --NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE  229 (307)
T ss_dssp             --TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHH
T ss_pred             --CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHH
Confidence              999999999999999999999999999986543222  23456899999999998643   58899999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||.....     .......+.... .+........++.++.+++.+||+.||.+|||++++++.|+
T Consensus       230 lltg~~Pf~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          230 LMTGELPYSHINN-----RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             HHHSSCTTTTCCC-----HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             HHHCCCCCCCCCh-----HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            9999999864321     111111221111 12222223456778999999999999999999999998775

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-55  Score=336.31  Aligned_cols=214  Identities=29%  Similarity=0.496  Sum_probs=181.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----------SAEELGWSRRINVIKGIA   71 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~~l~   71 (228)
                      +++|.+|++++++++|||||+++++|.+++..|+||||+++|+|.+++....          ....+++.+++.++.|++
T Consensus        59 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia  138 (299)
T 4asz_A           59 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA  138 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999999999999999997542          234589999999999999


Q ss_pred             HHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhh
Q 040501           72 HALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        72 ~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                      .|+.|||+.   +|+||||||+|||++.++.+||+|||+++........  .....||+.|+|||++.+..++.++||||
T Consensus       139 ~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS  215 (299)
T 4asz_A          139 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS  215 (299)
T ss_dssp             HHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHH
Confidence            999999999   9999999999999999999999999999865433222  12245889999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          150 FGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       150 lG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |||++|||+| |+.||....      ..+....+..+..+..+   ..++.++.+++.+||+.||++|||++++.+.|+
T Consensus       216 ~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          216 LGVVLWEIFTYGKQPWYQLS------NNEVIECITQGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHHHHHHHHTTTCCTTTTSC------HHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            9999999998 899986432      23344444444433322   246678999999999999999999999999886

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.2e-55  Score=343.15  Aligned_cols=209  Identities=23%  Similarity=0.395  Sum_probs=180.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||.||+|.+++....    +++.++..++.|++.||+|||++ 
T Consensus       192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~-  266 (423)
T 4fie_A          192 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQ-  266 (423)
T ss_dssp             GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHC-
Confidence            5678999999999999999999999999999999999999999999997543    89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||++..............||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus       267 --~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  344 (423)
T 4fie_A          267 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  344 (423)
T ss_dssp             --TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence              999999999999999999999999999988766555566778999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||....      .......+.....+ .......++.++.+||.+||..||.+|||++|+++
T Consensus       345 ~PF~~~~------~~~~~~~i~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          345 PPYFNEP------PLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTTTSC------HHHHHHHHHHSCCC-CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCcC------HHHHHHHHHcCCCC-CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9986432      22333333222211 11223456778999999999999999999999976

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=334.33  Aligned_cols=214  Identities=27%  Similarity=0.463  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC------------CCCCCHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS------------AEELGWSRRINVIKG   69 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~   69 (228)
                      +++|.+|++++++++|||||+++++|.+....|+||||+++|+|.+++.....            ...+++.+++.++.|
T Consensus        87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  166 (329)
T 4aoj_A           87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ  166 (329)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence            56799999999999999999999999999999999999999999999876432            235899999999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhh
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      ++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........  .....||+.|+|||++.+..++.++||
T Consensus       167 ia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDv  243 (329)
T 4aoj_A          167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV  243 (329)
T ss_dssp             HHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHH
T ss_pred             HHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccc
Confidence            99999999999   9999999999999999999999999999865433222  234578999999999999999999999


Q ss_pred             hhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |||||++|||++ |+.||....      .......+.....+..+   ..++.++.+++.+||+.||++|||+++|++.|
T Consensus       244 wS~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L  314 (329)
T 4aoj_A          244 WSFGVVLWEIFTYGKQPWYQLS------NTEAIDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARL  314 (329)
T ss_dssp             HHHHHHHHHHHTTSCCTTCSSC------HHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred             cchHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            999999999998 899986432      22333333333322222   24667899999999999999999999999988


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       315 ~  315 (329)
T 4aoj_A          315 Q  315 (329)
T ss_dssp             H
T ss_pred             H
Confidence            6

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-54  Score=332.19  Aligned_cols=214  Identities=22%  Similarity=0.361  Sum_probs=181.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +++|.+|+.++++++|||||+++++|.++...++||||+++|+|.+++.....             ...+++..++.++.
T Consensus        73 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  152 (308)
T 4gt4_A           73 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA  152 (308)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHH
Confidence            57899999999999999999999999999999999999999999999965321             23488999999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.|++|||+.   +|+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++|
T Consensus       153 qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksD  229 (308)
T 4gt4_A          153 QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD  229 (308)
T ss_dssp             HHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccch
Confidence            999999999999   999999999999999999999999999986543222  233457899999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      ||||||++|||++ |..||....      .......+.....++.+   ..++..+.+++.+||+.||.+|||+++|++.
T Consensus       230 VwSfGvvl~El~t~g~~Pf~~~~------~~~~~~~i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          230 IWSYGVVLWEVFSYGLQPYCGYS------NQDVVEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHHHHHHTTTCCTTTTCC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999998 899986432      23344444444433332   2566789999999999999999999999999


Q ss_pred             hh
Q 040501          226 LC  227 (228)
Q Consensus       226 l~  227 (228)
                      |+
T Consensus       301 L~  302 (308)
T 4gt4_A          301 LR  302 (308)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-54  Score=327.04  Aligned_cols=207  Identities=23%  Similarity=0.370  Sum_probs=170.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +++|.+|++++++++|||||+++++|..    +..+|+||||++||+|.+++....   .+++..+..++.|++.||+||
T Consensus        69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~yl  145 (290)
T 3fpq_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFL  145 (290)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999865    356899999999999999997643   389999999999999999999


Q ss_pred             hhCCCCC--eeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           78 HHDCIPP--IVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        78 h~~~~~~--i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      |++   |  |+||||||+|||++. +|.+||+|||+++...  ........||+.|+|||++.+ .++.++|||||||++
T Consensus       146 H~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil  219 (290)
T 3fpq_A          146 HTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM  219 (290)
T ss_dssp             HTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred             HHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence            999   8  999999999999974 7999999999997543  233456789999999998865 699999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|..||...     .........+.....+.  ......++++.++|.+||+.||.+|||++++++
T Consensus       220 yelltg~~Pf~~~-----~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          220 LEMATSEYPYSEC-----QNAAQIYRRVTSGVKPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHSSCTTTTC-----SSHHHHHHHHTTTCCCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCCCCCCC-----CcHHHHHHHHHcCCCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999999998532     12223333333332221  112345567899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7e-55  Score=331.58  Aligned_cols=206  Identities=22%  Similarity=0.334  Sum_probs=177.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||++++++|.+++.+|+||||+.||+|.+++....   .+++..+..++.|++.||+|||++ 
T Consensus        76 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~-  151 (311)
T 4aw0_A           76 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK-  151 (311)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3578999999999999999999999999999999999999999999997654   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+|||++.+|.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       152 --~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~  229 (311)
T 4aw0_A          152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA  229 (311)
T ss_dssp             --TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             --CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence              999999999999999999999999999987654332  2445789999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |..||...      +.......+........    ...+.++.+||.+||++||.+|||++|++
T Consensus       230 G~~PF~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          230 GLPPFRAG------NEGLIFAKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             SSCSSCCS------SHHHHHHHHHHTCCCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCCCCCCC------CHHHHHHHHHcCCCCCC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            99998532      33344445544443221    24566789999999999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-54  Score=333.09  Aligned_cols=209  Identities=24%  Similarity=0.305  Sum_probs=172.7

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      .+|+.+++.++|||||+++++|.++..+|+||||++|++|.+++....   .+++..+..++.|++.||+|||++   ||
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~I  171 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RI  171 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TE
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            579999999999999999999999999999999999999999997654   389999999999999999999999   99


Q ss_pred             eecCCCCCceEEcCCC-ceEEeecccccccCCCCCC-----ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           86 VHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSN-----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        86 ~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      +||||||+|||++.+| .+||+|||++.........     .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       172 iHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt  251 (336)
T 4g3f_A          172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN  251 (336)
T ss_dssp             ECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             eecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence            9999999999999987 6999999999876543221     223579999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+.....+ .......++..+.++|.+||++||.+|||+.|+++.|.
T Consensus       252 G~~Pf~~~~~------~~~~~~i~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          252 GCHPWTQYFR------GPLCLKIASEPPP-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             SSCSSTTTCC------SCCHHHHHHSCCG-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCCCCCCCH------HHHHHHHHcCCCC-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            9999864322      2222333222221 11122356778999999999999999999999988764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-54  Score=329.92  Aligned_cols=201  Identities=25%  Similarity=0.318  Sum_probs=166.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .++.+|++++++++||||++++++|.+++.+|+||||++||+|.+++.....   +++..+..++.|++.||+|||++  
T Consensus        71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~--  145 (304)
T 3ubd_A           71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSL--  145 (304)
T ss_dssp             C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4678999999999999999999999999999999999999999999986543   89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       ||+||||||+|||++.+|.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       146 -~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~  224 (304)
T 3ubd_A          146 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL  224 (304)
T ss_dssp             -TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence             9999999999999999999999999999876554444556789999999999999999999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      ||...      +.......+.....+..    ...+.++.++|.+||++||++|||+
T Consensus       225 PF~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          225 PFQGK------DRKETMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             SSCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CCCCc------CHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence            98643      23344444444433221    2456788999999999999999995

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-53  Score=320.56  Aligned_cols=205  Identities=23%  Similarity=0.334  Sum_probs=164.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++++.+|++++++++||||+++++++.+.+.+|+||||+ +|+|.+++....   .+++..+..++.|++.||+|||++ 
T Consensus        57 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~-  131 (275)
T 3hyh_A           57 QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH-  131 (275)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            457899999999999999999999999999999999999 568888887654   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.+||+|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus       132 --~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg  208 (275)
T 3hyh_A          132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR  208 (275)
T ss_dssp             --TCCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             --CcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence              9999999999999999999999999999875533 23345689999999999998876 5799999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.||...      +.......+....... +   ...+.++.++|.+||+.||.+|||++|+++
T Consensus       209 ~~PF~~~------~~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          209 RLPFDDE------SIPVLFKNISNGVYTL-P---KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             SCSSCCS------SHHHHHHHHHHTCCCC-C---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCC------CHHHHHHHHHcCCCCC-C---CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            9998632      2333334443333321 1   245667899999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-52  Score=325.79  Aligned_cols=215  Identities=23%  Similarity=0.391  Sum_probs=175.3

Q ss_pred             hHHHHHHHHHHhccCC-Cccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHH
Q 040501            2 KKEFLREITVLTEIRH-RNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINV   66 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~   66 (228)
                      +++|.+|++++++++| ||||+++++|.. +..+|+|||||++|+|.++++....             ...+++..++.+
T Consensus       111 ~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  190 (353)
T 4ase_A          111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY  190 (353)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence            4578999999999965 999999999865 4578999999999999999975321             234889999999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAK  144 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~  144 (228)
                      +.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+++........  .....||+.|+|||++.+..++.+
T Consensus       191 ~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k  267 (353)
T 4ase_A          191 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ  267 (353)
T ss_dssp             HHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc
Confidence            99999999999999   9999999999999999999999999999876544332  233568899999999999999999


Q ss_pred             hhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          145 CDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       145 ~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      +|||||||++|||++ |..||.....     .......+..+..+..+   ..++.++.++|.+||+.||.+|||+++++
T Consensus       268 sDVwS~Gv~l~El~t~G~~Pf~~~~~-----~~~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          268 SDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             HHHHHHHHHHHHHTTTSCCSSTTCCC-----SHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccEeehHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence            999999999999998 9999864321     11122222222222211   24566899999999999999999999999


Q ss_pred             HHhh
Q 040501          224 QLLC  227 (228)
Q Consensus       224 ~~l~  227 (228)
                      +.|+
T Consensus       340 ~~L~  343 (353)
T 4ase_A          340 EHLG  343 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.7e-52  Score=315.96  Aligned_cols=209  Identities=21%  Similarity=0.369  Sum_probs=163.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC------------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR------------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKG   69 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~   69 (228)
                      ++++.+|++++++++|||||+++++|.+.+            .+|+|||||.+++|.+++.............++.++.|
T Consensus        47 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~q  126 (299)
T 4g31_A           47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ  126 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHH
Confidence            467899999999999999999999987544            37999999999999999987665555677788999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC------------ceecccccceeCCcccc
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN------------WTEFAGTYGYVAPELAY  137 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~y~aPE~~~  137 (228)
                      ++.||+|||++   ||+||||||+|||++.+|.+||+|||+++........            .....||+.|+|||++.
T Consensus       127 i~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  203 (299)
T 4g31_A          127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH  203 (299)
T ss_dssp             HHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred             HHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence            99999999999   9999999999999999999999999999876543221            22357999999999999


Q ss_pred             cCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          138 TMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       138 ~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      +..++.++|||||||++|+|++   ||....     +.............+   ......++...++|.+||++||.+||
T Consensus       204 ~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rp  272 (299)
T 4g31_A          204 GNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERP  272 (299)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCc
Confidence            9999999999999999999995   654211     111222333333332   22344455678899999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.++++
T Consensus       273 s~~eil~  279 (299)
T 4g31_A          273 EAINIIE  279 (299)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.8e-50  Score=305.77  Aligned_cols=218  Identities=23%  Similarity=0.308  Sum_probs=165.4

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..|+..+.+++||||+++++++.+..    .+|+||||+++|+|.++++...    +++..+..++.|++.||+|||+.+
T Consensus        45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~  120 (303)
T 3hmm_A           45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI  120 (303)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred             HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhh
Confidence            34666667889999999999997653    5799999999999999997643    889999999999999999999752


Q ss_pred             -----CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC------Ccccchh
Q 040501           82 -----IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM------KVTAKCD  146 (228)
Q Consensus        82 -----~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~D  146 (228)
                           ..+|+||||||+|||++.++.+||+|||+++........    .....||+.|+|||++.+.      .++.++|
T Consensus       121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D  200 (303)
T 3hmm_A          121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD  200 (303)
T ss_dssp             CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred             hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence                 238999999999999999999999999999876543322    2235799999999998764      3678999


Q ss_pred             hhhHHHHHHHHHhCCCCccccccccC---------CCchhhhhhhcCCCC-CCCchh--hhhhHHHHHHHHHHhhccCCC
Q 040501          147 VYSFGVLALEVIKGKHPRDFLSNVSS---------SNPNILVNEMLDPRL-PPLSVD--IRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~li~~~l~~~p~  214 (228)
                      ||||||++|||++|.+||........         ............... +..+..  ....+..+.+++.+||+.||.
T Consensus       201 VwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~  280 (303)
T 3hmm_A          201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA  280 (303)
T ss_dssp             HHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred             hhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence            99999999999999888754322111         011111222222222 122211  234566789999999999999


Q ss_pred             CCCCHHHHHHHhh
Q 040501          215 SRPNMQTICQLLC  227 (228)
Q Consensus       215 ~Rpt~~~il~~l~  227 (228)
                      +|||+.++++.|+
T Consensus       281 ~RPt~~ei~~~L~  293 (303)
T 3hmm_A          281 ARLTALRIKKTLS  293 (303)
T ss_dssp             GSCCHHHHHHHHH
T ss_pred             HCcCHHHHHHHHH
Confidence            9999999999886

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-49  Score=322.82  Aligned_cols=211  Identities=19%  Similarity=0.321  Sum_probs=181.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++|+.++||||++++++|.+...+|+||||+.||+|.+++....  ..+++..+..++.||+.||.|||++ 
T Consensus       198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~-  274 (573)
T 3uto_A          198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN-  274 (573)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678899999999999999999999999999999999999999999986533  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC--CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLE--YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+||+++.+  +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       275 --~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~  351 (573)
T 3uto_A          275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS  351 (573)
T ss_dssp             --TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             --CeeeccCChhhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence              99999999999999854  89999999999876533 33455689999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||...      +.......+...............+.++.+||.+||+.||.+|||+.|+++
T Consensus       352 G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          352 GLSPFGGE------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCCSSCCS------SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCc------CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99998632      334455555555544444445567788999999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-49  Score=309.73  Aligned_cols=216  Identities=21%  Similarity=0.322  Sum_probs=165.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|+++|+.++||||+++++++..      ...+|+||||+. |+|.+++....   .+++..+..++.|++.||.
T Consensus        97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~  172 (398)
T 4b99_A           97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLK  172 (398)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999998753      367899999996 57888886543   3899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC----CCceecccccceeCCcccccCC-cccchhhhhH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS----SNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSF  150 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  150 (228)
                      |||+.   ||+||||||+|||++.+|.+||+|||++.......    .......||+.|+|||++.+.. ++.++||||+
T Consensus       173 ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl  249 (398)
T 4b99_A          173 YMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV  249 (398)
T ss_dssp             HHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred             HHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence            99999   99999999999999999999999999998654321    2234578999999999988764 6889999999


Q ss_pred             HHHHHHHHhCCCCccccccccCCCc---------------------hhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhh
Q 040501          151 GVLALEVIKGKHPRDFLSNVSSSNP---------------------NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCL  209 (228)
Q Consensus       151 G~~l~~~~~g~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  209 (228)
                      ||++|+|++|.+||...+.......                     ......................+.++.+||.+||
T Consensus       250 G~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL  329 (398)
T 4b99_A          250 GCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRML  329 (398)
T ss_dssp             HHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHC
Confidence            9999999999999964322110000                     0000000000000111112234667899999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 040501          210 DNNPESRPNMQTICQ  224 (228)
Q Consensus       210 ~~~p~~Rpt~~~il~  224 (228)
                      ..||.+|||++|+++
T Consensus       330 ~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          330 RFEPSARISAAAALR  344 (398)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhHCcCHHHHhc
Confidence            999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-48  Score=302.96  Aligned_cols=213  Identities=24%  Similarity=0.279  Sum_probs=163.7

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .++.+|+++++.+ +||||++++++|.+.+.+|+||||+++++|.+++.      .+++.++..++.|++.||+|||+. 
T Consensus        64 ~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~-  136 (361)
T 4f9c_A           64 IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF-  136 (361)
T ss_dssp             HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999998 69999999999999999999999999999999984      288999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCC----------------------------CceecccccceeC
Q 040501           82 IPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSS----------------------------NWTEFAGTYGYVA  132 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~----------------------------~~~~~~~~~~y~a  132 (228)
                        ||+||||||+|||++.+ +.+||+|||+++.......                            ......||+.|+|
T Consensus       137 --gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A  214 (361)
T 4f9c_A          137 --GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRA  214 (361)
T ss_dssp             --TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCC
T ss_pred             --CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccC
Confidence              99999999999999877 8999999999975543211                            1223469999999


Q ss_pred             CcccccC-CcccchhhhhHHHHHHHHHhCCCCcccccccc---------------------------------CCCchhh
Q 040501          133 PELAYTM-KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS---------------------------------SSNPNIL  178 (228)
Q Consensus       133 PE~~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~---------------------------------~~~~~~~  178 (228)
                      ||++.+. .++.++||||+||++|+|++|+.||.......                                 ..+....
T Consensus       215 PE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  294 (361)
T 4f9c_A          215 PEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKL  294 (361)
T ss_dssp             HHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHH
T ss_pred             HHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHH
Confidence            9998876 48899999999999999999999984321100                                 0000000


Q ss_pred             hhhhc--CCCCCC----------CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          179 VNEML--DPRLPP----------LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       179 ~~~~~--~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .....  ....+.          ....+...+.+..+||++||..||++|||++|+++
T Consensus       295 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          295 CERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000  000000          00112345567889999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.8e-47  Score=310.59  Aligned_cols=201  Identities=17%  Similarity=0.195  Sum_probs=166.0

Q ss_pred             HHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 040501            8 EITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVH   87 (228)
Q Consensus         8 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h   87 (228)
                      ++++++.++||||++++++|.+...+|+||||+.||+|.+++.....   +++..+..++.||+.||.|||+.   ||+|
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~---gIiH  315 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNR---FVVY  315 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTT---TEEC
T ss_pred             HHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            46677778999999999999999999999999999999999986543   89999999999999999999999   9999


Q ss_pred             cCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCCCCccc
Q 040501           88 RDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKHPRDF  166 (228)
Q Consensus        88 ~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~~  166 (228)
                      |||||+|||++.+|.+||+|||++.......  ..+.+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||..
T Consensus       316 RDLKPeNILld~~G~vKL~DFGlA~~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~  393 (689)
T 3v5w_A          316 RDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ  393 (689)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred             cCCchHHeEEeCCCCEEecccceeeecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999998765432  344689999999999864 5799999999999999999999999964


Q ss_pred             cccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHH
Q 040501          167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTIC  223 (228)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il  223 (228)
                      ....   +.......+.......    ....+.++.+||.+||..||.+|++     +++++
T Consensus       394 ~~~~---~~~~i~~~i~~~~~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          394 HKTK---DKHEIDRMTLTMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             GGCC---CHHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             CChH---HHHHHHHhhcCCCCCC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            3221   1222223332222211    1245667899999999999999998     56664

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.7e-46  Score=284.13  Aligned_cols=209  Identities=26%  Similarity=0.423  Sum_probs=176.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....    ++...+..++.|++.||.|||+. 
T Consensus        61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~-  135 (297)
T 3fxz_A           61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN-  135 (297)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4568899999999999999999999999999999999999999999997643    88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       136 --~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  213 (297)
T 3fxz_A          136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE  213 (297)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999987765555555678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+.....+.. ......+..+.++|.+||+.||.+|||++++++
T Consensus       214 ~pf~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          214 PPYLNENP------LRALYLIATNGTPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CTTTTSCH------HHHHHHHHHHCSCCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCH------HHHHHHHHhCCCCCC-CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            99854322      111111111111111 112356677899999999999999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.5e-46  Score=297.39  Aligned_cols=211  Identities=21%  Similarity=0.300  Sum_probs=180.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++||||+++++++.+....|+||||+.+++|.+.+.....   +++..+..++.|++.||.|||+. 
T Consensus        54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~-  129 (444)
T 3soa_A           54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQM-  129 (444)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35688999999999999999999999999999999999999999999876543   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEc---CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLD---LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++   .++.+||+|||++..............|++.|+|||++.+..++.++||||||+++|+|+
T Consensus       130 --givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell  207 (444)
T 3soa_A          130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL  207 (444)
T ss_dssp             --TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             --CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH
Confidence              999999999999998   457899999999987765555455678999999999999989999999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...      +.......+...........+...+.++.++|.+||+.||.+|||+.++++
T Consensus       208 ~G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          208 VGYPPFWDE------DQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HSSCSCCCS------SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCc------cHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999998532      233344444444443333344566778999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-45  Score=288.33  Aligned_cols=210  Identities=21%  Similarity=0.289  Sum_probs=179.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~-  134 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK-  134 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999999999999999999999999997543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC----ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        |++||||||+||+++.++    .+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus       135 --givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l  211 (361)
T 2yab_A          135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL  211 (361)
T ss_dssp             --TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             --CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence              999999999999998876    79999999998765432 23446789999999999988899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||...      ........+...........+...+..+.++|.+||..||.+|||+.++++
T Consensus       212 l~g~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          212 LSGASPFLGD------TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHSCCSSCCS------SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCCCCCCCC------CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999998532      233444555555444434444567778999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.5e-46  Score=287.09  Aligned_cols=213  Identities=33%  Similarity=0.508  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......++||||+.+++|.+++........+++..++.++.|++.||+|||+.  
T Consensus        79 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--  156 (309)
T 3p86_A           79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR--  156 (309)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS--
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC--
Confidence            468899999999999999999999999999999999999999999998655444589999999999999999999999  


Q ss_pred             CC--eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           83 PP--IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        83 ~~--i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                       |  ++||||||+||+++.++.+||+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus       157 -~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  235 (309)
T 3p86_A          157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL  235 (309)
T ss_dssp             -SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHC
T ss_pred             -CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence             9  9999999999999999999999999997655443334556789999999999999899999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||.....      ........ .......   ...++..+.++|.+||..||.+|||++++++.|+
T Consensus       236 ~~Pf~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          236 QQPWGNLNP------AQVVAAVGFKCKRLEI---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             CCTTTTSCH------HHHHHHHHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCH------HHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999864322      12222211 1111111   1245567899999999999999999999999886

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=281.42  Aligned_cols=214  Identities=28%  Similarity=0.469  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++..+...++||||+.+++|.+++.....  .+++.+++.++.|++.||+|||+. 
T Consensus        51 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~-  127 (310)
T 3s95_A           51 QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM-  127 (310)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            45788999999999999999999999999999999999999999999986433  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc--------------eecccccceeCCcccccCCcccchhh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW--------------TEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                        |++|+||||+||+++.++.+||+|||++..........              ....|++.|+|||.+.+..++.++||
T Consensus       128 --~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  205 (310)
T 3s95_A          128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV  205 (310)
T ss_dssp             --TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHH
T ss_pred             --CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHH
Confidence              99999999999999999999999999998764332211              13568999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||||+++|+|++|..||.............. ........+      ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       206 ~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          206 FSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDRYCP------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHHTCC------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccccCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999864332221111111 111111111      123346889999999999999999999999886

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-46  Score=286.28  Aligned_cols=211  Identities=20%  Similarity=0.310  Sum_probs=180.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++||||+++++++.+....++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        45 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-  121 (321)
T 1tki_A           45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH-  121 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567899999999999999999999999999999999999999999997543  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC--CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDL--EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.  ++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       122 --givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  198 (321)
T 1tki_A          122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS  198 (321)
T ss_dssp             --TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred             --CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence              9999999999999987  789999999999876533 23445678999999999998888999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      ........+...............+.++.++|.+||..||.+|||+.++++
T Consensus       199 g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          199 GINPFLAE------TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SSCTTCCS------SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCC------CHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            99998532      233444555555554444445567788999999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-45  Score=287.34  Aligned_cols=213  Identities=18%  Similarity=0.256  Sum_probs=178.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+++++.++||||+++++++......|+||||+.+++|.+.+... .....+++..+..++.|++.||.|||+.
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  149 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN  149 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            467899999999999999999999999999999999999999998877542 2223488999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCc---eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++||||||+||+++.++.   +||+|||++..............+++.|+|||++.+..++.++||||||+++|+|
T Consensus       150 ---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  226 (351)
T 3c0i_A          150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFIL  226 (351)
T ss_dssp             ---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred             ---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHH
Confidence               9999999999999987654   9999999998776544444456789999999999998899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....       ......+...........+...+.++.++|.+||..||.+|||+.++++
T Consensus       227 l~g~~pf~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          227 LSGCLPFYGTK-------ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHSSCSSCSSH-------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCcH-------HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            99999986421       2333444444444333444566778999999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=282.13  Aligned_cols=210  Identities=21%  Similarity=0.308  Sum_probs=176.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++......++||||+.+++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~-  133 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL-  133 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999999999999999999999999997543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC----ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        |++|+||||+||+++.++    .+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus       134 --~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  210 (326)
T 2y0a_A          134 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL  210 (326)
T ss_dssp             --TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             --CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHH
Confidence              999999999999998887    79999999998765332 23345789999999999988899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+..+.++|.+||..||.+|||+.++++
T Consensus       211 l~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          211 LSGASPFLGDT------KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHSCCSSCCSS------HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHCcCCCCCCC------HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99999985322      22233333333333223333456678899999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.2e-45  Score=282.94  Aligned_cols=216  Identities=24%  Similarity=0.347  Sum_probs=163.2

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|+.+++.+. ||||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-  125 (325)
T 3kn6_A           50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV-  125 (325)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            56789999999996 9999999999999999999999999999999997653   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC---ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++   .++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       126 --~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  203 (325)
T 3kn6_A          126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML  203 (325)
T ss_dssp             --TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             --CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence              999999999999998765   899999999987665544455567899999999999989999999999999999999


Q ss_pred             hCCCCccccccc-cCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNV-SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...... ...........+...........+...+.++.++|.+||..||.+|||++++++
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             hCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            999998754332 122333455555556655555555677889999999999999999999998863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.8e-45  Score=285.72  Aligned_cols=214  Identities=23%  Similarity=0.397  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++++ +||||+++++++......|+||||+.+++|.+++.....             ...+++..++.++.
T Consensus       131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  210 (370)
T 2psq_A          131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  210 (370)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence            5688999999999 899999999999999999999999999999999976432             23478999999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||.|||+.   |++||||||+||+++.++.+||+|||++.........  .....+++.|+|||++.+..++.++|
T Consensus       211 qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  287 (370)
T 2psq_A          211 QLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  287 (370)
T ss_dssp             HHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred             HHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence            999999999999   9999999999999999999999999999866543221  22345678899999999988999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|+|++ |..||....      .......+.........   ..++..+.++|.+||+.||.+|||+.++++.
T Consensus       288 vwslG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          288 VWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCC------GGGHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999 999986432      22222233222222211   2456679999999999999999999999999


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       359 L~~  361 (370)
T 2psq_A          359 LDR  361 (370)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-44  Score=280.07  Aligned_cols=207  Identities=24%  Similarity=0.293  Sum_probs=174.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        49 ~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  124 (337)
T 1o6l_A           49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR-  124 (337)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3467899999999999999999999999999999999999999999987643   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       125 --~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  202 (337)
T 1o6l_A          125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  202 (337)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             --CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence              999999999999999999999999999986544444455678999999999999989999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||...      +.......+....... +   ...+.++.++|.+||+.||.+||     +++++++
T Consensus       203 ~Pf~~~------~~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          203 LPFYNQ------DHERLFELILMEEIRF-P---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCC------CHHHHHHHHHcCCCCC-C---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            998532      2222333333222211 1   24566789999999999999999     8888875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=282.06  Aligned_cols=212  Identities=26%  Similarity=0.484  Sum_probs=174.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......|+||||+.+++|.+++.....  .+++..++.++.|++.||.|||+. 
T Consensus        94 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~-  170 (325)
T 3kul_A           94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL-  170 (325)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            45789999999999999999999999999999999999999999999975432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---eecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.++|+|||++..........   ....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       171 --~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  248 (325)
T 3kul_A          171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL  248 (325)
T ss_dssp             --TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             --CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence              99999999999999999999999999998765433221   2234467899999999888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||....      .......+.........   ..++..+.+++.+||..||.+|||+.++++.|+
T Consensus       249 ~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          249 AYGERPYWNMT------NRDVISSVEEGYRLPAP---MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             TTSCCTTTTSC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCcccCC------HHHHHHHHHcCCCCCCC---CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            8 999985432      22233333332222211   245668999999999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.2e-45  Score=279.37  Aligned_cols=214  Identities=26%  Similarity=0.366  Sum_probs=172.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++++......|+||||+.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        56 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  130 (294)
T 4eqm_A           56 KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM--  130 (294)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            578899999999999999999999999999999999999999999997654   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       131 -~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             -TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             -CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999865433222 23356899999999999988999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCC-chhhhhhHHHHHHHHHHhhccCCCCCC-CHHHHHHHhhC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPL-SVDIRGKVISIMEVAFLCLDNNPESRP-NMQTICQLLCK  228 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~~  228 (228)
                      .||.....      ............+.. .......+..+.++|.+||+.||.+|| +++++.+.|++
T Consensus       210 ~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          210 PPFNGETA------VSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             CSSCSSCH------HHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CCCCCCCh------HHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            99864322      222222223332222 112245667899999999999999998 88999888763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-45  Score=282.19  Aligned_cols=205  Identities=25%  Similarity=0.392  Sum_probs=172.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +++.+|+++++.++||||+++++++......|+||||+.+++|.+++.....   ++...+..++.|++.||+|||+.  
T Consensus        59 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~--  133 (328)
T 3fe3_A           59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK--  133 (328)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5678999999999999999999999999999999999999999999876533   88999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++...... .......|++.|+|||.+.+..+. .++||||||+++|+|++|.
T Consensus       134 -~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  211 (328)
T 3fe3_A          134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS  211 (328)
T ss_dssp             -TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred             -CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence             9999999999999999999999999999866533 233456789999999999888765 7899999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||...      +.......+........    ...+.++.+++.+||..||.+|||++++++
T Consensus       212 ~pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          212 LPFDGQ------NLKELRERVLRGKYRIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCC------CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            998643      22333333333332211    134557889999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.3e-45  Score=285.32  Aligned_cols=209  Identities=22%  Similarity=0.326  Sum_probs=176.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~--  147 (362)
T 2bdw_A           73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN--  147 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999886543   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++||||||+||+++.+   +.+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++
T Consensus       148 -~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  225 (362)
T 2bdw_A          148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV  225 (362)
T ss_dssp             -TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             -CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH
Confidence             99999999999999865   45999999999876533 23344678999999999998889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      +.......+...........+...+.++.++|.+||..||.+|||+.++++
T Consensus       226 g~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          226 GYPPFWDE------DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             SSCSSCCS------SHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCC------CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            99998532      223333444334333333344567788999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.8e-44  Score=277.99  Aligned_cols=221  Identities=32%  Similarity=0.514  Sum_probs=178.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.+.+|+++++.++||||+++++++......++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.
T Consensus        79 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  158 (321)
T 2qkw_B           79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR  158 (321)
T ss_dssp             HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC
Confidence            3578899999999999999999999999999999999999999999987543 223588999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                         |++|+||||+||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       159 ---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell  235 (321)
T 2qkw_B          159 ---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL  235 (321)
T ss_dssp             ---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH
T ss_pred             ---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH
Confidence               999999999999999999999999999976543222  123346889999999998888999999999999999999


Q ss_pred             hCCCCccccccccCCCchhh---------hhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 KGKHPRDFLSNVSSSNPNIL---------VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|..||..............         .....++...  .......+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       236 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             HCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            99999865433222211111         0111111111  1122467788999999999999999999999999886

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-44  Score=278.10  Aligned_cols=209  Identities=23%  Similarity=0.406  Sum_probs=176.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.++++++||||+++++++......|+||||+.+++|.+++...    .+++..+..++.|++.||.|||+. 
T Consensus        86 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~-  160 (321)
T 2c30_A           86 RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ-  160 (321)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            456889999999999999999999999999999999999999999998643    389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       161 --~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  238 (321)
T 2c30_A          161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE  238 (321)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999987665444445567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+.....+. .......+..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~pf~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          239 PPYFSDSP------VQAMKRLRDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CTTTTSCH------HHHHHHHHHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCH------HHHHHHHhcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99864322      22222222222221 1123456678999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-44  Score=279.91  Aligned_cols=224  Identities=34%  Similarity=0.620  Sum_probs=180.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|+++++.++||||+++++++......++||||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            368899999999999999999999999999999999999999999998643 3345899999999999999999999986


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                      .+|++|+||||+||+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus       152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence            669999999999999999999999999999876543333 2334589999999999888899999999999999999999


Q ss_pred             CCCccccccccCCCch--h---------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPN--I---------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~--~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||............  .         ...........  .......+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            9998643221111100  0         11111111111  11224567789999999999999999999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=284.29  Aligned_cols=211  Identities=18%  Similarity=0.263  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +..+.+|+++++.++||||+++++++......++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-  168 (387)
T 1kob_A           92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH-  168 (387)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999987543  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC--CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDL--EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.  ++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus       169 --givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  245 (387)
T 1kob_A          169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS  245 (387)
T ss_dssp             --TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             --CeeecccchHHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh
Confidence              9999999999999974  4779999999998765332 2344578999999999999889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+...............+.++.++|.+||..||.+|||+.++++
T Consensus       246 g~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          246 GLSPFAGED------DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SCCSSCCSS------HHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCC------HHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            999986432      22233333333322222233456778999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-44  Score=273.77  Aligned_cols=213  Identities=26%  Similarity=0.460  Sum_probs=175.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|++++++++||||+++++++.+....++||||+++++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~-  125 (269)
T 4hcu_A           49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA-  125 (269)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC-
Confidence            46789999999999999999999999999999999999999999999975443  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       126 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~  203 (269)
T 4hcu_A          126 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE  203 (269)
T ss_dssp             --TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence              999999999999999999999999999976543211 1223445678999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||....      .......+.........   ...+..+.+++.+||+.||.+|||++++++.|++
T Consensus       204 g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          204 GKIPYENRS------NSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             SCCTTTTCC------HHHHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHhcCccCCCC---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            999986432      22233333332221111   2345678999999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=275.00  Aligned_cols=220  Identities=23%  Similarity=0.348  Sum_probs=175.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC--eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR--HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|++++++++||||+++++++....  ..++||||+.+++|.+++........+++..++.++.|++.||.|||+
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  130 (319)
T 4euu_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (319)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            356789999999999999999999997654  789999999999999999875554558999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEE----cCCCceEEeecccccccCCCCCCceecccccceeCCcccc--------cCCcccchhh
Q 040501           80 DCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY--------TMKVTAKCDV  147 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di  147 (228)
                      .   |++|+||||+||++    +.++.+||+|||++....... ......+++.|+|||++.        +..++.++||
T Consensus       131 ~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di  206 (319)
T 4euu_A          131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL  206 (319)
T ss_dssp             T---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH
T ss_pred             C---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHH
Confidence            9   99999999999999    777889999999998765433 233457899999999876        4678899999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCC---------------------CCCCCchhhhhhHHHHHHHHH
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP---------------------RLPPLSVDIRGKVISIMEVAF  206 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~li~  206 (228)
                      ||||+++|+|++|..||.......  ........+..+                     ..+.........+..+.+++.
T Consensus       207 wslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~  284 (319)
T 4euu_A          207 WSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA  284 (319)
T ss_dssp             HHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH
Confidence            999999999999999986432211  111122222111                     111112223567778999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhh
Q 040501          207 LCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       207 ~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +||+.||.+|||++++++...
T Consensus       285 ~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          285 NILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHSCCCTTTSCCHHHHHHHHH
T ss_pred             HhccCChhhhccHHHhhhccH
Confidence            999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-44  Score=271.92  Aligned_cols=213  Identities=27%  Similarity=0.486  Sum_probs=175.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......++|||++++++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-  123 (268)
T 3sxs_A           47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH-  123 (268)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999999999999999999999999987643  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       124 --~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  201 (268)
T 3sxs_A          124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL  201 (268)
T ss_dssp             --TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred             --CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence              9999999999999999999999999999866533221 222345678999999998889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ...............+   ...+..+.+++.+||+.||.+|||++++++.|++
T Consensus       202 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          202 GKMPYDLYTN------SEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP  261 (268)
T ss_dssp             TCCTTTTSCH------HHHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred             CCCCccccCh------HHHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9999864322      2222222222221111   2345578999999999999999999999999873

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.3e-44  Score=274.50  Aligned_cols=213  Identities=24%  Similarity=0.336  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......++||||+.+ +|.+.+....  ..++...+..++.|++.||.|||+.  
T Consensus        64 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~--  138 (311)
T 3niz_A           64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH--  138 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5688999999999999999999999999999999999975 7777776543  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus       139 -~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  217 (311)
T 3niz_A          139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK  217 (311)
T ss_dssp             -TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             -CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999876655444555678999999999876 45799999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCC-----------------------CCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLP-----------------------PLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      .||.......   .............+                       ........++.++.++|.+||+.||.+|||
T Consensus       218 ~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  294 (311)
T 3niz_A          218 PLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS  294 (311)
T ss_dssp             CSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC
T ss_pred             CCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC
Confidence            9986432211   11111111100000                       001112234567899999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      ++++++
T Consensus       295 ~~ell~  300 (311)
T 3niz_A          295 ARDAMN  300 (311)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=283.88  Aligned_cols=211  Identities=23%  Similarity=0.287  Sum_probs=177.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......++||||+++++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus       130 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-  206 (373)
T 2x4f_A          130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM-  206 (373)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578899999999999999999999999999999999999999998886543  2388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEE--cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLL--DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||++  +.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus       207 --~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  283 (373)
T 2x4f_A          207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS  283 (373)
T ss_dssp             --TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH
T ss_pred             --CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh
Confidence              99999999999999  566889999999998765332 2334568999999999988889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+...............+.++.++|.+||+.||.+|||+.++++
T Consensus       284 g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          284 GLSPFLGDN------DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SSCTTCCSS------HHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999985432      23344444444443333344567778999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=273.90  Aligned_cols=207  Identities=23%  Similarity=0.340  Sum_probs=168.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++||||+++++++..  ....|+||||+.+++|.++...    ..+++..++.++.|++.||.|||+.
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~  156 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ  156 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            468899999999999999999999976  5689999999999999886543    3489999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC---cccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||+++.++.+||+|||++..............+++.|+|||.+.+..   ++.++||||||+++|+|
T Consensus       157 ---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l  233 (298)
T 2zv2_A          157 ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF  233 (298)
T ss_dssp             ---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred             ---CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence               999999999999999999999999999987654443344567899999999987765   36789999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....      .......+........  .....+..+.++|.+||+.||.+|||+.++++
T Consensus       234 ~~g~~pf~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          234 VFGQCPFMDER------IMCLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHSSCSSCCSS------HHHHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHCCCCCCCcc------HHHHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99999985322      1112222221111111  11245567899999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-43  Score=272.94  Aligned_cols=220  Identities=32%  Similarity=0.539  Sum_probs=177.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++||||+++++++......+++||++.+++|.+++........+++..++.++.|++.||.|||+. 
T Consensus        74 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-  152 (307)
T 2nru_A           74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-  152 (307)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            3578899999999999999999999999999999999999999999987644445589999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+ .++.++||||||+++|+|++
T Consensus       153 --~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~  229 (307)
T 2nru_A          153 --HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT  229 (307)
T ss_dssp             --TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred             --CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence              9999999999999999999999999998865533222  223468899999998765 47889999999999999999


Q ss_pred             CCCCccccccccCCCch--------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPN--------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||............        .............   .....+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       230 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          230 GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             CCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            99998754322111100        0111222222221   234567789999999999999999999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.7e-44  Score=282.34  Aligned_cols=207  Identities=25%  Similarity=0.369  Sum_probs=170.1

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|..++.++ +||||++++++|......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~-  172 (396)
T 4dc2_A           97 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER-  172 (396)
T ss_dssp             CHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3578899999887 89999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.+|.+||+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       173 --givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~  250 (396)
T 4dc2_A          173 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  250 (396)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999986444444455678999999999999999999999999999999999999


Q ss_pred             CCccccccccC---CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSS---SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||........   .........+....... +   ...+.++.++|++||+.||.+||++
T Consensus       251 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          251 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-P---RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CSSTTTTC------CCHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCcccccccccchhhHHHHHHHHhccccCC-C---CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            99964322111   11122223333222211 1   2355678999999999999999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.7e-44  Score=275.80  Aligned_cols=214  Identities=25%  Similarity=0.430  Sum_probs=176.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------------------CCCCCHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------------------AEELGWS   61 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~   61 (228)
                      +.+.+|++++++++||||+++++++......++||||+.+++|.+++.....                     ...+++.
T Consensus        71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (314)
T 2ivs_A           71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG  150 (314)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHH
T ss_pred             HHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHH
Confidence            5688999999999999999999999999999999999999999999976432                     2337899


Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccC
Q 040501           62 RRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTM  139 (228)
Q Consensus        62 ~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~  139 (228)
                      .++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+.
T Consensus       151 ~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  227 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH  227 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence            9999999999999999999   9999999999999999999999999999866543322  2234567889999999888


Q ss_pred             CcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          140 KVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       140 ~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      .++.++||||||+++|+|++ |..||.....      ......+.........   ..++..+.+++.+||+.||.+|||
T Consensus       228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps  298 (314)
T 2ivs_A          228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP------ERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPV  298 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHhhcCCcCCCC---ccCCHHHHHHHHHHccCChhhCcC
Confidence            89999999999999999999 9999864322      2222222222221111   245667999999999999999999


Q ss_pred             HHHHHHHhhC
Q 040501          219 MQTICQLLCK  228 (228)
Q Consensus       219 ~~~il~~l~~  228 (228)
                      +.++++.|++
T Consensus       299 ~~~l~~~l~~  308 (314)
T 2ivs_A          299 FADISKDLEK  308 (314)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=281.13  Aligned_cols=201  Identities=24%  Similarity=0.325  Sum_probs=166.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|..+++.+ +||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  143 (353)
T 3txo_A           68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK-  143 (353)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4577899999998 79999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       144 --givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  221 (353)
T 3txo_A          144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH  221 (353)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred             --CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCC
Confidence              999999999999999999999999999986544444455678999999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||...      +.......+........    ...+..+.++|++||..||.+||++
T Consensus       222 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          222 APFEAE------NEDDLFEAILNDEVVYP----TWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCCCC------CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhhCHHHccCC
Confidence            998643      23334444444333221    1345678899999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=280.68  Aligned_cols=211  Identities=23%  Similarity=0.313  Sum_probs=161.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......++||||+.+++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-  167 (349)
T 2w4o_A           92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN-  167 (349)
T ss_dssp             -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567889999999999999999999999999999999999999999987543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.   ++.+||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus       168 --~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  244 (349)
T 2w4o_A          168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL  244 (349)
T ss_dssp             --TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             --CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence              9999999999999975   789999999998865432 2233457899999999999988999999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||....     ........+...............+.++.++|.+||..||.+|||+.++++
T Consensus       245 ~g~~pf~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          245 CGFEPFYDER-----GDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HSSCTTCCTT-----CHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCc-----ccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999985322     122233344443333322333456778999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-43  Score=274.31  Aligned_cols=210  Identities=20%  Similarity=0.291  Sum_probs=176.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++||||+++++++......++|||++.+++|.+++....   .++...++.++.|++.||.|||+. 
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~-  134 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK-  134 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4678999999999999999999999999999999999999999999997543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC----ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        |++|+||||+||+++.++    .++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|
T Consensus       135 --~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l  211 (321)
T 2a2a_A          135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL  211 (321)
T ss_dssp             --TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             --CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence              999999999999999887    79999999998765432 23345689999999999988899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||...      ........+...............+..+.++|.+||..||.+|||+.++++
T Consensus       212 ~~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          212 LSGASPFLGD------TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHSCCSSCCS------SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCCCC------CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            9999998532      222333344333333322333456678999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-44  Score=271.99  Aligned_cols=211  Identities=20%  Similarity=0.300  Sum_probs=166.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++++..+...++||||+.++ +.+.+....  ..+++..+..++.|++.||.|||+.  
T Consensus        46 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~--  120 (292)
T 3o0g_A           46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR--  120 (292)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             hHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCC-HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            56789999999999999999999999999999999999864 444444322  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||.+..............+++.|+|||.+.+.. ++.++||||||+++|+|++|.
T Consensus       121 -~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~  199 (292)
T 3o0g_A          121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_dssp             -TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence             999999999999999999999999999987665544455567899999999987766 799999999999999999888


Q ss_pred             CCccccccccCCCchhhhhhhcC-------------------------CCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLD-------------------------PRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      .||.....     .......+..                         +............+..+.++|.+||+.||.+|
T Consensus       200 ~p~~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  274 (292)
T 3o0g_A          200 RPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR  274 (292)
T ss_dssp             CCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred             CCCcCCCC-----HHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhC
Confidence            88532111     1111111100                         00001111123456678999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||++++++
T Consensus       275 ~t~~e~l~  282 (292)
T 3o0g_A          275 ISAEEALQ  282 (292)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-43  Score=268.83  Aligned_cols=209  Identities=21%  Similarity=0.308  Sum_probs=176.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......++||||+.+++|.+++.....   +++..++.++.|++.||.|||+. 
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~-  125 (277)
T 3f3z_A           50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKL-  125 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC-
Confidence            46789999999999999999999999999999999999999999998876432   88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEE---cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||||+||++   +.++.++|+|||.+....... ......+++.|+|||.+.+. ++.++||||||+++|+|+
T Consensus       126 --~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~  201 (277)
T 3f3z_A          126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLL  201 (277)
T ss_dssp             --TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHH
T ss_pred             --CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHH
Confidence              99999999999999   778899999999998765332 23445789999999988664 899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...      ........+...............+..+.++|.+||+.||.+|||+.++++
T Consensus       202 ~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          202 CGYPPFSAP------TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HSSCSSCCS------SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HCCCCCCCC------CHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999998542      223344444444444444444567788999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-44  Score=280.92  Aligned_cols=212  Identities=21%  Similarity=0.310  Sum_probs=176.1

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ...+|++++.++ +||||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~--  135 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ--  135 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            346799999988 79999999999999999999999999999999987643   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCC----CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLE----YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                       |++||||||+||++..+    +.+||+|||++..............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       136 -givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  214 (342)
T 2qr7_A          136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML  214 (342)
T ss_dssp             -TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             -CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh
Confidence             99999999999998543    3599999999987665544455567899999999998888899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||....   ..........+...........+...+.++.++|.+||..||.+|||+.++++
T Consensus       215 ~g~~Pf~~~~---~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          215 TGYTPFANGP---DDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HSSCSSCSST---TSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCCCCCCCC---cCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9999986421   12233444444444444333334567778999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-44  Score=278.30  Aligned_cols=215  Identities=15%  Similarity=0.207  Sum_probs=174.7

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++++ +|+||+++++++......++|||++ +++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-  124 (330)
T 2izr_A           49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK-  124 (330)
T ss_dssp             CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4588999999999 8999999999999999999999999 899999998642  3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCc-----eEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhh
Q 040501           82 IPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                        |++||||||+||+++.++.     ++|+|||++.........       .....|++.|+|||.+.+..++.++||||
T Consensus       125 --~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  202 (330)
T 2izr_A          125 --NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA  202 (330)
T ss_dssp             --TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             --CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence              9999999999999998887     999999999876443321       23467899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCC-chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPL-SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||+++|+|++|..||.....   .........+.....+.. .......+ ++.+++.+||+.||.+|||++++.+.|+
T Consensus       203 lG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          203 LGHMFMYFLRGSLPWQGLKA---DTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHHHHSSCTTTTCCC---SSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCcccccc---ccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            99999999999999875321   112222222211111111 11112244 8999999999999999999999999885

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-44  Score=279.53  Aligned_cols=215  Identities=23%  Similarity=0.450  Sum_probs=176.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------------------CCCCCH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------------------AEELGW   60 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~   60 (228)
                      .+.+.+|++++++++||||+++++++......|+||||+.+++|.+++.....                     ...+++
T Consensus        94 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  173 (343)
T 1luf_A           94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  173 (343)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence            35688999999999999999999999999999999999999999999976421                     145899


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCccccc
Q 040501           61 SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYT  138 (228)
Q Consensus        61 ~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~  138 (228)
                      ..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++........  ......+++.|+|||.+.+
T Consensus       174 ~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  250 (343)
T 1luf_A          174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  250 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence            99999999999999999999   999999999999999999999999999876543221  1233567889999999998


Q ss_pred             CCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          139 MKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       139 ~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      ..++.++||||||+++|+|++ |..||....      .......+.........   ..++..+.+++.+||+.||.+||
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp  321 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------HEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRP  321 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCCCC------hHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCC
Confidence            889999999999999999999 999985432      22333333333332222   24566799999999999999999


Q ss_pred             CHHHHHHHhhC
Q 040501          218 NMQTICQLLCK  228 (228)
Q Consensus       218 t~~~il~~l~~  228 (228)
                      |+.++++.|++
T Consensus       322 s~~~~~~~L~~  332 (343)
T 1luf_A          322 SFCSIHRILQR  332 (343)
T ss_dssp             CHHHHHHHHHH
T ss_pred             CHHHHHHHHHH
Confidence            99999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-44  Score=285.82  Aligned_cols=211  Identities=25%  Similarity=0.378  Sum_probs=172.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.|.+|++++++++||||+++++++......|+||||+.+++|.+++....  ..++...++.++.|++.||+|||+.  
T Consensus       157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~--  232 (377)
T 3cbl_A          157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK--  232 (377)
T ss_dssp             TTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            467899999999999999999999999999999999999999999987543  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++||||||+||+++.++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       233 -~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~  311 (377)
T 3cbl_A          233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL  311 (377)
T ss_dssp             -TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             -CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhC
Confidence             9999999999999999999999999998764322111  111234678999999988889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+......+.+   ..++..+.++|.+||+.||.+|||+.++++.|+
T Consensus       312 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          312 GASPYPNLSN------QQTREFVEKGGRLPCP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             SCCSSTTSCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            9999865332      1222222222211111   235667899999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.5e-44  Score=271.96  Aligned_cols=211  Identities=24%  Similarity=0.394  Sum_probs=163.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.++++++||||+++++++. ....|+||||+.+++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-  135 (281)
T 1mp8_A           60 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK-  135 (281)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            356889999999999999999999985 457899999999999999997653  2388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       136 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~  213 (281)
T 1mp8_A          136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH  213 (281)
T ss_dssp             --TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             --CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhc
Confidence              9999999999999999999999999999876433221 223455678999999988889999999999999999996 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+.........   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       214 g~~pf~~~~~------~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          214 GVKPFQGVKN------NDVIGRIENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             SCCTTTTCCG------GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCcCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999864322      2223333332222211   345667999999999999999999999999886

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.9e-44  Score=275.88  Aligned_cols=209  Identities=20%  Similarity=0.357  Sum_probs=171.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC--------------------------------------------------
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR--------------------------------------------------   31 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------------------------------------------------   31 (228)
                      ++.+.+|++++++++||||++++++|.+..                                                  
T Consensus        48 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (332)
T 3qd2_B           48 REKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL  127 (332)
T ss_dssp             HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----------------------------------------
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccc
Confidence            467899999999999999999999985543                                                  


Q ss_pred             -------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceE
Q 040501           32 -------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH  104 (228)
Q Consensus        32 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~  104 (228)
                             ..++||||+.+++|.+++.............++.++.|++.||.|||+.   |++||||||+||+++.++.+|
T Consensus       128 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  204 (332)
T 3qd2_B          128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  204 (332)
T ss_dssp             ----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             cCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEE
Confidence                   3899999999999999998876666677778899999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCC------------CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccC
Q 040501          105 VSDFGIAKFIQPDSS------------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS  172 (228)
Q Consensus       105 l~df~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~  172 (228)
                      |+|||++........            ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...     
T Consensus       205 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----  279 (332)
T 3qd2_B          205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----  279 (332)
T ss_dssp             ECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----
T ss_pred             EeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----
Confidence            999999987664421            123356899999999999989999999999999999999998875321     


Q ss_pred             CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                         ...........   .+......+..+.++|.+||+.||.+|||++++++
T Consensus       280 ---~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          280 ---VRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ---HHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHhhccC---CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence               11222222222   22233455667899999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=278.95  Aligned_cols=209  Identities=23%  Similarity=0.401  Sum_probs=170.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++||||++++++|......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~-  134 (384)
T 4fr4_A           59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ-  134 (384)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567899999999999999999999999999999999999999999997643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc---CCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~~~  158 (228)
                        ||+||||||+||+++.+|.++|+|||++...... .......|++.|+|||++.+   ..++.++|+|||||++|+|+
T Consensus       135 --givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell  211 (384)
T 4fr4_A          135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL  211 (384)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH
T ss_pred             --CceeccCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH
Confidence              9999999999999999999999999999876533 33445679999999999864   35889999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-MQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~il~  224 (228)
                      +|..||......   ........+....... +   ...+..+.++|.+||+.||.+||+ ++++++
T Consensus       212 tG~~Pf~~~~~~---~~~~~~~~~~~~~~~~-p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          212 RGRRPYHIRSST---SSKEIVHTFETTVVTY-P---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HSSCSSCCCTTS---CHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             hCCCCCCCCCCc---cHHHHHHHHhhcccCC-C---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            999998643221   1222222222221111 1   234567899999999999999999 666653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.7e-44  Score=282.39  Aligned_cols=212  Identities=25%  Similarity=0.476  Sum_probs=164.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||+++++++......++||||+.+++|.+++....  ..+++.+++.++.|++.||+|||+. 
T Consensus        90 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-  166 (373)
T 2qol_A           90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM-  166 (373)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578999999999999999999999999999999999999999999997643  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.+||+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+++
T Consensus       167 --~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell  244 (373)
T 2qol_A          167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM  244 (373)
T ss_dssp             --TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             --CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHH
Confidence              9999999999999999999999999999876543222   11223467899999999888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||.....      ......+......+.   ...++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       245 t~g~~P~~~~~~------~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          245 SYGERPYWEMSN------QDVIKAVDEGYRLPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             TTC-CTTTTCCH------HHHHHHHHTTEECCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCCH------HHHHHHHHcCCCCCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            7 9999854321      222222222211111   1245567899999999999999999999999886

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-43  Score=270.03  Aligned_cols=210  Identities=29%  Similarity=0.493  Sum_probs=168.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++....  ++||||+.+++|.+.+....  ..+++..++.++.|++.||.|||+.  
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--  141 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ--  141 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS--
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC--
Confidence            67899999999999999999999987655  69999999999988886543  2489999999999999999999999  


Q ss_pred             CC--eeecCCCCCceEEcCCCc-----eEEeecccccccCCCCCCceecccccceeCCcccc--cCCcccchhhhhHHHH
Q 040501           83 PP--IVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY--TMKVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~--i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~  153 (228)
                       |  ++|+||||+||+++.++.     ++|+|||++.....   ......+++.|+|||.+.  ...++.++||||||++
T Consensus       142 -~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~  217 (287)
T 4f0f_A          142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI  217 (287)
T ss_dssp             -SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHH
T ss_pred             -CCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHH
Confidence             9  999999999999988776     99999999875432   334467899999999984  4457889999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +|+|++|..||......    ................  ....++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       218 l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          218 LYTILTGEGPFDEYSYG----KIKFINMIREEGLRPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHSSCTTTTCCCC----HHHHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHcCCCCCcccccc----HHHHHHHHhccCCCCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            99999999998643221    1111111111111110  112456679999999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-44  Score=272.70  Aligned_cols=214  Identities=24%  Similarity=0.372  Sum_probs=165.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......++|||++.+ +|.+++....  ..++...+..++.|++.||.|||+.  
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--  119 (288)
T 1ob3_A           45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR--  119 (288)
T ss_dssp             HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             hhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5688999999999999999999999999999999999976 8888886543  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus       120 -~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  198 (288)
T 1ob3_A          120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT  198 (288)
T ss_dssp             -TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999998765444444455789999999998764 5899999999999999999999


Q ss_pred             CCccccccccCCCchhhhhh----------------hcCCCCC-----CCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          162 HPRDFLSNVSSSNPNILVNE----------------MLDPRLP-----PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      .||.........  ......                ...+...     .........+.++.++|.+||+.||.+|||++
T Consensus       199 ~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  276 (288)
T 1ob3_A          199 PLFPGVSEADQL--MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK  276 (288)
T ss_dssp             CSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCHHHHH--HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence            998643221100  000000                0000000     00111234567789999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       277 e~l~  280 (288)
T 1ob3_A          277 QALE  280 (288)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.8e-44  Score=277.69  Aligned_cols=204  Identities=24%  Similarity=0.324  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......++||||+ +++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        54 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~--  127 (336)
T 3h4j_B           54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH--  127 (336)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            46889999999999999999999999999999999999 568888776543   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|.
T Consensus       128 -givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  205 (336)
T 3h4j_B          128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR  205 (336)
T ss_dssp             -TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS
T ss_pred             -CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC
Confidence             99999999999999999999999999998655332 2344578999999999988776 67999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||......      .....+...... .   ....+..+.++|.+||..||.+|||++++++
T Consensus       206 ~Pf~~~~~~------~~~~~i~~~~~~-~---p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          206 LPFDDEFIP------NLFKKVNSCVYV-M---PDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CSSBCSSST------TCBCCCCSSCCC-C---CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCCCccHH------HHHHHHHcCCCC-C---cccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            998643211      111111111111 1   1234567889999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=280.90  Aligned_cols=214  Identities=23%  Similarity=0.393  Sum_probs=177.4

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +++.+|+++++++ +||||+++++++......++||||+.+++|.+++.....             ...+++..++.++.
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  198 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  198 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHH
Confidence            5688999999999 899999999999999999999999999999999976432             23489999999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||.|||+.   |++||||||+||+++.++.+||+|||++.........  .....+++.|+|||++.+..++.++|
T Consensus       199 qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  275 (382)
T 3tt0_A          199 QVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD  275 (382)
T ss_dssp             HHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHH
T ss_pred             HHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhH
Confidence            999999999999   9999999999999999999999999999866543221  22345678899999999988999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|+|++ |..||....      .......+.........   ..++.++.+++.+||+.||.+|||++++++.
T Consensus       276 iwslG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          276 VWSFGVLLWEIFTLGGSPYPGVP------VEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999 999986432      22233333222222211   2456679999999999999999999999999


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       347 L~~  349 (382)
T 3tt0_A          347 LDR  349 (382)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-43  Score=276.14  Aligned_cols=207  Identities=25%  Similarity=0.369  Sum_probs=169.3

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|..+++++ +||||+++++++......|+||||+.+++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~-  129 (345)
T 3a8x_A           54 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER-  129 (345)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578899999988 89999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       130 --~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  207 (345)
T 3a8x_A          130 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  207 (345)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999986544444445568999999999999989999999999999999999999


Q ss_pred             CCccccccccC---CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSS---SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||........   .........+....... +   ...+..+.++|.+||..||.+||++
T Consensus       208 ~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          208 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-P---RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CTTTTTTC-------CHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCcCCcccccccccccHHHHHHHHHcCCCCC-C---CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            99864322111   11122222232222211 1   2455678999999999999999996

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-43  Score=272.44  Aligned_cols=217  Identities=25%  Similarity=0.366  Sum_probs=167.7

Q ss_pred             HHHHHHHHHHhc--cCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTE--IRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|.+++..  ++||||+++++++..    ....|+||||+.+++|.+++...    .+++..++.++.|++.||+|
T Consensus        45 ~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~  120 (301)
T 3q4u_A           45 KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAH  120 (301)
T ss_dssp             HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHH
Confidence            456677777777  789999999998754    34689999999999999999643    38999999999999999999


Q ss_pred             hh--------hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC-----
Q 040501           77 LH--------HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM-----  139 (228)
Q Consensus        77 lh--------~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-----  139 (228)
                      ||        +.   |++||||||+||+++.++.+||+|||++.........    .....+++.|+|||++.+.     
T Consensus       121 lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  197 (301)
T 3q4u_A          121 LHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDC  197 (301)
T ss_dssp             HHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred             HHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCc
Confidence            99        88   9999999999999999999999999999765543332    1234789999999998876     


Q ss_pred             -CcccchhhhhHHHHHHHHHhC----------CCCccccccccCCCchhhhhhh--cCCCCCCCch--hhhhhHHHHHHH
Q 040501          140 -KVTAKCDVYSFGVLALEVIKG----------KHPRDFLSNVSSSNPNILVNEM--LDPRLPPLSV--DIRGKVISIMEV  204 (228)
Q Consensus       140 -~~~~~~DiwslG~~l~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~l  204 (228)
                       .++.++||||||+++|+|++|          ..||........  ........  .....+..+.  .....+..+.++
T Consensus       198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  275 (301)
T 3q4u_A          198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP--SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKL  275 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHH
T ss_pred             ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc--chhhhhHHHhccCCCCCCChhhccCccHHHHHHH
Confidence             456799999999999999999          667643222111  11111111  1111222221  123467789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhhC
Q 040501          205 AFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +.+||+.||.+|||+.++++.|++
T Consensus       276 i~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          276 MKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhhcChhhCCCHHHHHHHHhc
Confidence            999999999999999999999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=275.37  Aligned_cols=211  Identities=22%  Similarity=0.365  Sum_probs=171.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++||||+++++++..+. .+++++++.+++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        61 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~-  136 (327)
T 3poz_A           61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR-  136 (327)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC-
Confidence            457899999999999999999999998754 7889999999999999976543  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       137 --~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             --TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence              9999999999999999999999999999876544332  223455778999999999999999999999999999999


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       |..||.....      ......+........   ....+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       215 ~g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          215 FGSKPYDGIPA------SEISSILEKGERLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             TSCCTTTTCCG------GGHHHHHHTTCCCCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             cCCCCccCCCH------HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence             9999864322      112222222221111   1235567899999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.8e-44  Score=275.63  Aligned_cols=209  Identities=25%  Similarity=0.374  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .+++..++.++.|++.||.|||+.  
T Consensus        50 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~--  124 (323)
T 3tki_A           50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI--  124 (323)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            567899999999999999999999999999999999999999999986543   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||||+||+++.++.++|+|||++.......  .......|++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus       125 -givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  203 (323)
T 3tki_A          125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  203 (323)
T ss_dssp             -TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             -CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh
Confidence             99999999999999999999999999997653222  12234578999999999987775 778999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||......     .............  .......+..+.+++.+||..||.+|||+.++++
T Consensus       204 g~~pf~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          204 GELPWDQPSDS-----CQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             SSCSCSSSCTT-----SHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCchH-----HHHHHHHhccccc--CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            99998643221     1111111111111  1123456678899999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-43  Score=267.92  Aligned_cols=209  Identities=25%  Similarity=0.412  Sum_probs=164.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......++||||+.+++|.+++...    .+++..++.++.|++.||.|||+.  
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~--  124 (271)
T 3dtc_A           51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDE--  124 (271)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            56889999999999999999999999999999999999999999998633    389999999999999999999999  


Q ss_pred             CC---eeecCCCCCceEEcC--------CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHH
Q 040501           83 PP---IVHRDISSKNVLLDL--------EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        83 ~~---i~h~di~p~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                       |   ++|+||||+||+++.        ++.++|+|||.+.......  .....+++.|+|||.+.+..++.++||||||
T Consensus       125 -~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  201 (271)
T 3dtc_A          125 -AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYG  201 (271)
T ss_dssp             -SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHH
T ss_pred             -CCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHH
Confidence             7   999999999999986        6789999999997654332  2245688999999999988899999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      +++|+|++|..||.....      ...............  ....++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       202 ~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          202 VLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            999999999999864322      112222221211111  112455679999999999999999999999999974

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.9e-44  Score=273.20  Aligned_cols=219  Identities=25%  Similarity=0.388  Sum_probs=174.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|+++++.++||||+++++++...  ...++|||++.+++|.+++.....  .++...++.++.|++.||+|||+
T Consensus        67 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~  144 (302)
T 4e5w_A           67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGS  144 (302)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhc
Confidence            36788999999999999999999999876  678999999999999999965432  38999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||||+||+++.++.++|+|||.+.........   .....++..|+|||.+.+..++.++||||||+++|+
T Consensus       145 ~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  221 (302)
T 4e5w_A          145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE  221 (302)
T ss_dssp             T---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             C---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHH
Confidence            9   9999999999999999999999999999876544322   233457778999999999889999999999999999


Q ss_pred             HHhCCCCcccccc--------c-cCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSN--------V-SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..|+.....        . ....................   ...++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       222 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          222 LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC---PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC---CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9999998643211        0 00111111122222221111   1245667999999999999999999999999986


Q ss_pred             C
Q 040501          228 K  228 (228)
Q Consensus       228 ~  228 (228)
                      +
T Consensus       299 ~  299 (302)
T 4e5w_A          299 A  299 (302)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=277.14  Aligned_cols=214  Identities=23%  Similarity=0.383  Sum_probs=174.3

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCC--------------------CCCCH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSA--------------------EELGW   60 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~~~   60 (228)
                      ++.+.+|+.+++++ +||||+++++++......++||||+.+++|.+++......                    ..+++
T Consensus        92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  171 (344)
T 1rjb_A           92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF  171 (344)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence            46789999999999 8999999999999999999999999999999999764321                    23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc
Q 040501           61 SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT  138 (228)
Q Consensus        61 ~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  138 (228)
                      ..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+
T Consensus       172 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  248 (344)
T 1rjb_A          172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  248 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence            99999999999999999999   9999999999999999999999999999866543332  223456778999999988


Q ss_pred             CCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCC-CCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          139 MKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       139 ~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      ..++.++||||||+++|+|++ |..||......      .......... ....   ....+..+.+++.+||..||.+|
T Consensus       249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R  319 (344)
T 1rjb_A          249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD------ANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKR  319 (344)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH------HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhC
Confidence            889999999999999999998 99998643211      1111111111 1111   12345679999999999999999


Q ss_pred             CCHHHHHHHhh
Q 040501          217 PNMQTICQLLC  227 (228)
Q Consensus       217 pt~~~il~~l~  227 (228)
                      ||+.++++.|+
T Consensus       320 ps~~~l~~~l~  330 (344)
T 1rjb_A          320 PSFPNLTSFLG  330 (344)
T ss_dssp             CCHHHHHHHHH
T ss_pred             cCHHHHHHHHH
Confidence            99999999886

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.8e-44  Score=273.39  Aligned_cols=216  Identities=18%  Similarity=0.234  Sum_probs=175.1

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.+++.+ +|+|++++++++......++|||++ +++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~-  125 (298)
T 1csn_A           50 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK-  125 (298)
T ss_dssp             CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4678999999999 7999999999999999999999999 8999999986532  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCc-----eEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhh
Q 040501           82 IPPIVHRDISSKNVLLDLEYE-----AHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                        |++||||||+||+++.++.     ++|+|||++.........       .....+++.|+|||.+.+..++.++||||
T Consensus       126 --~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  203 (298)
T 1csn_A          126 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA  203 (298)
T ss_dssp             --TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             --CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH
Confidence              9999999999999987766     999999999876543321       23456899999999999988999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||+++|+|++|..||.......   .......+..... .........++..+.+++.+||+.||.+|||++++++.|+
T Consensus       204 lG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          204 LGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCcchhhccc---cHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            9999999999999987533211   1111111111110 1111112345678999999999999999999999999886

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-43  Score=288.79  Aligned_cols=214  Identities=25%  Similarity=0.410  Sum_probs=176.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++++++++||||+++++++......|+||||+.+++|.+++..... ..++...++.++.|++.||+|||+. 
T Consensus       260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~-  337 (495)
T 1opk_A          260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-  337 (495)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            46789999999999999999999999999999999999999999999976432 3488999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       338 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~  415 (495)
T 1opk_A          338 --NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  415 (495)
T ss_dssp             --TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence              9999999999999999999999999999875432211 122345678999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ......+........   ...++..+.++|.+||+.||.+|||+.++++.|+.
T Consensus       416 g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          416 GMSPYPGIDL------SQVYELLEKDYRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             SCCSSTTCCG------GGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            9999864332      122222222211111   12456689999999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.3e-44  Score=277.27  Aligned_cols=205  Identities=25%  Similarity=0.329  Sum_probs=171.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|..+++.+ +||||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        62 ~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  137 (345)
T 1xjd_A           62 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK-  137 (345)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4577899999987 89999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       138 --~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  215 (345)
T 1xjd_A          138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ  215 (345)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCC
Confidence              999999999999999999999999999986544444455678999999999999989999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ-TIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il  223 (228)
                      .||....      .......+....... +   ...+.++.++|.+||..||.+||++. +++
T Consensus       216 ~Pf~~~~------~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          216 SPFHGQD------EEELFHSIRMDNPFY-P---RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CSSCCSS------HHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCCCC------HHHHHHHHHhCCCCC-C---cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            9986322      223333332222211 1   23556789999999999999999997 554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=268.53  Aligned_cols=207  Identities=22%  Similarity=0.386  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++++......|+|||++.+++|.+++....  ..++...++.++.|++.||.|||+.  
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--  131 (278)
T 3cok_A           56 QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH--  131 (278)
T ss_dssp             HHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999987543  3489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       132 -~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  210 (278)
T 3cok_A          132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP  210 (278)
T ss_dssp             -TEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence             9999999999999999999999999999876544333444678899999999988888999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||......      ............    .....+.++.++|.+||+.||.+|||++++++
T Consensus       211 p~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          211 PFDTDTVK------NTLNKVVLADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SSCCCSCC-----------CCSSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhHH------HHHHHHhhcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            98643221      111111111111    11234567899999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-43  Score=276.00  Aligned_cols=213  Identities=26%  Similarity=0.292  Sum_probs=171.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-----------------------------
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-----------------------------   53 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------------------   53 (228)
                      +.+.+|++++++++||||+++++++.+....++||||+.+++|.+++....                             
T Consensus        73 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (345)
T 3hko_A           73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING  152 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccc
Confidence            578899999999999999999999999999999999999999999885210                             


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCC--ceEEeecccccccCCCCC----
Q 040501           54 --------SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY--EAHVSDFGIAKFIQPDSS----  119 (228)
Q Consensus        54 --------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~----  119 (228)
                              ....+++..++.++.|++.||.|||+.   |++|+||||+||+++.++  .+||+|||++........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  229 (345)
T 3hko_A          153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY  229 (345)
T ss_dssp             CC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---
T ss_pred             ccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccc
Confidence                    011235677889999999999999999   999999999999998776  899999999986543221    


Q ss_pred             CceecccccceeCCccccc--CCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhh
Q 040501          120 NWTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGK  197 (228)
Q Consensus       120 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (228)
                      ......+++.|+|||.+.+  ..++.++||||||+++|+|++|..||....      .......+...............
T Consensus       230 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~  303 (345)
T 3hko_A          230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN------DADTISQVLNKKLCFENPNYNVL  303 (345)
T ss_dssp             -----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCTTSGGGGGS
T ss_pred             cccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcccccCCcccccC
Confidence            1344578999999999865  568899999999999999999999985432      23344444444444333444557


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          198 VISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       198 ~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +..+.++|.+||+.||.+|||+.++++
T Consensus       304 ~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          304 SPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            778999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-43  Score=272.30  Aligned_cols=218  Identities=21%  Similarity=0.364  Sum_probs=167.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+.++++++||||+++++++......++|||++.+++|.+++.... ....++...++.++.|++.||.|||+.
T Consensus        76 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  155 (310)
T 2wqm_A           76 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR  155 (310)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            3568899999999999999999999999999999999999999999986421 223488999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus       156 ---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g  232 (310)
T 2wqm_A          156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL  232 (310)
T ss_dssp             ---TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             ---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence               99999999999999999999999999988765444334445788999999999988899999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ..||....    .........+.....+...  ...++.++.+++.+||..||.+|||+.++++.|++
T Consensus       233 ~~p~~~~~----~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          233 QSPFYGDK----MNLYSLCKKIEQCDYPPLP--SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             SCTTC-------CCHHHHHHHHHTTCSCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcccc----hhHHHHHHHhhcccCCCCc--ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            99985321    1122222233222222221  13456679999999999999999999999998863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-43  Score=274.52  Aligned_cols=203  Identities=20%  Similarity=0.242  Sum_probs=172.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++.+....|+||||+.+++|.+++.....   +++..+..++.|++.||.|||+.  
T Consensus        86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~--  160 (350)
T 1rdq_E           86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL--  160 (350)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC--
Confidence            5678899999999999999999999999999999999999999999976432   89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.+|.++|+|||++......   .....|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus       161 -~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  236 (350)
T 1rdq_E          161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP  236 (350)
T ss_dssp             -TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -CcccccCccceEEECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCC
Confidence             9999999999999999999999999999876432   234578999999999999899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      ||...      +.......+........    ...+.++.++|.+||+.||.+||+     ++++++
T Consensus       237 Pf~~~------~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          237 PFFAD------QPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             SSCCS------SHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCC------CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            98532      22333444433332211    245667899999999999999998     777764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-44  Score=274.92  Aligned_cols=217  Identities=25%  Similarity=0.403  Sum_probs=168.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++||||+++++++..  ....++||||+.+++|.+++.....  .++...++.++.|++.||.|||+.
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~  133 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK  133 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC
Confidence            578899999999999999999999854  4568999999999999999976532  388999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|
T Consensus       134 ---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  210 (295)
T 3ugc_A          134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL  210 (295)
T ss_dssp             ---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHH
Confidence               9999999999999999999999999999876543221   2234567789999999998999999999999999999


Q ss_pred             HhCCCCccccccc-----cCCCc-----hhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          158 IKGKHPRDFLSNV-----SSSNP-----NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       158 ~~g~~p~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ++|..|+......     .....     ...............   ...++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       211 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          211 FTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            9999997543211     00000     011111111111111   1345678999999999999999999999999886

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-43  Score=280.50  Aligned_cols=215  Identities=21%  Similarity=0.263  Sum_probs=165.6

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ..+.+|++++.++ +||||++++++|..    ...+|+||||+.+++|.+++..... ..+++..+..++.|++.||.||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~L  177 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYL  177 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4678899988655 89999999999875    5678999999999999999976432 3489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      |+.   ||+||||||+||+++.   ++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++
T Consensus       178 H~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  253 (400)
T 1nxk_A          178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM  253 (400)
T ss_dssp             HHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHH
T ss_pred             HHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHH
Confidence            999   9999999999999987   788999999999865432 223456789999999999998999999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|..||..........  .....+...........+..++.++.++|.+||..||.+|||+.++++
T Consensus       254 ~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          254 YILLCGYPPFYSNHGLAISP--GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCccccccH--HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            99999999986543322111  111222222222222223456778999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=270.93  Aligned_cols=203  Identities=24%  Similarity=0.351  Sum_probs=171.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  125 (318)
T 1fot_A           51 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK--  125 (318)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457789999999999999999999999999999999999999999997643   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.+|.+||+|||++......   .....|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus       126 -~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  201 (318)
T 1fot_A          126 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT  201 (318)
T ss_dssp             -TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             -CccccCCChheEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence             9999999999999999999999999999865432   234578999999999999899999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||...      +.......+........    ...+.++.++|.+||..||.+||     +++++++
T Consensus       202 pf~~~------~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          202 PFYDS------NTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCC------CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            98532      22233333333332211    23456789999999999999999     8888764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-43  Score=274.40  Aligned_cols=205  Identities=21%  Similarity=0.293  Sum_probs=172.5

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|..++..+ +||+|+++++++......|+||||+.|++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  140 (353)
T 2i0e_A           65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK-  140 (353)
T ss_dssp             HHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578899999988 79999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       141 --givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~  218 (353)
T 2i0e_A          141 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  218 (353)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             --CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCC
Confidence              999999999999999999999999999986544444455578999999999999989999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il  223 (228)
                      .||...      +.......+........    ...+.++.++|.+||..||.+||+     +++++
T Consensus       219 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          219 APFEGE------DEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             CCCCCC------CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            998632      22333444433332211    245667899999999999999996     46655

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.4e-43  Score=268.24  Aligned_cols=209  Identities=22%  Similarity=0.326  Sum_probs=173.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++++......+++||++.+++|.+.+....   .++...+..++.|++.||.|||+.  
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--  124 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN--  124 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            567899999999999999999999999999999999999999988886543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCc---eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||||+||+++.++.   ++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       125 -~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  202 (284)
T 3kk8_A          125 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV  202 (284)
T ss_dssp             -TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred             -CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH
Confidence             9999999999999987655   999999999766533 22344678999999999999889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+...............+.++.+++.+||+.||.+|||+.++++
T Consensus       203 g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          203 GYPPFWDED------QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             SSCSSCCSS------HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCc------hhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            999985322      22233333333322222233456678999999999999999999999976

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=274.89  Aligned_cols=214  Identities=21%  Similarity=0.379  Sum_probs=165.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeE------EEEEEeecCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDT---SAEELGWSRRINVIKGIAH   72 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~l~~   72 (228)
                      .+.+.+|++++++++||||+++++++......      +++|||+.+++|.+++....   ....+++..++.++.|++.
T Consensus        69 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~  148 (323)
T 3qup_A           69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC  148 (323)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHH
Confidence            35788999999999999999999999776554      99999999999999986432   2224889999999999999


Q ss_pred             HHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhH
Q 040501           73 ALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSF  150 (228)
Q Consensus        73 ~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  150 (228)
                      ||+|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++|||||
T Consensus       149 al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  225 (323)
T 3qup_A          149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF  225 (323)
T ss_dssp             HHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhH
Confidence            99999999   9999999999999999999999999999865433322  223456778999999999889999999999


Q ss_pred             HHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          151 GVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       151 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+++|+|++ |..||.....      ......+.........   ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       226 G~il~ell~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          226 GVTMWEIMTRGQTPYAGIEN------AEIYNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             HHHHHHHHTTSCCTTTTCCG------GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCccccCh------HHHHHHHhcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999 9999864322      2233333332222211   245567999999999999999999999999886

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.7e-44  Score=270.92  Aligned_cols=212  Identities=24%  Similarity=0.464  Sum_probs=174.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|++++++++|+||+++++++......++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-  139 (283)
T 3gen_A           63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK-  139 (283)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999999999999999999999999997632  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       140 --~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~  217 (283)
T 3gen_A          140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL  217 (283)
T ss_dssp             --TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             --CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence              999999999999999999999999999976543211 1222345678999999998889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+.........   ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       218 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          218 GKMPYERFTN------SETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             TCCTTTTSCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccccCh------hHHHHHHhcccCCCCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            9999864322      2222222222211111   233557899999999999999999999999886

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=271.58  Aligned_cols=214  Identities=29%  Similarity=0.489  Sum_probs=166.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++.+  ..++||||+.+++|.+++........++...++.++.|++.||.|||+.+
T Consensus        45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  122 (307)
T 2eva_A           45 RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ  122 (307)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999999998874  47899999999999999987655455788999999999999999999921


Q ss_pred             CCCeeecCCCCCceEEcCCCc-eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYE-AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                      ..|++|+||||+||+++.++. +||+|||.+......   .....+++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus       123 ~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  199 (307)
T 2eva_A          123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR  199 (307)
T ss_dssp             SSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            119999999999999998876 799999998765422   2234688999999999998899999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..||.....    ..............+..   ...++..+.+++.+||+.||.+|||++++++.|+
T Consensus       200 ~~p~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          200 RKPFDEIGG----PAFRIMWAVHNGTRPPL---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             CCTTTTTCS----SHHHHHHHHHTTCCCCC---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCchhhCc----cHHHHHHHHhcCCCCCc---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            999863221    11112222222222221   1345667899999999999999999999999885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.1e-44  Score=271.34  Aligned_cols=216  Identities=25%  Similarity=0.443  Sum_probs=163.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++|+||+++++++ .....++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+. 
T Consensus        64 ~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~-  139 (289)
T 3og7_A           64 LQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK-  139 (289)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35688999999999999999999965 4557899999999999999986543  3389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCcccc---cCCcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~  156 (228)
                        |++|+||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.   +..++.++||||||+++|+
T Consensus       140 --~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  217 (289)
T 3og7_A          140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE  217 (289)
T ss_dssp             --TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHH
T ss_pred             --CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHH
Confidence              99999999999999999999999999987654322  1233456899999999886   5567889999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++|..||.....     ............. +........++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       218 l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  285 (289)
T 3og7_A          218 LMTGQLPYSNINN-----RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE  285 (289)
T ss_dssp             HHHSSCTTSSCCC-----HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHCCCCccccch-----HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            9999999864322     1112222211111 11122223566789999999999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-43  Score=284.93  Aligned_cols=209  Identities=23%  Similarity=0.358  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......|+|||++.+++|.+.+....   .+++..+..++.|++.||.|||+. 
T Consensus        65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~-  140 (486)
T 3mwu_A           65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH-  140 (486)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578899999999999999999999999999999999999999998886543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEc---CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLD---LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        ||+||||||+||+++   .++.+||+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|+
T Consensus       141 --~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll  216 (486)
T 3mwu_A          141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL  216 (486)
T ss_dssp             --TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred             --CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence              999999999999995   4567999999999865533 22344578999999999876 5899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...      ........+...........+...+.++.++|.+||..||.+|||+.++++
T Consensus       217 ~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          217 SGTPPFYGK------NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HSSCSSCCS------SHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCC------CHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            999998533      233344445445544444455677888999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.1e-43  Score=283.46  Aligned_cols=210  Identities=27%  Similarity=0.412  Sum_probs=172.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.|.+|++++++++||||+++++++.... ..|+||||+.+++|.+++..... ..++...++.++.|++.||+|||+.
T Consensus       230 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~  308 (450)
T 1k9a_A          230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN  308 (450)
T ss_dssp             SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999999999999987655 79999999999999999986532 2368899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                         |++||||||+||+++.++.+||+|||++......   .....++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       309 ---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~  382 (450)
T 1k9a_A          309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF  382 (450)
T ss_dssp             ---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence               9999999999999999999999999998854322   122356788999999999899999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+........+   ..++..+.++|.+||+.||.+|||+.++++.|+
T Consensus       383 g~~P~~~~~~------~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          383 GRVPYPRIPL------KDVVPRVEKGYKMDAP---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             TCCSSTTSCT------TTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            9999864322      1222223222221111   356678999999999999999999999999886

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-43  Score=273.65  Aligned_cols=216  Identities=25%  Similarity=0.418  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC---------------CCCCCHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS---------------AEELGWSRRIN   65 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~   65 (228)
                      ++.+.+|+++++++ +||||+++++++......++|||++.+++|.+++.....               ...+++..++.
T Consensus        70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (313)
T 1t46_A           70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (313)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence            46788999999999 899999999999999999999999999999999976532               12488999999


Q ss_pred             HHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCccc
Q 040501           66 VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        66 ~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  143 (228)
                      ++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||.+.........  .....+++.|+|||.+.+..++.
T Consensus       150 ~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  226 (313)
T 1t46_A          150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF  226 (313)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh
Confidence            999999999999999   9999999999999999999999999999876544332  22345677899999998888999


Q ss_pred             chhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          144 KCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      ++||||||+++|+|++ |..||......      ...............  ....+..+.+++.+||+.||.+|||+.++
T Consensus       227 ~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~el  298 (313)
T 1t46_A          227 ESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcccch------hHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            9999999999999998 99998643221      111111111111100  12455678999999999999999999999


Q ss_pred             HHHhhC
Q 040501          223 CQLLCK  228 (228)
Q Consensus       223 l~~l~~  228 (228)
                      ++.|++
T Consensus       299 l~~L~~  304 (313)
T 1t46_A          299 VQLIEK  304 (313)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-43  Score=273.97  Aligned_cols=221  Identities=26%  Similarity=0.392  Sum_probs=170.7

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+|+.++++++||||+++++++....    .+++||||+.+++|.+++....    +++..++.++.|++.||+|||+
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~  139 (322)
T 3soc_A           64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE  139 (322)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999999999998754    4799999999999999997643    8999999999999999999998


Q ss_pred             CC-------CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccC-----Ccccch
Q 040501           80 DC-------IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTM-----KVTAKC  145 (228)
Q Consensus        80 ~~-------~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-----~~~~~~  145 (228)
                      .+       ..|++||||||+||+++.++.+||+|||++.........  .....+++.|+|||++.+.     .++.++
T Consensus       140 ~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  219 (322)
T 3soc_A          140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI  219 (322)
T ss_dssp             CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHH
T ss_pred             hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccc
Confidence            51       128999999999999999999999999999776543322  2235689999999998763     456789


Q ss_pred             hhhhHHHHHHHHHhCCCCccccccccCC----------CchhhhhhhcCCCC-CCCch--hhhhhHHHHHHHHHHhhccC
Q 040501          146 DVYSFGVLALEVIKGKHPRDFLSNVSSS----------NPNILVNEMLDPRL-PPLSV--DIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       146 DiwslG~~l~~~~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~  212 (228)
                      ||||||+++|+|++|..||.........          .............. +....  .....+.++.++|.+||+.|
T Consensus       220 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  299 (322)
T 3soc_A          220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD  299 (322)
T ss_dssp             HHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC
Confidence            9999999999999999998643221111          11111111111111 11111  12244567999999999999


Q ss_pred             CCCCCCHHHHHHHhhC
Q 040501          213 PESRPNMQTICQLLCK  228 (228)
Q Consensus       213 p~~Rpt~~~il~~l~~  228 (228)
                      |.+|||+.++++.|++
T Consensus       300 P~~Rps~~ell~~L~~  315 (322)
T 3soc_A          300 AEARLSAGCVGERITQ  315 (322)
T ss_dssp             GGGSCCHHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHHH
Confidence            9999999999999863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-43  Score=274.58  Aligned_cols=206  Identities=23%  Similarity=0.304  Sum_probs=163.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .++...+..++.|++.||.|||+.  
T Consensus        66 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~--  140 (327)
T 3a62_A           66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK--  140 (327)
T ss_dssp             -----HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            456789999999999999999999999999999999999999999987643   378899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.++.+||+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       141 -~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  219 (327)
T 3a62_A          141 -GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP  219 (327)
T ss_dssp             -TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence             9999999999999999999999999998765433333444678999999999998889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||....      .......+........    ...+..+.++|.+||..||.+||     ++.++++
T Consensus       220 pf~~~~------~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          220 PFTGEN------RKKTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             SCCCSS------HHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCCCC------HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            986432      2223333333222111    23456789999999999999999     6777764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=281.13  Aligned_cols=213  Identities=25%  Similarity=0.375  Sum_probs=174.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT----SAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ..+.+|+.++++++||||+++++++......|+||||+.+++|.+++....    ....+++..++.++.|++.||.|||
T Consensus       119 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  198 (367)
T 3l9p_A          119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE  198 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999999999999999999999999987643    2234889999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC---ceEEeecccccccCCCC--CCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      +.   |++||||||+||+++.++   .+||+|||++.......  .......+++.|+|||.+.+..++.++|||||||+
T Consensus       199 ~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~i  275 (367)
T 3l9p_A          199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL  275 (367)
T ss_dssp             HT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             hC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHH
Confidence            99   999999999999999555   59999999997543221  12233567889999999988899999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|+|++ |..||....      .......+.........   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       276 l~ellt~g~~pf~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          276 LWEIFSLGYMPYPSKS------NQEVLEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHHHHTTSCCSSTTCC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            999998 999986432      22333333333222211   245567899999999999999999999999885

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-43  Score=273.20  Aligned_cols=212  Identities=26%  Similarity=0.468  Sum_probs=169.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++||||+++++++......++|||++.+++|.+++....  ..++...++.++.|++.||.|||+. 
T Consensus        90 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-  166 (333)
T 1mqb_A           90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM-  166 (333)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999997643  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||||+||+++.++.++|+|||.+.........   .....+++.|+|||.+.+..++.++||||||+++|+++
T Consensus       167 --~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  244 (333)
T 1mqb_A          167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM  244 (333)
T ss_dssp             --TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             --CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHH
Confidence              9999999999999999999999999999876543221   12234567899999998888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||....      .......+......+..   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       245 t~g~~pf~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          245 TYGERPYWELS------NHEVMKAINDGFRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             TTSCCTTTTCC------HHHHHHHHHTTCCCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             cCCCCCcccCC------HHHHHHHHHCCCcCCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8 999985332      22233333332222111   245667899999999999999999999999886

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.3e-43  Score=266.24  Aligned_cols=210  Identities=22%  Similarity=0.323  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......++|||++.+++|.+++....   .++...++.++.|++.||.|||+. 
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~-  127 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK-  127 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            5678999999999999999999999999999999999999999999987543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC----ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        |++|+||+|+||+++.++    .++|+|||.+....... ......+++.|+|||.+.+..++.++||||||+++|+|
T Consensus       128 --~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  204 (283)
T 3bhy_A          128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL  204 (283)
T ss_dssp             --TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             --CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence              999999999999998877    79999999998764332 23345688999999999888899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+..+.+++.+||..||.+|||+.++++
T Consensus       205 ~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          205 LSGASPFLGET------KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHSSCTTCCSS------HHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHCCCCCCCcc------hHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            99999985432      22233333333333223333456678999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-43  Score=278.18  Aligned_cols=214  Identities=23%  Similarity=0.391  Sum_probs=172.1

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCC--------------------------
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTS--------------------------   54 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------------------   54 (228)
                      +.+.+|+++++++ +||||+++++++.... ..++||||+.+++|.+++.....                          
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL  149 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhh
Confidence            5689999999999 7999999999997754 48999999999999999976432                          


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEE
Q 040501           55 -------------------------------------AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLL   97 (228)
Q Consensus        55 -------------------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~   97 (228)
                                                           ...+++..++.++.|++.||+|||+.   |++|+||||+||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll  226 (359)
T 3vhe_A          150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  226 (359)
T ss_dssp             ----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             hccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEE
Confidence                                                 12288899999999999999999999   99999999999999


Q ss_pred             cCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-CCCCccccccccCCC
Q 040501           98 DLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSN  174 (228)
Q Consensus        98 ~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~  174 (228)
                      +.++.++|+|||++.........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......    
T Consensus       227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----  302 (359)
T 3vhe_A          227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----  302 (359)
T ss_dssp             CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----
T ss_pred             cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----
Confidence            99999999999999866433322  233567888999999998889999999999999999998 99998643211    


Q ss_pred             chhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       ................   ...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       303 -~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          303 -EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             -HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence             1111111111111111   234567899999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-43  Score=268.17  Aligned_cols=213  Identities=24%  Similarity=0.375  Sum_probs=171.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeE-EEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.+.+|+.+++.++||||+++++++...... ++++|++.+++|.+++....  ..+++..++.++.|++.||.|||+.
T Consensus        66 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~  143 (298)
T 3pls_A           66 VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ  143 (298)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            35788999999999999999999999766554 99999999999999997643  3378899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC----CCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS----SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                         |++|+||||+||+++.++.++|+|||.+.......    .......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       144 ---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  220 (298)
T 3pls_A          144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE  220 (298)
T ss_dssp             ---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence               99999999999999999999999999997654321    12233567889999999999899999999999999999


Q ss_pred             HHhCCCC-ccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIKGKHP-RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++|..| |...      ........+.........   ...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       221 l~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          221 LLTRGAPPYRHI------DPFDLTHFLAQGRRLPQP---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             HHHTSCCTTTTS------CGGGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhCCCCCCccC------CHHHHHHHhhcCCCCCCC---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            9995555 4322      222222222222222111   2345678999999999999999999999998863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.9e-43  Score=268.29  Aligned_cols=213  Identities=26%  Similarity=0.415  Sum_probs=175.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......|+|||++.+++|.+++..... ..++...++.++.|++.||.|||+. 
T Consensus        53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~-  130 (288)
T 3kfa_A           53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-  130 (288)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC-
Confidence            36788999999999999999999999999999999999999999999976443 3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       131 --~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~  208 (288)
T 3kfa_A          131 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  208 (288)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence              9999999999999999999999999999876543322 222345678999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+........   ...++..+.+++.+||..||.+|||++++++.|+
T Consensus       209 g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          209 GMSPYPGIDL------SQVYELLEKDYRMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             SCCSSTTCCG------GGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCH------HHHHHHHhccCCCCC---CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            9999864322      122222222211111   1245667999999999999999999999999886

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-43  Score=271.01  Aligned_cols=212  Identities=20%  Similarity=0.291  Sum_probs=165.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++||||+++++++......|+++|++.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~--  153 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA--  153 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999987643   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       154 -~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  232 (309)
T 2h34_A          154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS  232 (309)
T ss_dssp             -TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred             -cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence             999999999999999999999999999876543322 123456889999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-CHHHHHHHhh
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-NMQTICQLLC  227 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~  227 (228)
                      .||......       ..........+........++..+.++|.+||+.||.+|| |++++++.|+
T Consensus       233 ~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          233 PPYQGDQLS-------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             CSSCSCHHH-------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCCchHH-------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence            998643221       1112222222222222345666799999999999999999 9999999886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-43  Score=267.43  Aligned_cols=212  Identities=26%  Similarity=0.450  Sum_probs=174.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......+++||++.+++|.+++.....  .++...++.++.|++.||.+||+. 
T Consensus        47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  123 (267)
T 3t9t_A           47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA-  123 (267)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            46789999999999999999999999999999999999999999999976532  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       124 --~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  201 (267)
T 3t9t_A          124 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE  201 (267)
T ss_dssp             --TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence              999999999999999999999999999876542211 1123456778999999988889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||....      .......+.........   ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       202 g~~p~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          202 GKIPYENRS------NSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             SCCTTTTCC------HHHHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHhcCCcCCCC---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            899986432      22223333222211111   234567899999999999999999999999886

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.2e-43  Score=281.58  Aligned_cols=205  Identities=25%  Similarity=0.385  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        61 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~--  135 (476)
T 2y94_A           61 GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH--  135 (476)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            468899999999999999999999999999999999999999999997543   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|.
T Consensus       136 -givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~  213 (476)
T 2y94_A          136 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT  213 (476)
T ss_dssp             -TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred             -CCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence             9999999999999999999999999999876533 22344678999999999988765 67999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||...      +.......+........    ...+.++.++|.+||..||.+|||+.++++
T Consensus       214 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          214 LPFDDD------HVPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CSSCCS------SSHHHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCC------CHHHHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            998632      22233344433332211    234557899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-43  Score=286.77  Aligned_cols=209  Identities=24%  Similarity=0.374  Sum_probs=177.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......|+|||++.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus        70 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-  145 (484)
T 3nyv_A           70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN-  145 (484)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999999999999999999999999887543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEE---cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||++   +.++.+||+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|+
T Consensus       146 --~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll  221 (484)
T 3nyv_A          146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL  221 (484)
T ss_dssp             --TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred             --CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH
Confidence              99999999999999   56789999999999876533 23344678999999999876 6899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|.+||...      ........+...........+...+..+.++|.+||+.||.+|||+.++++
T Consensus       222 ~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          222 SGCPPFNGA------NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HSSCSSCCS------SHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCC------CHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            999998643      233344445445444444455677888999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4e-43  Score=268.02  Aligned_cols=210  Identities=28%  Similarity=0.430  Sum_probs=172.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+++++.++||||+++++++ .....++|||++.+++|.+++....   .++...++.++.|++.||.|||+. 
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-  136 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES-  136 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            45788999999999999999999999 5667899999999999999997643   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCc---eecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNW---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||||+||+++.++.++|+|||++..........   ....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       137 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  214 (291)
T 1xbb_A          137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  214 (291)
T ss_dssp             --TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             --CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence              99999999999999999999999999998765433221   1234567899999998888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||.....      ......+.....+...   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       215 ~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          215 SYGQKPYRGMKG------SEVTAMLEKGERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             TTTCCSSTTCCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             hcCCCCCCCCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9 9999864322      2222222222222211   245668999999999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-43  Score=276.50  Aligned_cols=212  Identities=24%  Similarity=0.286  Sum_probs=162.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++....   .++...+..++.|++.||+|||+. 
T Consensus        60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~-  135 (361)
T 3uc3_A           60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM-  135 (361)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999999999999999999999999999987543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCc--eEEeecccccccCCCCCCceecccccceeCCcccccCCcccc-hhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYE--AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAK-CDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.  +||+|||++...... .......|++.|+|||++.+..++.+ +||||||+++|+|+
T Consensus       136 --~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  212 (361)
T 3uc3_A          136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML  212 (361)
T ss_dssp             --TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred             --CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH
Confidence              9999999999999987765  999999998743322 22334578999999999988877655 89999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||......  .........+........  .....+..+.++|.+||..||.+|||+.++++
T Consensus       213 ~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          213 VGAYPFEDPEEP--RDYRKTIQRILSVKYSIP--DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HSSCSCC----C--CCHHHHHHHHHTTCCCCC--TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCCCCCCccH--HHHHHHHHHHhcCCCCCC--CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            999998643321  112223333333222111  11234567899999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=275.88  Aligned_cols=217  Identities=19%  Similarity=0.255  Sum_probs=171.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.+.+|+..++.++||||+++++++..    ....|+|||++ +++|.+++....   .+++..++.++.|++.||+|||
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH  168 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH  168 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            356788899999999999999999987    67899999999 889999987654   4899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC--ceEEeecccccccCCCCC-------CceecccccceeCCcccccCCcccchhhhh
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEY--EAHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                      +.   |++||||||+||+++.++  .++|+|||++........       ......+++.|+|||++.+..++.++||||
T Consensus       169 ~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  245 (345)
T 2v62_A          169 EN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEI  245 (345)
T ss_dssp             HT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHH
T ss_pred             hC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHH
Confidence            99   999999999999999887  999999999976542211       123457899999999999988999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchh---hhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVD---IRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||+++|+|++|..||.......  ..............+.....   ....+.++.+++.+||..||.+|||+.++++.|
T Consensus       246 lG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  323 (345)
T 2v62_A          246 LGYCMLRWLCGKLPWEQNLKDP--VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL  323 (345)
T ss_dssp             HHHHHHHHHHSSCTTGGGTTCH--HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCcccccccc--HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            9999999999999985321100  00001111111111110000   014566899999999999999999999999998


Q ss_pred             hC
Q 040501          227 CK  228 (228)
Q Consensus       227 ~~  228 (228)
                      ++
T Consensus       324 ~~  325 (345)
T 2v62_A          324 NP  325 (345)
T ss_dssp             CT
T ss_pred             hc
Confidence            74

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=273.07  Aligned_cols=211  Identities=22%  Similarity=0.361  Sum_probs=166.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++||||+++++++..+. .+++++++.+++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~-  136 (327)
T 3lzb_A           61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR-  136 (327)
T ss_dssp             HHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC-
Confidence            467899999999999999999999998764 7889999999999999876543  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       137 --~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             --TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence              9999999999999999999999999999876443322  223445778999999999999999999999999999999


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       |..||......      .....+.........   ..++.++.+++.+||..||.+|||+.++++.|+
T Consensus       215 ~g~~p~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          215 FGSKPYDGIPAS------EISSILEKGERLPQP---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             TSCCTTTTCCGG------GHHHHHHTTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCCHH------HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             99998643221      222222222211111   235567899999999999999999999999886

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-43  Score=266.67  Aligned_cols=211  Identities=25%  Similarity=0.378  Sum_probs=173.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++ .....++|||++.+++|.+++....  ..+++..++.++.|++.||.+||+. 
T Consensus        54 ~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-  129 (287)
T 1u59_A           54 TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK-  129 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            35688999999999999999999999 4567999999999999999986543  3389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.++.++|+|||++.........   .....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus       130 --~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  207 (287)
T 1u59_A          130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  207 (287)
T ss_dssp             --TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             --CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence              9999999999999999999999999999876543322   12234578899999998888999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||.....      ......+.....+...   ..++..+.++|.+||..||.+|||+.++++.|+
T Consensus       208 t~g~~p~~~~~~------~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          208 SYGQKPYKKMKG------PEVMAFIEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TTSCCTTTTCCT------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCcccCCH------HHHHHHHhcCCcCCCC---CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8 9999864322      2222222222222211   245678999999999999999999999999886

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=272.85  Aligned_cols=214  Identities=22%  Similarity=0.356  Sum_probs=165.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......++||||+.+++|.+++....   .++...+..++.|++.||.|||+. 
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~-  121 (311)
T 4agu_A           46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH-  121 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3567899999999999999999999999999999999999999998876543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        |++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus       122 --~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  199 (311)
T 4agu_A          122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG  199 (311)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             --CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence              9999999999999999999999999999876644444455678999999999876 5678999999999999999999


Q ss_pred             CCCccccccccCCCchhhhhhh-----------------cC-CCC------CCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          161 KHPRDFLSNVSSSNPNILVNEM-----------------LD-PRL------PPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~-----------------~~-~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      ..||.........   ......                 .. ...      ..........+..+.+++.+||+.||.+|
T Consensus       200 ~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  276 (311)
T 4agu_A          200 VPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER  276 (311)
T ss_dssp             SCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred             CCCCCCCCHHHHH---HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence            9998643221100   000000                 00 000      00111123456678999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||++++++
T Consensus       277 pt~~ell~  284 (311)
T 4agu_A          277 LTCEQLLH  284 (311)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.4e-43  Score=284.40  Aligned_cols=209  Identities=25%  Similarity=0.396  Sum_probs=176.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++||||+++++++......|+||||+.+++|.+.+....   .+++..+..++.|++.||.|||+. 
T Consensus        80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-  155 (494)
T 3lij_A           80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH-  155 (494)
T ss_dssp             THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999999999999999999999999998886543   288999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++..   +.+||+|||++....... ......|++.|+|||++.+ .++.++||||+||++|+|+
T Consensus       156 --~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll  231 (494)
T 3lij_A          156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILL  231 (494)
T ss_dssp             --TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHH
T ss_pred             --CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHH
Confidence              99999999999999764   459999999998765332 2344678999999998764 6899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...      ........+...........+...+..+.++|.+||+.||.+|||+.++++
T Consensus       232 ~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          232 AGYPPFGGQ------TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HSSCSSCCS------SHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCC------CHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            999998643      233444555455554444455677788999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-43  Score=270.51  Aligned_cols=217  Identities=21%  Similarity=0.353  Sum_probs=168.9

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+++++++ +||||+++++++......|+||||+.+++|.+++....   .++...+..++.|++.||+|||+.
T Consensus        54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~  130 (316)
T 2ac3_A           54 RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK  130 (316)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            46789999999996 79999999999999999999999999999999987643   388999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCc---eEEeecccccccCCCCC-------CceecccccceeCCccccc-----CCcccch
Q 040501           81 CIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAYT-----MKVTAKC  145 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~-----~~~~~~~  145 (228)
                         |++|+||||+||+++.++.   +||+|||++........       ......+++.|+|||.+.+     ..++.++
T Consensus       131 ---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  207 (316)
T 2ac3_A          131 ---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC  207 (316)
T ss_dssp             ---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTH
T ss_pred             ---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCccc
Confidence               9999999999999988766   99999999876542211       1223458999999999875     4578899


Q ss_pred             hhhhHHHHHHHHHhCCCCccccccccCCC---------chhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          146 DVYSFGVLALEVIKGKHPRDFLSNVSSSN---------PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       146 DiwslG~~l~~~~~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      ||||||+++|+|++|..||..........         .......+...............+..+.++|.+||..||.+|
T Consensus       208 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  287 (316)
T 2ac3_A          208 DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR  287 (316)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred             ccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhC
Confidence            99999999999999999986543211000         011222333333332223334567789999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||++++++
T Consensus       288 ps~~e~l~  295 (316)
T 2ac3_A          288 LSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-43  Score=268.64  Aligned_cols=212  Identities=26%  Similarity=0.407  Sum_probs=169.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.+.+|+.++++++||||+++++++ ..+...+++||++.+++|.+++....  ..++...++.++.|++.||.|||+.
T Consensus        70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~  147 (298)
T 3f66_A           70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK  147 (298)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            35688999999999999999999986 45568899999999999999997643  3378999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC----CceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS----NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                         |++|+||||+||+++.++.++|+|||.+........    ......+++.|+|||.+.+..++.++||||||+++|+
T Consensus       148 ---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  224 (298)
T 3f66_A          148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  224 (298)
T ss_dssp             ---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             ---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence               999999999999999999999999999986543221    1233456788999999998889999999999999999


Q ss_pred             HHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++ |.+||.....      ................   ...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       225 l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          225 LMTRGAPPYPDVNT------FDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             HHTTSCCSSTTSCT------TTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCCCCCCccCCH------HHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999 5666543221      1222222222222111   234567899999999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-43  Score=284.38  Aligned_cols=206  Identities=25%  Similarity=0.289  Sum_probs=165.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~   81 (228)
                      ..+.+|+.+++.++||||++++++|......|+||||+.+++|.+++....   .+++..+..++.|++.||+|||+ . 
T Consensus       193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~-  268 (446)
T 4ejn_A          193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK-  268 (446)
T ss_dssp             --------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC-
Confidence            456789999999999999999999999999999999999999999987643   38999999999999999999998 8 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.++.+||+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       269 --giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  346 (446)
T 4ejn_A          269 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  346 (446)
T ss_dssp             --CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence              999999999999999999999999999986544444455578999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||....      .......+........    ...+.++.++|.+||+.||.+||     |++++++
T Consensus       347 ~Pf~~~~------~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          347 LPFYNQD------HEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CSSCCSS------HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCC------HHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            9985332      2223333322222111    23456789999999999999999     9999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.5e-43  Score=270.80  Aligned_cols=218  Identities=21%  Similarity=0.342  Sum_probs=169.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND---TSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +.+.+|++++++++||||+++++++......|+||||+. ++|.+++...   .....++...+..++.|++.||.|||+
T Consensus        48 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~  126 (317)
T 2pmi_A           48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE  126 (317)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            568899999999999999999999999999999999997 4888887642   222348899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~  158 (228)
                      .   |++||||||+||+++.++.+||+|||.+..............+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus       127 ~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  203 (317)
T 2pmi_A          127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI  203 (317)
T ss_dssp             T---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             C---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9   99999999999999999999999999998765444444456789999999998764 5799999999999999999


Q ss_pred             hCCCCccccccccCCCc---------hhhh---hhh--cCCCCC----C-Cc-----hhhhhhHHHHHHHHHHhhccCCC
Q 040501          159 KGKHPRDFLSNVSSSNP---------NILV---NEM--LDPRLP----P-LS-----VDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~---------~~~~---~~~--~~~~~~----~-~~-----~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      +|..||...........         ....   ...  ..+...    . ..     ......+.++.++|.+||+.||.
T Consensus       204 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  283 (317)
T 2pmi_A          204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD  283 (317)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence            99999864322110000         0000   000  000000    0 00     00113456789999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||++++++
T Consensus       284 ~Rpt~~e~l~  293 (317)
T 2pmi_A          284 MRLSAKQALH  293 (317)
T ss_dssp             GSCCHHHHTT
T ss_pred             cCCCHHHHhC
Confidence            9999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=277.93  Aligned_cols=212  Identities=25%  Similarity=0.401  Sum_probs=163.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCT-HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++++.+|+.++++++||||+++++++. .....++||||+.+++|.+++.....  .++...++.++.|++.||.|||+.
T Consensus       134 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~  211 (373)
T 3c1x_A          134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK  211 (373)
T ss_dssp             HHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            367899999999999999999999865 45688999999999999999976443  378899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                         |++||||||+||+++.++.+||+|||++.........    .....+++.|+|||.+.+..++.++||||||+++|+
T Consensus       212 ---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e  288 (373)
T 3c1x_A          212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  288 (373)
T ss_dssp             ---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             ---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence               9999999999999999999999999999865432211    223456778999999998899999999999999999


Q ss_pred             HHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++ |.+||......      .....+........+   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       289 llt~~~~p~~~~~~~------~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          289 LMTRGAPPYPDVNTF------DITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             HHTTSCCSCTTSCSS------CHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCcCCCCCCCCHH------HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999 77787543221      122222222221111   245567999999999999999999999999886

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-43  Score=274.75  Aligned_cols=210  Identities=25%  Similarity=0.375  Sum_probs=168.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++. +...++|+||+.+++|.+++....  ..+++..++.++.|++.||.|||+.  
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--  134 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH--  134 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            34678999999999999999999986 457899999999999999987642  2488899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                       |++||||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|++++ 
T Consensus       135 -~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  213 (325)
T 3kex_A          135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF  213 (325)
T ss_dssp             -TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhC
Confidence             9999999999999999999999999999876543322  334566778999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+.........   ..++..+.+++.+||..||.+|||+.++++.|+
T Consensus       214 g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          214 GAEPYAGLRL------AEVPDLLEKGERLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             SCCTTTTSCT------THHHHHHHTTCBCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             CCCCccccCH------HHHHHHHHcCCCCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999864321      1222222222111111   123446789999999999999999999999886

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.6e-43  Score=284.66  Aligned_cols=209  Identities=27%  Similarity=0.408  Sum_probs=177.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.++++++||||+++++++......|+||||+.+++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        90 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-  165 (504)
T 3q5i_A           90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH-  165 (504)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            3568899999999999999999999999999999999999999999887543   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC---ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++   .+||+|||++...... .......|++.|+|||++.+ .++.++||||+|+++|+|+
T Consensus       166 --~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll  241 (504)
T 3q5i_A          166 --NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILL  241 (504)
T ss_dssp             --TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHH
T ss_pred             --CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHH
Confidence              999999999999998876   6999999999876543 23344678999999998774 5899999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||...      ........+...........+...+.++.++|.+||..||.+|||+.++++
T Consensus       242 ~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          242 CGYPPFGGQ------NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HSSCSSCCS------SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCCCCC------CHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999998643      233445555555554444455667788999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-44  Score=275.13  Aligned_cols=210  Identities=28%  Similarity=0.418  Sum_probs=164.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.+.+|++++++++||||+++++++....    ..|+||||+.+++|.+++....   .++...++.++.|++.||.|||
T Consensus        57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH  133 (311)
T 3ork_A           57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH  133 (311)
T ss_dssp             HHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            46889999999999999999999987654    3499999999999999997643   3899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      +.   |++|+||||+||+++.++.+||+|||++.........   .....|++.|+|||.+.+..++.++||||||+++|
T Consensus       134 ~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~  210 (311)
T 3ork_A          134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY  210 (311)
T ss_dssp             HT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred             HC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHH
Confidence            99   9999999999999999999999999999866433222   22356899999999999988999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|++|..||....      .......................+.++.++|.+||+.||.+||++.+++.
T Consensus       211 ~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          211 EVLTGEPPFTGDS------PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHSSCSCCCSS------HHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHHhCCCCCCCCC------hHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            9999999985432      22222333333332222223456778999999999999999998776654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-43  Score=273.05  Aligned_cols=215  Identities=22%  Similarity=0.382  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------SAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +..+.+|+++++.++|+||+++++++......++|||++.+++|.+++....       ....+++..++.++.|++.||
T Consensus        72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  151 (322)
T 1p4o_A           72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM  151 (322)
T ss_dssp             HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence            3468899999999999999999999999999999999999999999987521       123468899999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      .|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++||||||+
T Consensus       152 ~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  228 (322)
T 1p4o_A          152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV  228 (322)
T ss_dssp             HHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence            999999   9999999999999999999999999998765433221  12234578899999998888999999999999


Q ss_pred             HHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          153 LALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       153 ~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ++|+|++ |..||....      .......+.........   ..++..+.+++.+||+.||.+|||+.++++.|++
T Consensus       229 il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~  296 (322)
T 1p4o_A          229 VLWEIATLAEQPYQGLS------NEQVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  296 (322)
T ss_dssp             HHHHHHHTSCCTTTTSC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             HHHHHHhcCCCccccCC------HHHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            9999999 899975432      22233333333322221   2456678999999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-43  Score=272.34  Aligned_cols=213  Identities=24%  Similarity=0.374  Sum_probs=172.8

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINVI   67 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~~   67 (228)
                      .+.+.+|+++++++ +||||+++++++......|+|||++.+++|.+++....             ....++...++.++
T Consensus        69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  148 (327)
T 1fvr_A           69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA  148 (327)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHH
Confidence            35688999999999 89999999999999999999999999999999997643             22358999999999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhh
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      .|++.||.|||+.   |++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+..++.++||
T Consensus       149 ~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  224 (327)
T 1fvr_A          149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDV  224 (327)
T ss_dssp             HHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcc
Confidence            9999999999999   9999999999999999999999999998743321 11223456778999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||||+++|+|++ |..||....      .......+........   ...++..+.++|.+||..||.+|||+.++++.|
T Consensus       225 ~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          225 WSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGGGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCCCCCCCc------HHHHHHHhhcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            999999999998 999985432      2222233322221111   124566799999999999999999999999987


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       296 ~  296 (327)
T 1fvr_A          296 N  296 (327)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-42  Score=275.69  Aligned_cols=212  Identities=21%  Similarity=0.317  Sum_probs=167.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.  
T Consensus        71 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--  147 (389)
T 3gni_B           71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM--  147 (389)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5678899999999999999999999999999999999999999999976532 2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC-------CCceecccccceeCCccccc--CCcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-------SNWTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~  153 (228)
                       |++||||||+||+++.++.++|+|||.+.......       .......+++.|+|||++.+  ..++.++|||||||+
T Consensus       148 -~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  226 (389)
T 3gni_B          148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT  226 (389)
T ss_dssp             -TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred             -CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence             99999999999999999999999999876442211       11122467888999999987  578999999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCC------------------------------------------CCc
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLP------------------------------------------PLS  191 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~  191 (228)
                      +|+|++|..||.......      ..........+                                          ...
T Consensus       227 l~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (389)
T 3gni_B          227 ACELANGHVPFKDMPATQ------MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH  300 (389)
T ss_dssp             HHHHHHSSCTTTTCCSTT------HHHHC---------------------------------------------------
T ss_pred             HHHHHHCCCCCCCCCHHH------HHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCC
Confidence            999999999986432211      11111110000                                          000


Q ss_pred             hhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          192 VDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       192 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ......+..+.++|.+||+.||.+|||+.++++
T Consensus       301 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          301 PYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            112345667899999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=272.69  Aligned_cols=198  Identities=22%  Similarity=0.380  Sum_probs=167.4

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENG-SLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|++++++++||||+++++++......++|||++.++ +|.+++.....   +++..++.++.|++.||.|||+.  
T Consensus        75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~--  149 (335)
T 3dls_A           75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLK--  149 (335)
T ss_dssp             EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC--
Confidence            4678999999999999999999999999999999998666 99999876543   89999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|.
T Consensus       150 -~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  227 (335)
T 3dls_A          150 -DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE  227 (335)
T ss_dssp             -TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred             -CeEEeccCHHHEEEcCCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC
Confidence             99999999999999999999999999998765433 2344678999999999988876 78999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||......            .......    ...++.++.++|.+||+.||.+|||+.++++
T Consensus       228 ~pf~~~~~~------------~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          228 NPFCELEET------------VEAAIHP----PYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CSCSSGGGG------------TTTCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhHHHH------------HhhccCC----CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            998642211            1111110    1124557899999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-43  Score=272.31  Aligned_cols=216  Identities=24%  Similarity=0.365  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ++.+.+|++++++++||||+++++++..  ....++||||+.+++|.+++....    +++..++.++.|++.||.+||+
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~  152 (318)
T 3lxp_A           77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA  152 (318)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHh
Confidence            4568999999999999999999999987  467899999999999999997643    8899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+
T Consensus       153 ~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  229 (318)
T 3lxp_A          153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE  229 (318)
T ss_dssp             T---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             C---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence            9   9999999999999999999999999999876544322   223456778999999998889999999999999999


Q ss_pred             HHhCCCCcccccccc-----CC----CchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVS-----SS----NPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~-----~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||.......     ..    .................   ...++..+.++|.+||+.||.+|||+.++++.|+
T Consensus       230 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR---PDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC---CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            999999986432110     00    00001111111111111   1345668999999999999999999999999886

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-42  Score=265.87  Aligned_cols=207  Identities=22%  Similarity=0.364  Sum_probs=174.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++|+||+++++++......++|||++.+++|.+++....   .++...++.++.|++.||.|||+. 
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~-  134 (294)
T 2rku_A           59 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN-  134 (294)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4568899999999999999999999999999999999999999999887543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       135 --~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  212 (294)
T 2rku_A          135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  212 (294)
T ss_dssp             --TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999987654444445567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+....... +   ...+..+.+++.+||+.||.+|||++++++
T Consensus       213 ~p~~~~~~------~~~~~~~~~~~~~~-~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          213 PPFETSCL------KETYLRIKKNEYSI-P---KHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CTTCCSSH------HHHHHHHHTTCCCC-C---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCCCCH------HHHHHHHhhccCCC-c---cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            99864321      22222222222211 1   234557889999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-42  Score=277.78  Aligned_cols=208  Identities=22%  Similarity=0.314  Sum_probs=164.3

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++||||+++++++.. ...|+||||+.+++|.+++....   .+++..+..++.|++.||+|||+.   
T Consensus       186 ~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---  258 (419)
T 3i6u_A          186 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---  258 (419)
T ss_dssp             CHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            47899999999999999999999754 56899999999999999886543   389999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCC---ceEEeecccccccCCCCCCceecccccceeCCccccc---CCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEY---EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~~  157 (228)
                      |++||||||+||+++.++   .+||+|||++...... .......|++.|+|||++.+   ..++.++||||||+++|+|
T Consensus       259 ~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~l  337 (419)
T 3i6u_A          259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC  337 (419)
T ss_dssp             TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHH
T ss_pred             CccccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHH
Confidence            999999999999997654   5999999999876532 22344678999999999864   5678899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....     ........+...............+..+.++|.+||+.||.+|||++++++
T Consensus       338 ltg~~pf~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          338 LSGYPPFSEHR-----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHSSCSSCCCS-----SSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCCCCc-----chHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            99999986422     112233333344444444444567788999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-43  Score=286.45  Aligned_cols=213  Identities=24%  Similarity=0.431  Sum_probs=173.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++++++++||||+++++++. ....|+||||+.+++|.+++..... ..++...++.++.|++.||.|||+. 
T Consensus       227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~-  303 (454)
T 1qcf_A          227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR-  303 (454)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            568999999999999999999999987 5678999999999999999975321 2378899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++........ ......++..|+|||.+....++.++||||||+++|+|++ 
T Consensus       304 --~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~  381 (454)
T 1qcf_A          304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY  381 (454)
T ss_dssp             --TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence              999999999999999999999999999986543211 1122345678999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ......+......+.   ...++..+.++|.+||..||.+|||+.++++.|+.
T Consensus       382 g~~P~~~~~~------~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~  441 (454)
T 1qcf_A          382 GRIPYPGMSN------PEVIRALERGYRMPR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  441 (454)
T ss_dssp             SCCSSTTCCH------HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            9999864322      222222222211111   12456789999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.1e-43  Score=276.65  Aligned_cols=204  Identities=25%  Similarity=0.290  Sum_probs=164.4

Q ss_pred             HHHHHHHH-HhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITV-LTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|..+ ++.++||||++++++|......|+||||+.|++|.+++....   .+++..+..++.|++.||.|||+.  
T Consensus        84 ~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--  158 (373)
T 2r5t_A           84 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL--  158 (373)
T ss_dssp             -------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            45667766 466899999999999999999999999999999999987643   388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus       159 -givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          159 -NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             -TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence             9999999999999999999999999999865444444455789999999999999999999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      ||...      +.......+........    ...+..+.++|.+||+.||.+||++.+.+
T Consensus       238 Pf~~~------~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          238 PFYSR------NTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             TTCCS------BHHHHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CCCCC------CHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            98532      22333334433322211    23556789999999999999999985433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-43  Score=271.70  Aligned_cols=214  Identities=23%  Similarity=0.397  Sum_probs=174.7

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVIK   68 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~   68 (228)
                      +.+.+|+++++++ +||||+++++++......|+||||+.+++|.+++.....             ...+++..++.++.
T Consensus        85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  164 (334)
T 2pvf_A           85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  164 (334)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence            5688999999999 899999999999999999999999999999999976432             22478999999999


Q ss_pred             HHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchh
Q 040501           69 GIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        69 ~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      |++.||.|||+.   |++|+||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++|
T Consensus       165 qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  241 (334)
T 2pvf_A          165 QLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  241 (334)
T ss_dssp             HHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred             HHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence            999999999999   9999999999999999999999999999876543221  22234577899999998888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 040501          147 VYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQL  225 (228)
Q Consensus       147 iwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  225 (228)
                      |||||+++|+|++ |..||....      .......+.........   ..++..+.+++.+||..||.+|||+.++++.
T Consensus       242 i~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          242 VWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcCcCC------HHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999 999986432      12222222222211111   2455678999999999999999999999998


Q ss_pred             hhC
Q 040501          226 LCK  228 (228)
Q Consensus       226 l~~  228 (228)
                      |++
T Consensus       313 L~~  315 (334)
T 2pvf_A          313 LDR  315 (334)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.2e-43  Score=263.77  Aligned_cols=208  Identities=23%  Similarity=0.362  Sum_probs=169.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|+.++++++||||+++++++...  ...++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~  129 (271)
T 3kmu_A           51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT  129 (271)
T ss_dssp             HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhc
Confidence            35689999999999999999999999876  788999999999999999986442 248999999999999999999999


Q ss_pred             CCCCC--eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCccc---chhhhhHHHHH
Q 040501           80 DCIPP--IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTA---KCDVYSFGVLA  154 (228)
Q Consensus        80 ~~~~~--i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l  154 (228)
                      .   |  ++|+||||+||+++.++.++++||+.+.....     ....+++.|+|||.+.+..++.   ++||||||+++
T Consensus       130 ~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il  201 (271)
T 3kmu_A          130 L---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL  201 (271)
T ss_dssp             S---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHH
T ss_pred             C---CCceecCCCccceEEEcCCcceeEEeccceeeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHH
Confidence            9   8  99999999999999999999998887654322     2246789999999988765544   79999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |+|++|..||.....      ........ ....+...   ...+..+.+++.+||+.||.+|||++++++.|+
T Consensus       202 ~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          202 WELVTREVPFADLSN------MEIGMKVALEGLRPTIP---PGISPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             HHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCCccccCh------HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999864322      11212221 11111111   245667999999999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-43  Score=282.08  Aligned_cols=205  Identities=20%  Similarity=0.285  Sum_probs=170.7

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||++++++|.+....|+||||+.|++|.+++...    .+++..+..++.|++.||.|||+.  
T Consensus       114 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~--  187 (410)
T 3v8s_A          114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM--  187 (410)
T ss_dssp             STHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            34789999999999999999999999999999999999999999998754    288999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCC----cccchhhhhHHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMK----VTAKCDVYSFGVLALEV  157 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~~  157 (228)
                       ||+||||||+||+++.+|.+||+|||++......... .....|++.|+|||++.+..    ++.++|+||||+++|+|
T Consensus       188 -givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyel  266 (410)
T 3v8s_A          188 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM  266 (410)
T ss_dssp             -TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHH
T ss_pred             -CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHH
Confidence             9999999999999999999999999999876543221 23467999999999987665    78899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCC----CCCCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDP----RLPPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+...    ..+.    ....+.++.++|.+||..+|.+  ||+++++++
T Consensus       267 l~G~~Pf~~~~------~~~~~~~i~~~~~~~~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          267 LVGDTPFYADS------LVGTYSKIMNHKNSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHSSCTTCCSS------HHHHHHHHHTHHHHCCCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HhCCCCCCCCC------hhhHHHHHHhccccccCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            99999986332      22333333221    1111    1245567899999999999988  999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-42  Score=267.11  Aligned_cols=208  Identities=25%  Similarity=0.330  Sum_probs=171.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+|||++.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  125 (304)
T 2jam_A           51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN--  125 (304)
T ss_dssp             -HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            468899999999999999999999999999999999999999999886543   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEE---cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||++   +.++.++|+|||.+......  ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       126 -~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  202 (304)
T 2jam_A          126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC  202 (304)
T ss_dssp             -TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH
T ss_pred             -CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence             99999999999999   67889999999998754322  2233568899999999998889999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+...............+..+.++|.+||..||.+|||+.++++
T Consensus       203 g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          203 GYPPFYEET------ESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             SSCTTTTSC------HHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            999985322      22233333333222222223456678999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-43  Score=283.98  Aligned_cols=213  Identities=26%  Similarity=0.458  Sum_probs=169.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++++++++||||+++++++.. ...|+||||+.+++|.+++.... ...++...++.++.|++.||+|||+. 
T Consensus       223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-  299 (452)
T 1fmk_A          223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM-  299 (452)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4679999999999999999999999876 67899999999999999997432 12388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       300 --~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~  377 (452)
T 1fmk_A          300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  377 (452)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence              9999999999999999999999999999866433221 223456778999999998889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ......+......+.+   ..++..+.++|.+||+.||.+|||++++++.|+.
T Consensus       378 g~~P~~~~~~------~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          378 GRVPYPGMVN------REVLDQVERGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  437 (452)
T ss_dssp             TCCSSTTCCH------HHHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            9999864322      2233333222221111   2456689999999999999999999999998863

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=289.31  Aligned_cols=211  Identities=24%  Similarity=0.367  Sum_probs=171.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||+++++++.. +..|+||||+.+++|.+++....  ..+++..++.++.|++.||+|||+. 
T Consensus       380 ~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~-  455 (613)
T 2ozo_A          380 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK-  455 (613)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999976 56899999999999999986543  3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.+||+|||++.........   .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       456 --~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  533 (613)
T 2ozo_A          456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  533 (613)
T ss_dssp             --TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             --CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence              9999999999999999999999999999876433222   11233467899999999889999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||.....      ......+........+   ..++.++.++|.+||..||.+|||+.++++.|+
T Consensus       534 t~G~~Pf~~~~~------~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          534 SYGQKPYKKMKG------PEVMAFIEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             TTSCCTTTTCCS------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             HCCCCCCCCCCH------HHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            8 9999864332      2233333333222211   246678999999999999999999999999886

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-43  Score=278.91  Aligned_cols=215  Identities=14%  Similarity=0.190  Sum_probs=165.6

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeec----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHA----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +..|+..++.++|+||+++++++...    ...|+||||+ +++|.+++....  ..+++..++.++.|++.||.|||+.
T Consensus        95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~  171 (364)
T 3op5_A           95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH  171 (364)
T ss_dssp             HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44566677778899999999998764    4589999999 889999997643  3389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEc--CCCceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           81 CIPPIVHRDISSKNVLLD--LEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                         |++||||||+||+++  .++.+||+|||++.........       .....|++.|+|||++.+..++.++||||||
T Consensus       172 ---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  248 (364)
T 3op5_A          172 ---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG  248 (364)
T ss_dssp             ---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred             ---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH
Confidence               999999999999999  8899999999999765432211       1334589999999999998999999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchh---hhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVD---IRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++|..||........  ...................   ...++.++.+++..||..||.+|||+.++++.|+
T Consensus       249 ~~l~el~~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          249 YCMIQWLTGHLPWEDNLKDPK--YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHSCCTTGGGTTCHH--HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhCCCCccccccCHH--HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            999999999999874221100  0000000000000000000   0244667999999999999999999999999886

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-42  Score=273.10  Aligned_cols=210  Identities=23%  Similarity=0.431  Sum_probs=175.0

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+.+++++ +||||+++++++......|+||||+.+++|.+++....   .++...+..++.|++.||.|||+.
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~  219 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN  219 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            35678999999999 79999999999999999999999999999999987543   389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC------CcccchhhhhHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM------KVTAKCDVYSFGVLA  154 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l  154 (228)
                         |++|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+.      .++.++||||||+++
T Consensus       220 ---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il  295 (365)
T 2y7j_A          220 ---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL  295 (365)
T ss_dssp             ---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred             ---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence               99999999999999999999999999988765432 23446789999999988632      578899999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|..||...      ........+...........+...+..+.++|.+||..||.+|||+.++++
T Consensus       296 ~ell~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          296 FTLLAGSPPFWHR------RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHSSCSSCCS------SHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHCCCCCCCC------CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9999999998532      222333333333333333334456678999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-43  Score=276.09  Aligned_cols=215  Identities=27%  Similarity=0.436  Sum_probs=172.6

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-----------CCCCCCHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-----------SAEELGWSRRINVIKG   69 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~~   69 (228)
                      ++.+.+|+++++.+ +||||+++++++......|+||||+.+++|.+++....           ....++...++.++.|
T Consensus        93 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  172 (333)
T 2i1m_A           93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ  172 (333)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHH
Confidence            35688999999999 89999999999999999999999999999999987532           1234789999999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhh
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      ++.||.|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++||
T Consensus       173 i~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  249 (333)
T 2i1m_A          173 VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV  249 (333)
T ss_dssp             HHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH
Confidence            99999999999   9999999999999999999999999999865433322  223456778999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||||+++|+|++ |..||.......  ..............+      ...+..+.+++.+||+.||.+|||+.++++.|
T Consensus       250 ~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  321 (333)
T 2i1m_A          250 WSYGILLWEIFSLGLNPYPGILVNS--KFYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFL  321 (333)
T ss_dssp             HHHHHHHHHHTTTSCCSSTTCCSSH--HHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCcccchhH--HHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence            999999999998 999986432111  001111111111111      23456789999999999999999999999988


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       322 ~  322 (333)
T 2i1m_A          322 Q  322 (333)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.5e-43  Score=265.57  Aligned_cols=211  Identities=23%  Similarity=0.372  Sum_probs=168.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++..+ ..|+|||++.+++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  132 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI-  132 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            45788999999999999999999998754 56899999999999999976432  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       133 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~  210 (281)
T 3cc6_A          133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF  210 (281)
T ss_dssp             --TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence              9999999999999999999999999999866543222 223456778999999988889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||......      .....+.........   ..++..+.+++.+||..||.+|||+.++++.|+
T Consensus       211 g~~p~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          211 GKQPFFWLENK------DVIGVLEKGDRLPKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             TCCTTTTSCGG------GHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcccCChH------HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            99998643221      111111111111111   235567899999999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-43  Score=269.49  Aligned_cols=206  Identities=24%  Similarity=0.447  Sum_probs=166.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++......++||||+.+++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~-  132 (289)
T 4fvq_A           56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN-  132 (289)
T ss_dssp             HHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC-
Confidence            46788999999999999999999999999999999999999999999976532  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCc--------eEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYE--------AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGV  152 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~  152 (228)
                        |++||||||+||+++.++.        ++|+|||.+.....    .....+++.|+|||.+.+ ..++.++||||||+
T Consensus       133 --~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  206 (289)
T 4fvq_A          133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGT  206 (289)
T ss_dssp             --TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred             --CeECCCcCcceEEEecCCcccccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence              9999999999999988876        99999999865432    223457888999999887 66899999999999


Q ss_pred             HHHHHHhC-CCCccccccccCCCchhhhhhhc-CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          153 LALEVIKG-KHPRDFLSNVSSSNPNILVNEML-DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       153 ~l~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ++|+|++| .+||....      ......... ....+.      ..+.++.+++.+||+.||.+|||+.++++.|++
T Consensus       207 il~el~~g~~~~~~~~~------~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          207 TLWEICSGGDKPLSALD------SQRKLQFYEDRHQLPA------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             HHHHHHTTTCCTTTTSC------HHHHHHHHHTTCCCCC------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHcCCCCCccccc------hHHHHHHhhccCCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            99999995 44543221      111111111 111111      123357899999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.2e-43  Score=272.09  Aligned_cols=218  Identities=26%  Similarity=0.366  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeee--ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ++.+.+|++++++++|+||+++++++.  .....|+||||+++++|.+++.....  .+++..++.++.|++.||+|||+
T Consensus        68 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~  145 (327)
T 3lxl_A           68 QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS  145 (327)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            356899999999999999999999886  45678999999999999999876432  38999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||||+||+++.++.++|+|||.+.........   .....++..|+|||.+.+..++.++||||||+++|+
T Consensus       146 ~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  222 (327)
T 3lxl_A          146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE  222 (327)
T ss_dssp             T---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             C---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHH
Confidence            9   9999999999999999999999999999876543322   223456778999999998889999999999999999


Q ss_pred             HHhCCCCccccccc---------cCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNV---------SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||......         ....................   ...++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       223 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999997543221         00000111111112221111   1355677999999999999999999999999886

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-42  Score=283.72  Aligned_cols=208  Identities=23%  Similarity=0.299  Sum_probs=173.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|++++++++||||+++++++......|+||||+.|++|.+++.... ....+++..++.++.|++.||.|||+. 
T Consensus       230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-  308 (543)
T 3c4z_A          230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-  308 (543)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-
Confidence            467899999999999999999999999999999999999999999987643 234589999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.+|.+||+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       309 --gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~  386 (543)
T 3c4z_A          309 --NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR  386 (543)
T ss_dssp             --TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCC
Confidence              999999999999999999999999999987665444444568999999999999989999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .||......  .........+....... +   ...+..+.++|.+||..||.+||++
T Consensus       387 ~PF~~~~~~--~~~~~~~~~i~~~~~~~-p---~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          387 GPFRARGEK--VENKELKQRVLEQAVTY-P---DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CSSCCTTCC--CCHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CCCCCCccc--hhHHHHHHHHhhcccCC-C---cccCHHHHHHHHHhccCCHhHCCCC
Confidence            998643211  11222333333322211 1   2456678999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-42  Score=269.51  Aligned_cols=212  Identities=23%  Similarity=0.316  Sum_probs=171.0

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +..+.+|+.+++.+ .||||+++++++......|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.
T Consensus        72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~  150 (327)
T 3lm5_A           72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN  150 (327)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            46788999999999 57999999999999999999999999999999986532 23489999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++||||||+||+++.   ++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|
T Consensus       151 ---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  226 (327)
T 3lm5_A          151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML  226 (327)
T ss_dssp             ---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             ---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHH
Confidence               9999999999999987   7899999999998765332 23345789999999999988999999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||....      .......+...............+..+.++|.+||+.||.+|||++++++
T Consensus       227 l~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          227 LTHTSPFVGED------NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHSSCSSCCSS------HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhCCCCCCCCC------chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            99999985432      22222222222222222233456678999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=266.48  Aligned_cols=211  Identities=25%  Similarity=0.390  Sum_probs=174.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++||||+++++++......|+|||++.+++|.+++....  ..++...++.++.|++.||.|||+. 
T Consensus        68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~-  144 (314)
T 3com_A           68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM-  144 (314)
T ss_dssp             CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3578899999999999999999999999999999999999999999986432  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       145 --~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  222 (314)
T 3com_A          145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK  222 (314)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             --CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC
Confidence              999999999999999999999999999987665444445567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||......      ...........+. .......+..+.++|.+||..||.+|||+.++++
T Consensus       223 ~p~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          223 PPYADIHPM------RAIFMIPTNPPPT-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CTTTTSCHH------HHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCChH------HHHHHHhcCCCcc-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            998643221      1111111111111 1112345667999999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-42  Score=284.84  Aligned_cols=211  Identities=21%  Similarity=0.255  Sum_probs=173.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+.+|+++++.++||||+++++++.+....|+||||+.|++|.+++..... ..+++..++.++.|++.||.|||+.  
T Consensus       229 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~--  305 (576)
T 2acx_A          229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE--  305 (576)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            4578999999999999999999999999999999999999999999876432 3489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       ||+||||||+||+++.+|.+||+|||++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       306 -gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~  383 (576)
T 2acx_A          306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS  383 (576)
T ss_dssp             -TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred             -CEeccCCchheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence             99999999999999999999999999998765332 2344679999999999999889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      ||.......  ........+..... ...   ...+.++.++|.+||..||.+||     +++++++
T Consensus       384 PF~~~~~~~--~~~~i~~~i~~~~~-~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          384 PFQQRKKKI--KREEVERLVKEVPE-EYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             SSSCSSSCC--CHHHHHHHHHHCCC-CCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CCcccccch--hHHHHHHHhhcccc-cCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            986432211  11112222211111 111   24566789999999999999999     6788764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.8e-43  Score=270.84  Aligned_cols=207  Identities=22%  Similarity=0.364  Sum_probs=173.6

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++|+||+++++++.+....|+||||+.+++|.+++....   .+++..++.++.|++.||.|||+. 
T Consensus        85 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~-  160 (335)
T 2owb_A           85 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN-  160 (335)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4568899999999999999999999999999999999999999999887543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||||+||+++.++.++|+|||++..............+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       161 --~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  238 (335)
T 2owb_A          161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             --TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence              999999999999999999999999999987654444445567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+....... .   ...+..+.++|.+||+.||.+|||+.++++
T Consensus       239 ~pf~~~~~------~~~~~~~~~~~~~~-~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          239 PPFETSCL------KETYLRIKKNEYSI-P---KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CTTCCSSH------HHHHHHHHHTCCCC-C---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCCCCH------HHHHHHHhcCCCCC-C---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99864321      11222222221111 1   134557889999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=265.72  Aligned_cols=213  Identities=24%  Similarity=0.351  Sum_probs=170.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++||||+++++++......++|||++.+++|.+++........++...+..++.|++.||.|||+. 
T Consensus        63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-  141 (295)
T 2clq_A           63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-  141 (295)
T ss_dssp             -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-
Confidence            4568899999999999999999999999999999999999999999998765444577899999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccCC--cccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++. ++.++|+|||.+..............+++.|+|||.+.+..  ++.++||||||+++|+|+
T Consensus       142 --~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  219 (295)
T 2clq_A          142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA  219 (295)
T ss_dssp             --TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH
T ss_pred             --CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH
Confidence              9999999999999987 89999999999987654433344567889999999987643  788999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||.......    ............+..   ....+.++.+++.+||+.||.+|||+.++++
T Consensus       220 ~g~~pf~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          220 TGKPPFYELGEPQ----AAMFKVGMFKVHPEI---PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HTSCTTGGGSSHH----HHHHHHHHHCCCCCC---CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HCCCCccCCCchh----HHHHhhccccccccc---cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999986432111    111111111111111   1245567899999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.7e-43  Score=265.72  Aligned_cols=211  Identities=26%  Similarity=0.401  Sum_probs=164.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+.+.+|++++++++||||+++++++......|+||||+.+++|.+.+... .....++...++.++.|++.||.|||+.
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  143 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ  143 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999999999999999999999999999999999888542 1123489999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEE---cCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||++   +.++.++|+|||++....... ......+++.|+|||.+. ..++.++||||||+++|+|
T Consensus       144 ---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~l  218 (285)
T 3is5_A          144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFL  218 (285)
T ss_dssp             ---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHH
T ss_pred             ---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHH
Confidence               99999999999999   455789999999997654332 234457899999999875 4678899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||.....      ............ .........+..+.+++.+||+.||.+|||+.++++
T Consensus       219 l~g~~pf~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          219 LTGCLPFTGTSL------EEVQQKATYKEP-NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHSSCSSCCSSH------HHHHHHHHHCCC-CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HhCCCCCCCCCH------HHHHhhhccCCc-ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999864321      111111111111 111112235567889999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-42  Score=265.49  Aligned_cols=207  Identities=27%  Similarity=0.459  Sum_probs=174.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.+++.++||||+++++++......|+||||+.+++|.+++...    .++...++.++.|++.||.+||+. 
T Consensus        64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~-  138 (303)
T 3a7i_A           64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE-  138 (303)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            367899999999999999999999999999999999999999999998643    389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       139 --~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  216 (303)
T 3a7i_A          139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE  216 (303)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence              999999999999999999999999999987665444445567899999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+.....+...   ..++..+.+++.+||..||.+|||+.++++
T Consensus       217 ~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          217 PPHSELHP------MKVLFLIPKNNPPTLE---GNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CTTTTSCH------HHHHHHHHHSCCCCCC---SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCCcCH------HHHHHHhhcCCCCCCc---cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            99864322      1222222222221111   245567899999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-42  Score=266.33  Aligned_cols=213  Identities=22%  Similarity=0.392  Sum_probs=166.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC-----eEEEEEEeecCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNND---TSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +.+.+|+.++++++||||+++++++....     ..++|||++.+++|.+++...   .....+++..++.++.|++.||
T Consensus        81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  160 (313)
T 3brb_A           81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM  160 (313)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHH
Confidence            56889999999999999999999997654     459999999999999998532   2234589999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      .|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++||||||+
T Consensus       161 ~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  237 (313)
T 3brb_A          161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV  237 (313)
T ss_dssp             HHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHH
T ss_pred             HHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHH
Confidence            999999   9999999999999999999999999998765433221  22345678899999999888999999999999


Q ss_pred             HHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          153 LALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       153 ~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ++|+|++ |..||.....      ................   ..++..+.+++.+||..||.+|||+.++++.|+
T Consensus       238 il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          238 TMWEIATRGMTPYPGVQN------HEMYDYLLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             HHHHHHTTSCCSSTTCCG------GGHHHHHHTTCCCCCB---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCccCCH------HHHHHHHHcCCCCCCC---ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999999 8999764322      2222333333222221   345667999999999999999999999999886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-43  Score=276.83  Aligned_cols=220  Identities=23%  Similarity=0.345  Sum_probs=175.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC--eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR--HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|++++++++||||+++++++....  ..++||||+.+++|.+++........+++..++.++.|++.||+|||+
T Consensus        51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  130 (396)
T 4eut_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (396)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            356789999999999999999999997654  789999999999999999865544458999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEE----cCCCceEEeecccccccCCCCCCceecccccceeCCccccc--------CCcccchhh
Q 040501           80 DCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT--------MKVTAKCDV  147 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di  147 (228)
                      .   |++||||||+||++    +.++.+||+|||++....... ......+++.|+|||++.+        ..++.++||
T Consensus       131 ~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di  206 (396)
T 4eut_A          131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL  206 (396)
T ss_dssp             T---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHH
T ss_pred             C---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHH
Confidence            9   99999999999999    777889999999998764332 2234568999999998865        457889999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCC---------------------CCCchhhhhhHHHHHHHHH
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL---------------------PPLSVDIRGKVISIMEVAF  206 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~  206 (228)
                      ||||+++|+|++|..||.......  ........+..+..                     +.........+..+.+++.
T Consensus       207 wSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~  284 (396)
T 4eut_A          207 WSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA  284 (396)
T ss_dssp             HHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHH
Confidence            999999999999999986432211  11222222222211                     1111222567778999999


Q ss_pred             HhhccCCCCCCCHHHHHHHhh
Q 040501          207 LCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       207 ~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +||+.||.+|||++++++.++
T Consensus       285 ~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          285 NILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             HHSCCCTTTSCCHHHHHHHHH
T ss_pred             HhhccChhhhccHHHHHHHHH
Confidence            999999999999999988764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.9e-43  Score=272.45  Aligned_cols=213  Identities=18%  Similarity=0.260  Sum_probs=159.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......|+||||+.+ +|.+++.....   +++..+..++.|++.||.|||+.  
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~--  151 (329)
T 3gbz_A           78 GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSR--  151 (329)
T ss_dssp             --CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             hhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC--
Confidence            4567999999999999999999999999999999999975 89888876543   88999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEc-----CCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHH
Q 040501           83 PPIVHRDISSKNVLLD-----LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALE  156 (228)
Q Consensus        83 ~~i~h~di~p~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~  156 (228)
                       |++|+||||+||+++     ..+.+||+|||++..............+++.|+|||++.+.. ++.++||||||+++|+
T Consensus       152 -~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  230 (329)
T 3gbz_A          152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE  230 (329)
T ss_dssp             -TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             -CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence             999999999999994     445699999999987665444445567799999999988754 7999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcC----------------CCCCCCch------hhhhhHHHHHHHHHHhhccCCC
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLD----------------PRLPPLSV------DIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      |++|..||.........  .........                ...+....      .....+.++.++|.+||+.||.
T Consensus       231 ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  308 (329)
T 3gbz_A          231 MLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV  308 (329)
T ss_dssp             HHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGG
T ss_pred             HHHCCCCcCCCCHHHHH--HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChh
Confidence            99999998643221100  000000000                00000000      0112456789999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||++++++
T Consensus       309 ~R~t~~e~l~  318 (329)
T 3gbz_A          309 KRISAKNALE  318 (329)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhC
Confidence            9999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.5e-42  Score=259.30  Aligned_cols=209  Identities=25%  Similarity=0.374  Sum_probs=170.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.+++.++||||+++++++..+...|+|+|++.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--  124 (276)
T 2yex_A           50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI--  124 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            578899999999999999999999999999999999999999999986532   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||+|+||+++.++.++|+|||.+.......  .......+++.|+|||.+.+..+ +.++||||||+++|+|++
T Consensus       125 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  203 (276)
T 2yex_A          125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  203 (276)
T ss_dssp             -TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             -CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence             99999999999999999999999999987653222  11234568899999999987765 778999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||......     .............  .......+..+.++|.+||..||.+|||++++++
T Consensus       204 g~~p~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          204 GELPWDQPSDS-----CQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             SSCCCSCSCTT-----SHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCchH-----HHHHHHhhhcccc--cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            99998643211     1111111111111  1123456678899999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-42  Score=265.58  Aligned_cols=217  Identities=17%  Similarity=0.257  Sum_probs=170.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++.++|++++..+..+ ......+++||++ +++|.+++.....  .+++..++.++.|++.||.|||+. 
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~-  124 (296)
T 4hgt_A           49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK-  124 (296)
T ss_dssp             CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578999999999887766666555 6677889999999 8899999875432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEE---cCCCceEEeecccccccCCCCC-------CceecccccceeCCcccccCCcccchhhhhHH
Q 040501           82 IPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                        |++|+||||+||++   +.++.+||+|||++........       ......+++.|+|||.+.+..++.++||||||
T Consensus       125 --~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  202 (296)
T 4hgt_A          125 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG  202 (296)
T ss_dssp             --TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred             --CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHH
Confidence              99999999999999   7889999999999987654332       12345789999999999998999999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++|..||.....................  .+.......++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       203 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          203 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCcccchhhhhhhhhhhhccccc--chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            9999999999999754433222221111111000  0111111344668999999999999999999999999886

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-42  Score=261.25  Aligned_cols=207  Identities=23%  Similarity=0.373  Sum_probs=167.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ++.+.+|+.+++.++||||+++++++..    ....++||||+++++|.+++....   .++...++.++.|++.||.||
T Consensus        69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~l  145 (290)
T 1t4h_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFL  145 (290)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHH
Confidence            4568899999999999999999999865    356899999999999999997643   388999999999999999999


Q ss_pred             hhCCCCC--eeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           78 HHDCIPP--IVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        78 h~~~~~~--i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      |+.   |  ++|+||||+||+++ .++.++|+|||++.....  .......+++.|+|||.+.+ .++.++||||||+++
T Consensus       146 H~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l  219 (290)
T 1t4h_A          146 HTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM  219 (290)
T ss_dssp             HTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred             HcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHH
Confidence            999   8  99999999999997 789999999999975432  23345678999999998764 589999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|..||....     ..............+.  ......+..+.++|.+||+.||.+|||+.++++
T Consensus       220 ~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          220 LEMATSEYPYSECQ-----NAAQIYRRVTSGVKPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHSSCTTTTCS-----SHHHHHHHHTTTCCCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCCCCCcC-----cHHHHHHHHhccCCcc--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            99999999985322     2222223332222211  112334467899999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-43  Score=272.15  Aligned_cols=214  Identities=24%  Similarity=0.316  Sum_probs=168.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......++||||+.+ +|.+++....  ..++...+..++.|++.||.|||+.  
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--  131 (346)
T 1ua2_A           57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH--  131 (346)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3678999999999999999999999999999999999976 7888776543  3378889999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus       132 -~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  210 (346)
T 1ua2_A          132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV  210 (346)
T ss_dssp             -TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             -CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence             99999999999999999999999999998765544445556789999999998764 4788999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCC------------------CCCCCc--hhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDP------------------RLPPLS--VDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      +||.........  .........+                  ..+...  ......+.++.++|.+||..||.+|||+.+
T Consensus       211 ~~~~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  288 (346)
T 1ua2_A          211 PFLPGDSDLDQL--TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  288 (346)
T ss_dssp             CSSCCSSHHHHH--HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             CCCCCCCHHHHH--HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence            998643221100  0000000000                  000000  011344578999999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       289 ll~  291 (346)
T 1ua2_A          289 ALK  291 (346)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-42  Score=262.29  Aligned_cols=205  Identities=26%  Similarity=0.438  Sum_probs=167.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......++||||+.+++|.+++....   .++...++.++.|++.||.|||+. 
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~-  128 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK-  128 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568899999999999999999999999999999999999999999987643   288999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||+|+||+++.++.++|+|||++......  ......+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       129 --~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  204 (279)
T 3fdn_A          129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK  204 (279)
T ss_dssp             --TCEECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             --CEecccCChHhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCC
Confidence              9999999999999999999999999988654322  223457889999999999888999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||....      .......+........    ...+..+.++|.+||+.||.+|||+.++++
T Consensus       205 ~p~~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          205 PPFEANT------YQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CTTCCSS------HHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCCCc------HHHHHHHHHhCCCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            9986332      2222222222221111    134557889999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.8e-43  Score=267.30  Aligned_cols=213  Identities=26%  Similarity=0.412  Sum_probs=171.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeee--ecCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCT--HARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++.+.+|++++++++||||+++++++.  .....|+||||+.+++|.+++.... ....+++..++.++.|++.||.|||
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  128 (279)
T 2w5a_A           49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  128 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            456889999999999999999999884  4678999999999999999987532 2234899999999999999999999


Q ss_pred             hCCCCC-----eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           79 HDCIPP-----IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 ~~~~~~-----i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      +.   |     ++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||++
T Consensus       129 ~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  205 (279)
T 2w5a_A          129 RR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL  205 (279)
T ss_dssp             HH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHH
T ss_pred             cc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHH
Confidence            99   8     999999999999999999999999999876543322334567889999999988889999999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      +|+|++|..||....      .......+.....+...   ..++.++.++|.+||+.||.+|||+.++++.+
T Consensus       206 l~~l~~g~~p~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          206 LYELCALMPPFTAFS------QKELAGKIREGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHSSCSSCCSS------HHHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHCCCCCcccC------HHHHHHHHhhcccccCC---cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            999999999986432      22223333333322222   24566799999999999999999999999765

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-42  Score=288.89  Aligned_cols=210  Identities=27%  Similarity=0.414  Sum_probs=171.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++.. ...++||||+.+++|.+++....   .+++..++.++.|++.||+|||+. 
T Consensus       414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~-  488 (635)
T 4fl3_A          414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES-  488 (635)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999864 56889999999999999997543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        ||+||||||+||+++.++.+||+|||++.........   .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus       489 --~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  566 (635)
T 4fl3_A          489 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  566 (635)
T ss_dssp             --TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             --CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence              9999999999999999999999999999876543322   22334577899999999989999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||.....      ......+.........   ..++.++.++|.+||+.||.+|||++++++.|+
T Consensus       567 t~G~~Pf~~~~~------~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          567 SYGQKPYRGMKG------SEVTAMLEKGERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             TTTCCSSTTCCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            8 9999864322      2233333333222221   246678999999999999999999999999886

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.7e-43  Score=270.72  Aligned_cols=216  Identities=24%  Similarity=0.387  Sum_probs=164.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+||||+.+++|.++.....   .+++..++.++.|++.||.|||+.  
T Consensus        69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~--  143 (331)
T 4aaa_A           69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH--  143 (331)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            457899999999999999999999999999999999999999988866443   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus       144 -~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  222 (331)
T 4aaa_A          144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE  222 (331)
T ss_dssp             -TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred             -CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999998765444444556789999999998775 6889999999999999999999


Q ss_pred             CCccccccccCCCchh------------------hhhhhcCCCC---CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          162 HPRDFLSNVSSSNPNI------------------LVNEMLDPRL---PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~------------------~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      .||.............                  .......+..   .........++..+.++|.+||+.||.+|||++
T Consensus       223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  302 (331)
T 4aaa_A          223 PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA  302 (331)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred             CCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence            9986432211000000                  0000000000   001111234567899999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       303 ell~  306 (331)
T 4aaa_A          303 ELLH  306 (331)
T ss_dssp             GGGG
T ss_pred             HHhc
Confidence            9875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-42  Score=264.03  Aligned_cols=217  Identities=17%  Similarity=0.257  Sum_probs=170.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeee-eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+.+++.++|++++..+..+ ......++|||++ +++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~-  124 (296)
T 3uzp_A           49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK-  124 (296)
T ss_dssp             CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4688999999999887766666555 6677889999999 8899999974432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEc---CCCceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           82 IPPIVHRDISSKNVLLD---LEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                        |++|+||||+||+++   .++.++|+|||.+.........       .....+++.|+|||.+.+..++.++||||||
T Consensus       125 --~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  202 (296)
T 3uzp_A          125 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG  202 (296)
T ss_dssp             --TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred             --CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHH
Confidence              999999999999994   7889999999999876544321       2345789999999999998899999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +++|+|++|..||.....................  .+.......++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       203 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          203 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC--CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            9999999999998754332222211111111000  0011112345667999999999999999999999999886

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.5e-42  Score=269.56  Aligned_cols=204  Identities=25%  Similarity=0.427  Sum_probs=166.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++......|+||||+.| +|.+++....  ..+++..+..++.|++.||.|||+.  
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--  173 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH--  173 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            5688999999999999999999999999999999999974 7777765432  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++||||||+||+++.++.+||+|||++......    ....+++.|+|||++.   +..++.++||||||+++|+|++
T Consensus       174 -~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~  248 (348)
T 1u5q_A          174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  248 (348)
T ss_dssp             -TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             -CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh
Confidence             9999999999999999999999999998765432    2357899999999884   4568899999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||.....      ......+.....+...  ....+..+.++|.+||+.||.+|||++++++
T Consensus       249 g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          249 RKPPLFNMNA------MSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             SSCTTTTSCH------HHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCh------HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            9999854322      1222222222222111  1245567899999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.6e-42  Score=262.92  Aligned_cols=210  Identities=21%  Similarity=0.364  Sum_probs=173.9

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+.+|+++++++. ||||+++++++......++|||++.+++|.+++....   .++...++.++.|++.||.|||+.
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~  143 (298)
T 1phk_A           67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL  143 (298)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            356789999999995 9999999999999999999999999999999997643   389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc------cCCcccchhhhhHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY------TMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l  154 (228)
                         |++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.      ...++.++||||||+++
T Consensus       144 ---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l  219 (298)
T 1phk_A          144 ---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM  219 (298)
T ss_dssp             ---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred             ---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence               99999999999999999999999999998765332 234456889999999875      34578899999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|..||....      .......+..............++..+.+++.+||+.||.+|||+.++++
T Consensus       220 ~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          220 YTLLAGSPPFWHRK------QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHSSCSSCCSS------HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCcCcc------HHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            99999999985322      22233333333333223334567778999999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-42  Score=263.10  Aligned_cols=212  Identities=24%  Similarity=0.444  Sum_probs=171.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++||||+++++++.. +..++|||++.+++|.+++..... ..++...++.++.|++.||.|||+. 
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~-  128 (279)
T 1qpc_A           52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER-  128 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678999999999999999999999864 468999999999999999865321 2388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       129 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  206 (279)
T 1qpc_A          129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (279)
T ss_dssp             --TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             --CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence              9999999999999999999999999999876533211 122345678999999988889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+........   ...++..+.+++.+||..||.+|||+.++++.|+
T Consensus       207 g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          207 GRIPYPGMTN------PEVIQNLERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             TCCSSTTCCH------HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcccCH------HHHHHHHhcccCCCC---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            9999864321      222222222221111   1245668999999999999999999999999886

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-42  Score=264.19  Aligned_cols=211  Identities=22%  Similarity=0.373  Sum_probs=170.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++.... .++|+|++.+++|.+++....  ..++...++.++.|++.||.|||+.  
T Consensus        66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--  140 (291)
T 1u46_A           66 DDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK--  140 (291)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC--
Confidence            57889999999999999999999998764 889999999999999987543  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       141 -~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             -TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             -CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence             9999999999999999999999999999876543322   123456778999999988889999999999999999999


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       |..||....      .......+........  ....++..+.+++.+||..||.+|||+.++++.|+
T Consensus       220 ~g~~p~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          220 YGQEPWIGLN------GSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             TSCCTTTTCC------HHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcccCC------HHHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence             999986432      2222333322211111  11345678999999999999999999999999886

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-42  Score=278.56  Aligned_cols=216  Identities=21%  Similarity=0.266  Sum_probs=159.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+++.+|+++++.++|+||+++++++..     ....|+|||++. ++|.+++....   .+++..+..++.|++.||+|
T Consensus        96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~  171 (458)
T 3rp9_A           96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKY  171 (458)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999943     357899999885 68888887543   38999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---------------------------Cceecccccc
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---------------------------NWTEFAGTYG  129 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---------------------------~~~~~~~~~~  129 (228)
                      ||+.   ||+||||||+||+++.++.+||+|||++........                           ......||+.
T Consensus       172 LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  248 (458)
T 3rp9_A          172 VHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW  248 (458)
T ss_dssp             HHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred             HHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence            9999   999999999999999999999999999987643221                           1233567899


Q ss_pred             eeCCccc-ccCCcccchhhhhHHHHHHHHHh-----------CCCCccccccccCCCc--------------hhhh----
Q 040501          130 YVAPELA-YTMKVTAKCDVYSFGVLALEVIK-----------GKHPRDFLSNVSSSNP--------------NILV----  179 (228)
Q Consensus       130 y~aPE~~-~~~~~~~~~DiwslG~~l~~~~~-----------g~~p~~~~~~~~~~~~--------------~~~~----  179 (228)
                      |+|||++ .+..++.++|||||||++|+|++           |.++|+..........              ....    
T Consensus       249 Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  328 (458)
T 3rp9_A          249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF  328 (458)
T ss_dssp             TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHH
T ss_pred             ccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHH
Confidence            9999976 45668999999999999999998           5555543221100000              0000    


Q ss_pred             -------------------hh----hcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          180 -------------------NE----MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       180 -------------------~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                                         ..    ................+.++.+||.+||..||.+|||++++++
T Consensus       329 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          329 NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                               00    0000111111122344677899999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.7e-42  Score=267.15  Aligned_cols=218  Identities=23%  Similarity=0.343  Sum_probs=170.8

Q ss_pred             hHHHHHHHHHHhc--cCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTE--IRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|+++++.  ++||||+++++++....    ..|+||||+.+++|.+++...    .+++..++.++.|++.||.
T Consensus        78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~  153 (342)
T 1b6c_B           78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA  153 (342)
T ss_dssp             HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHH
Confidence            3567889999888  68999999999998765    789999999999999999754    3889999999999999999


Q ss_pred             Hhh--------hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC----
Q 040501           76 YLH--------HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM----  139 (228)
Q Consensus        76 ~lh--------~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~----  139 (228)
                      |||        +.   |++|+||||+||+++.++.++|+|||++.........    .....+++.|+|||.+.+.    
T Consensus       154 ~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  230 (342)
T 1b6c_B          154 HLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK  230 (342)
T ss_dssp             HHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTT
T ss_pred             HHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccc
Confidence            999        78   9999999999999999999999999999876544322    2334688999999998765    


Q ss_pred             --CcccchhhhhHHHHHHHHHhC----------CCCccccccccCCCchhhhhhhcCCCC-CCCch--hhhhhHHHHHHH
Q 040501          140 --KVTAKCDVYSFGVLALEVIKG----------KHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSV--DIRGKVISIMEV  204 (228)
Q Consensus       140 --~~~~~~DiwslG~~l~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l  204 (228)
                        .++.++||||||+++|+|++|          ..||....... ............... +....  .....+..+.++
T Consensus       231 ~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  309 (342)
T 1b6c_B          231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD-PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI  309 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHH
T ss_pred             ccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc-ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHH
Confidence              334689999999999999999          66765332211 111122222222221 11111  123566789999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHhh
Q 040501          205 AFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +.+||+.||.+|||+.++++.|+
T Consensus       310 i~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          310 MRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHHHHH
Confidence            99999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-42  Score=266.10  Aligned_cols=214  Identities=23%  Similarity=0.394  Sum_probs=172.0

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecC-eEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHAR-HSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVI   67 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~   67 (228)
                      +.+.+|+++++++ +||||+++++++.... ..++||||+.+++|.+++.....             ...++...++.++
T Consensus        75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T 2xir_A           75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  154 (316)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHH
Confidence            4688999999999 7999999999987654 58999999999999999976543             1227889999999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccch
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKC  145 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  145 (228)
                      .|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++
T Consensus       155 ~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  231 (316)
T 2xir_A          155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS  231 (316)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence            9999999999999   9999999999999999999999999999866543332  2234567889999999988899999


Q ss_pred             hhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          146 DVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       146 DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||||+++|+|++ |..||.....     .................   ...+..+.+++.+||+.||.+|||+.++++
T Consensus       232 Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~  303 (316)
T 2xir_A          232 DVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVE  303 (316)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCC-----SHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcccch-----hHHHHHHhccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999998 9999864321     11111222111111111   234567899999999999999999999999


Q ss_pred             Hhh
Q 040501          225 LLC  227 (228)
Q Consensus       225 ~l~  227 (228)
                      .|+
T Consensus       304 ~L~  306 (316)
T 2xir_A          304 HLG  306 (316)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            886

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=271.75  Aligned_cols=211  Identities=18%  Similarity=0.283  Sum_probs=160.8

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPP   84 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~   84 (228)
                      +.+|+++++.++||||+++++++......++||||+.+ +|.+++.....  .++...+..++.|++.||.|||+.   |
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~  120 (324)
T 3mtl_A           47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---K  120 (324)
T ss_dssp             CCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            45799999999999999999999999999999999975 88888776543  388999999999999999999999   9


Q ss_pred             eeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCCCC
Q 040501           85 IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKHP  163 (228)
Q Consensus        85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p  163 (228)
                      ++||||||+||+++.++.++|+|||++..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus       121 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             EEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999999866544444455678999999999876 5679999999999999999999999


Q ss_pred             ccccccccCCCchhhhhhhcCC---------------------C--CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH
Q 040501          164 RDFLSNVSSSNPNILVNEMLDP---------------------R--LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ  220 (228)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~---------------------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  220 (228)
                      |........   .....+....                     .  ...........+.++.++|.+||+.||.+|||++
T Consensus       201 f~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  277 (324)
T 3mtl_A          201 FPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE  277 (324)
T ss_dssp             CCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCHHHH---HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence            864322110   0000000000                     0  0000111224556789999999999999999999


Q ss_pred             HHHH
Q 040501          221 TICQ  224 (228)
Q Consensus       221 ~il~  224 (228)
                      ++++
T Consensus       278 e~l~  281 (324)
T 3mtl_A          278 DAMK  281 (324)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=264.00  Aligned_cols=210  Identities=23%  Similarity=0.333  Sum_probs=167.2

Q ss_pred             HHHHHHHHHHhccC---CCccceeeeeeeecC-----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR---HRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ..+.+|++++++++   ||||+++++++....     ..+++||++. ++|.+++..... ..+++..++.++.|++.||
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al  133 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGL  133 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHH
Confidence            46778998888875   999999999997654     5899999997 599998876543 3389999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      +|||+.   |++|+||||+||+++.++.+||+|||.+...... .......+++.|+|||++.+..++.++||||||+++
T Consensus       134 ~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  209 (308)
T 3g33_A          134 DFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF  209 (308)
T ss_dssp             HHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHH
T ss_pred             HHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHH
Confidence            999999   9999999999999999999999999999865433 223446789999999999988999999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcC-----------------------CCCCCCchhhhhhHHHHHHHHHHhhcc
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLD-----------------------PRLPPLSVDIRGKVISIMEVAFLCLDN  211 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~  211 (228)
                      |+|++|..||.......      ....+..                       .............+..+.++|.+||+.
T Consensus       210 ~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  283 (308)
T 3g33_A          210 AEMFRRKPLFCGNSEAD------QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF  283 (308)
T ss_dssp             HHTTTSSCSCCCSSHHH------HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCCHHH------HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence            99999999985432211      1111100                       000001111234566789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 040501          212 NPESRPNMQTICQ  224 (228)
Q Consensus       212 ~p~~Rpt~~~il~  224 (228)
                      ||.+|||+.++++
T Consensus       284 dP~~R~t~~e~l~  296 (308)
T 3g33_A          284 NPHKRISAFRALQ  296 (308)
T ss_dssp             STTTSCCHHHHHT
T ss_pred             CCccCCCHHHHhc
Confidence            9999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=263.87  Aligned_cols=221  Identities=25%  Similarity=0.360  Sum_probs=165.6

Q ss_pred             HHHHHHHHHHhcc--CCCccceeeeeeeec----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI--RHRNIVKFYGFCTHA----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ..+.+|.+++...  +||||+++++++...    ...|+||||+.+++|.+++...    .+++..++.++.|++.||.|
T Consensus        74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~  149 (337)
T 3mdy_A           74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCH  149 (337)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHH
T ss_pred             chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHH
Confidence            3455666666665  899999999999876    7899999999999999999754    38999999999999999999


Q ss_pred             hhhCC-----CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCCcccc---
Q 040501           77 LHHDC-----IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTAK---  144 (228)
Q Consensus        77 lh~~~-----~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~---  144 (228)
                      ||+.+     ..|++||||||+||+++.++.+||+|||++.........    .....|++.|+|||++.+...+..   
T Consensus       150 lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  229 (337)
T 3mdy_A          150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS  229 (337)
T ss_dssp             HHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH
T ss_pred             HHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC
Confidence            99751     238999999999999999999999999999765433322    124578999999999887665544   


Q ss_pred             ---hhhhhHHHHHHHHHhC----------CCCccccccccCCCchhhhhhhcCCC-CCCCch--hhhhhHHHHHHHHHHh
Q 040501          145 ---CDVYSFGVLALEVIKG----------KHPRDFLSNVSSSNPNILVNEMLDPR-LPPLSV--DIRGKVISIMEVAFLC  208 (228)
Q Consensus       145 ---~DiwslG~~l~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~li~~~  208 (228)
                         +||||||+++|+|++|          ..||......... ............ .+....  ....++..+.+++.+|
T Consensus       230 ~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  308 (337)
T 3mdy_A          230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC  308 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHh
Confidence               9999999999999999          5554332211111 111111111111 111111  1236778899999999


Q ss_pred             hccCCCCCCCHHHHHHHhhC
Q 040501          209 LDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |+.||.+|||+.++++.|++
T Consensus       309 l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          309 WAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             SCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhChhhCCCHHHHHHHHHH
Confidence            99999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-42  Score=260.24  Aligned_cols=204  Identities=24%  Similarity=0.387  Sum_probs=171.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+|||++.+++|.+++....   .++...++.++.|++.||.|||+.  
T Consensus        59 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  133 (284)
T 2vgo_A           59 HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER--  133 (284)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999987643   388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus       134 -~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  210 (284)
T 2vgo_A          134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP  210 (284)
T ss_dssp             -TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             -CceecCCCHHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence             9999999999999999999999999998765432  2234568899999999999889999999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||....      .......+....... +   ...+..+.++|.+||+.||.+|||+.++++
T Consensus       211 pf~~~~------~~~~~~~~~~~~~~~-~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          211 PFDSPS------HTETHRRIVNVDLKF-P---PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             TTCCSS------HHHHHHHHHTTCCCC-C---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCC------HhHHHHHHhccccCC-C---CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            986432      122222232222211 1   234567899999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=274.50  Aligned_cols=219  Identities=17%  Similarity=0.220  Sum_probs=170.9

Q ss_pred             HHHHHHHHHHhccCCCccce---------------eeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVK---------------FYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV   66 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   66 (228)
                      +.+.+|++++++++||||++               +++++.. +...|+||||+ +++|.+++.... ...+++..++.+
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i  164 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQV  164 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHH
Confidence            35889999999999999988               5666665 67899999999 899999998652 234899999999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCC--ceEEeecccccccCCCCC-------CceecccccceeCCcccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEY--EAHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAY  137 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  137 (228)
                      +.|++.||.|||+.   |++||||||+||+++.++  .++|+|||++........       ......+++.|+|||.+.
T Consensus       165 ~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (352)
T 2jii_A          165 ACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK  241 (352)
T ss_dssp             HHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence            99999999999999   999999999999999998  899999999976543221       123347899999999999


Q ss_pred             cCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcC--CCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          138 TMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD--PRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       138 ~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      +..++.++||||||+++|+|++|..||....... ............  .............+..+.+++.+||..||.+
T Consensus       242 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  320 (352)
T 2jii_A          242 GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE  320 (352)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence            9889999999999999999999999987542111 000111111111  1111111112245678999999999999999


Q ss_pred             CCCHHHHHHHhh
Q 040501          216 RPNMQTICQLLC  227 (228)
Q Consensus       216 Rpt~~~il~~l~  227 (228)
                      |||++++++.|+
T Consensus       321 Rps~~~l~~~L~  332 (352)
T 2jii_A          321 KPPYAMLRNNLE  332 (352)
T ss_dssp             CCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHH
Confidence            999999999886

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-42  Score=266.50  Aligned_cols=211  Identities=25%  Similarity=0.412  Sum_probs=167.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+++++.++||||+++++++......++|||++.+++|.+++.....  .++...++.++.|++.||.|||+. 
T Consensus        60 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-  136 (302)
T 2j7t_A           60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK-  136 (302)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            46788999999999999999999999999999999999999999998865332  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~  156 (228)
                        |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.     +..++.++||||||+++|+
T Consensus       137 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~  214 (302)
T 2j7t_A          137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE  214 (302)
T ss_dssp             --TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred             --CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence              999999999999999999999999998754322211223356889999999873     5668889999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||.....      ............+.. .....++..+.++|.+||..||.+|||+.++++
T Consensus       215 l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          215 MAQIEPPHHELNP------MRVLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHSSCTTTTSCH------HHHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HhcCCCCCccCCH------HHHHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            9999999864322      122222222222111 122455678999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.1e-42  Score=275.69  Aligned_cols=216  Identities=21%  Similarity=0.298  Sum_probs=161.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+++.+|+++++.++|+||+++++++...     ...|+|||++. ++|.+++....   .+++..+..++.|++.||+|
T Consensus        69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~  144 (432)
T 3n9x_A           69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENF  144 (432)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHH
Confidence            36788999999999999999999999765     57999999986 58999887543   38999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC----------------------CceecccccceeCCc
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS----------------------NWTEFAGTYGYVAPE  134 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----------------------~~~~~~~~~~y~aPE  134 (228)
                      ||+.   |++||||||+||+++.++.+||+|||++........                      ......+++.|+|||
T Consensus       145 LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  221 (432)
T 3n9x_A          145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE  221 (432)
T ss_dssp             HHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred             HHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence            9999   999999999999999999999999999987653321                      124567899999999


Q ss_pred             cc-ccCCcccchhhhhHHHHHHHHHhCCCCcccccc-----ccCCC----------------------------------
Q 040501          135 LA-YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN-----VSSSN----------------------------------  174 (228)
Q Consensus       135 ~~-~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~-----~~~~~----------------------------------  174 (228)
                      ++ .+..++.++|||||||++|+|++|..||.....     +....                                  
T Consensus       222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~  301 (432)
T 3n9x_A          222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE  301 (432)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH
T ss_pred             HHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH
Confidence            86 556689999999999999999986555432110     00000                                  


Q ss_pred             -------chhhh---hhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          175 -------PNILV---NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       175 -------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                             .....   ..................+.++.+||.+||..||.+|||++++++
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   00000   000000001111112346678899999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-42  Score=264.02  Aligned_cols=210  Identities=28%  Similarity=0.403  Sum_probs=164.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+++.+|++++++++||||+++++++.. ....|+|||++.+++|.+++..... ..++...++.++.|++.||.|||+.
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~  136 (278)
T 1byg_A           58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN  136 (278)
T ss_dssp             -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999999999998754 4578999999999999999875421 2268889999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                         |++|+||||+||+++.++.++|+|||.+.......   ....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       137 ---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~  210 (278)
T 1byg_A          137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF  210 (278)
T ss_dssp             ---TCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---CccccCCCcceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhC
Confidence               99999999999999999999999999987654322   22356788999999988889999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||.....      ......+........   ...++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       211 g~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          211 GRVPYPRIPL------KDVVPRVEKGYKMDA---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             SCCSCTTSCG------GGHHHHHTTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCH------HHHHHHHhcCCCCCC---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence            9999864322      222222222221111   1345678999999999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-42  Score=267.27  Aligned_cols=213  Identities=25%  Similarity=0.375  Sum_probs=172.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS----AEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      .++.+|+.++++++||||+++++++......|+||||+.+++|.+++.....    ...+++..++.++.|++.||.|||
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH  157 (327)
T 2yfx_A           78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE  157 (327)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence            5688999999999999999999999999999999999999999999986432    134889999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      +.   |++|+||||+||+++.+   +.++|+|||.+.........  .....+++.|+|||.+.+..++.++||||||++
T Consensus       158 ~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  234 (327)
T 2yfx_A          158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL  234 (327)
T ss_dssp             HT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             hC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHH
Confidence            99   99999999999999844   46999999998755433221  233456889999999988889999999999999


Q ss_pred             HHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          154 ALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       154 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|+|++ |..||....      .......+.........   ..++..+.++|.+||+.||.+|||+.++++.|+
T Consensus       235 l~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          235 LWEIFSLGYMPYPSKS------NQEVLEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHHTTSCCSSTTCC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCCcC------HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            999998 999986432      22222333222222111   245567899999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-42  Score=271.00  Aligned_cols=214  Identities=23%  Similarity=0.364  Sum_probs=169.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.+++.++||||+++++++..+...|+||||+.+++|.+++....   .++...+..++.|++.||.|||+.+
T Consensus        75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~  151 (360)
T 3eqc_A           75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH  151 (360)
T ss_dssp             HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578899999999999999999999999999999999999999999997643   3889999999999999999999831


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++|+||||+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       152 --~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  227 (360)
T 3eqc_A          152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR  227 (360)
T ss_dssp             --CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS
T ss_pred             --CEEcCCccHHHEEECCCCCEEEEECCCCccccccc--ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence              89999999999999999999999999987543221  23356889999999999989999999999999999999999


Q ss_pred             CCccccccccC------------------------------------CCchhhhhhhcCCCCCCCchhhhhhHHHHHHHH
Q 040501          162 HPRDFLSNVSS------------------------------------SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVA  205 (228)
Q Consensus       162 ~p~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  205 (228)
                      .||........                                    ...............+...  ...++.++.++|
T Consensus       228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  305 (360)
T 3eqc_A          228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFV  305 (360)
T ss_dssp             CCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHH
Confidence            99864321100                                    0000011111111111111  123566799999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 040501          206 FLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       206 ~~~l~~~p~~Rpt~~~il~  224 (228)
                      .+||+.||.+|||++++++
T Consensus       306 ~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          306 NKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             HHHHCSSTTTSCCHHHHHT
T ss_pred             HHHhhcChhhCCCHHHHhh
Confidence            9999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-42  Score=277.13  Aligned_cols=207  Identities=20%  Similarity=0.275  Sum_probs=170.2

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|..++..++||||++++++|.+....|+||||+.+++|.+++....  ..+++..+..++.|++.||.|||+.   
T Consensus       120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---  194 (437)
T 4aw2_A          120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---  194 (437)
T ss_dssp             CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            47899999999999999999999999999999999999999999997633  2389999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~  157 (228)
                      ||+||||||+||+++.+|.+||+|||++......... .....||+.|+|||++.     ...++.++|||||||++|+|
T Consensus       195 giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~el  274 (437)
T 4aw2_A          195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM  274 (437)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHH
T ss_pred             CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHH
Confidence            9999999999999999999999999999766543332 23357999999999987     45689999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcC----CCCCCCchhhhhhHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLD----PRLPPLSVDIRGKVISIMEVAFLCLDNNPES--RPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~  224 (228)
                      ++|..||....      .......+..    ...+.   .....+.++.++|++||..+|++  ||+++++++
T Consensus       275 ltG~~Pf~~~~------~~~~~~~i~~~~~~~~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          275 LYGETPFYAES------LVETYGKIMNHKERFQFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHSSCTTCCSS------HHHHHHHHHTHHHHCCCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HhCCCCCCCCC------hhHHHHhhhhccccccCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            99999986432      2222222222    11221   11235667899999999888887  999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-42  Score=265.72  Aligned_cols=208  Identities=23%  Similarity=0.322  Sum_probs=167.3

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      .+.+|++++++++||||+++++++.... .|+||||+.+++|.+++....   .++...++.++.|++.||.|||+.   
T Consensus        61 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---  133 (322)
T 2ycf_A           61 NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---  133 (322)
T ss_dssp             CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             hHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            5789999999999999999999987654 899999999999999886543   389999999999999999999999   


Q ss_pred             CeeecCCCCCceEEcCCCc---eEEeecccccccCCCCCCceecccccceeCCcccc---cCCcccchhhhhHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY---TMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~~  157 (228)
                      |++|+||||+||+++.++.   ++|+|||++...... .......+++.|+|||.+.   ...++.++||||||+++|+|
T Consensus       134 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l  212 (322)
T 2ycf_A          134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC  212 (322)
T ss_dssp             TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHH
Confidence            9999999999999987654   999999999875432 1123356889999999874   45678899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||......     ......+...............+..+.++|.+||..||.+|||+.++++
T Consensus       213 ~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          213 LSGYPPFSEHRTQ-----VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHSSCSSCSTTCS-----SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCCCCCcccchH-----HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            9999998643211     1122222223333333334456778999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-42  Score=261.20  Aligned_cols=206  Identities=22%  Similarity=0.376  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee----------------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH----------------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV   66 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   66 (228)
                      +.+.+|++++++++||||+++++++..                ....++||||+.+++|.+++.... ...+++..++.+
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i  127 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALEL  127 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHH
Confidence            467899999999999999999998854                446899999999999999997542 234889999999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchh
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCD  146 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  146 (228)
                      +.|++.||.|||+.   |++|+||||+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|
T Consensus       128 ~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D  203 (284)
T 2a19_B          128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVD  203 (284)
T ss_dssp             HHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHH
T ss_pred             HHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhh
Confidence            99999999999999   99999999999999999999999999988765432 223456889999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          147 VYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |||||+++|+|++|..|+....        ...........+      ..++..+.++|.+||+.||.+|||+.++++.|
T Consensus       204 i~slG~il~~l~~~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l  269 (284)
T 2a19_B          204 LYALGLILAELLHVCDTAFETS--------KFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL  269 (284)
T ss_dssp             HHHHHHHHHHHHSCCSSHHHHH--------HHHHHHHTTCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHhcCCcchhHH--------HHHHHhhccccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            9999999999999999864321        111222222222      13445688999999999999999999999987


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       270 ~  270 (284)
T 2a19_B          270 T  270 (284)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-41  Score=285.25  Aligned_cols=205  Identities=21%  Similarity=0.295  Sum_probs=175.8

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+..|..++..+ +|++|+++++++.+...+|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+. 
T Consensus       386 ~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  461 (674)
T 3pfq_A          386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK-  461 (674)
T ss_dssp             HHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4578899999988 79999999999999999999999999999999998653   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       462 --gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~  539 (674)
T 3pfq_A          462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ  539 (674)
T ss_dssp             --SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             --CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCC
Confidence              999999999999999999999999999986544444455678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-----QTIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il  223 (228)
                      .||...      +.......+........    ...+.++.+||++||..||.+||++     ++|+
T Consensus       540 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          540 APFEGE------DEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             CSSCCS------SHHHHHHHHHSSCCCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             CCCCCC------CHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence            998642      33445555555443221    2456689999999999999999997     5655

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-41  Score=257.10  Aligned_cols=205  Identities=24%  Similarity=0.370  Sum_probs=162.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+++++.++||||+++++++......|+|||++.+++|.+++....   .++...++.++.|++.||.+||+.  
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--  130 (276)
T 2h6d_A           56 GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH--  130 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            568899999999999999999999999999999999999999999987643   288999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|.
T Consensus       131 -~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  208 (276)
T 2h6d_A          131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT  208 (276)
T ss_dssp             -CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             -CCccCCCChhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCC
Confidence             99999999999999999999999999988755332 2234567899999999887765 67999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||....      .......+....... +   ...+..+.+++.+||+.||.+|||+.++++
T Consensus       209 ~p~~~~~------~~~~~~~~~~~~~~~-~---~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          209 LPFDDEH------VPTLFKKIRGGVFYI-P---EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CSSCCSS------HHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCc------HHHHHHHhhcCcccC-c---hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            9985322      122222222221111 1   234557889999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=264.95  Aligned_cols=216  Identities=21%  Similarity=0.354  Sum_probs=169.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeee----ecCeEEEEEEeecCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCT----HARHSFLVYEYLENGSLSVILNND-TSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ++.+.+|+++++.++||||+++++++.    .....|+|+||+.+++|.+++... .....+++..++.++.|++.||.|
T Consensus        70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~  149 (317)
T 2buj_A           70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA  149 (317)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            457889999999999999999999986    234789999999999999988752 123348999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---------ceecccccceeCCcccccCC---cccc
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---------WTEFAGTYGYVAPELAYTMK---VTAK  144 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~---~~~~  144 (228)
                      ||+.   |++|+||||+||+++.++.++|+|||.+.........         .....+++.|+|||.+.+..   ++.+
T Consensus       150 LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  226 (317)
T 2buj_A          150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER  226 (317)
T ss_dssp             HHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH
T ss_pred             HHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch
Confidence            9999   9999999999999999999999999988754321111         11234688999999987654   6889


Q ss_pred             hhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          145 CDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       145 ~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +||||||+++|+|++|..||......... .......  ....+.    ....+..+.++|.+||+.||.+|||+.++++
T Consensus       227 ~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~--~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  299 (317)
T 2buj_A          227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN--QLSIPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLS  299 (317)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHHC--C--CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhhc--cCCCCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            99999999999999999998643221111 1111111  111111    1245567999999999999999999999999


Q ss_pred             Hhh
Q 040501          225 LLC  227 (228)
Q Consensus       225 ~l~  227 (228)
                      .|+
T Consensus       300 ~L~  302 (317)
T 2buj_A          300 QLE  302 (317)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            886

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-42  Score=273.19  Aligned_cols=209  Identities=24%  Similarity=0.384  Sum_probs=162.0

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      .+++.+|+.+++.+. ||||+++++++...  ..+|+||||+. ++|..++...    .++...+..++.|++.||+|||
T Consensus        52 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH  126 (388)
T 3oz6_A           52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH  126 (388)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH
Confidence            356789999999996 99999999999754  37899999997 4888888753    3888999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCC---------------------CCCceecccccceeCCcccc
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD---------------------SSNWTEFAGTYGYVAPELAY  137 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~  137 (228)
                      +.   |++||||||+||+++.++.+||+|||++......                     ........+++.|+|||++.
T Consensus       127 ~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          127 SG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             HT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             hC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            99   9999999999999999999999999999765321                     11123457899999999987


Q ss_pred             c-CCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcC--------------------------------
Q 040501          138 T-MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD--------------------------------  184 (228)
Q Consensus       138 ~-~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------------------------  184 (228)
                      + ..++.++|||||||++|+|++|.+||.......      ....+..                                
T Consensus       204 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (388)
T 3oz6_A          204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN------QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR  277 (388)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC--
T ss_pred             CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccccccc
Confidence            6 568999999999999999999999986432211      1111100                                


Q ss_pred             -CCCCCCchh----------hhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          185 -PRLPPLSVD----------IRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       185 -~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                       .........          ....+.++.+++.+||..||.+|||++++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          278 QSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             ---CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence             000000000          0134567899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-41  Score=265.50  Aligned_cols=211  Identities=22%  Similarity=0.365  Sum_probs=171.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVI------LNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|++++++++||||+++++++......|+||||+.+++|.++      +.... ...++...++.++.|++.||.|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~  166 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSY  166 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999998      54321 3448999999999999999999


Q ss_pred             hhh-CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-Cccc-chhhhhHHHH
Q 040501           77 LHH-DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTA-KCDVYSFGVL  153 (228)
Q Consensus        77 lh~-~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~~  153 (228)
                      ||+ .   |++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+. .++. ++||||||++
T Consensus       167 lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i  241 (348)
T 2pml_X          167 IHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC  241 (348)
T ss_dssp             HHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred             HhccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence            999 8   9999999999999999999999999999875433  23345788999999999877 5666 9999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCC---------------chhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPL---------------SVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      +|+|++|..||.....     .......+........               .......+..+.+++.+||..||.+|||
T Consensus       242 l~~l~~g~~pf~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps  316 (348)
T 2pml_X          242 LYVMFYNVVPFSLKIS-----LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT  316 (348)
T ss_dssp             HHHHHHSSCSSCCSSC-----SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHHHhCCCCCCCCCc-----HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC
Confidence            9999999999864322     1222222222221111               0011346678999999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      +.++++
T Consensus       317 ~~e~l~  322 (348)
T 2pml_X          317 SEDALK  322 (348)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.4e-42  Score=278.01  Aligned_cols=213  Identities=22%  Similarity=0.312  Sum_probs=159.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+++.+|+.+++.++||||+++++++...      ...|+||||+.++ +.+.+..     .++...+..++.|++.||+
T Consensus       105 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~  178 (464)
T 3ttj_A          105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIK  178 (464)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999654      4679999999765 5555532     2788999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      |||+.   ||+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|
T Consensus       179 ~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  254 (464)
T 3ttj_A          179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG  254 (464)
T ss_dssp             HHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             HHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence            99999   9999999999999999999999999999876532 2334567899999999999999999999999999999


Q ss_pred             HHHhCCCCccccccccCCC----------------chhhhhhhcCCCC----------------CCCchhhhhhHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSN----------------PNILVNEMLDPRL----------------PPLSVDIRGKVISIME  203 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~  203 (228)
                      +|++|..||..........                .............                +.........+.++.+
T Consensus       255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  334 (464)
T 3ttj_A          255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD  334 (464)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence            9999999986432211000                0000001111110                0011111223667899


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.+||..||.+|||++++++
T Consensus       335 Ll~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          335 LLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCChhhCCCHHHHhc
Confidence            999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=267.78  Aligned_cols=212  Identities=22%  Similarity=0.358  Sum_probs=166.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+++.+|+++++.++||||+++++++...      ..+|+|||++ +++|.+++...    .++...+..++.|++.||+
T Consensus        68 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~  142 (367)
T 1cm8_A           68 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLR  142 (367)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999765      3469999999 77999998753    3889999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLA  154 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l  154 (228)
                      |||+.   |++||||||+||+++.++.+||+|||++......   .....+++.|+|||.+.+ ..++.++||||+||++
T Consensus       143 ~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  216 (367)
T 1cm8_A          143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  216 (367)
T ss_dssp             HHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence            99999   9999999999999999999999999999875432   334578899999999877 6789999999999999


Q ss_pred             HHHHhCCCCccccccccC---------CCchhhh------------hhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          155 LEVIKGKHPRDFLSNVSS---------SNPNILV------------NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~---------~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |+|++|..||........         .......            ..................+..+.+++.+||..||
T Consensus       217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP  296 (367)
T 1cm8_A          217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA  296 (367)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence            999999999864322110         0000000            0000000011111123456678999999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||+.++++
T Consensus       297 ~~R~t~~e~l~  307 (367)
T 1cm8_A          297 EQRVTAGEALA  307 (367)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCCCHHHHhc
Confidence            99999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=285.52  Aligned_cols=213  Identities=26%  Similarity=0.457  Sum_probs=173.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++++++++|+||+++++++.. ...|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. 
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-  382 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM-  382 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4679999999999999999999999876 67899999999999999997432 12388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       383 --~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~  460 (535)
T 2h8h_A          383 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  460 (535)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             --CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence              999999999999999999999999999976542211 1122345678999999988889999999999999999999 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..||.....      ......+.........   ..++..+.++|.+||+.||.+|||+.++++.|++
T Consensus       461 g~~P~~~~~~------~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          461 GRVPYPGMVN------REVLDQVERGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             TCCSSTTCCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCCCCH------HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            9999864322      2223333222221111   2456679999999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.2e-43  Score=267.27  Aligned_cols=213  Identities=27%  Similarity=0.468  Sum_probs=159.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-----TSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|++++++++||||+++++++......++||||+.+++|.+++...     .....++...++.++.|++.||.||
T Consensus        58 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  137 (303)
T 2vwi_A           58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL  137 (303)
T ss_dssp             --------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            56789999999999999999999999999999999999999999998641     1233489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-----CceecccccceeCCccccc-CCcccchhhhhHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-----NWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFG  151 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG  151 (228)
                      |+.   |++|+||+|+||+++.++.++|+|||.+........     ......+++.|+|||.+.+ ..++.++||||||
T Consensus       138 H~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  214 (303)
T 2vwi_A          138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG  214 (303)
T ss_dssp             HHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred             HhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence            999   999999999999999999999999999876543221     1233568899999998875 4578999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCC------chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPL------SVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +++|+|++|..||.......      ..........+..      ......++..+.+++.+||+.||.+|||+.++++
T Consensus       215 ~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          215 ITAIELATGAAPYHKYPPMK------VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHHHHSSCTTTTSCGGG------HHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCCCccCchhh------HHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            99999999999986432211      1111111111110      0111345667899999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-41  Score=266.93  Aligned_cols=211  Identities=23%  Similarity=0.309  Sum_probs=165.9

Q ss_pred             HHHHHHHHHHhccC-----CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIR-----HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+..|+.+++.++     ||||+++++++......++|||++ +++|.+++..... ..++...+..++.|++.||+||
T Consensus        76 ~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~L  153 (360)
T 3llt_A           76 RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYL  153 (360)
T ss_dssp             HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Confidence            45678999999986     999999999999999999999999 8899999886543 2388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcC-------------------------CCceEEeecccccccCCCCCCceecccccceeC
Q 040501           78 HHDCIPPIVHRDISSKNVLLDL-------------------------EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVA  132 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~a  132 (228)
                      |+.   |++||||||+||+++.                         ++.+||+|||++......   .....+++.|+|
T Consensus       154 H~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~a  227 (360)
T 3llt_A          154 RKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRA  227 (360)
T ss_dssp             HHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCC
T ss_pred             HHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccC
Confidence            999   9999999999999975                         788999999999865432   234578999999


Q ss_pred             CcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCC-------------------------CC
Q 040501          133 PELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDP-------------------------RL  187 (228)
Q Consensus       133 PE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~  187 (228)
                      ||++.+..++.++|||||||++|+|++|..||........   .........+                         ..
T Consensus       228 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  304 (360)
T 3llt_A          228 PEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH---LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW  304 (360)
T ss_dssp             HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECT
T ss_pred             cHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH---HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecC
Confidence            9999999999999999999999999999999864321110   0000000000                         00


Q ss_pred             CCCch--------------hhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          188 PPLSV--------------DIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       188 ~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +....              ........+.++|.+||+.||.+|||++++++
T Consensus       305 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          305 PENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             TTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000              00111256789999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=266.48  Aligned_cols=207  Identities=24%  Similarity=0.384  Sum_probs=160.7

Q ss_pred             HHHHHHHHHHhccCC--CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|+.+++.++|  +||+++++++......|+||| +.+++|.+++....   .++...+..++.|++.||.|||+.
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~  127 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH  127 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            568899999999976  999999999999999999999 55779999998654   388999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc-----------CCcccchhh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT-----------MKVTAKCDV  147 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di  147 (228)
                         |++||||||+||+++ ++.+||+|||++.........  .....|++.|+|||++.+           ..++.++||
T Consensus       128 ---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di  203 (343)
T 3dbq_A          128 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV  203 (343)
T ss_dssp             ---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHH
T ss_pred             ---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhH
Confidence               999999999999997 678999999999876543322  234578999999999865           567889999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||+++|+|++|..||....     ...........+.......  ...+..+.+++.+||+.||.+|||+.++++
T Consensus       204 wslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          204 WSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            999999999999999986321     1112222222222211110  122346889999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-41  Score=269.50  Aligned_cols=207  Identities=24%  Similarity=0.379  Sum_probs=162.4

Q ss_pred             HHHHHHHHHHhccC--CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++  |+||+++++++......|+||| +.+++|.+++....   .++...+..++.|++.||.|||+.
T Consensus        99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~  174 (390)
T 2zmd_A           99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH  174 (390)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            56889999999996  5999999999999999999999 56789999987654   378889999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc-----------CCcccchhh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT-----------MKVTAKCDV  147 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di  147 (228)
                         ||+||||||+||+++ ++.+||+|||++.........  .....|++.|+|||++.+           ..++.++||
T Consensus       175 ---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di  250 (390)
T 2zmd_A          175 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV  250 (390)
T ss_dssp             ---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHH
T ss_pred             ---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhH
Confidence               999999999999995 589999999999876533221  234578999999999865           357889999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |||||++|+|++|..||....     ........+..+.......  ...+..+.++|.+||..||.+|||+.++++
T Consensus       251 wSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          251 WSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            999999999999999986321     1112233333322211110  112456889999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-41  Score=266.13  Aligned_cols=213  Identities=21%  Similarity=0.313  Sum_probs=161.9

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ..+.+|+++++.++||||+++++++..        ....|+||||+.+ +|.+.+....  ..+++..++.++.|++.||
T Consensus        61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l  137 (351)
T 3mi9_A           61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGL  137 (351)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHH
Confidence            467899999999999999999999976        4568999999976 6666665433  2389999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC----CceecccccceeCCcccccC-Ccccchhhhh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS----NWTEFAGTYGYVAPELAYTM-KVTAKCDVYS  149 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws  149 (228)
                      .|||+.   |++||||||+||+++.++.++|+|||++........    ......+++.|+|||.+.+. .++.++||||
T Consensus       138 ~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  214 (351)
T 3mi9_A          138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG  214 (351)
T ss_dssp             HHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH
T ss_pred             HHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHH
Confidence            999999   999999999999999999999999999986542221    23345679999999988764 5799999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCC-----------------------chh--hhhhHHHHHHH
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPL-----------------------SVD--IRGKVISIMEV  204 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~--~~~~~~~~~~l  204 (228)
                      ||+++|+|++|..||........   ............+..                       ...  ....+..+.++
T Consensus       215 lG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  291 (351)
T 3mi9_A          215 AGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL  291 (351)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHH
Confidence            99999999999999864322110   000000000000000                       000  00124568899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||+.||.+|||++++++
T Consensus       292 i~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          292 IDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCChhhCCCHHHHhC
Confidence            99999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-41  Score=258.44  Aligned_cols=209  Identities=22%  Similarity=0.350  Sum_probs=172.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||+++++++......|+|+|++.+++|.+++....   .++...++.++.|++.||.+||+. 
T Consensus        65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-  140 (287)
T 2wei_A           65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH-  140 (287)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678899999999999999999999999999999999999999988886543   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++|+||+|+||+++.+   +.++|+|||++....... ......+++.|+|||.+.+. ++.++||||||+++|+|+
T Consensus       141 --~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~  216 (287)
T 2wei_A          141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILL  216 (287)
T ss_dssp             --TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHH
T ss_pred             --CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHH
Confidence              99999999999999764   469999999988655332 22334678899999988764 889999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||....      .......+..............++.++.++|.+||..||.+|||+.++++
T Consensus       217 ~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          217 SGTPPFYGKN------EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HSSCSSCCSS------HHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCC------HHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            9999986432      22233333333333223333456778999999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=274.05  Aligned_cols=207  Identities=25%  Similarity=0.267  Sum_probs=168.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|..++..++||||++++++|.+....|+||||+.+++|.+++.....  .+++..+..++.|++.||.|||+.  
T Consensus       106 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--  181 (412)
T 2vd5_A          106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL--  181 (412)
T ss_dssp             CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            3478899999999999999999999999999999999999999999976432  389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccc-------cCCcccchhhhhHHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAY-------TMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l  154 (228)
                       ||+||||||+||+++.+|.+||+|||++......... .....|++.|+|||++.       ...++.++|+|||||++
T Consensus       182 -giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil  260 (412)
T 2vd5_A          182 -GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA  260 (412)
T ss_dssp             -TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred             -CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence             9999999999999999999999999999876543322 23457899999999987       35688999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcC----CCCCCCchhhhhhHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLD----PRLPPLSVDIRGKVISIMEVAFLCLDNNPESR---PNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---pt~~~il~  224 (228)
                      |+|++|..||....      .......+..    ...+.   .....+.++.++|.+||. +|.+|   |+++++++
T Consensus       261 yelltG~~Pf~~~~------~~~~~~~i~~~~~~~~~p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          261 YEMFYGQTPFYADS------TAETYGKIVHYKEHLSLPL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHSSCTTCCSS------HHHHHHHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHhCCCCCCCCC------HHHHHHHHHhcccCcCCCc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            99999999986432      2222222222    11111   113456688999999999 99998   58888864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=265.51  Aligned_cols=218  Identities=26%  Similarity=0.411  Sum_probs=171.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      .+.+.+|++++++++||||+++++++...  ...++|||++.+++|.+++.....  .++...++.++.|++.||.+||+
T Consensus        86 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~  163 (326)
T 2w1i_A           86 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGT  163 (326)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh
Confidence            35788999999999999999999998654  378999999999999999976542  38999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      .   |++|+||||+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+
T Consensus       164 ~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  240 (326)
T 2w1i_A          164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE  240 (326)
T ss_dssp             T---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             C---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence            9   9999999999999999999999999999876543322   122345678999999988889999999999999999


Q ss_pred             HHhCCCCccccccc-----cCCCc-h----hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          157 VIKGKHPRDFLSNV-----SSSNP-N----ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       157 ~~~g~~p~~~~~~~-----~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      |++|..||......     ..... .    ..............   ...++.++.++|.+||..||.+|||+.++++.|
T Consensus       241 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L  317 (326)
T 2w1i_A          241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  317 (326)
T ss_dssp             HHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99999997532110     00000 0    01111111111111   134567899999999999999999999999988


Q ss_pred             h
Q 040501          227 C  227 (228)
Q Consensus       227 ~  227 (228)
                      +
T Consensus       318 ~  318 (326)
T 2w1i_A          318 D  318 (326)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-42  Score=264.47  Aligned_cols=211  Identities=26%  Similarity=0.403  Sum_probs=162.8

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      .+.+.+|+.+++++ +||||+++++++..      ....|+||||+.+++|.+++.... ...++...++.++.|++.||
T Consensus        64 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l  142 (326)
T 2x7f_A           64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGL  142 (326)
T ss_dssp             THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHH
Confidence            46788999999999 79999999999976      468999999999999999997643 23488999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYS  149 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diws  149 (228)
                      .|||+.   |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.     +..++.++||||
T Consensus       143 ~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  219 (326)
T 2x7f_A          143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  219 (326)
T ss_dssp             HHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHH
T ss_pred             HHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHH
Confidence            999999   999999999999999999999999999887654333344457899999999986     456788999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||+++|+|++|..||.....      ......+.....+...  ...++..+.++|.+||..||.+|||+.++++
T Consensus       220 lG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          220 LGITAIEMAEGAPPLCDMHP------MRALFLIPRNPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCCCS--CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCccccCC--ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            99999999999999854322      1122222111111111  1245567899999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=261.05  Aligned_cols=202  Identities=20%  Similarity=0.215  Sum_probs=160.2

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+..|+..+.++ +|+||++++++|.++...|+|||++ +++|.+++....  ..+++..++.++.|++.||.|||+.  
T Consensus       102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--  176 (311)
T 3p1a_A          102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ--  176 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            455666666666 8999999999999999999999999 568888776543  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++|+||||+||+++.++.+||+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..
T Consensus       177 -~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~  253 (311)
T 3p1a_A          177 -GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME  253 (311)
T ss_dssp             -TEECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCC
T ss_pred             -CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCC
Confidence             99999999999999999999999999987664332 2334568999999998876 68999999999999999999966


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+....         ....+.....+  .......+..+.++|.+||+.||.+|||++++++
T Consensus       254 ~~~~~~---------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          254 LPHGGE---------GWQQLRQGYLP--PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CCSSHH---------HHHHHTTTCCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcc---------HHHHHhccCCC--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            643221         11222222211  1122355678999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=267.08  Aligned_cols=212  Identities=24%  Similarity=0.393  Sum_probs=167.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+.++++++|+||+++++++......++++|++.+++|.+++....  ..+++..++.++.|++.||.|||+.  
T Consensus        74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~--  149 (319)
T 2y4i_B           74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK--  149 (319)
T ss_dssp             CCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            456789999999999999999999999999999999999999999997643  2388999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC-----CCceecccccceeCCccccc---------CCcccchhhh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS-----SNWTEFAGTYGYVAPELAYT---------MKVTAKCDVY  148 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Diw  148 (228)
                       |++|+||||+||+++ ++.++|+|||++.......     .......+++.|+|||.+.+         ..++.++|||
T Consensus       150 -~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~  227 (319)
T 2y4i_B          150 -GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF  227 (319)
T ss_dssp             -TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred             -CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence             999999999999998 6799999999877543211     12233468899999998865         3468899999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |||+++|+|++|..||....      .............+....  ..++.++.+++.+||..||.+|||+.++++.|++
T Consensus       228 slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          228 ALGTIWYELHAREWPFKTQP------AEAIIWQMGTGMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK  299 (319)
T ss_dssp             HHHHHHHHHHHSSCSSSSCC------HHHHHHHHHTTCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCCC------HHHHHHHhccCCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            99999999999999986432      222222222222222111  1344568899999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=265.78  Aligned_cols=221  Identities=25%  Similarity=0.349  Sum_probs=163.7

Q ss_pred             HHHHHHHHH--HhccCCCccceeeeeee-----ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITV--LTEIRHRNIVKFYGFCT-----HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~--l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      +.+..|.++  +..++|+||+++++.+.     ....+++||||+++++|.+++....    .++..++.++.|++.||.
T Consensus        50 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~  125 (336)
T 3g2f_A           50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLA  125 (336)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHH
Confidence            344555555  44579999999998653     2336789999999999999997654    578889999999999999


Q ss_pred             HhhhCC------CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--------CceecccccceeCCccccc---
Q 040501           76 YLHHDC------IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--------NWTEFAGTYGYVAPELAYT---  138 (228)
Q Consensus        76 ~lh~~~------~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---  138 (228)
                      |||+.+      ..|++||||||+||+++.++.+||+|||++........        ......|++.|+|||++.+   
T Consensus       126 ~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  205 (336)
T 3g2f_A          126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN  205 (336)
T ss_dssp             HHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC
T ss_pred             HHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc
Confidence            999862      22899999999999999999999999999987643221        1223468999999999876   


Q ss_pred             ----CCcccchhhhhHHHHHHHHHhCCCCccccccccCCCch-----------h-----hhhhhcCCCCCCCchhhhhhH
Q 040501          139 ----MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN-----------I-----LVNEMLDPRLPPLSVDIRGKV  198 (228)
Q Consensus       139 ----~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~-----------~-----~~~~~~~~~~~~~~~~~~~~~  198 (228)
                          ..++.++||||||+++|+|++|..||............           .     .......+..+.........+
T Consensus       206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (336)
T 3g2f_A          206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV  285 (336)
T ss_dssp             GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHH
T ss_pred             cccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchH
Confidence                35667899999999999999997775432221111000           0     001111222232222334567


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          199 ISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       199 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..+.++|.+||+.||.+|||++++++.|+
T Consensus       286 ~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          286 RSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            78999999999999999999999999886

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-42  Score=269.18  Aligned_cols=211  Identities=23%  Similarity=0.301  Sum_probs=168.1

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++.+ +||||+++++++......++||||+.+++|.+++....   .++...+..++.|++.||.|||+. 
T Consensus       103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~-  178 (355)
T 1vzo_A          103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL-  178 (355)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4567899999999 69999999999999999999999999999999987643   388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccC--CcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.+||+|||++........ ......+++.|+|||++.+.  .++.++||||||+++|+|+
T Consensus       179 --~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell  256 (355)
T 1vzo_A          179 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL  256 (355)
T ss_dssp             --TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred             --CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence              999999999999999999999999999876532221 22345789999999998863  4688999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQL  225 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~~  225 (228)
                      +|..||.......  ..............+ ..   ...+..+.++|.+||..||.+||     |++++++.
T Consensus       257 ~g~~pf~~~~~~~--~~~~~~~~~~~~~~~-~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          257 TGASPFTVDGEKN--SQAEISRRILKSEPP-YP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HSSCTTSCTTSCC--CHHHHHHHHHHCCCC-CC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HCCCCCccCCccc--hHHHHHHHHhccCCC-CC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            9999986432211  112222222222211 11   23456788999999999999999     89998763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.2e-41  Score=265.00  Aligned_cols=206  Identities=22%  Similarity=0.341  Sum_probs=156.5

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+.+++.++||||+++++++....      ..|+|||++.+ +|.+.+..     .++...+..++.|++.||.|
T Consensus        69 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~  142 (371)
T 2xrw_A           69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKH  142 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHH
Confidence            56789999999999999999999997654      78999999975 67777752     27889999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   |++||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+
T Consensus       143 lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  218 (371)
T 2xrw_A          143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  218 (371)
T ss_dssp             HHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence            9999   9999999999999999999999999999865432 22334578899999999999889999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcC------------------------CC--------------CCCCchhhhhhH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLD------------------------PR--------------LPPLSVDIRGKV  198 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~--------------~~~~~~~~~~~~  198 (228)
                      |++|..||......      .....+..                        +.              .+.........+
T Consensus       219 l~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (371)
T 2xrw_A          219 MIKGGVLFPGTDHI------DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA  292 (371)
T ss_dssp             HHHSSCSSCCSSHH------HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred             HHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccccc
Confidence            99999998643221      11111111                        00              011111122346


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          199 ISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       199 ~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ..+.++|.+||..||.+|||++++++
T Consensus       293 ~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          293 SQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            77899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-41  Score=284.16  Aligned_cols=211  Identities=23%  Similarity=0.387  Sum_probs=170.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|+.++++++||||+++++++.+ ...|+||||+.+++|.+++.....  .+++..++.++.|++.||.|||+. 
T Consensus       435 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~-  510 (656)
T 2j0j_A          435 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESK-  510 (656)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3678999999999999999999999854 568999999999999999976432  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       511 --givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~  588 (656)
T 2j0j_A          511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH  588 (656)
T ss_dssp             --TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHc
Confidence              9999999999999999999999999999876433222 223455678999999988889999999999999999997 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |..||....      .......+........+   ..++..+.++|.+||..||.+|||+.++++.|+
T Consensus       589 g~~Pf~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          589 GVKPFQGVK------NNDVIGRIENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             SCCTTTTCC------HHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCC---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            999986432      22233333222222211   245667999999999999999999999999886

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-41  Score=258.15  Aligned_cols=204  Identities=18%  Similarity=0.308  Sum_probs=165.2

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-AEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ...+.+|+..+..+ +||||+++++++......++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+
T Consensus        54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  133 (289)
T 1x8b_A           54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS  133 (289)
T ss_dssp             HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            35678899999999 899999999999999999999999999999999875321 1338999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCC-------------------CceEEeecccccccCCCCCCceecccccceeCCcccccC-
Q 040501           80 DCIPPIVHRDISSKNVLLDLE-------------------YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-  139 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-  139 (228)
                      .   |++|+||||+||+++.+                   ..++|+|||.+.......    ...+++.|+|||.+.+. 
T Consensus       134 ~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~  206 (289)
T 1x8b_A          134 M---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENY  206 (289)
T ss_dssp             T---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCC
T ss_pred             C---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCC
Confidence            9   99999999999999844                   478999999988765432    23588999999998766 


Q ss_pred             CcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH
Q 040501          140 KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM  219 (228)
Q Consensus       140 ~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  219 (228)
                      .++.++||||||+++|+|++|.+++....         ....+.....+...   ..++..+.+++.+||+.||.+|||+
T Consensus       207 ~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~  274 (289)
T 1x8b_A          207 THLPKADIFALALTVVCAAGAEPLPRNGD---------QWHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSA  274 (289)
T ss_dssp             TTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------HHHHHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCchhhHHHHHHHHHHHhcCCCCCcchh---------HHHHHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCH
Confidence            56689999999999999999988753221         12222222222222   2355678999999999999999999


Q ss_pred             HHHHH
Q 040501          220 QTICQ  224 (228)
Q Consensus       220 ~~il~  224 (228)
                      .++++
T Consensus       275 ~~ll~  279 (289)
T 1x8b_A          275 MALVK  279 (289)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-42  Score=273.13  Aligned_cols=200  Identities=16%  Similarity=0.171  Sum_probs=155.3

Q ss_pred             HHHHHHH---HHHhccCCCccceee-------eeeeecC-----------------eEEEEEEeecCCChhhhhhcCCC-
Q 040501            3 KEFLREI---TVLTEIRHRNIVKFY-------GFCTHAR-----------------HSFLVYEYLENGSLSVILNNDTS-   54 (228)
Q Consensus         3 ~~~~~E~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~-   54 (228)
                      +.+.+|+   +.++.++||||++++       +++...+                 ..|++|||+ +++|.+++..... 
T Consensus       118 ~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~  196 (377)
T 3byv_A          118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH  196 (377)
T ss_dssp             HHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc
Confidence            6788999   555556899999998       5555443                 388999999 5799999875321 


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceeccccccee
Q 040501           55 ---AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYV  131 (228)
Q Consensus        55 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~  131 (228)
                         ...+++..++.++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++...+.   ......| +.|+
T Consensus       197 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~  269 (377)
T 3byv_A          197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFE  269 (377)
T ss_dssp             TTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCC
T ss_pred             ccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCcc
Confidence               11233588888999999999999999   999999999999999999999999999986432   2344566 9999


Q ss_pred             CCcccccC-----------CcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHH
Q 040501          132 APELAYTM-----------KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVIS  200 (228)
Q Consensus       132 aPE~~~~~-----------~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (228)
                      |||++.+.           .++.++||||||+++|+|++|..||.......      ....+... .       ..++.+
T Consensus       270 aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~-~-------~~~~~~  335 (377)
T 3byv_A          270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------GSEWIFRS-C-------KNIPQP  335 (377)
T ss_dssp             CHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C------CSGGGGSS-C-------CCCCHH
T ss_pred             ChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc------chhhhhhh-c-------cCCCHH
Confidence            99999887           78999999999999999999999986433221      11111111 1       234567


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 040501          201 IMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       201 ~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.++|.+||+.||.+|||+.++++
T Consensus       336 ~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          336 VRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHcCCCchhCCCHHHHhh
Confidence            899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.6e-42  Score=270.79  Aligned_cols=216  Identities=20%  Similarity=0.268  Sum_probs=161.0

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ..+|+++++.++||||++++++|....      ..++||||+.++.+............+++..+..++.|++.||+|||
T Consensus        79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  158 (394)
T 4e7w_A           79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH  158 (394)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347999999999999999999996543      38899999987554444332222344899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~  156 (228)
                      +.   |++||||||+||+++ .++.+||+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|+
T Consensus       159 ~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  234 (394)
T 4e7w_A          159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE  234 (394)
T ss_dssp             HT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence            99   999999999999999 78999999999998764332 23345778999999998765 48999999999999999


Q ss_pred             HHhCCCCccccccccCC---------Cchhhhh----hhcCCCCCCCc------hhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          157 VIKGKHPRDFLSNVSSS---------NPNILVN----EMLDPRLPPLS------VDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~---------~~~~~~~----~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      |++|..||.........         .......    .......+...      ......+.++.++|.+||..||.+||
T Consensus       235 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (394)
T 4e7w_A          235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL  314 (394)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC
Confidence            99999998653321100         0000000    00011111100      00123566899999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |+.++++
T Consensus       315 t~~e~l~  321 (394)
T 4e7w_A          315 TAIEALC  321 (394)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-41  Score=267.44  Aligned_cols=212  Identities=21%  Similarity=0.352  Sum_probs=152.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+++.+|+++++.++||||+++++++...      ...|+++|++ +++|.+++..    ..++...+..++.|++.||.
T Consensus        72 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~  146 (367)
T 2fst_X           72 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLK  146 (367)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999998653      5689999998 6788888764    23899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLA  154 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l  154 (228)
                      |||+.   |++||||||+||+++.++.+||+|||++......   .....+++.|+|||.+.+ ..++.++|||||||++
T Consensus       147 ~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  220 (367)
T 2fst_X          147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM  220 (367)
T ss_dssp             HHHHT---TCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred             HHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence            99999   9999999999999999999999999999765432   334578899999999877 5789999999999999


Q ss_pred             HHHHhCCCCccccccccCC---------Cchhhh--------hhhcC--CCCC--CCchhhhhhHHHHHHHHHHhhccCC
Q 040501          155 LEVIKGKHPRDFLSNVSSS---------NPNILV--------NEMLD--PRLP--PLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~---------~~~~~~--------~~~~~--~~~~--~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |+|++|..||.........         ......        .....  +..+  .......+.+..+.+||.+||..||
T Consensus       221 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP  300 (367)
T 2fst_X          221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS  300 (367)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence            9999999998653321100         000000        00000  0001  1111123445678999999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||+.++++
T Consensus       301 ~~R~t~~e~L~  311 (367)
T 2fst_X          301 DKRITAAQALA  311 (367)
T ss_dssp             GGSCCHHHHHT
T ss_pred             ccCcCHHHHhc
Confidence            99999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=254.83  Aligned_cols=208  Identities=21%  Similarity=0.327  Sum_probs=164.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeee--eecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFC--THARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      ++.+.+|+++++.++|+||+++++++  ......|+||||+.++ |.+++.... ...+++..++.++.|++.||.|||+
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999998  4556899999999876 666665433 2348999999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCC--cccchhhhhHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLAL  155 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~  155 (228)
                      .   |++|+||||+||+++.++.++|+|||.+.........  .....+++.|+|||.+.+..  .+.++||||||+++|
T Consensus       128 ~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  204 (305)
T 2wtk_C          128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY  204 (305)
T ss_dssp             T---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHH
T ss_pred             C---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHH
Confidence            9   9999999999999999999999999999876432222  23456889999999987654  377999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|++|..||....      .......+........    ..++..+.++|.+||..||.+|||+.++++
T Consensus       205 ~l~~g~~p~~~~~------~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          205 NITTGLYPFEGDN------IYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHSSCSCCCSS------HHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHhCCCCCCCch------HHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999986422      2222233222222111    234567889999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.3e-41  Score=259.14  Aligned_cols=213  Identities=23%  Similarity=0.297  Sum_probs=165.5

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++.+.+|++++++++ ||||+++++++..  ....++|||++.+++|.+++..      ++...+..++.|++.||+|||
T Consensus        74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH  147 (330)
T 3nsz_A           74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH  147 (330)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH
Confidence            567899999999997 9999999999987  6788999999999999998842      788999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~  156 (228)
                      +.   |++||||||+||+++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+
T Consensus       148 ~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  223 (330)
T 3nsz_A          148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS  223 (330)
T ss_dssp             HT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             hC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence            99   999999999999999776 89999999998665332 2334578889999999877 568999999999999999


Q ss_pred             HHhCCCCccccccccCC--------Cchhh--------------hhhhcCCCCC------CCchhhhhhHHHHHHHHHHh
Q 040501          157 VIKGKHPRDFLSNVSSS--------NPNIL--------------VNEMLDPRLP------PLSVDIRGKVISIMEVAFLC  208 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~--------~~~~~--------------~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~  208 (228)
                      |++|..||.........        .....              ..........      .........+.++.++|.+|
T Consensus       224 ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (330)
T 3nsz_A          224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL  303 (330)
T ss_dssp             HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred             HHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence            99999998422110000        00000              0000000000      00011123567899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |+.||.+|||++++++
T Consensus       304 L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          304 LRYDHQSRLTAREAME  319 (330)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             hcCCcccCCCHHHHhc
Confidence            9999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=261.72  Aligned_cols=209  Identities=17%  Similarity=0.140  Sum_probs=169.0

Q ss_pred             hHHHHHHHHHHhccC---CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND--TSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ...+.+|+++++.++   |+||+++++++...+..|+||||+.+++|.+++...  .....+++..++.++.|++.||+|
T Consensus       108 ~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~  187 (365)
T 3e7e_A          108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ  187 (365)
T ss_dssp             HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence            356788899888886   899999999999999999999999999999999742  123458999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcC-----------CCceEEeecccccccCCC--CCCceecccccceeCCcccccCCccc
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDL-----------EYEAHVSDFGIAKFIQPD--SSNWTEFAGTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~-----------~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  143 (228)
                      ||+.   ||+||||||+||+++.           ++.+||+|||++......  ........||+.|+|||++.+..++.
T Consensus       188 lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  264 (365)
T 3e7e_A          188 VHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY  264 (365)
T ss_dssp             HHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred             HhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc
Confidence            9999   9999999999999998           899999999999754322  22234467899999999999999999


Q ss_pred             chhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC-CCHHHH
Q 040501          144 KCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR-PNMQTI  222 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-pt~~~i  222 (228)
                      ++||||||+++|+|++|..||.......     ..    ........     .....+.+++.+||+.+|.+| |+++++
T Consensus       265 ~~DiwslG~il~elltg~~pf~~~~~~~-----~~----~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          265 QIDYFGVAATVYCMLFGTYMKVKNEGGE-----CK----PEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCEEEETTE-----EE----ECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCccccCCCCc-----ee----echhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            9999999999999999999985332210     00    11111111     234567899999999999999 667777


Q ss_pred             HHHhh
Q 040501          223 CQLLC  227 (228)
Q Consensus       223 l~~l~  227 (228)
                      .+.|+
T Consensus       331 ~~~l~  335 (365)
T 3e7e_A          331 RQKLK  335 (365)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.9e-41  Score=256.69  Aligned_cols=209  Identities=25%  Similarity=0.411  Sum_probs=158.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee-------------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH-------------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKG   69 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~   69 (228)
                      +.+.+|++++++++||||+++++++.+             ....|+|||++.+++|.+++....  ..++...++.++.|
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~q  124 (303)
T 1zy4_A           47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQ  124 (303)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHH
Confidence            568899999999999999999998854             457899999999999999997643  23788899999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCC--------------CCceecccccceeCCcc
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--------------SNWTEFAGTYGYVAPEL  135 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~  135 (228)
                      ++.||.|||+.   |++|+||||+||+++.++.++|+|||.+.......              .......+++.|+|||.
T Consensus       125 i~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (303)
T 1zy4_A          125 ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV  201 (303)
T ss_dssp             HHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred             HHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence            99999999999   99999999999999999999999999987654221              11234567889999999


Q ss_pred             cccC-CcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          136 AYTM-KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       136 ~~~~-~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      +.+. .++.++||||||+++|+|++   ||....     ........+...............+..+.+++.+||+.||.
T Consensus       202 ~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  273 (303)
T 1zy4_A          202 LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN  273 (303)
T ss_dssp             HTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred             ccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcc
Confidence            8765 68899999999999999998   432111     01111222222111111111234556788999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       274 ~Rps~~~ll~  283 (303)
T 1zy4_A          274 KRPGARTLLN  283 (303)
T ss_dssp             GSCCHHHHHH
T ss_pred             cCcCHHHHhC
Confidence            9999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=271.42  Aligned_cols=218  Identities=19%  Similarity=0.296  Sum_probs=154.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNND------TSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +.+.+|++++++++||||+++++++..  ....|+||||+.+ +|.+++...      .....+++..++.++.|++.||
T Consensus        63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  141 (405)
T 3rgf_A           63 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI  141 (405)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence            468899999999999999999999954  6789999999975 676666421      1122488999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEE----cCCCceEEeecccccccCCCCC---CceecccccceeCCcccccC-Ccccchh
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLL----DLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTM-KVTAKCD  146 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~D  146 (228)
                      .|||+.   ||+||||||+||++    +.++.+||+|||++........   ......+++.|+|||++.+. .++.++|
T Consensus       142 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  218 (405)
T 3rgf_A          142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID  218 (405)
T ss_dssp             HHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred             HHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhh
Confidence            999999   99999999999999    6778999999999987653321   12345789999999998874 4899999


Q ss_pred             hhhHHHHHHHHHhCCCCccccccccCC---CchhhhhhhcC----CCC------------------------CCCch---
Q 040501          147 VYSFGVLALEVIKGKHPRDFLSNVSSS---NPNILVNEMLD----PRL------------------------PPLSV---  192 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~~~~~~~~---~~~~~~~~~~~----~~~------------------------~~~~~---  192 (228)
                      ||||||++|+|++|..||.........   ........+..    +..                        .....   
T Consensus       219 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (405)
T 3rgf_A          219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY  298 (405)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhh
Confidence            999999999999999998643221000   00001111000    000                        00000   


Q ss_pred             ---hhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          193 ---DIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       193 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                         .....+..+.+||.+||..||.+|||++++++
T Consensus       299 ~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          299 MEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               00001446789999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=260.93  Aligned_cols=210  Identities=21%  Similarity=0.303  Sum_probs=150.6

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeee--------ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCT--------HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAH   72 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~   72 (228)
                      .+.+.+|+.+++++. ||||+++++++.        ....+++++|++. ++|.+++........+++..++.++.|++.
T Consensus        69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~  147 (337)
T 3ll6_A           69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCR  147 (337)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence            356789999999995 999999999983        3446899999996 588888765333345899999999999999


Q ss_pred             HHHHhhhCCCCC--eeecCCCCCceEEcCCCceEEeecccccccCCCCCC------------ceecccccceeCCccc--
Q 040501           73 ALSYLHHDCIPP--IVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN------------WTEFAGTYGYVAPELA--  136 (228)
Q Consensus        73 ~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~y~aPE~~--  136 (228)
                      ||.|||+.   |  ++|+||||+||+++.++.++|+|||++.........            .....+++.|+|||.+  
T Consensus       148 ~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  224 (337)
T 3ll6_A          148 AVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL  224 (337)
T ss_dssp             HHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------C
T ss_pred             HHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence            99999999   8  999999999999999999999999999876543221            1134578899999998  


Q ss_pred             -ccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          137 -YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       137 -~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                       .+..++.++||||||+++|+|++|..||.......      ...........      ...+..+.+++.+||+.||.+
T Consensus       225 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~  292 (337)
T 3ll6_A          225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------IVNGKYSIPPH------DTQYTVFHSLIRAMLQVNPEE  292 (337)
T ss_dssp             CTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTT------CCSSGGGHHHHHHHSCSSGGG
T ss_pred             cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------hhcCcccCCcc------cccchHHHHHHHHHccCChhh
Confidence             45668889999999999999999999986432211      11111111111      122335789999999999999


Q ss_pred             CCCHHHHHHHhh
Q 040501          216 RPNMQTICQLLC  227 (228)
Q Consensus       216 Rpt~~~il~~l~  227 (228)
                      |||+.++++.|+
T Consensus       293 Rps~~e~l~~l~  304 (337)
T 3ll6_A          293 RLSIAEVVHQLQ  304 (337)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHH
Confidence            999999999886

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-41  Score=268.15  Aligned_cols=212  Identities=7%  Similarity=-0.040  Sum_probs=147.4

Q ss_pred             HHHHHHHHHHhcc--CCCccceee-------eeeeec-----------------CeEEEEEEeecCCChhhhhhcCCCCC
Q 040501            3 KEFLREITVLTEI--RHRNIVKFY-------GFCTHA-----------------RHSFLVYEYLENGSLSVILNNDTSAE   56 (228)
Q Consensus         3 ~~~~~E~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~   56 (228)
                      +.+.+|+.+++.+  +||||++++       +++...                 ...|+||||+. ++|.+++...... 
T Consensus       107 ~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-  184 (371)
T 3q60_A          107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-  184 (371)
T ss_dssp             HHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-
T ss_pred             HHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-
Confidence            4567786555555  699988865       343322                 34899999998 7999999764221 


Q ss_pred             CCCHHHH------HHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccce
Q 040501           57 ELGWSRR------INVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGY  130 (228)
Q Consensus        57 ~~~~~~~------~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  130 (228)
                       +....+      +.++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++...+..   .....+++.|
T Consensus       185 -~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y  257 (371)
T 3q60_A          185 -YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTY  257 (371)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGG
T ss_pred             -cchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCC
Confidence             344444      67779999999999999   9999999999999999999999999999865422   2234566999


Q ss_pred             eCCccccc--CCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHh
Q 040501          131 VAPELAYT--MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLC  208 (228)
Q Consensus       131 ~aPE~~~~--~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  208 (228)
                      +|||++.+  ..++.++||||||+++|+|++|..||................ ................+..+.++|.+|
T Consensus       258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (371)
T 3q60_A          258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL-RVPGTDSLAFGSCTPLPDFVKTLIGRF  336 (371)
T ss_dssp             CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCT-TSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred             cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhh-hhccccccchhhccCCCHHHHHHHHHH
Confidence            99999987  678999999999999999999999987543221111100000 000011111111235667899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |+.||.+|||+.++++
T Consensus       337 L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          337 LNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TCSSTTTCCCHHHHTT
T ss_pred             cCCChhhCCCHHHHhc
Confidence            9999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-40  Score=261.69  Aligned_cols=214  Identities=22%  Similarity=0.353  Sum_probs=165.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|++++++++||||+++++++...     ...|+|+|++.+ +|.+++...    .++...+..++.|++.||.||
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~L  144 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYI  144 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHH
Confidence            5688999999999999999999998654     478999999975 888888653    288999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCccccc-CCcccchhhhhHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVL  153 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~  153 (228)
                      |+.   |++||||||+||+++.++.++|+|||++.........   .....+++.|+|||.+.+ ..++.++||||||++
T Consensus       145 H~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  221 (364)
T 3qyz_A          145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  221 (364)
T ss_dssp             HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHH
T ss_pred             HHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHH
Confidence            999   9999999999999999999999999999865433221   234578999999998654 448999999999999


Q ss_pred             HHHHHhCCCCccccccccCCCch---------h------------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPN---------I------------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~---------~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|..||............         .            ....................+.++.++|.+||+.|
T Consensus       222 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  301 (364)
T 3qyz_A          222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN  301 (364)
T ss_dssp             HHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC
Confidence            99999999998643321110000         0            00000001111111112345667899999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||+.++++
T Consensus       302 P~~R~t~~e~l~  313 (364)
T 3qyz_A          302 PHKRIEVEQALA  313 (364)
T ss_dssp             TTTSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.4e-41  Score=270.33  Aligned_cols=216  Identities=18%  Similarity=0.286  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHhccCC-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|+++++.++| +++..+..++......++||||+ +++|.+++.....  .+++..++.++.||+.||.|||+. 
T Consensus        47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~-  122 (483)
T 3sv0_A           47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK-  122 (483)
T ss_dssp             CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            457899999999976 66666667777888999999999 8899999975432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEE---cCCCceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           82 IPPIVHRDISSKNVLL---DLEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                        ||+||||||+|||+   +.++.+||+|||++.........       .....|++.|+|||.+.+..++.++||||||
T Consensus       123 --gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlG  200 (483)
T 3sv0_A          123 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG  200 (483)
T ss_dssp             --TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred             --CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHH
Confidence              99999999999999   57899999999999876544322       2246789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCC-CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|+|++|..||.......   .......+...... .......+++.++.+++.+||..+|.+||++.+|++.|+
T Consensus       201 vil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          201 YVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             HHHHHHHHSSCTTSSCCCSS---HHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCccccchh---HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            99999999999987533211   11111111111111 111112355678999999999999999999999999886

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.5e-41  Score=263.57  Aligned_cols=215  Identities=23%  Similarity=0.299  Sum_probs=157.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|++++++++||||+++++++..     ....|+|||++.+ +|.+.+....  ..++...+..++.|++.||.||
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~l  150 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--IVISPQHIQYFMYHILLGLHVL  150 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHH
Confidence            678999999999999999999999843     3468999999974 7777776433  3489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~  156 (228)
                      |+.   |++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus       151 H~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~  226 (362)
T 3pg1_A          151 HEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE  226 (362)
T ss_dssp             HHT---TCCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred             HHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHH
Confidence            999   9999999999999999999999999999754432 22334568889999998877 568999999999999999


Q ss_pred             HHhCCCCccccccccCCCch-----------------hhhhhhcCCCC---C--CCchhhhhhHHHHHHHHHHhhccCCC
Q 040501          157 VIKGKHPRDFLSNVSSSNPN-----------------ILVNEMLDPRL---P--PLSVDIRGKVISIMEVAFLCLDNNPE  214 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~-----------------~~~~~~~~~~~---~--~~~~~~~~~~~~~~~li~~~l~~~p~  214 (228)
                      |++|..||............                 ...........   +  .........+..+.++|.+||+.||.
T Consensus       227 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  306 (362)
T 3pg1_A          227 MFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ  306 (362)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh
Confidence            99999998643211100000                 00000000000   0  00111233456789999999999999


Q ss_pred             CCCCHHHHHH
Q 040501          215 SRPNMQTICQ  224 (228)
Q Consensus       215 ~Rpt~~~il~  224 (228)
                      +|||+.++++
T Consensus       307 ~Rpt~~ell~  316 (362)
T 3pg1_A          307 RRISTEQALR  316 (362)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHHc
Confidence            9999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-40  Score=267.30  Aligned_cols=213  Identities=24%  Similarity=0.389  Sum_probs=157.1

Q ss_pred             HHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCC----CCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE----LGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~----~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|+++++++ +||||+++++++......|+|||++. ++|.+++........    .+...++.++.|++.||+||
T Consensus        53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  131 (434)
T 2rio_A           53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL  131 (434)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence            4578999999987 89999999999999999999999996 599999976432211    12334578999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCC-------------CceEEeecccccccCCCCCC----ceecccccceeCCccccc--
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLE-------------YEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYT--  138 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~-------------~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--  138 (228)
                      |+.   |++||||||+||+++.+             +.++|+|||++.........    .....|++.|+|||++.+  
T Consensus       132 H~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  208 (434)
T 2rio_A          132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN  208 (434)
T ss_dssp             HHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCC
T ss_pred             HHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc
Confidence            999   99999999999999764             37999999999876543322    234578999999999865  


Q ss_pred             -----CCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          139 -----MKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       139 -----~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                           ..++.++|||||||++|+|++ |..||......    ............. .........+.++.++|.+||+.|
T Consensus       209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~i~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~d  283 (434)
T 2rio_A          209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----ESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHD  283 (434)
T ss_dssp             TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----HHHHHHTCCCCCC-CTTCCCHHHHHHHHHHHHHHTCSS
T ss_pred             ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----HHHHhcCCCCccc-ccccccccchHHHHHHHHHHhhCC
Confidence                 567889999999999999998 99998532211    1111111111111 111112456778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||+.++++
T Consensus       284 P~~Rps~~eil~  295 (434)
T 2rio_A          284 PLKRPTAMKVLR  295 (434)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHHh
Confidence            999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.8e-41  Score=266.28  Aligned_cols=216  Identities=21%  Similarity=0.314  Sum_probs=163.4

Q ss_pred             hHHHHHHHHHHhccC--------CCccceeeeeee----ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIR--------HRNIVKFYGFCT----HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKG   69 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~   69 (228)
                      .+.+.+|+++++.++        |+||+++++++.    .....|+|||++.+ ++.+.+.... ...+++..++.++.|
T Consensus        77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~i~~q  154 (397)
T 1wak_A           77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSN-YQGLPLPCVKKIIQQ  154 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCC-BHHHHHHHTT-TSCCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCc-cHHHHHHhcc-cCCCCHHHHHHHHHH
Confidence            356789999999995        788999999987    55689999999955 5555554332 134899999999999


Q ss_pred             HHHHHHHhhhCCCCCeeecCCCCCceEEcCCC------------------------------------------------
Q 040501           70 IAHALSYLHHDCIPPIVHRDISSKNVLLDLEY------------------------------------------------  101 (228)
Q Consensus        70 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~------------------------------------------------  101 (228)
                      ++.||.|||+.+  |++||||||+||+++.++                                                
T Consensus       155 i~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (397)
T 1wak_A          155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK  232 (397)
T ss_dssp             HHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred             HHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence            999999999953  899999999999999776                                                


Q ss_pred             -ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhh
Q 040501          102 -EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN  180 (228)
Q Consensus       102 -~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~  180 (228)
                       .++|+|||.+......   .....+++.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus       233 ~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  309 (397)
T 1wak_A          233 LKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA  309 (397)
T ss_dssp             CCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHH
T ss_pred             cceEecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHH
Confidence             7999999999875432   234578999999999999889999999999999999999999986433221111111000


Q ss_pred             hh---cCC--------------------------CCCCC---------chhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          181 EM---LDP--------------------------RLPPL---------SVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       181 ~~---~~~--------------------------~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      .+   ...                          .....         .......+..+.+||.+||+.||.+|||++++
T Consensus       310 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  389 (397)
T 1wak_A          310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC  389 (397)
T ss_dssp             HHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred             HHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence            00   000                          00000         00123456678999999999999999999999


Q ss_pred             HH
Q 040501          223 CQ  224 (228)
Q Consensus       223 l~  224 (228)
                      ++
T Consensus       390 l~  391 (397)
T 1wak_A          390 LR  391 (397)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-40  Score=260.87  Aligned_cols=214  Identities=21%  Similarity=0.304  Sum_probs=163.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .++.+|++++++++||||+++++++...     ...|++||++. ++|.+++...    .++...+..++.|++.||.||
T Consensus        54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~L  128 (353)
T 2b9h_A           54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVL  128 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999988654     67899999997 5888888753    388999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----------ceecccccceeCCccccc-CCcccchh
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----------WTEFAGTYGYVAPELAYT-MKVTAKCD  146 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~-~~~~~~~D  146 (228)
                      |+.   |++|+||||+||+++.++.++|+|||++.........          .....+++.|+|||++.+ ..++.++|
T Consensus       129 H~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             HHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             HHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence            999   9999999999999999999999999999876532211          122467899999998764 66889999


Q ss_pred             hhhHHHHHHHHHhCCCCccccccccCC-------------------Cc---hhhhhhhcCCCCCCCchhhhhhHHHHHHH
Q 040501          147 VYSFGVLALEVIKGKHPRDFLSNVSSS-------------------NP---NILVNEMLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       147 iwslG~~l~~~~~g~~p~~~~~~~~~~-------------------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                      |||||+++|+|++|..||.........                   ..   ......................+..+.++
T Consensus       206 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  285 (353)
T 2b9h_A          206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL  285 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHH
Confidence            999999999999999998643211000                   00   00000000000001111123566788999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||..||.+|||++++++
T Consensus       286 i~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          286 LQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCcCcccCCCHHHHhc
Confidence            99999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.6e-40  Score=255.84  Aligned_cols=211  Identities=19%  Similarity=0.317  Sum_probs=165.9

Q ss_pred             HHHHHHHHHHhccCCC------ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHR------NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+++++.++|+      +++++++++......++|||++ +++|.+++..... ..++...+..++.|++.||+|
T Consensus        56 ~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~  133 (339)
T 1z57_A           56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNF  133 (339)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHH
Confidence            5678999999998765      4999999999999999999999 7899998876542 248899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcC-------------------CCceEEeecccccccCCCCCCceecccccceeCCcccc
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDL-------------------EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY  137 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  137 (228)
                      ||+.   |++||||||+||+++.                   ++.++|+|||.+......   .....+++.|+|||++.
T Consensus       134 lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~  207 (339)
T 1z57_A          134 LHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVIL  207 (339)
T ss_dssp             HHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHT
T ss_pred             HHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhh
Confidence            9999   9999999999999987                   667999999999864432   23457899999999999


Q ss_pred             cCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCC-------------------------------
Q 040501          138 TMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR-------------------------------  186 (228)
Q Consensus       138 ~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------------------  186 (228)
                      +..++.++||||||+++|+|++|..||........   .........+.                               
T Consensus       208 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (339)
T 1z57_A          208 ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV  284 (339)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHH
T ss_pred             CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchh
Confidence            98999999999999999999999999864322110   00000000000                               


Q ss_pred             ------CCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          187 ------LPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                            ...........+..+.++|.+||+.||.+|||++++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence                  00000011234677899999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-40  Score=261.75  Aligned_cols=211  Identities=19%  Similarity=0.319  Sum_probs=160.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeE------EEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|+.+++.++||||+++++++......      |+|||++. ++|.+.+..     .+++..+..++.|++.||.
T Consensus        85 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~  158 (371)
T 4exu_A           85 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLK  158 (371)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHH
Confidence            35788999999999999999999999876654      99999997 477777632     2889999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLA  154 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l  154 (228)
                      |||+.   |++||||||+||+++.++.++|+|||++......   .....+++.|+|||.+.+ ..++.++||||||+++
T Consensus       159 ~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (371)
T 4exu_A          159 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM  232 (371)
T ss_dssp             HHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred             HHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence            99999   9999999999999999999999999999765432   234567899999999877 6789999999999999


Q ss_pred             HHHHhCCCCccccccccCCCc---------------------hhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          155 LEVIKGKHPRDFLSNVSSSNP---------------------NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |+|++|..||...........                     ......................+..+.++|.+||+.||
T Consensus       233 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  312 (371)
T 4exu_A          233 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV  312 (371)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence            999999999864321110000                     00000011111111111123456789999999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||++++++
T Consensus       313 ~~Rpt~~ell~  323 (371)
T 4exu_A          313 DKRLTAAQALT  323 (371)
T ss_dssp             TTSCCHHHHHT
T ss_pred             hhcCCHHHHhc
Confidence            99999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.6e-40  Score=264.01  Aligned_cols=157  Identities=20%  Similarity=0.315  Sum_probs=137.1

Q ss_pred             HHHHHHHHHHhcc------CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI------RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+.+|+++++.+      +|+||+++++++......++|||++. ++|.+++..... ..+++..+..++.|++.||+|
T Consensus       138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~  215 (429)
T 3kvw_A          138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDA  215 (429)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHH
Confidence            4567888888887      46799999999999999999999996 588888876543 338999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCc--eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYE--AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      ||+.   ||+||||||+||+++.++.  +||+|||++......   .....+++.|+|||++.+..++.++|||||||++
T Consensus       216 LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  289 (429)
T 3kvw_A          216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL  289 (429)
T ss_dssp             HHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHH
T ss_pred             HHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHH
Confidence            9999   9999999999999999887  999999999765432   2345788999999999999999999999999999


Q ss_pred             HHHHhCCCCcccc
Q 040501          155 LEVIKGKHPRDFL  167 (228)
Q Consensus       155 ~~~~~g~~p~~~~  167 (228)
                      |+|++|.+||...
T Consensus       290 ~elltG~~pf~~~  302 (429)
T 3kvw_A          290 AELLTGYPLLPGE  302 (429)
T ss_dssp             HHHHHSSCSSCCS
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999998643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=263.67  Aligned_cols=208  Identities=23%  Similarity=0.320  Sum_probs=156.2

Q ss_pred             HHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|+++++.+ +||||+++++++.+....|+|||++. ++|.+++......  .....++.++.|++.||.|||+.  
T Consensus        63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~--  137 (432)
T 3p23_A           63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSL--  137 (432)
T ss_dssp             ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHC--
Confidence            357899999999 79999999999999999999999996 5899988765422  44456678999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCC---C--ceEEeecccccccCCCCC---CceecccccceeCCccccc---CCcccchhhhhHH
Q 040501           83 PPIVHRDISSKNVLLDLE---Y--EAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFG  151 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~---~--~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG  151 (228)
                       ||+||||||+||+++.+   +  .++|+|||++........   ......|++.|+|||++.+   ..++.++||||||
T Consensus       138 -~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG  216 (432)
T 3p23_A          138 -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG  216 (432)
T ss_dssp             -TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred             -cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence             99999999999999532   3  477999999987653321   2334578999999999873   4567899999999


Q ss_pred             HHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          152 VLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       152 ~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|+|++ |..||.....       .....................+..+.++|.+||+.||.+|||+.++++
T Consensus       217 ~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          217 CVFYYVISEGSHPFGKSLQ-------RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHTTSCBTTBSTTT-------HHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCCCcchhhH-------HHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            99999999 9999853211       111111111111111112344556889999999999999999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-40  Score=256.93  Aligned_cols=211  Identities=20%  Similarity=0.262  Sum_probs=142.7

Q ss_pred             HHHHH-HHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            6 LREIT-VLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         6 ~~E~~-~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+|+. .++.++|+||+++++++..    ....++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+.
T Consensus        69 ~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~  147 (336)
T 3fhr_A           69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH  147 (336)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34444 3555689999999999976    4568999999999999999986542 3489999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCC---CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLE---YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                         |++|+||||+||+++.+   +.++|+|||++......  ......+++.|+|||.+.+..++.++||||||+++|+|
T Consensus       148 ---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l  222 (336)
T 3fhr_A          148 ---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  222 (336)
T ss_dssp             ---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred             ---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence               99999999999999764   55999999999765432  22345678999999999888899999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||...........  ....+..............++..+.++|.+||..||.+|||+.++++
T Consensus       223 ~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          223 LCGFPPFYSNTGQAISPG--MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             HHSSCCC-----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHCCCCCCCccchhhhhh--HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999864432211100  11111111111111222456678999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.8e-40  Score=259.28  Aligned_cols=212  Identities=21%  Similarity=0.224  Sum_probs=159.8

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCe-------EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARH-------SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ..+.+|++.+..++||||+++++++.....       .++||||+.++.+..+.........++...+..++.|++.||.
T Consensus        64 ~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  143 (360)
T 3e3p_A           64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG  143 (360)
T ss_dssp             CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence            456778888888999999999999965433       8899999987433333322223344888999999999999999


Q ss_pred             Hhh--hCCCCCeeecCCCCCceEEcC-CCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHH
Q 040501           76 YLH--HDCIPPIVHRDISSKNVLLDL-EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFG  151 (228)
Q Consensus        76 ~lh--~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG  151 (228)
                      |||  +.   |++||||||+||+++. ++.+||+|||++....... ......+++.|+|||.+.+.. ++.++||||||
T Consensus       144 ~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  219 (360)
T 3e3p_A          144 CLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG  219 (360)
T ss_dssp             HHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence            999  88   9999999999999997 8999999999998765332 233456799999999986654 79999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcC--------------CCCC----------C----CchhhhhhHHHHHH
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD--------------PRLP----------P----LSVDIRGKVISIME  203 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~----------~----~~~~~~~~~~~~~~  203 (228)
                      +++|+|++|..||......      .....+..              +...          .    ........+.++.+
T Consensus       220 ~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (360)
T 3e3p_A          220 CIFAEMMLGEPIFRGDNSA------GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD  293 (360)
T ss_dssp             HHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHH
T ss_pred             HHHHHHHhCCCCcCCCChH------HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHH
Confidence            9999999999998643221      11111100              0000          0    00001125678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|.+||+.||.+|||+.++++
T Consensus       294 li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          294 LLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhccCccccCCHHHHhc
Confidence            999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-40  Score=263.16  Aligned_cols=209  Identities=23%  Similarity=0.312  Sum_probs=160.2

Q ss_pred             HHHHHHHHhccCCCccceeeeeeee--------------------------------------cCeEEEEEEeecCCChh
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTH--------------------------------------ARHSFLVYEYLENGSLS   46 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~   46 (228)
                      ..+|+++++.++||||++++++|..                                      ....++||||+++ +|.
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~  125 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH  125 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHH
Confidence            4579999999999999999999843                                      3348899999985 766


Q ss_pred             hhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceec
Q 040501           47 VILNN-DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEF  124 (228)
Q Consensus        47 ~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~  124 (228)
                      +.+.. ......+++..+..++.|++.||+|||+.   |++||||||+||+++ .++.+||+|||++....... .....
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  201 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAY  201 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCc
Confidence            66553 11223489999999999999999999999   999999999999997 68899999999998664332 23345


Q ss_pred             ccccceeCCcccccCC-cccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcC-------------------
Q 040501          125 AGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD-------------------  184 (228)
Q Consensus       125 ~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------  184 (228)
                      .+++.|+|||.+.+.. ++.++||||+||++|+|++|..||.......      ....+..                   
T Consensus       202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~g~p~~~~~~~~~~~~~~  275 (383)
T 3eb0_A          202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID------QLVRIIQIMGTPTKEQMIRMNPHYTE  275 (383)
T ss_dssp             CCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCHHHHHHHCTTC--
T ss_pred             ccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCCHHHHHHhCccccc
Confidence            6788999999887654 8999999999999999999999986432211      1111100                   


Q ss_pred             CCCCCCc-h-----hhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          185 PRLPPLS-V-----DIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       185 ~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ...+... .     .....+.++.++|.+||..||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          276 VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000 0     01235567899999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-40  Score=252.76  Aligned_cols=209  Identities=22%  Similarity=0.345  Sum_probs=153.1

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-DTSAEELGWSRRINVIKGIAHALSYLHHDCIP   83 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~   83 (228)
                      +.++...++.++||||+++++++......++|||++++ +|.+++.. ......+++..++.++.|++.||.|||+.+  
T Consensus        53 ~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--  129 (290)
T 3fme_A           53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--  129 (290)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             HHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--
Confidence            34455557778999999999999999999999999975 77776653 112234899999999999999999999842  


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccc----ccCCcccchhhhhHHHHHHHHHh
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELA----YTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                      |++|+||||+||+++.++.++|+|||++....... ......+++.|+|||.+    .+..++.++||||||+++|+|++
T Consensus       130 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~  208 (290)
T 3fme_A          130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI  208 (290)
T ss_dssp             CCCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999997654332 22334688999999996    45568889999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....     ..............+...  ....+..+.+++.+||+.||.+|||+.++++
T Consensus       209 g~~p~~~~~-----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          209 LRFPYDSWG-----TPFQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TSCSSCCCS-----CHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCccccC-----chHHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            999986321     111222222222222211  1245667999999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.9e-40  Score=254.18  Aligned_cols=213  Identities=22%  Similarity=0.347  Sum_probs=165.8

Q ss_pred             HHHHHHHHHhcc---CCCccceeeeeee-----ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEI---RHRNIVKFYGFCT-----HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         4 ~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+|+.+++.+   +||||+++++++.     .....++|||++. ++|.+++..... ..++...++.++.|++.||.
T Consensus        57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~  134 (326)
T 1blx_A           57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLD  134 (326)
T ss_dssp             THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHH
Confidence            567888888877   7999999999987     4567899999997 599998876443 23889999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      |||+.   |++|+||||+||+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|
T Consensus       135 ~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  210 (326)
T 1blx_A          135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA  210 (326)
T ss_dssp             HHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             HHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence            99999   9999999999999999999999999998765422 1233456789999999999888999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhh-------------------hhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVN-------------------EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      +|++|..||.........  .....                   .................+..+.++|.+||..||.+|
T Consensus       211 ~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  288 (326)
T 1blx_A          211 EMFRRKPLFRGSSDVDQL--GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR  288 (326)
T ss_dssp             HHHHSSCSCCCSSHHHHH--HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred             HHHcCCCCCCCCCHHHHH--HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccC
Confidence            999999998643221100  00000                   000000111111223456778999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||+.++++
T Consensus       289 pt~~e~l~  296 (326)
T 1blx_A          289 ISAYSALS  296 (326)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999984

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=257.64  Aligned_cols=211  Identities=19%  Similarity=0.307  Sum_probs=160.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCe------EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARH------SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|+.+++.++||||+++++++.....      .|++||++. ++|.+++..     .++...+..++.|++.||.
T Consensus        67 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~  140 (353)
T 3coi_A           67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLK  140 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999976643      599999997 478777642     2889999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLA  154 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l  154 (228)
                      |||+.   |++|+||||+||+++.++.++|+|||.+......   .....+++.|+|||.+.+ ..++.++||||||+++
T Consensus       141 ~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il  214 (353)
T 3coi_A          141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM  214 (353)
T ss_dssp             HHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred             HHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence            99999   9999999999999999999999999998765422   234567899999998877 5688999999999999


Q ss_pred             HHHHhCCCCccccccccCC---------Cchh------------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          155 LEVIKGKHPRDFLSNVSSS---------NPNI------------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~---------~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |+|++|..||.........         ....            ....................+..+.++|.+||..||
T Consensus       215 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  294 (353)
T 3coi_A          215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV  294 (353)
T ss_dssp             HHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence            9999999998643221100         0000            000000111111112223556789999999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||++++++
T Consensus       295 ~~Rpt~~e~l~  305 (353)
T 3coi_A          295 DKRLTAAQALT  305 (353)
T ss_dssp             TTSCCHHHHHT
T ss_pred             ccCCCHHHHhc
Confidence            99999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.5e-40  Score=272.31  Aligned_cols=217  Identities=28%  Similarity=0.326  Sum_probs=167.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ++++.+|++++++++||||+++++++..      +...|+||||+.+++|.+++........+++..++.++.|++.||.
T Consensus        56 ~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~  135 (676)
T 3qa8_A           56 RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR  135 (676)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999998765      6778999999999999999987655555889999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCc---eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      |||+.   |++|+||||+||+++.++.   ++|+|||.+....... ......+++.|+|||.+.+..++.++||||||+
T Consensus       136 yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv  211 (676)
T 3qa8_A          136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT  211 (676)
T ss_dssp             HHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred             HHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence            99999   9999999999999997765   8999999998765432 234467899999999999989999999999999


Q ss_pred             HHHHHHhCCCCccccccccC--------CCchhhhhhh------cCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          153 LALEVIKGKHPRDFLSNVSS--------SNPNILVNEM------LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ++|++++|..||........        ..........      .....+.........+..+.++|.+||..||.+|||
T Consensus       212 iLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT  291 (676)
T 3qa8_A          212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT  291 (676)
T ss_dssp             HHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred             HHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence            99999999999853211000        0000000000      011111112223457788999999999999999999


Q ss_pred             HHHH
Q 040501          219 MQTI  222 (228)
Q Consensus       219 ~~~i  222 (228)
                      +.++
T Consensus       292 a~el  295 (676)
T 3qa8_A          292 DPQN  295 (676)
T ss_dssp             CTTC
T ss_pred             HHHH
Confidence            9774

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-40  Score=266.24  Aligned_cols=215  Identities=23%  Similarity=0.288  Sum_probs=158.5

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeec------CeEEEEEEeecCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNN-DTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+|+++++.++|+||++++++|...      ..+++||||+.+ ++.+.+.. ......+++..+..++.|++.||.||
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  172 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999998532      246799999976 55554432 11233489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLAL  155 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~  155 (228)
                      |+.   ||+||||||+||+++.+ +.+||+|||++....... ......+++.|+|||++.+. .++.++|||||||++|
T Consensus       173 H~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~  248 (420)
T 1j1b_A          173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA  248 (420)
T ss_dssp             HTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHH
Confidence            999   99999999999999965 678999999998654332 22345789999999998765 6899999999999999


Q ss_pred             HHHhCCCCccccccccCC---------Cchhhhhhhc----CCCCCCCc-hh-----hhhhHHHHHHHHHHhhccCCCCC
Q 040501          156 EVIKGKHPRDFLSNVSSS---------NPNILVNEML----DPRLPPLS-VD-----IRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~-~~-----~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      +|++|..||.........         ..........    ....+... ..     ....+.++.+||.+||..||.+|
T Consensus       249 ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R  328 (420)
T 1j1b_A          249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR  328 (420)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHC
Confidence            999999998653321100         0000000000    00111100 00     12345678999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||+.++++
T Consensus       329 ~t~~e~l~  336 (420)
T 1j1b_A          329 LTPLEACA  336 (420)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhC
Confidence            99999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=253.62  Aligned_cols=209  Identities=23%  Similarity=0.348  Sum_probs=161.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeee--------------ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCT--------------HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVI   67 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   67 (228)
                      .+.+.+|++++++++||||+++++++.              .....|+|||++. ++|.+++...    .++...++.++
T Consensus        52 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~  126 (320)
T 2i6l_A           52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFM  126 (320)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHH
Confidence            356889999999999999999998873              3468899999997 5899988642    38899999999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEc-CCCceEEeecccccccCCCCC---CceecccccceeCCccccc-CCcc
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYT-MKVT  142 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~  142 (228)
                      .|++.||+|||+.   |++|+||||+||+++ .++.+||+|||++........   ......++..|+|||.+.+ ..++
T Consensus       127 ~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             HHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             HHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence            9999999999999   999999999999997 567999999999986543211   1233456888999998765 5688


Q ss_pred             cchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhc--------------------------CCCCCCCchhhhh
Q 040501          143 AKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML--------------------------DPRLPPLSVDIRG  196 (228)
Q Consensus       143 ~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~  196 (228)
                      .++||||||+++|+|++|..||......      .....+.                          .............
T Consensus       204 ~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (320)
T 2i6l_A          204 KAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG  277 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTT
T ss_pred             chhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcch
Confidence            9999999999999999999998643321      1111110                          0011111111234


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          197 KVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       197 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++.++.++|.+||+.||.+|||++++++
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          278 ISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            6678999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-39  Score=251.54  Aligned_cols=207  Identities=24%  Similarity=0.381  Sum_probs=159.5

Q ss_pred             HHHHHHHHHHhccC--CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +.+.+|++++++++  |+||+++++++......|++|| +.+++|.+++....   .++...++.++.|++.||.|||+.
T Consensus        71 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~  146 (313)
T 3cek_A           71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH  146 (313)
T ss_dssp             HHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            56889999999996  5999999999999999999999 56789999987643   388899999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc-----------CCcccchhh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT-----------MKVTAKCDV  147 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di  147 (228)
                         |++|+||||+||+++ ++.++|+|||.+.........  .....+++.|+|||.+.+           ..++.++||
T Consensus       147 ---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di  222 (313)
T 3cek_A          147 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV  222 (313)
T ss_dssp             ---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHH
T ss_pred             ---CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHH
Confidence               999999999999996 489999999999866433221  234568999999999865           357889999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||+++|+|++|..||.....     ..........+......  ....+..+.+++.+||..||.+|||+.++++
T Consensus       223 ~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          223 WSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            9999999999999999863221     11222222222211100  0123457889999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-39  Score=253.70  Aligned_cols=212  Identities=20%  Similarity=0.337  Sum_probs=162.7

Q ss_pred             hHHHHHHHHHHhccCCCc------cceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRN------IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      ++.+.+|+.+++.++|++      ++.+.+++......++|||++. +++.+.+..... ..+++..++.++.|++.||.
T Consensus        60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~  137 (355)
T 2eu9_A           60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNF-QPYPLPHVRHMAYQLCHALR  137 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Confidence            356788999999997655      8999999999999999999994 566666554332 23899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEE-------------------cCCCceEEeecccccccCCCCCCceecccccceeCCccc
Q 040501           76 YLHHDCIPPIVHRDISSKNVLL-------------------DLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELA  136 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~-------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~  136 (228)
                      |||+.   |++|+||||+||++                   +.++.++|+|||++......   .....+++.|+|||++
T Consensus       138 ~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~  211 (355)
T 2eu9_A          138 FLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVI  211 (355)
T ss_dssp             HHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHH
T ss_pred             HHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeee
Confidence            99999   99999999999999                   56789999999999864432   2345789999999999


Q ss_pred             ccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCC--------------------CC--------
Q 040501          137 YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPR--------------------LP--------  188 (228)
Q Consensus       137 ~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~~--------  188 (228)
                      .+..++.++||||||+++|+|++|..||........   .........+.                    .+        
T Consensus       212 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 2eu9_A          212 LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY  288 (355)
T ss_dssp             TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred             ecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc
Confidence            988999999999999999999999999864322110   00000000000                    00        


Q ss_pred             ---------CCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          189 ---------PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       189 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                               .........+..+.++|.+||+.||.+|||++++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                     000011233557899999999999999999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.8e-40  Score=253.73  Aligned_cols=198  Identities=20%  Similarity=0.324  Sum_probs=164.2

Q ss_pred             HHHHHHHHHHhccC--CCccceeeeeeeecCeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 040501            3 KEFLREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH   79 (228)
Q Consensus         3 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~   79 (228)
                      +.+.+|+.++++++  |+||+++++++......++++|++.+ ++|.+++....   .++...++.++.|++.||.|||+
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~  167 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN  167 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            34668999999996  59999999999999999999999975 89999987643   38899999999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHH
Q 040501           80 DCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEV  157 (228)
Q Consensus        80 ~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~  157 (228)
                      .   |++|+||||+||+++ .++.+||+|||++......  ......+++.|+|||.+.+..+ +.++||||||+++|+|
T Consensus       168 ~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el  242 (320)
T 3a99_A          168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM  242 (320)
T ss_dssp             T---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred             C---CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHH
Confidence            9   999999999999999 7799999999998876532  2334568999999999887765 6789999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||......        ..    .....    ....+.++.++|.+||+.||.+|||++++++
T Consensus       243 ~~g~~pf~~~~~~--------~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          243 VCGDIPFEHDEEI--------IR----GQVFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHSSCSCCSHHHH--------HH----CCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHCCCCCCChhhh--------hc----ccccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999998643211        11    11100    1234567899999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-39  Score=257.01  Aligned_cols=216  Identities=20%  Similarity=0.309  Sum_probs=162.7

Q ss_pred             hHHHHHHHHHHhccC-----------CCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHH
Q 040501            2 KKEFLREITVLTEIR-----------HRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINV   66 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   66 (228)
                      .+.+.+|++++++++           |+||+++++++....    ..+++||++ +++|.+++..... ..++...++.+
T Consensus        59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i  136 (373)
T 1q8y_A           59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQI  136 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHH
T ss_pred             hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHH
Confidence            356788999999886           789999999997654    789999999 7899999876432 23889999999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEc------CCCceEEeecccccccCCCCCCceecccccceeCCcccccCC
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLD------LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK  140 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  140 (228)
                      +.|++.||.|||+.+  |++|+||||+||+++      ..+.++|+|||++......   .....+++.|+|||++.+..
T Consensus       137 ~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~  211 (373)
T 1q8y_A          137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP  211 (373)
T ss_dssp             HHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC
T ss_pred             HHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCC
Confidence            999999999999953  899999999999995      3347999999999865432   23346899999999999988


Q ss_pred             cccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcC--CCC------------------------CC-----
Q 040501          141 VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLD--PRL------------------------PP-----  189 (228)
Q Consensus       141 ~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~------------------------~~-----  189 (228)
                      ++.++||||||+++|+|++|..||.................+..  +..                        ..     
T Consensus       212 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (373)
T 1q8y_A          212 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP  291 (373)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc
Confidence            99999999999999999999999875432211111111111100  000                        00     


Q ss_pred             -------CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          190 -------LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       190 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                             ........+.++.++|.+||+.||.+|||++++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          292 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             hhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence                   00011356778999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-39  Score=251.03  Aligned_cols=212  Identities=24%  Similarity=0.352  Sum_probs=145.3

Q ss_pred             HHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            4 EFLREIT-VLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN--DTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         4 ~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .+..|+. +++.++||||+++++++......++|||++.+ +|.+++..  ......++...+..++.|++.||.|||+.
T Consensus        66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  144 (327)
T 3aln_A           66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN  144 (327)
T ss_dssp             HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc
Confidence            4556666 67777999999999999999999999999976 77776653  11123488999999999999999999994


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccc----ccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELA----YTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~  156 (228)
                      .  |++|+||||+||+++.++.+||+|||++....... ......+++.|+|||.+    .+..++.++||||||+++|+
T Consensus       145 ~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~  221 (327)
T 3aln_A          145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE  221 (327)
T ss_dssp             H--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHH
T ss_pred             C--CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHH
Confidence            2  89999999999999999999999999997654332 22334688999999998    45568899999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCc-hhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLS-VDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||......     ............+... .....++..+.+++.+||..||.+|||+.++++
T Consensus       222 l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          222 LATGRFPYPKWNSV-----FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             HHHSCCCSSCC------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchH-----HHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            99999998643221     1111222222221111 112345668999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.9e-39  Score=253.72  Aligned_cols=157  Identities=22%  Similarity=0.293  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHhccC-CC-----ccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR-HR-----NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +.+..|+.+++.++ |+     +|+++++++......|+|||++.+ +|.+++..... ..+++..+..++.|++.||.|
T Consensus        95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~  172 (382)
T 2vx3_A           95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLF  172 (382)
T ss_dssp             HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHH
Confidence            45678899998884 55     499999999999999999999964 89988876542 238999999999999999999


Q ss_pred             hhh--CCCCCeeecCCCCCceEEc--CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           77 LHH--DCIPPIVHRDISSKNVLLD--LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        77 lh~--~~~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      ||+  .   ||+||||||+||+++  .++.+||+|||++......   .....+++.|+|||++.+..++.++|||||||
T Consensus       173 lH~~~~---~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~  246 (382)
T 2vx3_A          173 LATPEL---SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC  246 (382)
T ss_dssp             HTSTTT---CEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             hccCCC---CEEcCCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHH
Confidence            994  5   999999999999995  4678999999999876432   23457889999999999989999999999999


Q ss_pred             HHHHHHhCCCCcccc
Q 040501          153 LALEVIKGKHPRDFL  167 (228)
Q Consensus       153 ~l~~~~~g~~p~~~~  167 (228)
                      ++|+|++|..||...
T Consensus       247 il~elltg~~pf~~~  261 (382)
T 2vx3_A          247 ILVEMHTGEPLFSGA  261 (382)
T ss_dssp             HHHHHHHSSCSSCCS
T ss_pred             HHHHHHhCCCCCCCC
Confidence            999999999998643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=249.30  Aligned_cols=207  Identities=22%  Similarity=0.310  Sum_probs=152.8

Q ss_pred             HHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCC
Q 040501            5 FLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-DCIP   83 (228)
Q Consensus         5 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~   83 (228)
                      +..+..+++.++||||+++++++......++|||++ ++.+..+.....  ..++...++.++.|++.||.|||+ .   
T Consensus        71 ~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---  144 (318)
T 2dyl_A           71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---  144 (318)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---
Confidence            344555677789999999999999999999999999 556665554322  238899999999999999999998 6   


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHHHH
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~~~  158 (228)
                      |++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.     +..++.++||||||+++|+|+
T Consensus       145 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  223 (318)
T 2dyl_A          145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA  223 (318)
T ss_dssp             CCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred             CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence            99999999999999999999999999987654322 223456889999999984     456788999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||....     ..............+... .....+..+.++|.+||..||.+|||++++++
T Consensus       224 ~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          224 TGQFPYKNCK-----TDFEVLTKVLQEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HSSCTTTTCC-----SHHHHHHHHHHSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hCCCCCCCCC-----ccHHHHHHHhccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            9999986321     122223333222222211 11245667899999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=250.18  Aligned_cols=197  Identities=23%  Similarity=0.370  Sum_probs=159.6

Q ss_pred             HHHHHHHHHhcc----CCCccceeeeeeeecCeEEEEEEe-ecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            4 EFLREITVLTEI----RHRNIVKFYGFCTHARHSFLVYEY-LENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         4 ~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      .+.+|+.+++++    +|+||+++++++......++|+|+ +.+++|.+++....   .+++..++.++.|++.||.|||
T Consensus        80 ~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH  156 (312)
T 2iwi_A           80 TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH  156 (312)
T ss_dssp             CCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            345799999998    899999999999999999999999 78899999987643   3899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcc-cchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT-AKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~  156 (228)
                      +.   |++|+||||+||+++ .++.++|+|||++......  ......++..|+|||.+.+..+. .++||||||+++|+
T Consensus       157 ~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~  231 (312)
T 2iwi_A          157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD  231 (312)
T ss_dssp             HH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred             HC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence            99   999999999999999 7899999999998876533  23345688999999998877664 58999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||.....        .....  ...+      ...+..+.++|.+||+.||.+|||+.++++
T Consensus       232 l~~g~~pf~~~~~--------~~~~~--~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          232 MVCGDIPFERDQE--------ILEAE--LHFP------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHHSSCSCCSHHH--------HHHTC--CCCC------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHCCCCCCChHH--------Hhhhc--cCCc------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999864321        11110  1111      234557889999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.1e-38  Score=241.16  Aligned_cols=195  Identities=19%  Similarity=0.258  Sum_probs=152.5

Q ss_pred             hHHHHHHHHHHhc-cCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTE-IRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ...+.+|+.++.+ .+||||+++++++..    ....++||||+.+++|.+++..... ..+++..++.++.|++.||.|
T Consensus        54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~  132 (299)
T 3m2w_A           54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQY  132 (299)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHH
Confidence            3567889999844 589999999999976    6789999999999999999986542 348999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      ||+.   |++|+||||+||+++.   ++.++|+|||++....                      +..++.++||||||++
T Consensus       133 lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~i  187 (299)
T 3m2w_A          133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVI  187 (299)
T ss_dssp             HHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHH
T ss_pred             HHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHH
Confidence            9999   9999999999999998   7889999999886432                      2346789999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|+|++|..||..........  ....................++.++.+++.+||+.||.+|||+.++++
T Consensus       188 l~el~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          188 MYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHHHHHSSCSCCC-------C--CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCCCCCCcchhhhH--HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999986433221110  011111112222222223456778999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.2e-38  Score=240.18  Aligned_cols=186  Identities=13%  Similarity=0.113  Sum_probs=149.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|+..+.+++||||+++++++..++..|+||||+.|++|.+++...     ....++..++.|++.||.|||+.  
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~--  148 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA--  148 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC--
Confidence            67899999999999999999999999999999999999999999998543     34557888999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH  162 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~  162 (228)
                       |++||||||+||+++.+|.++|++++                    |++       .++.++||||||+++|+|++|..
T Consensus       149 -givH~Dikp~NIll~~~g~~kl~~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~  200 (286)
T 3uqc_A          149 -GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRW  200 (286)
T ss_dssp             -TCCCCCCSGGGEEEETTSCEEECSCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred             -CCccCCCCcccEEEcCCCCEEEEecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence             99999999999999999999997432                    222       26889999999999999999999


Q ss_pred             CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       163 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||.........   .....................+..+.++|.+||+.||.+| |+.++++.|+
T Consensus       201 Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          201 PLPEAGVRSGL---APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             CSCCCSBCCCS---EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             CCCcCCcchhh---HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence            98754332111   0111111222222222234566789999999999999999 9999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.6e-38  Score=263.96  Aligned_cols=194  Identities=25%  Similarity=0.319  Sum_probs=156.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCe-----EEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARH-----SFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +.+.+|++++++++||||+++++++.....     .|+||||+.+++|.+++..     .+++.+++.++.|++.||.||
T Consensus       124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~l  198 (681)
T 2pzi_A          124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYL  198 (681)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999987655     7999999999999887653     389999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                      |+.   ||+||||||+||+++.+ .+||+|||++......    ....|++.|+|||++.+. ++.++||||||+++|+|
T Consensus       199 H~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l  269 (681)
T 2pzi_A          199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL  269 (681)
T ss_dssp             HHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred             HHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence            999   99999999999999875 8999999999876533    335689999999988765 48899999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCH-HHHHHHh
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM-QTICQLL  226 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~l  226 (228)
                      ++|..||......               ..+ ........+..+.++|.+||+.||.+||+. +++.+.|
T Consensus       270 ~~g~~~~~~~~~~---------------~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          270 TLDLPTRNGRYVD---------------GLP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             HSCCCEETTEECS---------------SCC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             HhCCCCCcccccc---------------ccc-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence            9999887532110               001 111223345678999999999999999964 4454443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-36  Score=242.59  Aligned_cols=201  Identities=15%  Similarity=0.145  Sum_probs=148.4

Q ss_pred             hHHHHHHHHHHhccCC-Ccccee---------------------eeeeee-----cCeEEEEEEeecCCChhhhhhc---
Q 040501            2 KKEFLREITVLTEIRH-RNIVKF---------------------YGFCTH-----ARHSFLVYEYLENGSLSVILNN---   51 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h-~~i~~~---------------------~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---   51 (228)
                      .+.+.+|+.+++.++| ++...+                     +.++..     ....+++|+.+ +++|.+++..   
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~  200 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS  200 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence            4678899999999976 322111                     111111     22456777765 5788888742   


Q ss_pred             -CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccce
Q 040501           52 -DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGY  130 (228)
Q Consensus        52 -~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  130 (228)
                       ......+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||++...+..   .....| +.|
T Consensus       201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y  273 (413)
T 3dzo_A          201 HSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGF  273 (413)
T ss_dssp             HTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTT
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-Cce
Confidence             12233477888999999999999999999   9999999999999999999999999998765433   334566 999


Q ss_pred             eCCccc----------ccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHH
Q 040501          131 VAPELA----------YTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVIS  200 (228)
Q Consensus       131 ~aPE~~----------~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (228)
                      +|||++          .+..++.++|||||||++|+|++|..||.......      .........        ...+..
T Consensus       274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~------~~~~~~~~~--------~~~~~~  339 (413)
T 3dzo_A          274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG------GSEWIFRSC--------KNIPQP  339 (413)
T ss_dssp             CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS------CSGGGGSSC--------CCCCHH
T ss_pred             eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh------hHHHHHhhc--------ccCCHH
Confidence            999998          55568889999999999999999999986443221      111121111        134467


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 040501          201 IMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       201 ~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +.++|.+||+.||.+|||+.++++
T Consensus       340 ~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          340 VRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHHh
Confidence            899999999999999999888754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-36  Score=235.64  Aligned_cols=201  Identities=13%  Similarity=0.108  Sum_probs=151.5

Q ss_pred             HHHHHHHHHHhccC---------CCcccee-----------------eeeeee-------------cCeEEEEEEeecCC
Q 040501            3 KEFLREITVLTEIR---------HRNIVKF-----------------YGFCTH-------------ARHSFLVYEYLENG   43 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---------h~~i~~~-----------------~~~~~~-------------~~~~~lv~e~~~~~   43 (228)
                      +.+.+|+.+++.++         |+||+++                 +++|..             ....|+||||+.++
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            67889999999986         5555555                 444443             67899999999988


Q ss_pred             ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeeecCCCCCceEEcCCC--------------------c
Q 040501           44 SLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH-HDCIPPIVHRDISSKNVLLDLEY--------------------E  102 (228)
Q Consensus        44 ~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~~i~h~di~p~nil~~~~~--------------------~  102 (228)
                      ++.+.+..    ..+++..+..++.|++.||.||| +.   ||+||||||+|||++.++                    .
T Consensus       148 ~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~  220 (336)
T 2vuw_A          148 IDLEQMRT----KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQ  220 (336)
T ss_dssp             EETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEE
T ss_pred             ccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCce
Confidence            76665543    23789999999999999999999 89   999999999999999887                    8


Q ss_pred             eEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH-HHHHHhCCCCccccccccCCCchhhhhh
Q 040501          103 AHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL-ALEVIKGKHPRDFLSNVSSSNPNILVNE  181 (228)
Q Consensus       103 ~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~-l~~~~~g~~p~~~~~~~~~~~~~~~~~~  181 (228)
                      +||+|||++......     ...|++.|+|||++.+.. +.++||||+|++ .+++++|..||........  .......
T Consensus       221 vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~~~~~  292 (336)
T 2vuw_A          221 VSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTDKMLK  292 (336)
T ss_dssp             EEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHHHHHH
T ss_pred             EEEeeccccEecCCC-----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HHHhhhh
Confidence            999999999876532     347899999999998776 889999998777 7778889999753211000  0001111


Q ss_pred             hcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      ................+.++.+||.+||+.|     |+++++
T Consensus       293 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             TCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            1111122223344678889999999999977     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.7e-36  Score=246.13  Aligned_cols=152  Identities=21%  Similarity=0.178  Sum_probs=117.4

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +++|.+|+++|+++ .|+||++++++++++...||||||++|++|.+++.....   ++..   .++.||+.||+|+|++
T Consensus       285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~  358 (569)
T 4azs_A          285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ  358 (569)
T ss_dssp             HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC
Confidence            56799999999999 799999999999999999999999999999999987543   5544   4789999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         ||+||||||+|||++.+|.+||+|||+++.............||+.|+|||++.+. +..++|+|++|++++.+.++
T Consensus       359 ---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          359 ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             ---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             ---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence               99999999999999999999999999998776555555667899999999998764 56789999999998877655


Q ss_pred             CCC
Q 040501          161 KHP  163 (228)
Q Consensus       161 ~~p  163 (228)
                      ..+
T Consensus       435 ~~~  437 (569)
T 4azs_A          435 WSN  437 (569)
T ss_dssp             HHH
T ss_pred             cch
Confidence            444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.6e-27  Score=194.07  Aligned_cols=147  Identities=16%  Similarity=0.236  Sum_probs=124.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++++.+|++++++++||||+++..++......|+||||+++++|.+++..           +..++.|++.+|.|||+. 
T Consensus       383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~-  450 (540)
T 3en9_A          383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN-  450 (540)
T ss_dssp             HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC-
Confidence            45689999999999999999666666677788999999999999999864           457999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-------ceecccccceeCCccccc--CCcccchhhhhHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYT--MKVTAKCDVYSFGV  152 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~  152 (228)
                        ||+||||||+||+++.  .+||+|||+++........       .....||+.|+|||++..  ..|+..+|+|+..+
T Consensus       451 --gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl  526 (540)
T 3en9_A          451 --DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL  526 (540)
T ss_dssp             --TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred             --cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence              9999999999999998  9999999999876543221       134678999999999887  56788899999998


Q ss_pred             HHHHHHhCCCCc
Q 040501          153 LALEVIKGKHPR  164 (228)
Q Consensus       153 ~l~~~~~g~~p~  164 (228)
                      -..+.+.++-+|
T Consensus       527 ~~l~~v~~r~rY  538 (540)
T 3en9_A          527 ELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHTCSCC
T ss_pred             HHHHHHHhcccc
Confidence            888877666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.81  E-value=1.4e-20  Score=142.37  Aligned_cols=94  Identities=19%  Similarity=0.220  Sum_probs=78.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.++.+|++++++++  | +++.+++.. +..|+||||++|++|.+ +..         .....++.|++.|+.+||+. 
T Consensus       148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~-  212 (282)
T 1zar_A          148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR-  212 (282)
T ss_dssp             HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC-
Confidence            356889999999998  4 666665544 45699999999999988 421         22346999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                        |++||||||+||+++ ++.++|+|||++..
T Consensus       213 --giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          213 --GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             --TEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             --CCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence              999999999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.65  E-value=2.7e-16  Score=117.47  Aligned_cols=96  Identities=17%  Similarity=0.224  Sum_probs=76.0

Q ss_pred             HHHHHHHHHhccCCCcc--ceeeeeeeecCeEEEEEEeecC-C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            4 EFLREITVLTEIRHRNI--VKFYGFCTHARHSFLVYEYLEN-G----SLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+.+|+..++++.|+++  +.+++.    ...++||||+.+ |    +|.+....      .+...+..++.|++.++.+
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHH
Confidence            67899999999988754  344432    356899999943 3    56655432      2244667899999999999


Q ss_pred             hh-hCCCCCeeecCCCCCceEEcCCCceEEeeccccccc
Q 040501           77 LH-HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        77 lh-~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~  114 (228)
                      || +.   |++||||||+||+++.  .++|+|||++...
T Consensus       186 lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          186 LYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99 88   9999999999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.44  E-value=1.4e-13  Score=107.30  Aligned_cols=96  Identities=9%  Similarity=0.146  Sum_probs=69.8

Q ss_pred             HHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 040501            6 LREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPI   85 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i   85 (228)
                      .+|...|.++.+.++.-..-+..  ...++||||+.|.+|..+...         .....++.|++.+|.+||+.   |+
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gI  226 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GL  226 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HHHHHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CC
Confidence            45777777775554422211111  123799999999888665321         12346789999999999999   99


Q ss_pred             eecCCCCCceEEcCCC----------ceEEeecccccccC
Q 040501           86 VHRDISSKNVLLDLEY----------EAHVSDFGIAKFIQ  115 (228)
Q Consensus        86 ~h~di~p~nil~~~~~----------~~~l~df~~~~~~~  115 (228)
                      +||||||.|||++.+|          .+.|+||+.+....
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999999998876          37899999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=4.9e-12  Score=94.54  Aligned_cols=102  Identities=16%  Similarity=0.104  Sum_probs=81.5

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|+.+++.+. +..++++++++......|+|||+++|.+|.+...        +......++.+++.++..||+..
T Consensus        54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~  125 (263)
T 3tm0_A           54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCC
Confidence            35889999999994 6778899999998889999999999999877631        11223467889999999999810


Q ss_pred             --------------------------------------------------------CCCeeecCCCCCceEEcCCCceEE
Q 040501           82 --------------------------------------------------------IPPIVHRDISSKNVLLDLEYEAHV  105 (228)
Q Consensus        82 --------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l  105 (228)
                                                                              +..++|+|++|.||+++.++.+.|
T Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l  205 (263)
T 3tm0_A          126 ISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGF  205 (263)
T ss_dssp             CTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEE
T ss_pred             cccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEE
Confidence                                                                    025899999999999987666679


Q ss_pred             eeccccc
Q 040501          106 SDFGIAK  112 (228)
Q Consensus       106 ~df~~~~  112 (228)
                      +||+.+.
T Consensus       206 IDwe~a~  212 (263)
T 3tm0_A          206 IDLGRSG  212 (263)
T ss_dssp             CCCTTCE
T ss_pred             EEchhcc
Confidence            9998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=5e-10  Score=87.45  Aligned_cols=106  Identities=17%  Similarity=0.321  Sum_probs=82.9

Q ss_pred             HHHHHHHHHHhccC--CCccceeeeeeeec---CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIR--HRNIVKFYGFCTHA---RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ..+.+|+.+++.+.  +..+++++.++.+.   ...|+|||+++|..+.+..     ...++......++.+++.+|..|
T Consensus        81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~L  155 (359)
T 3dxp_A           81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAM  155 (359)
T ss_dssp             -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHH
Confidence            35788999999996  45578888888766   4589999999988775421     12266777888999999999999


Q ss_pred             hhCC-------------------------------------------------------CCCeeecCCCCCceEEcCCCc
Q 040501           78 HHDC-------------------------------------------------------IPPIVHRDISSKNVLLDLEYE  102 (228)
Q Consensus        78 h~~~-------------------------------------------------------~~~i~h~di~p~nil~~~~~~  102 (228)
                      |+..                                                       +.+++|+|+++.||+++.++.
T Consensus       156 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~  235 (359)
T 3dxp_A          156 HTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP  235 (359)
T ss_dssp             HHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS
T ss_pred             hCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC
Confidence            9731                                                       237999999999999997753


Q ss_pred             --eEEeecccccc
Q 040501          103 --AHVSDFGIAKF  113 (228)
Q Consensus       103 --~~l~df~~~~~  113 (228)
                        +.|+||+.+..
T Consensus       236 ~v~~viDwe~a~~  248 (359)
T 3dxp_A          236 RVLAVLDWELSTL  248 (359)
T ss_dssp             CEEEECCCTTCEE
T ss_pred             cEEEEECcccccc
Confidence              68999998865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=2.9e-10  Score=84.62  Aligned_cols=100  Identities=17%  Similarity=0.150  Sum_probs=74.7

Q ss_pred             HHHHHHHHHHhccCCCc--cceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            3 KEFLREITVLTEIRHRN--IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ..+.+|+.+++.+.+.+  +++++.++..++..++|||+++|.++.  ...      ..   ...++.+++..+..||+.
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~  126 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTL  126 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTS
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCC
Confidence            35789999999995434  566888888778899999999998874  211      11   124667777888888875


Q ss_pred             C-------------------------------------------------------CCCeeecCCCCCceEEcCCCceEE
Q 040501           81 C-------------------------------------------------------IPPIVHRDISSKNVLLDLEYEAHV  105 (228)
Q Consensus        81 ~-------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l  105 (228)
                      .                                                       +.+++|+|++|.||+++.++.+.|
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l  206 (264)
T 1nd4_A          127 DPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGF  206 (264)
T ss_dssp             CGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEE
T ss_pred             CCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEE
Confidence            1                                                       112999999999999987766779


Q ss_pred             eecccccc
Q 040501          106 SDFGIAKF  113 (228)
Q Consensus       106 ~df~~~~~  113 (228)
                      +||+.+..
T Consensus       207 iD~~~a~~  214 (264)
T 1nd4_A          207 IDCGRLGV  214 (264)
T ss_dssp             CCCTTCEE
T ss_pred             Ecchhccc
Confidence            99998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.91  E-value=7e-10  Score=84.63  Aligned_cols=155  Identities=24%  Similarity=0.271  Sum_probs=97.5

Q ss_pred             HHHHHHHHHHhcc-CCCc--cceeeeeeeecC---eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI-RHRN--IVKFYGFCTHAR---HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      ..+.+|+.+++.+ .+..  +++++.......   ..|+||++++|.++.+...     ..++..+...++.+++..++.
T Consensus        55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~  129 (304)
T 3sg8_A           55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSE  129 (304)
T ss_dssp             HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHH
Confidence            4678999999988 3333  445555544333   3589999999988865332     125566667777788887777


Q ss_pred             hhhC-------------------------------------------------------CCCCeeecCCCCCceEEcC--
Q 040501           77 LHHD-------------------------------------------------------CIPPIVHRDISSKNVLLDL--   99 (228)
Q Consensus        77 lh~~-------------------------------------------------------~~~~i~h~di~p~nil~~~--   99 (228)
                      ||+.                                                       .+..++|+|++|.||+++.  
T Consensus       130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~  209 (304)
T 3sg8_A          130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK  209 (304)
T ss_dssp             HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred             HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence            7752                                                       1125799999999999998  


Q ss_pred             CCceEEeecccccccCCCCCCc--eec---ccc-------cce--eC-CcccccCCcccchhhhhHHHHHHHHHhCCCCc
Q 040501          100 EYEAHVSDFGIAKFIQPDSSNW--TEF---AGT-------YGY--VA-PELAYTMKVTAKCDVYSFGVLALEVIKGKHPR  164 (228)
Q Consensus       100 ~~~~~l~df~~~~~~~~~~~~~--~~~---~~~-------~~y--~a-PE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~  164 (228)
                      ++.+.++||+.+..........  ...   .+.       ..|  .. |+...  ......+.|++|.++|.+.+|..+|
T Consensus       210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          210 NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            5667899999887543210000  000   000       011  00 11100  0112268999999999999999885

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=1.3e-07  Score=70.75  Aligned_cols=104  Identities=16%  Similarity=0.178  Sum_probs=76.2

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ..+.+|...|+.+. +-.+.+++.++.+.+..|+|||+++|.++.+......       .....+..++...+..||+..
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~  136 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIP  136 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSC
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCC
Confidence            35778999999884 4447888999998899999999999988776543211       122345566666666666531


Q ss_pred             -------------------------------------------------------CCCeeecCCCCCceEEcCCCceEEe
Q 040501           82 -------------------------------------------------------IPPIVHRDISSKNVLLDLEYEAHVS  106 (228)
Q Consensus        82 -------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l~  106 (228)
                                                                             +..++|+|+.+.||+++.++.+-|+
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi  216 (272)
T 4gkh_A          137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI  216 (272)
T ss_dssp             GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred             cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence                                                                   0026999999999999988777899


Q ss_pred             ecccccc
Q 040501          107 DFGIAKF  113 (228)
Q Consensus       107 df~~~~~  113 (228)
                      ||+.+..
T Consensus       217 Dwe~a~~  223 (272)
T 4gkh_A          217 DVGRVGI  223 (272)
T ss_dssp             CCTTCEE
T ss_pred             ECccccc
Confidence            9997753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=8.7e-07  Score=67.53  Aligned_cols=106  Identities=21%  Similarity=0.236  Sum_probs=70.0

Q ss_pred             HHHHHHHHHHhccCCC---ccceeeeeee-ecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHR---NIVKFYGFCT-HARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ..+.+|+++++.+.+.   .+++++.++. ..+..+++|++++|.++.+..-.     .++......++.++...+..||
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH  128 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELS  128 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHh
Confidence            4678999999999642   3566676664 44567899999999887653211     0233333344444444444444


Q ss_pred             hC---------------------------------------------------------CCCCeeecCCCCCceEEcC--
Q 040501           79 HD---------------------------------------------------------CIPPIVHRDISSKNVLLDL--   99 (228)
Q Consensus        79 ~~---------------------------------------------------------~~~~i~h~di~p~nil~~~--   99 (228)
                      +.                                                         .+..++|+|++|.||+++.  
T Consensus       129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~  208 (306)
T 3tdw_A          129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS  208 (306)
T ss_dssp             HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred             cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence            32                                                         1225799999999999987  


Q ss_pred             -CCc-eEEeecccccc
Q 040501          100 -EYE-AHVSDFGIAKF  113 (228)
Q Consensus       100 -~~~-~~l~df~~~~~  113 (228)
                       ++. +.|+||+.+..
T Consensus       209 ~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          209 RQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SSCCEEEECCCTTCEE
T ss_pred             CCCceEEEEehhhcCC
Confidence             355 48999998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.32  E-value=1e-05  Score=57.62  Aligned_cols=138  Identities=14%  Similarity=0.069  Sum_probs=88.7

Q ss_pred             CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCce
Q 040501           43 GSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT  122 (228)
Q Consensus        43 ~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  122 (228)
                      -+|.+.+.....  +++++++|.++.|.+.++..+-.+.  .-...=+.|..|++..+|.+.+.+ ..+.          
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            368888876543  3999999999999999998873220  212334567999999999988763 1110          


Q ss_pred             ecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHH
Q 040501          123 EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIM  202 (228)
Q Consensus       123 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (228)
                        .....+.|||... ...+.+.=|+|||+++|..+--..|-.                           ..+..++.+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~---------------------------eE~eLS~~LE  147 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN---------------------------EERELSPPLE  147 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT---------------------------EEECCCHHHH
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc---------------------------cchhhCHHHH
Confidence              1123456788653 345677889999999999985444411                           1123444577


Q ss_pred             HHHHHhhcc-------------------------CCCCCCCHHHHHHH
Q 040501          203 EVAFLCLDN-------------------------NPESRPNMQTICQL  225 (228)
Q Consensus       203 ~li~~~l~~-------------------------~p~~Rpt~~~il~~  225 (228)
                      +||..|..-                         .+..|++.++|++.
T Consensus       148 ~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          148 QLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             HHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHH
T ss_pred             HHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHH
Confidence            788778755                         35688999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=5.2e-06  Score=64.55  Aligned_cols=45  Identities=11%  Similarity=0.120  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHhccC-C--Cccceeeeeeeec---CeEEEEEEeecCCChhh
Q 040501            3 KEFLREITVLTEIR-H--RNIVKFYGFCTHA---RHSFLVYEYLENGSLSV   47 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~   47 (228)
                      ..+.+|+.+++.+. +  -.+.+++.++...   ...|+|||+++|.++.+
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence            35788999999984 3  3577788877654   35789999998876643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.75  E-value=0.00013  Score=56.02  Aligned_cols=30  Identities=27%  Similarity=0.408  Sum_probs=27.2

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      +++|+|+++.||+++.++.+.++||+.+..
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            899999999999998888999999997753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.49  E-value=0.00056  Score=52.08  Aligned_cols=43  Identities=28%  Similarity=0.359  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHhccC---CCccceeeeeeeecCeEEEEEEeecCCCh
Q 040501            3 KEFLREITVLTEIR---HRNIVKFYGFCTHARHSFLVYEYLENGSL   45 (228)
Q Consensus         3 ~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   45 (228)
                      ..+.+|+..|+.|.   ...+++++.++......|+|||+++|..+
T Consensus        73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           73 SMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             HHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            46789999999983   36788889888877889999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.38  E-value=0.00027  Score=53.45  Aligned_cols=29  Identities=21%  Similarity=0.252  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5567789999998765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.36  E-value=0.00039  Score=54.45  Aligned_cols=107  Identities=17%  Similarity=0.238  Sum_probs=65.2

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhh--------------hhc-CCC----CCCC--CH
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVI--------------LNN-DTS----AEEL--GW   60 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------~~~-~~~----~~~~--~~   60 (228)
                      ....+|..+++.+. +.-..++++.+..+    +|+||++|.++..-              +.. +..    .+..  .+
T Consensus        98 ~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~  173 (379)
T 3feg_A           98 DSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLF  173 (379)
T ss_dssp             HHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHH
Confidence            35668999999984 43346677766542    89999988655311              000 110    1111  23


Q ss_pred             HHHHHHHHHHHH-------------------HHHH----hhhC-CCCCeeecCCCCCceEEcCC----CceEEeeccccc
Q 040501           61 SRRINVIKGIAH-------------------ALSY----LHHD-CIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAK  112 (228)
Q Consensus        61 ~~~~~~~~~l~~-------------------~l~~----lh~~-~~~~i~h~di~p~nil~~~~----~~~~l~df~~~~  112 (228)
                      .++..|..++..                   .+..    |... .+..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            455555544422                   1222    2221 22368999999999999876    789999999876


Q ss_pred             c
Q 040501          113 F  113 (228)
Q Consensus       113 ~  113 (228)
                      .
T Consensus       254 ~  254 (379)
T 3feg_A          254 Y  254 (379)
T ss_dssp             E
T ss_pred             c
Confidence            4

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.32  E-value=0.00094  Score=52.57  Aligned_cols=30  Identities=20%  Similarity=0.321  Sum_probs=25.8

Q ss_pred             CeeecCCCCCceEEcCCCceEEeeccccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~  114 (228)
                      .++|||+.+.||+++.+ .+.++||..+...
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            89999999999999876 4889999877643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.00067  Score=52.04  Aligned_cols=32  Identities=38%  Similarity=0.352  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCceEEcCC----CceEEeeccccccc
Q 040501           83 PPIVHRDISSKNVLLDLE----YEAHVSDFGIAKFI  114 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~  114 (228)
                      ..++|+|+.+.||+++.+    +.+.++||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            389999999999999875    67899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.94  E-value=0.0012  Score=52.65  Aligned_cols=39  Identities=21%  Similarity=0.295  Sum_probs=26.5

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCCh
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSL   45 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   45 (228)
                      +.+.+|+.+++.+. +.-.+++++.+..    .+|++|++|.++
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            45678999999984 3334667766543    288999976443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.27  E-value=0.0052  Score=48.76  Aligned_cols=30  Identities=17%  Similarity=0.334  Sum_probs=26.9

Q ss_pred             CeeecCCCCCceEEcCCCceEEeeccccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~  114 (228)
                      .++|+|++|.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            899999999999998876 999999988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.09  E-value=0.011  Score=46.55  Aligned_cols=31  Identities=23%  Similarity=0.355  Sum_probs=25.6

Q ss_pred             CeeecCCCCCceEE------cCCCceEEeeccccccc
Q 040501           84 PIVHRDISSKNVLL------DLEYEAHVSDFGIAKFI  114 (228)
Q Consensus        84 ~i~h~di~p~nil~------~~~~~~~l~df~~~~~~  114 (228)
                      .++|+|+.+.||++      +.++.+.++||..+...
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            36899999999999      34567999999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.37  E-value=0.0056  Score=46.55  Aligned_cols=31  Identities=23%  Similarity=0.223  Sum_probs=26.3

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3799999999999999876668999987653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.95  E-value=0.03  Score=43.02  Aligned_cols=30  Identities=27%  Similarity=0.350  Sum_probs=27.1

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+.+.||+++.++.+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            799999999999999888899999987764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.95  E-value=0.032  Score=42.44  Aligned_cols=28  Identities=21%  Similarity=0.245  Sum_probs=24.7

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+++.||+++ + .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            789999999999998 4 789999987754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.44  E-value=0.24  Score=35.22  Aligned_cols=116  Identities=8%  Similarity=0.086  Sum_probs=75.1

Q ss_pred             CCCccceeeeeeeecCeEEEEEEeec-CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCc
Q 040501           16 RHRNIVKFYGFCTHARHSFLVYEYLE-NGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKN   94 (228)
Q Consensus        16 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~n   94 (228)
                      .||+++.. .+-...+.+.+.++.-+ +.++.. +      +..+....+.++.+|+....++++.     +|--++|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            57887766 44455555555554332 222332 2      2277888899999999988666544     788999999


Q ss_pred             eEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCccc
Q 040501           95 VLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDF  166 (228)
Q Consensus        95 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~~  166 (228)
                      ++++.++.+++.-.|....                 ++|.     ..+...=.-..=|++..++.++..|..
T Consensus       110 L~f~~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEEcCCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999875554322                 2222     122222334677888888989888753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.36  E-value=0.054  Score=43.50  Aligned_cols=36  Identities=28%  Similarity=0.368  Sum_probs=24.9

Q ss_pred             HHHHHHHhccCCCcc-ceeeeeeeecCeEEEEEEeecCCCh
Q 040501            6 LREITVLTEIRHRNI-VKFYGFCTHARHSFLVYEYLENGSL   45 (228)
Q Consensus         6 ~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L   45 (228)
                      .+|+.+++.+...++ +++++.+..    ..|++|++|.++
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            579999999964444 567776632    259999987544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.17  E-value=0.46  Score=33.89  Aligned_cols=114  Identities=10%  Similarity=0.074  Sum_probs=73.2

Q ss_pred             CCCccceeeeeeeecCeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCCeeecCCCCC
Q 040501           16 RHRNIVKFYGFCTHARHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHALS-YLHHDCIPPIVHRDISSK   93 (228)
Q Consensus        16 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~~~~i~h~di~p~   93 (228)
                      .||++  -..+-.+.+.+.+.++.-.+ .++.. +.      ..+....++++.+++.... ++++     -+|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57777  33333555666666664323 23332 21      2777888999999988877 5554     478899999


Q ss_pred             ceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           94 NVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        94 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      |++++.++.+++.-.|.-..                 ++|..     .+...=.-+.=|++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-----------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-----------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-----------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999975554322                 23332     1222223366778888888877765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.12  E-value=0.021  Score=44.39  Aligned_cols=29  Identities=21%  Similarity=0.406  Sum_probs=24.4

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      +++|+|+.+.||+++.++ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            689999999999998654 89999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=89.74  E-value=0.17  Score=40.18  Aligned_cols=29  Identities=17%  Similarity=0.395  Sum_probs=26.0

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            6899999999999 7778999999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=86.19  E-value=0.31  Score=36.24  Aligned_cols=25  Identities=32%  Similarity=0.340  Sum_probs=20.1

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEee
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSD  107 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~d  107 (228)
                      ++.++|+|+.+.|++++.++. .++|
T Consensus       187 ~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          187 PPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            347999999999999998874 3444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	228
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-50
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-45
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 8e-57
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 15/231 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + F  E+ VL + RH NI+ F G+ T      +V ++ E  SL   L+      +   
Sbjct: 47  QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEM 103

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + I++ +  A  + YLH      I+HRD+ S N+ L  +    + DFG+A      S +
Sbjct: 104 IKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160

Query: 121 --WTEFAGTYGYVAPELAYTMK---VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
             + + +G+  ++APE+         + + DVY+FG++  E++ G+ P   ++N      
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII- 219

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            ++    L P L  +  +    +  +M     CL    + RP    I   +
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASI 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-53
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 14/229 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS--FLVYEYLENGSL-SVILNNDTSAEE 57
           +K+  + E+ +L E++H NIV++Y       ++  ++V EY E G L SVI       + 
Sbjct: 46  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 105

Query: 58  LGWSRRINVIKGIAHALSYLH--HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           L     + V+  +  AL   H   D    ++HRD+   NV LD +    + DFG+A+ + 
Sbjct: 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
            D+S    F GT  Y++PE    M    K D++S G L  E+     P        + + 
Sbjct: 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQ 219

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             L  ++ + +   +      ++  I+      L+     RP+++ I +
Sbjct: 220 KELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-50
 Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 41/258 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + + +RE+ VL E     IV FYG         +  E+++ GSL  +L     A  +  
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPE 103

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                V   +   L+YL       I+HRD+   N+L++   E  + DFG++  +    + 
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP----------------- 163
              F GT  Y++PE       + + D++S G+  +E+  G++P                 
Sbjct: 161 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

Query: 164 ---------------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL- 207
                          R   S    S P + + E+LD  +      +   V S+    F+ 
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

Query: 208 -CLDNNPESRPNMQTICQ 224
            CL  NP  R +++ +  
Sbjct: 280 KCLIKNPAERADLKQLMV 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 9e-50
 Identities = 49/227 (21%), Positives = 96/227 (42%), Gaps = 14/227 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
               FL E  ++ +++H+ +V+ Y   T     +++ EY+ENGSL   L    S  +L  
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTI 108

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           ++ +++   IA  ++++        +HRD+ + N+L+       ++DFG+A+ I+ +   
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165

Query: 121 W-TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                     + APE       T K DV+SFG+L  E++                   ++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVI 220

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +          +   ++  +M    LC    PE RP    +  +L
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-48
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 19/230 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D +E +RE  ++ ++ +  IV+  G C  A    LV E    G L   L      EE+  
Sbjct: 52  DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPV 108

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S    ++  ++  + YL        VHRD++++NVLL   + A +SDFG++K +  D S 
Sbjct: 109 SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165

Query: 121 WTE---FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPN 176
           +T          + APE     K +++ DV+S+GV   E +  G+ P   +         
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----- 220

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            ++  +   +      +   ++ ++M     C     E RP+  T+ Q +
Sbjct: 221 -VMAFIEQGKRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRM 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-48
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 16/228 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++F+ E  V+ ++ H  +V+ YG C       LV+E++E+G LS  L           
Sbjct: 43  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--A 100

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              + +   +      + +     ++HRD++++N L+       VSDFG+ +F+  D   
Sbjct: 101 ETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157

Query: 121 WTE-FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNIL 178
            +        + +PE+    + ++K DV+SFGVL  EV  +GK P +  SN         
Sbjct: 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +  PRL    V          ++   C    PE RP    + + L
Sbjct: 218 GFRLYKPRLASTHV---------YQIMNHCWKERPEDRPAFSRLLRQL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-47
 Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 16/227 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELG 59
             + FL E +V+T++RH N+V+  G     +   ++V EY+  GSL   L +      LG
Sbjct: 43  TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLG 101

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
               +     +  A+ YL        VHRD++++NVL+  +  A VSDFG+ K     SS
Sbjct: 102 GDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SS 155

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                     + APE     K + K DV+SFG+L  E+                    +V
Sbjct: 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV 210

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +               V  +M+    C   +   RP+   + + L
Sbjct: 211 PRVEKGYKMDAPDGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQL 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 2e-46
 Identities = 48/249 (19%), Positives = 101/249 (40%), Gaps = 34/249 (13%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN--------- 51
            + +F RE  ++ E  + NIVK  G C   +   L++EY+  G L+  L +         
Sbjct: 59  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 52  ------------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
                             L  + ++ + + +A  ++YL        VHRD++++N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175

Query: 100 EYEAHVSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
                ++DFG+++ I            A    ++ PE  +  + T + DV+++GV+  E+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP 217
                   +           ++  + D  +     +   ++ ++M    LC    P  RP
Sbjct: 236 FSYGLQPYY-----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRP 287

Query: 218 NMQTICQLL 226
           +  +I ++L
Sbjct: 288 SFCSIHRIL 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-46
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 14/227 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             + FL+E  V+ ++RH  +V+ Y   +     ++V EY+  GSL   L  +T  + L  
Sbjct: 55  SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRL 112

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SS 119
            + +++   IA  ++Y+        VHRD+ + N+L+       V+DFG+A+ I+ +  +
Sbjct: 113 PQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                     + APE A   + T K DV+SFG+L  E+                    ++
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-----PGMVNREVL 224

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +++      P   +    +  +M     C    PE RP  + +   L
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-46
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 16/228 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + EF+ E  V+  + H  +V+ YG CT  R  F++ EY+ NG L   L           
Sbjct: 42  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQT 99

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPD-SS 119
            + + + K +  A+ YL        +HRD++++N L++ +    VSDFG+++++  D  +
Sbjct: 100 QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNIL 178
           +         +  PE+    K ++K D+++FGVL  E+   GK P +  +N  ++     
Sbjct: 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              +  P L    V           + + C     + RP  + +   +
Sbjct: 217 GLRLYRPHLASEKV---------YTIMYSCWHEKADERPTFKILLSNI 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-46
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 20/230 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K E L E  V+ ++ +  IV+  G C       LV E  E G L+  L  +     +  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKD 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              I ++  ++  + YL        VHRD++++NVLL  ++ A +SDFG++K ++ D + 
Sbjct: 107 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

Query: 121 W---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPN 176
           +   T       + APE     K ++K DV+SFGVL  E    G+ P            +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP------YRGMKGS 217

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
            +   +              ++  +M    LC   + E+RP    +   L
Sbjct: 218 EVTAMLEKGERMGCPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 5e-46
 Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 20/232 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL E +++ +  H N++   G  T +    ++ E++ENGSL   L  +        
Sbjct: 70  QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT--V 127

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + + +++GIA  + YL        VHRD++++N+L++      VSDFG+++F++ D+S+
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 121 WTE-----FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSN 174
            T            + APE     K T+  DV+S+G++  EV+  G+ P           
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------YWDMT 238

Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
              ++N +      P  +D    +  +M     C   +   RP    I   L
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTL 287

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 9e-46
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 19/229 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHA----RHSFLVYEYLENGSLSVILNNDTSAE 56
           +++ F  E  +L  ++H NIV+FY          +   LV E + +G+L   L      +
Sbjct: 51  ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---K 107

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQ 115
            +      +  + I   L +LH    PPI+HRD+   N+ +        + D G+A   +
Sbjct: 108 VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
              +      GT  ++APE+ Y  K     DVY+FG+  LE+   ++P     N +    
Sbjct: 167 ASFA--KAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY- 222

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             + + +       +++        + E+   C+  N + R +++ +  
Sbjct: 223 RRVTSGVKPASFDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 1e-45
 Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 21/227 (9%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             ++ ++E+  L ++RH N +++ G       ++LV EY    +  ++  +      L  
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQE 114

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                V  G    L+YLH      ++HRD+ + N+LL       + DFG A  + P +S 
Sbjct: 115 VEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS- 170

Query: 121 WTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
              F GT  ++APE+   M   +   K DV+S G+  +E+ + K P       + +  + 
Sbjct: 171 ---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSA 222

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           L +   +      S        + ++    CL   P+ RP  + + +
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-45
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 18/224 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + +  RE+ + + +RH NI++ YG+   A   +L+ EY   G++   L   +       
Sbjct: 49  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDE 105

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            R    I  +A+ALSY H      ++HRDI  +N+LL    E  ++DFG +      SS 
Sbjct: 106 QRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSR 160

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
            T   GT  Y+ PE+        K D++S GVL  E + GK P +  +   +      V 
Sbjct: 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                 +   + D+  +           L +NP  RP ++ + +
Sbjct: 221 FTFPDFVTEGARDLISR----------LLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-45
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 14/224 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            K+  + EI V+ E ++ NIV +          ++V EYL  GSL+ ++      E    
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            +   V +    AL +LH + +   +HRDI S N+LL ++    ++DFG    I P+ S 
Sbjct: 117 -QIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
            +   GT  ++APE+        K D++S G++A+E+I+G+ P    + + +    I  N
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              + + P     +       +     CLD + E R + + + Q
Sbjct: 232 GTPELQNPE---KLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-45
 Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 17/229 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + ++++ EI +L    H NIVK      +  + +++ E+   G++  ++        L  
Sbjct: 52  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTE 109

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           S+   V K    AL+YLH      I+HRD+ + N+L  L+ +  ++DFG++         
Sbjct: 110 SQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166

Query: 121 WTEFAGTYGYVAPELAYTM-----KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
              F GT  ++APE+             K DV+S G+  +E+ + + P   L+ +     
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL- 225

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            I  +E      P             ++    CL+ N ++R     + Q
Sbjct: 226 KIAKSEPPTLAQPS---RWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 6e-45
 Identities = 51/250 (20%), Positives = 96/250 (38%), Gaps = 35/250 (14%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-------- 51
           +++  + E+ ++T++  H NIV   G CT +   +L++EY   G L   L +        
Sbjct: 83  EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142

Query: 52  ------------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDL 99
                       +     L +   +     +A  + +L        VHRD++++NVL+  
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTH 199

Query: 100 EYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV 157
                + DFG+A+ I  DS+            ++APE  +    T K DV+S+G+L  E+
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259

Query: 158 I-KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESR 216
              G +P                  + +            ++  IM+    C   +   R
Sbjct: 260 FSLGVNPYP-----GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKR 311

Query: 217 PNMQTICQLL 226
           P+   +   L
Sbjct: 312 PSFPNLTSFL 321

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (375), Expect = 1e-44
 Identities = 54/227 (23%), Positives = 99/227 (43%), Gaps = 13/227 (5%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           + +EFL+E  V+ EI+H N+V+  G CT     +++ E++  G+L   L  + + +E+  
Sbjct: 56  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSA 114

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              + +   I+ A+ YL        +HRD++++N L+   +   V+DFG+++ +  D+  
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171

Query: 121 -WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
                     + APE     K + K DV++FGVL  E+                + + + 
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVY 226

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +              KV  +M     C   NP  RP+   I Q  
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-44
 Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 39/260 (15%)

Query: 1   DKKEFLR--EITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTS 54
           +++ + R  EI     +RH NI+ F         +    +LV +Y E+GSL   LN    
Sbjct: 38  EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--- 94

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCI-----PPIVHRDISSKNVLLDLEYEAHVSDFG 109
              +     I +    A  L++LH + +     P I HRD+ SKN+L+       ++D G
Sbjct: 95  -YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153

Query: 110 IAKFIQPDSSNW----TEFAGTYGYVAPELAYTM------KVTAKCDVYSFGVLALEVIK 159
           +A      +           GT  Y+APE+          +   + D+Y+ G++  E+ +
Sbjct: 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213

Query: 160 GKHP-------RDFLSNVSSSNPNI------LVNEMLDPRLPPLSVDIRGKVISIMEVAF 206
                      +    ++  S+P++      +  + L P +P         +  + ++  
Sbjct: 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA-LRVMAKIMR 272

Query: 207 LCLDNNPESRPNMQTICQLL 226
            C   N  +R     I + L
Sbjct: 273 ECWYANGAARLTALRIKKTL 292

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-43
 Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 16/227 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +   +EI +   + H N+VKFYG        +L  EY   G L   +  D     +  
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPE 102

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                    +   + YLH      I HRDI  +N+LLD      +SDFG+A   + ++  
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159

Query: 121 --WTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
               +  GT  YVAPEL    +      DV+S G++   ++ G+ P D  S+      + 
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
              +        +             +    L  NP +R  +  I +
Sbjct: 220 KEKKTYLNPWKKIDSAPL-------ALLHKILVENPSARITIPDIKK 259

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-43
 Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 16/229 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            + +FL E  ++ +  H NI++  G  +  +   ++ EY+ENG+L   L       E   
Sbjct: 52  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSV 109

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
            + + +++GIA  + YL +      VHRD++++N+L++      VSDFG+++ ++ D   
Sbjct: 110 LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166

Query: 121 W---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNI 177
               +       + APE     K T+  DV+SFG++  EV+       +       + + 
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-----ELSNHE 221

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           ++  + D    P  +D    +  +M     C       RP    I  +L
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSIL 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-43
 Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 18/231 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS-FLVYEYLENGSLSVILNNDTSAEELG 59
           +  +FL E  ++ +  H N++   G C  +  S  +V  Y+++G L   + N+T    + 
Sbjct: 71  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS- 118
                 +          +        VHRD++++N +LD ++   V+DFG+A+ +     
Sbjct: 131 DLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

Query: 119 ---SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNP 175
               N T       ++A E   T K T K DV+SFGVL  E++    P          N 
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNT 240

Query: 176 NILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +   +L  R           +  +M     C     E RP+   +   +
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-43
 Identities = 50/244 (20%), Positives = 95/244 (38%), Gaps = 28/244 (11%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEE-- 57
           +++  + E+ VL+ +  H NIV   G CT    + ++ EY   G L   L     +    
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128

Query: 58  -------------LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH 104
                        L     ++    +A  +++L        +HRD++++N+LL       
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK 185

Query: 105 VSDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           + DFG+A+ I+ DS+            ++APE  +    T + DV+S+G+   E+     
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
                  V S    ++              ++        ++   C D +P  RP  + I
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-------DIMKTCWDADPLKRPTFKQI 298

Query: 223 CQLL 226
            QL+
Sbjct: 299 VQLI 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 5e-43
 Identities = 51/240 (21%), Positives = 95/240 (39%), Gaps = 26/240 (10%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNN-------- 51
           D ++F  E+ VL ++  H NI+   G C H  + +L  EY  +G+L   L          
Sbjct: 53  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112

Query: 52  -----DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
                +++A  L   + ++    +A  + YL        +HRD++++N+L+   Y A ++
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 169

Query: 107 DFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDF 166
           DFG+++  +              ++A E       T   DV+S+GVL  E++        
Sbjct: 170 DFGLSRGQEVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY- 227

Query: 167 LSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
                      L  ++         ++   +V  +M     C    P  RP+   I   L
Sbjct: 228 ----CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (367), Expect = 1e-42
 Identities = 48/232 (20%), Positives = 95/232 (40%), Gaps = 26/232 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           DK+   +EI  ++ +RH  +V  +          ++YE++  G L   + ++ +   +  
Sbjct: 66  DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSE 123

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDS 118
              +  ++ +   L ++H +     VH D+  +N++   +    +   DFG+   + P  
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVSS 172
           S      GT  + APE+A    V    D++S GVL+  ++ G  P       + L NV S
Sbjct: 181 SVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
            + N     M D     +S D +       +     L  +P +R  +    +
Sbjct: 240 CDWN-----MDDSAFSGISEDGK-------DFIRKLLLADPNTRMTIHQALE 279

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-42
 Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 18/230 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
              +F+RE+  +  + HRN+++ YG         +V E    GSL   L        LG 
Sbjct: 54  AMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGT 112

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
             R      +A  + YL        +HRD++++N+LL       + DFG+ + +  +  +
Sbjct: 113 LSRY--AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

Query: 121 W---TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPN 176
           +         + + APE   T   +   D + FGV   E+   G+ P         +   
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQ 222

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           IL     +    P   D    + ++M     C  + PE RP    +   L
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFL 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (359), Expect = 1e-41
 Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 28/233 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSL-SVILNNDTSAEELG 59
           DK     EI+++ ++ H  ++  +          L+ E+L  G L   I   D     + 
Sbjct: 69  DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MS 125

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPD 117
            +  IN ++     L ++H      IVH DI  +N++ + +  + V   DFG+A  + PD
Sbjct: 126 EAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182

Query: 118 SSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------RDFLSNVS 171
                    T  + APE+     V    D+++ GVL   ++ G  P       + L NV 
Sbjct: 183 EIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241

Query: 172 SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             +     +E     + P + D               L   P  R  +    +
Sbjct: 242 RCDWEF--DEDAFSSVSPEAKDFIKN----------LLQKEPRKRLTVHDALE 282

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-41
 Identities = 51/228 (22%), Positives = 97/228 (42%), Gaps = 17/228 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++FL+E   + +  H +IVK  G  T     +++ E    G L   L     +  L  
Sbjct: 51  VREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDL 107

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS- 119
           +  I     ++ AL+YL        VHRDI+++NVL+       + DFG++++++  +  
Sbjct: 108 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNIL 178
             ++      ++APE     + T+  DV+ FGV   E++  G  P            N +
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDV 218

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           +  + +    P+  +    + S+M     C   +P  RP    +   L
Sbjct: 219 IGRIENGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-40
 Identities = 46/226 (20%), Positives = 90/226 (39%), Gaps = 14/226 (6%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           D+    +EI++L   RHRNI+  +          +++E++    +   +N  TSA EL  
Sbjct: 44  DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNE 101

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV--SDFGIAKFIQPDS 118
              ++ +  +  AL +LH      I H DI  +N++      + +   +FG A+ ++P  
Sbjct: 102 REIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

Query: 119 SNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
           +          Y APE+     V+   D++S G L   ++ G +P        +     +
Sbjct: 159 NFRL-LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP------FLAETNQQI 211

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           +  +++          +   I  M+     L    +SR       Q
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-39
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 18/224 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
                 RE  V++ + H   VK Y         +    Y +NG L   +    S      
Sbjct: 51  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDE 107

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
           +        I  AL YLH      I+HRD+  +N+LL+ +    ++DFG AK + P+S  
Sbjct: 108 TCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164

Query: 121 W--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL 178
                F GT  YV+PEL          D+++ G +  +++ G  P        + N  ++
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLI 218

Query: 179 VNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI 222
             +++             K   ++E     L  +   R   + +
Sbjct: 219 FQKIIKLEYDFPE-KFFPKARDLVE---KLLVLDATKRLGCEEM 258

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-39
 Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 18/229 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             KE L E  V+  + + ++ +  G C  +    L+ + +  G L  +       + +G 
Sbjct: 54  ANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGS 110

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
              +N    IA  ++YL       +VHRD++++NVL+       ++DFG+AK +  +   
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

Query: 121 W--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI-KGKHPRDFLSNVSSSNPNI 177
           +          ++A E       T + DV+S+GV   E++  G  P D          + 
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------GIPASE 221

Query: 178 LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
           + + +      P        V  IM     C   + +SRP  + +    
Sbjct: 222 ISSILEKGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-39
 Identities = 46/235 (19%), Positives = 96/235 (40%), Gaps = 20/235 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILN-------NDT 53
           ++ EFL E +V+ E    ++V+  G  +  + + ++ E +  G L   L        N+ 
Sbjct: 66  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125

Query: 54  SAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF 113
                  S+ I +   IA  ++YL+       VHRD++++N ++  ++   + DFG+ + 
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 114 IQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS 171
           I          +      +++PE       T   DV+SFGV+  E+              
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----Q 237

Query: 172 SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             +   ++  +++  L     +    +  +M    +C   NP+ RP+   I   +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSI 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-39
 Identities = 49/242 (20%), Positives = 93/242 (38%), Gaps = 27/242 (11%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVIL---------- 49
           D  + + E+ ++  I +H+NI+   G CT     +++ EY   G+L   L          
Sbjct: 61  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120

Query: 50  ---NNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVS 106
               +    E+L     ++    +A  + YL        +HRD++++NVL+  +    ++
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIA 177

Query: 107 DFGIAKFIQPDSSNWT--EFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPR 164
           DFG+A+ I                 ++APE  +    T + DV+SFGVL  E+       
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

Query: 165 DFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                        L   + +        +   ++  +M     C    P  RP  + + +
Sbjct: 238 Y-----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVE 289

Query: 225 LL 226
            L
Sbjct: 290 DL 291

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 9e-39
 Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 10/224 (4%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +     EI VL +I+H NIV          H +L+ + +  G L   +           
Sbjct: 50  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTE 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +I  +  A+ YLH   I     +  +     LD + +  +SDFG++K   P S  
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
            T   GT GYVAPE+      +   D +S GV+A  ++ G  P          N   L  
Sbjct: 167 ST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP------FYDENDAKLFE 219

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           ++L       S        S  +     ++ +PE R   +   Q
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (325), Expect = 2e-37
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 23/226 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS----FLVYEYLENGSLSVILNNDTSAE 56
               F RE      + H  IV  Y        +    ++V EY++  +L  I++ +    
Sbjct: 50  FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---G 106

Query: 57  ELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQP 116
            +   R I VI     AL++ H      I+HRD+   N+++       V DFGIA+ I  
Sbjct: 107 PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163

Query: 117 DSSNWTE---FAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSS 173
             ++ T+     GT  Y++PE A    V A+ DVYS G +  EV+ G+ P         S
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDS 218

Query: 174 NPNILVNEMLDPRLPPLSV--DIRGKVISIMEVAFLCLDNNPESRP 217
             ++    + +  +PP +    +   + +++      L  NPE+R 
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVL---KALAKNPENRY 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-36
 Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 17/221 (7%)

Query: 1   DKKEFLREITVLT-EIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           D +  + E  VL+    H  +   +       + F V EYL  G L   + +     +  
Sbjct: 45  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFD 101

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
            SR       I   L +LH   I   V+RD+   N+LLD +    ++DFG+ K      +
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158

Query: 120 NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILV 179
               F GT  Y+APE+    K     D +SFGVL  E++ G+ P          +   + 
Sbjct: 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 218

Query: 180 NEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
           N      L   + D+  K               PE R  ++
Sbjct: 219 NPFYPRWLEKEAKDLLVK----------LFVREPEKRLGVR 249

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-35
 Identities = 42/228 (18%), Positives = 86/228 (37%), Gaps = 17/228 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
            +++  RE+++L EI+H N++  +    +     L+ E +  G L           E   
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL------FDFLAEKES 109

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE----YEAHVSDFGIAKFIQP 116
                  + +   L+ +++     I H D+  +N++L           + DFG+A  I  
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169

Query: 117 DSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            +  +    GT  +VAPE+     +  + D++S GV+   ++ G  P    +   +    
Sbjct: 170 GNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             VN   +        +        +      L  +P+ R  +Q   Q
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (307), Expect = 1e-34
 Identities = 45/230 (19%), Positives = 92/230 (40%), Gaps = 20/230 (8%)

Query: 2   KKEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           ++  L+E+ +L ++  H NI++           FLV++ ++ G L   L    +   L  
Sbjct: 53  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSE 109

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                +++ +   +  LH      IVHRD+  +N+LLD +    ++DFG +  + P    
Sbjct: 110 KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 166

Query: 121 WTEFAGTYGYVAPELAYTM------KVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSN 174
             E  GT  Y+APE+              + D++S GV+   ++ G  P           
Sbjct: 167 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRK 219

Query: 175 PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
             +++  ++       S +      ++ ++    L   P+ R   +    
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 2e-34
 Identities = 33/237 (13%), Positives = 73/237 (30%), Gaps = 19/237 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFC-THARHSFLVYEYLENGSLSVILNNDTSAEELG 59
              +   E  +   ++    +    +C     ++ +V E L      +         +  
Sbjct: 45  KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFS 101

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVL---LDLEYEAHVSDFGIAKFIQP 116
               + +   +   + Y+H       +HRD+   N L          ++ DFG+AK  + 
Sbjct: 102 LKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158

Query: 117 DSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSN 169
             ++            GT  Y +      ++ + + D+ S G + +    G  P   L  
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218

Query: 170 VSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL 226
             ++               P+ V  +G           C     + +P+   + QL 
Sbjct: 219 --ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 3e-34
 Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 17/233 (7%)

Query: 1   DKKEFLREITVLTEI-RHRNIVKFYGFCTHA----RHSFLVYEYLENGSLSVILNNDTSA 55
           D  +  RE+ +     +  +IV+      +     +   +V E L+ G L   +  D   
Sbjct: 47  DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGD 105

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYE---AHVSDFGIAK 112
           +         ++K I  A+ YLH   I    HRD+  +N+L   +       ++DFG AK
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAK 162

Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
                +S  T    T  YVAPE+    K    CD++S GV+   ++ G  P      ++ 
Sbjct: 163 ETTSHNSLTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221

Query: 173 SNPNILVNEMLDPRLP-PLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
           S        M     P P   ++  +V  ++      L   P  R  +     
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-34
 Identities = 50/241 (20%), Positives = 90/241 (37%), Gaps = 25/241 (10%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
           +  LREI +L E+ H NI+       H  +  LV++++E     +I +N      L  S 
Sbjct: 45  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSH 101

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
               +      L YLH   I   +HRD+   N+LLD      ++DFG+AK     +  +T
Sbjct: 102 IKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158

Query: 123 EFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHPRDFLSNVS---------- 171
               T  Y APEL +  ++     D+++ G +  E++         S++           
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218

Query: 172 ------SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQTIC 223
                   +   L + +     P + +           +  +      NP +R       
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

Query: 224 Q 224
           +
Sbjct: 279 K 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-33
 Identities = 49/243 (20%), Positives = 88/243 (36%), Gaps = 27/243 (11%)

Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHS-FLVYEYLENGSLSVILNN------- 51
           + +  + E+ +L  I H  N+V   G CT       ++ E+ + G+LS  L +       
Sbjct: 59  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 52  ------DTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHV 105
                 D   + L     I     +A  + +L        +HRD++++N+LL  +    +
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 175

Query: 106 SDFGIAKFIQPDSSNW--TEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
            DFG+A+ I  D       +      ++APE  +    T + DV+SFGVL  E+      
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235

Query: 164 RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC 223
                             + +            ++   M     C    P  RP    + 
Sbjct: 236 PYP----GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELV 288

Query: 224 QLL 226
           + L
Sbjct: 289 EHL 291

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (302), Expect = 1e-33
 Identities = 46/228 (20%), Positives = 84/228 (36%), Gaps = 21/228 (9%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +    E  +L+ + H  I++ +G    A+  F++ +Y+E G L  +L           
Sbjct: 47  QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA 106

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +         L +     I++RD+  +N+LLD      ++DFG AK++      
Sbjct: 107 KFYAAEV------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DV 157

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT  Y+APE+  T       D +SFG+L  E++ G  P         SN      
Sbjct: 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP------FYDSNTMKTYE 211

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNM--QTICQLL 226
           ++L+  L          V  ++      +  +   R          + 
Sbjct: 212 KILNAELRFPP-FFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVK 255

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-33
 Identities = 51/251 (20%), Positives = 90/251 (35%), Gaps = 31/251 (12%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHA------RHSFLVYEYLENGSLSVILNNDTS 54
           DK+   RE+ ++ ++ H NIV+   F   +       +  LV +Y+      V  +   +
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-VSDFGIAKF 113
            + L        +  +  +L+Y+H      I HRDI  +N+LLD +     + DFG AK 
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172

Query: 114 IQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVS-- 171
           +     N +     Y      +      T+  DV+S G +  E++ G+      S V   
Sbjct: 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

Query: 172 ----------------SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNP 213
                             NPN    +    +  P +  +         +A     L+  P
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTP 291

Query: 214 ESRPNMQTICQ 224
            +R      C 
Sbjct: 292 TARLTPLEACA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  119 bits (298), Expect = 4e-33
 Identities = 38/241 (15%), Positives = 76/241 (31%), Gaps = 21/241 (8%)

Query: 1   DKKEFLREITVLTEIRHRN-IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
           D  +   E      +     I   Y F     H+ LV + L      ++        +  
Sbjct: 43  DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFS 99

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAH-----VSDFGIAKFI 114
                   K +   +  +H      +V+RDI   N L+      +     V DFG+ KF 
Sbjct: 100 VKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156

Query: 115 QPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFL 167
           +   +            +GT  Y++       + + + D+ + G + +  ++G  P   L
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216

Query: 168 SNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC 227
              ++      + E       PL     G      +      +   ++ P+   +  L  
Sbjct: 217 KAATNKQKYERIGEKKQS--TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

Query: 228 K 228
           K
Sbjct: 275 K 275

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  117 bits (294), Expect = 1e-32
 Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 26/244 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
                +REI++L E++H NIVK Y      +   LV+E+L+     ++   +     L  
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LES 99

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
               + +  + + ++Y H      ++HRD+  +N+L++ E E  ++DFG+A+        
Sbjct: 100 VTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156

Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV--------- 170
           +T    T  Y AP+ L  + K +   D++S G +  E++ G      +S           
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

Query: 171 -----SSSNPNILVNEMLDPRLP---PLSVDIRGKVISIMEVAFL--CLDNNPESRPNMQ 220
                S + PN+      DP      PL  +   K +    +  L   L  +P  R   +
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

Query: 221 TICQ 224
              +
Sbjct: 277 QALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-32
 Identities = 42/228 (18%), Positives = 79/228 (34%), Gaps = 27/228 (11%)

Query: 1   DKKEFLREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEEL 58
           +      E+ +L ++      +++   +        L+ E  E          +  A  L
Sbjct: 50  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--L 107

Query: 59  GWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPD 117
                 +    +  A+ + H+     ++HRDI  +N+L+DL   E  + DFG    +   
Sbjct: 108 QEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--K 162

Query: 118 SSNWTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
            + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P +    +      
Sbjct: 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ 224
                    R+      +             CL   P  RP  + I  
Sbjct: 223 F------RQRVSSECQHLIRW----------CLALRPSDRPTFEEIQN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 39/219 (17%), Positives = 79/219 (36%), Gaps = 16/219 (7%)

Query: 3   KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSR 62
                 +++++      IV              + + +  G L   L+      E   + 
Sbjct: 52  LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---AD 108

Query: 63  RINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWT 122
                  I   L ++H+     +V+RD+   N+LLD      +SD G+A        + +
Sbjct: 109 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165

Query: 123 EFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNE 181
              GT+GY+APE L   +   +  D +S G +  ++++G  P        + + + +   
Sbjct: 166 V--GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR---QHKTKDKHEIDRM 220

Query: 182 MLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ 220
            L      L      ++ S++E     L  +   R    
Sbjct: 221 TLTMA-VELPDSFSPELRSLLE---GLLQRDVNRRLGCL 255

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-31
 Identities = 46/244 (18%), Positives = 90/244 (36%), Gaps = 25/244 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
                +REI++L E+ H NIVK           +LV+E+L       +  +  +   +  
Sbjct: 44  VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPL 101

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
               + +  +   L++ H   +   +HRD+  +N+L++ E    ++DFG+A+        
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158

Query: 121 WTEFAGTYGYVAPE-LAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV--------- 170
           +T    T  Y APE L      +   D++S G +  E++  +      S +         
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218

Query: 171 -----SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL-----CLDNNPESRPNMQ 220
                    P +       P  P  +     KV+  ++          L  +P  R + +
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

Query: 221 TICQ 224
               
Sbjct: 279 AALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-30
 Identities = 48/249 (19%), Positives = 81/249 (32%), Gaps = 28/249 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +  LREI +L   RH NI+             +   YL    +   L      + L  
Sbjct: 49  YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN 108

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                 +  I   L Y+H      ++HRD+   N+LL+   +  + DFG+A+   PD  +
Sbjct: 109 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165

Query: 121 ---WTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKHPRDFLSNV------ 170
               TE+  T  Y APE+       T   D++S G +  E++  +        +      
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

Query: 171 -------------SSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNNPES 215
                           N       +  P    +  +          +  L   L  NP  
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285

Query: 216 RPNMQTICQ 224
           R  ++    
Sbjct: 286 RIEVEQALA 294

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 4e-29
 Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 18/228 (7%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
           +    + E  VL   RH  +               V EY   G L   L+ +    E   
Sbjct: 48  EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--- 104

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
             R       A  +S L +     +V+RDI  +N++LD +    ++DFG+ K    D + 
Sbjct: 105 -ERARFY--GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
              F GT  Y+APE+          D +  GV+  E++ G+ P        + +   L  
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFE 215

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ--TICQLL 226
            +L   +      +  +  S++      L  +P+ R         +++
Sbjct: 216 LILMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVM 259

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-28
 Identities = 46/249 (18%), Positives = 91/249 (36%), Gaps = 31/249 (12%)

Query: 1   DKKEFLREITVLTEI---RHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNND 52
                +RE+ VL  +    H N+V+ +  CT +R        LV+E+++    + +    
Sbjct: 50  MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 108

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
                +      +++  +   L +LH   +   VHRD+  +N+L+    +  ++DFG+A+
Sbjct: 109 -PEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLAR 164

Query: 113 FIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSS 172
                 +  +    T  Y APE+          D++S G +  E+ + K      S+V  
Sbjct: 165 IYSFQMALTS-VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223

Query: 173 SNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL-----------------CLDNNPES 215
               + V  +      P  V +  +         +                 CL  NP  
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283

Query: 216 RPNMQTICQ 224
           R +  +   
Sbjct: 284 RISAYSALS 292

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-28
 Identities = 42/259 (16%), Positives = 88/259 (33%), Gaps = 41/259 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHA--------RHSFLVYEYLENGSLSVILNND 52
                LREI +L  ++H N+V     C              +LV+++ E+    ++ N  
Sbjct: 52  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 111

Query: 53  TSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK 112
               +   S    V++ +   L+ L++     I+HRD+ + NVL+  +    ++DFG+A+
Sbjct: 112 ---VKFTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165

Query: 113 FIQPDSS----NWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHPRDFL 167
                 +     +T    T  Y  PEL    +      D++  G +  E+          
Sbjct: 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225

Query: 168 SNVS--------------------SSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL 207
           +                        +       E++  +   +   ++  V     +  +
Sbjct: 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285

Query: 208 --CLDNNPESRPNMQTICQ 224
              L  +P  R +      
Sbjct: 286 DKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 1e-27
 Identities = 45/245 (18%), Positives = 91/245 (37%), Gaps = 27/245 (11%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
                LREI +L E++H+NIV+ +      +   LV+E+ +        + +      G 
Sbjct: 44  VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GD 97

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                V   +   L  L       ++HRD+  +N+L++   E  +++FG+A+        
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 121 WTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNIL- 178
           ++    T  Y  P++ +  K+ +   D++S G +  E+     P    ++V      I  
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217

Query: 179 ---------------VNEMLDPRLPPLSVDIRGKVISIMEVA--FL--CLDNNPESRPNM 219
                          + +     + P +  +   V  +       L   L  NP  R + 
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

Query: 220 QTICQ 224
           +   Q
Sbjct: 278 EEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-26
 Identities = 48/232 (20%), Positives = 88/232 (37%), Gaps = 18/232 (7%)

Query: 1   DKKEFLREITVLTEIRHR-NIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELG 59
             +    E  VL  IR    +V  +          L+ +Y+  G L   L+      E  
Sbjct: 71  TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE 130

Query: 60  WSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS 119
               +         +  L H     I++RDI  +N+LLD      ++DFG++K    D +
Sbjct: 131 VQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184

Query: 120 NWT-EFAGTYGYVAPELAYTMK--VTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPN 176
               +F GT  Y+AP++            D +S GVL  E++ G  P  F  +   ++  
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQA 242

Query: 177 ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP--NMQTICQLL 226
            +   +L    PP   ++      +++     L  +P+ R     +   ++ 
Sbjct: 243 EISRRILKSE-PPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIK 290

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.9 bits (248), Expect = 2e-25
 Identities = 40/218 (18%), Positives = 70/218 (32%), Gaps = 19/218 (8%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
             +  L E  +L  +    +VK         + ++V EY+  G +   L           
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSE 140

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN 120
                    I     YLH   +   ++RD+  +N+L+D +    V+DFG AK ++     
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GR 194

Query: 121 WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVN 180
                GT   +APE+  +       D ++ GVL  E+  G  P      +      +   
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254

Query: 181 EMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN 218
                       D+              L  +   R  
Sbjct: 255 VRFPSHFSSDLKDLLRN----------LLQVDLTKRFG 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.8 bits (240), Expect = 1e-24
 Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 43/257 (16%)

Query: 1   DKKEFLREITVLTEIR-HRNIVKFYGFCTHA--RHSFLVYEYLENGSLSVILNNDTSAEE 57
            KK+  REI +L  +R   NI+           R   LV+E++ N     +         
Sbjct: 72  KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------ 125

Query: 58  LGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQP 116
           L        +  I  AL Y H   I    HRD+   NV++D E  +  + D+G+A+F  P
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182

Query: 117 DSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKGKHP------------ 163
               +     +  +  PEL    +      D++S G +   +I  K P            
Sbjct: 183 GQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 164 -----------RDFLSNVSSSNP---NILVNEMLDPRLPPLSVDIRGKVISIMEVAFL-- 207
                       D++   +       N ++      R           ++S   + FL  
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 208 CLDNNPESRPNMQTICQ 224
            L  + +SR   +   +
Sbjct: 302 LLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 3e-24
 Identities = 48/253 (18%), Positives = 86/253 (33%), Gaps = 41/253 (16%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
             K   RE+ +L  +RH N++      T           +LV  ++      ++ +    
Sbjct: 60  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--- 116

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
             +LG  R   ++  +   L Y+H   I    HRD+   N+ ++ + E  + DFG+A+  
Sbjct: 117 --KLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR-- 169

Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP----------- 163
           Q DS         +      +   M+ T   D++S G +  E+I GK             
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 164 ----------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDN 211
                      +F+  + S      +  +  P L            S + V  L   L  
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKMLVL 287

Query: 212 NPESRPNMQTICQ 224
           + E R        
Sbjct: 288 DAEQRVTAGEALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 1e-22
 Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 16/169 (9%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHS------FLVYEYLENGSLSVILNNDTS 54
             K   RE+ ++  + H+NI+      T  +        +LV E ++     VI      
Sbjct: 59  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD- 117

Query: 55  AEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFI 114
                  R   ++  +   + +LH   I   +HRD+   N+++  +    + DFG+A+  
Sbjct: 118 -----HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA 169

Query: 115 QPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP 163
                  T +  T  Y APE+   M      D++S G +  E+++ K  
Sbjct: 170 GTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 1e-21
 Identities = 44/252 (17%), Positives = 88/252 (34%), Gaps = 39/252 (15%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHAR-----HSFLVYEYLENGSLSVILNNDTSA 55
             K   RE+ +L  ++H N++      T AR     +   +  +L    L+ I+      
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---- 115

Query: 56  EELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQ 115
           ++L       +I  I   L Y+H   I    HRD+   N+ ++ + E  + DFG+A+   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT- 171

Query: 116 PDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKHP------------ 163
            D       A  +      +   M      D++S G +  E++ G+              
Sbjct: 172 -DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 164 ---------RDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFL--CLDNN 212
                     + L  +SS +    +  +   ++P ++        + + V  L   L  +
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSL--TQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

Query: 213 PESRPNMQTICQ 224
            + R        
Sbjct: 289 SDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 76.2 bits (186), Expect = 6e-17
 Identities = 41/213 (19%), Positives = 79/213 (37%), Gaps = 22/213 (10%)

Query: 1   DKKEFLREITVLTEIRHRNIVK---------------FYGFCTHARHSFLVYEYLENGSL 45
             +    EI +L  +   +  K               F     +  H  +V+E L    L
Sbjct: 52  YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 111

Query: 46  SVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLE-YEAH 104
           ++I   +     L + ++I   K +   L Y+H  C   I+H DI  +NVL+++     +
Sbjct: 112 ALIKKYEHRGIPLIYVKQI--SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 167

Query: 105 VSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGKH 162
           +    IA          ++T    T  Y +PE+          D++S   L  E+I G  
Sbjct: 168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

Query: 163 PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIR 195
             +     S +  +  + ++++      S  +R
Sbjct: 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 260

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.9 bits (126), Expect = 2e-09
 Identities = 25/142 (17%), Positives = 45/142 (31%), Gaps = 20/142 (14%)

Query: 1   DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGW 60
               F            R + K  G      +++      E  ++ + L +      +  
Sbjct: 49  GDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRV 102

Query: 61  SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAK-------- 112
                V+  I   ++  +H  I   VH D+S  NVL+  E    + DF  +         
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGI---VHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR 158

Query: 113 -FIQPDSSNWTE-FAGTYGYVA 132
             ++ D  N    F+ TY    
Sbjct: 159 EILERDVRNIITYFSRTYRTEK 180

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	228
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.78
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.23
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.06

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=323.46  Aligned_cols=209  Identities=27%  Similarity=0.423  Sum_probs=178.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||++++++|.+++.+|+||||++|++|.+++..+    .+++.++..++.|++.||+|||++ 
T Consensus        61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~-  135 (293)
T d1yhwa1          61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN-  135 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            567899999999999999999999999999999999999999999988754    289999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       136 --~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~  213 (293)
T d1yhwa1         136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE  213 (293)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCC
Confidence              999999999999999999999999999988765555556678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||.....      ......+.....+.. ......+.++.++|.+||+.||.+|||++|+++
T Consensus       214 ~Pf~~~~~------~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         214 PPYLNENP------LRALYLIATNGTPEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CTTTTSCH------HHHHHHHHHHCSCCC-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCH------HHHHHHHHhCCCCCC-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99854322      222222222221111 112456778999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=319.20  Aligned_cols=209  Identities=25%  Similarity=0.377  Sum_probs=172.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++.+++..|+||||+++++|.+++....   .+++..+..++.|++.||+|||+.  
T Consensus        48 ~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~--  122 (271)
T d1nvra_          48 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI--  122 (271)
T ss_dssp             -CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc--
Confidence            568899999999999999999999999999999999999999999986543   489999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCC--CCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDS--SNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~~  159 (228)
                       ||+||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       123 -~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~  201 (271)
T d1nvra_         123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  201 (271)
T ss_dssp             -TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             -CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence             99999999999999999999999999998764332  22345679999999999988776 578999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||.....     ..............  .......+.++.++|.+||+.||.+|||++++++
T Consensus       202 G~~pf~~~~~-----~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         202 GELPWDQPSD-----SCQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             SSCSCSSSST-----TSHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCCh-----HHHHHHHHhcCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            9999864321     11111222121111  1123456778899999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=315.17  Aligned_cols=205  Identities=26%  Similarity=0.432  Sum_probs=176.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||+++++++.++...|+||||+++++|.+++....   .+++..+..++.|++.||+|||+. 
T Consensus        50 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~-  125 (263)
T d2j4za1          50 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK-  125 (263)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4568899999999999999999999999999999999999999999987643   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.++.+||+|||++......  ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       126 --~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~  201 (263)
T d2j4za1         126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK  201 (263)
T ss_dssp             --TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             --CeeeeeeccccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC
Confidence              9999999999999999999999999999765432  334568999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      .||...      +.......+........    ...+.++.++|.+||+.||.+|||++|+++
T Consensus       202 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         202 PPFEAN------TYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CTTCCS------SHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCC------CHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            998532      23334444444433211    235667899999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-53  Score=320.26  Aligned_cols=213  Identities=25%  Similarity=0.476  Sum_probs=168.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||+++++++..+...|+||||+.+|+|.+++.....  .+++.++..++.|++.||+|||+. 
T Consensus        71 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~-  147 (299)
T d1jpaa_          71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM-  147 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC-
Confidence            46799999999999999999999999999999999999999999998876433  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-----ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                        |++||||||+|||++.++.+||+|||+++........     .....+++.|+|||.+.+..++.++|||||||++||
T Consensus       148 --~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~e  225 (299)
T d1jpaa_         148 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE  225 (299)
T ss_dssp             --TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred             --CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHH
Confidence              9999999999999999999999999999876543222     122457889999999999899999999999999999


Q ss_pred             HHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          157 VIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       157 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++ |..||....      .......+.....++.+   ..++..+.+++.+||+.||.+|||++++++.|++
T Consensus       226 l~t~g~~Pf~~~~------~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         226 VMSYGERPYWDMT------NQDVINAIEQDYRLPPP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             HHTTSCCTTTTCC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCC------HHHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            998 899986432      22333333333222222   3466789999999999999999999999998863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-53  Score=317.10  Aligned_cols=215  Identities=26%  Similarity=0.427  Sum_probs=170.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.|.+|++++++++||||+++++++.. ...++||||+++++|.+++.....  .+++..+..++.|++.||+|||+. 
T Consensus        48 ~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~-  123 (276)
T d1uwha_          48 LQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK-  123 (276)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            4678999999999999999999998754 568999999999999999975433  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC--CceecccccceeCCcccccC---CcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS--NWTEFAGTYGYVAPELAYTM---KVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~  156 (228)
                        ||+||||||+||+++.++.+||+|||++........  ......||+.|+|||++.+.   .++.++|||||||++|+
T Consensus       124 --~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~e  201 (276)
T d1uwha_         124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE  201 (276)
T ss_dssp             --TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHH
T ss_pred             --CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHH
Confidence              999999999999999999999999999977653322  23456789999999998643   47889999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||......     ............ +........++.++.++|.+||+.||.+|||++++++.|+
T Consensus       202 l~tg~~Pf~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         202 LMTGQLPYSNINNR-----DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             HHHSSCTTTTCCCH-----HHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHCCCCCCCCChH-----HHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            99999998643221     111111111211 1222223456778999999999999999999999999886

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=321.55  Aligned_cols=211  Identities=24%  Similarity=0.386  Sum_probs=175.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++....  ..+++.++..++.|++.||.|||++ 
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~-  129 (288)
T d2jfla1          53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN-  129 (288)
T ss_dssp             GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4678899999999999999999999999999999999999999999876533  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccc-----cCCcccchhhhhHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAY-----TMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~  156 (228)
                        ||+||||||+||+++.++.+||+|||++..............||+.|+|||++.     +..++.++|||||||++|+
T Consensus       130 --~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye  207 (288)
T d2jfla1         130 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  207 (288)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred             --CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence              999999999999999999999999999876543222233467899999999884     4457889999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||....      .......+.....+... .....+.++.++|.+||+.||.+|||++|+++
T Consensus       208 mltg~~Pf~~~~------~~~~~~~i~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         208 MAEIEPPHHELN------PMRVLLKIAKSEPPTLA-QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSSCTTTTSC------GGGHHHHHHHSCCCCCS-SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhCCCCCCCCC------HHHHHHHHHcCCCCCCC-ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            999999986432      23334444443333222 22466778999999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=320.10  Aligned_cols=214  Identities=25%  Similarity=0.410  Sum_probs=164.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDT-SAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++.+.+|++++++++||||+++++++.+  +..+|+||||+++|+|.+++.... ....+++..++.++.|++.||+|||
T Consensus        47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH  126 (269)
T d2java1          47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  126 (269)
T ss_dssp             HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4568899999999999999999999854  457899999999999999986421 2334899999999999999999999


Q ss_pred             hCCC--CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           79 HDCI--PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~--~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      +++.  .+|+||||||+|||++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+
T Consensus       127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilye  206 (269)
T d2java1         127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE  206 (269)
T ss_dssp             HHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHH
Confidence            9710  03999999999999999999999999999887655444556789999999999999999999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++|..||...      +.......+.....+..+   ..++.++.++|.+||+.||.+|||++|+++
T Consensus       207 l~tg~~Pf~~~------~~~~~~~~i~~~~~~~~~---~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         207 LCALMPPFTAF------SQKELAGKIREGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHSSCSCCCS------SHHHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhhCCCCCCCC------CHHHHHHHHHcCCCCCCC---cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            99999998532      233344444444433322   245678999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=310.77  Aligned_cols=207  Identities=23%  Similarity=0.373  Sum_probs=169.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      ++.|.+|++++++++||||++++++|..    +..+|+||||+++++|.+++....   .+++..+..++.|++.||+||
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yL  128 (270)
T d1t4ha_          52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFL  128 (270)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999865    346899999999999999997643   389999999999999999999


Q ss_pred             hhCCCCC--eeecCCCCCceEEc-CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           78 HHDCIPP--IVHRDISSKNVLLD-LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        78 h~~~~~~--i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      |++   +  |+||||||+||+++ .++.+||+|||+++....  .......||+.|+|||++.+ .++.++|||||||++
T Consensus       129 H~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvil  202 (270)
T d1t4ha_         129 HTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM  202 (270)
T ss_dssp             HTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred             HHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHH
Confidence            999   8  99999999999996 478999999999976432  23455789999999998865 599999999999999


Q ss_pred             HHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          155 LEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |+|++|+.||...     .+.......+.....+.  ......++++.++|.+||+.||++|||++|+++
T Consensus       203 yel~~g~~Pf~~~-----~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         203 LEMATSEYPYSEC-----QNAAQIYRRVTSGVKPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHSSCTTTTC-----SSHHHHHHHHTTTCCCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCCCCCCc-----ccHHHHHHHHHcCCCCc--ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            9999999998532     12223333333332221  112345667899999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-52  Score=318.33  Aligned_cols=209  Identities=27%  Similarity=0.333  Sum_probs=165.4

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++.++..+|+||||++|++|.+++....   .+++..+..++.|++.||+|||+.  
T Consensus        52 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~--  126 (307)
T d1a06a_          52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL--  126 (307)
T ss_dssp             ---CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc--
Confidence            467799999999999999999999999999999999999999999997643   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEc---CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLD---LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++||||||+||++.   .++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       127 -~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~  204 (307)
T d1a06a_         127 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC  204 (307)
T ss_dssp             -TCCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             -eeeeEEecccceeecccCCCceEEEeccceeEEccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh
Confidence             999999999999995   46899999999998655332 2344679999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      ........+...............++++.++|.+||+.||.+|||++|+++
T Consensus       205 g~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         205 GYPPFYDE------NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             SSCSCCCS------SHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCC------CHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            99998532      233344455554444333334567778999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=312.11  Aligned_cols=213  Identities=25%  Similarity=0.447  Sum_probs=167.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++|.+|++++++++||||+++++++..++..|+||||+.+++|.+++.....  .+++..++.++.|++.||+|||+. 
T Consensus        44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~-  120 (263)
T d1sm2a_          44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA-  120 (263)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc-
Confidence            57799999999999999999999999999999999999999999999875433  388999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        +++||||||+||+++.++.+||+|||+++........ .....|++.|+|||++.+..++.++||||||+++|+|+++
T Consensus       121 --~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~  198 (263)
T d1sm2a_         121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE  198 (263)
T ss_dssp             --TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             --ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHC
Confidence              9999999999999999999999999999876543322 2345688999999999999999999999999999999994


Q ss_pred             -CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          161 -KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       161 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       .+||...      ........+.....+..+   ..++.++.+++.+||+.||.+|||++++++.|++
T Consensus       199 ~~~~~~~~------~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         199 GKIPYENR------SNSEVVEDISTGFRLYKP---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             SCCTTCSC------CHHHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCC------CHHHHHHHHHhcCCCCCc---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             6555422      222233333222222211   2345678999999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=313.72  Aligned_cols=211  Identities=25%  Similarity=0.368  Sum_probs=176.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++|.+|++++++++||||+++++++.. +..|+||||+++|+|.+++....  ..+++..+..++.|++.||+|||+. 
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~-  128 (285)
T d1u59a_          53 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK-  128 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4678999999999999999999999865 46899999999999999875433  3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.+||+|||+++........   .....+++.|+|||++.+..++.++|||||||++|||+
T Consensus       129 --~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l  206 (285)
T d1u59a_         129 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  206 (285)
T ss_dssp             --TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             --CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence              9999999999999999999999999999876543322   22346788999999999889999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||....      .......+..+..+..+   ..++.++.++|.+||+.||.+|||+.++++.|+
T Consensus       207 t~G~~Pf~~~~------~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         207 SYGQKPYKKMK------GPEVMAFIEQGKRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             TTSCCTTTTCC------THHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCC------HHHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            8 999986432      22333333333333222   346678999999999999999999999998875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-52  Score=313.89  Aligned_cols=214  Identities=25%  Similarity=0.379  Sum_probs=175.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++|.+|++++++++||||++++++|.++...|+||||+.+|+|.+++..... ..+++..++.++.|++.||+|||+. 
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~-  134 (287)
T d1opja_          57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-  134 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC-
Confidence            56799999999999999999999999999999999999999999999876433 3489999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       135 --~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~  212 (287)
T d1opja_         135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  212 (287)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence              9999999999999999999999999999876543322 2234578899999999999999999999999999999997


Q ss_pred             CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ..|+...     .+.......+.....+..+   ..++.++.++|.+||+.||.+|||++++++.|+
T Consensus       213 ~~p~~~~-----~~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         213 GMSPYPG-----IDLSQVYELLEKDYRMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             SCCSSTT-----CCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCc-----chHHHHHHHHhcCCCCCCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            6664321     1122222222222222211   245678999999999999999999999998875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=311.61  Aligned_cols=210  Identities=27%  Similarity=0.410  Sum_probs=174.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++|.+|++++++++||||++++++|.. +..|+||||+++|+|.+++.....   +++..++.++.|++.||+|||+. 
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~-  126 (277)
T d1xbba_          52 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-  126 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhC-
Confidence            4679999999999999999999999865 467899999999999999876543   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.++.+|++|||+++........   .....||+.|+|||.+.+..++.++||||||+++|+|+
T Consensus       127 --~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell  204 (277)
T d1xbba_         127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  204 (277)
T ss_dssp             --TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             --CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence              9999999999999999999999999999876543332   22356789999999999999999999999999999999


Q ss_pred             h-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 K-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      + |..||....      .......+..+..+..+   ..++.++.++|.+||+.||.+|||++++++.|+
T Consensus       205 t~g~~Pf~~~~------~~~~~~~i~~~~~~~~p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         205 SYGQKPYRGMK------GSEVTAMLEKGERMGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             TTTCCSSTTCC------HHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCC------HHHHHHHHHcCCCCCCC---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            7 899986432      22233333333332222   245678999999999999999999999988775

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-51  Score=319.42  Aligned_cols=211  Identities=19%  Similarity=0.319  Sum_probs=181.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||++++++|.+.+.+|+||||++|++|.+++....  ..+++..+..++.|++.||+|||+. 
T Consensus        67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~-  143 (350)
T d1koaa2          67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN-  143 (350)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc-
Confidence            4678899999999999999999999999999999999999999999986443  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC--CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDL--EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        |++||||||+||+++.  ++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       144 --~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~  220 (350)
T d1koaa2         144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS  220 (350)
T ss_dssp             --TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             --CCeeeeechhHeeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh
Confidence              9999999999999964  578999999999876533 33455788999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      +.......+...............+.++.++|.+||..||++|||++|+++
T Consensus       221 G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         221 GLSPFGGE------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             SSCSSCCS------SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCC------CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99998532      333445555554444444444567788999999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-51  Score=319.58  Aligned_cols=211  Identities=18%  Similarity=0.266  Sum_probs=179.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||++++++|.++..+|+||||++|++|.+++.....  .+++..++.++.|++.||+|||+. 
T Consensus        70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~-  146 (352)
T d1koba_          70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH-  146 (352)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            46788999999999999999999999999999999999999999988765432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEc--CCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLD--LEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+|||++  .++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus       147 --~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt  223 (352)
T d1koba_         147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS  223 (352)
T ss_dssp             --TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             --CeeecccccccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh
Confidence              999999999999997  5689999999999877643 33455688999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      +.......+...............+.++.+||.+||+.||.+|||++|+++
T Consensus       224 G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         224 GLSPFAGE------DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SCCSSCCS------SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCC------CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99998532      233344444444433333334567778999999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=313.68  Aligned_cols=206  Identities=23%  Similarity=0.336  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|++++++++||||++++++|.+.+..|+||||+.+++|.+++.....   +++..+..++.|++.||+|||+. 
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~-  127 (288)
T d1uu3a_          52 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK-  127 (288)
T ss_dssp             HHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccc-
Confidence            35688999999999999999999999999999999999999999998876543   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+||+++.+|.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       128 --~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~  205 (288)
T d1uu3a_         128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA  205 (288)
T ss_dssp             --TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             --cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence              9999999999999999999999999999876543322  344679999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      |..||...      +.......+........    ...+.++.+||.+||+.||.+|||++|++
T Consensus       206 g~~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         206 GLPPFRAG------NEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             SSCSSCCS------SHHHHHHHHHTTCCCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCCCCCCc------CHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            99998632      33344444444433211    24566789999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=310.54  Aligned_cols=210  Identities=21%  Similarity=0.306  Sum_probs=180.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.+.+|++++++++||||++++++|.+...+|+||||+++++|.+++....   .+++..+..++.|++.||+|||+. 
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~-  132 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL-  132 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc-
Confidence            4678999999999999999999999999999999999999999999997653   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCC----ceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEY----EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEV  157 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~  157 (228)
                        |++||||||+||+++.++    .+|++|||++....... ......+++.|+|||++.+..++.++||||+||++|+|
T Consensus       133 --~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyel  209 (293)
T d1jksa_         133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL  209 (293)
T ss_dssp             --TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred             --ceeecccccceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHH
Confidence              999999999999998776    49999999998765332 33446789999999999998999999999999999999


Q ss_pred             HhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          158 IKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       158 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ++|..||...      +.......+...............+..+.++|++||+.||.+|||++++++
T Consensus       210 l~g~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         210 LSGASPFLGD------TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHSSCSSCCS------SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCCCC------CHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999998633      233444555555444444444567778999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=316.51  Aligned_cols=214  Identities=23%  Similarity=0.401  Sum_probs=175.9

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC--------------------CCCCCH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS--------------------AEELGW   60 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~   60 (228)
                      ++.+.+|+.+++++ +||||+++++++.+....|+||||+++|+|.+++.....                    ...+++
T Consensus        84 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  163 (325)
T d1rjba_          84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF  163 (325)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred             HHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCH
Confidence            45788999999998 899999999999999999999999999999999975432                    234788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc
Q 040501           61 SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT  138 (228)
Q Consensus        61 ~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  138 (228)
                      ..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++........  .....+|+.|+|||++.+
T Consensus       164 ~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            99999999999999999999   9999999999999999999999999999876544332  223567899999999999


Q ss_pred             CCcccchhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          139 MKVTAKCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       139 ~~~~~~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      ..++.++|||||||++|+|++ |..||.....      ......+..... +..+   ..++.++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~------~~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~R  311 (325)
T d1rjba_         241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------DANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKR  311 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCcceeccchhHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHC
Confidence            999999999999999999997 8999864322      112222222211 1111   2456689999999999999999


Q ss_pred             CCHHHHHHHhh
Q 040501          217 PNMQTICQLLC  227 (228)
Q Consensus       217 pt~~~il~~l~  227 (228)
                      ||+++|++.|.
T Consensus       312 Pt~~ei~~~L~  322 (325)
T d1rjba_         312 PSFPNLTSFLG  322 (325)
T ss_dssp             CCHHHHHHHHH
T ss_pred             cCHHHHHHHHh
Confidence            99999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=317.43  Aligned_cols=213  Identities=23%  Similarity=0.368  Sum_probs=170.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-C
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHH-D   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~   80 (228)
                      ++++.+|+.++++++||||++++++|.+....|+||||+.+++|.+++....   .+++..+..++.|++.||.|||+ .
T Consensus        48 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~  124 (322)
T d1s9ja_          48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH  124 (322)
T ss_dssp             HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4578999999999999999999999999999999999999999999997643   38999999999999999999996 6


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                         ||+||||||+||+++.+|.+||+|||++.......  .....||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus       125 ---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G  199 (322)
T d1s9ja_         125 ---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  199 (322)
T ss_dssp             ---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             ---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence               89999999999999999999999999998654322  2346899999999999999999999999999999999999


Q ss_pred             CCCccccccccC------------------------------------CCchhhhhhhcCCCCCCCchhhhhhHHHHHHH
Q 040501          161 KHPRDFLSNVSS------------------------------------SNPNILVNEMLDPRLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       161 ~~p~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  204 (228)
                      +.||........                                    ...............+...  ....+.++.++
T Consensus       200 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dl  277 (322)
T d1s9ja_         200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDF  277 (322)
T ss_dssp             SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHH
Confidence            999864321100                                    0000000001111111111  12345678999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |.+||+.||.+|||++|+++
T Consensus       278 i~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         278 VNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHhh
Confidence            99999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-51  Score=312.49  Aligned_cols=204  Identities=24%  Similarity=0.419  Sum_probs=171.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++.++...|+||||+.+++|..++....   .+++..+..++.|++.||.|||+.  
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~--  134 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH--  134 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            568899999999999999999999999999999999999999887765443   389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc---CCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT---MKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~~~~  159 (228)
                       ||+||||||+|||++.++.+||+|||++......    ....||+.|+|||++.+   ..++.++|||||||++|+|++
T Consensus       135 -~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~  209 (309)
T d1u5ra_         135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (309)
T ss_dssp             -TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             -CEeccCCCcceEEECCCCCEEEeecccccccCCC----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence             9999999999999999999999999999865432    34579999999999864   358899999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||....      .......+.....+...  ...++.++.++|.+||+.||.+|||++++++
T Consensus       210 g~~Pf~~~~------~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         210 RKPPLFNMN------AMSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SSCTTTTSC------HHHHHHHHHHSCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCC------HHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            999985322      22333333333332222  1245678999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=307.16  Aligned_cols=213  Identities=24%  Similarity=0.435  Sum_probs=169.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++|.+|++++++++||||+++++++.+....++|||++.++++.+.+.....  .+++.+++.++.|++.|+.|||+. 
T Consensus        53 ~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~-  129 (283)
T d1mqba_          53 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM-  129 (283)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc-
Confidence            35789999999999999999999999999999999999999999988765443  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~  158 (228)
                        +|+||||||+|||++.++.+||+|||+++........   .....||+.|+|||++.+..++.++||||||+++|||+
T Consensus       130 --~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~  207 (283)
T d1mqba_         130 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM  207 (283)
T ss_dssp             --TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             --ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHH
Confidence              9999999999999999999999999999876433222   22346789999999999999999999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      +|..|+...     .........+..+..++.+   ..++..+.++|.+||+.||.+|||+.++++.|+
T Consensus       208 t~~~~~~~~-----~~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         208 TYGERPYWE-----LSNHEVMKAINDGFRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             TTSCCTTTT-----CCHHHHHHHHHTTCCCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             hCCCCcccc-----CCHHHHHHHHhccCCCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            965554221     1222333334333333322   245667999999999999999999999999885

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=307.93  Aligned_cols=212  Identities=23%  Similarity=0.419  Sum_probs=172.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||+++++++.+ +..|+||||+.+|+|.+++..... ..+++..++.++.|++.||+|||+. 
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~-  128 (272)
T d1qpca_          52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER-  128 (272)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            5679999999999999999999998765 567999999999999987754332 2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       129 --~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~  206 (272)
T d1qpca_         129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (272)
T ss_dssp             --TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence              9999999999999999999999999999876543222 2335678899999999988899999999999999999995


Q ss_pred             CC-CccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          161 KH-PRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       161 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      .. |+..      .........+.....+..+   ..++.++.+++.+||+.||++|||++++++.|+
T Consensus       207 ~~~~~~~------~~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         207 GRIPYPG------MTNPEVIQNLERGYRMVRP---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             TCCSSTT------CCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCC------CCHHHHHHHHHhcCCCCCc---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            54 4432      2222333333333322222   245668999999999999999999999999886

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=309.92  Aligned_cols=207  Identities=24%  Similarity=0.284  Sum_probs=177.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++||||++++++|.+...+|+||||+.||+|.+++.....   +++..+..++.|++.||.|||++ 
T Consensus        49 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~-  124 (337)
T d1o6la_          49 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSR-  124 (337)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhc-
Confidence            35688999999999999999999999999999999999999999999886543   88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.+|.+||+|||+++.............||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus       125 --~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~  202 (337)
T d1o6la_         125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR  202 (337)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             --CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence              999999999999999999999999999987665555556678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      +||...+      .......+.......    ....+.++.+||.+||++||.+|++     +.++++
T Consensus       203 ~pf~~~~------~~~~~~~i~~~~~~~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         203 LPFYNQD------HERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CSSCCSS------HHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCcC------HHHHHHHHhcCCCCC----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            9986432      233334443333221    1245667899999999999999995     777764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=301.19  Aligned_cols=214  Identities=23%  Similarity=0.459  Sum_probs=179.2

Q ss_pred             ChHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            1 DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++++|.+|++++++++||||++++++|.++..+++||||+.+|+|..++.....  .+++..++.++.|+++||+|||+.
T Consensus        42 ~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~  119 (258)
T d1k2pa_          42 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK  119 (258)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc
Confidence            357899999999999999999999999999999999999999999998765432  388999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                         |++||||||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       120 ---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t  196 (258)
T d1k2pa_         120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS  196 (258)
T ss_dssp             ---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence               9999999999999999999999999999865543332 334668899999999999999999999999999999998


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |+.||.....      .+....+........+   ...+.++.++|.+||+.||.+|||++++++.|..
T Consensus       197 ~g~~Pf~~~~~------~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         197 LGKMPYERFTN------SETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TSCCTTTTSCH------HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cCCCCCCCCCH------HHHHHHHHhCCCCCCc---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             8999864432      2233333333222222   2455689999999999999999999999998853

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.8e-50  Score=301.13  Aligned_cols=209  Identities=22%  Similarity=0.362  Sum_probs=177.8

Q ss_pred             HHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++.+|+.++++++ ||||+++++++.++..+|+||||+.+++|.+++....   .+++.++..++.|++.||+|||+. 
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~-  129 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL-  129 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc-
Confidence            46889999999996 9999999999999999999999999999999997654   389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc------CCcccchhhhhHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT------MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~  155 (228)
                        |++||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+      ..++.++||||+||++|
T Consensus       130 --~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily  206 (277)
T d1phka_         130 --NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY  206 (277)
T ss_dssp             --TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred             --CCcccccccceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence              99999999999999999999999999998776433 3344678999999998763      24678999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|++|+.||...      +.......+...............++++.+++.+||+.||.+|||++++++
T Consensus       207 eml~g~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         207 TLLAGSPPFWHR------KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHSSCSSCCS------SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhccCCCCCCCC------CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            999999998633      233344444444443333344577889999999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=307.63  Aligned_cols=211  Identities=20%  Similarity=0.310  Sum_probs=181.0

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +..+.+|+++|++++||||++++++|.++..+|+||||++|++|.+++....  ..+++.++..++.|++.||+|||+. 
T Consensus        45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~-  121 (321)
T d1tkia_          45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH-  121 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc-
Confidence            3467899999999999999999999999999999999999999999997643  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCC--CceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLE--YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+||+++.+  +.++|+|||++...... .......+++.|+|||...+..++.++|||||||++|+|++
T Consensus       122 --~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~  198 (321)
T d1tkia_         122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS  198 (321)
T ss_dssp             --TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred             --CCCcccccccceeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHh
Confidence              99999999999999855  47999999999876432 33455678999999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      |..||...      +.......+...............+.++.++|.+||..||.+|||++|+++
T Consensus       199 G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         199 GINPFLAE------TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             SSCTTCCS------SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCC------CHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99998643      334455556555555444445567788999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=302.75  Aligned_cols=211  Identities=23%  Similarity=0.389  Sum_probs=165.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||+++++++.+ ...|+||||+.+++|.+++.....  .+++..++.++.|++.||.|||+. 
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~-  127 (273)
T d1mp8a_          52 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK-  127 (273)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc-
Confidence            4678999999999999999999999864 578999999999999998765432  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                        |++||||||+||+++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ 
T Consensus       128 --~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~  205 (273)
T d1mp8a_         128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH  205 (273)
T ss_dssp             --TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             --CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhc
Confidence              9999999999999999999999999999876543322 334567899999999999999999999999999999997 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |.+||....      .......+.....++.+   .+++.++.++|.+||+.||.+|||+.+|++.|+
T Consensus       206 g~~P~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         206 GVKPFQGVK------NNDVIGRIENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             SCCTTTTCC------GGGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            899976433      22333333333333222   356678999999999999999999999999886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=305.86  Aligned_cols=216  Identities=21%  Similarity=0.258  Sum_probs=173.6

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeee----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTH----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      .+.+.+|++++.++ +||||++++++|.+    +..+|+|||||+||+|.+++..... ..+++..+..++.|++.||+|
T Consensus        48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~y  126 (335)
T d2ozaa1          48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQY  126 (335)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHH
Confidence            45678999987665 89999999999865    4678999999999999999976432 348999999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                      ||+.   ||+||||||+||+++.   ++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||+
T Consensus       127 lH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvi  202 (335)
T d2ozaa1         127 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI  202 (335)
T ss_dssp             HHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHH
T ss_pred             HHHc---CCccccccccccccccccccccccccccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchh
Confidence            9999   9999999999999985   4679999999998765433 3345689999999999999999999999999999


Q ss_pred             HHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|+|++|..||.........  ......+..............++.++.+||.+||+.||.+|||+.++++
T Consensus       203 ly~lltg~~Pf~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         203 MYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHTTSSCSCEETTCC----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhhCCCCCCCCCHHHHH--HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            99999999999654322211  1112222223332223334567788999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-50  Score=302.07  Aligned_cols=214  Identities=28%  Similarity=0.415  Sum_probs=171.1

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      +.|.+|+++++.++||||+++++++....    .+|+||||++|++|.+++.....   +++.++..++.|++.||+|||
T Consensus        52 ~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH  128 (277)
T d1o6ya_          52 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH  128 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHH
Confidence            46889999999999999999999997653    48999999999999998876543   899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---CceecccccceeCCcccccCCcccchhhhhHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~  155 (228)
                      +.   |++||||||+||+++.++..+++|||.+........   ......|++.|+|||++.+..++.++|||||||++|
T Consensus       129 ~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvily  205 (277)
T d1o6ya_         129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY  205 (277)
T ss_dssp             HT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             hC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHH
Confidence            99   999999999999999999999999998875543322   234467899999999999989999999999999999


Q ss_pred             HHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-CHHHHHHHhhC
Q 040501          156 EVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-NMQTICQLLCK  228 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~~  228 (228)
                      +|++|.+||...      +.......................+.++.++|.+||++||.+|| |++++++.|.|
T Consensus       206 elltG~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         206 EVLTGEPPFTGD------SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHSSCSCCCS------SHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhCCCCCCCc------CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            999999998633      22333444444433333333456677899999999999999999 89999888753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-49  Score=301.43  Aligned_cols=204  Identities=24%  Similarity=0.346  Sum_probs=174.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+.++++++||||+++++++.+....|+||||+.|++|..++.....   ++...+..++.|++.||.|||++ 
T Consensus        48 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~-  123 (316)
T d1fota_          48 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK-  123 (316)
T ss_dssp             HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC-
Confidence            45788999999999999999999999999999999999999999999876543   78888899999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+||+++.+|.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       124 --~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~  198 (316)
T d1fota_         124 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY  198 (316)
T ss_dssp             --TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             --cEEccccCchheeEcCCCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCC
Confidence              9999999999999999999999999999876533   33467999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||...      +.......+........    ...+.++.+++.+||.+||.+|+     |++++++
T Consensus       199 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         199 TPFYDS------NTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTCCS------SHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCc------CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            998632      23334444444333211    24556789999999999999996     8888875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-50  Score=300.90  Aligned_cols=215  Identities=25%  Similarity=0.411  Sum_probs=168.8

Q ss_pred             ChHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            1 DKKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         1 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +++.|.+|+.++++++|+||+++++++.+ +..|+||||+.+|+|..++..... ..+++.+++.++.|++.||+|||+.
T Consensus        55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~  132 (285)
T d1fmka3          55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM  132 (285)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh
Confidence            35789999999999999999999999865 567999999999999988765321 2389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC-ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN-WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                         |++||||||+||+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||+|+++|+|++
T Consensus       133 ---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t  209 (285)
T d1fmka3         133 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT  209 (285)
T ss_dssp             ---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             ---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence               9999999999999999999999999999866433222 334678899999999999999999999999999999999


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |..|+..     ..........+......+..   ..++.++.++|.+||+.||++|||+++|++.|++
T Consensus       210 ~~~p~~~-----~~~~~~~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         210 KGRVPYP-----GMVNREVLDQVERGYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             TTCCSST-----TCCHHHHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCC-----CCCHHHHHHHHHhcCCCCCC---cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            6555422     12222333333333222222   3456789999999999999999999999998864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=298.35  Aligned_cols=212  Identities=22%  Similarity=0.375  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ++|.+|++++++++||||++++++|.+ ...++||||+.++++.+.+....  ..+++..++.++.|++.||.|||+.  
T Consensus        56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~--  130 (273)
T d1u46a_          56 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK--  130 (273)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC--
Confidence            578999999999999999999999975 46789999999999998876543  2389999999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC---ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN---WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                       |++||||||+||+++.++.+||+|||++.........   .....++..|+|||.+.+..++.++||||||+++|||++
T Consensus       131 -~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt  209 (273)
T d1u46a_         131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT  209 (273)
T ss_dssp             -TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             -CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence             9999999999999999999999999999976544332   223456789999999999999999999999999999998


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                       |..||...      +.......+........  ....++.++.++|.+||+.||++|||+++|++.|++
T Consensus       210 ~G~~Pf~~~------~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         210 YGQEPWIGL------NGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             TSCCTTTTC------CHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCc------CHHHHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             89998633      22333344433322111  113556789999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=301.92  Aligned_cols=216  Identities=23%  Similarity=0.268  Sum_probs=170.0

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      +.+.+|++++++++||||+++++++..+...|+||||+.++++..+....   ..+++..+..++.|++.||+|||+.  
T Consensus        45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~--  119 (299)
T d1ua2a_          45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH--  119 (299)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc--
Confidence            46889999999999999999999999999999999999988777666433   3388899999999999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHHHHHHhCC
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~~~~g~  161 (228)
                       |++||||||+||+++.++.+||+|||.+..............+|+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus       120 -~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~  198 (299)
T d1ua2a_         120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV  198 (299)
T ss_dssp             -TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             -ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCc
Confidence             99999999999999999999999999998776555555556789999999988655 5789999999999999999999


Q ss_pred             CCccccccccCCCc---------hh-------hhhhhcCCCCCCC--chhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          162 HPRDFLSNVSSSNP---------NI-------LVNEMLDPRLPPL--SVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~---------~~-------~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      +||......+....         ..       ..........+..  .......+.++.+||.+||+.||++|||++|++
T Consensus       199 ~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L  278 (299)
T d1ua2a_         199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL  278 (299)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            99864322110000         00       0000000011111  011124456789999999999999999999998


Q ss_pred             H
Q 040501          224 Q  224 (228)
Q Consensus       224 ~  224 (228)
                      +
T Consensus       279 ~  279 (299)
T d1ua2a_         279 K  279 (299)
T ss_dssp             T
T ss_pred             C
Confidence            6

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=296.80  Aligned_cols=211  Identities=27%  Similarity=0.403  Sum_probs=167.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      .++|.+|++++++++||||+++++++.+ +..+|+||||+.+|+|.+++..... ..+++..++.++.|++.|+.|||+.
T Consensus        44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~  122 (262)
T d1byga_          44 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN  122 (262)
T ss_dssp             -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC
Confidence            4679999999999999999999999854 4678999999999999999865321 2378999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh-
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK-  159 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~-  159 (228)
                         +++||||||+||+++.++.+|++|||++......   .....+++.|+|||++.+..++.++||||||+++|+|++ 
T Consensus       123 ---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~  196 (262)
T d1byga_         123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF  196 (262)
T ss_dssp             ---TCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---ceeccccchHhheecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHC
Confidence               9999999999999999999999999999865432   233467889999999998899999999999999999998 


Q ss_pred             CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          160 GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       160 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      |++||....      .......+.....+..+   ...+.++.++|.+||+.||.+|||+.++++.|++
T Consensus       197 ~~~p~~~~~------~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         197 GRVPYPRIP------LKDVVPRVEKGYKMDAP---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             SCCSCTTSC------GGGHHHHHTTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCC------HHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            788865432      22333333333333322   2455678999999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-49  Score=300.53  Aligned_cols=214  Identities=23%  Similarity=0.365  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-------------CCCCCCCHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-------------TSAEELGWSRRINVI   67 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~~   67 (228)
                      ++.|.+|+++++++ +||||+++++++.+....|+||||+++|+|.+++...             .....+++..++.++
T Consensus        54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  133 (309)
T d1fvra_          54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA  133 (309)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHH
Confidence            45789999999999 7999999999999999999999999999999998754             223458999999999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhh
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDV  147 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  147 (228)
                      .|++.|+.|+|+.   |++||||||+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||
T Consensus       134 ~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv  209 (309)
T d1fvra_         134 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDV  209 (309)
T ss_dssp             HHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcccccccccccccc-ccceecCCcccchHHhccCCCCcccee
Confidence            9999999999999   999999999999999999999999999876543222 234568899999999999999999999


Q ss_pred             hhHHHHHHHHHhCC-CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHh
Q 040501          148 YSFGVLALEVIKGK-HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLL  226 (228)
Q Consensus       148 wslG~~l~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  226 (228)
                      ||||+++|+|++|. +||...      +.......+.....+..+   ..++.++.++|.+||+.||++|||+.++++.|
T Consensus       210 wSfGvil~ell~~~~~p~~~~------~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L  280 (309)
T d1fvra_         210 WSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSL  280 (309)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGGTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ehhHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhcCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            99999999999965 565432      233333444333322222   34667899999999999999999999999988


Q ss_pred             hC
Q 040501          227 CK  228 (228)
Q Consensus       227 ~~  228 (228)
                      ++
T Consensus       281 ~~  282 (309)
T d1fvra_         281 NR  282 (309)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-49  Score=299.52  Aligned_cols=215  Identities=22%  Similarity=0.431  Sum_probs=177.8

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC---------------------CCCCCCH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---------------------SAEELGW   60 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~   60 (228)
                      +++|.+|++++++++||||+++++++......++++|++.+++|.+++....                     ....+++
T Consensus        60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  139 (301)
T d1lufa_          60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  139 (301)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence            4679999999999999999999999999999999999999999999986422                     1234788


Q ss_pred             HHHHHHHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCccccc
Q 040501           61 SRRINVIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYT  138 (228)
Q Consensus        61 ~~~~~~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~  138 (228)
                      ..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+
T Consensus       140 ~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (301)
T d1lufa_         140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  216 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence            99999999999999999999   9999999999999999999999999999765433222  234567889999999999


Q ss_pred             CCcccchhhhhHHHHHHHHHhCC-CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          139 MKVTAKCDVYSFGVLALEVIKGK-HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       139 ~~~~~~~DiwslG~~l~~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      ..++.++|||||||++|+|++|. +||...      +..+....+..+..+..+   ..++.++.+++.+||+.||.+||
T Consensus       217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~------~~~e~~~~v~~~~~~~~p---~~~~~~~~~li~~cl~~~P~~RP  287 (301)
T d1lufa_         217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGM------AHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRP  287 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCChhhhhccchhhHHHHHccCCCCCCCC------CHHHHHHHHHcCCCCCCC---ccchHHHHHHHHHHcCCChhHCc
Confidence            99999999999999999999985 565432      333444455555444332   24556799999999999999999


Q ss_pred             CHHHHHHHhhC
Q 040501          218 NMQTICQLLCK  228 (228)
Q Consensus       218 t~~~il~~l~~  228 (228)
                      |+.+|++.|++
T Consensus       288 t~~ev~~~L~~  298 (301)
T d1lufa_         288 SFCSIHRILQR  298 (301)
T ss_dssp             CHHHHHHHHHH
T ss_pred             CHHHHHHHHHH
Confidence            99999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-48  Score=300.92  Aligned_cols=204  Identities=20%  Similarity=0.238  Sum_probs=175.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+.+.+|+++++.++||||+++++++......++|||++.+++|..++.....   +++..+..++.||+.||.|||+. 
T Consensus        85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~-  160 (350)
T d1rdqe_          85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSL-  160 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC-
Confidence            35688999999999999999999999999999999999999999999876543   89999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        ||+||||||+|||++.+|.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       161 --~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~  235 (350)
T d1rdqe_         161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY  235 (350)
T ss_dssp             --TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCC
Confidence              9999999999999999999999999999876533   23467999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP-----NMQTICQ  224 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  224 (228)
                      .||...      +.......+........    ...+.++.++|++||+.||.+|+     |++++++
T Consensus       236 ~Pf~~~------~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         236 PPFFAD------QPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCc------CHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            998632      23344444444433221    24566789999999999999994     8998875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-49  Score=300.27  Aligned_cols=211  Identities=22%  Similarity=0.369  Sum_probs=171.2

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++.|.+|++++++++||||++++++|.++ ..+++++++.+++|.+.+.....  .+++..++.++.|++.||+|||+. 
T Consensus        55 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~-  130 (317)
T d1xkka_          55 NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR-  130 (317)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc-
Confidence            46799999999999999999999999865 56788899999999888776543  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHHHHHHHHh
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIK  159 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~  159 (228)
                        ||+||||||+||+++.++.+||+|||++.........  .....||+.|+|||.+.+..++.++|||||||++|+|++
T Consensus       131 --~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t  208 (317)
T d1xkka_         131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  208 (317)
T ss_dssp             --TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence              9999999999999999999999999999876544333  233467899999999999999999999999999999998


Q ss_pred             -CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          160 -GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       160 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                       |.+||.....      ......+..+..++.+   ..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus       209 ~g~~p~~~~~~------~~~~~~i~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         209 FGSKPYDGIPA------SEISSILEKGERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             TSCCTTTTSCG------GGHHHHHHHTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCCH------HHHHHHHHcCCCCCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence             8889764322      1222222222222211   245667999999999999999999999998775

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=298.94  Aligned_cols=205  Identities=25%  Similarity=0.332  Sum_probs=173.8

Q ss_pred             HHHHHHHHHHh-ccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLT-EIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|..++. .++||||+++++++.++...|+||||+.+|+|.+++.....   +++..+..++.|++.||.|||+. 
T Consensus        47 ~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~-  122 (320)
T d1xjda_          47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK-  122 (320)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhC-
Confidence            45677877766 57999999999999999999999999999999999976543   88999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHHHHhCC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALEVIKGK  161 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~~~~g~  161 (228)
                        |++||||||+|||++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       123 --~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~  200 (320)
T d1xjda_         123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ  200 (320)
T ss_dssp             --TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             --CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCC
Confidence              999999999999999999999999999987765555566678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 040501          162 HPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQ-TIC  223 (228)
Q Consensus       162 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il  223 (228)
                      .||...      +.......+....... +   ...+.++.+||.+||..||.+|||+. +++
T Consensus       201 ~PF~~~------~~~~~~~~i~~~~~~~-p---~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         201 SPFHGQ------DEEELFHSIRMDNPFY-P---RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CSSCCS------SHHHHHHHHHHCCCCC-C---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCCC------CHHHHHHHHHcCCCCC-C---ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            998632      2333333333333221 1   24566789999999999999999985 664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=296.57  Aligned_cols=213  Identities=25%  Similarity=0.376  Sum_probs=173.4

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      +++|.+|++++++++||||+++++++.. +...++||||+++++|.+++.....  ..++..++.++.|++.||.|+|+.
T Consensus        72 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~  149 (311)
T d1r0pa_          72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK  149 (311)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc
Confidence            4679999999999999999999999875 4588999999999999999875443  377888999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                         +++||||||+||+++.++.+||+|||+++........    .....+++.|+|||.+.+..++.++||||||+++||
T Consensus       150 ---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~E  226 (311)
T d1r0pa_         150 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  226 (311)
T ss_dssp             ---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             ---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHH
Confidence               9999999999999999999999999999876533222    223567899999999999999999999999999999


Q ss_pred             HHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          157 VIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|..||.....     .......+.....+..+   ..++.++.++|.+||+.||++|||+.||++.|+
T Consensus       227 l~t~~~p~~~~~~-----~~~~~~~i~~g~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         227 LMTRGAPPYPDVN-----TFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             HHTTSCCSCC-----------CHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHCCCCCCCCCC-----HHHHHHHHHcCCCCCCc---ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            9998777643221     11222333333332222   245567999999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9e-48  Score=299.06  Aligned_cols=203  Identities=17%  Similarity=0.195  Sum_probs=165.7

Q ss_pred             HHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 040501            7 REITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCIPPIV   86 (228)
Q Consensus         7 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~~i~   86 (228)
                      .|+++++.++||||++++++|.+.+.+|+||||+.|++|.+++.....   +++..+..++.|++.||.|||+.   |++
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~---~ii  129 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNR---FVV  129 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            346777778899999999999999999999999999999999976543   78899999999999999999999   999


Q ss_pred             ecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHHHHHhCCCCcc
Q 040501           87 HRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLALEVIKGKHPRD  165 (228)
Q Consensus        87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~~~~g~~p~~  165 (228)
                      ||||||+|||++.+|.+||+|||++.......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         130 YRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             CCCCSGGGEEECSSSCEEECCCTTCEECSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ceeeccceeEEcCCCcEEEeeeceeeecCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999998765432  334579999999999864 568999999999999999999999986


Q ss_pred             ccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          166 FLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      ....   .................    ...++.++.++|.+||+.||.+|||     ++++++
T Consensus       208 ~~~~---~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         208 QHKT---KDKHEIDRMTLTMAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSCS---SCHHHHHHHSSSCCCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCH---HHHHHHHHhcccCCCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            4321   11222222222222211    1245667899999999999999999     677764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=294.87  Aligned_cols=218  Identities=21%  Similarity=0.294  Sum_probs=169.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      ++++.+|++++++++||||++++++|.++...|+|||++.++.+........  ..+++..+..++.|++.||+|||+. 
T Consensus        45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~-  121 (298)
T d1gz8a_          45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH-  121 (298)
T ss_dssp             CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC-
Confidence            4678999999999999999999999999999999999997654544433332  3389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.+||+|||.+..............|++.|+|||.+.... ++.++||||+||++|+|++|
T Consensus       122 --~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G  199 (298)
T d1gz8a_         122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR  199 (298)
T ss_dssp             --TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             --CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence              999999999999999999999999999988765555555668999999999877665 47899999999999999999


Q ss_pred             CCCccccccccCC------------Cchhhhhhh--cCCCCCC-----CchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSSS------------NPNILVNEM--LDPRLPP-----LSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~~------------~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      +.||...+.....            .........  .....+.     ........+.++.+++.+||..||++|||++|
T Consensus       200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e  279 (298)
T d1gz8a_         200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA  279 (298)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            9998643211100            000000000  0000000     01112345567899999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       280 ll~  282 (298)
T d1gz8a_         280 ALA  282 (298)
T ss_dssp             HHT
T ss_pred             HhC
Confidence            986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=295.16  Aligned_cols=215  Identities=23%  Similarity=0.388  Sum_probs=178.7

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCC-------------CCCCCHHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTS-------------AEELGWSRRINVI   67 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~   67 (228)
                      .+.+.+|...+.++ +||||++++++|.++...++||||+.+|+|.+++.....             ...+++.+++.++
T Consensus        62 ~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  141 (299)
T d1fgka_          62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA  141 (299)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence            35678899999998 899999999999999999999999999999999975431             2458999999999


Q ss_pred             HHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccch
Q 040501           68 KGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKC  145 (228)
Q Consensus        68 ~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~  145 (228)
                      .|++.||+|||+.   +++||||||+||+++.++.+||+|||.+.........  .....+++.|+|||.+.+..++.++
T Consensus       142 ~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~  218 (299)
T d1fgka_         142 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  218 (299)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchh
Confidence            9999999999999   9999999999999999999999999999876543322  2335678899999999999999999


Q ss_pred             hhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          146 DVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       146 DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||||||+++|+|++ |.+||.....      ......+..+..+..+   ..++.++.++|.+||+.||.+|||+.++++
T Consensus       219 DiwS~Gvvl~ell~~g~~p~~~~~~------~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         219 DVWSFGVLLWEIFTLGGSPYPGVPV------EELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhHHhHHHHHHhccCCCCCCCCCCH------HHHHHHHHcCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            99999999999997 7888764322      2233333333322222   245667999999999999999999999999


Q ss_pred             HhhC
Q 040501          225 LLCK  228 (228)
Q Consensus       225 ~l~~  228 (228)
                      .|++
T Consensus       290 ~L~~  293 (299)
T d1fgka_         290 DLDR  293 (299)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=295.53  Aligned_cols=216  Identities=25%  Similarity=0.427  Sum_probs=174.9

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCC---------------CCCCCCHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDT---------------SAEELGWSRRIN   65 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~   65 (228)
                      +..|.+|+.+++++ +||||+++++++.+....|++|||+++++|.+++....               ....+++..+..
T Consensus        70 ~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  149 (311)
T d1t46a_          70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence            45788999999999 69999999999999999999999999999999987543               122488999999


Q ss_pred             HHHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCccc
Q 040501           66 VIKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTA  143 (228)
Q Consensus        66 ~~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  143 (228)
                      ++.|++.|++|||++   |++||||||+||+++.++.++++|||.+.........  .....+++.|+|||.+.+..++.
T Consensus       150 ~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  226 (311)
T d1t46a_         150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF  226 (311)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC
Confidence            999999999999999   9999999999999999999999999999876544333  23357899999999999989999


Q ss_pred             chhhhhHHHHHHHHHh-CCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHH
Q 040501          144 KCDVYSFGVLALEVIK-GKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTI  222 (228)
Q Consensus       144 ~~DiwslG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  222 (228)
                      ++||||||+++|+|++ |.+||....      ......+++.........  ...+..+.+||.+||+.||.+|||++++
T Consensus       227 ~~DIwS~G~~l~ellt~g~p~~~~~~------~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~i  298 (311)
T d1t46a_         227 ESDVWSYGIFLWELFSLGSSPYPGMP------VDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCC------SSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccccchHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            9999999999999998 566654322      112222222211111111  2345678999999999999999999999


Q ss_pred             HHHhhC
Q 040501          223 CQLLCK  228 (228)
Q Consensus       223 l~~l~~  228 (228)
                      ++.|++
T Consensus       299 l~~L~~  304 (311)
T d1t46a_         299 VQLIEK  304 (311)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=292.85  Aligned_cols=215  Identities=22%  Similarity=0.372  Sum_probs=164.6

Q ss_pred             hHHHHHHHHHHhcc-CCCccceeeeeeee-cCeEEEEEEeecCCChhhhhhcCC-------------CCCCCCHHHHHHH
Q 040501            2 KKEFLREITVLTEI-RHRNIVKFYGFCTH-ARHSFLVYEYLENGSLSVILNNDT-------------SAEELGWSRRINV   66 (228)
Q Consensus         2 ~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~   66 (228)
                      .+.+.+|...+.++ +|+||+.+++++.. +...++||||+++|+|.+++....             ....+++..+..+
T Consensus        60 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  139 (299)
T d1ywna1          60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY  139 (299)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHH
Confidence            35678888888887 68999999998765 456899999999999999986532             1234889999999


Q ss_pred             HHHHHHHHHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccc
Q 040501           67 IKGIAHALSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAK  144 (228)
Q Consensus        67 ~~~l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~  144 (228)
                      +.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++........  .....||+.|+|||++.+..++.+
T Consensus       140 ~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~  216 (299)
T d1ywna1         140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ  216 (299)
T ss_dssp             HHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc
Confidence            99999999999999   9999999999999999999999999999865433322  334578999999999999999999


Q ss_pred             hhhhhHHHHHHHHHhC-CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHH
Q 040501          145 CDVYSFGVLALEVIKG-KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTIC  223 (228)
Q Consensus       145 ~DiwslG~~l~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  223 (228)
                      +||||+||++|+|++| .+||.....     .......+..+..+..+   ...+.++.++|.+||+.||.+|||+++++
T Consensus       217 sDiwS~Gvil~ellt~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil  288 (299)
T d1ywna1         217 SDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELV  288 (299)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCC-----SHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cceeehHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9999999999999986 557653221     11111222222222211   23556789999999999999999999999


Q ss_pred             HHhh
Q 040501          224 QLLC  227 (228)
Q Consensus       224 ~~l~  227 (228)
                      +.|+
T Consensus       289 ~~L~  292 (299)
T d1ywna1         289 EHLG  292 (299)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=289.85  Aligned_cols=215  Identities=22%  Similarity=0.373  Sum_probs=179.1

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNND-------TSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      +..|.+|++++++++||||+++++++......++||||+.+|+|.+++...       .....+++..+..++.|++.||
T Consensus        67 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl  146 (308)
T d1p4oa_          67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM  146 (308)
T ss_dssp             HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHH
Confidence            356899999999999999999999999999999999999999999987642       2223468899999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC--ceecccccceeCCcccccCCcccchhhhhHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN--WTEFAGTYGYVAPELAYTMKVTAKCDVYSFGV  152 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  152 (228)
                      .|||+.   +++||||||+||+++.++.+||+|||++.........  .....+++.|+|||.+.+..++.++||||||+
T Consensus       147 ~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~  223 (308)
T d1p4oa_         147 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV  223 (308)
T ss_dssp             HHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence            999999   9999999999999999999999999999866443332  23346789999999999999999999999999


Q ss_pred             HHHHHHhC-CCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhhC
Q 040501          153 LALEVIKG-KHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLCK  228 (228)
Q Consensus       153 ~l~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  228 (228)
                      ++|+|++| .+||...      ........+.++..+..+   ..++..+.++|.+||+.||.+|||+.++++.|++
T Consensus       224 il~El~t~~~~p~~~~------~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         224 VLWEIATLAEQPYQGL------SNEQVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             HHHHHHHTSCCTTTTS------CHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             HHHHHHhCCCCCCCCC------CHHHHHHHHHhCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            99999998 4676432      333445555555444332   2456679999999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=287.23  Aligned_cols=217  Identities=24%  Similarity=0.309  Sum_probs=164.4

Q ss_pred             HHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q 040501            7 REITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC-   81 (228)
Q Consensus         7 ~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-   81 (228)
                      .|+..+..++||||+++++++.+..    .+|+||||+.+++|.+++++..    +++.+++.++.|++.|+.|+|+.+ 
T Consensus        46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~  121 (303)
T d1vjya_          46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV  121 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred             HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhh
Confidence            3455556789999999999997653    6899999999999999998643    889999999999999999999621 


Q ss_pred             ----CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccCC------cccchhh
Q 040501           82 ----IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTMK------VTAKCDV  147 (228)
Q Consensus        82 ----~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~Di  147 (228)
                          ..||+||||||+||+++.++.+||+|||++.........    .....||+.|+|||++.+..      ++.++||
T Consensus       122 ~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di  201 (303)
T d1vjya_         122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI  201 (303)
T ss_dssp             STTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred             hhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhh
Confidence                129999999999999999999999999999877544322    33467899999999987642      5678999


Q ss_pred             hhHHHHHHHHHhCCCCccccccccC---------CCchhhhhhhcCCCC-CCCchh--hhhhHHHHHHHHHHhhccCCCC
Q 040501          148 YSFGVLALEVIKGKHPRDFLSNVSS---------SNPNILVNEMLDPRL-PPLSVD--IRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       148 wslG~~l~~~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      |||||++|+|++|..||........         ............... +.....  .......+.+++.+||+.||++
T Consensus       202 ~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~  281 (303)
T d1vjya_         202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA  281 (303)
T ss_dssp             HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred             hhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhH
Confidence            9999999999999988754322111         111111122222222 111111  2345567999999999999999


Q ss_pred             CCCHHHHHHHhh
Q 040501          216 RPNMQTICQLLC  227 (228)
Q Consensus       216 Rpt~~~il~~l~  227 (228)
                      |||+.|+++.|+
T Consensus       282 Rps~~ei~~~L~  293 (303)
T d1vjya_         282 RLTALRIKKTLS  293 (303)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHH
Confidence            999999999886

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.8e-47  Score=285.89  Aligned_cols=217  Identities=22%  Similarity=0.307  Sum_probs=165.7

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.++++++||||++++++|...+..+++++++.++++..+....   ..+++..+..++.|++.||+|||+. 
T Consensus        44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-  119 (286)
T d1ob3a_          44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR-  119 (286)
T ss_dssp             CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC-
Confidence            367899999999999999999999999999999999999887776666543   3389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.+|++|||.+..............+++.|+|||.+.+.. ++.++|||||||++|+|++|
T Consensus       120 --~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G  197 (286)
T d1ob3a_         120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG  197 (286)
T ss_dssp             --TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             --cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence              999999999999999999999999999988765555555567889999999987654 68999999999999999999


Q ss_pred             CCCccccccccCCCc---------------hhhhhhh----cCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHH
Q 040501          161 KHPRDFLSNVSSSNP---------------NILVNEM----LDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQT  221 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~---------------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  221 (228)
                      +.||...........               .......    ......+........+..+.++|++||+.||++|||++|
T Consensus       198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e  277 (286)
T d1ob3a_         198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ  277 (286)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            999864321110000               0000000    000000011112345567899999999999999999999


Q ss_pred             HHH
Q 040501          222 ICQ  224 (228)
Q Consensus       222 il~  224 (228)
                      +++
T Consensus       278 ll~  280 (286)
T d1ob3a_         278 ALE  280 (286)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=286.96  Aligned_cols=197  Identities=20%  Similarity=0.335  Sum_probs=163.2

Q ss_pred             HHHHHHHHHhccC--CCccceeeeeeeecCeEEEEEEeecC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q 040501            4 EFLREITVLTEIR--HRNIVKFYGFCTHARHSFLVYEYLEN-GSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD   80 (228)
Q Consensus         4 ~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~   80 (228)
                      ++.+|+.++++++  ||||+++++++.+.+..|+|||++.+ +++.+++....   .+++..+..++.|++.||+|||+.
T Consensus        53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~  129 (273)
T d1xwsa_          53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC  129 (273)
T ss_dssp             EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4678999999996  89999999999999999999999975 57777776543   389999999999999999999999


Q ss_pred             CCCCeeecCCCCCceEEcCC-CceEEeecccccccCCCCCCceecccccceeCCcccccCCc-ccchhhhhHHHHHHHHH
Q 040501           81 CIPPIVHRDISSKNVLLDLE-YEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKV-TAKCDVYSFGVLALEVI  158 (228)
Q Consensus        81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~~~  158 (228)
                         |++||||||+||+++.+ +.+||+|||++......  ......||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus       130 ---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell  204 (273)
T d1xwsa_         130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV  204 (273)
T ss_dssp             ---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             ---CCccccCcccceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence               99999999999999854 79999999999865432  2345679999999999987765 56789999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                      +|..||.....            +.......    ....+.++.++|.+||+.||++|||++|+++
T Consensus       205 ~g~~Pf~~~~~------------i~~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         205 CGDIPFEHDEE------------IIRGQVFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HSSCSCCSHHH------------HHHCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCchH------------HhhcccCC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            99999864321            11111111    1234567899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=285.60  Aligned_cols=216  Identities=20%  Similarity=0.301  Sum_probs=164.2

Q ss_pred             HHHHHHHHHHhcc---CCCccceeeeeeee-----cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEI---RHRNIVKFYGFCTH-----ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHAL   74 (228)
Q Consensus         3 ~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l   74 (228)
                      ..+.+|+.+++.+   +||||++++++|..     ....++++|++.++++........  ..+++..+..++.|++.||
T Consensus        52 ~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL  129 (305)
T d1blxa_          52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGL  129 (305)
T ss_dssp             CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHH
Confidence            3567888888776   79999999999853     347899999998877655544332  3388999999999999999


Q ss_pred             HHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHH
Q 040501           75 SYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLA  154 (228)
Q Consensus        75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  154 (228)
                      +|||+.   ||+||||||+|||++.++.+||+|||.+...... .......||+.|+|||++.+..++.++||||+||++
T Consensus       130 ~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il  205 (305)
T d1blxa_         130 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF  205 (305)
T ss_dssp             HHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred             HHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHH
Confidence            999999   9999999999999999999999999998754322 234557889999999999999999999999999999


Q ss_pred             HHHHhCCCCccccccccCCC-----------------chhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCC
Q 040501          155 LEVIKGKHPRDFLSNVSSSN-----------------PNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRP  217 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  217 (228)
                      |+|++|..||..........                 .......................+..+.+||.+||+.||.+||
T Consensus       206 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  285 (305)
T d1blxa_         206 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI  285 (305)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc
Confidence            99999999986432111000                 0000000000111111111234566788999999999999999


Q ss_pred             CHHHHHH
Q 040501          218 NMQTICQ  224 (228)
Q Consensus       218 t~~~il~  224 (228)
                      |++|+++
T Consensus       286 sa~e~L~  292 (305)
T d1blxa_         286 SAYSALS  292 (305)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=280.47  Aligned_cols=212  Identities=21%  Similarity=0.339  Sum_probs=164.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC------eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR------HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALS   75 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~   75 (228)
                      .+.+.+|+++|+.++||||++++++|...+      .+|+||||+ +.+|..+....    .+++..+..++.|++.||+
T Consensus        61 ~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~  135 (346)
T d1cm8a_          61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLR  135 (346)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHH
Confidence            356889999999999999999999997554      579999999 56777777543    2899999999999999999


Q ss_pred             HhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccC-CcccchhhhhHHHHH
Q 040501           76 YLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTM-KVTAKCDVYSFGVLA  154 (228)
Q Consensus        76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l  154 (228)
                      |||+.   ||+||||||+||+++.++.+|++|||++......   .....+++.|+|||.+.+. .++.++||||+||++
T Consensus       136 ~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (346)
T d1cm8a_         136 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  209 (346)
T ss_dssp             HHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHHhC---CCcccccCcchhhcccccccccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence            99999   9999999999999999999999999999876533   3446789999999998764 468899999999999


Q ss_pred             HHHHhCCCCccccccccCC---------Cchh------------hhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCC
Q 040501          155 LEVIKGKHPRDFLSNVSSS---------NPNI------------LVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNP  213 (228)
Q Consensus       155 ~~~~~g~~p~~~~~~~~~~---------~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  213 (228)
                      |+|++|.+||.........         .+..            ....................+..+.+||.+||..||
T Consensus       210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP  289 (346)
T d1cm8a_         210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA  289 (346)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred             HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence            9999999998643211100         0000            000000111111111223455678899999999999


Q ss_pred             CCCCCHHHHHH
Q 040501          214 ESRPNMQTICQ  224 (228)
Q Consensus       214 ~~Rpt~~~il~  224 (228)
                      .+|||++|+++
T Consensus       290 ~~R~ta~eiL~  300 (346)
T d1cm8a_         290 EQRVTAGEALA  300 (346)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCcCHHHHhc
Confidence            99999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=280.99  Aligned_cols=210  Identities=24%  Similarity=0.301  Sum_probs=168.8

Q ss_pred             HHHHHHHHHHhccCC-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|++++++++| |||+++++++.+....+++|||+.+++|.+++.....   ++...+..++.|++.||.|+|+. 
T Consensus        73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~-  148 (322)
T d1vzoa_          73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL-  148 (322)
T ss_dssp             GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC-
Confidence            467799999999976 8999999999999999999999999999999876553   67889999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC-CceecccccceeCCcccccC--CcccchhhhhHHHHHHHHH
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS-NWTEFAGTYGYVAPELAYTM--KVTAKCDVYSFGVLALEVI  158 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~~~  158 (228)
                        |++||||||+||+++.+|.++|+|||++........ ......+++.|++||.+.+.  .++.++|||||||++|+|+
T Consensus       149 --~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell  226 (322)
T d1vzoa_         149 --GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL  226 (322)
T ss_dssp             --TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred             --CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH
Confidence              999999999999999999999999999986543322 23456789999999998764  3678999999999999999


Q ss_pred             hCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 040501          159 KGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN-----MQTICQ  224 (228)
Q Consensus       159 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~  224 (228)
                      +|..||........  .............+.    ....+.++.+++++||++||.+|||     ++|+++
T Consensus       227 tG~~PF~~~~~~~~--~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         227 TGASPFTVDGEKNS--QAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HSSCTTSCTTSCCC--HHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             hCCCCCCCCCHHHH--HHHHHHhcccCCCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            99999865433221  111222222222211    1245678999999999999999994     788875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=279.61  Aligned_cols=216  Identities=22%  Similarity=0.310  Sum_probs=163.3

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecC----eEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHAR----HSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .+++.+|+++|++++||||+++++++....    ..+++++++.+++|.+++...    .+++..+..++.|++.||+||
T Consensus        50 ~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yL  125 (345)
T d1pmea_          50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYI  125 (345)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHH
Confidence            357889999999999999999999986543    234444556688999999754    389999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCC---CceecccccceeCCccccc-CCcccchhhhhHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSS---NWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVL  153 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~  153 (228)
                      |+.   ||+||||||+||+++.++.+||+|||++........   ......+++.|+|||.+.. ..++.++||||+||+
T Consensus       126 H~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i  202 (345)
T d1pmea_         126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  202 (345)
T ss_dssp             HHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHH
T ss_pred             HHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCce
Confidence            999   999999999999999999999999999976543322   1344678999999998854 457889999999999


Q ss_pred             HHHHHhCCCCccccccccCCCch---------------------hhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccC
Q 040501          154 ALEVIKGKHPRDFLSNVSSSNPN---------------------ILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNN  212 (228)
Q Consensus       154 l~~~~~g~~p~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  212 (228)
                      +|+|++|..||............                     ............+........+.++.+++.+||..|
T Consensus       203 l~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  282 (345)
T d1pmea_         203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN  282 (345)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred             ehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC
Confidence            99999999998643221000000                     000001111111111122344567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 040501          213 PESRPNMQTICQ  224 (228)
Q Consensus       213 p~~Rpt~~~il~  224 (228)
                      |.+|||++++++
T Consensus       283 P~~R~ta~e~L~  294 (345)
T d1pmea_         283 PHKRIEVEQALA  294 (345)
T ss_dssp             TTTSCCHHHHHT
T ss_pred             hhHCcCHHHHhc
Confidence            999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=283.08  Aligned_cols=217  Identities=24%  Similarity=0.282  Sum_probs=161.4

Q ss_pred             HHHHHHHHHhccCCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            4 EFLREITVLTEIRHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         4 ~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      .+.+|++++++++|+||++++++|..      ..++|+||||++++++..+.........+++..+..++.|++.||+||
T Consensus        59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL  138 (350)
T d1q5ka_          59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  138 (350)
T ss_dssp             SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34589999999999999999999853      235799999998765444433222233489999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCccccc-CCcccchhhhhHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYT-MKVTAKCDVYSFGVLAL  155 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~  155 (228)
                      |+.   ||+||||||+|||++.++ .+||+|||++....... ......|++.|+|||.+.+ ..++.++||||+||++|
T Consensus       139 H~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~  214 (350)
T d1q5ka_         139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA  214 (350)
T ss_dssp             HTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             Hhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEE
Confidence            999   999999999999999775 89999999998765433 2344678999999998765 46899999999999999


Q ss_pred             HHHhCCCCccccccccC---------CCchhhhhhh----cCCCCCCC------chhhhhhHHHHHHHHHHhhccCCCCC
Q 040501          156 EVIKGKHPRDFLSNVSS---------SNPNILVNEM----LDPRLPPL------SVDIRGKVISIMEVAFLCLDNNPESR  216 (228)
Q Consensus       156 ~~~~g~~p~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R  216 (228)
                      +|++|+.||........         ..........    .....+..      .......+.++.+||.+||..||++|
T Consensus       215 el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  294 (350)
T d1q5ka_         215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR  294 (350)
T ss_dssp             HHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             ehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence            99999999864322110         0000000000    00011100      01122456678999999999999999


Q ss_pred             CCHHHHHH
Q 040501          217 PNMQTICQ  224 (228)
Q Consensus       217 pt~~~il~  224 (228)
                      ||+.|+++
T Consensus       295 ~ta~e~L~  302 (350)
T d1q5ka_         295 LTPLEACA  302 (350)
T ss_dssp             CCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=271.55  Aligned_cols=215  Identities=20%  Similarity=0.266  Sum_probs=170.5

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      .+++.+|+.+++.++||||+++++++......+++++++.++++..++....   .+++..+..++.|++.||+|||+. 
T Consensus        45 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~-  120 (292)
T d1unla_          45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR-  120 (292)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC-
Confidence            3578899999999999999999999999999999999999988888876543   378999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHHHHhC
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALEVIKG  160 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~~~~g  160 (228)
                        ||+||||||+||+++.++.+|++|||.+..............+++.|.|||.+.+.. ++.++||||+||++|+|++|
T Consensus       121 --~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g  198 (292)
T d1unla_         121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             --TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             --CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence              999999999999999999999999999988765555555566788999999887765 58899999999999999999


Q ss_pred             CCCccccccccCCCchhhhh---------------hhc-------CCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCC
Q 040501          161 KHPRDFLSNVSSSNPNILVN---------------EML-------DPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPN  218 (228)
Q Consensus       161 ~~p~~~~~~~~~~~~~~~~~---------------~~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  218 (228)
                      ..||........  ......               ...       ..............+..+.+|+.+||+.||++|||
T Consensus       199 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s  276 (292)
T d1unla_         199 GRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS  276 (292)
T ss_dssp             SCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence            999632111000  000000               000       00001111122345567889999999999999999


Q ss_pred             HHHHHH
Q 040501          219 MQTICQ  224 (228)
Q Consensus       219 ~~~il~  224 (228)
                      ++|+++
T Consensus       277 a~e~L~  282 (292)
T d1unla_         277 AEEALQ  282 (292)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=273.26  Aligned_cols=214  Identities=20%  Similarity=0.271  Sum_probs=159.9

Q ss_pred             hHHHHHHHHHHhccCCCccceeeeeeee--------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 040501            2 KKEFLREITVLTEIRHRNIVKFYGFCTH--------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHA   73 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~   73 (228)
                      .+++.+|+++|++++|+||+++++++..        ....|++||++.++++.......   ..+++..+..++.|++.|
T Consensus        53 ~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~  129 (318)
T d3blha1          53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNG  129 (318)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHH
Confidence            3568899999999999999999999854        34689999999877666554332   338899999999999999


Q ss_pred             HHHhhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCC----ceecccccceeCCcccccC-Ccccchhhh
Q 040501           74 LSYLHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSN----WTEFAGTYGYVAPELAYTM-KVTAKCDVY  148 (228)
Q Consensus        74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Diw  148 (228)
                      |.|||+.   ||+||||||+||+++.++.+|++|||++.........    .....+|+.|+|||.+.+. .++.++|||
T Consensus       130 l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw  206 (318)
T d3blha1         130 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW  206 (318)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence            9999999   9999999999999999999999999999766533221    2335689999999998765 588999999


Q ss_pred             hHHHHHHHHHhCCCCccccccccCCCchhhhhhhc--------------------CCCCCCCchh-----hhhhHHHHHH
Q 040501          149 SFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEML--------------------DPRLPPLSVD-----IRGKVISIME  203 (228)
Q Consensus       149 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~-----~~~~~~~~~~  203 (228)
                      |+||++|+|++|+.||.........   ....+..                    ..........     .......+.+
T Consensus       207 SlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  283 (318)
T d3blha1         207 GAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD  283 (318)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHH
T ss_pred             cCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHH
Confidence            9999999999999998642211100   0000000                    0000000000     0112445778


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 040501          204 VAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       204 li~~~l~~~p~~Rpt~~~il~  224 (228)
                      ||.+||+.||++|||++|+++
T Consensus       284 Ll~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         284 LIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHCcCChhHCcCHHHHHc
Confidence            999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-44  Score=272.04  Aligned_cols=217  Identities=18%  Similarity=0.244  Sum_probs=163.6

Q ss_pred             HHHHHHHHHHhccCCCc-cceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRHRN-IVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +++.+|+++++.++|++ |+.+..++.++...++|||++++ ++.+.+....  ..+++..+..++.|++.||+|||++ 
T Consensus        47 ~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~-  122 (299)
T d1ckia_          47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK-  122 (299)
T ss_dssp             CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC-
Confidence            46789999999997655 55556666788899999999954 5655554433  2389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeecccccccCCCCCC-------ceecccccceeCCcccccCCcccchhhhhHH
Q 040501           82 IPPIVHRDISSKNVLLDL---EYEAHVSDFGIAKFIQPDSSN-------WTEFAGTYGYVAPELAYTMKVTAKCDVYSFG  151 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  151 (228)
                        ||+||||||+||+++.   +..++++|||++.........       .....||+.|+|||.+.+..++.++||||||
T Consensus       123 --~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  200 (299)
T d1ckia_         123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG  200 (299)
T ss_dssp             --TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHH
T ss_pred             --CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecC
Confidence              9999999999999864   457999999999876543321       2345789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCccccccccCCCchhhhhhhcCCCCCCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          152 VLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRLPPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       152 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      |++|+|++|..||.....................  .+......+++.++.+++.+||+.||.+|||++++.+.|+
T Consensus       201 ~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             HHHHHHHHSSCTTCCCC-------HHHHHHHHHH--SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            9999999999999754433222221111111000  1111122356678999999999999999999999888775

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.3e-44  Score=270.79  Aligned_cols=216  Identities=18%  Similarity=0.235  Sum_probs=170.9

Q ss_pred             HHHHHHHHHHhccCC-CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 040501            3 KEFLREITVLTEIRH-RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDC   81 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~   81 (228)
                      +.+.+|++.++.++| +|++.+++++..+...++|||++ +++|.+++.....  .++..++..++.|++.||.|||+. 
T Consensus        45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~-  120 (293)
T d1csna_          45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK-  120 (293)
T ss_dssp             CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC-
Confidence            457889999999964 99999999999999999999999 6788888875443  389999999999999999999999 


Q ss_pred             CCCeeecCCCCCceEEcC-----CCceEEeecccccccCCCCC-------CceecccccceeCCcccccCCcccchhhhh
Q 040501           82 IPPIVHRDISSKNVLLDL-----EYEAHVSDFGIAKFIQPDSS-------NWTEFAGTYGYVAPELAYTMKVTAKCDVYS  149 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~-----~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  149 (228)
                        |++||||||+||+++.     ++.++|+|||+++.......       ......||+.|+|||++.+..++.++||||
T Consensus       121 --giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwS  198 (293)
T d1csna_         121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA  198 (293)
T ss_dssp             --TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             --CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHH
Confidence              9999999999999974     57899999999987643321       123457899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccCCCchhhhhhhcCCCC-CCCchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHHHhh
Q 040501          150 FGVLALEVIKGKHPRDFLSNVSSSNPNILVNEMLDPRL-PPLSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQLLC  227 (228)
Q Consensus       150 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  227 (228)
                      ||+++|+|++|..||........   ......+..... .+......++++++.+++..|+..+|.+||+++.+.+.|+
T Consensus       199 lG~~l~elltg~~Pf~~~~~~~~---~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         199 LGHVFMYFLRGSLPWQGLKAATN---KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHHHHHHSSCTTSSCCSCCH---HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             hhHHHHHHHhCCCcCCCccchhH---HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            99999999999999964332211   111111111000 1111112345678999999999999999999998887765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-43  Score=271.98  Aligned_cols=213  Identities=23%  Similarity=0.290  Sum_probs=164.0

Q ss_pred             hHHHHHHHHHHhccC-CCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 040501            2 KKEFLREITVLTEIR-HRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLH   78 (228)
Q Consensus         2 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh   78 (228)
                      ++++.+|+++|+.++ ||||++++++|..  ....++||||+.+++|....+      .+++..+..++.|++.||.|||
T Consensus        73 ~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH  146 (328)
T d3bqca1          73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH  146 (328)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh
Confidence            567899999999995 9999999999974  457999999999999877642      3899999999999999999999


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC-ceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHH
Q 040501           79 HDCIPPIVHRDISSKNVLLDLEY-EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALE  156 (228)
Q Consensus        79 ~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~  156 (228)
                      +.   ||+||||||+|||++.++ .++|+|||++....... ......+|+.|+|||.+.+.. ++.++||||+||++|+
T Consensus       147 ~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  222 (328)
T d3bqca1         147 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS  222 (328)
T ss_dssp             HT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             hc---ccccccccccceEEcCCCCeeeecccccceeccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHH
Confidence            99   999999999999998654 68999999998765432 234467899999999987654 7899999999999999


Q ss_pred             HHhCCCCccccccccC----------------------CCchhhhhhhcCCCCC------CCchhhhhhHHHHHHHHHHh
Q 040501          157 VIKGKHPRDFLSNVSS----------------------SNPNILVNEMLDPRLP------PLSVDIRGKVISIMEVAFLC  208 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~----------------------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~  208 (228)
                      |++|..||........                      ................      .........+.++.+||++|
T Consensus       223 ~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m  302 (328)
T d3bqca1         223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL  302 (328)
T ss_dssp             HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHH
T ss_pred             hccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHH
Confidence            9999999853321100                      0000000000000000      01112234566789999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 040501          209 LDNNPESRPNMQTICQ  224 (228)
Q Consensus       209 l~~~p~~Rpt~~~il~  224 (228)
                      |..||++|||++|+++
T Consensus       303 L~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         303 LRYDHQSRLTAREAME  318 (328)
T ss_dssp             SCSSGGGSCCHHHHHT
T ss_pred             ccCChhHCcCHHHHhc
Confidence            9999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=273.22  Aligned_cols=212  Identities=22%  Similarity=0.291  Sum_probs=157.3

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeee------cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTH------ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSY   76 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~   76 (228)
                      +++.+|+.++++++||||++++++|..      ...+|+||||+.++++....      ..+++..++.++.|++.||.|
T Consensus        61 ~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~  134 (355)
T d2b1pa1          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKH  134 (355)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999953      46889999999876555442      238899999999999999999


Q ss_pred             hhhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHHHHH
Q 040501           77 LHHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVLALE  156 (228)
Q Consensus        77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~  156 (228)
                      ||+.   ||+||||||+||+++.++.++++|||++...... .......+|+.|+|||++.+..++.++||||+||++|+
T Consensus       135 LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e  210 (355)
T d2b1pa1         135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  210 (355)
T ss_dssp             HHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             hhhc---ccccccCCccccccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence            9999   9999999999999999999999999988765533 23344578899999999999999999999999999999


Q ss_pred             HHhCCCCccccccccCC----------------CchhhhhhhcCC----------------CCCCCchhhhhhHHHHHHH
Q 040501          157 VIKGKHPRDFLSNVSSS----------------NPNILVNEMLDP----------------RLPPLSVDIRGKVISIMEV  204 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~l  204 (228)
                      |++|+.||...+.....                ............                ..+.........+.++.+|
T Consensus       211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  290 (355)
T d2b1pa1         211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL  290 (355)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred             HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence            99999998533211000                000000000000                1111222234467788999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 040501          205 AFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       205 i~~~l~~~p~~Rpt~~~il~  224 (228)
                      |++||..||++|||++|+++
T Consensus       291 l~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         291 LSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=272.16  Aligned_cols=212  Identities=20%  Similarity=0.307  Sum_probs=159.2

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeec-----CeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHA-----RHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYL   77 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l   77 (228)
                      +++.+|++++++++||||+++++++...     ...+++++++.+++|.+++..+    .+++..+..++.|++.||+||
T Consensus        62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~L  137 (348)
T d2gfsa1          62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYI  137 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHH
Confidence            5688999999999999999999998532     3445667778899999998643    389999999999999999999


Q ss_pred             hhCCCCCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCC-cccchhhhhHHHHHHH
Q 040501           78 HHDCIPPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMK-VTAKCDVYSFGVLALE  156 (228)
Q Consensus        78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~  156 (228)
                      |+.   ||+||||||+||+++.+|.++++|||.+.....   ......|++.|+|||...+.. ++.++|||||||++|+
T Consensus       138 H~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~  211 (348)
T d2gfsa1         138 HSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE  211 (348)
T ss_dssp             HHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred             HhC---CCcccccCCccccccccccccccccchhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence            999   999999999999999999999999999875432   234467889999999876654 5889999999999999


Q ss_pred             HHhCCCCccccccccCCCc-----------------hhhhhhhcC--CCCC--CCchhhhhhHHHHHHHHHHhhccCCCC
Q 040501          157 VIKGKHPRDFLSNVSSSNP-----------------NILVNEMLD--PRLP--PLSVDIRGKVISIMEVAFLCLDNNPES  215 (228)
Q Consensus       157 ~~~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~  215 (228)
                      |++|..||...........                 .........  ...+  .......+.+.++.+||.+||..||.+
T Consensus       212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~  291 (348)
T d2gfsa1         212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK  291 (348)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence            9999999864321110000                 000000000  0111  111112345667899999999999999


Q ss_pred             CCCHHHHHH
Q 040501          216 RPNMQTICQ  224 (228)
Q Consensus       216 Rpt~~~il~  224 (228)
                      |||++|+++
T Consensus       292 R~ta~elL~  300 (348)
T d2gfsa1         292 RITAAQALA  300 (348)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-37  Score=239.27  Aligned_cols=216  Identities=18%  Similarity=0.240  Sum_probs=154.2

Q ss_pred             HHHHHHHHHHhccC-----------CCccceeeeeeee--cCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHH
Q 040501            3 KEFLREITVLTEIR-----------HRNIVKFYGFCTH--ARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKG   69 (228)
Q Consensus         3 ~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~   69 (228)
                      +.+.+|+++++.++           |+||+++++++..  ....+.++.++..+..............+++..+..++.|
T Consensus        54 ~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~q  133 (362)
T d1q8ya_          54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ  133 (362)
T ss_dssp             HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHH
Confidence            45688999988875           4789999988864  3466677776655443333333333345889999999999


Q ss_pred             HHHHHHHhhh-CCCCCeeecCCCCCceEEcCCC------ceEEeecccccccCCCCCCceecccccceeCCcccccCCcc
Q 040501           70 IAHALSYLHH-DCIPPIVHRDISSKNVLLDLEY------EAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVT  142 (228)
Q Consensus        70 l~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  142 (228)
                      ++.|+.|||+ .   ||+||||||+|||++.++      .++++|||.+......   .....+++.|+|||.+.+..++
T Consensus       134 il~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  207 (362)
T d1q8ya_         134 LLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWG  207 (362)
T ss_dssp             HHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeecccccccccc---cccccccccccChhhccccCCC
Confidence            9999999998 6   999999999999998765      3899999998765432   2345789999999999998999


Q ss_pred             cchhhhhHHHHHHHHHhCCCCccccccccCCCchhhhhhh---------------------c-----CCCCCC-------
Q 040501          143 AKCDVYSFGVLALEVIKGKHPRDFLSNVSSSNPNILVNEM---------------------L-----DPRLPP-------  189 (228)
Q Consensus       143 ~~~DiwslG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------~-----~~~~~~-------  189 (228)
                      .++|+||+||++++|++|+.||..................                     .     ......       
T Consensus       208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (362)
T d1q8ya_         208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE  287 (362)
T ss_dssp             THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred             ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence            9999999999999999999998643221111110000000                     0     000000       


Q ss_pred             -----CchhhhhhHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 040501          190 -----LSVDIRGKVISIMEVAFLCLDNNPESRPNMQTICQ  224 (228)
Q Consensus       190 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  224 (228)
                           ........+.++.+||.+||..||.+|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             hhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 00112355678999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.78  E-value=1.4e-19  Score=127.67  Aligned_cols=130  Identities=17%  Similarity=0.148  Sum_probs=90.6

Q ss_pred             HHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            3 KEFLREITVLTEIRHRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         3 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      ..+..|...+.++.|.+++..+++..    .+++||++.+..+..          ++...+..++.|++.++++||+.  
T Consensus        59 ~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~--  122 (191)
T d1zara2          59 RSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR--  122 (191)
T ss_dssp             HHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC--
Confidence            34567899999999999998876532    369999998765433          33344567899999999999999  


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccccCCCCCCceecccccceeCCcccccCCcccchhhhhHHHH
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKFIQPDSSNWTEFAGTYGYVAPELAYTMKVTAKCDVYSFGVL  153 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~  153 (228)
                       |++||||||+||++++++ ++|+|||++.....+.... ....+... -.+ .....++.++|+||+.--
T Consensus       123 -giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~~~-~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         123 -GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE-ILERDVRN-IIT-YFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             -TEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTHHH-HHHHHHHH-HHH-HHHHHHCCCCCHHHHHHH
T ss_pred             -CEEEccCChhheeeeCCC-EEEEECCCcccCCCCCcHH-HHHHHHHH-HHH-HHcCCCCCcccHHHHHHH
Confidence             999999999999999654 8899999987654221110 00000000 001 113457889999998643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.6e-07  Score=66.92  Aligned_cols=102  Identities=17%  Similarity=0.152  Sum_probs=71.7

Q ss_pred             HHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 040501            4 EFLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHDCI   82 (228)
Q Consensus         4 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~   82 (228)
                      .+.+|...++.+. +--+.+++.++...+..++||++++|.++.+.....        .....++.+++..+..||+...
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~  126 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCC
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCc
Confidence            4678998888874 444678888888888999999999998776543211        1112344555555666664311


Q ss_pred             --------------------------------------------------------CCeeecCCCCCceEEcCCCceEEe
Q 040501           83 --------------------------------------------------------PPIVHRDISSKNVLLDLEYEAHVS  106 (228)
Q Consensus        83 --------------------------------------------------------~~i~h~di~p~nil~~~~~~~~l~  106 (228)
                                                                              ..++|+|+.|.||++++++.+-|+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lI  206 (263)
T d1j7la_         127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI  206 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred             cccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEe
Confidence                                                                    026999999999999987767799


Q ss_pred             ecccccc
Q 040501          107 DFGIAKF  113 (228)
Q Consensus       107 df~~~~~  113 (228)
                      ||+.+..
T Consensus       207 Dwe~a~~  213 (263)
T d1j7la_         207 DLGRSGR  213 (263)
T ss_dssp             CCTTCEE
T ss_pred             echhccc
Confidence            9987753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.23  E-value=2.1e-06  Score=61.67  Aligned_cols=99  Identities=17%  Similarity=0.116  Sum_probs=64.9

Q ss_pred             HHHHHHHHHhccCC--CccceeeeeeeecCeEEEEEEeecCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 040501            4 EFLREITVLTEIRH--RNIVKFYGFCTHARHSFLVYEYLENGSLSVILNNDTSAEELGWSRRINVIKGIAHALSYLHHD-   80 (228)
Q Consensus         4 ~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-   80 (228)
                      .+..|...++.+..  -.+.+++.+..+.+..++||++++|.++.+..        ....   ..+.++...+..||+. 
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~~---~~~~~l~~~la~LH~~~  118 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAPA---EKVSIMADAMRRLHTLD  118 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCHH---HHHHHHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccHH---HHHHHHHHHHHHHccCC
Confidence            46789999988843  33577788878888899999999886653311        1111   1122333333333321 


Q ss_pred             ------------------------------------------------------CCCCeeecCCCCCceEEcCCCceEEe
Q 040501           81 ------------------------------------------------------CIPPIVHRDISSKNVLLDLEYEAHVS  106 (228)
Q Consensus        81 ------------------------------------------------------~~~~i~h~di~p~nil~~~~~~~~l~  106 (228)
                                                                            .+..++|+|+.|.||+++.++.+-|+
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iI  198 (255)
T d1nd4a_         119 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFI  198 (255)
T ss_dssp             GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEEC
T ss_pred             hhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEE
Confidence                                                                  01126999999999999987767899


Q ss_pred             ecccccc
Q 040501          107 DFGIAKF  113 (228)
Q Consensus       107 df~~~~~  113 (228)
                      ||+.+..
T Consensus       199 D~~~~~~  205 (255)
T d1nd4a_         199 DCGRLGV  205 (255)
T ss_dssp             CCTTCEE
T ss_pred             Echhccc
Confidence            9987653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.36  E-value=0.00028  Score=53.68  Aligned_cols=29  Identities=17%  Similarity=0.312  Sum_probs=25.4

Q ss_pred             CeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           84 PIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .++|||+.+.|||++.++ ++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            689999999999998764 89999998765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.16  E-value=0.00025  Score=54.05  Aligned_cols=37  Identities=22%  Similarity=0.307  Sum_probs=26.5

Q ss_pred             HHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEeecCCCh
Q 040501            5 FLREITVLTEIR-HRNIVKFYGFCTHARHSFLVYEYLENGSL   45 (228)
Q Consensus         5 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   45 (228)
                      ..+|..+++.+. +.-.++++++|..    .+|++|+.|.++
T Consensus        91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            357999999884 5445677887754    478999887544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.10  E-value=0.00092  Score=49.05  Aligned_cols=31  Identities=23%  Similarity=0.223  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           83 PPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      .|++|+|+.++||+++.++..-++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3899999999999999887778999997753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.06  E-value=0.02  Score=41.90  Aligned_cols=30  Identities=20%  Similarity=0.128  Sum_probs=24.1

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecccccc
Q 040501           82 IPPIVHRDISSKNVLLDLEYEAHVSDFGIAKF  113 (228)
Q Consensus        82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~  113 (228)
                      +.+++|+|+.+.||+++.+  ..++||+.+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            3478999999999999743  34789998764